data_5ird_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ird _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 111.968 0.359 . . . . 72.340000000000003 111.968 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.81 148.87 90.21 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.633 2.222 . . . . 73.439999999999998 111.474 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.62 -37.53 40.82 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.785 0.661 . . . . 73.140000000000001 112.785 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.53 -51.92 56.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.198 0.523 . . . . 72.409999999999997 110.243 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -46.41 65.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.251 -0.886 . . . . 71.209999999999994 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.51 -50.15 68.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.566 -0.743 . . . . 75.109999999999999 110.785 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.55 -59.6 4.26 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.943 0.402 . . . . 71.0 111.301 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.62 77.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.182 -0.463 . . . . 42.509999999999998 111.224 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.98 -44.38 92.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.521 . . . . 73.140000000000001 110.837 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -68.46 -34.72 67.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.944 -0.391 . . . . 54.210000000000001 109.944 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.93 -43.32 91.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.695 -0.484 . . . . 74.200000000000003 109.695 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 44.7 mt-10 -66.46 -50.84 61.99 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.015 -0.539 . . . . 73.099999999999994 110.614 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -56.47 -44.24 80.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 111.044 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.0 mmt -62.68 -13.59 33.96 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.65 -0.705 . . . . 71.209999999999994 111.584 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 23.9 ttp85 -80.14 -30.64 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.394 -0.224 . . . . 75.140000000000001 110.394 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -99.8 -27.15 13.77 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.881 0.326 . . . . 70.299999999999997 111.881 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 22' ' ' ALA . 23.6 m -99.58 20.39 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.837 0.351 . . . . 63.310000000000002 111.658 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.2 p -128.0 171.5 16.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.628 -0.508 . . . . 71.25 109.628 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -107.31 90.86 6.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.356 -0.609 . . . . 72.299999999999997 109.356 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.99 -1.43 10.82 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.3 2.0 . . . . 64.420000000000002 111.444 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.45 -57.69 5.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.57 -0.741 . . . . 75.439999999999998 110.5 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.4 -10.02 14.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 75.510000000000005 110.235 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.11 52.84 2.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.205 -0.521 . . . . 74.239999999999995 113.124 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -112.45 141.78 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.749 -0.463 . . . . 71.319999999999993 109.749 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -122.37 112.55 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.987 -0.552 . . . . 74.299999999999997 109.685 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.0 m -54.81 -34.47 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.108 -0.497 . . . . 74.120000000000005 112.12 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.464 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 9.3 p -56.0 -30.66 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.447 -0.342 . . . . 71.129999999999995 111.322 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.11 -18.36 63.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.162 -0.472 . . . . 74.239999999999995 111.503 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.9 mm? -69.03 -12.54 61.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.443 0.64 . . . . 71.150000000000006 109.861 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.35 21.89 62.69 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 114.881 -1.054 . . . . 74.219999999999999 114.849 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' O ' HD21 ' A' ' 40' ' ' LEU . 3.3 tt -98.19 -31.71 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.902 -1.147 . . . . 74.200000000000003 107.902 164.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 26.0 t -65.69 -8.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.862 -1.063 . . . . 75.239999999999995 110.831 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -59.39 -26.11 64.85 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.073 0.464 . . . . 72.519999999999996 109.762 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.06 91.23 1.72 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.595 -0.729 . . . . 71.420000000000002 112.015 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.04 136.8 38.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.534 -0.543 . . . . 73.219999999999999 109.534 174.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.55 109.37 7.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.568 -0.53 . . . . 44.119999999999997 109.568 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 46' ' ' VAL . 17.2 m -94.24 108.75 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.693 0.758 . . . . 72.409999999999997 109.757 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -100.13 120.96 40.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.455 -0.793 . . . . 64.420000000000002 110.027 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -107.08 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.678 -0.49 . . . . 65.120000000000005 109.678 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.85 -163.75 12.54 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.216 -0.516 . . . . 72.519999999999996 112.003 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.9 -27.9 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.515 0.674 . . . . 74.109999999999999 109.692 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.43 -39.33 81.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.013 -0.994 . . . . 63.329999999999998 109.77 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.84 -171.82 43.49 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.682 -0.69 . . . . 54.299999999999997 111.852 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.2 m -124.48 104.42 8.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.379 -0.6 . . . . 64.099999999999994 109.379 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.4 p -114.99 124.26 71.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.346 0.593 . . . . 64.239999999999995 112.1 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -92.08 107.53 19.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.766 . . . . 71.140000000000001 109.993 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -87.64 130.32 34.82 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.636 -0.505 . . . . 62.140000000000001 109.636 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 59' ' ' MET . 45.1 mt -130.86 113.82 25.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.75 0.31 . . . . 63.530000000000001 110.622 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.36 116.5 20.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 72.420000000000002 109.723 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.495 ' HG3' HG21 ' A' ' 57' ' ' ILE . 81.9 mtp -134.61 170.85 15.17 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.326 0.584 . . . . 72.310000000000002 111.373 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -152.59 161.13 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.289 -0.869 . . . . 74.519999999999996 109.245 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.57 174.1 10.63 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.362 -0.607 . . . . 74.530000000000001 109.362 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.7 m -44.18 -42.43 6.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.483 0.489 . . . . 74.420000000000002 112.04 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -141.37 4.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.428 -0.351 . . . . 64.239999999999995 110.325 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.64 8.88 0.72 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.744 0.646 . . . . 64.239999999999995 112.744 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.73 15.06 15.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.224 0.535 . . . . 63.32 110.285 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 68' ' ' LEU . 35.1 m -91.46 144.2 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.756 . . . . 73.239999999999995 110.296 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 26.6 Cg_exo -64.66 10.38 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 123.346 2.697 . . . . 74.420000000000002 113.377 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.587 HD21 ' HB ' ' A' ' 71' ' ' VAL . 1.2 tt -75.08 -15.12 60.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.259 -0.645 . . . . 74.019999999999996 109.259 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -57.52 -45.76 84.6 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.651 -0.704 . . . . 62.130000000000003 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.51 -41.64 85.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.251 0.548 . . . . 74.120000000000005 110.253 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.587 ' HB ' HD21 ' A' ' 68' ' ' LEU . 60.3 t -63.4 -52.25 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.251 -0.886 . . . . 52.109999999999999 111.078 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.97 -41.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 120.779 -0.368 . . . . 72.209999999999994 111.13 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.23 -51.26 68.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.6 0.238 . . . . 73.340000000000003 110.803 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.84 -51.83 66.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 74.430000000000007 110.9 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -64.2 -43.97 93.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.356 -0.384 . . . . 72.329999999999998 111.146 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 -59.19 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 65.349999999999994 110.23 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -55.17 -45.95 75.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.552 -0.295 . . . . 71.409999999999997 110.83 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -55.16 -47.49 75.09 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.631 0.582 . . . . 74.25 111.131 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.3 -51.05 16.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.503 -0.317 . . . . 74.120000000000005 111.083 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.03 -39.62 82.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 111.377 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.87 -28.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.106 0.479 . . . . 52.43 109.882 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.07 -27.97 47.35 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.139 -0.553 . . . . 65.120000000000005 111.739 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 85' ' ' LEU . 19.4 m -70.93 -23.21 62.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.966 0.412 . . . . 74.040000000000006 110.461 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.09 -10.02 59.18 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.992 -0.549 . . . . 73.409999999999997 113.125 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 83' ' ' SER . 9.5 mp -61.51 -39.43 90.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.648 0.261 . . . . 62.240000000000002 110.652 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 m -143.39 152.29 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.12 -0.491 . . . . 75.019999999999996 109.752 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.12 -40.67 6.36 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 75.549999999999997 110.059 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 20.0 m-20 -102.99 139.43 38.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.923 -0.58 . . . . 72.25 109.9 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 9.4 pt -133.98 169.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.151 -0.685 . . . . 75.409999999999997 109.151 170.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 89' ' ' ILE . 22.8 mtt85 -156.35 106.61 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.134 -0.485 . . . . 64.340000000000003 109.837 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.73 113.46 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.819 -0.808 . . . . 71.140000000000001 108.819 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 103' ' ' LYS . 4.4 p-10 -105.53 140.69 38.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.981 0.419 . . . . 65.209999999999994 110.687 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.82 106.64 17.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.715 -0.675 . . . . 74.5 109.597 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG11 ' CD1' ' A' ' 99' ' ' TRP . 10.7 m -113.04 131.09 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 72.109999999999999 112.065 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -152.73 8.86 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.023 -0.989 . . . . 72.129999999999995 110.621 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -167.12 -60.05 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.586 0.354 . . . . 72.5 111.275 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 159.51 30.02 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.042 1.828 . . . . 75.120000000000005 113.097 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.7 137.07 37.72 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.053 2.502 . . . . 52.32 111.633 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.656 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 12.9 m-90 -53.88 109.79 0.51 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.724 0.64 . . . . 74.430000000000007 111.313 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.3 -78.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.862 -0.608 . . . . 63.399999999999999 111.817 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.59 -37.05 90.82 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.782 2.322 . . . . 64.540000000000006 111.375 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.54 -20.62 47.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.221 -0.899 . . . . 61.25 111.6 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.656 ' HZ3' ' HB3' ' A' ' 99' ' ' TRP . 54.4 mttp . . . . . 0 C--N 1.33 -0.249 0 N-CA-C 111.753 0.279 . . . . 70.439999999999998 111.753 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.377 0.51 . . . . 71.510000000000005 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.65 153.72 54.38 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.55 2.167 . . . . 72.200000000000003 111.209 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.6 -40.69 28.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.579 0.585 . . . . 51.240000000000002 112.579 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.54 -50.14 68.61 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.165 0.507 . . . . 73.140000000000001 111.086 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -81.29 -47.48 13.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 75.219999999999999 110.452 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.04 -48.33 70.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.949 -1.023 . . . . 61.219999999999999 112.463 -172.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 tp -54.63 -59.28 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.68 0.276 . . . . 74.239999999999995 110.866 -174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -65.36 -40.19 93.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 74.519999999999996 110.829 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.21 -48.94 79.6 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.807 -0.633 . . . . 60.219999999999999 110.668 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.447 HG22 ' HG2' ' A' ' 23' ' ' MET . 7.9 p -73.93 -32.79 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 70.230000000000004 109.675 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.1 -39.04 77.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.106 -0.497 . . . . 73.239999999999995 110.263 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 41.9 mt-10 -72.65 -51.7 18.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.429 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.99 -48.77 75.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 74.319999999999993 111.037 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.447 ' HG2' HG22 ' A' ' 19' ' ' VAL . 23.8 mmt -58.0 -13.55 4.85 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.51 -0.768 . . . . 62.520000000000003 111.832 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -87.97 -35.8 17.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.68 0.276 . . . . 74.140000000000001 110.584 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -90.15 -26.82 19.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.439 -0.346 . . . . 71.400000000000006 111.44 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 22' ' ' ALA . 29.7 m -98.12 27.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.92 0.391 . . . . 71.219999999999999 111.35 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.96 162.68 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 62.039999999999999 110.172 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -110.15 82.92 2.77 Favored Pre-proline 0 C--O 1.233 0.218 0 N-CA-C 109.071 -0.714 . . . . 54.530000000000001 109.071 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 14.38 2.07 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.736 2.291 . . . . 74.439999999999998 112.618 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.55 -58.34 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 72.129999999999995 110.145 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.481 ' HB2' HD12 ' A' ' 33' ' ' ILE . 87.9 mt -115.78 3.64 13.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 75.230000000000004 110.438 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.44 39.72 4.96 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.037 -0.602 . . . . 72.030000000000001 112.633 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 31' ' ' LEU . 3.7 mp -88.68 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.843 -0.799 . . . . 71.129999999999995 108.843 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 52.1 t-20 -143.83 120.14 10.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.102 -0.333 . . . . 74.530000000000001 110.102 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -59.83 -32.03 48.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 71.329999999999998 110.739 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.403 HG21 HG13 ' A' ' 41' ' ' VAL . 91.7 t -59.27 -26.41 33.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.897 -0.592 . . . . 62.350000000000001 110.566 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 8.3 t0 -59.2 -27.46 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.971 -0.559 . . . . 75.200000000000003 111.022 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.72 -8.41 57.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.755 0.312 . . . . 71.129999999999995 110.93 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.25 22.95 59.25 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.001 -0.545 . . . . 62.420000000000002 113.03 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.684 HD21 HG22 ' A' ' 94' ' ' VAL . 39.2 tp -93.3 -26.29 17.37 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.616 -0.343 . . . . 72.150000000000006 110.249 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG13 HG21 ' A' ' 36' ' ' VAL . 11.8 p -62.0 -12.19 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.924 -0.58 . . . . 72.230000000000004 110.824 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.94 -14.09 42.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.826 -0.624 . . . . 72.439999999999998 110.264 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.78 67.89 2.59 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.196 -0.761 . . . . 62.530000000000001 111.196 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.0 pp -120.96 141.77 50.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.103 -0.332 . . . . 64.099999999999994 110.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.03 110.77 1.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 71.340000000000003 110.185 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 38.7 t -93.66 126.06 46.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.441 -0.345 . . . . 74.219999999999999 110.304 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -121.35 133.06 55.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.428 -0.351 . . . . 75.430000000000007 110.662 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.2 p-10 -92.4 147.04 23.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.144 -0.687 . . . . 75.549999999999997 109.144 173.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.78 177.87 35.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.729 . . . . 62.539999999999999 112.171 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.08 -41.62 65.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.21 0.529 . . . . 74.400000000000006 111.059 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.54 17.73 9.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.54 -0.754 . . . . 73.040000000000006 111.701 -174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.41 174.91 17.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.151 -0.547 . . . . 73.219999999999999 112.981 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 13.9 m -102.79 109.15 20.64 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.126 -0.324 . . . . 74.219999999999999 110.126 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.73 135.97 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 75.209999999999994 111.168 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB3' HG13 ' A' ' 86' ' ' VAL . . . -93.78 105.02 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 61.310000000000002 109.917 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 103' ' ' LYS . 69.9 mt -70.97 113.39 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.538 -0.542 . . . . 73.030000000000001 109.538 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 63.9 mt -120.69 114.04 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.264 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -89.9 116.51 28.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.886 0.374 . . . . 75.409999999999997 110.188 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.1 mtp -125.57 170.66 11.25 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.538 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -137.67 150.43 47.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.915 0.388 . . . . 73.409999999999997 110.7 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.753 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 3.2 mm? -118.17 147.5 43.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.312 -0.996 . . . . 53.439999999999998 108.312 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 m -42.42 -51.74 4.85 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.614 0.598 . . . . 63.009999999999998 112.614 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 t -116.83 6.54 13.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.567 0.222 . . . . 71.120000000000005 110.723 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.22 8.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.282 0.475 . . . . 71.340000000000003 112.282 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.93 16.67 12.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.591 0.71 . . . . 75.209999999999994 109.324 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 61' ' ' LEU . 10.3 m -72.25 133.24 83.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.797 -1.092 . . . . 44.43 110.753 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.38 -3.45 13.01 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.453 2.102 . . . . 75.319999999999993 111.694 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.21 -0.39 36.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 75.209999999999994 111.195 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -62.54 -48.91 77.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.546 0.212 . . . . 73.099999999999994 110.551 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.255 0.55 . . . . 71.239999999999995 109.794 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 81.1 t -67.48 -52.61 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.78 -0.645 . . . . 73.549999999999997 110.912 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -68.31 -35.94 73.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 121.03 -0.268 . . . . 73.340000000000003 110.819 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' HD13 ' A' ' 72' ' ' ILE . 45.3 mt-10 -58.37 -50.67 72.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.351 -0.611 . . . . 73.430000000000007 109.351 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.07 -51.37 69.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.729 . . . . 64.129999999999995 111.112 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 23.7 mm-40 -60.87 -56.76 17.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.999 0.428 . . . . 75.140000000000001 110.781 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' HD21 ' A' ' 80' ' ' LEU . 32.4 t -61.27 -53.58 54.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.898 -0.592 . . . . 60.329999999999998 110.592 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HG2' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -57.02 -46.96 81.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.079 -0.509 . . . . 74.109999999999999 110.434 -176.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 t -58.93 -43.36 91.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 73.349999999999994 110.95 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.97 -51.56 17.88 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.944 -0.302 . . . . 72.25 110.869 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.523 HD11 HD13 ' A' ' 85' ' ' LEU . 4.5 mm? -56.12 -41.07 74.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.312 -0.404 . . . . 64.420000000000002 110.771 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.76 -27.8 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 63.409999999999997 110.467 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.43 -47.58 56.6 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.842 -0.695 . . . . 74.450000000000003 111.766 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -77.36 -22.91 51.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.865 0.364 . . . . 61.43 110.029 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.25 26.32 28.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.155 -0.475 . . . . 44.049999999999997 113.262 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 80' ' ' LEU . 83.0 mt -62.55 -33.92 75.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.156 0.503 . . . . 75.120000000000005 110.168 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 55' ' ' ALA . 5.0 m -147.06 164.82 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.574 -0.739 . . . . 74.120000000000005 109.734 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.95 -40.96 75.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 62.0 110.188 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -158.15 172.89 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.672 -0.862 . . . . 63.310000000000002 108.672 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.517 HG12 ' HG2' ' A' ' 77' ' ' ARG . 16.6 pt -131.95 145.09 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.889 0.376 . . . . 71.310000000000002 110.074 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 4.5 tpt180 -120.66 106.77 12.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.625 -0.509 . . . . 75.329999999999998 109.625 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.7 mt -88.66 140.86 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 65.319999999999993 110.675 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.659 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -118.7 127.48 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.407 -0.59 . . . . 71.430000000000007 109.407 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.436 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.3 m-90 -87.23 106.62 18.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.891 -0.411 . . . . 73.450000000000003 109.891 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.684 HG22 HD21 ' A' ' 40' ' ' LEU . 14.6 m -118.5 158.95 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.746 0.308 . . . . 75.450000000000003 110.557 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -177.68 -31.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 73.010000000000005 110.262 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.686 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 44.2 t30 -155.27 -49.2 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.911 -0.586 . . . . 74.409999999999997 110.168 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 5.6 Cg_exo -76.68 147.76 28.24 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.07 1.846 . . . . 61.32 110.687 169.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 14.7 Cg_exo -69.58 -163.97 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.775 2.317 . . . . 75.140000000000001 112.439 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.4 m-90 -89.84 124.4 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 73.120000000000005 110.942 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -113.48 0.3 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.181 -0.533 . . . . 61.329999999999998 112.213 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.39 -17.84 54.25 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.724 2.282 . . . . 75.019999999999996 111.568 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.537 ' HB2' ' ND2' ' A' ' 92' ' ' ASN . 7.0 m-20 -67.09 -3.92 8.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 71.439999999999998 111.373 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 35.8 mmtm . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.7 0.286 . . . . 71.510000000000005 110.319 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 111.742 0.275 . . . . 64.120000000000005 111.742 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 28.3 Cg_endo -64.49 -178.98 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.352 2.034 . . . . 65.530000000000001 111.836 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.6 -66.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.081 0.771 . . . . 60.32 113.081 -170.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -65.84 -41.07 92.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.504 -0.317 . . . . 75.25 111.543 -174.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -60.99 -39.4 89.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.412 . . . . 61.109999999999999 110.678 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.01 -43.38 91.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.286 -0.416 . . . . 70.140000000000001 110.349 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -57.71 -52.21 66.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 74.299999999999997 110.087 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.69 -51.96 67.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.725 -0.67 . . . . 73.310000000000002 110.94 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.6 -48.04 82.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.915 -0.584 . . . . 64.310000000000002 111.125 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.1 p -66.64 -32.97 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.131 -0.322 . . . . 72.230000000000004 110.131 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.28 -45.22 92.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.092 -0.336 . . . . 73.310000000000002 110.092 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.57 -51.56 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.205 0.526 . . . . 65.450000000000003 110.0 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.99 -47.38 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.407 -0.815 . . . . 71.209999999999994 110.889 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.4 mmt -62.54 -13.39 30.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.354 0.502 . . . . 60.530000000000001 112.354 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HA ' HH11 ' A' ' 24' ' ' ARG . 2.7 tpp180 -99.06 -13.8 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.142 -0.349 . . . . 74.439999999999998 111.059 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -119.52 -26.5 5.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.295 0.569 . . . . 63.539999999999999 110.411 -173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.08 -15.8 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.946 0.879 . . . . 73.310000000000002 109.805 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.95 163.77 2.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 114.917 -1.038 . . . . 74.439999999999998 109.67 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -104.0 91.86 4.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.453 -0.943 . . . . 52.210000000000001 108.453 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.01 -4.31 11.21 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.483 2.122 . . . . 63.030000000000001 111.944 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -69.02 -57.64 5.17 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.036 -0.529 . . . . 74.129999999999995 110.288 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.45 -17.49 17.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 71.439999999999998 110.546 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.82 43.34 3.62 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.026 -0.533 . . . . 73.120000000000005 113.351 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.0 mp -108.28 140.82 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.559 -0.534 . . . . 74.25 109.559 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.45 121.2 37.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 70.150000000000006 109.411 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.19 -27.38 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.972 -0.558 . . . . 73.430000000000007 112.014 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 p -62.19 -24.5 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.993 0.425 . . . . 72.420000000000002 110.817 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.94 -15.45 62.98 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.122 -0.49 . . . . 61.240000000000002 111.333 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.76 -16.67 61.75 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.039 0.447 . . . . 73.349999999999994 110.051 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.69 22.72 64.4 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.628 -0.715 . . . . 71.420000000000002 114.12 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -98.71 -31.35 11.95 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.143 -0.688 . . . . 73.109999999999999 109.143 170.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.47 -19.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.153 -0.93 . . . . 65.0 112.342 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.26 -23.81 16.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.786 0.327 . . . . 74.209999999999994 110.742 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.25 76.08 2.18 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.504 -0.638 . . . . 44.200000000000003 111.504 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -128.3 132.69 48.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 74.439999999999998 110.792 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -149.75 173.0 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.509 -0.922 . . . . 71.230000000000004 108.509 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 55' ' ' ALA . 20.5 m -137.2 142.63 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.791 -0.448 . . . . 75.450000000000003 109.791 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.02 121.01 43.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.987 -0.375 . . . . 63.43 109.987 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 112.43 15.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.116 -0.493 . . . . 74.109999999999999 109.819 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.07 158.34 14.53 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.064 -0.589 . . . . 41.32 112.273 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.32 -34.99 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.863 0.465 . . . . 63.43 111.377 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.63 -0.7 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 73.409999999999997 111.186 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.47 155.1 6.42 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.316 -0.468 . . . . 62.539999999999999 112.318 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -74.7 121.68 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.251 -0.277 . . . . 65.120000000000005 110.251 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.75 135.26 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 110.125 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HA ' HG13 ' A' ' 46' ' ' VAL . . . -98.8 124.48 43.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.398 0.142 . . . . 62.140000000000001 110.802 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.2 mt -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.168 -0.308 . . . . 74.219999999999999 110.168 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.476 HG22 ' HG3' ' A' ' 59' ' ' MET . 30.9 mm -126.28 112.72 30.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 120.686 0.279 . . . . 64.299999999999997 110.384 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m-20 -80.24 121.69 25.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.497 -0.557 . . . . 73.200000000000003 109.497 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 85.7 mtp -136.62 171.2 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.709 0.29 . . . . 70.129999999999995 110.63 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 40' ' ' LEU . 15.2 t -152.92 163.14 40.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.07 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.8 mt -132.47 160.35 36.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.314 -0.624 . . . . 73.319999999999993 109.314 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -48.02 -54.6 12.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.585 0.553 . . . . 63.009999999999998 112.117 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 t -111.64 -9.68 14.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.771 0.32 . . . . 54.240000000000002 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 63.68 8.4 3.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.86 -0.609 . . . . 74.540000000000006 112.194 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.38 10.48 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.605 0.717 . . . . 73.120000000000005 109.072 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.425 ' HB3' HD11 ' A' ' 68' ' ' LEU . 27.8 m -75.63 140.31 71.44 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 114.884 -1.053 . . . . 65.439999999999998 110.362 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.85 15.35 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.804 2.336 . . . . 70.129999999999995 112.81 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.0 mp -86.99 -5.78 58.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.38 -0.373 . . . . 74.209999999999994 110.459 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.6 t -61.58 -53.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.461 -0.336 . . . . 64.420000000000002 110.964 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.32 -27.65 67.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 74.409999999999997 110.266 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.512 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 70.0 t -65.01 -52.5 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.51 . . . . 55.039999999999999 110.369 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.565 HD11 ' HE1' ' A' ' 93' ' ' TRP . 2.8 pp -68.74 -29.58 44.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.637 0.256 . . . . 64.329999999999998 110.753 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' HD13 ' A' ' 72' ' ' ILE . 44.8 mt-10 -62.4 -48.16 80.95 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.409 -0.359 . . . . 75.310000000000002 110.131 173.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.87 -46.81 87.79 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.949 0.404 . . . . 74.439999999999998 110.419 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 96.6 mt-30 -55.53 -53.34 57.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.694 . . . . 74.049999999999997 111.143 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -68.04 -52.26 37.38 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.03 -0.532 . . . . 75.340000000000003 111.123 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -54.78 -46.38 74.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.652 -0.129 . . . . 63.439999999999998 110.652 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.2 p -60.27 -45.08 94.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.339 -0.392 . . . . 64.25 111.425 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.6 20.26 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.811 -0.355 . . . . 40.310000000000002 110.847 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.96 -29.49 70.85 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.884 0.373 . . . . 75.510000000000005 110.977 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -84.19 -27.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 54.329999999999998 109.925 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.5 -31.04 77.56 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.448 -0.661 . . . . 62.140000000000001 111.448 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 46.8 m -92.55 -10.02 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.379 . . . . 75.400000000000006 110.312 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.63 43.38 92.19 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.93 -0.577 . . . . 73.109999999999999 112.262 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 74.6 mt -86.43 -36.48 19.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.838 0.352 . . . . 74.530000000000001 110.9 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 55' ' ' ALA . 29.6 m -139.24 162.39 27.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.921 -0.581 . . . . 74.409999999999997 110.242 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.35 -37.28 28.53 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.855 0.36 . . . . 42.439999999999998 110.217 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.5 167.92 28.95 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.44 0.638 . . . . 53.43 110.715 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 55' ' ' ALA . 44.6 pt -124.44 135.55 63.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.42 -0.809 . . . . 73.409999999999997 110.689 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.526 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.81 106.32 16.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.276 -0.638 . . . . 54.43 109.276 171.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.32 120.02 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.782 -0.822 . . . . 74.430000000000007 108.782 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -111.5 129.93 55.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.87 -0.419 . . . . 73.129999999999995 109.87 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.565 ' HE1' HD11 ' A' ' 72' ' ' ILE . 4.8 m-90 -100.76 106.13 17.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 72.209999999999994 110.541 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.93 124.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 73.319999999999993 109.987 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -139.19 -6.93 1.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 74.140000000000001 111.845 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.429 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.5 t30 174.93 -52.82 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 122.409 0.283 . . . . 63.039999999999999 110.869 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 61.6 Cg_endo -70.55 145.75 53.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.739 1.626 . . . . 71.299999999999997 112.004 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.71 142.24 82.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.648 2.232 . . . . 74.310000000000002 111.647 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -46.63 109.24 0.18 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 123.691 0.619 . . . . 71.400000000000006 111.904 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -87.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.766 -0.652 . . . . 52.119999999999997 112.132 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.37 -30.49 80.76 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.928 2.419 . . . . 75.340000000000003 112.365 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -65.16 -10.67 33.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 73.129999999999995 111.18 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 C--O 1.235 0.336 0 CA-C-N 116.277 -0.42 . . . . 71.120000000000005 111.623 179.586 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 111.965 0.357 . . . . 74.510000000000005 111.965 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 44.0 Cg_endo -68.83 169.02 18.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.258 1.972 . . . . 52.43 111.992 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.48 3.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.43 0.9 . . . . 61.439999999999998 113.43 -172.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -63.92 -48.56 76.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.921 0.391 . . . . 63.020000000000003 111.001 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -63.34 -40.63 97.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.763 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.79 -46.36 88.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 73.25 110.14 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 tp -54.93 -55.37 31.36 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.41 -0.359 . . . . 63.020000000000003 110.998 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.987 -0.551 . . . . 74.219999999999999 111.292 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.3 -48.39 81.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.894 -0.594 . . . . 74.129999999999995 111.12 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.43 -33.83 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.928 -0.397 . . . . 74.120000000000005 109.928 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -58.96 -48.74 80.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.088 -0.338 . . . . 64.109999999999999 110.088 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.15 -45.61 73.08 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 74.129999999999995 110.839 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.15 -38.85 74.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 72.109999999999999 110.679 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.5 mmt -62.69 -12.68 25.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.606 -0.725 . . . . 72.239999999999995 111.563 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -85.79 -23.36 27.26 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.623 0.249 . . . . 72.450000000000003 110.82 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.63 -27.43 9.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.363 0.505 . . . . 74.040000000000006 112.363 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.5 m -95.92 21.11 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.22 0.533 . . . . 73.120000000000005 111.099 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 5.2 p -134.27 161.32 40.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 71.319999999999993 110.589 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.25 93.68 1.94 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.957 -1.127 . . . . 51.049999999999997 107.957 165.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 95.6 Cg_endo -82.93 -9.8 10.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.226 1.951 . . . . 72.230000000000004 111.392 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.5 -41.81 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.146 -0.934 . . . . 72.109999999999999 110.439 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.94 -18.56 11.24 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.276 -0.42 . . . . 74.329999999999998 110.377 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.86 44.02 3.45 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.224 -0.512 . . . . 74.239999999999995 113.655 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -121.64 141.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.965 -0.754 . . . . 61.25 108.965 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' OD1' ' HB ' ' A' ' 36' ' ' VAL . 8.7 p30 -107.73 141.85 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.771 -0.455 . . . . 74.239999999999995 109.771 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.77 -29.41 42.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.328 0.585 . . . . 72.450000000000003 110.747 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.505 ' HB ' ' OD1' ' A' ' 34' ' ' ASN . 43.8 t -60.11 -24.62 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.688 -0.687 . . . . 75.040000000000006 110.548 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -56.04 -28.93 59.48 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.503 -0.317 . . . . 72.319999999999993 111.254 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.13 -14.55 60.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.154 0.502 . . . . 75.310000000000002 110.504 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.65 22.17 52.22 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.218 -0.901 . . . . 73.120000000000005 114.024 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.0 tp -98.22 -29.69 13.05 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.329 -0.619 . . . . 44.130000000000003 109.329 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.45 -13.15 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.204 -0.907 . . . . 62.229999999999997 111.145 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.14 -23.26 62.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.06 0.457 . . . . 71.239999999999995 109.882 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 50.37 3.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.741 -0.663 . . . . 53.340000000000003 112.163 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' O ' HD11 ' A' ' 44' ' ' LEU . 4.2 pp -109.09 136.88 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.715 -0.476 . . . . 75.409999999999997 109.715 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -157.25 113.82 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 74.140000000000001 109.76 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.7 p -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.781 -0.452 . . . . 74.540000000000006 109.781 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -125.13 153.24 43.31 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.053 0.454 . . . . 74.120000000000005 110.314 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -81.34 151.86 27.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.557 -0.747 . . . . 73.209999999999994 110.387 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.57 159.77 33.04 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.074 -0.81 . . . . 73.439999999999998 111.074 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.14 -21.06 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.079 0.439 . . . . 62.509999999999998 110.929 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.01 -20.27 62.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.979 -0.748 . . . . 61.439999999999998 108.979 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.15 162.24 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.909 -1.041 . . . . 72.239999999999995 111.103 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -70.92 107.03 3.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.505 -0.924 . . . . 73.439999999999998 108.505 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.24 130.01 60.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 54.140000000000001 111.46 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.45 104.38 16.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 62.200000000000003 110.558 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -78.18 128.67 34.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.003 -0.74 . . . . 65.400000000000006 109.003 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 HG23 ' HG3' ' A' ' 59' ' ' MET . 43.0 mt -141.01 116.64 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.833 0.349 . . . . 64.439999999999998 110.686 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.41 122.76 30.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 75.209999999999994 109.726 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.467 ' HG3' HG23 ' A' ' 57' ' ' ILE . 87.2 mtp -135.63 170.56 15.78 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.4 0.619 . . . . 72.340000000000003 111.721 -174.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -161.97 150.16 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.104 -0.953 . . . . 65.439999999999998 109.39 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.59 148.46 22.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.738 -0.838 . . . . 73.319999999999993 108.738 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 -48.58 30.82 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.51 0.559 . . . . 64.319999999999993 112.51 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 t -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.677 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.52 8.33 1.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.762 -0.653 . . . . 73.030000000000001 112.003 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.22 3.81 10.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.211 0.529 . . . . 75.219999999999999 110.177 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.5 m -81.04 126.72 76.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.486 -0.779 . . . . 74.519999999999996 110.657 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.63 32.02 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.014 2.476 . . . . 65.030000000000001 112.346 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.02 6.61 18.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.044 -0.526 . . . . 74.019999999999996 110.794 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -56.94 -42.8 80.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 73.019999999999996 110.866 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.47 -41.31 98.69 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.401 0.62 . . . . 75.030000000000001 110.163 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.39 -46.5 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.234 -0.894 . . . . 70.109999999999999 110.857 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.17 -37.87 77.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 121.198 -0.201 . . . . 72.540000000000006 111.068 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.84 -49.6 77.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.219999999999999 110.683 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.08 -51.39 68.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 111.118 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -63.1 -38.55 91.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.43 -0.35 . . . . 71.040000000000006 111.816 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' HD22 ' A' ' 80' ' ' LEU . 61.6 p -67.22 -54.97 16.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.904 -0.406 . . . . 61.439999999999998 109.904 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -54.76 -41.6 70.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.968 -0.56 . . . . 72.219999999999999 110.932 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.8 m -54.89 -53.16 59.0 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.275 -0.42 . . . . 71.230000000000004 111.763 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -51.56 13.85 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.65 -0.42 . . . . 74.030000000000001 111.221 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -58.6 -37.9 76.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.046 0.451 . . . . 74.310000000000002 111.51 -173.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.8 t -82.34 -27.37 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.193 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.28 -47.26 91.68 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.303 -0.475 . . . . 34.219999999999999 112.496 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.6 m -87.54 -5.1 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.498 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.88 31.46 69.97 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.922 -0.581 . . . . 64.030000000000001 112.811 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 -38.21 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.029 0.442 . . . . 74.540000000000006 110.319 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 80' ' ' LEU . 20.6 m -128.39 159.48 39.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.94 -0.573 . . . . 53.119999999999997 110.049 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.7 -30.95 24.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.496 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -158.23 165.78 34.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.134 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.05 144.35 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.76 -0.459 . . . . 75.150000000000006 109.76 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -127.43 106.09 8.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.2 -0.667 . . . . 74.129999999999995 109.2 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.45 143.85 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 73.200000000000003 110.751 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.696 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -117.38 120.36 37.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.348 -0.982 . . . . 74.049999999999997 108.348 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -97.85 106.32 18.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.779 -0.452 . . . . 74.530000000000001 109.779 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.435 HG23 ' HE1' ' A' ' 99' ' ' TRP . 12.1 t -90.97 123.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.326 -0.397 . . . . 64.430000000000007 110.123 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -119.53 -24.13 6.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.809 -0.632 . . . . 73.400000000000006 109.592 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.525 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 49.7 t30 175.8 -49.7 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.095 -0.957 . . . . 61.520000000000003 110.418 -173.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 48.9 Cg_endo -67.59 145.17 69.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.818 1.679 . . . . 54.0 111.971 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.91 168.55 11.86 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.003 2.469 . . . . 73.540000000000006 112.485 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.435 ' HE1' HG23 ' A' ' 94' ' ' VAL . 10.8 m0 -69.54 165.46 20.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.945 -0.57 . . . . 73.450000000000003 111.222 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.11 -129.53 2.75 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.977 -0.556 . . . . 41.030000000000001 111.827 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.7 -9.63 19.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.859 2.372 . . . . 72.439999999999998 112.489 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.59 -15.39 58.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 110.77 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.696 ' HG2' ' HB2' ' A' ' 92' ' ' ASN . 52.3 mttp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-N 116.329 -0.396 . . . . 72.400000000000006 110.939 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 110.685 -0.117 . . . . 74.409999999999997 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 26.2 Cg_endo -62.55 153.43 71.52 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.241 1.96 . . . . 73.409999999999997 111.761 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.46 -44.63 12.48 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.878 0.696 . . . . 71.430000000000007 112.878 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -63.2 -51.63 65.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.999 0.428 . . . . 63.020000000000003 110.896 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.44 -44.25 79.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 72.329999999999998 110.611 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.49 -42.34 78.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 54.119999999999997 110.537 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 tp -55.91 -58.32 8.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 73.549999999999997 110.875 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.24 89.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.02 -0.536 . . . . 61.340000000000003 111.331 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.64 -48.03 81.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.009 -0.541 . . . . 74.010000000000005 110.871 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.13 -33.65 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 54.32 110.356 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.61 -49.81 73.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.024 0.44 . . . . 71.049999999999997 109.849 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.72 -48.47 71.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 74.310000000000002 110.513 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -37.66 73.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.853 -0.612 . . . . 72.010000000000005 111.758 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 mmt -71.22 -13.54 61.95 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.078 0.466 . . . . 63.32 110.051 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -101.61 0.74 36.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.511 -0.768 . . . . 74.540000000000006 111.372 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -119.46 -27.85 5.47 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.289 0.566 . . . . 74.200000000000003 110.063 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -92.39 -16.91 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.895 -1.048 . . . . 71.310000000000002 110.757 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 34' ' ' ASN . 9.3 p -84.83 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 54.409999999999997 110.33 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' HG23 ' A' ' 27' ' ' VAL . 17.7 t70 -104.45 87.82 1.88 Allowed Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 108.758 -0.83 . . . . 70.310000000000002 108.758 169.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 89.4 Cg_endo -84.98 -1.66 9.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.457 2.105 . . . . 75.040000000000006 111.071 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HG2' HD11 ' A' ' 31' ' ' LEU . 41.7 tt0 -68.58 -57.65 5.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.442 -0.799 . . . . 74.25 110.206 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD11 ' HG2' ' A' ' 30' ' ' GLU . 7.3 mp -98.95 -17.14 18.48 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.841 -0.429 . . . . 73.049999999999997 109.841 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.76 40.97 4.24 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.984 -0.553 . . . . 61.149999999999999 113.415 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.517 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.5 mp -108.9 140.18 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.343 -0.614 . . . . 71.140000000000001 109.343 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.572 ' N ' HD22 ' A' ' 34' ' ' ASN . 0.6 OUTLIER -108.67 138.17 45.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.229 -0.656 . . . . 64.109999999999999 109.229 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.11 -30.17 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.168 0.509 . . . . 63.409999999999997 110.678 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 34' ' ' ASN . 13.5 p -58.24 -24.39 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.798 -0.637 . . . . 74.329999999999998 110.655 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.62 -29.1 58.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.707 -0.678 . . . . 61.409999999999997 111.195 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.7 -17.06 61.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.913 0.387 . . . . 73.200000000000003 110.488 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.51 22.71 57.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.732 -0.667 . . . . 64.019999999999996 113.371 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 HG12 ' A' ' 94' ' ' VAL . 33.1 tp -98.06 -16.73 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 64.299999999999997 110.079 175.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.55 -15.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.898 -0.592 . . . . 74.430000000000007 111.298 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -70.04 -23.16 63.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.598 0.713 . . . . 74.329999999999998 109.121 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 58' ' ' ASP . . . -85.44 95.67 2.01 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.956 -1.02 . . . . 61.149999999999999 111.031 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -146.47 132.74 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.157 -0.683 . . . . 63.299999999999997 109.157 173.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.99 109.02 9.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.306 -0.628 . . . . 74.400000000000006 109.306 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 55' ' ' ALA . 16.1 m -93.56 115.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.276 -0.638 . . . . 74.209999999999994 109.276 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.8 124.27 42.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.191 -0.458 . . . . 72.129999999999995 110.531 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.29 89.13 5.5 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.729 0.776 . . . . 62.100000000000001 109.729 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.38 164.55 45.71 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.511 -1.222 . . . . 72.349999999999994 111.481 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.2 -37.04 69.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.001 0.429 . . . . 61.409999999999997 110.575 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.24 -39.66 71.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 75.319999999999993 110.079 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.48 -178.44 39.73 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.702 -0.681 . . . . 64.209999999999994 111.549 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.1 m -81.75 112.2 18.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.811 0.339 . . . . 73.120000000000005 110.62 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.39 124.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 74.010000000000005 109.866 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.483 ' HB2' HG13 ' A' ' 86' ' ' VAL . . . -88.54 106.34 18.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 73.540000000000006 111.083 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.97 101.97 14.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 74.109999999999999 109.913 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.486 HG21 ' HG3' ' A' ' 59' ' ' MET . 53.3 mt -96.93 132.31 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.567 -0.288 . . . . 73.239999999999995 110.617 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.2 m-20 -94.01 113.45 25.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.030000000000001 110.076 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 90.2 mtp -141.04 171.05 14.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 73.340000000000003 110.646 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -163.05 162.05 25.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 65.230000000000004 109.649 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.6 171.83 7.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.945 -0.761 . . . . 61.210000000000001 108.945 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -44.63 -56.76 4.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.118 0.485 . . . . 73.540000000000006 111.48 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.6 t -104.22 -2.28 25.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 64.430000000000007 110.672 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.85 8.82 2.63 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.917 -0.583 . . . . 64.099999999999994 112.033 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.88 -8.81 12.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.994 0.426 . . . . 63.520000000000003 110.47 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.426 ' C ' ' H ' ' A' ' 68' ' ' LEU . 8.0 m -57.49 139.82 80.47 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.459 -0.791 . . . . 74.230000000000004 111.004 -176.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.85 17.56 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.011 2.474 . . . . 71.430000000000007 112.788 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 66' ' ' CYS . 92.0 mt -89.33 -4.16 58.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 65.239999999999995 110.462 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -61.93 -54.01 47.72 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.329 -0.396 . . . . 70.439999999999998 111.339 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.98 -28.54 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 73.439999999999998 109.597 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 60.1 t -65.88 -52.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.49 -0.777 . . . . 75.530000000000001 110.52 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -69.02 -32.39 54.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 121.108 -0.237 . . . . 73.010000000000005 111.585 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.527 ' N ' HD13 ' A' ' 72' ' ' ILE . 8.5 mt-10 -64.5 -45.04 89.01 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.589 -0.444 . . . . 64.310000000000002 109.874 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.01 -49.12 77.94 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 74.150000000000006 110.764 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 95.3 mt-30 -56.82 -55.91 28.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.981 -0.554 . . . . 73.239999999999995 110.868 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -61.15 -53.23 59.57 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.94 -0.573 . . . . 73.540000000000006 110.798 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -56.12 -48.88 75.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.637 -0.256 . . . . 65.219999999999999 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -53.68 -50.58 65.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 64.340000000000003 111.161 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.74 14.21 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.694 -0.402 . . . . 71.409999999999997 111.556 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 89' ' ' ILE . 78.8 mt -60.96 -37.35 82.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 53.43 110.921 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.2 t -78.21 -27.73 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 64.120000000000005 110.145 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.5 -48.05 46.55 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.018 -0.611 . . . . 64.450000000000003 111.746 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -82.09 -23.13 35.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.134 0.492 . . . . 74.25 109.854 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.77 42.03 6.98 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.977 -0.556 . . . . 63.009999999999998 113.533 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 85' ' ' LEU . 6.2 mp -71.0 -38.27 72.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.975 0.417 . . . . 74.430000000000007 109.887 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 55' ' ' ALA . 31.5 m -137.1 170.02 18.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.61 -0.723 . . . . 74.219999999999999 110.011 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.19 -48.66 64.62 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.285 0.564 . . . . 70.230000000000004 109.556 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.4 -179.03 5.77 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.089 -0.959 . . . . 64.349999999999994 108.587 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 80' ' ' LEU . 35.1 pt -122.43 177.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.371 0.605 . . . . 75.230000000000004 111.167 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -155.56 106.01 2.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.496 -1.298 . . . . 74.219999999999999 107.496 170.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 73' ' ' GLU . 52.6 mt -95.56 101.25 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.609 -0.515 . . . . 74.450000000000003 109.609 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -88.78 139.93 29.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.712 -0.676 . . . . 52.130000000000003 109.364 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' MET . 3.3 m-90 -95.25 106.07 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.553 -0.536 . . . . 73.430000000000007 109.553 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.462 HG12 HD23 ' A' ' 40' ' ' LEU . 3.4 p -120.03 124.25 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.31 0.576 . . . . 73.439999999999998 110.175 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 1.1 p-90 -147.96 11.89 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.27 -0.877 . . . . 75.349999999999994 110.111 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.593 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 35.5 t30 -174.94 -60.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.968 -0.56 . . . . 74.420000000000002 111.347 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 85.0 Cg_endo -78.26 140.02 17.18 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.755 1.637 . . . . 42.049999999999997 112.528 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.56 151.84 51.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.662 2.241 . . . . 62.100000000000001 111.38 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -59.74 123.9 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 70.430000000000007 111.224 -172.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.54 -120.04 1.52 Allowed Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.003 -0.544 . . . . 64.129999999999995 111.765 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 -14.91 45.07 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.628 2.219 . . . . 74.340000000000003 111.66 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.47 -26.62 61.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.533 -0.758 . . . . 71.129999999999995 110.325 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 73.8 mmtt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 115.925 -0.58 . . . . 74.510000000000005 111.457 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.944 0.402 . . . . 72.230000000000004 112.023 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 14' ' ' GLU . 29.8 Cg_endo -66.01 168.61 15.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.469 2.112 . . . . 63.43 111.951 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.96 -67.22 0.27 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.184 1.179 . . . . 72.239999999999995 114.184 -167.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.82 -35.1 67.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 74.400000000000006 111.187 -172.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 20.0 mp0 -57.7 -46.84 83.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.591 -0.522 . . . . 74.329999999999998 109.591 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.8 -46.72 89.4 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.475 -0.784 . . . . 75.099999999999994 110.739 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.6 tp -52.79 -60.31 3.43 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.295 0.569 . . . . 54.350000000000001 110.874 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.44 69.28 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.702 -0.681 . . . . 73.030000000000001 111.091 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.86 -41.19 97.84 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.74 -0.664 . . . . 74.420000000000002 111.322 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.83 -35.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.575 -0.528 . . . . 62.439999999999998 109.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.19 -45.94 79.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.948 0.404 . . . . 74.219999999999999 109.966 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.37 -43.55 63.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 63.020000000000003 111.014 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.06 78.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.803 -0.635 . . . . 73.400000000000006 110.885 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -62.66 -13.44 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.579 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -87.28 -23.04 24.81 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.503 0.192 . . . . 65.340000000000003 111.428 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -116.01 -27.02 7.08 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.318 0.58 . . . . 73.129999999999995 110.11 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -27.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.032 -0.985 . . . . 62.32 110.101 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 34' ' ' ASN . 5.5 p -91.32 165.1 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 63.32 109.697 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.5 91.95 5.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.81 . . . . 74.040000000000006 108.812 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.9 -7.53 13.3 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.326 2.017 . . . . 75.019999999999996 111.178 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -68.67 -57.96 4.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 72.430000000000007 110.619 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.49 -18.61 17.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 75.120000000000005 110.241 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.21 52.12 1.94 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.247 -0.501 . . . . 64.310000000000002 113.173 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.8 mp -126.91 141.55 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.667 -0.494 . . . . 62.109999999999999 109.667 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' HA ' HG22 ' A' ' 27' ' ' VAL . 9.4 p30 -108.77 138.6 44.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.017 -0.734 . . . . 75.219999999999999 109.017 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.15 -36.25 50.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.161 0.505 . . . . 74.439999999999998 111.312 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.78 -24.93 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.931 -0.577 . . . . 74.409999999999997 110.875 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.2 -26.04 64.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.357 -0.383 . . . . 65.519999999999996 111.358 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.53 -15.34 63.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 75.219999999999999 110.588 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.64 22.38 46.15 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.71 -0.677 . . . . 63.049999999999997 113.949 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -22.66 16.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.825 -0.806 . . . . 74.439999999999998 108.825 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.77 -4.96 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.188 -0.914 . . . . 72.150000000000006 111.731 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -66.3 -19.08 65.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.066 0.46 . . . . 73.25 110.044 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.96 110.47 3.94 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.241 -0.744 . . . . 44.229999999999997 111.241 174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.9 pp -167.34 149.63 5.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.302 -0.258 . . . . 70.400000000000006 110.302 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -163.69 122.51 1.98 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.804 -0.443 . . . . 75.140000000000001 109.804 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -99.54 118.34 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 75.310000000000002 110.129 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -113.4 137.47 51.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.156 -0.474 . . . . 74.120000000000005 110.128 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -91.83 154.36 18.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 74.0 110.158 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.16 162.47 30.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.16 -0.543 . . . . 72.420000000000002 112.031 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.21 -29.48 70.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.126 0.489 . . . . 64.409999999999997 110.507 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.98 -24.5 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.765 -0.652 . . . . 71.239999999999995 109.907 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.53 15.21 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.044 -0.525 . . . . 44.219999999999999 111.925 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -93.68 120.41 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.881 -0.414 . . . . 72.109999999999999 109.881 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.2 p -115.62 131.58 67.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.218 0.533 . . . . 73.450000000000003 111.442 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -98.51 116.04 29.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.56 -0.746 . . . . 53.119999999999997 110.544 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 55.8 mt -96.44 117.4 30.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.088 -0.338 . . . . 71.439999999999998 110.088 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.486 HG23 ' HG3' ' A' ' 59' ' ' MET . 39.9 mm -115.09 118.05 57.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.717 -0.475 . . . . 74.400000000000006 109.717 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.39 118.63 28.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.531 -0.544 . . . . 64.209999999999994 109.531 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.486 ' HG3' HG23 ' A' ' 57' ' ' ILE . 71.9 mtp -141.02 170.92 14.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 45.32 111.364 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 t -147.13 175.16 10.94 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.944 -0.761 . . . . 61.520000000000003 108.944 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mm? -109.73 150.78 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.585 -0.524 . . . . 63.210000000000001 109.585 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.2 p -46.61 -54.8 8.73 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.616 0.572 . . . . 73.120000000000005 112.489 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 t -104.02 -1.38 27.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 73.510000000000005 110.627 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.3 1.43 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.058 0.543 . . . . 74.510000000000005 112.184 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.95 -17.46 8.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.279 0.562 . . . . 44.030000000000001 109.966 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 4.1 p -87.3 114.43 58.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 71.129999999999995 110.42 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 7.5 Cg_exo -72.83 73.78 2.95 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.996 2.464 . . . . 62.25 112.89 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.494 ' HB2' HD11 ' A' ' 61' ' ' LEU . 4.2 mm? -94.29 9.53 37.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.3 0.572 . . . . 74.109999999999999 109.81 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.478 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.1 t -60.25 -37.81 81.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.703 -0.68 . . . . 74.430000000000007 110.572 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.74 -53.32 59.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.137 0.494 . . . . 71.420000000000002 110.199 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 11.8 p -66.11 -46.37 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 74.109999999999999 111.01 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -62.61 -38.92 82.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.42 -0.512 . . . . 72.409999999999997 111.018 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.49 -43.38 90.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.011 -0.54 . . . . 62.020000000000003 110.71 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.84 -39.76 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.858 -0.337 . . . . 71.25 110.28 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 98.8 mt-30 -56.15 -52.59 63.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.07 0.462 . . . . 65.329999999999998 110.218 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.3 m -60.03 -52.18 66.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.697 -0.683 . . . . 74.349999999999994 110.627 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.588 ' O ' HG12 ' A' ' 81' ' ' VAL . 6.0 tmm_? -54.43 -52.91 60.29 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.852 -0.613 . . . . 71.019999999999996 111.0 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -52.85 -53.24 51.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.605 0.566 . . . . 63.329999999999998 111.535 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -52.51 11.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.259 -0.576 . . . . 64.200000000000003 110.995 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.74 -40.2 75.32 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.816 0.341 . . . . 72.519999999999996 111.441 -169.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 77' ' ' ARG . 4.8 p -89.31 -27.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 74.400000000000006 110.193 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.01 -24.92 70.4 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.646 -0.787 . . . . 71.540000000000006 111.658 -167.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.752 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 9.2 t -87.17 -11.85 48.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.224 0.535 . . . . 61.009999999999998 109.962 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.84 61.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.581 -0.736 . . . . 34.020000000000003 112.023 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.752 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 82.1 mt -74.39 -53.51 9.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.028 0.442 . . . . 72.329999999999998 110.415 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.501 HG12 ' HB3' ' A' ' 55' ' ' ALA . 33.4 m -124.91 165.91 21.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.986 -0.552 . . . . 64.140000000000001 110.611 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.66 -47.92 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 52.030000000000001 109.787 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 m-20 -135.11 169.7 17.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.634 -0.712 . . . . 53.210000000000001 110.65 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.2 pt -134.94 175.97 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.92 -0.582 . . . . 72.209999999999994 110.368 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 26.3 tpt180 -164.61 119.84 1.44 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.551 -0.75 . . . . 74.109999999999999 109.815 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 47.2 mt -97.12 123.28 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 73.319999999999993 110.009 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.498 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 26.6 t30 -93.89 115.0 27.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.851 -0.613 . . . . 63.240000000000002 109.539 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -84.39 106.22 15.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.582 -0.525 . . . . 72.129999999999995 109.582 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.418 HG21 ' HE1' ' A' ' 99' ' ' TRP . 28.0 t -93.93 124.13 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.639 . . . . 75.519999999999996 110.473 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -113.33 -20.62 11.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.030000000000001 110.801 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.416 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 t-20 -177.01 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.036 -0.529 . . . . 65.400000000000006 111.092 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.0 Cg_endo -64.1 151.39 85.54 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.137 1.891 . . . . 61.439999999999998 112.701 -172.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.44 157.15 52.26 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.627 2.218 . . . . 75.140000000000001 111.582 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.804 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 5.9 m0 -64.78 130.78 44.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.034 -0.53 . . . . 74.040000000000006 110.7 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.08 -120.95 0.59 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.728 -0.749 . . . . 73.549999999999997 113.415 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.5 -36.34 66.09 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.287 2.658 . . . . 75.25 113.638 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.3 -14.46 11.45 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.028 0.442 . . . . 60.130000000000003 111.247 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.804 ' HD2' ' HB3' ' A' ' 99' ' ' TRP . 36.3 mtpt . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 116.268 -0.423 . . . . 72.230000000000004 111.041 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 110.671 -0.122 . . . . 75.329999999999998 110.671 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.91 131.07 41.56 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.74 2.293 . . . . 62.43 111.731 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.29 -51.92 17.77 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.494 0.924 . . . . 64.299999999999997 113.494 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.68 -50.32 74.32 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.009 0.433 . . . . 71.140000000000001 111.043 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.62 -46.7 81.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 72.200000000000003 110.353 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.89 -36.55 84.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.919 -1.037 . . . . 74.340000000000003 111.209 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 tp -53.07 -55.31 24.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.172 0.51 . . . . 75.040000000000006 109.772 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.13 79.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 40.039999999999999 110.847 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.211 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.37 -34.35 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 71.219999999999999 110.211 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.04 -40.3 93.09 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.998 0.428 . . . . 71.25 110.025 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 24.8 mm-40 -72.26 -47.24 51.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.906 -0.588 . . . . 73.239999999999995 110.226 176.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.94 65.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.934 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.05 -13.65 7.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 111.579 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 63.1 ttt-85 -93.8 -29.44 15.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.596 0.358 . . . . 74.430000000000007 111.31 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.97 -5.14 10.07 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.215 0.531 . . . . 64.120000000000005 110.346 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 26' ' ' VAL . 99.9 t -107.01 19.95 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.505 1.145 . . . . 74.219999999999999 109.317 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.589 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 11.6 p -148.25 160.8 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.571 -1.195 . . . . 71.230000000000004 108.47 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.57 98.28 3.55 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.461 -0.57 . . . . 75.129999999999995 109.461 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 96.2 Cg_endo -87.68 -1.08 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.705 2.27 . . . . 74.409999999999997 111.655 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.6 -57.49 5.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 75.120000000000005 109.957 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.32 -14.56 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 75.5 110.654 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.97 47.76 2.59 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.182 -0.532 . . . . 71.409999999999997 112.981 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.2 mp -110.52 143.27 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 109.822 -0.436 . . . . 75.040000000000006 109.822 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.507 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.8 t30 -115.02 111.67 21.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.098 -0.501 . . . . 65.530000000000001 110.015 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.8 -39.68 72.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.28 0.562 . . . . 61.049999999999997 110.105 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.94 -24.57 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.508 -0.769 . . . . 73.310000000000002 110.598 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 25.3 t70 -64.43 -22.97 67.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.195 -0.457 . . . . 63.439999999999998 110.902 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.74 -8.6 56.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.185 0.517 . . . . 74.340000000000003 110.227 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.32 53.03 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.142 -0.935 . . . . 63.420000000000002 114.229 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 tt -98.23 -32.13 11.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.453 -0.573 . . . . 73.209999999999994 109.453 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.26 -11.0 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 65.230000000000004 110.217 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -64.07 -21.19 66.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.512 -0.767 . . . . 75.430000000000007 109.406 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.42 64.25 3.55 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.522 -0.763 . . . . 71.430000000000007 112.024 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 pp -107.66 142.31 37.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.899 -0.408 . . . . 74.430000000000007 109.899 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.3 118.86 4.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 74.450000000000003 109.088 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.59 123.93 56.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.757 0.313 . . . . 74.230000000000004 110.677 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.559 HE22 HD23 ' A' ' 56' ' ' LEU . 24.8 pt20 -97.74 120.9 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.255 -0.646 . . . . 53.450000000000003 109.255 175.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.07 129.75 56.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 64.329999999999998 110.348 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.89 167.7 28.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.221 -0.752 . . . . 71.0 111.221 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.6 -31.67 66.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.898 0.38 . . . . 72.420000000000002 110.687 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.44 -31.14 70.24 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.862 -0.608 . . . . 63.32 110.565 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.98 163.44 16.91 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 116.081 -0.509 . . . . 71.219999999999999 112.189 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.2 m -110.71 109.09 19.19 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.558 -0.534 . . . . 74.140000000000001 109.558 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.05 123.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 110.577 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -89.98 109.88 20.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.28 -0.418 . . . . 52.130000000000003 110.966 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.559 HD23 HE22 ' A' ' 47' ' ' GLN . 12.3 mt -91.23 107.43 19.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.749 -0.463 . . . . 73.239999999999995 109.749 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.6 117.61 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.094 -0.335 . . . . 72.450000000000003 110.094 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.36 122.04 26.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 110.247 -0.279 . . . . 72.239999999999995 110.247 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 83.5 mtp -141.17 170.88 14.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.428 0.632 . . . . 74.409999999999997 111.246 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.2 t -160.49 158.8 29.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 72.329999999999998 109.486 174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -99.89 160.74 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.985 -0.376 . . . . 75.109999999999999 109.985 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 m -45.92 -56.03 5.97 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.604 0.565 . . . . 65.349999999999994 112.405 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 m -103.0 4.58 37.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.934 0.397 . . . . 74.450000000000003 110.633 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.448 0.699 . . . . 71.430000000000007 112.398 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.42 2.45 10.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 73.219999999999999 110.048 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.596 ' HB3' HD12 ' A' ' 68' ' ' LEU . 14.1 m -81.66 120.93 79.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.391 -0.822 . . . . 74.430000000000007 110.389 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.13 33.44 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.921 2.414 . . . . 74.420000000000002 113.186 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 66' ' ' CYS . 9.0 mp -79.76 3.08 20.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.946 0.403 . . . . 73.329999999999998 110.616 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.8 t -57.37 -44.23 84.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.03 -0.532 . . . . 61.049999999999997 110.789 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.32 -41.44 69.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.222 0.534 . . . . 75.420000000000002 110.384 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.24 -52.71 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.36 -0.836 . . . . 71.530000000000001 110.668 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 69' ' ' THR . 33.3 pt -63.52 -39.69 86.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 120.824 0.345 . . . . 75.099999999999994 111.225 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.18 -49.96 72.22 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.936 -0.574 . . . . 74.049999999999997 110.323 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.77 -49.8 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.422 -0.353 . . . . 70.430000000000007 110.667 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -55.57 -58.94 5.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.743 -0.662 . . . . 51.399999999999999 111.773 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -52.66 52.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.071 0.463 . . . . 63.399999999999999 111.026 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -56.72 -49.52 74.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.761 -0.654 . . . . 64.409999999999997 110.731 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -54.0 -48.28 70.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.676 -0.693 . . . . 64.239999999999995 111.346 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.09 13.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.907 -0.317 . . . . 71.319999999999993 111.384 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 HD11 HG23 ' A' ' 89' ' ' ILE . 82.9 mt -61.05 -36.17 78.89 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.985 0.422 . . . . 70.219999999999999 111.162 -172.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.56 -27.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 60.409999999999997 110.033 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.71 -47.29 34.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.171 -0.538 . . . . 63.32 112.221 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.8 m -75.97 -23.12 55.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.1 0.476 . . . . 65.010000000000005 110.14 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 33.36 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.123 -0.56 . . . . 74.400000000000006 113.35 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.71 -44.33 67.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.87 0.367 . . . . 74.310000000000002 110.017 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 55' ' ' ALA . 31.1 m -135.91 166.82 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 71.510000000000005 110.36 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -41.69 74.66 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.583 -0.525 . . . . 72.040000000000006 109.583 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -167.11 175.91 7.2 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.224 -0.898 . . . . 73.530000000000001 109.146 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 80' ' ' LEU . 38.7 pt -120.19 178.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.6 0.714 . . . . 75.530000000000001 111.065 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -150.72 106.31 3.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.791 -1.095 . . . . 63.229999999999997 108.096 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.26 117.96 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.093 -0.706 . . . . 74.019999999999996 109.093 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -88.63 143.57 26.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.938 -0.574 . . . . 72.25 109.481 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -111.16 109.58 19.7 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.791 -0.818 . . . . 74.310000000000002 108.791 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 t -85.1 123.61 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 64.409999999999997 110.711 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -120.86 -21.07 6.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.318 -0.855 . . . . 74.450000000000003 109.769 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 36.9 t30 178.27 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.498 -0.773 . . . . 55.130000000000003 111.439 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 91.9 Cg_exo -44.44 131.91 9.48 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.795 2.33 . . . . 55.409999999999997 113.469 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 2.4 Cg_endo -82.25 41.97 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.446 2.764 . . . . 71.510000000000005 112.119 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.8 m0 63.42 -154.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.155 -0.475 . . . . 75.030000000000001 110.787 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 101' ' ' PRO . . . 97.07 -134.31 11.71 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.478 -0.649 . . . . 71.120000000000005 111.478 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 100' ' ' GLY . 27.8 Cg_endo -61.41 -22.54 74.82 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.442 2.094 . . . . 72.540000000000006 110.803 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.19 -12.85 22.32 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.791 -1.095 . . . . 54.0 111.06 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt . . . . . 0 C--O 1.224 -0.256 0 CA-C-N 116.408 -0.36 . . . . 72.430000000000007 111.162 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.384 0.135 . . . . 71.530000000000001 110.803 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 31.1 Cg_endo -63.1 152.18 80.91 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.558 2.172 . . . . 54.240000000000002 111.921 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.54 -47.88 63.25 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.953 0.723 . . . . 72.540000000000006 112.953 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.74 -46.03 88.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.614 0.245 . . . . 63.329999999999998 111.438 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 52.399999999999999 110.298 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' HD21 ' A' ' 15' ' ' LEU . 4.4 tt -54.15 -44.98 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.41 -0.813 . . . . 72.049999999999997 109.636 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 53.2 tp -54.04 -59.65 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.873 -0.603 . . . . 73.239999999999995 110.714 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -51.98 67.12 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.052 0.453 . . . . 64.140000000000001 111.122 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.73 -44.26 85.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.387 -0.824 . . . . 75.099999999999994 110.98 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.9 -38.41 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.781 -0.368 . . . . 61.140000000000001 110.821 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 16' ' ' LEU . 42.9 mt-10 -61.03 -44.03 98.01 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.96 -0.296 . . . . 72.420000000000002 110.623 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.91 -43.79 67.56 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.277 -0.569 . . . . 73.230000000000004 110.327 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -35.56 72.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 111.017 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.3 mmt -62.44 -12.53 22.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.829 -0.623 . . . . 74.239999999999995 111.93 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -72.01 -31.92 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.424 0.154 . . . . 71.209999999999994 111.344 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -115.31 -27.27 7.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.874 0.845 . . . . 54.549999999999997 109.54 -171.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 26' ' ' VAL . 62.4 t -90.21 55.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 109.496 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.2 p -173.02 170.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.19 -0.914 . . . . 74.319999999999993 109.575 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -110.61 91.94 13.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 54.409999999999997 109.102 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HD3' HG13 ' A' ' 27' ' ' VAL . 59.5 Cg_endo -82.92 0.35 9.68 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.286 1.99 . . . . 61.310000000000002 111.906 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.66 -57.83 5.13 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.18 0.514 . . . . 75.420000000000002 109.822 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.66 -18.49 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 73.349999999999994 110.187 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 52.02 2.5 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.044 -0.525 . . . . 54.310000000000002 113.148 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 33' ' ' ILE . 4.0 mp -128.42 140.76 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.968 -0.382 . . . . 73.430000000000007 109.968 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.9 t-20 -100.43 141.13 33.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 74.209999999999994 109.252 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.13 -35.32 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 63.100000000000001 111.675 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.11 -24.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.351 -0.386 . . . . 73.150000000000006 110.848 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.7 -21.62 66.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.043 -0.526 . . . . 74.329999999999998 111.275 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.87 -15.12 63.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.546 0.689 . . . . 74.239999999999995 109.98 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.18 22.08 66.74 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 114.844 -1.071 . . . . 55.229999999999997 114.356 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.9 tp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.28 0.562 . . . . 71.340000000000003 109.553 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.54 -4.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.206 -0.906 . . . . 65.319999999999993 111.637 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -70.36 -15.01 62.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.194 0.521 . . . . 73.200000000000003 109.777 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.95 66.65 3.82 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.284 -0.726 . . . . 62.399999999999999 111.284 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.1 pp -98.68 135.84 39.6 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.643 -0.502 . . . . 74.099999999999994 109.643 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.48 109.02 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.861 -0.792 . . . . 71.409999999999997 108.861 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -114.23 145.24 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 122.147 -0.346 . . . . 73.510000000000005 110.32 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -136.61 124.49 22.67 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 70.030000000000001 109.646 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.9 p-10 -91.59 88.54 6.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.566 0.698 . . . . 63.549999999999997 110.172 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.25 42.16 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.386 -0.825 . . . . 31.329999999999998 111.722 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -67.28 -18.17 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.793 0.33 . . . . 73.099999999999994 110.518 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -98.16 -21.03 16.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.222 -0.444 . . . . 73.510000000000005 111.375 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 131.69 1.83 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.807 -0.711 . . . . 42.119999999999997 112.648 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.9 m -85.33 109.07 18.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.791 -0.448 . . . . 73.420000000000002 109.791 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.6 p -115.23 133.6 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.079 0.466 . . . . 61.32 111.193 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -103.74 115.69 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.716 -0.674 . . . . 74.219999999999999 110.329 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.5 mt -96.91 129.61 44.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.218 -0.66 . . . . 64.230000000000004 109.218 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.9 118.59 49.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.234 -0.284 . . . . 72.430000000000007 110.234 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.55 116.2 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.010000000000005 110.494 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.5 ' CE ' HD13 ' A' ' 72' ' ' ILE . 26.0 mtm -134.93 170.83 15.29 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 111.216 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -160.06 146.16 15.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.489 -1.232 . . . . 74.409999999999997 108.012 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.502 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 87.8 mt -90.29 163.17 14.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.64 -0.504 . . . . 75.209999999999994 109.64 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -45.45 -47.61 13.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.18 0.437 . . . . 65.200000000000003 112.18 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -96.04 -17.96 20.57 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.156 0.503 . . . . 71.420000000000002 110.548 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.42 8.59 2.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.798 -0.637 . . . . 72.540000000000006 111.544 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.05 -3.7 13.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 73.099999999999994 109.973 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.433 ' HB3' HD13 ' A' ' 68' ' ' LEU . 23.3 m -69.75 123.91 89.55 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.608 -0.724 . . . . 74.400000000000006 110.042 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.18 35.08 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.04 2.493 . . . . 75.329999999999998 113.119 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.2 mp -98.04 13.65 30.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.578 -0.283 . . . . 73.230000000000004 110.685 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.2 t -55.07 -54.17 46.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.822 0.344 . . . . 71.450000000000003 111.29 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' N ' HG23 ' A' ' 69' ' ' THR . 28.3 t70 -65.71 -27.44 68.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 75.25 110.224 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 62.0 t -70.17 -52.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.986 -0.552 . . . . 64.530000000000001 110.681 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.619 HD11 ' N ' ' A' ' 73' ' ' GLU . 2.7 pp -64.07 -37.95 81.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.789 0.328 . . . . 64.25 110.259 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.619 ' N ' HD11 ' A' ' 72' ' ' ILE . 42.8 mt-10 -64.89 -42.23 94.96 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.163 -0.471 . . . . 70.299999999999997 110.521 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.42 -48.25 82.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 64.109999999999999 110.054 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.581 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 22.3 mm-40 -60.15 -46.76 88.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 110.198 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.59 -62.31 1.97 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.641 -0.709 . . . . 65.140000000000001 110.799 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -56.82 -43.73 81.31 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.354 -0.384 . . . . 75.219999999999999 111.687 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -60.02 -42.03 93.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 72.349999999999994 110.652 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 -50.97 16.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 62.049999999999997 110.671 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.459 HD11 HG22 ' A' ' 89' ' ' ILE . 83.1 mt -56.65 -37.46 70.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 111.348 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.89 -28.3 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 63.32 110.328 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.34 -34.58 60.68 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.721 -0.951 . . . . 63.439999999999998 110.721 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 m -81.8 -23.09 36.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.186 -0.507 . . . . 64.209999999999994 110.379 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.46 11.75 81.5 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.983 -0.553 . . . . 73.219999999999999 113.326 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.51 -41.03 93.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.604 0.24 . . . . 53.450000000000003 111.563 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 55' ' ' ALA . 23.8 m -136.29 170.21 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.482 -0.326 . . . . 73.099999999999994 110.77 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.64 -38.14 10.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 62.450000000000003 110.507 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 21.2 t70 -145.67 164.05 32.98 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.727 -0.67 . . . . 63.109999999999999 109.31 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 80' ' ' LEU . 19.6 pt -136.24 172.58 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.201 0.524 . . . . 73.239999999999995 110.532 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.9 tpm_? -160.83 106.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.531 -0.759 . . . . 70.120000000000005 109.541 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.459 HD11 ' HE1' ' A' ' 59' ' ' MET . 62.7 mt -90.74 110.48 22.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.017 -0.364 . . . . 74.239999999999995 110.017 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 5.6 t30 -88.55 125.11 34.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 72.420000000000002 110.173 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.3 m95 -89.77 112.99 24.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 73.239999999999995 111.066 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.13 123.93 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.367 -0.605 . . . . 74.239999999999995 109.367 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -153.69 8.34 0.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.492 . . . . 75.129999999999995 110.904 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.625 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 24.5 t-20 171.51 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.916 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 69.0 Cg_endo -84.68 149.78 11.3 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.047 1.831 . . . . 60.109999999999999 112.448 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 22.7 Cg_exo -65.42 166.44 19.48 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.599 2.199 . . . . 74.109999999999999 111.86 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.511 ' HB3' ' HZ1' ' A' ' 103' ' ' LYS . 3.9 m0 -64.19 109.93 2.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 75.540000000000006 110.333 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.02 -79.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.701 -0.761 . . . . 52.530000000000001 112.912 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.28 -58.59 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.792 2.328 . . . . 65.150000000000006 112.508 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.485 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 3.2 m-20 -66.29 -4.36 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 64.400000000000006 111.524 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HZ1' ' HB3' ' A' ' 99' ' ' TRP . 21.5 mmtp . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 111.752 0.278 . . . . 75.519999999999996 111.752 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 110.316 -0.253 . . . . 74.010000000000005 110.316 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 36.6 Cg_endo -65.47 153.24 79.13 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.822 1.681 . . . . 75.049999999999997 111.455 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.33 -32.53 49.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.302 -0.408 . . . . 71.340000000000003 111.952 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.57 -52.51 63.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 111.363 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.72 -39.14 70.31 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.688 0.28 . . . . 73.120000000000005 110.256 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.37 -46.39 86.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 64.439999999999998 110.08 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.16 -56.77 17.79 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.82 0.343 . . . . 70.140000000000001 110.831 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.88 67.4 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.987 -0.551 . . . . 45.119999999999997 111.04 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.55 -48.33 82.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.903 -0.59 . . . . 63.25 111.064 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' A' ' 23' ' ' MET . 2.4 p -66.95 -36.58 77.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.974 -0.291 . . . . 62.210000000000001 110.435 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.8 -47.24 86.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.96 -0.385 . . . . 63.049999999999997 109.96 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.75 -51.18 68.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 63.420000000000002 110.281 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.2 -49.78 71.05 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.667 -0.697 . . . . 72.129999999999995 110.766 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.9 mmt -61.16 -20.32 62.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.866 0.321 . . . . 73.409999999999997 111.866 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -101.38 -13.77 17.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 73.040000000000006 110.464 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' GLN . 8.6 t70 -119.43 -10.1 9.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.244 0.545 . . . . 74.150000000000006 109.845 -168.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -117.83 -19.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.525 -0.762 . . . . 53.219999999999999 110.501 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.6 p -77.83 163.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.513 -0.767 . . . . 75.340000000000003 110.577 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.07 87.65 1.11 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.279 -1.378 . . . . 44.399999999999999 107.279 166.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 51.6 Cg_endo -82.17 -9.35 11.66 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.158 1.905 . . . . 55.109999999999999 111.903 -172.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -56.94 6.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.817 -0.629 . . . . 74.150000000000006 110.463 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.87 -19.01 29.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.516 -0.311 . . . . 74.420000000000002 110.544 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.38 40.1 6.57 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 116.054 -0.521 . . . . 62.149999999999999 113.493 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -127.84 140.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 117.201 0.5 . . . . 75.209999999999994 110.22 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.407 ' HA ' HG23 ' A' ' 27' ' ' VAL . 21.2 t-20 -101.48 147.72 26.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.464 -0.939 . . . . 63.43 108.464 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.66 -36.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 73.430000000000007 111.118 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.71 -24.58 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 70.409999999999997 110.942 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.75 -28.04 63.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 111.231 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.72 -15.37 63.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.308 0.575 . . . . 64.5 110.268 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 57.53 21.92 43.73 Favored Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.037 -0.983 . . . . 73.040000000000006 114.015 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' HD11 ' A' ' 40' ' ' LEU . 2.6 tm? -98.78 -29.0 13.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.327 -0.99 . . . . 73.450000000000003 108.327 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 HG21 ' HG2' ' A' ' 59' ' ' MET . 16.4 t -69.82 1.74 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.629 -1.169 . . . . 75.219999999999999 111.75 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.423 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 60.2 m-85 -64.76 -22.74 67.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.319 -0.622 . . . . 75.340000000000003 109.319 171.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.39 72.35 1.94 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.388 -0.824 . . . . 73.209999999999994 112.209 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.52 121.28 44.65 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.072 -0.714 . . . . 73.409999999999997 109.072 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.42 108.88 7.88 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.028 -0.36 . . . . 74.219999999999999 110.028 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.65 126.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.621 -0.511 . . . . 73.310000000000002 109.621 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.66 136.18 46.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.684 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.19 148.2 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 73.340000000000003 110.705 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.51 40.77 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.803 -0.919 . . . . 53.329999999999998 110.803 175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.9 -18.62 63.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.433 0.616 . . . . 42.299999999999997 109.995 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.59 -31.74 71.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.44 0.638 . . . . 72.540000000000006 109.582 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.89 -163.64 24.77 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.1 -0.954 . . . . 21.010000000000002 111.094 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 p -93.21 118.85 31.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.849 0.357 . . . . 73.120000000000005 110.54 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.44 123.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.774 -0.454 . . . . 74.200000000000003 109.774 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -101.38 121.62 42.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.413 -0.358 . . . . 64.129999999999995 111.228 -175.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -98.84 129.52 45.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.918 -0.771 . . . . 73.239999999999995 108.918 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 59' ' ' MET . 58.1 mt -125.38 113.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 62.219999999999999 110.544 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.85 117.68 22.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.715 -0.476 . . . . 71.0 109.715 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 88.2 mtp -140.96 170.93 14.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 71.519999999999996 110.617 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -158.95 159.15 34.55 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.629 -0.714 . . . . 72.420000000000002 109.886 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.45 155.68 34.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.576 -0.898 . . . . 71.510000000000005 108.576 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -48.05 -59.79 3.11 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.406 0.441 . . . . 63.32 112.04 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 p -96.7 -13.61 22.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.416 -0.356 . . . . 74.420000000000002 110.977 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.87 8.66 3.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.755 -0.657 . . . . 64.420000000000002 111.51 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.18 -8.52 13.98 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.113 0.483 . . . . 72.049999999999997 110.697 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.577 ' HB3' HD11 ' A' ' 68' ' ' LEU . 62.9 m -67.73 136.13 92.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.636 -0.711 . . . . 70.420000000000002 110.626 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.76 36.0 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.104 2.536 . . . . 63.109999999999999 112.644 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 66' ' ' CYS . 8.6 mp -97.25 1.19 49.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.336 -0.393 . . . . 73.129999999999995 110.249 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -58.53 8.07 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 75.219999999999999 111.432 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.27 -27.08 68.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 75.109999999999999 109.893 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.04 -52.43 38.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.674 -0.694 . . . . 74.329999999999998 110.663 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 pt -64.14 -38.61 82.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.917 -0.313 . . . . 73.200000000000003 110.72 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 91' ' ' ILE . 3.4 mt-10 -63.33 -44.53 94.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.673 -0.239 . . . . 54.399999999999999 111.391 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.18 -51.11 70.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 60.530000000000001 110.427 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 25' ' ' ASP . 25.9 mt-30 -56.27 -52.35 64.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.873 -0.603 . . . . 51.409999999999997 110.806 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.5 t -62.11 -55.13 31.95 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.806 -0.634 . . . . 72.409999999999997 111.183 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -58.59 -41.49 85.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.779 -0.191 . . . . 74.340000000000003 110.94 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -56.12 -47.15 78.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.378 -0.374 . . . . 72.340000000000003 110.693 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.22 16.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 71.549999999999997 111.189 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.12 -38.87 80.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.865 0.364 . . . . 65.530000000000001 111.107 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.36 -27.92 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 64.120000000000005 109.97 175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.74 -47.31 56.58 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.123 -0.561 . . . . 75.25 111.706 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.8 m -73.25 -11.36 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 64.329999999999998 110.563 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.07 38.66 95.63 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.001 -0.545 . . . . 63.25 112.538 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.5 -33.21 19.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 74.219999999999999 110.729 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.502 ' HA ' ' OG1' ' A' ' 53' ' ' THR . 31.2 m -136.26 169.36 20.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.174 -0.467 . . . . 75.329999999999998 110.907 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.86 -41.73 6.07 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.44 . . . . 54.240000000000002 110.748 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -137.71 143.69 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.345 -0.613 . . . . 75.450000000000003 109.345 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.77 146.62 28.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.729 -0.471 . . . . 74.310000000000002 109.729 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 112.85 13.6 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.885 -0.413 . . . . 64.25 109.885 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 73' ' ' GLU . 56.1 mt -90.72 98.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.164 -0.68 . . . . 72.239999999999995 109.164 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.45 121.36 30.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.2 0.524 . . . . 74.5 109.887 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.565 ' HA ' ' O ' ' A' ' 59' ' ' MET . 2.9 m-90 -90.45 106.44 18.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.557 -0.747 . . . . 73.340000000000003 109.47 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.62 123.62 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.415 0.626 . . . . 65.310000000000002 110.138 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -136.97 -7.97 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 75.530000000000001 111.215 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -179.7 -55.68 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 O-C-N 123.1 0.25 . . . . 74.400000000000006 110.952 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -87.09 169.07 7.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.299 1.999 . . . . 62.439999999999998 112.402 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.38 159.51 19.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.485 2.123 . . . . 72.420000000000002 111.545 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -69.72 -22.04 63.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.549 -0.296 . . . . 70.340000000000003 110.759 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -39.53 -63.81 1.12 Allowed Glycine 0 C--N 1.338 0.688 0 O-C-N 123.803 0.689 . . . . 62.210000000000001 114.521 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -46.72 5.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.147 1.898 . . . . 75.239999999999995 111.949 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 -4.19 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 71.409999999999997 111.512 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm . . . . . 0 N--CA 1.463 0.215 0 N-CA-C 109.835 -0.431 . . . . 71.409999999999997 109.835 173.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.519 0.199 . . . . 71.040000000000006 111.513 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.87 152.14 52.27 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.439 2.093 . . . . 42.530000000000001 111.161 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.76 -42.37 7.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 73.439999999999998 112.679 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.2 -52.1 51.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.167 0.508 . . . . 71.019999999999996 110.274 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 -32.4 73.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 64.420000000000002 110.299 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -50.31 66.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.694 -0.685 . . . . 73.310000000000002 109.448 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.04 -51.82 67.75 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.991 -0.55 . . . . 63.530000000000001 110.768 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -60.95 -49.18 78.48 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.947 -0.569 . . . . 61.439999999999998 110.906 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -57.76 -48.53 79.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.703 -0.681 . . . . 64.25 110.857 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.0 p -68.77 -42.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 116.161 -0.472 . . . . 65.230000000000004 110.656 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -67.32 -37.68 83.72 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.577 -0.449 . . . . 71.329999999999998 110.805 -175.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.7 pt-20 -72.7 -46.44 53.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.601 -0.439 . . . . 71.209999999999994 110.529 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -59.49 -31.36 69.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.867 0.365 . . . . 62.299999999999997 110.755 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 13.2 mmt -62.97 -13.14 31.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.067 -0.515 . . . . 63.100000000000001 110.719 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -33.37 16.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.831 -0.622 . . . . 74.120000000000005 110.326 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 4.5 m-20 -85.51 -27.5 25.58 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.392 -0.367 . . . . 74.409999999999997 111.713 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 22' ' ' ALA . 35.0 m -113.37 42.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.715 0.769 . . . . 61.509999999999998 110.972 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 34' ' ' ASN . 8.9 p -144.13 159.93 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.317 -0.856 . . . . 71.209999999999994 110.135 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.05 89.88 2.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.535 -0.913 . . . . 45.420000000000002 108.535 167.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.09 -5.72 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.551 2.167 . . . . 74.140000000000001 111.924 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -68.68 -53.74 20.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.903 -0.589 . . . . 53.130000000000003 110.03 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.98 -16.76 16.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.097 -0.502 . . . . 62.409999999999997 110.295 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.81 40.76 4.87 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.175 -0.536 . . . . 51.229999999999997 113.237 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -106.91 140.04 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.154 -0.684 . . . . 70.230000000000004 109.154 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' N ' HD22 ' A' ' 34' ' ' ASN . 0.6 OUTLIER -114.26 124.92 53.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.082 -0.71 . . . . 73.129999999999995 109.082 178.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HA ' HD22 ' A' ' 38' ' ' LEU . 28.3 m -57.91 -28.65 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.44 . . . . 74.150000000000006 110.82 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 34' ' ' ASN . 10.3 p -57.77 -30.81 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.616 . . . . 74.530000000000001 111.186 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.25 -21.15 66.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.633 -0.258 . . . . 72.25 110.862 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -75.34 -16.53 60.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.101 0.477 . . . . 72.439999999999998 110.039 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.65 61.19 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.513 -0.767 . . . . 71.310000000000002 113.994 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 tp -96.06 -31.68 12.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.37 0.585 . . . . 73.140000000000001 109.688 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 36' ' ' VAL . 11.1 p -67.74 -11.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.493 0.663 . . . . 74.530000000000001 109.55 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -63.52 -27.14 69.06 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.273 -0.876 . . . . 73.019999999999996 108.805 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.57 68.59 2.95 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.672 -1.149 . . . . 63.219999999999999 111.098 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.52 HD11 ' O ' ' A' ' 44' ' ' LEU . 3.3 pp -115.27 138.45 50.93 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.105 -0.702 . . . . 74.25 109.105 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.25 108.99 3.84 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.355 -0.609 . . . . 71.109999999999999 109.355 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 45.9 t -89.17 114.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.616 -0.513 . . . . 62.439999999999998 109.616 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -97.46 133.06 42.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 74.209999999999994 110.702 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.46 68.8 10.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.93 -0.767 . . . . 71.409999999999997 108.93 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 164.68 53.79 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.376 -0.829 . . . . 54.299999999999997 112.868 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.78 -26.94 68.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.672 0.389 . . . . 75.099999999999994 110.43 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -81.85 -7.46 59.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 72.150000000000006 111.162 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.82 177.11 14.73 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 112.0 -0.44 . . . . 54.340000000000003 112.0 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 m -72.55 110.18 6.75 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.172 -0.307 . . . . 74.120000000000005 110.172 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.3 p -115.14 124.49 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.828 0.347 . . . . 54.310000000000002 110.716 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -86.95 107.3 18.32 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.31 -0.405 . . . . 43.149999999999999 110.653 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 90' ' ' ARG . 28.3 mt -87.57 105.08 17.08 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.449 . . . . 64.340000000000003 109.789 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.53 124.19 68.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 110.257 -0.275 . . . . 50.109999999999999 110.257 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.61 128.49 36.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 55.350000000000001 111.367 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 80.6 mtp -141.24 171.12 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.652 -0.704 . . . . 64.409999999999997 110.636 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -145.49 171.51 14.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.326 -0.397 . . . . 74.450000000000003 109.935 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -121.18 166.64 13.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.468 -0.567 . . . . 75.040000000000006 109.468 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.4 p -62.13 -60.28 3.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.87 0.367 . . . . 74.450000000000003 111.967 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -114.28 -8.09 12.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.318 -0.401 . . . . 73.109999999999999 110.749 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.35 8.84 4.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.903 -0.589 . . . . 74.319999999999993 111.912 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.9 -25.6 13.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.113 0.483 . . . . 61.350000000000001 110.22 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.5 m -79.14 138.13 56.54 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 115.598 -0.728 . . . . 74.150000000000006 110.351 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.89 50.57 2.82 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.867 2.378 . . . . 74.299999999999997 112.335 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.14 -9.31 59.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.376 -0.375 . . . . 71.129999999999995 110.673 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.8 t -60.19 -43.4 95.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.006 -0.543 . . . . 63.450000000000003 110.838 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.95 -42.28 79.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.368 0.604 . . . . 75.109999999999999 109.941 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -65.41 -52.5 51.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 114.942 -1.026 . . . . 62.520000000000003 110.615 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.67 -41.35 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.617 -0.265 . . . . 73.140000000000001 111.224 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.55 -47.77 82.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.527 0.203 . . . . 54.020000000000003 110.671 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 35.8 t70 -59.71 -48.15 82.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 75.129999999999995 110.942 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 25' ' ' ASP . 18.2 mt-30 -62.51 -43.72 98.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 63.340000000000003 111.182 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.3 m -62.57 -55.22 29.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.258 -0.428 . . . . 71.329999999999998 110.689 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 6.9 ppt_? -57.04 -38.03 72.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.943 -0.303 . . . . 73.129999999999995 110.32 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.8 t -55.66 -53.71 53.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 111.184 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.59 -52.41 11.86 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.546 -0.462 . . . . 70.430000000000007 111.395 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -39.74 89.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.924 0.392 . . . . 73.25 111.55 -171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.23 -27.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 74.219999999999999 109.847 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.81 -45.83 56.12 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.832 -0.699 . . . . 42.43 111.622 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 p -75.9 -22.98 55.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.967 0.413 . . . . 70.420000000000002 110.195 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.13 45.34 41.01 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.87 -0.604 . . . . 74.109999999999999 112.107 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.26 -32.8 33.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 65.299999999999997 110.576 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 55' ' ' ALA . 28.2 m -141.18 165.51 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.646 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.35 -47.46 19.86 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.668 -0.493 . . . . 65.099999999999994 109.668 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 22.1 m-20 -133.54 158.14 43.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 65.099999999999994 110.475 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -111.46 164.92 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.102 -0.703 . . . . 72.129999999999995 109.102 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB3' HD22 ' A' ' 56' ' ' LEU . 14.5 tpp85 -153.23 106.63 3.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.02 -0.272 . . . . 70.230000000000004 110.43 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.0 mt -94.31 131.03 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 75.140000000000001 110.071 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -107.9 131.73 54.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.951 . . . . 63.32 108.431 175.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.606 ' N ' HD22 ' A' ' 92' ' ' ASN . 2.7 m-90 -102.67 106.12 16.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.46 -0.57 . . . . 75.340000000000003 109.46 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.4 m -102.93 124.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.141 0.495 . . . . 74.209999999999994 109.711 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -111.27 -33.23 6.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 72.299999999999997 110.373 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.617 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 20.1 t-20 -171.71 -50.89 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.768 -0.651 . . . . 72.25 110.761 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 17.1 Cg_exo -68.33 157.78 60.37 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.296 1.997 . . . . 72.430000000000007 111.8 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.72 167.21 15.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.831 2.354 . . . . 51.399999999999999 112.402 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -62.56 142.85 57.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.68 -0.691 . . . . 72.420000000000002 111.371 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -120.21 0.53 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.143 -0.48 . . . . 72.140000000000001 111.966 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.0 -20.36 67.7 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.64 2.227 . . . . 44.409999999999997 111.266 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -5.54 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.905 -1.043 . . . . 74.510000000000005 111.753 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 57.2 mmtt . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.267 -0.272 . . . . 72.5 110.267 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.289 0.09 . . . . 73.420000000000002 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 12.0 Cg_endo -55.61 152.88 31.94 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.535 2.157 . . . . 72.439999999999998 112.147 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.86 -38.51 35.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.969 0.507 . . . . 61.350000000000001 112.365 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -68.2 -51.95 39.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 74.349999999999994 110.362 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.88 -45.99 80.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.541 -0.754 . . . . 73.430000000000007 110.324 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -55.19 -49.37 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.298 -0.864 . . . . 73.409999999999997 110.272 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.67 -53.72 47.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.771 -0.649 . . . . 73.239999999999995 110.903 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.2 74.37 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.546 . . . . 75.049999999999997 111.124 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 75.319999999999993 110.902 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' MET . 8.8 p -69.45 -32.67 53.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 110.085 -0.339 . . . . 54.119999999999997 110.085 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -62.17 -41.14 98.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.78 -0.452 . . . . 50.240000000000002 109.78 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 38.0 mt-10 -69.26 -43.91 72.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.066 -0.515 . . . . 72.129999999999995 110.342 174.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -45.17 77.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 63.409999999999997 110.434 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.72 -13.48 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.613 -0.721 . . . . 75.140000000000001 111.639 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 32.3 ttp180 -87.86 -32.66 18.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.832 0.453 . . . . 63.450000000000003 110.53 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -100.27 -26.93 13.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 112.17 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -84.96 3.01 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 43.25 111.063 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 34' ' ' ASN . 9.5 p -125.59 158.45 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.236 -0.653 . . . . 63.509999999999998 109.236 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -101.21 95.37 4.78 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.72 -0.844 . . . . 71.230000000000004 108.72 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 78.2 Cg_endo -83.08 -6.15 11.23 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.647 2.231 . . . . 74.409999999999997 111.926 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -69.04 -57.62 5.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.787 -0.642 . . . . 63.340000000000003 110.265 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.55 -18.68 21.2 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.272 -0.422 . . . . 72.329999999999998 109.95 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 48.76 4.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.675 -0.693 . . . . 54.210000000000001 113.365 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.408 ' N ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.91 145.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 117.144 0.472 . . . . 72.420000000000002 110.499 177.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.534 ' HB2' HG13 ' A' ' 36' ' ' VAL . 18.5 p-10 -112.86 107.21 15.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 74.319999999999993 111.789 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.43 -31.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.843 -0.617 . . . . 75.209999999999994 110.865 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.534 HG13 ' HB2' ' A' ' 34' ' ' ASN . 12.2 p -55.75 -25.04 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.881 -0.6 . . . . 74.340000000000003 111.399 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.05 -22.46 65.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.569 -0.287 . . . . 54.32 111.498 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.59 -23.35 65.94 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.103 0.477 . . . . 75.219999999999999 110.384 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.61 61.07 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.396 -0.82 . . . . 65.540000000000006 114.081 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.4 -32.09 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.332 0.566 . . . . 55.340000000000003 109.744 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.78 -14.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.491 -0.777 . . . . 63.43 110.254 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -65.97 -17.76 64.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.155 -0.929 . . . . 73.450000000000003 110.291 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.81 62.43 4.17 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.024 -0.534 . . . . 64.219999999999999 112.0 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 44' ' ' LEU . 1.9 pp -101.42 148.63 24.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 64.209999999999994 110.706 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -161.36 110.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.979 -0.378 . . . . 73.430000000000007 109.979 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.8 p -92.5 121.01 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 110.292 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -109.21 127.87 54.58 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.872 -0.603 . . . . 71.010000000000005 110.434 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -82.94 138.75 33.7 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.681 -0.691 . . . . 75.230000000000004 110.405 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.56 154.0 21.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.832 -0.907 . . . . 60.240000000000002 110.832 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -58.25 -36.9 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 72.219999999999999 110.719 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -78.5 -24.67 45.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.705 -0.679 . . . . 71.140000000000001 110.409 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.98 158.38 12.8 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.225 -0.512 . . . . 61.020000000000003 112.526 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.29 117.28 29.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.138 -0.319 . . . . 74.030000000000001 110.138 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 8.7 p -108.82 134.88 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.727 0.298 . . . . 72.450000000000003 111.081 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -100.76 110.39 22.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.511 -0.313 . . . . 72.329999999999998 110.638 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 90' ' ' ARG . 52.6 mt -84.85 137.92 32.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.119 -0.326 . . . . 74.310000000000002 110.119 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.482 ' HB ' HG12 ' A' ' 91' ' ' ILE . 62.4 mt -135.66 118.51 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.783 -0.451 . . . . 73.430000000000007 109.783 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.38 116.33 22.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 75.409999999999997 110.723 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 82.5 mtp -141.41 170.92 14.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.292 0.567 . . . . 62.310000000000002 111.46 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -150.23 176.69 10.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.366 -0.834 . . . . 62.219999999999999 108.801 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.52 145.67 47.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.624 -0.509 . . . . 74.209999999999994 109.624 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.7 p -52.53 -55.11 24.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 72.0 112.614 -172.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -99.84 -4.49 30.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 75.319999999999993 111.104 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.89 8.91 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.98 -0.554 . . . . 72.400000000000006 112.363 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.26 -35.91 3.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.951 0.405 . . . . 64.25 110.491 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -67.02 123.53 86.48 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.719 -0.673 . . . . 62.240000000000002 110.141 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.49 64.94 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.986 2.458 . . . . 73.409999999999997 113.055 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.89 -3.21 58.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.478 -0.328 . . . . 73.299999999999997 110.791 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 t -56.98 -44.97 83.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.321 -0.4 . . . . 73.040000000000006 111.168 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.95 -41.49 87.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.073 0.463 . . . . 72.230000000000004 110.152 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.93 -51.56 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.349 -0.841 . . . . 51.439999999999998 110.926 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.5 pt -64.01 -41.26 91.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 74.0 111.185 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' CD ' HH22 ' A' ' 90' ' ' ARG . 1.8 mm-40 -68.78 -38.21 79.85 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.525 -0.307 . . . . 75.010000000000005 111.162 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.62 -46.69 71.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.988 -0.285 . . . . 73.219999999999999 110.561 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.12 -41.54 94.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.484 0.183 . . . . 70.439999999999998 110.53 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 t -61.15 -52.38 65.1 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.451 -0.574 . . . . 54.020000000000003 109.451 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HD3' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -54.59 -40.28 68.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.534 -0.757 . . . . 74.239999999999995 111.424 176.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.433 ' N ' ' HD3' ' A' ' 77' ' ' ARG . 75.7 m -54.48 -53.04 59.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.415 0.15 . . . . 74.25 111.188 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.7 -51.47 14.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.995 -0.282 . . . . 41.399999999999999 111.499 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.31 -30.39 69.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.77 0.319 . . . . 72.120000000000005 111.408 -172.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.74 -27.61 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 71.540000000000006 110.053 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.57 90.69 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.31 -0.405 . . . . 32.219999999999999 112.371 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -102.65 -0.57 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 71.140000000000001 110.551 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.03 52.16 54.51 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.071 -0.513 . . . . 74.140000000000001 112.093 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.4 -30.49 69.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.708 0.289 . . . . 61.32 110.824 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.8 m -137.15 175.46 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.04 -0.527 . . . . 71.340000000000003 110.505 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.7 -37.68 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.111 0.481 . . . . 71.200000000000003 110.322 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 28.9 t70 -145.82 157.78 43.9 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.838 -0.619 . . . . 73.519999999999996 110.038 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.47 157.03 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.948 -0.389 . . . . 73.239999999999995 109.948 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.483 ' HA ' ' NH1' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -154.71 106.38 2.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.478 -0.328 . . . . 72.120000000000005 110.932 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' HB ' ' A' ' 57' ' ' ILE . 57.9 mt -93.54 113.53 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.181 -0.674 . . . . 74.209999999999994 109.181 171.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.512 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 2.5 p-10 -90.5 140.23 29.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.246 -0.65 . . . . 73.409999999999997 109.246 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.446 ' HA ' ' O ' ' A' ' 59' ' ' MET . 6.2 m-90 -107.35 106.76 17.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.49 -0.323 . . . . 74.530000000000001 110.314 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.15 124.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.141 0.496 . . . . 71.040000000000006 110.406 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -103.87 -43.57 5.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.216 -0.661 . . . . 75.439999999999998 109.216 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.591 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 m120 -164.77 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 114.468 -1.242 . . . . 75.019999999999996 109.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 27.7 Cg_exo -64.45 164.78 22.18 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.284 1.989 . . . . 72.340000000000003 111.561 173.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.14 -179.32 5.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.562 2.175 . . . . 75.409999999999997 113.065 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.512 ' HD1' ' ND2' ' A' ' 92' ' ' ASN . 4.7 m-90 -73.12 112.08 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.375 -0.83 . . . . 74.430000000000007 109.983 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.55 -115.45 1.49 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.974 -0.631 . . . . 64.030000000000001 112.12 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 -24.68 74.84 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.826 2.351 . . . . 64.109999999999999 112.074 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.44 -13.07 11.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.749 -0.66 . . . . 72.030000000000001 111.025 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 75.209999999999994 111.219 -179.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.82 0.343 . . . . 54.119999999999997 111.698 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 32.5 Cg_exo -55.89 143.37 82.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.505 2.137 . . . . 71.239999999999995 110.944 171.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.01 17.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.853 0.316 . . . . 51.350000000000001 111.853 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -62.73 -42.56 99.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.994 0.426 . . . . 70.040000000000006 110.845 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.59 -49.67 74.3 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.784 -0.644 . . . . 64.340000000000003 110.144 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 tp -54.44 -41.75 69.78 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.069 -0.969 . . . . 73.349999999999994 110.737 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 tp -53.39 -56.57 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 54.350000000000001 110.868 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.2 -51.97 52.53 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 116.086 -0.506 . . . . 64.019999999999996 111.242 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.47 -44.92 95.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.637 -0.711 . . . . 74.420000000000002 111.202 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 15' ' ' LEU . 3.3 p -71.49 -33.54 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.015 -0.365 . . . . 73.430000000000007 110.015 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.85 -51.57 68.51 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.992 0.425 . . . . 62.530000000000001 109.956 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.32 -39.33 68.29 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.096 -0.502 . . . . 62.530000000000001 111.373 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.23 79.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.158 0.504 . . . . 25.140000000000001 110.567 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.56 -13.31 58.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 73.430000000000007 111.069 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -97.71 -7.31 31.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.768 0.318 . . . . 74.030000000000001 110.639 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.55 -27.56 5.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.333 0.587 . . . . 75.209999999999994 110.506 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -84.08 -26.29 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.903 -1.044 . . . . 55.039999999999999 110.821 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.3 p -86.84 154.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.555 . . . . 75.450000000000003 109.881 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 12.4 t70 -86.29 102.3 2.69 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.861 -1.162 . . . . 74.219999999999999 107.861 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 5.9 Cg_endo -84.24 -10.05 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.857 2.371 . . . . 73.129999999999995 112.498 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.55 -56.54 7.96 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.028 0.442 . . . . 44.310000000000002 110.208 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.442 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 65.8 mt -93.98 -18.49 21.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 74.030000000000001 109.855 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.15 56.13 3.11 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.782 -0.644 . . . . 65.400000000000006 113.078 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.7 140.52 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.049 0.424 . . . . 74.530000000000001 111.085 179.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -102.11 138.33 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 72.140000000000001 109.545 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.69 -25.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.019 0.437 . . . . 73.019999999999996 111.292 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.77 -25.51 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.9 -0.591 . . . . 72.310000000000002 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.11 -21.94 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.771 -0.649 . . . . 73.420000000000002 111.679 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.43 -6.88 43.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.931 0.396 . . . . 74.230000000000004 110.89 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.81 22.82 54.95 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.633 -0.712 . . . . 43.140000000000001 114.15 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.89 -31.72 12.05 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.888 -0.412 . . . . 65.230000000000004 109.888 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.94 -13.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.62 -0.718 . . . . 75.230000000000004 110.246 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -56.73 -29.96 63.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.185 -0.916 . . . . 64.109999999999999 110.168 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.73 92.0 1.77 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.643 -0.708 . . . . 60.109999999999999 111.695 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.93 160.18 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.61 -0.347 . . . . 75.409999999999997 110.124 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.76 123.14 6.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 72.430000000000007 109.466 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.69 122.69 56.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.016 0.436 . . . . 74.239999999999995 110.171 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.542 ' NE2' HD12 ' A' ' 56' ' ' LEU . 40.7 mt-30 -97.69 120.36 37.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 71.030000000000001 109.727 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.36 83.45 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.732 0.777 . . . . 72.140000000000001 109.672 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.97 163.82 19.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 114.998 -1.001 . . . . 60.25 112.184 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -55.27 -40.03 70.52 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.181 0.515 . . . . 62.340000000000003 110.941 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -68.38 -30.54 69.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.653 -0.703 . . . . 63.340000000000003 110.664 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.31 154.99 7.79 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.966 -0.635 . . . . 63.130000000000003 112.41 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.8 m -85.78 102.33 13.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.936 0.398 . . . . 74.200000000000003 110.12 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 60.0 t -107.07 126.72 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.093 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.34 107.28 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 53.439999999999998 110.849 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.542 HD12 ' NE2' ' A' ' 47' ' ' GLN . 48.4 mt -82.12 131.89 35.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.469 -0.567 . . . . 73.010000000000005 109.469 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.475 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.1 mt -129.76 129.7 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.443 0.164 . . . . 74.109999999999999 110.623 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.09 114.56 26.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.693 -0.484 . . . . 61.310000000000002 109.693 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.839 ' HE1' HG21 ' A' ' 72' ' ' ILE . 82.9 mtp -141.03 170.76 15.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.622 0.725 . . . . 62.539999999999999 111.69 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.452 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 6.3 t -162.63 160.69 26.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.642 -1.163 . . . . 72.450000000000003 108.302 171.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -88.67 158.13 18.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.752 -0.462 . . . . 74.549999999999997 109.752 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -43.13 -52.92 5.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.968 0.507 . . . . 73.430000000000007 112.187 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -113.32 13.11 19.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 72.109999999999999 110.951 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.2 8.7 1.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.956 0.724 . . . . 64.239999999999995 112.956 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.36 11.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.45 . . . . 64.209999999999994 110.423 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.3 m -92.59 129.28 41.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 71.420000000000002 110.463 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.63 34.29 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.857 2.372 . . . . 73.430000000000007 112.061 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.73 HD21 ' HB ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -83.15 -11.34 58.01 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 74.310000000000002 109.974 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.581 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 10.2 t -49.92 -56.03 12.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.895 -0.593 . . . . 65.219999999999999 111.348 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' N ' HG21 ' A' ' 69' ' ' THR . 5.6 m-20 -56.59 -34.94 67.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.484 . . . . 74.329999999999998 110.46 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.73 ' HB ' HD21 ' A' ' 68' ' ' LEU . 47.2 t -70.93 -52.71 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 64.219999999999999 110.864 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.839 HG21 ' HE1' ' A' ' 59' ' ' MET . 0.3 OUTLIER -60.31 -43.03 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.33 0.586 . . . . 65.340000000000003 109.47 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 69' ' ' THR . 23.5 mt-10 -61.72 -53.57 54.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.123 -0.944 . . . . 73.439999999999998 110.871 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.05 -51.42 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.653 0.263 . . . . 71.420000000000002 110.891 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -55.83 -58.73 6.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.084 -0.507 . . . . 72.239999999999995 111.141 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.432 ' O ' HD21 ' A' ' 80' ' ' LEU . 43.4 t -65.06 -55.63 17.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 73.439999999999998 110.911 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.502 ' HG3' HG12 ' A' ' 89' ' ' ILE . 47.8 ttt180 -55.63 -52.84 62.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.304 -0.407 . . . . 73.239999999999995 111.281 -174.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -64.51 -33.95 77.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.814 -0.63 . . . . 70.549999999999997 111.006 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.0 -51.31 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.83 -0.348 . . . . 73.409999999999997 110.364 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 76' ' ' SER . 4.4 mm? -56.21 -44.4 79.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.214 -0.448 . . . . 72.099999999999994 111.015 -177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.18 -28.25 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.422 -0.353 . . . . 74.239999999999995 110.538 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.74 -23.47 55.82 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.03 -0.605 . . . . 62.43 111.983 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -94.41 -11.69 29.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 75.319999999999993 110.178 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.38 75.89 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.873 -0.603 . . . . 75.310000000000002 113.347 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.01 -33.67 76.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.961 0.41 . . . . 70.120000000000005 109.949 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.11 175.75 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.581 -0.736 . . . . 64.329999999999998 109.556 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.23 -50.97 10.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 71.319999999999993 110.181 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 37.2 t70 -167.54 169.79 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.937 -0.764 . . . . 65.150000000000006 108.937 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.502 HG12 ' HG3' ' A' ' 77' ' ' ARG . 18.0 pt -125.06 166.86 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.962 0.411 . . . . 60.240000000000002 110.914 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 19.8 ttm180 -152.38 113.25 4.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.698 -0.683 . . . . 75.540000000000006 109.247 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.417 HG12 ' HB ' ' A' ' 57' ' ' ILE . 67.7 mt -100.68 124.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 74.239999999999995 110.496 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -95.37 122.14 37.77 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.259 -0.645 . . . . 64.420000000000002 109.259 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.636 ' HH2' HD13 ' A' ' 72' ' ' ILE . 88.5 m95 -90.37 106.67 18.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.019 -0.537 . . . . 72.420000000000002 109.94 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 m -91.11 124.34 43.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.412 0.625 . . . . 75.420000000000002 111.395 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -112.15 -32.24 6.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 74.310000000000002 109.832 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.561 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 31.2 t30 -166.49 -51.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.362 -0.836 . . . . 73.430000000000007 110.53 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 43.5 Cg_endo -66.61 132.17 28.16 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.11 1.873 . . . . 63.140000000000001 112.005 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.73 81.66 2.5 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.566 2.177 . . . . 71.299999999999997 112.912 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 56.07 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.571 -0.74 . . . . 74.420000000000002 112.267 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.89 -113.14 0.76 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.214 -0.754 . . . . 73.209999999999994 111.214 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.77 -15.44 50.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.173 1.915 . . . . 64.129999999999995 110.599 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.39 -17.64 31.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.838 -1.074 . . . . 70.109999999999999 110.709 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 97.9 mttt . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 115.783 -0.644 . . . . 74.340000000000003 111.33 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.849 -0.426 . . . . 70.010000000000005 109.849 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . 81.8 Cg_exo -44.17 115.29 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.742 2.294 . . . . 73.120000000000005 112.137 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.41 -20.62 7.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.693 0.627 . . . . 40.219999999999999 112.693 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -71.13 -53.31 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 74.129999999999995 110.552 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 12.0 pt-20 -82.01 -30.88 31.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.988 -0.551 . . . . 64.150000000000006 110.702 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 10' ' ' ALA . 3.3 tm? -54.49 -37.04 64.81 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.668 -0.696 . . . . 55.25 110.577 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.22 -53.41 57.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.063 0.459 . . . . 75.120000000000005 110.168 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.55 -52.03 62.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 65.129999999999995 110.699 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.14 -44.01 92.03 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.184 -0.462 . . . . 63.140000000000001 111.571 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.7 p -67.27 -37.75 79.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.744 -0.465 . . . . 62.210000000000001 109.744 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.47 -35.58 79.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.802 0.334 . . . . 75.409999999999997 110.406 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 9.6 mm-40 -66.34 -51.07 60.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.319 -0.4 . . . . 70.239999999999995 110.349 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.7 83.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 110.599 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 22.3 mmt -58.78 -12.64 4.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.737 -0.665 . . . . 72.510000000000005 111.709 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -76.23 -25.48 55.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.597 0.221 . . . . 72.140000000000001 111.597 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.65 -27.54 5.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.141 0.496 . . . . 70.099999999999994 109.917 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 26' ' ' VAL . 58.9 t -81.51 51.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.153 -0.931 . . . . 51.43 109.4 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.522 HG11 ' HD3' ' A' ' 29' ' ' PRO . 9.6 p -171.56 162.89 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.706 -0.679 . . . . 72.239999999999995 110.628 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.43 91.28 9.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.422 -1.325 . . . . 61.420000000000002 107.422 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HD3' HG11 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -80.42 -3.77 12.7 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.128 1.885 . . . . 73.25 111.772 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.1 -57.63 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 74.219999999999999 110.055 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 31' ' ' LEU . 3.2 mm? -90.1 -16.75 29.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.725 -0.67 . . . . 73.549999999999997 109.894 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 40.55 6.62 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.867 -0.606 . . . . 45.229999999999997 113.5 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.52 140.27 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.107 0.479 . . . . 74.109999999999999 110.416 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.3 p-10 -116.63 115.04 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 74.349999999999994 110.274 -176.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -46.0 -32.45 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.465 0.542 . . . . 72.329999999999998 112.465 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.58 -24.81 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.223 0.453 . . . . 74.329999999999998 112.223 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.93 -15.33 62.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.468 0.175 . . . . 62.25 111.228 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.65 -17.16 62.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.205 0.526 . . . . 72.150000000000006 109.771 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.44 22.7 67.85 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.371 -0.831 . . . . 65.519999999999996 113.425 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.613 HD13 ' HA ' ' A' ' 59' ' ' MET . 3.0 tm? -97.46 -31.46 12.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.918 -1.141 . . . . 74.430000000000007 107.918 171.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.07 -7.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.235 -0.893 . . . . 63.450000000000003 110.409 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.12 -24.83 56.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 64.140000000000001 109.65 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.13 67.74 1.42 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 111.14 -0.784 . . . . 35.43 111.14 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -125.64 121.45 33.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.246 -0.65 . . . . 61.5 109.246 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -141.74 113.15 7.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.333 -0.618 . . . . 71.450000000000003 109.333 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 m -102.86 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.26 -0.644 . . . . 73.209999999999994 109.26 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -121.07 120.17 34.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.771 0.32 . . . . 74.430000000000007 110.28 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' HA ' HG21 ' A' ' 53' ' ' THR . 9.1 p-10 -94.11 88.24 5.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 72.0 109.658 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.36 159.17 24.98 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.414 -0.812 . . . . 50.130000000000003 111.869 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.88 -23.39 66.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.74 0.305 . . . . 74.310000000000002 110.717 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.36 -38.48 21.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 61.530000000000001 110.252 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.1 157.76 23.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.066 -0.587 . . . . 55.539999999999999 112.26 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 HG11 ' A' ' 86' ' ' VAL . 12.4 m -101.0 119.1 38.26 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.97 -0.381 . . . . 70.5 109.97 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 61.2 t -122.93 143.23 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.468 -0.333 . . . . 71.420000000000002 110.652 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.509 ' HB1' HG12 ' A' ' 86' ' ' VAL . . . -108.38 119.08 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 70.319999999999993 110.209 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.97 121.27 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.509 -0.552 . . . . 72.329999999999998 109.509 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.511 HG12 ' HG ' ' A' ' 44' ' ' LEU . 57.5 mt -125.2 138.61 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.82 -0.437 . . . . 63.399999999999999 109.82 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.563 ' OD2' ' HB3' ' A' ' 92' ' ' ASN . 42.7 m-20 -111.87 120.7 42.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.076 -0.342 . . . . 72.510000000000005 110.076 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.613 ' HA ' HD13 ' A' ' 40' ' ' LEU . 30.3 mtm -141.38 171.2 14.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.204 0.526 . . . . 75.409999999999997 111.538 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.42 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 12.1 t -154.45 147.26 24.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.249 -0.887 . . . . 74.540000000000006 109.957 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 85.0 mt -109.19 149.25 29.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.847 -0.797 . . . . 64.430000000000007 108.847 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -34.69 -49.84 0.43 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.755 1.02 . . . . 73.230000000000004 113.755 -170.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.7 t -119.57 0.2 10.96 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.293 -0.255 . . . . 73.340000000000003 111.207 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.32 8.4 1.59 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.29 0.478 . . . . 63.420000000000002 112.29 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.45 -5.33 18.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.304 0.573 . . . . 62.310000000000002 109.708 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.408 ' C ' ' H ' ' A' ' 68' ' ' LEU . 22.6 m -65.29 128.07 93.47 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.226 -0.897 . . . . 62.229999999999997 109.945 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.27 16.88 0.36 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.76 2.307 . . . . 71.409999999999997 113.129 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 66' ' ' CYS . 3.4 mm? -85.64 0.52 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 72.439999999999998 111.254 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 70' ' ' ASP . 11.6 t -58.24 -57.23 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.47 0.176 . . . . 72.540000000000006 110.614 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' N ' HG21 ' A' ' 69' ' ' THR . 11.3 t70 -68.18 -25.47 65.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.041 0.448 . . . . 70.030000000000001 110.171 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.22 -52.79 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.065 -0.516 . . . . 75.420000000000002 110.534 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.583 HD11 ' N ' ' A' ' 73' ' ' GLU . 2.6 pp -69.37 -33.77 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 121.043 -0.263 . . . . 65.109999999999999 110.608 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' N ' HD11 ' A' ' 72' ' ' ILE . 43.9 mt-10 -64.56 -45.07 88.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.699 0.285 . . . . 75.140000000000001 110.259 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.21 -51.0 69.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.162 -0.472 . . . . 62.520000000000003 110.881 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -57.22 -52.8 63.87 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.014 -0.539 . . . . 72.099999999999994 110.391 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.431 ' O ' HD22 ' A' ' 80' ' ' LEU . 34.8 t -56.49 -60.21 3.86 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.612 -0.722 . . . . 73.349999999999994 111.207 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -55.87 -42.42 75.87 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 121.257 -0.177 . . . . 74.129999999999995 111.007 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 t -62.16 -46.59 88.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.469 -0.332 . . . . 75.140000000000001 110.803 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.84 -51.43 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.878 -0.329 . . . . 74.200000000000003 110.237 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.505 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -56.51 -39.02 72.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 73.329999999999998 111.218 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.98 -27.47 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.471 -0.332 . . . . 63.039999999999999 110.302 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.78 -31.56 62.31 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.997 -0.841 . . . . 61.310000000000002 110.997 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -76.94 -22.09 53.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.027 -0.587 . . . . 45.32 110.329 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.58 74.0 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 116.088 -0.505 . . . . 73.450000000000003 113.064 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.22 -50.76 11.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 72.109999999999999 110.503 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.509 HG12 ' HB1' ' A' ' 55' ' ' ALA . 17.6 m -124.93 168.8 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 64.319999999999993 110.478 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -111.06 -39.69 4.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.328 0.585 . . . . 71.030000000000001 110.166 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.1 t70 -126.43 151.06 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.755 -0.657 . . . . 70.209999999999994 110.273 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.482 HG21 ' HB3' ' A' ' 55' ' ' ALA . 20.8 pt -136.91 152.75 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.858 -0.423 . . . . 71.0 109.858 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -135.98 116.03 13.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 63.5 110.146 172.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 63.7 mt -98.13 110.99 26.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 73.310000000000002 109.504 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.637 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 3.2 t30 -88.34 120.09 29.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.558 -0.746 . . . . 71.120000000000005 109.447 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.561 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.6 m95 -86.83 106.75 17.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 73.230000000000004 110.764 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.89 124.54 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.002 0.429 . . . . 72.310000000000002 110.589 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -117.65 -34.33 4.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.414 0.626 . . . . 73.299999999999997 109.636 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.51 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.0 t30 -172.47 -47.17 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.041 . . . . 54.43 109.589 -176.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 29.8 Cg_endo -63.64 140.95 77.52 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.519 1.48 . . . . 62.100000000000001 109.548 167.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.99 -95.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.144 1.896 . . . . 74.010000000000005 112.712 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -146.34 124.74 12.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.783 -0.451 . . . . 70.409999999999997 109.783 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.45 -98.74 0.11 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.714 -0.755 . . . . 63.020000000000003 113.04 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.72 -37.98 64.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.973 2.448 . . . . 62.140000000000001 112.432 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.544 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 6.0 m-20 -67.11 -4.79 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 71.409999999999997 111.424 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.637 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 72.7 mmtt . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.577 -0.283 . . . . 62.100000000000001 110.387 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 111.938 0.347 . . . . 40.329999999999998 111.938 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.44 149.32 80.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.705 2.27 . . . . 63.119999999999997 111.703 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.42 -49.68 24.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.353 0.871 . . . . 74.099999999999994 113.353 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.84 -49.52 75.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.621 0.248 . . . . 65.310000000000002 111.572 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -74.99 -46.46 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.47 -0.332 . . . . 74.540000000000006 110.881 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 10' ' ' ALA . 3.4 tm? -54.75 -44.86 73.97 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.714 -0.676 . . . . 71.150000000000006 110.803 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -53.52 -59.81 4.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 64.349999999999994 111.189 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.63 80.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.065 -0.516 . . . . 73.010000000000005 110.899 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.69 -48.05 82.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 71.230000000000004 110.594 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 23' ' ' MET . 5.3 p -69.36 -34.06 60.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 110.058 -0.349 . . . . 65.420000000000002 110.058 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -54.06 -49.27 69.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.264 -0.643 . . . . 54.450000000000003 109.264 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.15 -50.88 43.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.1 -0.5 . . . . 75.049999999999997 110.834 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.25 67.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.049 -0.523 . . . . 62.109999999999999 111.897 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' VAL . 13.3 mmt -58.67 -24.89 62.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 61.210000000000001 111.578 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -66.13 -16.96 64.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.607 0.241 . . . . 74.049999999999997 111.034 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -119.37 -23.37 6.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.145 0.498 . . . . 71.010000000000005 109.926 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 23' ' ' MET . 43.2 t -66.78 -40.05 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.295 -0.866 . . . . 72.129999999999995 110.623 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.587 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.7 p -89.88 153.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.479 -0.563 . . . . 71.219999999999999 109.479 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -92.25 97.65 1.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 108.753 -0.832 . . . . 71.340000000000003 108.753 170.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 86.1 Cg_endo -85.38 -7.55 8.85 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.547 2.164 . . . . 72.409999999999997 111.852 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.66 -57.75 5.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 74.540000000000006 110.452 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.31 -18.54 16.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.716 0.293 . . . . 61.32 110.317 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.84 54.23 1.81 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.96 -0.638 . . . . 73.439999999999998 112.591 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.3 mp -117.81 143.23 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.193 -0.669 . . . . 62.219999999999999 109.193 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -125.45 109.85 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.557 -0.292 . . . . 65.140000000000001 110.603 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' HD21 ' A' ' 38' ' ' LEU . 29.9 m -54.63 -41.96 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.84 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HA ' HG23 ' A' ' 41' ' ' VAL . 68.9 t -56.96 -32.18 38.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.126 0.489 . . . . 52.229999999999997 110.748 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.8 -14.82 62.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.696 -0.684 . . . . 73.310000000000002 111.005 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 35' ' ' VAL . 4.4 mm? -63.61 -17.69 63.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.153 0.501 . . . . 75.299999999999997 110.093 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 72.1 22.86 78.67 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.423 -0.808 . . . . 74.219999999999999 114.363 172.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 40' ' ' LEU . 5.0 mt -98.25 -27.06 14.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.483 0.641 . . . . 64.230000000000004 110.421 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 59' ' ' MET . 35.8 t -63.57 -11.91 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.693 -0.685 . . . . 75.540000000000006 111.908 -169.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.451 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 98.7 m-85 -62.09 -17.68 58.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.187 0.518 . . . . 73.200000000000003 109.98 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.38 63.57 3.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.811 -0.915 . . . . 61.030000000000001 110.811 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.7 tt -125.62 128.94 48.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.212 -0.662 . . . . 74.540000000000006 109.212 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.428 ' N ' HD22 ' A' ' 44' ' ' LEU . 7.3 m-20 -149.16 173.47 13.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.483 -0.932 . . . . 45.450000000000003 108.483 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 55' ' ' ALA . 23.8 m -136.48 132.52 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 62.25 109.37 173.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.26 145.83 47.45 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.714 -0.476 . . . . 71.540000000000006 109.714 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.0 p-10 -100.62 129.31 46.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.313 0.578 . . . . 74.409999999999997 111.098 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.32 164.32 29.42 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.623 -1.791 . . . . 43.420000000000002 108.623 163.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.36 -19.62 66.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.164 0.982 . . . . 65.319999999999993 109.902 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.64 -39.05 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.456 -0.793 . . . . 74.299999999999997 109.938 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.7 170.36 35.61 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.526 -0.761 . . . . 64.230000000000004 111.807 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 30.3 m -85.74 129.05 34.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.731 0.301 . . . . 70.299999999999997 111.299 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.54 140.68 39.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.993 -0.549 . . . . 72.510000000000005 110.23 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HA ' HG13 ' A' ' 46' ' ' VAL . . . -85.22 154.56 21.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.15 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -128.72 122.74 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.281 0.632 . . . . 71.430000000000007 109.332 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.493 HG12 ' HG ' ' A' ' 44' ' ' LEU . 54.3 mt -130.47 116.6 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.428 0.156 . . . . 72.150000000000006 111.124 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.37 118.8 24.46 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.261 -0.644 . . . . 70.099999999999994 109.261 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 41' ' ' VAL . 43.6 mmm -139.8 170.44 15.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.248 0.547 . . . . 71.019999999999996 111.941 -174.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -153.59 178.92 9.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.226 -0.897 . . . . 62.329999999999998 109.405 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 61.8 mt -120.48 156.35 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.012 -0.366 . . . . 42.299999999999997 110.012 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.9 p -47.46 -60.11 2.76 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.032 0.533 . . . . 75.010000000000005 112.343 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.9 t -104.23 2.17 31.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.843 0.354 . . . . 72.230000000000004 110.234 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.578 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.87 8.0 1.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.568 0.747 . . . . 72.439999999999998 112.154 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.36 -7.67 9.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 71.019999999999996 110.239 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.538 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.8 m -76.84 145.09 73.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.506 -0.77 . . . . 73.340000000000003 110.41 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.69 27.89 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.579 2.186 . . . . 62.420000000000002 112.328 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 ' HB2' HD21 ' A' ' 61' ' ' LEU . 91.8 mt -77.35 -6.52 53.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.218 -0.446 . . . . 71.129999999999995 110.747 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.461 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.9 t -58.2 -35.68 71.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.724 -0.473 . . . . 71.239999999999995 109.724 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.6 -50.01 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 64.409999999999997 111.217 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.436 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 14.2 p -68.66 -39.55 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.755 -0.202 . . . . 74.319999999999993 111.343 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 69' ' ' THR . 34.8 pt -66.81 -40.46 85.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 120.418 -0.513 . . . . 75.409999999999997 110.34 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.88 -46.93 88.67 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 116.41 -0.359 . . . . 65.439999999999998 110.186 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.76 -51.89 67.72 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.969 -0.56 . . . . 70.430000000000007 110.827 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 4.0 pt20 -64.86 -45.05 87.71 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.136 -0.484 . . . . 72.120000000000005 110.955 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' HD23 ' A' ' 80' ' ' LEU . 77.4 p -66.74 -55.6 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.709 -0.223 . . . . 63.130000000000003 110.847 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.686 ' HD2' HG12 ' A' ' 89' ' ' ILE . 19.7 mmm180 -55.22 -53.07 60.61 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.731 0.3 . . . . 72.420000000000002 110.466 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 t -60.44 -43.49 96.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.575 -0.739 . . . . 73.439999999999998 111.49 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.91 -51.22 16.83 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 121.02 -0.272 . . . . 63.329999999999998 110.931 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -57.8 -37.98 74.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.305 -0.407 . . . . 71.439999999999998 111.156 -175.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 77' ' ' ARG . 20.6 m -78.0 -28.04 15.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.678 -0.409 . . . . 74.219999999999999 110.786 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.26 -42.63 97.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 61.329999999999998 112.087 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 p -94.27 1.4 55.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.93 0.395 . . . . 73.109999999999999 110.852 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.76 35.42 89.85 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.829 -0.623 . . . . 61.43 112.588 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.33 -36.94 80.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.353 0.597 . . . . 64.430000000000007 109.416 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 55' ' ' ALA . 16.4 m -145.31 153.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.074 -0.966 . . . . 52.240000000000002 109.059 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.6 -44.46 70.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.267 0.556 . . . . 70.109999999999999 110.263 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.64 156.73 45.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 73.230000000000004 109.276 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.686 HG12 ' HD2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -125.97 144.04 37.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.716 -0.476 . . . . 72.319999999999993 109.716 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -123.7 106.75 10.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.373 0.606 . . . . 64.219999999999999 109.981 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.49 HG12 ' HB ' ' A' ' 57' ' ' ILE . 59.6 mt -95.58 128.02 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 71.129999999999995 109.545 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -102.27 111.29 23.51 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.061 -0.718 . . . . 73.129999999999995 109.061 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -86.78 106.29 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 70.140000000000001 109.692 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.66 123.75 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.647 -0.501 . . . . 62.539999999999999 109.647 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -121.18 -27.16 4.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.224 -0.443 . . . . 74.129999999999995 109.89 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -179.57 -48.82 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.229 -0.896 . . . . 61.340000000000003 110.599 -169.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.35 152.21 75.7 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.206 1.938 . . . . 70.239999999999995 112.45 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.73 145.66 63.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.717 2.278 . . . . 74.219999999999999 110.963 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -48.94 109.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.657 0.598 . . . . 74.219999999999999 111.378 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.63 -87.85 0.07 OUTLIER Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.266 -0.492 . . . . 75.530000000000001 112.276 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.45 -28.68 62.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.536 2.157 . . . . 75.019999999999996 111.266 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 2.7 p-10 -66.98 -5.75 14.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.858 -1.065 . . . . 74.25 111.648 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mttt . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.516 0.198 . . . . 75.400000000000006 111.01 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.823 0.344 . . . . 55.520000000000003 111.692 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.52 159.41 36.45 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.572 2.181 . . . . 62.439999999999998 112.549 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.0 -51.57 65.82 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.781 1.03 . . . . 72.030000000000001 113.781 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.62 -52.45 64.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.674 0.273 . . . . 71.140000000000001 111.534 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.43 -41.29 63.44 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.95 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.68 -43.12 72.16 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 110.257 -0.275 . . . . 74.450000000000003 110.257 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.7 tp -57.42 -56.32 23.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.279 -0.419 . . . . 73.040000000000006 110.906 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.03 65.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.877 -0.601 . . . . 72.120000000000005 111.018 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -60.9 -42.72 98.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.986 -0.552 . . . . 63.240000000000002 111.465 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -69.87 -40.91 79.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.711 -0.396 . . . . 74.530000000000001 110.4 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.91 -46.01 92.37 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.527 -0.546 . . . . 75.319999999999993 109.527 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -50.6 71.79 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.888 -0.596 . . . . 71.140000000000001 110.831 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -44.92 76.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.088 0.471 . . . . 64.019999999999996 110.333 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.554 ' HA ' HG21 ' A' ' 26' ' ' VAL . 25.1 mmt -57.88 -28.36 64.11 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.452 -0.795 . . . . 73.310000000000002 110.507 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -24.99 59.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.537 -0.301 . . . . 74.420000000000002 110.88 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.76 -20.95 15.34 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.923 0.342 . . . . 74.420000000000002 111.923 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' A' ' 23' ' ' MET . 26.4 m -87.71 -17.47 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.975 0.417 . . . . 72.140000000000001 110.455 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 34' ' ' ASN . 5.7 p -89.15 168.83 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.969 -0.559 . . . . 73.340000000000003 109.65 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.9 92.39 6.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.115 -0.698 . . . . 53.329999999999998 109.115 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.1 -4.77 10.42 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.465 2.11 . . . . 60.509999999999998 111.93 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.85 -57.71 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 53.109999999999999 110.632 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.98 -18.59 16.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.977 0.418 . . . . 75.329999999999998 110.285 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.5 49.21 2.41 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.138 -0.553 . . . . 64.120000000000005 113.13 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -111.56 140.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.131 -0.692 . . . . 72.340000000000003 109.131 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.512 ' HA ' HG22 ' A' ' 27' ' ' VAL . 9.3 p30 -122.82 113.13 18.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.427 0.632 . . . . 54.399999999999999 110.59 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.81 -28.51 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.642 -0.708 . . . . 72.239999999999995 110.811 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG13 HG23 ' A' ' 41' ' ' VAL . 34.7 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.041 -0.527 . . . . 64.019999999999996 111.166 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.457 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 36.6 t70 -58.88 -26.01 63.86 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.894 0.378 . . . . 72.219999999999999 111.131 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.94 -15.04 63.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.238 -0.437 . . . . 44.43 110.301 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.0 61.83 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.661 -0.7 . . . . 61.149999999999999 113.542 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.72 -16.29 22.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.999 0.428 . . . . 64.120000000000005 110.192 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 36' ' ' VAL . 47.7 t -59.66 -15.88 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.881 -0.599 . . . . 75.329999999999998 110.618 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.56 -24.11 44.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.722 -0.672 . . . . 73.400000000000006 110.628 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.78 67.29 1.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.997 -0.547 . . . . 71.019999999999996 112.303 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.3 tp -110.98 130.72 55.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.639 -0.504 . . . . 71.019999999999996 109.639 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -157.91 109.12 2.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.527 -0.546 . . . . 71.219999999999999 109.527 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 118.74 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.704 -0.225 . . . . 71.25 110.505 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.66 120.65 38.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.078 -0.712 . . . . 73.140000000000001 109.078 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.68 140.99 37.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 74.120000000000005 110.198 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.15 167.34 35.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.713 -0.755 . . . . 61.32 112.079 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.95 -18.84 65.6 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.981 0.419 . . . . 75.099999999999994 110.657 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.22 -11.69 61.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.592 -0.731 . . . . 72.420000000000002 110.44 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.48 116.56 2.0 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.417 -0.673 . . . . 72.530000000000001 111.417 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.8 m -70.94 102.48 2.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.702 -0.481 . . . . 43.299999999999997 109.702 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 5.5 p -113.52 125.02 70.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.796 . . . . 54.229999999999997 111.834 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.99 114.21 26.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.664 . . . . 63.020000000000003 110.095 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -85.67 119.13 25.67 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.103 -0.332 . . . . 75.340000000000003 110.103 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.483 HG23 ' HG3' ' A' ' 59' ' ' MET . 27.3 mm -116.73 127.98 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.742 -0.663 . . . . 74.239999999999995 109.45 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -107.47 116.48 32.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.477 -0.564 . . . . 54.229999999999997 109.477 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.483 ' HG3' HG23 ' A' ' 57' ' ' ILE . 42.5 mtm -140.87 170.56 15.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.748 0.785 . . . . 71.209999999999994 112.187 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -155.9 140.97 17.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.565 -1.198 . . . . 73.430000000000007 109.277 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 72' ' ' ILE . 3.7 mm? -85.4 167.43 15.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.589 -0.523 . . . . 73.120000000000005 109.589 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -50.1 -49.55 51.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.083 0.24 . . . . 75.329999999999998 111.431 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 m -102.27 -11.69 18.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.142 0.496 . . . . 71.349999999999994 110.34 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 62.58 8.21 2.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.347 -0.842 . . . . 75.010000000000005 112.467 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.04 -16.13 8.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.919 0.39 . . . . 51.530000000000001 110.958 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 p -66.15 144.99 98.97 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.967 -0.56 . . . . 65.310000000000002 111.327 -176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 8.3 Cg_exo -73.74 38.96 0.47 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.625 2.883 . . . . 74.540000000000006 113.852 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.8 mm? -92.98 -12.05 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.174 -0.306 . . . . 75.129999999999995 110.174 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -49.77 -57.71 6.79 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.682 -0.69 . . . . 74.430000000000007 111.733 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.15 -32.95 74.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.598 -0.274 . . . . 74.319999999999993 110.726 -174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 59.6 t -64.17 -53.43 43.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 54.439999999999998 110.68 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 68' ' ' LEU . 5.4 pt -71.93 -27.11 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 111.762 0.282 . . . . 64.239999999999995 111.762 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HA ' HD11 ' A' ' 91' ' ' ILE . 43.4 mt-10 -66.19 -45.64 80.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.946 0.403 . . . . 70.530000000000001 110.695 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.51 -49.53 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.734 . . . . 64.140000000000001 110.335 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 79.9 mm-40 -58.16 -45.61 87.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 72.209999999999994 110.491 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.402 ' O ' HD11 ' A' ' 80' ' ' LEU . 41.0 t -58.15 -63.69 1.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 62.350000000000001 110.541 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -54.85 -47.83 73.68 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.885 -0.326 . . . . 75.129999999999995 110.812 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -55.54 -45.23 77.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.127 -0.488 . . . . 74.099999999999994 111.277 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.49 -51.07 18.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 74.310000000000002 110.816 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HA ' HD11 ' A' ' 85' ' ' LEU . 10.8 mp -58.75 -32.65 69.45 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.335 -0.393 . . . . 71.319999999999993 111.065 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.2 -27.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 63.310000000000002 110.084 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.08 71.02 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.087 -0.578 . . . . 55.5 111.989 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.1 t -97.53 1.67 49.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.194 0.521 . . . . 55.340000000000003 110.064 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.39 23.06 78.49 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.895 -0.593 . . . . 23.239999999999998 112.913 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 80' ' ' LEU . 43.9 mt -66.81 -57.81 6.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.58 0.705 . . . . 74.409999999999997 109.186 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.02 -173.77 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.803 -1.09 . . . . 75.25 108.953 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -119.72 -39.01 2.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.161 -0.681 . . . . 71.510000000000005 109.161 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.8 m-20 -112.64 151.68 29.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 63.399999999999999 109.916 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 pt -140.17 170.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.532 -0.544 . . . . 62.039999999999999 109.532 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -148.57 106.7 3.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.101 -0.5 . . . . 74.209999999999994 109.665 172.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 73' ' ' GLU . 53.6 mt -93.55 121.35 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 74.409999999999997 109.81 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' HE2' ' A' ' 103' ' ' LYS . 7.9 t30 -100.23 133.09 45.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.89 -0.596 . . . . 73.310000000000002 109.804 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -97.9 106.7 19.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.47 . . . . 75.510000000000005 110.423 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.28 124.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.424 -0.584 . . . . 63.439999999999998 109.424 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.423 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 4.3 m-90 -102.35 -34.99 8.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.422 -0.584 . . . . 74.319999999999993 109.422 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 23.1 t-20 168.67 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.419 -1.264 . . . . 74.5 109.243 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 49.5 Cg_exo -60.14 161.1 20.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.545 2.164 . . . . 64.349999999999994 112.324 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.59 -177.54 2.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.123 2.548 . . . . 71.25 112.986 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -89.21 -163.1 0.94 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.389 -0.823 . . . . 74.319999999999993 110.515 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.73 -173.88 45.99 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.079 -0.581 . . . . 73.450000000000003 112.485 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.74 -5.7 7.8 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.217 2.611 . . . . 50.439999999999998 112.512 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 31.7 t70 -57.53 -19.9 28.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 74.540000000000006 110.631 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 90.8 mttt . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.228 -0.442 . . . . 63.299999999999997 111.512 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.809 -0.441 . . . . 73.209999999999994 109.809 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.53 146.38 95.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.51 2.14 . . . . 62.229999999999997 111.906 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.88 -44.37 49.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.345 0.869 . . . . 71.129999999999995 113.345 -169.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.2 -52.41 62.39 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.899 0.381 . . . . 72.099999999999994 110.845 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -72.11 -43.8 64.17 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.295 0.569 . . . . 74.25 110.449 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.74 -39.86 82.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.294 -0.866 . . . . 52.530000000000001 110.249 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.59 -53.21 57.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.905 0.383 . . . . 73.25 110.472 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.62 -51.93 66.48 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.785 -0.643 . . . . 61.130000000000003 110.996 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.2 -48.44 80.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.904 -0.589 . . . . 54.049999999999997 111.02 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 23' ' ' MET . 5.4 p -65.96 -34.48 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.945 -0.391 . . . . 63.310000000000002 109.945 -177.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.91 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.696 -0.483 . . . . 71.209999999999994 109.696 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 28.5 mm-40 -65.92 -46.39 78.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.64 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.05 86.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 50.130000000000003 110.827 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.38 -12.62 14.9 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.042 -0.527 . . . . 71.219999999999999 111.564 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 76.9 ttt180 -87.31 -20.86 26.2 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.158 0.583 . . . . 72.230000000000004 111.459 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.27 -27.22 5.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.243 0.544 . . . . 74.209999999999994 110.84 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -74.74 -16.69 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.197 -0.911 . . . . 61.509999999999998 110.163 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p -94.2 155.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 74.120000000000005 110.445 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.15 89.74 0.62 Allowed Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 107.072 -1.455 . . . . 71.049999999999997 107.072 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 55.6 Cg_endo -81.27 -6.95 12.96 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.084 1.856 . . . . 63.130000000000003 111.712 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.82 -57.57 5.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.434 -0.803 . . . . 74.439999999999998 109.894 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.29 -18.77 22.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.137 -0.483 . . . . 62.43 110.178 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.83 52.75 3.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.782 -0.644 . . . . 60.409999999999997 113.846 171.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.29 140.09 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 117.263 0.531 . . . . 74.230000000000004 109.939 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 24.2 m-80 -103.1 130.6 50.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.807 -0.442 . . . . 73.209999999999994 109.807 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.5 t -56.72 -33.11 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.545 0.688 . . . . 65.230000000000004 109.866 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.94 -30.61 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.245 -0.889 . . . . 70.140000000000001 111.005 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 2.0 m-20 -63.08 -23.58 67.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.57 -0.286 . . . . 73.340000000000003 111.581 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 -16.37 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.094 0.473 . . . . 74.129999999999995 110.276 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.03 22.82 60.87 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.618 -0.719 . . . . 71.200000000000003 112.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.5 tp -90.53 -24.76 20.53 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.476 -0.565 . . . . 74.450000000000003 109.476 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.59 -8.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.534 -0.757 . . . . 72.310000000000002 110.32 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.16 -16.13 62.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.881 -0.599 . . . . 74.230000000000004 109.692 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 52.12 3.51 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.834 -0.906 . . . . 63.32 110.834 172.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.553 HD11 HG12 ' A' ' 57' ' ' ILE . 61.6 tp -102.1 121.06 41.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.027 0.441 . . . . 73.420000000000002 109.974 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.42 108.58 10.95 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.144 -1.058 . . . . 51.100000000000001 108.144 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 55' ' ' ALA . 10.8 m -99.43 128.0 51.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.476 -0.565 . . . . 75.329999999999998 109.476 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -120.54 145.55 47.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 74.099999999999994 110.844 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.47 163.34 19.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.498 -0.773 . . . . 73.299999999999997 110.309 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.9 155.71 26.68 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.866 -0.894 . . . . 63.200000000000003 110.866 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.66 -20.27 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.484 . . . . 73.140000000000001 110.48 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -89.48 -27.92 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.746 -0.661 . . . . 64.109999999999999 110.575 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.89 176.42 32.99 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.395 -0.682 . . . . 54.030000000000001 111.395 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.1 m -99.29 129.91 45.54 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.792 0.33 . . . . 72.109999999999999 110.483 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 137.09 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.145 -0.48 . . . . 74.239999999999995 110.814 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -98.71 120.5 39.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.081 -0.509 . . . . 62.310000000000002 110.285 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.585 HD21 ' O ' ' A' ' 103' ' ' LYS . 20.7 mt -96.65 114.02 25.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.564 -0.532 . . . . 64.230000000000004 109.564 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.553 HG12 HD11 ' A' ' 44' ' ' LEU . 51.1 mt -111.42 118.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.544 0.211 . . . . 75.310000000000002 110.822 -176.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -82.86 120.86 26.19 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.282 -0.266 . . . . 64.010000000000005 110.282 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 87.5 mtp -139.23 163.5 32.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.363 0.602 . . . . 73.319999999999993 111.339 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.423 ' OG1' ' HB ' ' A' ' 94' ' ' VAL . 73.7 m -136.62 137.73 40.43 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.839 -0.618 . . . . 73.109999999999999 109.595 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.23 146.92 24.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.656 -0.498 . . . . 74.329999999999998 109.656 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -36.1 -57.26 0.71 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.839 0.856 . . . . 71.319999999999993 113.027 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -121.29 12.6 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 72.409999999999997 110.622 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . . . 59.38 8.56 1.19 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.718 -0.674 . . . . 62.420000000000002 112.567 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.83 13.07 12.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 73.310000000000002 110.547 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 44.5 t -95.9 139.82 22.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 71.5 110.507 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.37 17.45 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.922 2.415 . . . . 73.099999999999994 112.376 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.565 ' HB2' ' SG ' ' A' ' 66' ' ' CYS . 48.5 tp -69.09 -13.83 62.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.956 -0.565 . . . . 72.200000000000003 110.499 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 70' ' ' ASP . 12.7 t -49.72 -56.8 8.88 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.591 -0.731 . . . . 74.430000000000007 111.903 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' THR . 22.7 t70 -63.67 -37.24 86.61 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.889 0.376 . . . . 64.109999999999999 110.356 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 60.9 t -62.28 -52.76 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 63.329999999999998 110.753 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.8 pp -68.47 -34.94 68.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.791 -0.186 . . . . 74.319999999999993 111.258 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' N ' HD12 ' A' ' 72' ' ' ILE . 41.2 mt-10 -62.47 -46.58 87.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.697 0.284 . . . . 71.549999999999997 110.462 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 78' ' ' SER . 23.4 t70 -63.27 -47.53 81.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 110.917 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 26.4 mm-40 -57.46 -55.64 32.2 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.444 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.418 ' O ' HD22 ' A' ' 80' ' ' LEU . 36.6 t -59.44 -54.61 44.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.819 -0.628 . . . . 72.010000000000005 110.587 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -54.79 -42.79 72.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.448 -0.342 . . . . 72.5 110.555 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 7.1 t -56.28 -52.89 62.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 52.439999999999998 110.88 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.49 -51.89 13.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.87 -0.332 . . . . 72.439999999999998 111.446 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 76' ' ' SER . 4.3 mm? -60.68 -33.92 73.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.272 0.558 . . . . 72.140000000000001 111.186 -173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -85.85 -27.2 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.785 -0.643 . . . . 70.409999999999997 109.911 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.72 79.05 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.292 -0.48 . . . . 71.019999999999996 112.149 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -79.25 -23.04 43.94 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.649 -0.5 . . . . 64.409999999999997 109.649 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 48.58 3.56 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.578 -0.737 . . . . 53.509999999999998 113.25 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.0 mt -80.47 -35.3 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.989 -0.745 . . . . 71.150000000000006 108.989 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB1' ' A' ' 55' ' ' ALA . 16.7 m -143.84 160.35 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.109 -0.95 . . . . 73.140000000000001 109.336 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.69 -30.92 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 63.109999999999999 110.675 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -152.5 166.07 33.14 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.02 -0.536 . . . . 73.319999999999993 110.238 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.443 HG21 ' HB3' ' A' ' 55' ' ' ALA . 35.7 pt -136.95 154.46 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.132 0.492 . . . . 74.510000000000005 110.86 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 8.6 tpt85 -133.24 110.42 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.74 -0.664 . . . . 72.040000000000006 109.215 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 58.6 mt -91.61 123.17 43.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.224 -0.443 . . . . 72.140000000000001 110.224 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.452 ' C ' HD22 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -88.2 118.21 27.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.42 -0.956 . . . . 72.519999999999996 108.42 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.411 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.8 m-90 -89.69 114.0 25.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.242 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HB ' ' OG1' ' A' ' 60' ' ' THR . 7.4 t -86.07 124.02 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.863 -0.421 . . . . 73.030000000000001 109.863 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' HD1' ' HB3' ' A' ' 64' ' ' ALA . 3.5 m-90 -112.08 -32.16 6.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 75.530000000000001 109.408 174.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.427 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 1.6 m120 -179.57 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 114.354 -1.294 . . . . 71.140000000000001 109.379 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 23.6 Cg_exo -65.96 154.15 75.17 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.222 1.948 . . . . 63.039999999999999 111.664 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.18 -176.64 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 52.43 112.061 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.531 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m-90 -79.64 145.59 32.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 72.310000000000002 110.276 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.29 -110.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.923 -0.656 . . . . 71.099999999999994 112.226 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.57 -33.76 86.44 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.563 2.175 . . . . 71.109999999999999 112.163 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.63 -4.11 14.3 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.895 -0.593 . . . . 73.329999999999998 110.719 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.585 ' O ' HD21 ' A' ' 56' ' ' LEU . 30.2 mtpp . . . . . 0 CA--C 1.535 0.377 0 O-C-N 121.86 -0.525 . . . . 65.099999999999994 110.277 172.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.823 0.305 . . . . 53.109999999999999 111.823 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 80.9 Cg_exo -47.86 153.59 2.44 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.978 2.452 . . . . 64.549999999999997 112.194 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.5 -29.87 51.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 61.310000000000002 112.072 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -63.63 -45.4 90.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.173 0.511 . . . . 74.0 109.932 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.73 -47.35 39.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.408 -0.815 . . . . 74.209999999999994 109.402 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.45 -45.49 73.1 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 114.819 -1.082 . . . . 74.200000000000003 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.99 -59.72 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.977 0.418 . . . . 62.43 111.163 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.86 66.41 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.118 -0.492 . . . . 62.5 111.129 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.16 -32.58 72.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.6 -0.727 . . . . 71.299999999999997 111.915 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -72.39 -38.17 60.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 109.396 -0.594 . . . . 62.130000000000003 109.396 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -58.88 -41.62 87.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.512 -0.313 . . . . 65.530000000000001 110.731 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -69.67 -51.66 32.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.036 0.446 . . . . 74.439999999999998 110.683 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.24 -34.64 75.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.839 -0.618 . . . . 65.430000000000007 111.391 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.4 mmt -61.25 -13.29 17.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 112.114 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -90.77 -17.46 26.63 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.748 0.249 . . . . 72.150000000000006 111.493 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.52 -25.81 5.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.503 0.668 . . . . 74.450000000000003 110.466 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.85 -23.13 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.092 -0.958 . . . . 60.210000000000001 109.878 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.449 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 9.9 p -89.0 159.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 72.430000000000007 109.071 174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 94.61 4.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.527 -0.916 . . . . 73.230000000000004 108.527 168.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 72.8 Cg_endo -81.54 -3.84 12.08 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.257 1.971 . . . . 63.350000000000001 111.989 -176.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.72 -57.55 5.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.14 0.495 . . . . 74.340000000000003 109.862 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.5 mt -92.79 -18.75 22.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.708 -0.678 . . . . 62.299999999999997 109.864 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.34 51.46 3.7 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.955 -0.566 . . . . 25.199999999999999 113.49 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 143.85 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.026 0.413 . . . . 65.319999999999993 110.432 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.41 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.2 p30 -108.79 134.82 50.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 75.010000000000005 110.637 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.42 -25.69 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.012 0.434 . . . . 74.420000000000002 111.121 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.81 -24.96 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.927 -0.579 . . . . 62.119999999999997 110.348 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.75 -33.61 68.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 73.299999999999997 110.642 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.91 -16.7 62.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 74.430000000000007 110.297 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.98 21.1 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.48 -0.782 . . . . 62.140000000000001 113.782 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 40' ' ' LEU . 2.5 mt -88.58 -19.2 26.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.892 0.346 . . . . 72.109999999999999 110.157 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.6 -9.59 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.853 -0.612 . . . . 75.150000000000006 110.512 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.89 -31.23 62.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.546 -0.752 . . . . 74.109999999999999 109.678 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 75.76 1.48 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.539 -0.755 . . . . 72.319999999999993 111.585 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.521 HD11 HG12 ' A' ' 57' ' ' ILE . 50.8 tp -119.94 126.33 50.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.768 0.427 . . . . 75.219999999999999 109.951 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -150.92 115.38 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.498 -0.556 . . . . 73.430000000000007 109.498 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -94.8 136.25 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.848 0.356 . . . . 60.149999999999999 110.176 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -130.63 150.21 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.626 -0.509 . . . . 72.200000000000003 109.626 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 33.2 t70 -92.01 117.39 29.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.446 -0.343 . . . . 72.25 110.891 -176.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.45 174.16 24.62 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.406 -0.426 . . . . 63.219999999999999 112.087 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.04 -32.16 69.49 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.917 0.389 . . . . 72.230000000000004 111.46 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.39 -14.29 22.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.148 -0.478 . . . . 61.030000000000001 111.513 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.18 172.23 22.63 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.094 -0.574 . . . . 24.449999999999999 111.992 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.0 m -78.88 115.46 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.712 0.256 . . . . 65.150000000000006 110.782 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 33.3 m -103.94 144.97 13.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.46 -0.337 . . . . 75.099999999999994 110.648 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -98.59 112.85 24.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 70.230000000000004 110.599 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.5 115.62 19.23 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.126 -0.694 . . . . 73.420000000000002 109.126 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 44' ' ' LEU . 49.5 mt -120.51 125.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.091 -0.337 . . . . 74.400000000000006 110.091 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD2' HG23 ' A' ' 94' ' ' VAL . 24.8 t0 -96.12 130.83 43.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 74.530000000000001 110.772 176.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.406 ' HE1' ' HZ3' ' A' ' 93' ' ' TRP . 84.4 mtp -141.64 170.96 14.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.292 0.568 . . . . 54.310000000000002 111.268 -175.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -154.43 153.46 31.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.735 . . . . 72.409999999999997 109.86 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 72' ' ' ILE . 6.5 mp -110.72 170.8 7.85 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.971 -0.381 . . . . 63.439999999999998 109.971 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 p -57.12 -60.22 3.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.21 -0.45 . . . . 64.319999999999993 111.824 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.409 ' OG ' ' SG ' ' A' ' 66' ' ' CYS . 86.2 p -91.88 -24.34 19.36 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.362 -0.381 . . . . 75.230000000000004 110.315 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.4 8.93 4.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.427 -0.806 . . . . 62.530000000000001 110.826 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.63 -25.93 8.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.589 . . . . 70.439999999999998 110.53 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.409 ' SG ' ' OG ' ' A' ' 63' ' ' SER . 64.3 m -59.43 135.57 88.82 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.007 -0.542 . . . . 70.200000000000003 110.628 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.29 25.7 0.31 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.892 2.395 . . . . 75.439999999999998 113.038 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 72' ' ' ILE . 89.8 mt -78.19 -6.26 54.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.988 -0.375 . . . . 74.530000000000001 109.988 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.635 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.3 t -49.37 -44.31 44.8 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.548 -0.751 . . . . 74.310000000000002 109.946 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.48 -51.57 68.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.67 -0.695 . . . . 71.439999999999998 110.693 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 49.2 t -62.78 -53.04 51.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.533 -0.758 . . . . 61.329999999999998 111.46 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 68' ' ' LEU . 6.7 pt -71.01 -35.96 61.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.759 -0.376 . . . . 74.299999999999997 111.713 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.635 ' HB2' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.51 -54.27 46.06 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.892 0.853 . . . . 72.349999999999994 108.76 173.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.89 -51.29 70.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.864 -1.516 . . . . 71.049999999999997 111.231 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 21.2 mm-40 -59.36 -49.08 79.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.657 0.265 . . . . 72.140000000000001 110.564 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.497 ' O ' HD23 ' A' ' 80' ' ' LEU . 45.7 m -59.29 -60.56 3.66 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.432 . . . . 74.319999999999993 111.016 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HB3' HG12 ' A' ' 89' ' ' ILE . 14.4 ptm180 -62.11 -36.68 82.47 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.047 -0.261 . . . . 71.25 111.208 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 t -60.07 -40.94 91.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.252 -0.431 . . . . 72.450000000000003 110.672 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -51.18 16.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.73 0.3 . . . . 65.019999999999996 110.749 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -55.26 -38.12 68.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.108 -0.496 . . . . 70.120000000000005 111.148 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.24 -27.77 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.594 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.71 -34.04 69.34 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.32 -0.467 . . . . 74.109999999999999 112.094 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.536 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 29.9 m -107.67 6.79 28.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.797 0.332 . . . . 64.25 111.15 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.71 69.51 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.125 -0.559 . . . . 72.239999999999995 112.07 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.536 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 78.2 mt -60.68 -43.12 98.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.672 0.749 . . . . 70.310000000000002 108.99 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' A' ' 55' ' ' ALA . 19.2 m -143.9 159.15 16.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.361 -1.29 . . . . 71.239999999999995 108.114 170.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.42 -43.19 86.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.309 0.576 . . . . 73.099999999999994 110.081 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 27.2 t70 -161.55 168.63 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.248 -0.887 . . . . 72.129999999999995 108.753 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 77' ' ' ARG . 32.6 pt -122.68 148.05 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.815 0.341 . . . . 71.450000000000003 110.118 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 90' ' ' ARG . 2.8 tpp180 -119.44 106.38 12.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.473 -0.936 . . . . 74.319999999999993 108.473 176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.3 mt -93.78 145.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.78 0.324 . . . . 71.25 110.853 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -118.71 139.67 51.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.877 -0.786 . . . . 71.200000000000003 108.877 172.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.434 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 49.1 m95 -106.43 106.79 17.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.748 -0.464 . . . . 73.519999999999996 109.748 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.518 HG23 ' OD2' ' A' ' 58' ' ' ASP . 39.5 t -87.3 123.84 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.945 -0.702 . . . . 73.219999999999999 109.882 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -140.88 -0.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.071 -0.513 . . . . 70.0 111.105 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.574 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t-20 167.88 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 116.071 -0.513 . . . . 53.439999999999998 110.435 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 94.5 Cg_endo -80.72 156.69 21.2 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.947 1.765 . . . . 54.520000000000003 111.855 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.08 170.09 17.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.208 1.939 . . . . 50.130000000000003 111.653 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -61.11 101.69 0.17 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.057 -0.52 . . . . 73.109999999999999 110.412 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.85 -83.75 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.075 -0.512 . . . . 63.420000000000002 112.451 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.52 -51.96 3.65 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.725 2.284 . . . . 72.010000000000005 112.244 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 93' ' ' TRP . 6.1 m-20 -64.01 -4.01 3.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 64.439999999999998 112.466 -176.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.598 0.237 . . . . 74.120000000000005 110.508 176.733 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.664 -0.124 . . . . 63.109999999999999 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.33 176.77 3.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.847 2.364 . . . . 74.200000000000003 112.05 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.08 -64.45 0.81 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.039 0.755 . . . . 74.230000000000004 113.039 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -64.43 -46.77 81.73 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.026 0.441 . . . . 74.340000000000003 110.937 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.34 -46.67 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.344 -0.844 . . . . 75.530000000000001 110.761 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.9 -49.12 77.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 110.16 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.33 -59.89 3.99 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 52.130000000000003 111.449 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -45.06 80.51 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.098 -0.501 . . . . 75.420000000000002 111.25 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.26 -41.24 73.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 73.099999999999994 110.812 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.11 -32.82 55.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 109.54 -0.541 . . . . 73.310000000000002 109.54 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.19 -48.79 75.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.211 -0.663 . . . . 75.349999999999994 109.211 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -61.58 -50.57 72.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.798 -0.637 . . . . 62.539999999999999 111.267 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.04 75.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.153 0.501 . . . . 60.039999999999999 111.188 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.28 -13.52 62.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.812 -0.631 . . . . 61.43 110.651 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -96.85 -8.01 32.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.635 . . . . 70.140000000000001 110.405 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.61 -27.13 5.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.499 0.666 . . . . 55.43 110.127 -173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -90.98 -33.04 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.152 -0.931 . . . . 74.010000000000005 111.257 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 33' ' ' ILE . 1.2 p -74.7 174.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.221 -0.445 . . . . 73.129999999999995 110.12 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.55 96.22 8.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 109.722 -0.473 . . . . 53.030000000000001 109.722 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 67.8 Cg_endo -89.13 3.16 5.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.627 2.218 . . . . 74.120000000000005 111.775 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.81 -57.93 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 74.230000000000004 110.461 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.58 -11.29 14.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.897 -0.592 . . . . 73.530000000000001 110.444 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 51.48 2.58 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.952 -0.567 . . . . 30.300000000000001 112.905 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.546 ' O ' HG21 ' A' ' 27' ' ' VAL . 3.2 mp -106.69 140.09 26.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.531 -0.544 . . . . 63.420000000000002 109.531 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -116.62 109.03 16.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.509 -0.769 . . . . 51.140000000000001 109.59 -176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 ' HE3' ' A' ' 59' ' ' MET . 39.9 t -54.23 -39.09 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.051 0.453 . . . . 75.219999999999999 111.257 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.1 -24.85 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.025 -0.534 . . . . 64.409999999999997 111.323 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.57 -24.75 67.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 71.129999999999995 110.988 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.16 -10.74 59.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.266 0.555 . . . . 72.239999999999995 110.509 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 22.52 66.09 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.358 -0.837 . . . . 75.409999999999997 114.321 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.4 tp -98.46 -30.08 12.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.06 0.457 . . . . 73.519999999999996 110.372 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.53 -14.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.587 -0.733 . . . . 74.099999999999994 111.826 -172.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -62.04 -23.4 66.44 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 73.239999999999995 109.888 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.89 70.18 2.56 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.684 -0.689 . . . . 74.310000000000002 112.085 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' O ' HD11 ' A' ' 44' ' ' LEU . 3.4 pp -126.06 144.51 50.69 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 74.120000000000005 109.896 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -163.7 138.06 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.679 -0.86 . . . . 72.439999999999998 108.679 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.66 132.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.84 0.352 . . . . 73.239999999999995 110.822 -175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -115.7 127.3 55.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.132 -0.486 . . . . 62.009999999999998 111.346 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -81.6 113.88 19.91 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 109.275 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.02 158.94 18.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.139 -0.553 . . . . 65.219999999999999 111.732 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.9 -24.74 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 73.019999999999996 110.258 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.31 -16.19 50.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.145 -0.479 . . . . 72.430000000000007 110.254 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.87 158.75 9.48 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.879 -0.6 . . . . 73.340000000000003 111.971 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 m -98.48 102.43 14.17 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.625 -0.88 . . . . 72.519999999999996 108.625 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 t -102.92 123.65 56.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 63.439999999999998 111.219 -168.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.91 115.29 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.846 -0.616 . . . . 73.040000000000006 109.585 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 90' ' ' ARG . 50.3 mt -93.89 127.89 39.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.553 0.341 . . . . 74.319999999999993 110.404 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.27 129.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.829 -0.434 . . . . 75.150000000000006 109.829 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.86 129.78 35.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.037 0.446 . . . . 73.150000000000006 111.1 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.528 ' HE3' HG12 ' A' ' 35' ' ' VAL . 79.9 mtp -141.18 171.07 14.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.972 -0.558 . . . . 73.030000000000001 110.183 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -148.63 157.48 43.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 74.099999999999994 110.144 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mm? -117.1 150.93 37.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.185 -0.672 . . . . 70.439999999999998 109.185 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -51.03 -53.86 29.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.651 0.611 . . . . 74.319999999999993 112.651 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -113.65 0.2 14.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.69 -0.232 . . . . 74.230000000000004 111.227 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 7.81 1.8 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.983 0.513 . . . . 62.340000000000003 112.228 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.33 3.78 10.8 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.498 0.666 . . . . 70.209999999999994 109.644 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.403 ' C ' ' H ' ' A' ' 68' ' ' LEU . 7.5 m -83.87 138.64 40.25 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.169 -0.923 . . . . 73.140000000000001 110.476 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.3 23.87 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.907 2.405 . . . . 75.140000000000001 112.622 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.466 ' HB2' HD12 ' A' ' 61' ' ' LEU . 83.5 mt -78.28 -18.01 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.427 . . . . 70.209999999999994 110.171 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -59.8 -46.44 89.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.915 -0.584 . . . . 63.219999999999999 110.824 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.13 -43.27 78.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.269 0.557 . . . . 64.310000000000002 110.209 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.4 t -65.15 -52.59 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 72.349999999999994 110.85 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.14 -37.29 78.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.751 0.31 . . . . 74.120000000000005 110.958 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.79 -47.23 84.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.177 -0.465 . . . . 64.420000000000002 110.213 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 78' ' ' SER . 32.4 t70 -60.23 -48.49 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 74.030000000000001 110.906 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 19.5 mm-40 -61.7 -51.2 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.874 0.369 . . . . 74.450000000000003 110.54 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -60.44 -56.21 24.19 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.954 -0.566 . . . . 72.120000000000005 110.437 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.19 -41.74 72.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.949 -0.568 . . . . 73.010000000000005 110.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 22.9 t -53.57 -53.02 57.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.589 -0.732 . . . . 62.210000000000001 110.783 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.74 -52.08 12.47 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.71 -0.396 . . . . 65.329999999999998 111.234 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.68 -44.33 73.25 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.213 0.53 . . . . 63.43 110.895 -171.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.97 -27.45 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.105 -0.952 . . . . 72.439999999999998 110.127 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -48.03 79.26 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.998 -0.62 . . . . 43.420000000000002 112.442 -170.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . 14.1 m -91.22 -12.65 34.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.117 0.484 . . . . 74.310000000000002 110.414 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.93 43.0 6.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.099999999999994 113.168 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 83' ' ' SER . 3.0 mm? -73.29 -45.25 56.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.57 -0.9 . . . . 71.129999999999995 108.57 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.41 162.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 53.409999999999997 108.897 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.54 -45.29 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.265 0.555 . . . . 71.010000000000005 109.992 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -101.13 133.74 45.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 64.310000000000002 109.809 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.6 pt -127.66 156.27 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 75.299999999999997 110.336 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HB3' HD21 ' A' ' 56' ' ' LEU . 3.4 tpm_? -150.49 106.77 3.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.176 -0.466 . . . . 74.099999999999994 109.753 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.3 mt -95.03 108.95 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.053 -0.721 . . . . 75.219999999999999 109.053 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 7.3 t30 -88.3 121.84 31.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.419 -0.585 . . . . 75.109999999999999 109.419 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.9 m-90 -97.9 108.78 21.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.169 -0.308 . . . . 72.420000000000002 110.169 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 98' ' ' PRO . 32.8 m -87.18 123.9 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.672 -0.492 . . . . 71.540000000000006 109.672 176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -111.91 -35.51 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.733 0.778 . . . . 72.450000000000003 109.669 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.657 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 8.7 t30 -175.19 -47.9 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.277 -1.329 . . . . 73.340000000000003 108.354 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 26.7 Cg_exo -64.75 134.15 39.43 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.811 1.674 . . . . 50.539999999999999 109.387 165.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.42 ' O ' HG13 ' A' ' 94' ' ' VAL . 22.0 Cg_exo -63.52 -88.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.376 2.051 . . . . 54.130000000000003 113.18 -173.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 10.7 m-90 -141.39 100.64 3.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.658 0.266 . . . . 74.310000000000002 110.333 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.69 -133.06 3.77 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-O 119.795 -0.447 . . . . 62.25 112.24 -173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.93 -24.31 75.82 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.748 2.299 . . . . 75.219999999999999 112.54 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.99 -4.53 13.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.994 0.426 . . . . 64.019999999999996 111.088 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HD3' ' HB3' ' A' ' 99' ' ' TRP . 33.7 mtmm . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 72.319999999999993 110.184 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.476 0.176 . . . . 70.510000000000005 111.476 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 11.1 Cg_endo -53.69 131.41 43.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.822 2.348 . . . . 75.439999999999998 111.921 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.16 -66.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.358 0.873 . . . . 53.340000000000003 113.358 -168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.01 -50.49 73.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.949 0.404 . . . . 72.329999999999998 111.147 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -57.25 -46.41 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 74.010000000000005 110.916 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.65 -39.77 91.76 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.828 -0.624 . . . . 72.099999999999994 110.082 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.6 tp -54.67 -59.63 4.44 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.837 0.351 . . . . 75.430000000000007 110.698 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.67 75.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.996 -0.547 . . . . 75.049999999999997 110.995 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.4 -45.12 92.4 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 111.14 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.45 -33.06 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.229 -0.285 . . . . 71.219999999999999 110.229 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -59.13 -41.52 88.45 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.345 0.593 . . . . 55.32 109.617 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.69 -45.8 57.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.486 -0.779 . . . . 75.439999999999998 111.008 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.58 72.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.336 -0.393 . . . . 75.030000000000001 111.567 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.15 -13.49 48.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 41.520000000000003 110.642 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.26 -15.63 35.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.448 -0.342 . . . . 73.530000000000001 110.731 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -109.38 -27.02 9.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 122.02 0.914 . . . . 62.329999999999998 108.891 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 26' ' ' VAL . 70.1 t -112.98 70.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 114.011 -1.449 . . . . 63.509999999999998 109.461 -175.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 34' ' ' ASN . 4.5 p -179.77 173.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.272 -0.876 . . . . 54.039999999999999 108.716 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.26 89.58 4.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.877 -0.786 . . . . 54.119999999999997 108.877 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.72 -23.77 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.176 1.917 . . . . 71.430000000000007 112.485 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -68.68 -57.75 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 111.013 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.48 -18.55 26.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.831 0.348 . . . . 72.230000000000004 110.117 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.04 47.03 3.46 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 60.43 113.704 169.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.6 mp -112.95 140.2 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.514 -0.55 . . . . 71.239999999999995 109.514 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.433 ' HA ' HG21 ' A' ' 27' ' ' VAL . 4.4 p30 -108.46 129.73 55.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.153 -0.684 . . . . 73.439999999999998 109.153 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.13 -28.37 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.84 -0.618 . . . . 72.239999999999995 112.196 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.42 -24.7 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.706 -0.225 . . . . 73.109999999999999 111.064 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -52.86 -35.53 57.74 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.238 0.336 . . . . 74.140000000000001 110.667 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 38' ' ' LEU . 6.6 mp -78.05 -18.39 55.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.377 -0.374 . . . . 53.219999999999999 110.757 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.26 22.89 38.72 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.797 -0.638 . . . . 71.310000000000002 113.548 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -93.04 -22.02 19.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.877 0.37 . . . . 53.5 110.103 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.97 -11.88 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.918 -0.583 . . . . 51.439999999999998 110.905 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -71.75 -24.34 61.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 75.120000000000005 109.94 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.6 81.96 0.96 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.214 -0.754 . . . . 34.109999999999999 111.214 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 44' ' ' LEU . 4.1 pp -130.44 137.04 49.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.262 0.553 . . . . 64.019999999999996 111.006 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 16.3 m-20 -134.4 160.41 38.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.103 -1.443 . . . . 63.119999999999997 107.103 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.9 t -149.12 123.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.506 . . . . 52.240000000000002 109.635 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.688 -0.486 . . . . 71.019999999999996 109.688 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 53' ' ' THR . 7.0 p-10 -88.78 136.66 32.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.92 0.39 . . . . 72.450000000000003 110.086 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.96 134.55 4.75 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.482 -1.047 . . . . 54.43 110.482 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -25.58 67.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.098 0.475 . . . . 75.430000000000007 110.654 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.35 -34.15 65.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.578 -0.737 . . . . 74.219999999999999 109.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.48 124.27 0.77 Allowed Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.683 -0.689 . . . . 72.109999999999999 111.608 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 48' ' ' ASP . 26.1 m -77.62 117.32 18.93 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.248 -0.279 . . . . 65.019999999999996 110.248 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 88' ' ' ASP . 43.7 t -108.2 123.68 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.905 0.383 . . . . 73.319999999999993 110.912 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB3' HG13 ' A' ' 86' ' ' VAL . . . -94.76 122.42 37.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.108 -0.496 . . . . 71.310000000000002 110.269 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 12.2 mt -97.29 102.01 13.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.655 -0.498 . . . . 74.329999999999998 109.655 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -108.65 125.15 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.092 0.157 . . . . 70.319999999999993 110.69 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.11 118.98 25.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.849 0.357 . . . . 75.150000000000006 110.099 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 72.0 mtp -140.87 170.87 14.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.383 0.611 . . . . 53.140000000000001 111.01 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -157.03 177.47 11.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.973 -1.012 . . . . 65.030000000000001 108.907 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -108.57 163.11 13.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.29 -0.633 . . . . 74.420000000000002 109.29 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -47.46 -57.48 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.484 0.49 . . . . 73.400000000000006 112.008 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -96.88 -13.59 22.38 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.385 -0.37 . . . . 74.530000000000001 111.024 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.39 8.84 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.89 0.7 . . . . 53.210000000000001 112.89 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.81 9.61 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.05 0.453 . . . . 53.229999999999997 110.486 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.3 t -119.92 124.47 27.87 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.865 -0.607 . . . . 75.230000000000004 109.786 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.17 83.16 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.682 2.254 . . . . 73.340000000000003 112.087 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 tp -107.05 8.2 30.17 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.678 0.752 . . . . 64.409999999999997 108.997 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.685 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.1 t -63.7 -39.72 95.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.303 -0.862 . . . . 63.420000000000002 111.341 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.8 -44.71 74.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 74.430000000000007 110.198 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.46 -51.93 52.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.436 -0.802 . . . . 70.409999999999997 110.795 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 69' ' ' THR . 27.0 pt -62.55 -33.73 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.697 -0.401 . . . . 74.420000000000002 111.075 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.438 ' HG2' HD12 ' A' ' 91' ' ' ILE . 43.8 mt-10 -68.0 -44.17 77.19 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.457 -0.338 . . . . 70.25 110.225 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.88 -44.24 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 73.040000000000006 110.425 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -65.06 -46.2 82.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.331 -0.395 . . . . 75.540000000000006 110.72 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -58.91 -53.81 54.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.066 -0.516 . . . . 73.329999999999998 109.944 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 ttp85 -54.87 -44.11 73.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 75.230000000000004 110.395 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -53.32 -53.65 47.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.815 -0.63 . . . . 71.120000000000005 111.159 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.22 -52.49 10.78 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.55 -0.46 . . . . 74.430000000000007 111.462 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 86' ' ' VAL . 92.1 mt -60.14 -41.09 91.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.05 0.452 . . . . 74.120000000000005 111.227 -169.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.04 -27.42 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 74.040000000000006 110.188 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.21 -45.71 18.57 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.688 -0.768 . . . . 63.229999999999997 111.776 -171.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 m -82.89 2.87 32.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.41 . . . . 73.120000000000005 110.659 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.76 35.91 90.41 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.013 -0.539 . . . . 74.340000000000003 112.811 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.57 -43.65 38.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 51.32 109.555 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 55' ' ' ALA . 27.2 m -144.29 169.32 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.367 -0.833 . . . . 72.329999999999998 109.387 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -91.71 -48.0 7.06 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.961 0.41 . . . . 64.040000000000006 110.447 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' HB2' HG21 ' A' ' 54' ' ' VAL . 18.6 m-20 -131.38 151.12 51.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.059 -0.519 . . . . 51.350000000000001 110.687 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.1 pt -113.96 151.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 71.420000000000002 110.447 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -137.98 106.64 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.207 -1.034 . . . . 70.340000000000003 108.207 177.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 HD12 ' HG2' ' A' ' 73' ' ' GLU . 47.7 mt -95.94 114.33 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 73.329999999999998 110.373 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 3.4 t30 -88.68 102.85 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 72.310000000000002 109.093 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -82.34 106.87 14.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.501 -0.318 . . . . 73.450000000000003 110.585 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.9 123.56 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.387 -0.597 . . . . 64.439999999999998 109.387 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -122.08 -17.62 7.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.047 0.451 . . . . 75.230000000000004 110.18 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.521 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 28.0 t-20 173.86 -47.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.186 -0.915 . . . . 72.0 109.449 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.3 Cg_endo -68.08 140.12 48.72 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.629 1.553 . . . . 61.299999999999997 110.123 168.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.55 -92.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.203 1.935 . . . . 73.109999999999999 112.482 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -146.09 163.12 36.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.962 -0.384 . . . . 73.340000000000003 109.962 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.44 -127.17 1.58 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.72 -0.552 . . . . 71.420000000000002 111.72 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.64 -17.73 56.1 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.627 2.218 . . . . 65.409999999999997 111.685 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 4.0 m-20 -63.96 -11.1 25.47 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.577 -0.738 . . . . 62.240000000000002 110.978 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 71.9 mmtt . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.071 -0.513 . . . . 73.129999999999995 110.431 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.56 0.219 . . . . 42.439999999999998 111.336 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 30.1 Cg_endo -64.28 143.52 83.55 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.366 2.044 . . . . 71.219999999999999 111.707 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -38.75 58.57 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.644 0.609 . . . . 75.400000000000006 112.644 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -55.01 -50.24 69.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.411 0.624 . . . . 64.109999999999999 110.843 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 -40.42 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.539 -0.755 . . . . 53.109999999999999 110.187 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.97 -53.75 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.763 -0.653 . . . . 72.230000000000004 111.367 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.7 pp -58.09 -48.87 78.83 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.952 0.406 . . . . 74.239999999999995 110.951 -172.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.69 -46.89 65.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.059 -0.519 . . . . 45.210000000000001 110.714 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -64.09 -45.0 90.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.495 -0.775 . . . . 74.099999999999994 110.419 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.3 -38.02 80.14 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 109.946 -0.39 . . . . 54.0 109.946 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.71 -43.19 72.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.008 0.433 . . . . 73.439999999999998 110.079 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 43.9 mt-10 -72.36 -43.36 64.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 71.329999999999998 111.067 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.82 73.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.416 0.627 . . . . 60.200000000000003 110.751 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 21.7 mmt -63.11 -13.63 38.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.425 -0.807 . . . . 75.010000000000005 111.213 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 40.3 ttt180 -74.8 -24.17 58.61 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.739 0.304 . . . . 74.349999999999994 111.15 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.14 -23.56 9.43 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.672 0.749 . . . . 74.109999999999999 109.911 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.532 ' O ' HG11 ' A' ' 26' ' ' VAL . 60.5 t -95.08 26.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.728 -1.123 . . . . 74.530000000000001 110.23 -178.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.8 p -150.08 169.23 2.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.592 -0.892 . . . . 71.209999999999994 108.592 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -103.2 100.22 17.02 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 110.012 -0.366 . . . . 72.219999999999999 110.012 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 97.1 Cg_endo -88.93 -3.75 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.758 2.306 . . . . 71.310000000000002 111.827 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.1 -57.75 5.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.05 0.452 . . . . 71.310000000000002 110.642 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.1 -17.49 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 73.010000000000005 109.994 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.19 52.62 1.71 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.746 -0.661 . . . . 22.32 112.999 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -109.67 142.66 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.116 0.484 . . . . 72.299999999999997 109.902 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' A' ' 37' ' ' ASP . 6.0 p30 -120.16 112.6 19.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 72.219999999999999 109.347 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD22 ' A' ' 38' ' ' LEU . 35.8 m -55.22 -30.05 24.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.544 -0.753 . . . . 63.140000000000001 112.086 -173.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.84 -31.5 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 74.450000000000003 111.377 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t70 -67.3 -19.56 65.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.462 -0.335 . . . . 65.349999999999994 111.351 -176.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -72.85 -17.5 61.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.084 0.469 . . . . 74.129999999999995 109.992 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.86 65.39 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.549 -0.751 . . . . 65.0 113.362 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.99 -20.14 17.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.14 0.495 . . . . 72.340000000000003 110.011 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG13 HD23 ' A' ' 44' ' ' LEU . 42.1 t -59.27 -9.62 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.695 -0.684 . . . . 71.430000000000007 111.422 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.18 -7.24 40.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.059 0.457 . . . . 73.5 110.0 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 58' ' ' ASP . . . -81.52 18.96 9.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.524 -0.762 . . . . 42.119999999999997 112.249 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.513 HD23 HG13 ' A' ' 41' ' ' VAL . 4.6 pp -89.16 129.8 35.7 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.939 -0.763 . . . . 73.409999999999997 108.939 171.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -161.59 113.29 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.75 -0.463 . . . . 72.319999999999993 109.75 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.1 p -93.02 116.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.178 0.513 . . . . 71.510000000000005 110.782 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.54 128.25 56.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.785 -0.643 . . . . 74.230000000000004 109.606 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 2.1 p-10 -101.66 161.06 13.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 110.651 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.54 -175.03 32.12 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.641 -0.984 . . . . 72.299999999999997 110.641 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.4 -35.48 71.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.271 0.558 . . . . 75.340000000000003 109.916 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.98 -18.17 63.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.157 -0.928 . . . . 73.239999999999995 110.584 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.64 172.37 18.41 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 112.527 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 29.1 m -105.85 111.03 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.461 -0.57 . . . . 74.319999999999993 109.461 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -112.26 133.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.671 0.272 . . . . 62.329999999999998 111.095 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -97.82 106.52 18.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.29 -0.414 . . . . 75.209999999999994 110.431 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 46.1 mt -75.61 141.0 42.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 73.219999999999999 109.707 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.5 HG23 ' HG3' ' A' ' 59' ' ' MET . 60.6 mt -144.64 113.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.148 -0.315 . . . . 74.450000000000003 110.148 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 30.7 m-20 -86.95 128.72 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.654 -0.248 . . . . 74.109999999999999 110.463 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.5 ' HG3' HG23 ' A' ' 57' ' ' ILE . 87.4 mtp -140.9 170.51 15.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 122.261 1.029 . . . . 63.030000000000001 113.051 -174.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 94' ' ' VAL . 19.9 p -149.51 172.74 14.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 113.294 -1.775 . . . . 72.519999999999996 109.089 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.26 145.3 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.685 -1.228 . . . . 63.329999999999998 107.685 164.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 p -59.69 -48.43 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 74.129999999999995 111.021 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -67.99 -38.64 82.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.394 -0.821 . . . . 75.319999999999993 111.335 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.71 8.16 2.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.102 -0.954 . . . . 70.209999999999994 111.361 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.08 -36.0 3.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.215 0.531 . . . . 71.150000000000006 109.887 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.9 116.18 53.11 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.643 -0.708 . . . . 75.25 110.039 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.94 77.38 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.812 2.341 . . . . 74.150000000000006 113.577 -173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.85 7.27 31.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.26 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 4.2 t -50.35 -60.21 3.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.569 -0.741 . . . . 73.230000000000004 112.113 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.92 -35.83 73.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.139 0.495 . . . . 74.019999999999996 110.335 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.9 t -65.32 -53.29 41.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.547 -0.751 . . . . 62.229999999999997 110.857 -175.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.579 HG12 ' HH2' ' A' ' 93' ' ' TRP . 1.8 pp -69.12 -36.63 74.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.428 -0.351 . . . . 71.540000000000006 110.246 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.402 ' N ' HD13 ' A' ' 72' ' ' ILE . 40.2 mt-10 -63.37 -45.81 89.41 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 74.510000000000005 110.603 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.52 -42.91 86.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 65.040000000000006 110.921 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 56.5 mt-30 -59.57 -54.05 50.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.11 0.481 . . . . 61.43 110.671 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.52 -53.98 51.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.579 -0.737 . . . . 62.340000000000003 110.603 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -55.05 -51.2 67.07 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.114 -0.494 . . . . 75.409999999999997 111.326 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.7 t -53.29 -51.76 61.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.077 -0.51 . . . . 60.229999999999997 111.01 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.06 -52.0 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.517 -0.473 . . . . 64.409999999999997 111.334 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.79 -39.46 85.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.761 0.315 . . . . 74.340000000000003 111.116 -172.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.07 -27.83 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.361 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.14 -33.15 33.42 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.857 -0.687 . . . . 64.409999999999997 112.194 -172.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 85' ' ' LEU . 15.0 m -95.97 -0.17 51.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 53.32 110.962 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.56 29.86 67.31 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.353 -0.451 . . . . 61.509999999999998 113.488 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 83' ' ' SER . 9.4 mp -79.8 -8.14 59.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.11 0.481 . . . . 72.400000000000006 110.233 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 53' ' ' THR . 9.9 p -164.02 161.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.601 -0.727 . . . . 74.140000000000001 109.332 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.18 -19.68 58.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.847 -0.427 . . . . 75.230000000000004 109.847 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 174.85 150.89 0.1 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.352 -170.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 18.6 pt -116.4 152.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 61.32 110.335 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 2.4 tpp180 -133.35 106.15 7.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.145 -0.687 . . . . 63.299999999999997 109.145 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.24 143.55 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.349 -0.387 . . . . 61.119999999999997 110.227 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -119.54 143.45 47.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 72.519999999999996 110.286 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.579 ' HH2' HG12 ' A' ' 72' ' ' ILE . 70.6 m95 -110.96 106.41 15.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 75.109999999999999 110.102 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 60' ' ' THR . 31.5 m -100.09 123.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.009 -0.676 . . . . 44.329999999999998 110.788 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -109.14 -35.37 6.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.023 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.582 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 3.1 t-20 -171.21 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.116 -0.947 . . . . 54.340000000000003 110.746 -173.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.582 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 53.1 Cg_endo -68.02 158.05 59.12 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.929 1.752 . . . . 55.409999999999997 112.213 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.87 175.0 6.9 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.963 2.442 . . . . 72.349999999999994 111.756 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 25.0 m0 -75.57 123.4 25.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.64 -0.254 . . . . 74.430000000000007 110.477 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.66 -123.02 1.11 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.384 -0.436 . . . . 72.239999999999995 112.428 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.24 -19.28 38.8 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.688 2.258 . . . . 43.539999999999999 111.452 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -17.03 16.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.035 -0.984 . . . . 63.030000000000001 111.713 177.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 29.1 mtpp . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.687 0.279 . . . . 74.0 111.034 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.273 -0.331 . . . . 63.119999999999997 112.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.48 -159.34 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.82 2.347 . . . . 61.100000000000001 112.017 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.65 169.94 12.18 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.667 -0.573 . . . . 62.119999999999997 111.667 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 t -76.88 78.54 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.492 -0.559 . . . . 60.0 109.492 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.7 ttp -91.66 171.33 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.654 . . . . 75.329999999999998 109.714 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 p -130.96 95.75 3.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.792 0.329 . . . . 64.099999999999994 111.704 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' HB2' HD23 ' A' ' 15' ' ' LEU . 1.8 mp0 -91.39 -4.13 56.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.233 -0.439 . . . . 63.100000000000001 110.474 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 m 74.63 -35.98 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.604 0.762 . . . . 72.310000000000002 112.295 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -78.25 147.96 34.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.669 -0.242 . . . . 53.030000000000001 110.699 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.18 154.12 0.14 Allowed Pre-proline 0 N--CA 1.471 0.601 0 O-C-N 123.588 0.555 . . . . 72.340000000000003 111.968 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.81 148.87 90.21 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.633 2.222 . . . . 73.439999999999998 111.474 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.62 -37.53 40.82 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.785 0.661 . . . . 73.140000000000001 112.785 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.53 -51.92 56.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.198 0.523 . . . . 72.409999999999997 110.243 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -46.41 65.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.251 -0.886 . . . . 71.209999999999994 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 7' ' ' GLU . 3.2 tm? -54.51 -50.15 68.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.566 -0.743 . . . . 75.109999999999999 110.785 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.55 -59.6 4.26 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.943 0.402 . . . . 71.0 111.301 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.62 77.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.182 -0.463 . . . . 42.509999999999998 111.224 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.98 -44.38 92.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.521 . . . . 73.140000000000001 110.837 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -68.46 -34.72 67.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.944 -0.391 . . . . 54.210000000000001 109.944 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.93 -43.32 91.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.695 -0.484 . . . . 74.200000000000003 109.695 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 44.7 mt-10 -66.46 -50.84 61.99 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.015 -0.539 . . . . 73.099999999999994 110.614 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -56.47 -44.24 80.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 111.044 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.0 mmt -62.68 -13.59 33.96 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.65 -0.705 . . . . 71.209999999999994 111.584 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 23.9 ttp85 -80.14 -30.64 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.394 -0.224 . . . . 75.140000000000001 110.394 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -99.8 -27.15 13.77 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.881 0.326 . . . . 70.299999999999997 111.881 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 22' ' ' ALA . 23.6 m -99.58 20.39 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.837 0.351 . . . . 63.310000000000002 111.658 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.2 p -128.0 171.5 16.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.628 -0.508 . . . . 71.25 109.628 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -107.31 90.86 6.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.356 -0.609 . . . . 72.299999999999997 109.356 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.99 -1.43 10.82 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.3 2.0 . . . . 64.420000000000002 111.444 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.45 -57.69 5.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.57 -0.741 . . . . 75.439999999999998 110.5 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.4 -10.02 14.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 75.510000000000005 110.235 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.11 52.84 2.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.205 -0.521 . . . . 74.239999999999995 113.124 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -112.45 141.78 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.749 -0.463 . . . . 71.319999999999993 109.749 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -122.37 112.55 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.987 -0.552 . . . . 74.299999999999997 109.685 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.469 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.0 m -54.81 -34.47 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.108 -0.497 . . . . 74.120000000000005 112.12 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 9.3 p -56.0 -30.66 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.447 -0.342 . . . . 71.129999999999995 111.322 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.11 -18.36 63.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.162 -0.472 . . . . 74.239999999999995 111.503 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.9 mm? -69.03 -12.54 61.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.443 0.64 . . . . 71.150000000000006 109.861 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.35 21.89 62.69 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 114.881 -1.054 . . . . 74.219999999999999 114.849 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' O ' HD21 ' A' ' 40' ' ' LEU . 3.3 tt -98.19 -31.71 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.902 -1.147 . . . . 74.200000000000003 107.902 164.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 26.0 t -65.69 -8.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.862 -1.063 . . . . 75.239999999999995 110.831 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -59.39 -26.11 64.85 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.073 0.464 . . . . 72.519999999999996 109.762 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.06 91.23 1.72 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.595 -0.729 . . . . 71.420000000000002 112.015 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.04 136.8 38.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.534 -0.543 . . . . 73.219999999999999 109.534 174.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.55 109.37 7.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.568 -0.53 . . . . 44.119999999999997 109.568 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 46' ' ' VAL . 17.2 m -94.24 108.75 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.693 0.758 . . . . 72.409999999999997 109.757 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -100.13 120.96 40.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.455 -0.793 . . . . 64.420000000000002 110.027 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -107.08 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.678 -0.49 . . . . 65.120000000000005 109.678 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.85 -163.75 12.54 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.216 -0.516 . . . . 72.519999999999996 112.003 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.9 -27.9 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.515 0.674 . . . . 74.109999999999999 109.692 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.43 -39.33 81.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.013 -0.994 . . . . 63.329999999999998 109.77 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.84 -171.82 43.49 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.682 -0.69 . . . . 54.299999999999997 111.852 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.2 m -124.48 104.42 8.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.379 -0.6 . . . . 64.099999999999994 109.379 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.4 p -114.99 124.26 71.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.346 0.593 . . . . 64.239999999999995 112.1 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -92.08 107.53 19.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.766 . . . . 71.140000000000001 109.993 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -87.64 130.32 34.82 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.636 -0.505 . . . . 62.140000000000001 109.636 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 59' ' ' MET . 45.1 mt -130.86 113.82 25.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.75 0.31 . . . . 63.530000000000001 110.622 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.36 116.5 20.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 72.420000000000002 109.723 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.495 ' HG3' HG21 ' A' ' 57' ' ' ILE . 81.9 mtp -134.61 170.85 15.17 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.326 0.584 . . . . 72.310000000000002 111.373 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -152.59 161.13 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.289 -0.869 . . . . 74.519999999999996 109.245 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.57 174.1 10.63 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.362 -0.607 . . . . 74.530000000000001 109.362 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.7 m -44.18 -42.43 6.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.483 0.489 . . . . 74.420000000000002 112.04 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -141.37 4.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.428 -0.351 . . . . 64.239999999999995 110.325 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.64 8.88 0.72 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.744 0.646 . . . . 64.239999999999995 112.744 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.73 15.06 15.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.224 0.535 . . . . 63.32 110.285 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 68' ' ' LEU . 35.1 m -91.46 144.2 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.756 . . . . 73.239999999999995 110.296 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 26.6 Cg_exo -64.66 10.38 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 123.346 2.697 . . . . 74.420000000000002 113.377 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.587 HD21 ' HB ' ' A' ' 71' ' ' VAL . 1.2 tt -75.08 -15.12 60.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.259 -0.645 . . . . 74.019999999999996 109.259 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -57.52 -45.76 84.6 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.651 -0.704 . . . . 62.130000000000003 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.51 -41.64 85.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.251 0.548 . . . . 74.120000000000005 110.253 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.587 ' HB ' HD21 ' A' ' 68' ' ' LEU . 60.3 t -63.4 -52.25 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.251 -0.886 . . . . 52.109999999999999 111.078 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.97 -41.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 120.779 -0.368 . . . . 72.209999999999994 111.13 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.23 -51.26 68.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.6 0.238 . . . . 73.340000000000003 110.803 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.84 -51.83 66.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 74.430000000000007 110.9 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -64.2 -43.97 93.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.356 -0.384 . . . . 72.329999999999998 111.146 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 -59.19 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 65.349999999999994 110.23 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.474 HH12 ' HB2' ' A' ' 107' ' ' ASP . 61.7 ttt180 -55.17 -45.95 75.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.552 -0.295 . . . . 71.409999999999997 110.83 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -55.16 -47.49 75.09 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.631 0.582 . . . . 74.25 111.131 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.3 -51.05 16.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.503 -0.317 . . . . 74.120000000000005 111.083 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.03 -39.62 82.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 111.377 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.87 -28.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.106 0.479 . . . . 52.43 109.882 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.07 -27.97 47.35 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.139 -0.553 . . . . 65.120000000000005 111.739 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 85' ' ' LEU . 19.4 m -70.93 -23.21 62.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.966 0.412 . . . . 74.040000000000006 110.461 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.09 -10.02 59.18 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.992 -0.549 . . . . 73.409999999999997 113.125 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 83' ' ' SER . 9.5 mp -61.51 -39.43 90.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.648 0.261 . . . . 62.240000000000002 110.652 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 m -143.39 152.29 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.12 -0.491 . . . . 75.019999999999996 109.752 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.12 -40.67 6.36 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 75.549999999999997 110.059 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 20.0 m-20 -102.99 139.43 38.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.923 -0.58 . . . . 72.25 109.9 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 9.4 pt -133.98 169.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.151 -0.685 . . . . 75.409999999999997 109.151 170.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 89' ' ' ILE . 22.8 mtt85 -156.35 106.61 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.134 -0.485 . . . . 64.340000000000003 109.837 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.73 113.46 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.819 -0.808 . . . . 71.140000000000001 108.819 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 103' ' ' LYS . 4.4 p-10 -105.53 140.69 38.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.981 0.419 . . . . 65.209999999999994 110.687 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.82 106.64 17.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.715 -0.675 . . . . 74.5 109.597 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG11 ' CD1' ' A' ' 99' ' ' TRP . 10.7 m -113.04 131.09 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 72.109999999999999 112.065 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -152.73 8.86 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.023 -0.989 . . . . 72.129999999999995 110.621 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -167.12 -60.05 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.586 0.354 . . . . 72.5 111.275 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.17 159.51 30.02 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.042 1.828 . . . . 75.120000000000005 113.097 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.7 137.07 37.72 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.053 2.502 . . . . 52.32 111.633 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.656 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 12.9 m-90 -53.88 109.79 0.51 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.724 0.64 . . . . 74.430000000000007 111.313 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.3 -78.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.862 -0.608 . . . . 63.399999999999999 111.817 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.59 -37.05 90.82 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.782 2.322 . . . . 64.540000000000006 111.375 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.54 -20.62 47.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.221 -0.899 . . . . 61.25 111.6 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.656 ' HZ3' ' HB3' ' A' ' 99' ' ' TRP . 54.4 mttp -89.4 10.55 22.15 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.753 0.279 . . . . 70.439999999999998 111.753 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -96.44 92.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.849 -0.426 . . . . 73.0 109.849 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.6 p -85.14 -179.26 6.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.212 -0.449 . . . . 73.540000000000006 111.305 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -29.9 44.14 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.958 -0.564 . . . . 65.420000000000002 111.484 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.474 ' HB2' HH12 ' A' ' 77' ' ' ARG . 32.1 t70 -57.13 -48.99 77.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.868 -0.606 . . . . 63.409999999999997 110.579 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.85 22.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.811 -0.631 . . . . 53.219999999999999 112.653 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -74.19 -50.75 17.87 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.054 0.39 . . . . 74.439999999999998 112.054 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -79.4 -34.41 41.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.993 0.425 . . . . 73.230000000000004 111.274 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.484 ' HG2' ' HD2' ' A' ' 117' ' ' PHE . 41.9 mt-30 -102.12 26.63 7.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.061 -0.518 . . . . 72.5 111.017 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.61 HD21 ' H ' ' A' ' 113' ' ' ARG . 1.6 tt -71.23 147.52 48.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.196 -0.668 . . . . 74.230000000000004 109.196 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.61 ' H ' HD21 ' A' ' 112' ' ' LEU . 1.7 tmm_? -57.45 -35.07 69.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 72.310000000000002 110.444 -175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -33.01 67.0 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.025 -0.534 . . . . 63.229999999999997 110.966 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.2 mm? -83.33 -34.13 25.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 71.319999999999993 109.823 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.15 15.09 81.31 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.784 -0.644 . . . . 74.439999999999998 112.239 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.484 ' HD2' ' HG2' ' A' ' 111' ' ' GLN . 74.2 t80 -74.21 143.08 45.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 73.340000000000003 110.79 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.6 m -147.39 129.57 15.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.676 -0.693 . . . . 72.420000000000002 109.278 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.205 -0.903 . . . . 60.43 110.8 -176.53 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 112.21 -0.356 . . . . 52.119999999999997 112.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.05 64.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.536 2.158 . . . . 64.209999999999994 112.305 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' HA3' ' SD ' ' A' ' 5' ' ' MET . . . 148.95 -52.79 0.53 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 111.74 -0.544 . . . . 74.140000000000001 111.74 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p 48.57 43.96 20.59 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.086 0.554 . . . . 75.140000000000001 111.425 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.498 ' SD ' ' HA3' ' A' ' 3' ' ' GLY . 3.5 mpp? -70.82 -168.86 0.3 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.709 -0.678 . . . . 75.109999999999999 110.943 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m -133.68 -63.07 0.76 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.704 0.288 . . . . 74.329999999999998 111.267 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.659 ' HB3' HD22 ' A' ' 15' ' ' LEU . 1.1 mp0 53.4 36.2 22.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.57 0.7 . . . . 73.340000000000003 110.426 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -77.39 -16.68 58.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.423 -0.808 . . . . 72.540000000000006 111.746 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.406 ' O ' HD11 ' A' ' 15' ' ' LEU . 22.7 p -93.34 154.25 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 74.209999999999994 111.158 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 149.36 0.12 Allowed Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.359 0.664 . . . . 71.510000000000005 112.377 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.65 153.72 54.38 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.55 2.167 . . . . 72.200000000000003 111.209 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.6 -40.69 28.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.579 0.585 . . . . 51.240000000000002 112.579 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.54 -50.14 68.61 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.165 0.507 . . . . 73.140000000000001 111.086 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -81.29 -47.48 13.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 75.219999999999999 110.452 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 7' ' ' GLU . 46.5 tp -54.04 -48.33 70.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.949 -1.023 . . . . 61.219999999999999 112.463 -172.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 tp -54.63 -59.28 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.68 0.276 . . . . 74.239999999999995 110.866 -174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -65.36 -40.19 93.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 74.519999999999996 110.829 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.21 -48.94 79.6 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.807 -0.633 . . . . 60.219999999999999 110.668 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.447 HG22 ' HG2' ' A' ' 23' ' ' MET . 7.9 p -73.93 -32.79 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 70.230000000000004 109.675 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.1 -39.04 77.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.106 -0.497 . . . . 73.239999999999995 110.263 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 41.9 mt-10 -72.65 -51.7 18.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.429 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.99 -48.77 75.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 74.319999999999993 111.037 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.447 ' HG2' HG22 ' A' ' 19' ' ' VAL . 23.8 mmt -58.0 -13.55 4.85 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.51 -0.768 . . . . 62.520000000000003 111.832 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -87.97 -35.8 17.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.68 0.276 . . . . 74.140000000000001 110.584 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -90.15 -26.82 19.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.439 -0.346 . . . . 71.400000000000006 111.44 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 22' ' ' ALA . 29.7 m -98.12 27.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.92 0.391 . . . . 71.219999999999999 111.35 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.96 162.68 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 62.039999999999999 110.172 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -110.15 82.92 2.77 Favored Pre-proline 0 C--O 1.233 0.218 0 N-CA-C 109.071 -0.714 . . . . 54.530000000000001 109.071 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 14.38 2.07 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.736 2.291 . . . . 74.439999999999998 112.618 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.55 -58.34 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 72.129999999999995 110.145 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.481 ' HB2' HD12 ' A' ' 33' ' ' ILE . 87.9 mt -115.78 3.64 13.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 75.230000000000004 110.438 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.44 39.72 4.96 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.037 -0.602 . . . . 72.030000000000001 112.633 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.481 HD12 ' HB2' ' A' ' 31' ' ' LEU . 3.7 mp -88.68 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.843 -0.799 . . . . 71.129999999999995 108.843 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 52.1 t-20 -143.83 120.14 10.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.102 -0.333 . . . . 74.530000000000001 110.102 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -59.83 -32.03 48.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 71.329999999999998 110.739 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.403 HG21 HG13 ' A' ' 41' ' ' VAL . 91.7 t -59.27 -26.41 33.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.897 -0.592 . . . . 62.350000000000001 110.566 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 8.3 t0 -59.2 -27.46 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.971 -0.559 . . . . 75.200000000000003 111.022 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.72 -8.41 57.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.755 0.312 . . . . 71.129999999999995 110.93 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.25 22.95 59.25 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.001 -0.545 . . . . 62.420000000000002 113.03 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.684 HD21 HG22 ' A' ' 94' ' ' VAL . 39.2 tp -93.3 -26.29 17.37 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.616 -0.343 . . . . 72.150000000000006 110.249 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG13 HG21 ' A' ' 36' ' ' VAL . 11.8 p -62.0 -12.19 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.924 -0.58 . . . . 72.230000000000004 110.824 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.94 -14.09 42.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.826 -0.624 . . . . 72.439999999999998 110.264 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.78 67.89 2.59 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.196 -0.761 . . . . 62.530000000000001 111.196 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.0 pp -120.96 141.77 50.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.103 -0.332 . . . . 64.099999999999994 110.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.03 110.77 1.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 71.340000000000003 110.185 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 38.7 t -93.66 126.06 46.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.441 -0.345 . . . . 74.219999999999999 110.304 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -121.35 133.06 55.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.428 -0.351 . . . . 75.430000000000007 110.662 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.2 p-10 -92.4 147.04 23.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.144 -0.687 . . . . 75.549999999999997 109.144 173.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.78 177.87 35.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.729 . . . . 62.539999999999999 112.171 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.08 -41.62 65.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.21 0.529 . . . . 74.400000000000006 111.059 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.54 17.73 9.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.54 -0.754 . . . . 73.040000000000006 111.701 -174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.41 174.91 17.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.151 -0.547 . . . . 73.219999999999999 112.981 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 13.9 m -102.79 109.15 20.64 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.126 -0.324 . . . . 74.219999999999999 110.126 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.73 135.97 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 75.209999999999994 111.168 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB3' HG13 ' A' ' 86' ' ' VAL . . . -93.78 105.02 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 61.310000000000002 109.917 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 103' ' ' LYS . 69.9 mt -70.97 113.39 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.538 -0.542 . . . . 73.030000000000001 109.538 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 63.9 mt -120.69 114.04 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.264 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -89.9 116.51 28.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.886 0.374 . . . . 75.409999999999997 110.188 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.1 mtp -125.57 170.66 11.25 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.538 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -137.67 150.43 47.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.915 0.388 . . . . 73.409999999999997 110.7 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.753 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 3.2 mm? -118.17 147.5 43.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.312 -0.996 . . . . 53.439999999999998 108.312 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 m -42.42 -51.74 4.85 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.614 0.598 . . . . 63.009999999999998 112.614 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 t -116.83 6.54 13.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.567 0.222 . . . . 71.120000000000005 110.723 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.22 8.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.282 0.475 . . . . 71.340000000000003 112.282 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.93 16.67 12.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.591 0.71 . . . . 75.209999999999994 109.324 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 61' ' ' LEU . 10.3 m -72.25 133.24 83.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.797 -1.092 . . . . 44.43 110.753 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.38 -3.45 13.01 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.453 2.102 . . . . 75.319999999999993 111.694 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.21 -0.39 36.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 75.209999999999994 111.195 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.1 t -62.54 -48.91 77.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.546 0.212 . . . . 73.099999999999994 110.551 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.255 0.55 . . . . 71.239999999999995 109.794 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 81.1 t -67.48 -52.61 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.78 -0.645 . . . . 73.549999999999997 110.912 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -68.31 -35.94 73.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 121.03 -0.268 . . . . 73.340000000000003 110.819 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.549 ' N ' HD13 ' A' ' 72' ' ' ILE . 45.3 mt-10 -58.37 -50.67 72.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.351 -0.611 . . . . 73.430000000000007 109.351 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.07 -51.37 69.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.729 . . . . 64.129999999999995 111.112 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 23.7 mm-40 -60.87 -56.76 17.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.999 0.428 . . . . 75.140000000000001 110.781 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' HD21 ' A' ' 80' ' ' LEU . 32.4 t -61.27 -53.58 54.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.898 -0.592 . . . . 60.329999999999998 110.592 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HG2' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -57.02 -46.96 81.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.079 -0.509 . . . . 74.109999999999999 110.434 -176.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 t -58.93 -43.36 91.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 73.349999999999994 110.95 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.97 -51.56 17.88 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.944 -0.302 . . . . 72.25 110.869 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.523 HD11 HD13 ' A' ' 85' ' ' LEU . 4.5 mm? -56.12 -41.07 74.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.312 -0.404 . . . . 64.420000000000002 110.771 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.76 -27.8 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 63.409999999999997 110.467 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.43 -47.58 56.6 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.842 -0.695 . . . . 74.450000000000003 111.766 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -77.36 -22.91 51.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.865 0.364 . . . . 61.43 110.029 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.25 26.32 28.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.155 -0.475 . . . . 44.049999999999997 113.262 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 80' ' ' LEU . 83.0 mt -62.55 -33.92 75.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.156 0.503 . . . . 75.120000000000005 110.168 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 55' ' ' ALA . 5.0 m -147.06 164.82 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.574 -0.739 . . . . 74.120000000000005 109.734 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.95 -40.96 75.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 62.0 110.188 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -158.15 172.89 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.672 -0.862 . . . . 63.310000000000002 108.672 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.517 HG12 ' HG2' ' A' ' 77' ' ' ARG . 16.6 pt -131.95 145.09 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.889 0.376 . . . . 71.310000000000002 110.074 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 4.5 tpt180 -120.66 106.77 12.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.625 -0.509 . . . . 75.329999999999998 109.625 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.7 mt -88.66 140.86 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 65.319999999999993 110.675 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.659 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -118.7 127.48 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.407 -0.59 . . . . 71.430000000000007 109.407 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.436 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.3 m-90 -87.23 106.62 18.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.891 -0.411 . . . . 73.450000000000003 109.891 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.684 HG22 HD21 ' A' ' 40' ' ' LEU . 14.6 m -118.5 158.95 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.746 0.308 . . . . 75.450000000000003 110.557 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -177.68 -31.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 73.010000000000005 110.262 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.686 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 44.2 t30 -155.27 -49.2 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.911 -0.586 . . . . 74.409999999999997 110.168 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 5.6 Cg_exo -76.68 147.76 28.24 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.07 1.846 . . . . 61.32 110.687 169.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 14.7 Cg_exo -69.58 -163.97 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.775 2.317 . . . . 75.140000000000001 112.439 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.4 m-90 -89.84 124.4 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 73.120000000000005 110.942 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -113.48 0.3 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.181 -0.533 . . . . 61.329999999999998 112.213 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.39 -17.84 54.25 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.724 2.282 . . . . 75.019999999999996 111.568 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.537 ' HB2' ' ND2' ' A' ' 92' ' ' ASN . 7.0 m-20 -67.09 -3.92 8.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 71.439999999999998 111.373 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 35.8 mmtm -76.54 -18.52 58.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.7 0.286 . . . . 71.510000000000005 110.319 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -75.75 99.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.766 -0.457 . . . . 72.299999999999997 109.766 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.441 ' HB ' ' OE1' ' A' ' 73' ' ' GLU . 41.0 p -59.71 154.08 18.84 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.74 -0.663 . . . . 74.209999999999994 112.175 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.99 -26.78 63.29 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.004 -0.739 . . . . 75.329999999999998 109.004 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 10.9 t70 -57.01 -39.44 74.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.439 -0.801 . . . . 61.219999999999999 110.035 171.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -39.99 53.85 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.85 -0.614 . . . . 72.030000000000001 112.855 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -60.28 -33.85 72.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.968 0.414 . . . . 73.549999999999997 111.329 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -75.72 -14.06 60.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 111.31 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.474 ' HA ' HD21 ' A' ' 115' ' ' LEU . 43.3 mt-30 -112.11 77.26 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.268 0.556 . . . . 65.209999999999994 110.842 -172.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -111.22 -172.82 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.327 -0.851 . . . . 72.230000000000004 109.826 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -60.83 -35.94 77.84 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.917 0.389 . . . . 71.010000000000005 111.192 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.31 -16.68 62.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 111.587 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.474 HD21 ' HA ' ' A' ' 111' ' ' GLN . 53.0 tp -73.72 -13.08 60.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.853 0.359 . . . . 73.420000000000002 110.59 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.04 -4.7 73.27 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.188 -0.53 . . . . 42.409999999999997 112.64 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.08 40.25 1.7 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.07 0.462 . . . . 75.109999999999999 110.796 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -75.42 138.42 41.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.071 -0.513 . . . . 73.310000000000002 110.764 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.822 -0.608 . . . . 61.340000000000003 110.049 -178.408 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.706 -0.558 . . . . 44.130000000000003 111.706 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.85 -70.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.707 2.272 . . . . 63.520000000000003 112.124 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.82 75.95 1.23 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.037 -0.601 . . . . 63.149999999999999 111.84 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 m -64.3 -37.53 87.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.033 0.444 . . . . 72.439999999999998 110.297 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 19.9 ptp -108.36 101.15 10.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.561 -0.533 . . . . 74.340000000000003 109.561 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -144.07 -65.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.041 -0.527 . . . . 72.430000000000007 110.543 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.59 103.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.567 . . . . 74.530000000000001 110.855 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.4 m -104.86 104.03 13.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.430000000000007 110.711 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.464 ' O ' HD13 ' A' ' 15' ' ' LEU . 32.3 t -158.55 149.3 20.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.759 -0.46 . . . . 72.439999999999998 109.759 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . 67.96 162.78 0.14 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.303 0.377 . . . . 64.120000000000005 111.742 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 28.3 Cg_endo -64.49 -178.98 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.352 2.034 . . . . 65.530000000000001 111.836 172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.6 -66.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.081 0.771 . . . . 60.32 113.081 -170.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -65.84 -41.07 92.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.504 -0.317 . . . . 75.25 111.543 -174.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -60.99 -39.4 89.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.412 . . . . 61.109999999999999 110.678 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 9' ' ' SER . 38.4 tp -59.01 -43.38 91.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.286 -0.416 . . . . 70.140000000000001 110.349 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -57.71 -52.21 66.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 74.299999999999997 110.087 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.69 -51.96 67.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.725 -0.67 . . . . 73.310000000000002 110.94 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.6 -48.04 82.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.915 -0.584 . . . . 64.310000000000002 111.125 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.1 p -66.64 -32.97 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.131 -0.322 . . . . 72.230000000000004 110.131 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.28 -45.22 92.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.092 -0.336 . . . . 73.310000000000002 110.092 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.57 -51.56 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.205 0.526 . . . . 65.450000000000003 110.0 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.99 -47.38 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.407 -0.815 . . . . 71.209999999999994 110.889 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.4 mmt -62.54 -13.39 30.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.354 0.502 . . . . 60.530000000000001 112.354 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HA ' HH11 ' A' ' 24' ' ' ARG . 2.7 tpp180 -99.06 -13.8 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.142 -0.349 . . . . 74.439999999999998 111.059 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -119.52 -26.5 5.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.295 0.569 . . . . 63.539999999999999 110.411 -173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.08 -15.8 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.946 0.879 . . . . 73.310000000000002 109.805 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -92.95 163.77 2.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 114.917 -1.038 . . . . 74.439999999999998 109.67 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -104.0 91.86 4.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.453 -0.943 . . . . 52.210000000000001 108.453 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.01 -4.31 11.21 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.483 2.122 . . . . 63.030000000000001 111.944 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -69.02 -57.64 5.17 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.036 -0.529 . . . . 74.129999999999995 110.288 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.45 -17.49 17.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 71.439999999999998 110.546 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.82 43.34 3.62 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.026 -0.533 . . . . 73.120000000000005 113.351 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.0 mp -108.28 140.82 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.559 -0.534 . . . . 74.25 109.559 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.45 121.2 37.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 70.150000000000006 109.411 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.19 -27.38 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.972 -0.558 . . . . 73.430000000000007 112.014 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 p -62.19 -24.5 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.993 0.425 . . . . 72.420000000000002 110.817 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.94 -15.45 62.98 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.122 -0.49 . . . . 61.240000000000002 111.333 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.76 -16.67 61.75 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.039 0.447 . . . . 73.349999999999994 110.051 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.69 22.72 64.4 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.628 -0.715 . . . . 71.420000000000002 114.12 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -98.71 -31.35 11.95 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.143 -0.688 . . . . 73.109999999999999 109.143 170.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.47 -19.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.153 -0.93 . . . . 65.0 112.342 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.26 -23.81 16.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.786 0.327 . . . . 74.209999999999994 110.742 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.25 76.08 2.18 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.504 -0.638 . . . . 44.200000000000003 111.504 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -128.3 132.69 48.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 74.439999999999998 110.792 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -149.75 173.0 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.509 -0.922 . . . . 71.230000000000004 108.509 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 55' ' ' ALA . 20.5 m -137.2 142.63 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.791 -0.448 . . . . 75.450000000000003 109.791 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.02 121.01 43.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.987 -0.375 . . . . 63.43 109.987 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 112.43 15.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.116 -0.493 . . . . 74.109999999999999 109.819 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.07 158.34 14.53 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.064 -0.589 . . . . 41.32 112.273 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.32 -34.99 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.863 0.465 . . . . 63.43 111.377 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.63 -0.7 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 73.409999999999997 111.186 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.47 155.1 6.42 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.316 -0.468 . . . . 62.539999999999999 112.318 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -74.7 121.68 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.251 -0.277 . . . . 65.120000000000005 110.251 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.75 135.26 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 110.125 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HA ' HG13 ' A' ' 46' ' ' VAL . . . -98.8 124.48 43.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.398 0.142 . . . . 62.140000000000001 110.802 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.2 mt -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.168 -0.308 . . . . 74.219999999999999 110.168 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.476 HG22 ' HG3' ' A' ' 59' ' ' MET . 30.9 mm -126.28 112.72 30.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 120.686 0.279 . . . . 64.299999999999997 110.384 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m-20 -80.24 121.69 25.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.497 -0.557 . . . . 73.200000000000003 109.497 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 85.7 mtp -136.62 171.2 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.709 0.29 . . . . 70.129999999999995 110.63 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 40' ' ' LEU . 15.2 t -152.92 163.14 40.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.07 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.8 mt -132.47 160.35 36.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.314 -0.624 . . . . 73.319999999999993 109.314 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -48.02 -54.6 12.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.585 0.553 . . . . 63.009999999999998 112.117 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 t -111.64 -9.68 14.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.771 0.32 . . . . 54.240000000000002 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 63.68 8.4 3.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.86 -0.609 . . . . 74.540000000000006 112.194 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.38 10.48 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.605 0.717 . . . . 73.120000000000005 109.072 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.425 ' HB3' HD11 ' A' ' 68' ' ' LEU . 27.8 m -75.63 140.31 71.44 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 114.884 -1.053 . . . . 65.439999999999998 110.362 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.85 15.35 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.804 2.336 . . . . 70.129999999999995 112.81 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 68' ' ' LEU . 7.0 mp -86.99 -5.78 58.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.38 -0.373 . . . . 74.209999999999994 110.459 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.6 t -61.58 -53.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.461 -0.336 . . . . 64.420000000000002 110.964 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.32 -27.65 67.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 74.409999999999997 110.266 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.512 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 70.0 t -65.01 -52.5 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.51 . . . . 55.039999999999999 110.369 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.565 HD11 ' HE1' ' A' ' 93' ' ' TRP . 2.8 pp -68.74 -29.58 44.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.637 0.256 . . . . 64.329999999999998 110.753 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' N ' HD13 ' A' ' 72' ' ' ILE . 44.8 mt-10 -62.4 -48.16 80.95 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.409 -0.359 . . . . 75.310000000000002 110.131 173.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.87 -46.81 87.79 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.949 0.404 . . . . 74.439999999999998 110.419 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 96.6 mt-30 -55.53 -53.34 57.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.694 . . . . 74.049999999999997 111.143 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -68.04 -52.26 37.38 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.03 -0.532 . . . . 75.340000000000003 111.123 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -54.78 -46.38 74.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.652 -0.129 . . . . 63.439999999999998 110.652 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.2 p -60.27 -45.08 94.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.339 -0.392 . . . . 64.25 111.425 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.6 20.26 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.811 -0.355 . . . . 40.310000000000002 110.847 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.96 -29.49 70.85 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.884 0.373 . . . . 75.510000000000005 110.977 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -84.19 -27.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 54.329999999999998 109.925 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.5 -31.04 77.56 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.448 -0.661 . . . . 62.140000000000001 111.448 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 46.8 m -92.55 -10.02 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.379 . . . . 75.400000000000006 110.312 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.63 43.38 92.19 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.93 -0.577 . . . . 73.109999999999999 112.262 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 74.6 mt -86.43 -36.48 19.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.838 0.352 . . . . 74.530000000000001 110.9 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 55' ' ' ALA . 29.6 m -139.24 162.39 27.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.921 -0.581 . . . . 74.409999999999997 110.242 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.35 -37.28 28.53 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.855 0.36 . . . . 42.439999999999998 110.217 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.5 167.92 28.95 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.44 0.638 . . . . 53.43 110.715 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 55' ' ' ALA . 44.6 pt -124.44 135.55 63.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.42 -0.809 . . . . 73.409999999999997 110.689 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.526 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.81 106.32 16.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.276 -0.638 . . . . 54.43 109.276 171.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.32 120.02 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.782 -0.822 . . . . 74.430000000000007 108.782 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -111.5 129.93 55.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.87 -0.419 . . . . 73.129999999999995 109.87 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.565 ' HE1' HD11 ' A' ' 72' ' ' ILE . 4.8 m-90 -100.76 106.13 17.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 72.209999999999994 110.541 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.93 124.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 73.319999999999993 109.987 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -139.19 -6.93 1.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 74.140000000000001 111.845 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.429 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.5 t30 174.93 -52.82 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 122.409 0.283 . . . . 63.039999999999999 110.869 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 61.6 Cg_endo -70.55 145.75 53.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.739 1.626 . . . . 71.299999999999997 112.004 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.71 142.24 82.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.648 2.232 . . . . 74.310000000000002 111.647 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -46.63 109.24 0.18 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 123.691 0.619 . . . . 71.400000000000006 111.904 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -87.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.766 -0.652 . . . . 52.119999999999997 112.132 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.37 -30.49 80.76 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.928 2.419 . . . . 75.340000000000003 112.365 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -65.16 -10.67 33.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 73.129999999999995 111.18 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.08 -3.51 57.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.277 -0.42 . . . . 71.120000000000005 111.623 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.34 98.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 61.039999999999999 110.875 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 90' ' ' ARG . 17.7 p -76.52 -178.11 4.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.571 -0.741 . . . . 73.329999999999998 112.305 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 14.3 pt-20 -51.25 -21.07 1.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.508 -0.769 . . . . 74.230000000000004 112.686 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -52.5 64.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.793 0.33 . . . . 72.049999999999997 110.34 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.35 -42.5 9.25 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 116.083 -0.508 . . . . 73.239999999999995 111.975 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.54 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 59.5 ttt180 -53.52 -42.31 67.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.155 0.582 . . . . 71.239999999999995 111.85 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.73 -24.64 63.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.906 -0.588 . . . . 62.210000000000001 111.26 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -124.54 90.41 3.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.299999999999997 110.846 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.4 tp -152.71 154.93 36.25 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.099 0.476 . . . . 53.32 110.513 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -67.79 -30.22 69.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 75.299999999999997 111.02 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.38 -13.69 32.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.506 . . . . 64.540000000000006 112.023 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.504 ' O ' HD21 ' A' ' 115' ' ' LEU . 5.9 tt -86.49 -26.08 24.79 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.723 -0.473 . . . . 63.049999999999997 109.723 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.83 21.78 2.0 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.958 -0.564 . . . . 72.420000000000002 114.135 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -93.54 -8.05 42.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.233 0.517 . . . . 72.430000000000007 109.942 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.4 m -80.51 108.28 14.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.544 -0.753 . . . . 54.329999999999998 111.558 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.757 -0.656 . . . . 70.310000000000002 109.755 175.094 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.596 -0.602 . . . . 20.219999999999999 111.596 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.13 -62.71 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.6 2.2 . . . . 74.140000000000001 111.781 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.3 16.45 8.61 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.834 -0.621 . . . . 72.150000000000006 111.626 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -66.78 84.0 0.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.709 0.29 . . . . 75.109999999999999 110.423 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.413 ' HE3' ' HB2' ' A' ' 5' ' ' MET . 36.0 ttm -156.89 34.43 0.3 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.614 0.721 . . . . 71.519999999999996 109.538 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 p -85.57 1.42 49.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.23 -0.895 . . . . 51.25 110.742 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.32 103.61 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.166 -0.924 . . . . 72.25 110.495 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -91.36 95.13 9.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.989 -0.551 . . . . 72.25 110.822 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -162.0 140.45 9.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.721 -0.474 . . . . 75.340000000000003 109.721 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . 64.74 160.93 0.12 Allowed Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 123.477 0.485 . . . . 74.510000000000005 111.965 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 44.0 Cg_endo -68.83 169.02 18.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.258 1.972 . . . . 52.43 111.992 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.48 3.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.43 0.9 . . . . 61.439999999999998 113.43 -172.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -63.92 -48.56 76.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.921 0.391 . . . . 63.020000000000003 111.001 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -63.34 -40.63 97.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.763 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.79 -46.36 88.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 73.25 110.14 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 tp -54.93 -55.37 31.36 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.41 -0.359 . . . . 63.020000000000003 110.998 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.987 -0.551 . . . . 74.219999999999999 111.292 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.3 -48.39 81.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.894 -0.594 . . . . 74.129999999999995 111.12 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.43 -33.83 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.928 -0.397 . . . . 74.120000000000005 109.928 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -58.96 -48.74 80.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.088 -0.338 . . . . 64.109999999999999 110.088 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.15 -45.61 73.08 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 74.129999999999995 110.839 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.15 -38.85 74.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 72.109999999999999 110.679 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.5 mmt -62.69 -12.68 25.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.606 -0.725 . . . . 72.239999999999995 111.563 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -85.79 -23.36 27.26 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.623 0.249 . . . . 72.450000000000003 110.82 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.63 -27.43 9.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.363 0.505 . . . . 74.040000000000006 112.363 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.5 m -95.92 21.11 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.22 0.533 . . . . 73.120000000000005 111.099 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 5.2 p -134.27 161.32 40.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 71.319999999999993 110.589 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.25 93.68 1.94 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.957 -1.127 . . . . 51.049999999999997 107.957 165.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 95.6 Cg_endo -82.93 -9.8 10.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.226 1.951 . . . . 72.230000000000004 111.392 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.5 -41.81 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.146 -0.934 . . . . 72.109999999999999 110.439 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.94 -18.56 11.24 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.276 -0.42 . . . . 74.329999999999998 110.377 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.86 44.02 3.45 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.224 -0.512 . . . . 74.239999999999995 113.655 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -121.64 141.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.965 -0.754 . . . . 61.25 108.965 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' OD1' ' HB ' ' A' ' 36' ' ' VAL . 8.7 p30 -107.73 141.85 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.771 -0.455 . . . . 74.239999999999995 109.771 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.77 -29.41 42.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.328 0.585 . . . . 72.450000000000003 110.747 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.505 ' HB ' ' OD1' ' A' ' 34' ' ' ASN . 43.8 t -60.11 -24.62 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.688 -0.687 . . . . 75.040000000000006 110.548 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -56.04 -28.93 59.48 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.503 -0.317 . . . . 72.319999999999993 111.254 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.13 -14.55 60.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.154 0.502 . . . . 75.310000000000002 110.504 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.65 22.17 52.22 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.218 -0.901 . . . . 73.120000000000005 114.024 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.0 tp -98.22 -29.69 13.05 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.329 -0.619 . . . . 44.130000000000003 109.329 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.45 -13.15 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.204 -0.907 . . . . 62.229999999999997 111.145 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.14 -23.26 62.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.06 0.457 . . . . 71.239999999999995 109.882 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 50.37 3.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.741 -0.663 . . . . 53.340000000000003 112.163 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' O ' HD11 ' A' ' 44' ' ' LEU . 4.2 pp -109.09 136.88 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.715 -0.476 . . . . 75.409999999999997 109.715 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -157.25 113.82 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 74.140000000000001 109.76 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.7 p -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.781 -0.452 . . . . 74.540000000000006 109.781 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -125.13 153.24 43.31 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.053 0.454 . . . . 74.120000000000005 110.314 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -81.34 151.86 27.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.557 -0.747 . . . . 73.209999999999994 110.387 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.57 159.77 33.04 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.074 -0.81 . . . . 73.439999999999998 111.074 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.14 -21.06 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.079 0.439 . . . . 62.509999999999998 110.929 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.01 -20.27 62.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.979 -0.748 . . . . 61.439999999999998 108.979 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.15 162.24 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.909 -1.041 . . . . 72.239999999999995 111.103 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -70.92 107.03 3.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.505 -0.924 . . . . 73.439999999999998 108.505 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.24 130.01 60.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 54.140000000000001 111.46 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.45 104.38 16.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 62.200000000000003 110.558 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -78.18 128.67 34.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.003 -0.74 . . . . 65.400000000000006 109.003 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 HG23 ' HG3' ' A' ' 59' ' ' MET . 43.0 mt -141.01 116.64 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.833 0.349 . . . . 64.439999999999998 110.686 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.41 122.76 30.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 75.209999999999994 109.726 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.467 ' HG3' HG23 ' A' ' 57' ' ' ILE . 87.2 mtp -135.63 170.56 15.78 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.4 0.619 . . . . 72.340000000000003 111.721 -174.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -161.97 150.16 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.104 -0.953 . . . . 65.439999999999998 109.39 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.59 148.46 22.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.738 -0.838 . . . . 73.319999999999993 108.738 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 -48.58 30.82 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.51 0.559 . . . . 64.319999999999993 112.51 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 t -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.677 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.52 8.33 1.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.762 -0.653 . . . . 73.030000000000001 112.003 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.22 3.81 10.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.211 0.529 . . . . 75.219999999999999 110.177 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 27.5 m -81.04 126.72 76.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.486 -0.779 . . . . 74.519999999999996 110.657 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.63 32.02 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.014 2.476 . . . . 65.030000000000001 112.346 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.02 6.61 18.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.044 -0.526 . . . . 74.019999999999996 110.794 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -56.94 -42.8 80.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 73.019999999999996 110.866 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.47 -41.31 98.69 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.401 0.62 . . . . 75.030000000000001 110.163 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.39 -46.5 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.234 -0.894 . . . . 70.109999999999999 110.857 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.17 -37.87 77.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 121.198 -0.201 . . . . 72.540000000000006 111.068 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.84 -49.6 77.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.219999999999999 110.683 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.08 -51.39 68.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 111.118 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -63.1 -38.55 91.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.43 -0.35 . . . . 71.040000000000006 111.816 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' HD22 ' A' ' 80' ' ' LEU . 61.6 p -67.22 -54.97 16.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.904 -0.406 . . . . 61.439999999999998 109.904 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -54.76 -41.6 70.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.968 -0.56 . . . . 72.219999999999999 110.932 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.8 m -54.89 -53.16 59.0 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.275 -0.42 . . . . 71.230000000000004 111.763 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -51.56 13.85 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.65 -0.42 . . . . 74.030000000000001 111.221 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.512 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -58.6 -37.9 76.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.046 0.451 . . . . 74.310000000000002 111.51 -173.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.8 t -82.34 -27.37 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.193 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.28 -47.26 91.68 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.303 -0.475 . . . . 34.219999999999999 112.496 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.6 m -87.54 -5.1 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.409 . . . . 74.439999999999998 110.498 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.88 31.46 69.97 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.922 -0.581 . . . . 64.030000000000001 112.811 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 -38.21 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.029 0.442 . . . . 74.540000000000006 110.319 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 80' ' ' LEU . 20.6 m -128.39 159.48 39.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.94 -0.573 . . . . 53.119999999999997 110.049 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.7 -30.95 24.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.496 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -158.23 165.78 34.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.134 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.05 144.35 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.76 -0.459 . . . . 75.150000000000006 109.76 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -127.43 106.09 8.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.2 -0.667 . . . . 74.129999999999995 109.2 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.45 143.85 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 73.200000000000003 110.751 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.696 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -117.38 120.36 37.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.348 -0.982 . . . . 74.049999999999997 108.348 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.558 ' HH2' ' HA ' ' A' ' 105' ' ' THR . 8.8 m-90 -97.85 106.32 18.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.779 -0.452 . . . . 74.530000000000001 109.779 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.435 HG23 ' HE1' ' A' ' 99' ' ' TRP . 12.1 t -90.97 123.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.326 -0.397 . . . . 64.430000000000007 110.123 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -119.53 -24.13 6.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.809 -0.632 . . . . 73.400000000000006 109.592 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.525 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 49.7 t30 175.8 -49.7 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.095 -0.957 . . . . 61.520000000000003 110.418 -173.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 48.9 Cg_endo -67.59 145.17 69.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.818 1.679 . . . . 54.0 111.971 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.91 168.55 11.86 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.003 2.469 . . . . 73.540000000000006 112.485 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.435 ' HE1' HG23 ' A' ' 94' ' ' VAL . 10.8 m0 -69.54 165.46 20.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.945 -0.57 . . . . 73.450000000000003 111.222 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.11 -129.53 2.75 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.977 -0.556 . . . . 41.030000000000001 111.827 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.7 -9.63 19.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.859 2.372 . . . . 72.439999999999998 112.489 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.59 -15.39 58.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 110.77 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.696 ' HG2' ' HB2' ' A' ' 92' ' ' ASN . 52.3 mttp -76.17 -9.76 58.88 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.329 -0.396 . . . . 72.400000000000006 110.939 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 96.83 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.132 -0.692 . . . . 74.209999999999994 109.132 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.558 ' HA ' ' HH2' ' A' ' 93' ' ' TRP . 19.5 p -62.24 156.35 22.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.871 -0.604 . . . . 74.209999999999994 111.693 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -56.85 -33.18 66.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.762 -0.654 . . . . 64.209999999999994 110.217 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 21.8 t70 -56.78 -45.58 82.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.616 -0.72 . . . . 63.509999999999998 110.358 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.54 98.68 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.804 -0.634 . . . . 71.099999999999994 111.965 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -57.63 -41.65 81.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.009 0.433 . . . . 75.5 110.161 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.32 -23.59 65.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.7 . . . . 74.430000000000007 111.886 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 107' ' ' ASP . 43.6 mt-30 -109.08 5.61 24.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 74.120000000000005 110.836 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.6 -69.57 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.496 -0.774 . . . . 71.099999999999994 109.826 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -53.42 -29.44 35.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 74.150000000000006 109.604 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.56 -7.17 36.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.826 -1.079 . . . . 42.200000000000003 112.166 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.55 -18.75 62.71 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.921 0.341 . . . . 74.439999999999998 111.921 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.0 39.4 1.96 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.905 -0.664 . . . . 75.329999999999998 112.701 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 t80 64.82 4.31 2.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.006 0.431 . . . . 75.540000000000006 111.565 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 m -71.2 85.55 0.76 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.945 0.402 . . . . 72.400000000000006 110.792 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.17 -0.919 . . . . 72.129999999999995 110.315 178.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' H2 ' ' CD ' ' A' ' 20' ' ' GLU . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 111.838 -0.505 . . . . 31.43 111.838 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.76 110.3 2.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.585 2.19 . . . . 75.239999999999995 111.902 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.78 102.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.166 -0.54 . . . . 73.530000000000001 111.77 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.8 t -166.89 -178.62 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 43.229999999999997 109.986 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.99 14.83 6.32 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.177 -0.675 . . . . 70.319999999999993 109.177 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 p -150.16 -157.3 0.8 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.13 -0.941 . . . . 64.0 109.456 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.62 83.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 71.420000000000002 111.745 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.0 p -136.95 107.8 6.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.03 -0.532 . . . . 61.299999999999997 110.816 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.589 ' HB3' HD23 ' A' ' 85' ' ' LEU . 22.8 t -158.5 157.96 33.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.661 -0.866 . . . . 71.209999999999994 108.661 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . 67.85 164.84 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 123.317 0.386 . . . . 74.409999999999997 110.685 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 26.2 Cg_endo -62.55 153.43 71.52 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.241 1.96 . . . . 73.409999999999997 111.761 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.46 -44.63 12.48 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.878 0.696 . . . . 71.430000000000007 112.878 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -63.2 -51.63 65.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.999 0.428 . . . . 63.020000000000003 110.896 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.44 -44.25 79.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 72.329999999999998 110.611 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.49 -42.34 78.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 54.119999999999997 110.537 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 tp -55.91 -58.32 8.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 73.549999999999997 110.875 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.24 89.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.02 -0.536 . . . . 61.340000000000003 111.331 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.64 -48.03 81.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.009 -0.541 . . . . 74.010000000000005 110.871 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.13 -33.65 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 54.32 110.356 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' CD ' ' H2 ' ' A' ' 1' ' ' GLY . 16.6 tp10 -56.61 -49.81 73.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.024 0.44 . . . . 71.049999999999997 109.849 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.72 -48.47 71.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 74.310000000000002 110.513 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -37.66 73.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.853 -0.612 . . . . 72.010000000000005 111.758 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 mmt -71.22 -13.54 61.95 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.078 0.466 . . . . 63.32 110.051 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -101.61 0.74 36.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.511 -0.768 . . . . 74.540000000000006 111.372 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -119.46 -27.85 5.47 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.289 0.566 . . . . 74.200000000000003 110.063 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -92.39 -16.91 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.895 -1.048 . . . . 71.310000000000002 110.757 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 34' ' ' ASN . 9.3 p -84.83 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 54.409999999999997 110.33 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' N ' HG23 ' A' ' 27' ' ' VAL . 17.7 t70 -104.45 87.82 1.88 Allowed Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 108.758 -0.83 . . . . 70.310000000000002 108.758 169.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 89.4 Cg_endo -84.98 -1.66 9.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.457 2.105 . . . . 75.040000000000006 111.071 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HG2' HD11 ' A' ' 31' ' ' LEU . 41.7 tt0 -68.58 -57.65 5.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.442 -0.799 . . . . 74.25 110.206 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD11 ' HG2' ' A' ' 30' ' ' GLU . 7.3 mp -98.95 -17.14 18.48 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.841 -0.429 . . . . 73.049999999999997 109.841 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.76 40.97 4.24 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.984 -0.553 . . . . 61.149999999999999 113.415 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.517 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.5 mp -108.9 140.18 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.343 -0.614 . . . . 71.140000000000001 109.343 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.572 ' N ' HD22 ' A' ' 34' ' ' ASN . 0.6 OUTLIER -108.67 138.17 45.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.229 -0.656 . . . . 64.109999999999999 109.229 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.11 -30.17 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.168 0.509 . . . . 63.409999999999997 110.678 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 34' ' ' ASN . 13.5 p -58.24 -24.39 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.798 -0.637 . . . . 74.329999999999998 110.655 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.62 -29.1 58.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.707 -0.678 . . . . 61.409999999999997 111.195 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.7 -17.06 61.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.913 0.387 . . . . 73.200000000000003 110.488 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.51 22.71 57.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.732 -0.667 . . . . 64.019999999999996 113.371 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD23 HG12 ' A' ' 94' ' ' VAL . 33.1 tp -98.06 -16.73 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 64.299999999999997 110.079 175.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.55 -15.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.898 -0.592 . . . . 74.430000000000007 111.298 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -70.04 -23.16 63.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.598 0.713 . . . . 74.329999999999998 109.121 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 58' ' ' ASP . . . -85.44 95.67 2.01 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.956 -1.02 . . . . 61.149999999999999 111.031 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -146.47 132.74 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.157 -0.683 . . . . 63.299999999999997 109.157 173.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.99 109.02 9.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.306 -0.628 . . . . 74.400000000000006 109.306 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 55' ' ' ALA . 16.1 m -93.56 115.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.276 -0.638 . . . . 74.209999999999994 109.276 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.8 124.27 42.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.191 -0.458 . . . . 72.129999999999995 110.531 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.29 89.13 5.5 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.729 0.776 . . . . 62.100000000000001 109.729 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.38 164.55 45.71 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.511 -1.222 . . . . 72.349999999999994 111.481 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.2 -37.04 69.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.001 0.429 . . . . 61.409999999999997 110.575 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.24 -39.66 71.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 75.319999999999993 110.079 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.48 -178.44 39.73 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.702 -0.681 . . . . 64.209999999999994 111.549 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.1 m -81.75 112.2 18.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.811 0.339 . . . . 73.120000000000005 110.62 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.39 124.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 74.010000000000005 109.866 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.483 ' HB2' HG13 ' A' ' 86' ' ' VAL . . . -88.54 106.34 18.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 73.540000000000006 111.083 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.97 101.97 14.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 74.109999999999999 109.913 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.486 HG21 ' HG3' ' A' ' 59' ' ' MET . 53.3 mt -96.93 132.31 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.567 -0.288 . . . . 73.239999999999995 110.617 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.2 m-20 -94.01 113.45 25.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.030000000000001 110.076 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 90.2 mtp -141.04 171.05 14.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 73.340000000000003 110.646 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -163.05 162.05 25.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 65.230000000000004 109.649 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -106.6 171.83 7.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.945 -0.761 . . . . 61.210000000000001 108.945 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -44.63 -56.76 4.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.118 0.485 . . . . 73.540000000000006 111.48 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.6 t -104.22 -2.28 25.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 64.430000000000007 110.672 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.85 8.82 2.63 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.917 -0.583 . . . . 64.099999999999994 112.033 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.88 -8.81 12.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.994 0.426 . . . . 63.520000000000003 110.47 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.426 ' C ' ' H ' ' A' ' 68' ' ' LEU . 8.0 m -57.49 139.82 80.47 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.459 -0.791 . . . . 74.230000000000004 111.004 -176.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.85 17.56 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.011 2.474 . . . . 71.430000000000007 112.788 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 66' ' ' CYS . 92.0 mt -89.33 -4.16 58.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 65.239999999999995 110.462 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 t -61.93 -54.01 47.72 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.329 -0.396 . . . . 70.439999999999998 111.339 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.98 -28.54 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 73.439999999999998 109.597 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 60.1 t -65.88 -52.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.49 -0.777 . . . . 75.530000000000001 110.52 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -69.02 -32.39 54.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 121.108 -0.237 . . . . 73.010000000000005 111.585 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.527 ' N ' HD13 ' A' ' 72' ' ' ILE . 8.5 mt-10 -64.5 -45.04 89.01 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.589 -0.444 . . . . 64.310000000000002 109.874 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.01 -49.12 77.94 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 74.150000000000006 110.764 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 95.3 mt-30 -56.82 -55.91 28.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.981 -0.554 . . . . 73.239999999999995 110.868 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -61.15 -53.23 59.57 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.94 -0.573 . . . . 73.540000000000006 110.798 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -56.12 -48.88 75.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.637 -0.256 . . . . 65.219999999999999 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -53.68 -50.58 65.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 64.340000000000003 111.161 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.74 14.21 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.694 -0.402 . . . . 71.409999999999997 111.556 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 89' ' ' ILE . 78.8 mt -60.96 -37.35 82.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 53.43 110.921 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.2 t -78.21 -27.73 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 64.120000000000005 110.145 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.5 -48.05 46.55 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.018 -0.611 . . . . 64.450000000000003 111.746 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -82.09 -23.13 35.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.134 0.492 . . . . 74.25 109.854 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.77 42.03 6.98 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.977 -0.556 . . . . 63.009999999999998 113.533 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.589 HD23 ' HB3' ' A' ' 9' ' ' SER . 6.2 mp -71.0 -38.27 72.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.975 0.417 . . . . 74.430000000000007 109.887 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 55' ' ' ALA . 31.5 m -137.1 170.02 18.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.61 -0.723 . . . . 74.219999999999999 110.011 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.19 -48.66 64.62 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.285 0.564 . . . . 70.230000000000004 109.556 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.4 -179.03 5.77 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.089 -0.959 . . . . 64.349999999999994 108.587 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 80' ' ' LEU . 35.1 pt -122.43 177.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.371 0.605 . . . . 75.230000000000004 111.167 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.682 ' HG2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -155.56 106.01 2.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.496 -1.298 . . . . 74.219999999999999 107.496 170.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 73' ' ' GLU . 52.6 mt -95.56 101.25 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.609 -0.515 . . . . 74.450000000000003 109.609 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -88.78 139.93 29.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.712 -0.676 . . . . 52.130000000000003 109.364 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' MET . 3.3 m-90 -95.25 106.07 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.553 -0.536 . . . . 73.430000000000007 109.553 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.462 HG12 HD23 ' A' ' 40' ' ' LEU . 3.4 p -120.03 124.25 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.31 0.576 . . . . 73.439999999999998 110.175 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 1.1 p-90 -147.96 11.89 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.27 -0.877 . . . . 75.349999999999994 110.111 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.593 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 35.5 t30 -174.94 -60.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.968 -0.56 . . . . 74.420000000000002 111.347 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 85.0 Cg_endo -78.26 140.02 17.18 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.755 1.637 . . . . 42.049999999999997 112.528 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.56 151.84 51.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.662 2.241 . . . . 62.100000000000001 111.38 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -59.74 123.9 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 70.430000000000007 111.224 -172.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.54 -120.04 1.52 Allowed Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.003 -0.544 . . . . 64.129999999999995 111.765 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 -14.91 45.07 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.628 2.219 . . . . 74.340000000000003 111.66 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.47 -26.62 61.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.533 -0.758 . . . . 71.129999999999995 110.325 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 73.8 mmtt -77.09 9.03 3.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.925 -0.58 . . . . 74.510000000000005 111.457 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.41 134.16 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 110.047 -0.353 . . . . 72.439999999999998 110.047 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.682 HG23 ' HG2' ' A' ' 90' ' ' ARG . 12.3 p -66.12 151.29 47.24 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.787 0.327 . . . . 54.140000000000001 111.587 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.28 -39.54 89.46 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.887 -0.783 . . . . 74.099999999999994 108.887 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.03 -48.63 78.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.945 -1.025 . . . . 75.219999999999999 109.747 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.06 -44.23 98.06 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.373 -0.83 . . . . 22.420000000000002 112.692 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -63.58 -40.49 97.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.674 0.237 . . . . 74.420000000000002 110.708 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -61.82 -35.82 79.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.146 0.498 . . . . 73.299999999999997 110.836 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -105.87 24.94 11.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.782 -0.645 . . . . 71.109999999999999 110.717 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.4 tp -80.07 158.24 26.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 72.540000000000006 109.697 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -66.89 -32.33 73.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 75.109999999999999 110.522 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.77 -7.45 53.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.723 -0.671 . . . . 62.340000000000003 111.51 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.95 24.71 8.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.219 0.533 . . . . 75.0 109.92 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.54 68.64 0.22 Allowed Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.866 -0.607 . . . . 73.209999999999994 112.673 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -121.2 167.11 13.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 74.310000000000002 110.589 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -81.83 150.68 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.854 -0.612 . . . . 74.209999999999994 110.637 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.676 -0.678 . . . . 64.209999999999994 110.066 178.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 111.807 -0.517 . . . . 50.119999999999997 111.807 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.84 121.24 8.69 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.41 2.073 . . . . 74.230000000000004 111.167 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.75 117.4 3.45 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 121.029 -0.605 . . . . 43.140000000000001 111.724 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 t -92.54 118.43 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.333 -0.617 . . . . 70.129999999999995 109.333 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.3 mtm -80.09 158.86 26.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.02 0.438 . . . . 75.319999999999993 110.932 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -144.5 -51.87 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.076 -0.713 . . . . 63.43 109.076 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 51.68 33.49 11.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.081 -0.963 . . . . 74.510000000000005 112.321 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 m -73.19 84.98 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.696 0.284 . . . . 51.43 110.578 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 t -171.78 152.66 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 74.099999999999994 109.78 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.63 154.82 0.14 Allowed Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 123.441 0.463 . . . . 72.230000000000004 112.023 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' A' ' 14' ' ' GLU . 29.8 Cg_endo -66.01 168.61 15.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.469 2.112 . . . . 63.43 111.951 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.96 -67.22 0.27 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.184 1.179 . . . . 72.239999999999995 114.184 -167.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.82 -35.1 67.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 74.400000000000006 111.187 -172.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 20.0 mp0 -57.7 -46.84 83.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.591 -0.522 . . . . 74.329999999999998 109.591 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.8 -46.72 89.4 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.475 -0.784 . . . . 75.099999999999994 110.739 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.6 tp -52.79 -60.31 3.43 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.295 0.569 . . . . 54.350000000000001 110.874 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.44 69.28 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.702 -0.681 . . . . 73.030000000000001 111.091 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.86 -41.19 97.84 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.74 -0.664 . . . . 74.420000000000002 111.322 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.83 -35.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.575 -0.528 . . . . 62.439999999999998 109.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.19 -45.94 79.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.948 0.404 . . . . 74.219999999999999 109.966 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.37 -43.55 63.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 63.020000000000003 111.014 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.06 78.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.803 -0.635 . . . . 73.400000000000006 110.885 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -62.66 -13.44 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.579 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -87.28 -23.04 24.81 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.503 0.192 . . . . 65.340000000000003 111.428 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -116.01 -27.02 7.08 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.318 0.58 . . . . 73.129999999999995 110.11 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -27.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.032 -0.985 . . . . 62.32 110.101 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 34' ' ' ASN . 5.5 p -91.32 165.1 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 63.32 109.697 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.5 91.95 5.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.81 . . . . 74.040000000000006 108.812 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.9 -7.53 13.3 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.326 2.017 . . . . 75.019999999999996 111.178 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -68.67 -57.96 4.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 72.430000000000007 110.619 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.49 -18.61 17.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 75.120000000000005 110.241 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.21 52.12 1.94 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.247 -0.501 . . . . 64.310000000000002 113.173 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.8 mp -126.91 141.55 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.667 -0.494 . . . . 62.109999999999999 109.667 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' HA ' HG22 ' A' ' 27' ' ' VAL . 9.4 p30 -108.77 138.6 44.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.017 -0.734 . . . . 75.219999999999999 109.017 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.15 -36.25 50.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.161 0.505 . . . . 74.439999999999998 111.312 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.78 -24.93 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.931 -0.577 . . . . 74.409999999999997 110.875 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.2 -26.04 64.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.357 -0.383 . . . . 65.519999999999996 111.358 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.53 -15.34 63.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 75.219999999999999 110.588 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.64 22.38 46.15 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.71 -0.677 . . . . 63.049999999999997 113.949 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -22.66 16.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.825 -0.806 . . . . 74.439999999999998 108.825 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.77 -4.96 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.188 -0.914 . . . . 72.150000000000006 111.731 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -66.3 -19.08 65.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.066 0.46 . . . . 73.25 110.044 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.96 110.47 3.94 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.241 -0.744 . . . . 44.229999999999997 111.241 174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.9 pp -167.34 149.63 5.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.302 -0.258 . . . . 70.400000000000006 110.302 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -163.69 122.51 1.98 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.804 -0.443 . . . . 75.140000000000001 109.804 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -99.54 118.34 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 75.310000000000002 110.129 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -113.4 137.47 51.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.156 -0.474 . . . . 74.120000000000005 110.128 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -91.83 154.36 18.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 74.0 110.158 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.16 162.47 30.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.16 -0.543 . . . . 72.420000000000002 112.031 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.21 -29.48 70.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.126 0.489 . . . . 64.409999999999997 110.507 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.98 -24.5 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.765 -0.652 . . . . 71.239999999999995 109.907 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.53 15.21 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.044 -0.525 . . . . 44.219999999999999 111.925 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.8 m -93.68 120.41 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.881 -0.414 . . . . 72.109999999999999 109.881 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.2 p -115.62 131.58 67.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.218 0.533 . . . . 73.450000000000003 111.442 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -98.51 116.04 29.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.56 -0.746 . . . . 53.119999999999997 110.544 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 55.8 mt -96.44 117.4 30.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.088 -0.338 . . . . 71.439999999999998 110.088 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.486 HG23 ' HG3' ' A' ' 59' ' ' MET . 39.9 mm -115.09 118.05 57.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.717 -0.475 . . . . 74.400000000000006 109.717 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.39 118.63 28.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.531 -0.544 . . . . 64.209999999999994 109.531 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.486 ' HG3' HG23 ' A' ' 57' ' ' ILE . 71.9 mtp -141.02 170.92 14.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 45.32 111.364 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 t -147.13 175.16 10.94 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.944 -0.761 . . . . 61.520000000000003 108.944 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mm? -109.73 150.78 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.585 -0.524 . . . . 63.210000000000001 109.585 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.2 p -46.61 -54.8 8.73 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.616 0.572 . . . . 73.120000000000005 112.489 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 t -104.02 -1.38 27.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 73.510000000000005 110.627 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.3 1.43 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.058 0.543 . . . . 74.510000000000005 112.184 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.95 -17.46 8.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.279 0.562 . . . . 44.030000000000001 109.966 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 4.1 p -87.3 114.43 58.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 71.129999999999995 110.42 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 7.5 Cg_exo -72.83 73.78 2.95 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.996 2.464 . . . . 62.25 112.89 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.494 ' HB2' HD11 ' A' ' 61' ' ' LEU . 4.2 mm? -94.29 9.53 37.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.3 0.572 . . . . 74.109999999999999 109.81 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.478 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.1 t -60.25 -37.81 81.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.703 -0.68 . . . . 74.430000000000007 110.572 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.74 -53.32 59.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.137 0.494 . . . . 71.420000000000002 110.199 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 11.8 p -66.11 -46.37 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 74.109999999999999 111.01 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.478 HG12 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -62.61 -38.92 82.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.42 -0.512 . . . . 72.409999999999997 111.018 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.49 -43.38 90.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.011 -0.54 . . . . 62.020000000000003 110.71 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.84 -39.76 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.858 -0.337 . . . . 71.25 110.28 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 98.8 mt-30 -56.15 -52.59 63.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.07 0.462 . . . . 65.329999999999998 110.218 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.3 m -60.03 -52.18 66.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.697 -0.683 . . . . 74.349999999999994 110.627 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.588 ' O ' HG12 ' A' ' 81' ' ' VAL . 6.0 tmm_? -54.43 -52.91 60.29 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.852 -0.613 . . . . 71.019999999999996 111.0 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -52.85 -53.24 51.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.605 0.566 . . . . 63.329999999999998 111.535 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -52.51 11.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.259 -0.576 . . . . 64.200000000000003 110.995 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.74 -40.2 75.32 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.816 0.341 . . . . 72.519999999999996 111.441 -169.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 77' ' ' ARG . 4.8 p -89.31 -27.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 74.400000000000006 110.193 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.01 -24.92 70.4 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.646 -0.787 . . . . 71.540000000000006 111.658 -167.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.752 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 9.2 t -87.17 -11.85 48.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.224 0.535 . . . . 61.009999999999998 109.962 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.84 61.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.581 -0.736 . . . . 34.020000000000003 112.023 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.752 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 82.1 mt -74.39 -53.51 9.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.028 0.442 . . . . 72.329999999999998 110.415 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG12 ' HB3' ' A' ' 55' ' ' ALA . 33.4 m -124.91 165.91 21.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.986 -0.552 . . . . 64.140000000000001 110.611 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.66 -47.92 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 52.030000000000001 109.787 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 m-20 -135.11 169.7 17.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.634 -0.712 . . . . 53.210000000000001 110.65 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.2 pt -134.94 175.97 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.92 -0.582 . . . . 72.209999999999994 110.368 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.709 ' HD3' ' HA ' ' A' ' 105' ' ' THR . 26.3 tpt180 -164.61 119.84 1.44 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.551 -0.75 . . . . 74.109999999999999 109.815 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 47.2 mt -97.12 123.28 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 73.319999999999993 110.009 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.498 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 26.6 t30 -93.89 115.0 27.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.851 -0.613 . . . . 63.240000000000002 109.539 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -84.39 106.22 15.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.582 -0.525 . . . . 72.129999999999995 109.582 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.418 HG21 ' HE1' ' A' ' 99' ' ' TRP . 28.0 t -93.93 124.13 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.639 . . . . 75.519999999999996 110.473 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -113.33 -20.62 11.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.030000000000001 110.801 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.416 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 t-20 -177.01 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.036 -0.529 . . . . 65.400000000000006 111.092 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.0 Cg_endo -64.1 151.39 85.54 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.137 1.891 . . . . 61.439999999999998 112.701 -172.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.44 157.15 52.26 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.627 2.218 . . . . 75.140000000000001 111.582 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.804 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 5.9 m0 -64.78 130.78 44.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.034 -0.53 . . . . 74.040000000000006 110.7 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.08 -120.95 0.59 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.728 -0.749 . . . . 73.549999999999997 113.415 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.5 -36.34 66.09 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.287 2.658 . . . . 75.25 113.638 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.3 -14.46 11.45 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.028 0.442 . . . . 60.130000000000003 111.247 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.804 ' HD2' ' HB3' ' A' ' 99' ' ' TRP . 36.3 mtpt -77.17 10.04 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.268 -0.423 . . . . 72.230000000000004 111.041 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.4 122.92 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 110.003 -0.369 . . . . 64.439999999999998 110.003 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.709 ' HA ' ' HD3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -50.79 161.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.919 0.711 . . . . 74.319999999999993 112.919 176.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.26 -39.58 57.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.945 -1.025 . . . . 75.329999999999998 112.53 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -56.78 -40.7 76.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.319 -0.401 . . . . 71.340000000000003 110.83 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.15 -27.68 72.58 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 116.16 -0.473 . . . . 65.25 112.636 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -73.49 -51.07 18.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 74.510000000000005 111.583 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.71 -35.34 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.348 . . . . 62.299999999999997 111.75 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -120.09 99.12 6.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.125 0.488 . . . . 75.120000000000005 111.365 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 112' ' ' LEU . 3.3 mm? -83.05 165.91 19.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 71.420000000000002 109.725 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -61.55 -29.89 70.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 73.010000000000005 110.298 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.26 -24.12 40.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.776 -0.647 . . . . 71.340000000000003 111.115 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.77 18.48 2.88 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.862 -0.608 . . . . 71.329999999999998 109.827 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.54 85.09 0.03 OUTLIER Glycine 0 C--N 1.338 0.669 0 N-CA-C 111.258 -0.737 . . . . 62.340000000000003 111.258 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -61.61 146.79 47.84 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.16 0.505 . . . . 72.329999999999998 111.898 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.4 m -85.08 129.33 34.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.503 -0.771 . . . . 75.140000000000001 109.937 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.922 -0.561 . . . . 72.030000000000001 109.708 178.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.968 -0.453 . . . . 74.209999999999994 111.968 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 135.19 40.42 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 62.109999999999999 111.834 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.33 53.58 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.177 -0.535 . . . . 71.340000000000003 112.495 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.513 ' HA ' HG22 ' A' ' 36' ' ' VAL . 16.8 p -66.06 130.85 44.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.558 0.218 . . . . 64.140000000000001 110.638 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.634 ' HA ' ' HE3' ' A' ' 5' ' ' MET . 29.3 mmt -72.26 135.38 46.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 75.540000000000006 110.721 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 19' ' ' VAL . 9.8 t -171.98 -42.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.179 -1.045 . . . . 73.230000000000004 108.179 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.63 ' HB3' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.42 56.49 0.86 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.647 -1.16 . . . . 74.409999999999997 110.483 176.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 m -116.39 91.75 3.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.026 -0.533 . . . . 74.439999999999998 110.845 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t 64.19 14.05 8.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.774 -0.648 . . . . 71.219999999999999 112.387 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.05 148.9 51.74 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 110.671 -0.122 . . . . 75.329999999999998 110.671 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.91 131.07 41.56 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.74 2.293 . . . . 62.43 111.731 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.29 -51.92 17.77 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.494 0.924 . . . . 64.299999999999997 113.494 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.68 -50.32 74.32 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.009 0.433 . . . . 71.140000000000001 111.043 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.62 -46.7 81.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 72.200000000000003 110.353 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.63 HD13 ' HB3' ' A' ' 7' ' ' GLU . 3.1 tm? -63.89 -36.55 84.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.919 -1.037 . . . . 74.340000000000003 111.209 -173.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 tp -53.07 -55.31 24.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.172 0.51 . . . . 75.040000000000006 109.772 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.83 -47.13 79.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 40.039999999999999 110.847 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.211 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 6' ' ' SER . 4.6 p -71.37 -34.35 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 71.219999999999999 110.211 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.04 -40.3 93.09 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.998 0.428 . . . . 71.25 110.025 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 24.8 mm-40 -72.26 -47.24 51.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.906 -0.588 . . . . 73.239999999999995 110.226 176.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.94 65.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.934 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.05 -13.65 7.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 111.579 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 63.1 ttt-85 -93.8 -29.44 15.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.596 0.358 . . . . 74.430000000000007 111.31 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.97 -5.14 10.07 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.215 0.531 . . . . 64.120000000000005 110.346 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 26' ' ' VAL . 99.9 t -107.01 19.95 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.505 1.145 . . . . 74.219999999999999 109.317 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.589 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 11.6 p -148.25 160.8 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.571 -1.195 . . . . 71.230000000000004 108.47 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.57 98.28 3.55 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.461 -0.57 . . . . 75.129999999999995 109.461 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 96.2 Cg_endo -87.68 -1.08 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.705 2.27 . . . . 74.409999999999997 111.655 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.6 -57.49 5.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 75.120000000000005 109.957 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.32 -14.56 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 75.5 110.654 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.97 47.76 2.59 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.182 -0.532 . . . . 71.409999999999997 112.981 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.2 mp -110.52 143.27 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 109.822 -0.436 . . . . 75.040000000000006 109.822 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.507 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.8 t30 -115.02 111.67 21.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.098 -0.501 . . . . 65.530000000000001 110.015 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.8 -39.68 72.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.28 0.562 . . . . 61.049999999999997 110.105 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 4' ' ' SER . 47.6 t -60.94 -24.57 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.508 -0.769 . . . . 73.310000000000002 110.598 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 25.3 t70 -64.43 -22.97 67.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.195 -0.457 . . . . 63.439999999999998 110.902 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.74 -8.6 56.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.185 0.517 . . . . 74.340000000000003 110.227 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.32 53.03 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.142 -0.935 . . . . 63.420000000000002 114.229 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 tt -98.23 -32.13 11.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.453 -0.573 . . . . 73.209999999999994 109.453 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.26 -11.0 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 65.230000000000004 110.217 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -64.07 -21.19 66.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.512 -0.767 . . . . 75.430000000000007 109.406 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.42 64.25 3.55 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.522 -0.763 . . . . 71.430000000000007 112.024 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 pp -107.66 142.31 37.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.899 -0.408 . . . . 74.430000000000007 109.899 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.3 118.86 4.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 74.450000000000003 109.088 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.59 123.93 56.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.757 0.313 . . . . 74.230000000000004 110.677 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.559 HE22 HD23 ' A' ' 56' ' ' LEU . 24.8 pt20 -97.74 120.9 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.255 -0.646 . . . . 53.450000000000003 109.255 175.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.07 129.75 56.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 64.329999999999998 110.348 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.89 167.7 28.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.221 -0.752 . . . . 71.0 111.221 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.6 -31.67 66.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.898 0.38 . . . . 72.420000000000002 110.687 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.44 -31.14 70.24 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.862 -0.608 . . . . 63.32 110.565 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.98 163.44 16.91 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 116.081 -0.509 . . . . 71.219999999999999 112.189 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.2 m -110.71 109.09 19.19 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.558 -0.534 . . . . 74.140000000000001 109.558 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.05 123.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 110.577 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -89.98 109.88 20.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.28 -0.418 . . . . 52.130000000000003 110.966 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.559 HD23 HE22 ' A' ' 47' ' ' GLN . 12.3 mt -91.23 107.43 19.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.749 -0.463 . . . . 73.239999999999995 109.749 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.6 117.61 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.094 -0.335 . . . . 72.450000000000003 110.094 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.36 122.04 26.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 110.247 -0.279 . . . . 72.239999999999995 110.247 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 83.5 mtp -141.17 170.88 14.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.428 0.632 . . . . 74.409999999999997 111.246 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.2 t -160.49 158.8 29.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 72.329999999999998 109.486 174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.7 mm? -99.89 160.74 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.985 -0.376 . . . . 75.109999999999999 109.985 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 m -45.92 -56.03 5.97 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.604 0.565 . . . . 65.349999999999994 112.405 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 m -103.0 4.58 37.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.934 0.397 . . . . 74.450000000000003 110.633 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.448 0.699 . . . . 71.430000000000007 112.398 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.42 2.45 10.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 73.219999999999999 110.048 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.596 ' HB3' HD12 ' A' ' 68' ' ' LEU . 14.1 m -81.66 120.93 79.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.391 -0.822 . . . . 74.430000000000007 110.389 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.13 33.44 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.921 2.414 . . . . 74.420000000000002 113.186 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 66' ' ' CYS . 9.0 mp -79.76 3.08 20.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.946 0.403 . . . . 73.329999999999998 110.616 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.8 t -57.37 -44.23 84.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.03 -0.532 . . . . 61.049999999999997 110.789 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.32 -41.44 69.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.222 0.534 . . . . 75.420000000000002 110.384 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.24 -52.71 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.36 -0.836 . . . . 71.530000000000001 110.668 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 69' ' ' THR . 33.3 pt -63.52 -39.69 86.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 120.824 0.345 . . . . 75.099999999999994 111.225 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.18 -49.96 72.22 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.936 -0.574 . . . . 74.049999999999997 110.323 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.77 -49.8 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.422 -0.353 . . . . 70.430000000000007 110.667 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -55.57 -58.94 5.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.743 -0.662 . . . . 51.399999999999999 111.773 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -52.66 52.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.071 0.463 . . . . 63.399999999999999 111.026 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -56.72 -49.52 74.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.761 -0.654 . . . . 64.409999999999997 110.731 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -54.0 -48.28 70.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.676 -0.693 . . . . 64.239999999999995 111.346 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.09 13.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.907 -0.317 . . . . 71.319999999999993 111.384 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 HD11 HG23 ' A' ' 89' ' ' ILE . 82.9 mt -61.05 -36.17 78.89 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.985 0.422 . . . . 70.219999999999999 111.162 -172.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.56 -27.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 60.409999999999997 110.033 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.71 -47.29 34.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.171 -0.538 . . . . 63.32 112.221 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.8 m -75.97 -23.12 55.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.1 0.476 . . . . 65.010000000000005 110.14 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 33.36 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.123 -0.56 . . . . 74.400000000000006 113.35 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.71 -44.33 67.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.87 0.367 . . . . 74.310000000000002 110.017 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 55' ' ' ALA . 31.1 m -135.91 166.82 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 71.510000000000005 110.36 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -41.69 74.66 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.583 -0.525 . . . . 72.040000000000006 109.583 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -167.11 175.91 7.2 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.224 -0.898 . . . . 73.530000000000001 109.146 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 80' ' ' LEU . 38.7 pt -120.19 178.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.6 0.714 . . . . 75.530000000000001 111.065 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.903 ' HD3' HG21 ' A' ' 105' ' ' THR . 12.5 tpt180 -150.72 106.31 3.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.791 -1.095 . . . . 63.229999999999997 108.096 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.26 117.96 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.093 -0.706 . . . . 74.019999999999996 109.093 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -88.63 143.57 26.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.938 -0.574 . . . . 72.25 109.481 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -111.16 109.58 19.7 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.791 -0.818 . . . . 74.310000000000002 108.791 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 t -85.1 123.61 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 64.409999999999997 110.711 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -120.86 -21.07 6.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.318 -0.855 . . . . 74.450000000000003 109.769 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.433 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 36.9 t30 178.27 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.498 -0.773 . . . . 55.130000000000003 111.439 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 91.9 Cg_exo -44.44 131.91 9.48 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.795 2.33 . . . . 55.409999999999997 113.469 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 2.4 Cg_endo -82.25 41.97 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.446 2.764 . . . . 71.510000000000005 112.119 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.8 m0 63.42 -154.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.155 -0.475 . . . . 75.030000000000001 110.787 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.403 ' HA3' ' HD2' ' A' ' 101' ' ' PRO . . . 97.07 -134.31 11.71 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.478 -0.649 . . . . 71.120000000000005 111.478 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.403 ' HD2' ' HA3' ' A' ' 100' ' ' GLY . 27.8 Cg_endo -61.41 -22.54 74.82 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.442 2.094 . . . . 72.540000000000006 110.803 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.19 -12.85 22.32 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.791 -1.095 . . . . 54.0 111.06 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -76.43 -11.07 59.83 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.408 -0.36 . . . . 72.430000000000007 111.162 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.423 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 43.6 mt -120.12 140.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.466 0.174 . . . . 64.310000000000002 111.383 -174.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.903 HG21 ' HD3' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -72.11 151.07 43.3 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.775 0.322 . . . . 43.039999999999999 110.257 172.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.02 -33.13 71.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.434 -0.58 . . . . 64.420000000000002 109.434 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.62 -53.16 61.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.411 -0.813 . . . . 75.319999999999993 110.314 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.22 -28.08 73.1 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.575 -0.739 . . . . 65.109999999999999 112.437 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.87 -37.05 83.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.515 -0.55 . . . . 74.099999999999994 109.515 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.3 -57.3 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.78 -0.646 . . . . 73.439999999999998 111.42 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.572 ' NE2' HD12 ' A' ' 115' ' ' LEU . 18.9 mt-30 -140.44 167.63 21.69 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.63 0.253 . . . . 64.150000000000006 110.602 -176.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 112' ' ' LEU . 2.0 pt? -79.03 173.11 12.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 111.826 -173.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -55.45 -33.4 63.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.366 -0.834 . . . . 72.510000000000005 111.483 -176.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.08 -6.71 2.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.932 0.716 . . . . 74.230000000000004 112.932 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.572 HD12 ' NE2' ' A' ' 111' ' ' GLN . 56.1 tp -62.11 -34.51 76.47 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.567 0.21 . . . . 74.299999999999997 111.567 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 133.77 -4.79 4.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.208 -0.996 . . . . 44.219999999999999 113.912 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' A' ' 113' ' ' ARG . 45.3 p90 -79.56 12.6 2.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.484 0.642 . . . . 70.239999999999995 110.891 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 113' ' ' ARG . 2.7 m -134.03 32.91 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.696 0.76 . . . . 65.439999999999998 109.024 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.251 1.144 0 CA-C-N 115.07 -0.968 . . . . 73.420000000000002 111.393 -178.059 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.947 -0.461 . . . . 71.150000000000006 111.947 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.9 -29.27 67.28 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.606 2.204 . . . . 72.5 111.471 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.15 -114.04 0.6 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.596 -0.729 . . . . 45.25 111.666 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 p -166.89 172.83 9.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.68 -0.489 . . . . 61.039999999999999 109.68 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -70.5 142.52 51.86 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 110.063 -0.347 . . . . 74.439999999999998 110.063 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 t -146.01 88.13 1.8 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.22 -0.659 . . . . 72.209999999999994 109.22 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.62 101.26 0.18 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.168 -0.924 . . . . 74.120000000000005 110.062 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -57.68 91.69 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.404 -0.816 . . . . 63.219999999999999 112.826 -172.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -166.93 133.32 2.3 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.864 -0.791 . . . . 70.219999999999999 108.864 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . 72.33 162.23 0.15 Allowed Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 123.336 0.397 . . . . 71.530000000000001 110.803 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 31.1 Cg_endo -63.1 152.18 80.91 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.558 2.172 . . . . 54.240000000000002 111.921 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.54 -47.88 63.25 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.953 0.723 . . . . 72.540000000000006 112.953 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.74 -46.03 88.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.614 0.245 . . . . 63.329999999999998 111.438 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 52.399999999999999 110.298 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' HD21 ' A' ' 15' ' ' LEU . 4.4 tt -54.15 -44.98 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.41 -0.813 . . . . 72.049999999999997 109.636 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 53.2 tp -54.04 -59.65 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.873 -0.603 . . . . 73.239999999999995 110.714 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -51.98 67.12 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.052 0.453 . . . . 64.140000000000001 111.122 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.73 -44.26 85.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.387 -0.824 . . . . 75.099999999999994 110.98 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.9 -38.41 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.781 -0.368 . . . . 61.140000000000001 110.821 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 16' ' ' LEU . 42.9 mt-10 -61.03 -44.03 98.01 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.96 -0.296 . . . . 72.420000000000002 110.623 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.91 -43.79 67.56 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.277 -0.569 . . . . 73.230000000000004 110.327 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -35.56 72.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.889 0.376 . . . . 73.209999999999994 111.017 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.3 mmt -62.44 -12.53 22.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.829 -0.623 . . . . 74.239999999999995 111.93 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -72.01 -31.92 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.424 0.154 . . . . 71.209999999999994 111.344 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -115.31 -27.27 7.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.874 0.845 . . . . 54.549999999999997 109.54 -171.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 26' ' ' VAL . 62.4 t -90.21 55.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.595 -1.184 . . . . 73.120000000000005 109.496 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.2 p -173.02 170.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.19 -0.914 . . . . 74.319999999999993 109.575 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -110.61 91.94 13.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 54.409999999999997 109.102 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' HD3' HG13 ' A' ' 27' ' ' VAL . 59.5 Cg_endo -82.92 0.35 9.68 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.286 1.99 . . . . 61.310000000000002 111.906 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.66 -57.83 5.13 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.18 0.514 . . . . 75.420000000000002 109.822 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.66 -18.49 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 73.349999999999994 110.187 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 52.02 2.5 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.044 -0.525 . . . . 54.310000000000002 113.148 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 33' ' ' ILE . 4.0 mp -128.42 140.76 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.968 -0.382 . . . . 73.430000000000007 109.968 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.9 t-20 -100.43 141.13 33.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 74.209999999999994 109.252 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.13 -35.32 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 63.100000000000001 111.675 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.11 -24.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.351 -0.386 . . . . 73.150000000000006 110.848 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.7 -21.62 66.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.043 -0.526 . . . . 74.329999999999998 111.275 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.87 -15.12 63.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.546 0.689 . . . . 74.239999999999995 109.98 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.18 22.08 66.74 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 114.844 -1.071 . . . . 55.229999999999997 114.356 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.9 tp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.28 0.562 . . . . 71.340000000000003 109.553 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.54 -4.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.206 -0.906 . . . . 65.319999999999993 111.637 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -70.36 -15.01 62.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.194 0.521 . . . . 73.200000000000003 109.777 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.95 66.65 3.82 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.284 -0.726 . . . . 62.399999999999999 111.284 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.1 pp -98.68 135.84 39.6 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.643 -0.502 . . . . 74.099999999999994 109.643 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.48 109.02 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.861 -0.792 . . . . 71.409999999999997 108.861 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -114.23 145.24 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 122.147 -0.346 . . . . 73.510000000000005 110.32 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -136.61 124.49 22.67 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 70.030000000000001 109.646 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.9 p-10 -91.59 88.54 6.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.566 0.698 . . . . 63.549999999999997 110.172 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.25 42.16 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.386 -0.825 . . . . 31.329999999999998 111.722 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -67.28 -18.17 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.793 0.33 . . . . 73.099999999999994 110.518 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -98.16 -21.03 16.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.222 -0.444 . . . . 73.510000000000005 111.375 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 131.69 1.83 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.807 -0.711 . . . . 42.119999999999997 112.648 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.9 m -85.33 109.07 18.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.791 -0.448 . . . . 73.420000000000002 109.791 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.6 p -115.23 133.6 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.079 0.466 . . . . 61.32 111.193 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -103.74 115.69 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.716 -0.674 . . . . 74.219999999999999 110.329 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD11 ' HD2' ' A' ' 103' ' ' LYS . 6.5 mt -96.91 129.61 44.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.218 -0.66 . . . . 64.230000000000004 109.218 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.9 118.59 49.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.234 -0.284 . . . . 72.430000000000007 110.234 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.55 116.2 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.010000000000005 110.494 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.5 ' CE ' HD13 ' A' ' 72' ' ' ILE . 26.0 mtm -134.93 170.83 15.29 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 111.216 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -160.06 146.16 15.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.489 -1.232 . . . . 74.409999999999997 108.012 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.502 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 87.8 mt -90.29 163.17 14.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.64 -0.504 . . . . 75.209999999999994 109.64 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -45.45 -47.61 13.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.18 0.437 . . . . 65.200000000000003 112.18 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -96.04 -17.96 20.57 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.156 0.503 . . . . 71.420000000000002 110.548 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.42 8.59 2.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.798 -0.637 . . . . 72.540000000000006 111.544 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.05 -3.7 13.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 73.099999999999994 109.973 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.433 ' HB3' HD13 ' A' ' 68' ' ' LEU . 23.3 m -69.75 123.91 89.55 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.608 -0.724 . . . . 74.400000000000006 110.042 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.18 35.08 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.04 2.493 . . . . 75.329999999999998 113.119 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.2 mp -98.04 13.65 30.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.578 -0.283 . . . . 73.230000000000004 110.685 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.2 t -55.07 -54.17 46.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.822 0.344 . . . . 71.450000000000003 111.29 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' N ' HG23 ' A' ' 69' ' ' THR . 28.3 t70 -65.71 -27.44 68.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 75.25 110.224 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 62.0 t -70.17 -52.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.986 -0.552 . . . . 64.530000000000001 110.681 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.619 HD11 ' N ' ' A' ' 73' ' ' GLU . 2.7 pp -64.07 -37.95 81.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.789 0.328 . . . . 64.25 110.259 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.619 ' N ' HD11 ' A' ' 72' ' ' ILE . 42.8 mt-10 -64.89 -42.23 94.96 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.163 -0.471 . . . . 70.299999999999997 110.521 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.42 -48.25 82.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 64.109999999999999 110.054 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.581 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 22.3 mm-40 -60.15 -46.76 88.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.853 -0.612 . . . . 73.430000000000007 110.198 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.59 -62.31 1.97 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.641 -0.709 . . . . 65.140000000000001 110.799 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -56.82 -43.73 81.31 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.354 -0.384 . . . . 75.219999999999999 111.687 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -60.02 -42.03 93.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 72.349999999999994 110.652 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 -50.97 16.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 62.049999999999997 110.671 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.459 HD11 HG22 ' A' ' 89' ' ' ILE . 83.1 mt -56.65 -37.46 70.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 111.348 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.89 -28.3 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 63.32 110.328 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.34 -34.58 60.68 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.721 -0.951 . . . . 63.439999999999998 110.721 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 m -81.8 -23.09 36.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.186 -0.507 . . . . 64.209999999999994 110.379 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.46 11.75 81.5 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.983 -0.553 . . . . 73.219999999999999 113.326 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.51 -41.03 93.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.604 0.24 . . . . 53.450000000000003 111.563 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 55' ' ' ALA . 23.8 m -136.29 170.21 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.482 -0.326 . . . . 73.099999999999994 110.77 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.64 -38.14 10.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 62.450000000000003 110.507 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 21.2 t70 -145.67 164.05 32.98 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.727 -0.67 . . . . 63.109999999999999 109.31 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 80' ' ' LEU . 19.6 pt -136.24 172.58 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.201 0.524 . . . . 73.239999999999995 110.532 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 105' ' ' THR . 6.9 tpm_? -160.83 106.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.531 -0.759 . . . . 70.120000000000005 109.541 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.459 HD11 ' HE1' ' A' ' 59' ' ' MET . 62.7 mt -90.74 110.48 22.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.017 -0.364 . . . . 74.239999999999995 110.017 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 5.6 t30 -88.55 125.11 34.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 72.420000000000002 110.173 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.502 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.3 m95 -89.77 112.99 24.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 73.239999999999995 111.066 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.13 123.93 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.367 -0.605 . . . . 74.239999999999995 109.367 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -153.69 8.34 0.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.492 . . . . 75.129999999999995 110.904 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.625 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 24.5 t-20 171.51 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.916 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 69.0 Cg_endo -84.68 149.78 11.3 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.047 1.831 . . . . 60.109999999999999 112.448 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 22.7 Cg_exo -65.42 166.44 19.48 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.599 2.199 . . . . 74.109999999999999 111.86 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.511 ' HB3' ' HZ1' ' A' ' 103' ' ' LYS . 3.9 m0 -64.19 109.93 2.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 75.540000000000006 110.333 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.02 -79.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.701 -0.761 . . . . 52.530000000000001 112.912 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.28 -58.59 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.792 2.328 . . . . 65.150000000000006 112.508 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.485 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 3.2 m-20 -66.29 -4.36 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 64.400000000000006 111.524 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HZ1' ' HB3' ' A' ' 99' ' ' TRP . 21.5 mmtp -86.38 2.79 46.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.752 0.278 . . . . 75.519999999999996 111.752 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.0 mt -118.45 111.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.598 0.237 . . . . 73.019999999999996 110.619 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.514 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -55.98 154.41 7.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.065 0.46 . . . . 64.219999999999999 111.97 177.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -53.13 -41.4 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.54 -0.754 . . . . 70.25 111.807 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.73 -53.08 61.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.332 -0.395 . . . . 62.210000000000001 111.115 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.76 -33.71 55.96 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-N 116.058 -0.519 . . . . 44.539999999999999 112.376 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -73.62 -39.17 64.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 65.150000000000006 110.611 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.83 -55.52 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.993 -0.549 . . . . 72.319999999999993 111.298 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.92 92.39 3.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 73.340000000000003 110.513 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 152.94 44.14 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.611 -0.722 . . . . 64.450000000000003 110.322 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -58.43 -30.02 66.57 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.831 0.348 . . . . 74.230000000000004 110.426 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 73.230000000000004 110.402 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.1 tp -83.56 -12.79 55.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.9 -0.591 . . . . 74.439999999999998 110.717 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.98 66.87 2.44 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 112.632 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -85.59 -53.23 5.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.293 0.568 . . . . 74.140000000000001 110.111 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.7 p -105.25 146.18 29.65 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.59 -0.732 . . . . 72.010000000000005 110.882 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.999 -0.741 . . . . 75.25 108.999 173.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 CA-C-O 119.919 -0.379 . . . . 74.140000000000001 112.243 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.4 161.02 19.87 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.549 2.166 . . . . 74.349999999999994 111.999 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.94 125.54 37.52 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.145 -0.55 . . . . 64.209999999999994 111.959 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.0 m -133.97 103.69 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.103 -0.332 . . . . 72.209999999999994 110.103 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 62.26 11.99 4.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.043 0.537 . . . . 73.150000000000006 110.93 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 p -98.17 -10.75 23.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 73.340000000000003 110.345 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.14 -5.63 7.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.043 -0.98 . . . . 75.519999999999996 110.536 -174.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -64.33 94.51 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 75.329999999999998 111.416 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.2 p -159.74 168.89 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.392 -0.822 . . . . 54.450000000000003 108.993 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . 66.34 166.07 0.12 Allowed Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 123.322 0.389 . . . . 74.010000000000005 110.316 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 36.6 Cg_endo -65.47 153.24 79.13 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.822 1.681 . . . . 75.049999999999997 111.455 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.33 -32.53 49.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.302 -0.408 . . . . 71.340000000000003 111.952 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.57 -52.51 63.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 111.363 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.72 -39.14 70.31 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.688 0.28 . . . . 73.120000000000005 110.256 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.37 -46.39 86.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 64.439999999999998 110.08 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.16 -56.77 17.79 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.82 0.343 . . . . 70.140000000000001 110.831 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.88 67.4 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.987 -0.551 . . . . 45.119999999999997 111.04 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.55 -48.33 82.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.903 -0.59 . . . . 63.25 111.064 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' A' ' 23' ' ' MET . 2.4 p -66.95 -36.58 77.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.974 -0.291 . . . . 62.210000000000001 110.435 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.8 -47.24 86.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.96 -0.385 . . . . 63.049999999999997 109.96 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.75 -51.18 68.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 63.420000000000002 110.281 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.2 -49.78 71.05 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.667 -0.697 . . . . 72.129999999999995 110.766 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.9 mmt -61.16 -20.32 62.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.866 0.321 . . . . 73.409999999999997 111.866 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -101.38 -13.77 17.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 73.040000000000006 110.464 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' GLN . 8.6 t70 -119.43 -10.1 9.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.244 0.545 . . . . 74.150000000000006 109.845 -168.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -117.83 -19.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.525 -0.762 . . . . 53.219999999999999 110.501 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.6 p -77.83 163.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.513 -0.767 . . . . 75.340000000000003 110.577 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.07 87.65 1.11 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.279 -1.378 . . . . 44.399999999999999 107.279 166.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 51.6 Cg_endo -82.17 -9.35 11.66 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.158 1.905 . . . . 55.109999999999999 111.903 -172.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -56.94 6.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.817 -0.629 . . . . 74.150000000000006 110.463 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.87 -19.01 29.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.516 -0.311 . . . . 74.420000000000002 110.544 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.38 40.1 6.57 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 116.054 -0.521 . . . . 62.149999999999999 113.493 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -127.84 140.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 117.201 0.5 . . . . 75.209999999999994 110.22 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.407 ' HA ' HG23 ' A' ' 27' ' ' VAL . 21.2 t-20 -101.48 147.72 26.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.464 -0.939 . . . . 63.43 108.464 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.66 -36.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 73.430000000000007 111.118 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.71 -24.58 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 70.409999999999997 110.942 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.75 -28.04 63.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 111.231 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.72 -15.37 63.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.308 0.575 . . . . 64.5 110.268 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.423 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 57.53 21.92 43.73 Favored Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.037 -0.983 . . . . 73.040000000000006 114.015 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' O ' HD11 ' A' ' 40' ' ' LEU . 2.6 tm? -98.78 -29.0 13.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.327 -0.99 . . . . 73.450000000000003 108.327 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 HG21 ' HG2' ' A' ' 59' ' ' MET . 16.4 t -69.82 1.74 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.629 -1.169 . . . . 75.219999999999999 111.75 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.423 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 60.2 m-85 -64.76 -22.74 67.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.319 -0.622 . . . . 75.340000000000003 109.319 171.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.39 72.35 1.94 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.388 -0.824 . . . . 73.209999999999994 112.209 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.52 121.28 44.65 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.072 -0.714 . . . . 73.409999999999997 109.072 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.42 108.88 7.88 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.028 -0.36 . . . . 74.219999999999999 110.028 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.65 126.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.621 -0.511 . . . . 73.310000000000002 109.621 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.66 136.18 46.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.684 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.19 148.2 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 73.340000000000003 110.705 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.51 40.77 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.803 -0.919 . . . . 53.329999999999998 110.803 175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.9 -18.62 63.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.433 0.616 . . . . 42.299999999999997 109.995 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.59 -31.74 71.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.44 0.638 . . . . 72.540000000000006 109.582 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.89 -163.64 24.77 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.1 -0.954 . . . . 21.010000000000002 111.094 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 p -93.21 118.85 31.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.849 0.357 . . . . 73.120000000000005 110.54 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.44 123.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.774 -0.454 . . . . 74.200000000000003 109.774 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -101.38 121.62 42.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.413 -0.358 . . . . 64.129999999999995 111.228 -175.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -98.84 129.52 45.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.918 -0.771 . . . . 73.239999999999995 108.918 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 HG21 ' HG3' ' A' ' 59' ' ' MET . 58.1 mt -125.38 113.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 62.219999999999999 110.544 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.85 117.68 22.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.715 -0.476 . . . . 71.0 109.715 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 88.2 mtp -140.96 170.93 14.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 71.519999999999996 110.617 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -158.95 159.15 34.55 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.629 -0.714 . . . . 72.420000000000002 109.886 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.45 155.68 34.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.576 -0.898 . . . . 71.510000000000005 108.576 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -48.05 -59.79 3.11 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.406 0.441 . . . . 63.32 112.04 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 p -96.7 -13.61 22.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.416 -0.356 . . . . 74.420000000000002 110.977 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.87 8.66 3.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.755 -0.657 . . . . 64.420000000000002 111.51 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.18 -8.52 13.98 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.113 0.483 . . . . 72.049999999999997 110.697 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.577 ' HB3' HD11 ' A' ' 68' ' ' LEU . 62.9 m -67.73 136.13 92.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.636 -0.711 . . . . 70.420000000000002 110.626 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.76 36.0 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.104 2.536 . . . . 63.109999999999999 112.644 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 66' ' ' CYS . 8.6 mp -97.25 1.19 49.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.336 -0.393 . . . . 73.129999999999995 110.249 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -58.53 8.07 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 75.219999999999999 111.432 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.27 -27.08 68.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 75.109999999999999 109.893 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.04 -52.43 38.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.674 -0.694 . . . . 74.329999999999998 110.663 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 pt -64.14 -38.61 82.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.917 -0.313 . . . . 73.200000000000003 110.72 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 91' ' ' ILE . 3.4 mt-10 -63.33 -44.53 94.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.673 -0.239 . . . . 54.399999999999999 111.391 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.18 -51.11 70.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 60.530000000000001 110.427 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 25' ' ' ASP . 25.9 mt-30 -56.27 -52.35 64.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.873 -0.603 . . . . 51.409999999999997 110.806 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.5 t -62.11 -55.13 31.95 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.806 -0.634 . . . . 72.409999999999997 111.183 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -58.59 -41.49 85.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.779 -0.191 . . . . 74.340000000000003 110.94 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -56.12 -47.15 78.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.378 -0.374 . . . . 72.340000000000003 110.693 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.22 16.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 71.549999999999997 111.189 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.12 -38.87 80.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.865 0.364 . . . . 65.530000000000001 111.107 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.36 -27.92 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 64.120000000000005 109.97 175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.74 -47.31 56.58 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.123 -0.561 . . . . 75.25 111.706 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.8 m -73.25 -11.36 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 64.329999999999998 110.563 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.07 38.66 95.63 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.001 -0.545 . . . . 63.25 112.538 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.5 -33.21 19.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 74.219999999999999 110.729 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.502 ' HA ' ' OG1' ' A' ' 53' ' ' THR . 31.2 m -136.26 169.36 20.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.174 -0.467 . . . . 75.329999999999998 110.907 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.86 -41.73 6.07 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.44 . . . . 54.240000000000002 110.748 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -137.71 143.69 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.345 -0.613 . . . . 75.450000000000003 109.345 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.77 146.62 28.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.729 -0.471 . . . . 74.310000000000002 109.729 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 112.85 13.6 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.885 -0.413 . . . . 64.25 109.885 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 73' ' ' GLU . 56.1 mt -90.72 98.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.164 -0.68 . . . . 72.239999999999995 109.164 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.45 121.36 30.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.2 0.524 . . . . 74.5 109.887 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.565 ' HA ' ' O ' ' A' ' 59' ' ' MET . 2.9 m-90 -90.45 106.44 18.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.557 -0.747 . . . . 73.340000000000003 109.47 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.62 123.62 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.415 0.626 . . . . 65.310000000000002 110.138 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -136.97 -7.97 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 75.530000000000001 111.215 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -179.7 -55.68 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 O-C-N 123.1 0.25 . . . . 74.400000000000006 110.952 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -87.09 169.07 7.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.299 1.999 . . . . 62.439999999999998 112.402 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.38 159.51 19.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.485 2.123 . . . . 72.420000000000002 111.545 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -69.72 -22.04 63.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.549 -0.296 . . . . 70.340000000000003 110.759 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -39.53 -63.81 1.12 Allowed Glycine 0 C--N 1.338 0.688 0 O-C-N 123.803 0.689 . . . . 62.210000000000001 114.521 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -46.72 5.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.147 1.898 . . . . 75.239999999999995 111.949 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 -4.19 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 71.409999999999997 111.512 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -76.22 -18.49 59.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.835 -0.431 . . . . 71.409999999999997 109.835 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.26 89.19 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.028 -0.73 . . . . 75.439999999999998 109.028 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.406 ' HB ' ' OE2' ' A' ' 73' ' ' GLU . 17.6 p -71.3 178.49 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.244 -0.889 . . . . 73.099999999999994 112.16 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.57 -28.57 67.26 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.604 0.594 . . . . 53.130000000000003 112.604 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -58.78 -38.87 79.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.105 0.479 . . . . 73.420000000000002 110.157 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.2 -27.89 47.17 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.864 -0.607 . . . . 52.109999999999999 112.456 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.471 ' HE ' ' HA ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -73.26 -49.04 29.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.716 0.293 . . . . 74.439999999999998 111.602 -175.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.21 -39.38 65.59 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.949 0.722 . . . . 72.400000000000006 112.949 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -91.76 82.85 5.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.424 0.631 . . . . 74.230000000000004 111.742 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 tp -93.35 157.81 16.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 71.430000000000007 109.677 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.0 mtm-85 -65.33 -40.14 93.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 74.329999999999998 111.197 -173.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.66 -24.2 60.76 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 111.659 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.43 25.93 1.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.215 -0.448 . . . . 64.120000000000005 111.251 -175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.05 72.28 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.269 -0.423 . . . . 71.010000000000005 112.248 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -124.72 131.18 53.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.665 -0.494 . . . . 73.310000000000002 109.665 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -139.09 160.39 39.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.294 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.037 -0.982 . . . . 75.549999999999997 110.298 -179.907 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.864 -0.495 . . . . 54.420000000000002 111.864 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.14 -28.21 56.6 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.757 2.305 . . . . 74.420000000000002 112.15 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.51 100.85 0.14 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.891 -0.595 . . . . 72.409999999999997 113.002 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.1 t -153.9 106.82 2.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 71.319999999999993 109.218 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -168.8 16.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.573 -0.285 . . . . 71.150000000000006 111.134 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.473 ' HB3' HD23 ' A' ' 44' ' ' LEU . 16.0 m -125.71 -12.38 6.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.358 0.599 . . . . 74.019999999999996 110.642 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.554 ' HB3' HD22 ' A' ' 15' ' ' LEU . 10.1 mp0 -76.15 89.62 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 73.239999999999995 109.894 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -143.2 28.87 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.108 -0.497 . . . . 71.25 111.494 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -125.34 147.91 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 74.349999999999994 110.396 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 71.74 155.76 0.16 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.627 0.579 . . . . 71.040000000000006 111.513 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.87 152.14 52.27 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.439 2.093 . . . . 42.530000000000001 111.161 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.76 -42.37 7.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 73.439999999999998 112.679 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.2 -52.1 51.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.167 0.508 . . . . 71.019999999999996 110.274 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 -32.4 73.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 64.420000000000002 110.299 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 7' ' ' GLU . 6.1 tt -64.98 -50.31 66.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.694 -0.685 . . . . 73.310000000000002 109.448 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.04 -51.82 67.75 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.991 -0.55 . . . . 63.530000000000001 110.768 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -60.95 -49.18 78.48 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.947 -0.569 . . . . 61.439999999999998 110.906 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -57.76 -48.53 79.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.703 -0.681 . . . . 64.25 110.857 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.0 p -68.77 -42.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 116.161 -0.472 . . . . 65.230000000000004 110.656 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -67.32 -37.68 83.72 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.577 -0.449 . . . . 71.329999999999998 110.805 -175.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.7 pt-20 -72.7 -46.44 53.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.601 -0.439 . . . . 71.209999999999994 110.529 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.575 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -59.49 -31.36 69.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.867 0.365 . . . . 62.299999999999997 110.755 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 13.2 mmt -62.97 -13.14 31.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.067 -0.515 . . . . 63.100000000000001 110.719 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -33.37 16.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.831 -0.622 . . . . 74.120000000000005 110.326 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 4.5 m-20 -85.51 -27.5 25.58 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.392 -0.367 . . . . 74.409999999999997 111.713 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 22' ' ' ALA . 35.0 m -113.37 42.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.715 0.769 . . . . 61.509999999999998 110.972 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 34' ' ' ASN . 8.9 p -144.13 159.93 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.317 -0.856 . . . . 71.209999999999994 110.135 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.05 89.88 2.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.535 -0.913 . . . . 45.420000000000002 108.535 167.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.09 -5.72 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.551 2.167 . . . . 74.140000000000001 111.924 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -68.68 -53.74 20.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.903 -0.589 . . . . 53.130000000000003 110.03 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.98 -16.76 16.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.097 -0.502 . . . . 62.409999999999997 110.295 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.81 40.76 4.87 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.175 -0.536 . . . . 51.229999999999997 113.237 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -106.91 140.04 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.154 -0.684 . . . . 70.230000000000004 109.154 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' N ' HD22 ' A' ' 34' ' ' ASN . 0.6 OUTLIER -114.26 124.92 53.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.082 -0.71 . . . . 73.129999999999995 109.082 178.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HA ' HD22 ' A' ' 38' ' ' LEU . 28.3 m -57.91 -28.65 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.44 . . . . 74.150000000000006 110.82 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 34' ' ' ASN . 10.3 p -57.77 -30.81 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.616 . . . . 74.530000000000001 111.186 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.25 -21.15 66.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.633 -0.258 . . . . 72.25 110.862 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -75.34 -16.53 60.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.101 0.477 . . . . 72.439999999999998 110.039 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.65 61.19 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.513 -0.767 . . . . 71.310000000000002 113.994 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 tp -96.06 -31.68 12.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.37 0.585 . . . . 73.140000000000001 109.688 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 36' ' ' VAL . 11.1 p -67.74 -11.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.493 0.663 . . . . 74.530000000000001 109.55 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -63.52 -27.14 69.06 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.273 -0.876 . . . . 73.019999999999996 108.805 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.57 68.59 2.95 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.672 -1.149 . . . . 63.219999999999999 111.098 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.52 HD11 ' O ' ' A' ' 44' ' ' LEU . 3.3 pp -115.27 138.45 50.93 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.105 -0.702 . . . . 74.25 109.105 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.25 108.99 3.84 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.355 -0.609 . . . . 71.109999999999999 109.355 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 45.9 t -89.17 114.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.616 -0.513 . . . . 62.439999999999998 109.616 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -97.46 133.06 42.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 74.209999999999994 110.702 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.46 68.8 10.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.93 -0.767 . . . . 71.409999999999997 108.93 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 164.68 53.79 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.376 -0.829 . . . . 54.299999999999997 112.868 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.78 -26.94 68.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.672 0.389 . . . . 75.099999999999994 110.43 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -81.85 -7.46 59.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 72.150000000000006 111.162 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.82 177.11 14.73 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 112.0 -0.44 . . . . 54.340000000000003 112.0 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 m -72.55 110.18 6.75 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.172 -0.307 . . . . 74.120000000000005 110.172 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.3 p -115.14 124.49 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.828 0.347 . . . . 54.310000000000002 110.716 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 86' ' ' VAL . . . -86.95 107.3 18.32 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.31 -0.405 . . . . 43.149999999999999 110.653 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 90' ' ' ARG . 28.3 mt -87.57 105.08 17.08 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.449 . . . . 64.340000000000003 109.789 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.53 124.19 68.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 110.257 -0.275 . . . . 50.109999999999999 110.257 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.61 128.49 36.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 55.350000000000001 111.367 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 80.6 mtp -141.24 171.12 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.652 -0.704 . . . . 64.409999999999997 110.636 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -145.49 171.51 14.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.326 -0.397 . . . . 74.450000000000003 109.935 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -121.18 166.64 13.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.468 -0.567 . . . . 75.040000000000006 109.468 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.4 p -62.13 -60.28 3.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.87 0.367 . . . . 74.450000000000003 111.967 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -114.28 -8.09 12.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.318 -0.401 . . . . 73.109999999999999 110.749 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.35 8.84 4.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.903 -0.589 . . . . 74.319999999999993 111.912 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.9 -25.6 13.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.113 0.483 . . . . 61.350000000000001 110.22 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.5 m -79.14 138.13 56.54 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 115.598 -0.728 . . . . 74.150000000000006 110.351 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.89 50.57 2.82 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.867 2.378 . . . . 74.299999999999997 112.335 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.14 -9.31 59.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.376 -0.375 . . . . 71.129999999999995 110.673 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.8 t -60.19 -43.4 95.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.006 -0.543 . . . . 63.450000000000003 110.838 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.95 -42.28 79.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.368 0.604 . . . . 75.109999999999999 109.941 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -65.41 -52.5 51.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 114.942 -1.026 . . . . 62.520000000000003 110.615 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.67 -41.35 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.617 -0.265 . . . . 73.140000000000001 111.224 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.55 -47.77 82.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.527 0.203 . . . . 54.020000000000003 110.671 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 35.8 t70 -59.71 -48.15 82.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 75.129999999999995 110.942 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 25' ' ' ASP . 18.2 mt-30 -62.51 -43.72 98.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 63.340000000000003 111.182 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.3 m -62.57 -55.22 29.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.258 -0.428 . . . . 71.329999999999998 110.689 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 6.9 ppt_? -57.04 -38.03 72.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.943 -0.303 . . . . 73.129999999999995 110.32 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.8 t -55.66 -53.71 53.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 111.184 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.59 -52.41 11.86 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.546 -0.462 . . . . 70.430000000000007 111.395 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -39.74 89.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.924 0.392 . . . . 73.25 111.55 -171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.23 -27.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 74.219999999999999 109.847 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.81 -45.83 56.12 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.832 -0.699 . . . . 42.43 111.622 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 p -75.9 -22.98 55.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.967 0.413 . . . . 70.420000000000002 110.195 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.13 45.34 41.01 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.87 -0.604 . . . . 74.109999999999999 112.107 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.26 -32.8 33.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 65.299999999999997 110.576 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG12 ' HB3' ' A' ' 55' ' ' ALA . 28.2 m -141.18 165.51 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.646 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.35 -47.46 19.86 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.668 -0.493 . . . . 65.099999999999994 109.668 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 22.1 m-20 -133.54 158.14 43.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 65.099999999999994 110.475 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -111.46 164.92 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.102 -0.703 . . . . 72.129999999999995 109.102 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' HB3' HD22 ' A' ' 56' ' ' LEU . 14.5 tpp85 -153.23 106.63 3.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.02 -0.272 . . . . 70.230000000000004 110.43 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.0 mt -94.31 131.03 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 75.140000000000001 110.071 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.606 HD22 ' N ' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -107.9 131.73 54.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.951 . . . . 63.32 108.431 175.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.606 ' N ' HD22 ' A' ' 92' ' ' ASN . 2.7 m-90 -102.67 106.12 16.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.46 -0.57 . . . . 75.340000000000003 109.46 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.4 m -102.93 124.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.141 0.495 . . . . 74.209999999999994 109.711 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -111.27 -33.23 6.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 72.299999999999997 110.373 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.617 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 20.1 t-20 -171.71 -50.89 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.768 -0.651 . . . . 72.25 110.761 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 17.1 Cg_exo -68.33 157.78 60.37 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.296 1.997 . . . . 72.430000000000007 111.8 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.72 167.21 15.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.831 2.354 . . . . 51.399999999999999 112.402 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -62.56 142.85 57.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.68 -0.691 . . . . 72.420000000000002 111.371 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -120.21 0.53 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.143 -0.48 . . . . 72.140000000000001 111.966 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.0 -20.36 67.7 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.64 2.227 . . . . 44.409999999999997 111.266 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -5.54 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.905 -1.043 . . . . 74.510000000000005 111.753 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 57.2 mmtt -81.13 9.78 6.27 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 110.267 -0.272 . . . . 72.5 110.267 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.87 134.61 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.846 -0.428 . . . . 73.120000000000005 109.846 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.8 p -79.15 153.49 30.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.607 -0.27 . . . . 73.109999999999999 111.241 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.95 -25.52 66.38 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.794 -0.817 . . . . 71.409999999999997 108.794 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.85 -34.41 67.76 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.225 -0.898 . . . . 74.040000000000006 110.575 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.73 -36.49 92.37 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.049 -0.596 . . . . 70.129999999999995 112.054 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -58.52 -36.41 73.79 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.221 0.534 . . . . 52.32 110.423 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.46 -17.36 64.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 64.319999999999993 111.354 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -115.59 102.29 9.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.26 0.553 . . . . 64.439999999999998 111.969 -170.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.4 tp -156.65 155.81 32.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.817 -0.808 . . . . 72.099999999999994 108.817 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.33 -37.27 80.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.895 0.378 . . . . 62.229999999999997 110.89 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 -21.33 65.66 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.061 -0.518 . . . . 65.129999999999995 111.288 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.76 -17.56 37.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 74.239999999999995 110.094 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.51 82.71 1.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.947 -0.57 . . . . 30.440000000000001 111.692 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -64.69 111.57 2.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.711 0.291 . . . . 73.239999999999995 110.847 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.4 m -69.45 142.27 53.83 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.167 -0.469 . . . . 71.030000000000001 111.059 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.703 -0.665 . . . . 72.030000000000001 110.129 176.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.215 -0.354 . . . . 24.210000000000001 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.88 151.09 14.33 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.847 2.365 . . . . 74.030000000000001 112.064 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.19 -105.53 0.58 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.075 -0.584 . . . . 72.239999999999995 111.655 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -88.43 -37.29 15.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.086 0.47 . . . . 74.349999999999994 110.005 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mmt -68.84 101.89 1.44 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.826 -0.625 . . . . 72.310000000000002 110.076 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -148.6 -159.84 1.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.723 -0.671 . . . . 70.439999999999998 109.336 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.854 ' HB3' HD13 ' A' ' 15' ' ' LEU . 1.6 mp0 -61.03 87.75 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.981 0.419 . . . . 73.25 110.819 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.4 m -143.64 86.01 1.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.164 0.507 . . . . 74.200000000000003 110.026 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -173.46 126.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.484 -0.78 . . . . 53.0 109.498 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . 71.67 162.24 0.15 Allowed Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.361 0.413 . . . . 73.420000000000002 110.889 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 12.0 Cg_endo -55.61 152.88 31.94 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.535 2.157 . . . . 72.439999999999998 112.147 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.86 -38.51 35.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.969 0.507 . . . . 61.350000000000001 112.365 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -68.2 -51.95 39.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 74.349999999999994 110.362 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.88 -45.99 80.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.541 -0.754 . . . . 73.430000000000007 110.324 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 7' ' ' GLU . 2.7 tm? -55.19 -49.37 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.298 -0.864 . . . . 73.409999999999997 110.272 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.67 -53.72 47.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.771 -0.649 . . . . 73.239999999999995 110.903 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.2 74.37 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.546 . . . . 75.049999999999997 111.124 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 75.319999999999993 110.902 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 23' ' ' MET . 8.8 p -69.45 -32.67 53.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 110.085 -0.339 . . . . 54.119999999999997 110.085 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -62.17 -41.14 98.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.78 -0.452 . . . . 50.240000000000002 109.78 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 38.0 mt-10 -69.26 -43.91 72.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.066 -0.515 . . . . 72.129999999999995 110.342 174.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -45.17 77.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 63.409999999999997 110.434 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.72 -13.48 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.613 -0.721 . . . . 75.140000000000001 111.639 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 32.3 ttp180 -87.86 -32.66 18.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.832 0.453 . . . . 63.450000000000003 110.53 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -100.27 -26.93 13.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 112.17 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -84.96 3.01 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 43.25 111.063 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 34' ' ' ASN . 9.5 p -125.59 158.45 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.236 -0.653 . . . . 63.509999999999998 109.236 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -101.21 95.37 4.78 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.72 -0.844 . . . . 71.230000000000004 108.72 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 78.2 Cg_endo -83.08 -6.15 11.23 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.647 2.231 . . . . 74.409999999999997 111.926 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -69.04 -57.62 5.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.787 -0.642 . . . . 63.340000000000003 110.265 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.55 -18.68 21.2 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.272 -0.422 . . . . 72.329999999999998 109.95 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 48.76 4.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.675 -0.693 . . . . 54.210000000000001 113.365 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.408 ' N ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.91 145.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 117.144 0.472 . . . . 72.420000000000002 110.499 177.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.534 ' HB2' HG13 ' A' ' 36' ' ' VAL . 18.5 p-10 -112.86 107.21 15.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 74.319999999999993 111.789 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.43 -31.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.843 -0.617 . . . . 75.209999999999994 110.865 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.534 HG13 ' HB2' ' A' ' 34' ' ' ASN . 12.2 p -55.75 -25.04 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.881 -0.6 . . . . 74.340000000000003 111.399 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.05 -22.46 65.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.569 -0.287 . . . . 54.32 111.498 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.59 -23.35 65.94 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.103 0.477 . . . . 75.219999999999999 110.384 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.61 61.07 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.396 -0.82 . . . . 65.540000000000006 114.081 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.4 -32.09 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.332 0.566 . . . . 55.340000000000003 109.744 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.78 -14.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.491 -0.777 . . . . 63.43 110.254 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -65.97 -17.76 64.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.155 -0.929 . . . . 73.450000000000003 110.291 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.81 62.43 4.17 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.024 -0.534 . . . . 64.219999999999999 112.0 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 44' ' ' LEU . 1.9 pp -101.42 148.63 24.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 64.209999999999994 110.706 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -161.36 110.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.979 -0.378 . . . . 73.430000000000007 109.979 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.8 p -92.5 121.01 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 110.292 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -109.21 127.87 54.58 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.872 -0.603 . . . . 71.010000000000005 110.434 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -82.94 138.75 33.7 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.681 -0.691 . . . . 75.230000000000004 110.405 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.56 154.0 21.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.832 -0.907 . . . . 60.240000000000002 110.832 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -58.25 -36.9 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 72.219999999999999 110.719 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -78.5 -24.67 45.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.705 -0.679 . . . . 71.140000000000001 110.409 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.98 158.38 12.8 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.225 -0.512 . . . . 61.020000000000003 112.526 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.29 117.28 29.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.138 -0.319 . . . . 74.030000000000001 110.138 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 8.7 p -108.82 134.88 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.727 0.298 . . . . 72.450000000000003 111.081 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -100.76 110.39 22.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.511 -0.313 . . . . 72.329999999999998 110.638 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 90' ' ' ARG . 52.6 mt -84.85 137.92 32.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.119 -0.326 . . . . 74.310000000000002 110.119 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.482 ' HB ' HG12 ' A' ' 91' ' ' ILE . 62.4 mt -135.66 118.51 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.783 -0.451 . . . . 73.430000000000007 109.783 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.38 116.33 22.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 75.409999999999997 110.723 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 82.5 mtp -141.41 170.92 14.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.292 0.567 . . . . 62.310000000000002 111.46 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -150.23 176.69 10.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.366 -0.834 . . . . 62.219999999999999 108.801 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.52 145.67 47.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.624 -0.509 . . . . 74.209999999999994 109.624 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.7 p -52.53 -55.11 24.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 72.0 112.614 -172.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -99.84 -4.49 30.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 75.319999999999993 111.104 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.89 8.91 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.98 -0.554 . . . . 72.400000000000006 112.363 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.26 -35.91 3.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.951 0.405 . . . . 64.25 110.491 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -67.02 123.53 86.48 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.719 -0.673 . . . . 62.240000000000002 110.141 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.49 64.94 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.986 2.458 . . . . 73.409999999999997 113.055 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.89 -3.21 58.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.478 -0.328 . . . . 73.299999999999997 110.791 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 t -56.98 -44.97 83.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.321 -0.4 . . . . 73.040000000000006 111.168 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.95 -41.49 87.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.073 0.463 . . . . 72.230000000000004 110.152 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.93 -51.56 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.349 -0.841 . . . . 51.439999999999998 110.926 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.5 pt -64.01 -41.26 91.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 74.0 111.185 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' CD ' HH22 ' A' ' 90' ' ' ARG . 1.8 mm-40 -68.78 -38.21 79.85 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.525 -0.307 . . . . 75.010000000000005 111.162 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.62 -46.69 71.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.988 -0.285 . . . . 73.219999999999999 110.561 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.12 -41.54 94.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.484 0.183 . . . . 70.439999999999998 110.53 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 t -61.15 -52.38 65.1 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.451 -0.574 . . . . 54.020000000000003 109.451 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' HD3' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -54.59 -40.28 68.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.534 -0.757 . . . . 74.239999999999995 111.424 176.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.433 ' N ' ' HD3' ' A' ' 77' ' ' ARG . 75.7 m -54.48 -53.04 59.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.415 0.15 . . . . 74.25 111.188 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.7 -51.47 14.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.995 -0.282 . . . . 41.399999999999999 111.499 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.31 -30.39 69.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.77 0.319 . . . . 72.120000000000005 111.408 -172.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.74 -27.61 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 71.540000000000006 110.053 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.57 90.69 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.31 -0.405 . . . . 32.219999999999999 112.371 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -102.65 -0.57 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 71.140000000000001 110.551 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.03 52.16 54.51 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.071 -0.513 . . . . 74.140000000000001 112.093 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.4 -30.49 69.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.708 0.289 . . . . 61.32 110.824 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.8 m -137.15 175.46 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.04 -0.527 . . . . 71.340000000000003 110.505 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.7 -37.68 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.111 0.481 . . . . 71.200000000000003 110.322 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 28.9 t70 -145.82 157.78 43.9 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.838 -0.619 . . . . 73.519999999999996 110.038 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.47 157.03 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.948 -0.389 . . . . 73.239999999999995 109.948 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.628 HH11 HG22 ' A' ' 105' ' ' THR . 0.9 OUTLIER -154.71 106.38 2.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.478 -0.328 . . . . 72.120000000000005 110.932 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.482 HG12 ' HB ' ' A' ' 57' ' ' ILE . 57.9 mt -93.54 113.53 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.181 -0.674 . . . . 74.209999999999994 109.181 171.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 2.5 p-10 -90.5 140.23 29.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.246 -0.65 . . . . 73.409999999999997 109.246 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.446 ' HA ' ' O ' ' A' ' 59' ' ' MET . 6.2 m-90 -107.35 106.76 17.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.49 -0.323 . . . . 74.530000000000001 110.314 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.15 124.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.141 0.496 . . . . 71.040000000000006 110.406 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -103.87 -43.57 5.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.216 -0.661 . . . . 75.439999999999998 109.216 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.591 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 m120 -164.77 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 114.468 -1.242 . . . . 75.019999999999996 109.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 27.7 Cg_exo -64.45 164.78 22.18 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.284 1.989 . . . . 72.340000000000003 111.561 173.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.14 -179.32 5.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.562 2.175 . . . . 75.409999999999997 113.065 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.512 ' HD1' ' ND2' ' A' ' 92' ' ' ASN . 4.7 m-90 -73.12 112.08 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.375 -0.83 . . . . 74.430000000000007 109.983 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.55 -115.45 1.49 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.974 -0.631 . . . . 64.030000000000001 112.12 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 -24.68 74.84 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.826 2.351 . . . . 64.109999999999999 112.074 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.44 -13.07 11.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.749 -0.66 . . . . 72.030000000000001 111.025 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -87.61 6.98 31.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 75.209999999999994 111.219 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.65 108.89 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.726 0.298 . . . . 74.129999999999995 110.849 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.628 HG22 HH11 ' A' ' 90' ' ' ARG . 0.2 OUTLIER -58.49 155.53 11.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.297 0.639 . . . . 73.140000000000001 112.229 176.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -51.55 -47.99 63.22 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.867 -0.606 . . . . 71.239999999999995 111.065 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.99 -34.82 68.5 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.046 -0.525 . . . . 64.450000000000003 110.733 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.57 -34.31 57.13 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.832 -0.622 . . . . 52.350000000000001 112.223 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' O ' ' HD2' ' A' ' 109' ' ' ARG . 3.5 tmm_? -73.99 -32.0 63.21 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.265 0.555 . . . . 75.150000000000006 110.255 177.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.413 ' OE2' ' HA3' ' A' ' 116' ' ' GLY . 30.9 tt0 -69.78 -58.67 3.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.182 -0.917 . . . . 65.219999999999999 112.677 -170.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 61.67 5.53 1.31 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.004 -0.998 . . . . 74.420000000000002 113.501 171.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.748 ' HB3' HD21 ' A' ' 115' ' ' LEU . 32.5 tp -170.63 150.69 3.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.23 0.538 . . . . 75.150000000000006 110.473 175.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.681 ' HG3' HG23 ' A' ' 118' ' ' THR . 34.5 ttt180 -69.45 -30.13 67.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.992 -1.004 . . . . 61.450000000000003 111.522 -172.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.59 60.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 64.209999999999994 112.119 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.748 HD21 ' HB3' ' A' ' 112' ' ' LEU . 4.1 mm? -90.03 -34.92 15.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.649 0.261 . . . . 72.319999999999993 111.257 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.413 ' HA3' ' OE2' ' A' ' 110' ' ' GLU . . . -95.43 154.16 20.95 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.985 -0.626 . . . . 54.310000000000002 112.152 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -69.67 89.07 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 74.0 110.192 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.681 HG23 ' HG3' ' A' ' 113' ' ' ARG . 22.3 p -98.76 133.21 43.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.673 -0.694 . . . . 73.209999999999994 109.68 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.486 -0.769 . . . . 71.120000000000005 111.693 -175.146 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.991 -0.444 . . . . 52.229999999999997 111.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.11 115.3 4.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.047 2.498 . . . . 72.409999999999997 111.544 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.92 -168.46 16.5 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.13 -0.486 . . . . 53.109999999999999 112.029 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -141.38 129.27 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.376 -0.602 . . . . 73.530000000000001 109.376 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.3 mtt -79.69 30.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.989 0.423 . . . . 71.510000000000005 111.448 -176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -75.35 -28.17 59.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.243 0.544 . . . . 74.409999999999997 109.852 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -71.52 111.59 6.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.516 -0.765 . . . . 73.140000000000001 111.822 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -140.28 24.26 2.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.031 -0.986 . . . . 75.239999999999995 108.792 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 t -107.28 173.5 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.647 -0.706 . . . . 54.210000000000001 110.589 -176.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . 64.81 167.61 0.11 Allowed Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 123.72 0.638 . . . . 54.119999999999997 111.698 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 32.5 Cg_exo -55.89 143.37 82.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.505 2.137 . . . . 71.239999999999995 110.944 171.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.01 17.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.853 0.316 . . . . 51.350000000000001 111.853 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -62.73 -42.56 99.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.994 0.426 . . . . 70.040000000000006 110.845 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.59 -49.67 74.3 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.784 -0.644 . . . . 64.340000000000003 110.144 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 tp -54.44 -41.75 69.78 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.069 -0.969 . . . . 73.349999999999994 110.737 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 tp -53.39 -56.57 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 54.350000000000001 110.868 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.2 -51.97 52.53 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 116.086 -0.506 . . . . 64.019999999999996 111.242 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.47 -44.92 95.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.637 -0.711 . . . . 74.420000000000002 111.202 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 15' ' ' LEU . 3.3 p -71.49 -33.54 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.015 -0.365 . . . . 73.430000000000007 110.015 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.85 -51.57 68.51 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.992 0.425 . . . . 62.530000000000001 109.956 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.32 -39.33 68.29 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.096 -0.502 . . . . 62.530000000000001 111.373 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.23 79.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.158 0.504 . . . . 25.140000000000001 110.567 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.56 -13.31 58.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 73.430000000000007 111.069 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -97.71 -7.31 31.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.768 0.318 . . . . 74.030000000000001 110.639 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.55 -27.56 5.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.333 0.587 . . . . 75.209999999999994 110.506 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -84.08 -26.29 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.903 -1.044 . . . . 55.039999999999999 110.821 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.3 p -86.84 154.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.555 . . . . 75.450000000000003 109.881 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 12.4 t70 -86.29 102.3 2.69 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.861 -1.162 . . . . 74.219999999999999 107.861 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 5.9 Cg_endo -84.24 -10.05 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.857 2.371 . . . . 73.129999999999995 112.498 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.55 -56.54 7.96 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.028 0.442 . . . . 44.310000000000002 110.208 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.442 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 65.8 mt -93.98 -18.49 21.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 74.030000000000001 109.855 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.15 56.13 3.11 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.782 -0.644 . . . . 65.400000000000006 113.078 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.7 140.52 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.049 0.424 . . . . 74.530000000000001 111.085 179.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -102.11 138.33 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 72.140000000000001 109.545 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.69 -25.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.019 0.437 . . . . 73.019999999999996 111.292 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.77 -25.51 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.9 -0.591 . . . . 72.310000000000002 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.11 -21.94 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.771 -0.649 . . . . 73.420000000000002 111.679 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.43 -6.88 43.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.931 0.396 . . . . 74.230000000000004 110.89 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.81 22.82 54.95 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.633 -0.712 . . . . 43.140000000000001 114.15 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.89 -31.72 12.05 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.888 -0.412 . . . . 65.230000000000004 109.888 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.94 -13.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.62 -0.718 . . . . 75.230000000000004 110.246 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -56.73 -29.96 63.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.185 -0.916 . . . . 64.109999999999999 110.168 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.73 92.0 1.77 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.643 -0.708 . . . . 60.109999999999999 111.695 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.93 160.18 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.61 -0.347 . . . . 75.409999999999997 110.124 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.76 123.14 6.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 72.430000000000007 109.466 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 p -103.69 122.69 56.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.016 0.436 . . . . 74.239999999999995 110.171 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.542 ' NE2' HD12 ' A' ' 56' ' ' LEU . 40.7 mt-30 -97.69 120.36 37.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 71.030000000000001 109.727 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.36 83.45 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.732 0.777 . . . . 72.140000000000001 109.672 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.97 163.82 19.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 114.998 -1.001 . . . . 60.25 112.184 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -55.27 -40.03 70.52 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.181 0.515 . . . . 62.340000000000003 110.941 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -68.38 -30.54 69.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.653 -0.703 . . . . 63.340000000000003 110.664 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.31 154.99 7.79 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.966 -0.635 . . . . 63.130000000000003 112.41 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.8 m -85.78 102.33 13.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.936 0.398 . . . . 74.200000000000003 110.12 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 60.0 t -107.07 126.72 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.093 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.34 107.28 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 53.439999999999998 110.849 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.542 HD12 ' NE2' ' A' ' 47' ' ' GLN . 48.4 mt -82.12 131.89 35.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.469 -0.567 . . . . 73.010000000000005 109.469 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.475 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.1 mt -129.76 129.7 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.443 0.164 . . . . 74.109999999999999 110.623 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.09 114.56 26.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.693 -0.484 . . . . 61.310000000000002 109.693 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.839 ' HE1' HG21 ' A' ' 72' ' ' ILE . 82.9 mtp -141.03 170.76 15.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.622 0.725 . . . . 62.539999999999999 111.69 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.452 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 6.3 t -162.63 160.69 26.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.642 -1.163 . . . . 72.450000000000003 108.302 171.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -88.67 158.13 18.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.752 -0.462 . . . . 74.549999999999997 109.752 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -43.13 -52.92 5.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.968 0.507 . . . . 73.430000000000007 112.187 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -113.32 13.11 19.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 72.109999999999999 110.951 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.2 8.7 1.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.956 0.724 . . . . 64.239999999999995 112.956 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.36 11.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.45 . . . . 64.209999999999994 110.423 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.3 m -92.59 129.28 41.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 71.420000000000002 110.463 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.63 34.29 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.857 2.372 . . . . 73.430000000000007 112.061 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.73 HD21 ' HB ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -83.15 -11.34 58.01 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 74.310000000000002 109.974 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.581 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 10.2 t -49.92 -56.03 12.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.895 -0.593 . . . . 65.219999999999999 111.348 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' N ' HG21 ' A' ' 69' ' ' THR . 5.6 m-20 -56.59 -34.94 67.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.484 . . . . 74.329999999999998 110.46 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.73 ' HB ' HD21 ' A' ' 68' ' ' LEU . 47.2 t -70.93 -52.71 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 64.219999999999999 110.864 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.839 HG21 ' HE1' ' A' ' 59' ' ' MET . 0.3 OUTLIER -60.31 -43.03 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.33 0.586 . . . . 65.340000000000003 109.47 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 69' ' ' THR . 23.5 mt-10 -61.72 -53.57 54.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.123 -0.944 . . . . 73.439999999999998 110.871 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.05 -51.42 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.653 0.263 . . . . 71.420000000000002 110.891 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -55.83 -58.73 6.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.084 -0.507 . . . . 72.239999999999995 111.141 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.432 ' O ' HD21 ' A' ' 80' ' ' LEU . 43.4 t -65.06 -55.63 17.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 73.439999999999998 110.911 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.502 ' HG3' HG12 ' A' ' 89' ' ' ILE . 47.8 ttt180 -55.63 -52.84 62.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.304 -0.407 . . . . 73.239999999999995 111.281 -174.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -64.51 -33.95 77.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.814 -0.63 . . . . 70.549999999999997 111.006 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.0 -51.31 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.83 -0.348 . . . . 73.409999999999997 110.364 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 76' ' ' SER . 4.4 mm? -56.21 -44.4 79.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.214 -0.448 . . . . 72.099999999999994 111.015 -177.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.18 -28.25 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.422 -0.353 . . . . 74.239999999999995 110.538 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.74 -23.47 55.82 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.03 -0.605 . . . . 62.43 111.983 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -94.41 -11.69 29.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 75.319999999999993 110.178 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.38 75.89 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.873 -0.603 . . . . 75.310000000000002 113.347 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.01 -33.67 76.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.961 0.41 . . . . 70.120000000000005 109.949 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.11 175.75 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.581 -0.736 . . . . 64.329999999999998 109.556 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.23 -50.97 10.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 71.319999999999993 110.181 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 37.2 t70 -167.54 169.79 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.937 -0.764 . . . . 65.150000000000006 108.937 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.502 HG12 ' HG3' ' A' ' 77' ' ' ARG . 18.0 pt -125.06 166.86 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.962 0.411 . . . . 60.240000000000002 110.914 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 19.8 ttm180 -152.38 113.25 4.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.698 -0.683 . . . . 75.540000000000006 109.247 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.417 HG12 ' HB ' ' A' ' 57' ' ' ILE . 67.7 mt -100.68 124.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 74.239999999999995 110.496 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -95.37 122.14 37.77 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.259 -0.645 . . . . 64.420000000000002 109.259 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.636 ' HH2' HD13 ' A' ' 72' ' ' ILE . 88.5 m95 -90.37 106.67 18.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.019 -0.537 . . . . 72.420000000000002 109.94 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 m -91.11 124.34 43.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.412 0.625 . . . . 75.420000000000002 111.395 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -112.15 -32.24 6.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 74.310000000000002 109.832 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.561 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 31.2 t30 -166.49 -51.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.362 -0.836 . . . . 73.430000000000007 110.53 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 43.5 Cg_endo -66.61 132.17 28.16 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.11 1.873 . . . . 63.140000000000001 112.005 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.73 81.66 2.5 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.566 2.177 . . . . 71.299999999999997 112.912 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 56.07 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.571 -0.74 . . . . 74.420000000000002 112.267 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.89 -113.14 0.76 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.214 -0.754 . . . . 73.209999999999994 111.214 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.77 -15.44 50.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.173 1.915 . . . . 64.129999999999995 110.599 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.39 -17.64 31.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.838 -1.074 . . . . 70.109999999999999 110.709 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 90' ' ' ARG . 97.9 mttt -76.65 -19.31 57.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.783 -0.644 . . . . 74.340000000000003 111.33 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.34 92.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 64.049999999999997 111.078 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 p -61.67 154.85 24.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.65 -0.705 . . . . 52.109999999999999 110.82 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.99 -29.52 57.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.284 0.846 . . . . 74.140000000000001 113.284 -168.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -57.13 -30.21 64.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.778 0.263 . . . . 73.439999999999998 110.659 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.57 98.11 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.994 -0.622 . . . . 71.340000000000003 111.963 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -73.75 -46.88 43.13 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.07 0.462 . . . . 63.329999999999998 110.187 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.94 -38.54 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.304 -0.862 . . . . 71.329999999999998 111.55 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -103.93 23.82 12.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.018 -0.537 . . . . 70.400000000000006 111.285 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.741 ' HB3' HD23 ' A' ' 115' ' ' LEU . 22.8 tp -85.49 158.15 20.25 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.257 -0.645 . . . . 72.439999999999998 109.257 176.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -60.31 -50.02 75.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.847 0.355 . . . . 75.450000000000003 111.631 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.88 -20.92 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 64.519999999999996 112.015 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? -90.9 -0.97 57.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.788 0.328 . . . . 73.140000000000001 110.827 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.1 63.61 4.28 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 116.179 -0.464 . . . . 54.140000000000001 112.227 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.75 136.47 18.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.932 -0.396 . . . . 74.400000000000006 109.932 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -164.9 175.33 9.66 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.935 -0.575 . . . . 64.439999999999998 109.763 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.484 -0.77 . . . . 72.299999999999997 110.444 178.582 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.963 -0.455 . . . . 64.409999999999997 111.963 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.47 80.95 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.752 2.301 . . . . 73.439999999999998 111.648 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.66 99.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.946 -0.57 . . . . 74.430000000000007 112.288 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.6 t -171.05 103.54 0.22 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.965 0.412 . . . . 65.140000000000001 109.927 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 6' ' ' SER . 1.7 mpt? -132.28 -46.39 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 74.519999999999996 109.86 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 5' ' ' MET . 15.8 t 173.74 95.44 0.01 OUTLIER 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.732 -0.84 . . . . 72.129999999999995 108.732 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HA ' HD13 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -141.12 108.17 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.023 0.439 . . . . 72.319999999999993 111.806 -171.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 m 72.51 147.04 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.561 -0.745 . . . . 74.140000000000001 112.115 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -117.64 120.07 36.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.859 -0.609 . . . . 74.129999999999995 109.418 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . -169.77 163.24 6.78 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.849 -0.426 . . . . 70.010000000000005 109.849 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . 81.8 Cg_exo -44.17 115.29 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.742 2.294 . . . . 73.120000000000005 112.137 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.41 -20.62 7.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.693 0.627 . . . . 40.219999999999999 112.693 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -71.13 -53.31 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 74.129999999999995 110.552 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 12.0 pt-20 -82.01 -30.88 31.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.988 -0.551 . . . . 64.150000000000006 110.702 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 10' ' ' ALA . 3.3 tm? -54.49 -37.04 64.81 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.668 -0.696 . . . . 55.25 110.577 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.22 -53.41 57.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.063 0.459 . . . . 75.120000000000005 110.168 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.55 -52.03 62.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 65.129999999999995 110.699 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.14 -44.01 92.03 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.184 -0.462 . . . . 63.140000000000001 111.571 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.7 p -67.27 -37.75 79.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.744 -0.465 . . . . 62.210000000000001 109.744 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.47 -35.58 79.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.802 0.334 . . . . 75.409999999999997 110.406 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 9.6 mm-40 -66.34 -51.07 60.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.319 -0.4 . . . . 70.239999999999995 110.349 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.7 83.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 110.599 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 22.3 mmt -58.78 -12.64 4.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.737 -0.665 . . . . 72.510000000000005 111.709 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -76.23 -25.48 55.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.597 0.221 . . . . 72.140000000000001 111.597 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.65 -27.54 5.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.141 0.496 . . . . 70.099999999999994 109.917 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 26' ' ' VAL . 58.9 t -81.51 51.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.153 -0.931 . . . . 51.43 109.4 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.522 HG11 ' HD3' ' A' ' 29' ' ' PRO . 9.6 p -171.56 162.89 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.706 -0.679 . . . . 72.239999999999995 110.628 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.43 91.28 9.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.422 -1.325 . . . . 61.420000000000002 107.422 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HD3' HG11 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -80.42 -3.77 12.7 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.128 1.885 . . . . 73.25 111.772 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.1 -57.63 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 74.219999999999999 110.055 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 31' ' ' LEU . 3.2 mm? -90.1 -16.75 29.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.725 -0.67 . . . . 73.549999999999997 109.894 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 40.55 6.62 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.867 -0.606 . . . . 45.229999999999997 113.5 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.52 140.27 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.107 0.479 . . . . 74.109999999999999 110.416 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 27' ' ' VAL . 1.3 p-10 -116.63 115.04 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 74.349999999999994 110.274 -176.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -46.0 -32.45 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.465 0.542 . . . . 72.329999999999998 112.465 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.58 -24.81 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.223 0.453 . . . . 74.329999999999998 112.223 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.93 -15.33 62.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.468 0.175 . . . . 62.25 111.228 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.65 -17.16 62.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.205 0.526 . . . . 72.150000000000006 109.771 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.44 22.7 67.85 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.371 -0.831 . . . . 65.519999999999996 113.425 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.613 HD13 ' HA ' ' A' ' 59' ' ' MET . 3.0 tm? -97.46 -31.46 12.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.918 -1.141 . . . . 74.430000000000007 107.918 171.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.07 -7.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.235 -0.893 . . . . 63.450000000000003 110.409 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.12 -24.83 56.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 64.140000000000001 109.65 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.13 67.74 1.42 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 111.14 -0.784 . . . . 35.43 111.14 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -125.64 121.45 33.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.246 -0.65 . . . . 61.5 109.246 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -141.74 113.15 7.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.333 -0.618 . . . . 71.450000000000003 109.333 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.2 m -102.86 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.26 -0.644 . . . . 73.209999999999994 109.26 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -121.07 120.17 34.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.771 0.32 . . . . 74.430000000000007 110.28 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' HA ' HG21 ' A' ' 53' ' ' THR . 9.1 p-10 -94.11 88.24 5.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 72.0 109.658 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.36 159.17 24.98 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.414 -0.812 . . . . 50.130000000000003 111.869 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.88 -23.39 66.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.74 0.305 . . . . 74.310000000000002 110.717 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.36 -38.48 21.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 61.530000000000001 110.252 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.1 157.76 23.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.066 -0.587 . . . . 55.539999999999999 112.26 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 HG11 ' A' ' 86' ' ' VAL . 12.4 m -101.0 119.1 38.26 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.97 -0.381 . . . . 70.5 109.97 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 61.2 t -122.93 143.23 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.468 -0.333 . . . . 71.420000000000002 110.652 -176.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.509 ' HB1' HG12 ' A' ' 86' ' ' VAL . . . -108.38 119.08 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 70.319999999999993 110.209 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.97 121.27 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.509 -0.552 . . . . 72.329999999999998 109.509 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.511 HG12 ' HG ' ' A' ' 44' ' ' LEU . 57.5 mt -125.2 138.61 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.82 -0.437 . . . . 63.399999999999999 109.82 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.563 ' OD2' ' HB3' ' A' ' 92' ' ' ASN . 42.7 m-20 -111.87 120.7 42.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.076 -0.342 . . . . 72.510000000000005 110.076 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.613 ' HA ' HD13 ' A' ' 40' ' ' LEU . 30.3 mtm -141.38 171.2 14.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.204 0.526 . . . . 75.409999999999997 111.538 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.42 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 12.1 t -154.45 147.26 24.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.249 -0.887 . . . . 74.540000000000006 109.957 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 85.0 mt -109.19 149.25 29.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.847 -0.797 . . . . 64.430000000000007 108.847 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -34.69 -49.84 0.43 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.755 1.02 . . . . 73.230000000000004 113.755 -170.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.7 t -119.57 0.2 10.96 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.293 -0.255 . . . . 73.340000000000003 111.207 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.32 8.4 1.59 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.29 0.478 . . . . 63.420000000000002 112.29 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.45 -5.33 18.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.304 0.573 . . . . 62.310000000000002 109.708 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.408 ' C ' ' H ' ' A' ' 68' ' ' LEU . 22.6 m -65.29 128.07 93.47 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.226 -0.897 . . . . 62.229999999999997 109.945 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.27 16.88 0.36 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.76 2.307 . . . . 71.409999999999997 113.129 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 66' ' ' CYS . 3.4 mm? -85.64 0.52 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 72.439999999999998 111.254 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 70' ' ' ASP . 11.6 t -58.24 -57.23 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.47 0.176 . . . . 72.540000000000006 110.614 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' N ' HG21 ' A' ' 69' ' ' THR . 11.3 t70 -68.18 -25.47 65.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.041 0.448 . . . . 70.030000000000001 110.171 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.22 -52.79 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.065 -0.516 . . . . 75.420000000000002 110.534 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.583 HD11 ' N ' ' A' ' 73' ' ' GLU . 2.6 pp -69.37 -33.77 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 121.043 -0.263 . . . . 65.109999999999999 110.608 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' N ' HD11 ' A' ' 72' ' ' ILE . 43.9 mt-10 -64.56 -45.07 88.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.699 0.285 . . . . 75.140000000000001 110.259 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.21 -51.0 69.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.162 -0.472 . . . . 62.520000000000003 110.881 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -57.22 -52.8 63.87 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.014 -0.539 . . . . 72.099999999999994 110.391 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.431 ' O ' HD22 ' A' ' 80' ' ' LEU . 34.8 t -56.49 -60.21 3.86 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.612 -0.722 . . . . 73.349999999999994 111.207 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -55.87 -42.42 75.87 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 121.257 -0.177 . . . . 74.129999999999995 111.007 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 t -62.16 -46.59 88.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.469 -0.332 . . . . 75.140000000000001 110.803 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.84 -51.43 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.878 -0.329 . . . . 74.200000000000003 110.237 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.505 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -56.51 -39.02 72.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 73.329999999999998 111.218 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.98 -27.47 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.471 -0.332 . . . . 63.039999999999999 110.302 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.78 -31.56 62.31 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.997 -0.841 . . . . 61.310000000000002 110.997 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.7 m -76.94 -22.09 53.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.027 -0.587 . . . . 45.32 110.329 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.58 74.0 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 116.088 -0.505 . . . . 73.450000000000003 113.064 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.22 -50.76 11.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 72.109999999999999 110.503 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.509 HG12 ' HB1' ' A' ' 55' ' ' ALA . 17.6 m -124.93 168.8 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 64.319999999999993 110.478 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -111.06 -39.69 4.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.328 0.585 . . . . 71.030000000000001 110.166 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.1 t70 -126.43 151.06 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.755 -0.657 . . . . 70.209999999999994 110.273 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.482 HG21 ' HB3' ' A' ' 55' ' ' ALA . 20.8 pt -136.91 152.75 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.858 -0.423 . . . . 71.0 109.858 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -135.98 116.03 13.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 63.5 110.146 172.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 63.7 mt -98.13 110.99 26.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 73.310000000000002 109.504 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.637 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 3.2 t30 -88.34 120.09 29.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.558 -0.746 . . . . 71.120000000000005 109.447 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.561 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.6 m95 -86.83 106.75 17.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 73.230000000000004 110.764 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.89 124.54 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.002 0.429 . . . . 72.310000000000002 110.589 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -117.65 -34.33 4.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.414 0.626 . . . . 73.299999999999997 109.636 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.51 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.0 t30 -172.47 -47.17 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.041 . . . . 54.43 109.589 -176.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 29.8 Cg_endo -63.64 140.95 77.52 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.519 1.48 . . . . 62.100000000000001 109.548 167.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.99 -95.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.144 1.896 . . . . 74.010000000000005 112.712 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -146.34 124.74 12.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.783 -0.451 . . . . 70.409999999999997 109.783 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.45 -98.74 0.11 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.714 -0.755 . . . . 63.020000000000003 113.04 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.72 -37.98 64.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.973 2.448 . . . . 62.140000000000001 112.432 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.544 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 6.0 m-20 -67.11 -4.79 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 71.409999999999997 111.424 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.637 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 72.7 mmtt -76.65 1.56 16.63 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.577 -0.283 . . . . 62.100000000000001 110.387 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.56 115.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.928 -0.397 . . . . 73.530000000000001 109.928 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 p -86.08 167.58 14.85 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.948 0.404 . . . . 75.239999999999995 111.416 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.73 -22.15 61.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.775 -0.648 . . . . 62.240000000000002 111.211 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.15 -53.17 61.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.879 0.371 . . . . 63.420000000000002 110.878 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.35 -27.85 46.63 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.001 -0.619 . . . . 61.219999999999999 112.125 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' O ' ' HD2' ' A' ' 109' ' ' ARG . 2.8 tmm_? -67.27 -39.64 86.07 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.648 -0.501 . . . . 75.209999999999994 109.648 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.657 ' HG3' ' HG3' ' A' ' 111' ' ' GLN . 9.3 tp10 -77.03 -57.55 3.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.932 -0.576 . . . . 72.5 110.934 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.701 ' HB3' HD13 ' A' ' 115' ' ' LEU . 92.1 mt-30 -143.2 139.37 30.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.505 -0.316 . . . . 74.510000000000005 110.544 -176.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.511 HD11 ' HB1' ' A' ' 114' ' ' ALA . 3.5 pp -69.57 142.84 53.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.262 0.553 . . . . 72.340000000000003 110.537 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -55.81 -29.8 60.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.221 -0.9 . . . . 74.299999999999997 111.877 -171.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 112' ' ' LEU . . . -65.47 -7.48 14.47 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.529 0.566 . . . . 73.530000000000001 112.529 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 111' ' ' GLN . 27.4 mt -78.35 13.46 1.53 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.347 0.499 . . . . 75.439999999999998 112.347 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.29 92.2 0.05 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.364 -0.446 . . . . 51.420000000000002 112.143 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -68.94 105.86 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 73.239999999999995 111.343 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.8 m -128.0 129.85 47.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.189 -0.46 . . . . 60.25 110.299 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.87 -0.586 . . . . 65.299999999999997 109.568 178.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.823 -0.511 . . . . 72.510000000000005 111.823 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.88 -54.41 5.51 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.008 2.472 . . . . 74.099999999999994 112.553 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 74.05 1.44 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.088 -0.577 . . . . 74.430000000000007 111.814 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -78.21 -41.35 34.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.584 0.23 . . . . 72.319999999999993 110.893 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.8 mtm -146.1 148.49 32.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.888 -0.412 . . . . 62.030000000000001 109.888 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 t -147.82 15.55 1.08 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.074 0.464 . . . . 45.009999999999998 110.506 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 5.8 mp0 -77.26 131.49 38.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 63.109999999999999 110.655 -175.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -116.24 2.01 13.21 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.236 -0.438 . . . . 73.439999999999998 111.518 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -118.1 161.44 19.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.622 -0.263 . . . . 75.530000000000001 111.142 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . 74.77 142.86 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.42 0 O-C-N 124.145 0.903 . . . . 40.329999999999998 111.938 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.44 149.32 80.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.705 2.27 . . . . 63.119999999999997 111.703 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.42 -49.68 24.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.353 0.871 . . . . 74.099999999999994 113.353 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.84 -49.52 75.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.621 0.248 . . . . 65.310000000000002 111.572 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -74.99 -46.46 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.47 -0.332 . . . . 74.540000000000006 110.881 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 10' ' ' ALA . 3.4 tm? -54.75 -44.86 73.97 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.714 -0.676 . . . . 71.150000000000006 110.803 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.6 tp -53.52 -59.81 4.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 64.349999999999994 111.189 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.63 80.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.065 -0.516 . . . . 73.010000000000005 110.899 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.69 -48.05 82.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 71.230000000000004 110.594 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 HG21 ' HG2' ' A' ' 23' ' ' MET . 5.3 p -69.36 -34.06 60.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 110.058 -0.349 . . . . 65.420000000000002 110.058 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -54.06 -49.27 69.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.264 -0.643 . . . . 54.450000000000003 109.264 177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.15 -50.88 43.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.1 -0.5 . . . . 75.049999999999997 110.834 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.25 67.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.049 -0.523 . . . . 62.109999999999999 111.897 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' VAL . 13.3 mmt -58.67 -24.89 62.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 61.210000000000001 111.578 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -66.13 -16.96 64.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.607 0.241 . . . . 74.049999999999997 111.034 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -119.37 -23.37 6.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.145 0.498 . . . . 71.010000000000005 109.926 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 23' ' ' MET . 43.2 t -66.78 -40.05 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.295 -0.866 . . . . 72.129999999999995 110.623 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.587 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.7 p -89.88 153.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.479 -0.563 . . . . 71.219999999999999 109.479 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -92.25 97.65 1.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 108.753 -0.832 . . . . 71.340000000000003 108.753 170.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 86.1 Cg_endo -85.38 -7.55 8.85 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.547 2.164 . . . . 72.409999999999997 111.852 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.66 -57.75 5.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 74.540000000000006 110.452 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.31 -18.54 16.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.716 0.293 . . . . 61.32 110.317 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.84 54.23 1.81 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.96 -0.638 . . . . 73.439999999999998 112.591 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.3 mp -117.81 143.23 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.193 -0.669 . . . . 62.219999999999999 109.193 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -125.45 109.85 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.557 -0.292 . . . . 65.140000000000001 110.603 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' HD21 ' A' ' 38' ' ' LEU . 29.9 m -54.63 -41.96 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.84 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HA ' HG23 ' A' ' 41' ' ' VAL . 68.9 t -56.96 -32.18 38.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.126 0.489 . . . . 52.229999999999997 110.748 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.8 -14.82 62.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.696 -0.684 . . . . 73.310000000000002 111.005 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 35' ' ' VAL . 4.4 mm? -63.61 -17.69 63.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.153 0.501 . . . . 75.299999999999997 110.093 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 72.1 22.86 78.67 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.423 -0.808 . . . . 74.219999999999999 114.363 172.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 40' ' ' LEU . 5.0 mt -98.25 -27.06 14.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.483 0.641 . . . . 64.230000000000004 110.421 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 59' ' ' MET . 35.8 t -63.57 -11.91 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.693 -0.685 . . . . 75.540000000000006 111.908 -169.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.451 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 98.7 m-85 -62.09 -17.68 58.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.187 0.518 . . . . 73.200000000000003 109.98 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.38 63.57 3.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.811 -0.915 . . . . 61.030000000000001 110.811 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.7 tt -125.62 128.94 48.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.212 -0.662 . . . . 74.540000000000006 109.212 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.428 ' N ' HD22 ' A' ' 44' ' ' LEU . 7.3 m-20 -149.16 173.47 13.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.483 -0.932 . . . . 45.450000000000003 108.483 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 55' ' ' ALA . 23.8 m -136.48 132.52 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 62.25 109.37 173.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.26 145.83 47.45 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.714 -0.476 . . . . 71.540000000000006 109.714 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.0 p-10 -100.62 129.31 46.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.313 0.578 . . . . 74.409999999999997 111.098 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.32 164.32 29.42 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.623 -1.791 . . . . 43.420000000000002 108.623 163.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.36 -19.62 66.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.164 0.982 . . . . 65.319999999999993 109.902 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.64 -39.05 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.456 -0.793 . . . . 74.299999999999997 109.938 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.7 170.36 35.61 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.526 -0.761 . . . . 64.230000000000004 111.807 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 30.3 m -85.74 129.05 34.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.731 0.301 . . . . 70.299999999999997 111.299 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.54 140.68 39.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.993 -0.549 . . . . 72.510000000000005 110.23 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HA ' HG13 ' A' ' 46' ' ' VAL . . . -85.22 154.56 21.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.15 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -128.72 122.74 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.281 0.632 . . . . 71.430000000000007 109.332 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.493 HG12 ' HG ' ' A' ' 44' ' ' LEU . 54.3 mt -130.47 116.6 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.428 0.156 . . . . 72.150000000000006 111.124 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.37 118.8 24.46 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.261 -0.644 . . . . 70.099999999999994 109.261 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 41' ' ' VAL . 43.6 mmm -139.8 170.44 15.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.248 0.547 . . . . 71.019999999999996 111.941 -174.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -153.59 178.92 9.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.226 -0.897 . . . . 62.329999999999998 109.405 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 61.8 mt -120.48 156.35 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.012 -0.366 . . . . 42.299999999999997 110.012 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.9 p -47.46 -60.11 2.76 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.032 0.533 . . . . 75.010000000000005 112.343 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.9 t -104.23 2.17 31.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.843 0.354 . . . . 72.230000000000004 110.234 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.578 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.87 8.0 1.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.568 0.747 . . . . 72.439999999999998 112.154 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.36 -7.67 9.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 71.019999999999996 110.239 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.538 ' O ' HD12 ' A' ' 61' ' ' LEU . 11.8 m -76.84 145.09 73.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.506 -0.77 . . . . 73.340000000000003 110.41 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.69 27.89 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.579 2.186 . . . . 62.420000000000002 112.328 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 ' HB2' HD21 ' A' ' 61' ' ' LEU . 91.8 mt -77.35 -6.52 53.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.218 -0.446 . . . . 71.129999999999995 110.747 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.461 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.9 t -58.2 -35.68 71.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.724 -0.473 . . . . 71.239999999999995 109.724 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.6 -50.01 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 64.409999999999997 111.217 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.436 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 14.2 p -68.66 -39.55 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.755 -0.202 . . . . 74.319999999999993 111.343 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 69' ' ' THR . 34.8 pt -66.81 -40.46 85.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 120.418 -0.513 . . . . 75.409999999999997 110.34 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.88 -46.93 88.67 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 116.41 -0.359 . . . . 65.439999999999998 110.186 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.76 -51.89 67.72 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.969 -0.56 . . . . 70.430000000000007 110.827 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 4.0 pt20 -64.86 -45.05 87.71 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.136 -0.484 . . . . 72.120000000000005 110.955 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.474 ' O ' HD23 ' A' ' 80' ' ' LEU . 77.4 p -66.74 -55.6 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.709 -0.223 . . . . 63.130000000000003 110.847 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.686 ' HD2' HG12 ' A' ' 89' ' ' ILE . 19.7 mmm180 -55.22 -53.07 60.61 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.731 0.3 . . . . 72.420000000000002 110.466 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 t -60.44 -43.49 96.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.575 -0.739 . . . . 73.439999999999998 111.49 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.91 -51.22 16.83 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 121.02 -0.272 . . . . 63.329999999999998 110.931 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -57.8 -37.98 74.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.305 -0.407 . . . . 71.439999999999998 111.156 -175.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 77' ' ' ARG . 20.6 m -78.0 -28.04 15.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.678 -0.409 . . . . 74.219999999999999 110.786 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.26 -42.63 97.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 61.329999999999998 112.087 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 p -94.27 1.4 55.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.93 0.395 . . . . 73.109999999999999 110.852 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.76 35.42 89.85 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.829 -0.623 . . . . 61.43 112.588 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.33 -36.94 80.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.353 0.597 . . . . 64.430000000000007 109.416 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 55' ' ' ALA . 16.4 m -145.31 153.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.074 -0.966 . . . . 52.240000000000002 109.059 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.6 -44.46 70.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.267 0.556 . . . . 70.109999999999999 110.263 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.64 156.73 45.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 73.230000000000004 109.276 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.686 HG12 ' HD2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -125.97 144.04 37.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.716 -0.476 . . . . 72.319999999999993 109.716 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.5 ' HA ' HG22 ' A' ' 105' ' ' THR . 12.0 ttp180 -123.7 106.75 10.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.373 0.606 . . . . 64.219999999999999 109.981 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.49 HG12 ' HB ' ' A' ' 57' ' ' ILE . 59.6 mt -95.58 128.02 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 71.129999999999995 109.545 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -102.27 111.29 23.51 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.061 -0.718 . . . . 73.129999999999995 109.061 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -86.78 106.29 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 70.140000000000001 109.692 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.66 123.75 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.647 -0.501 . . . . 62.539999999999999 109.647 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -121.18 -27.16 4.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.224 -0.443 . . . . 74.129999999999995 109.89 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -179.57 -48.82 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.229 -0.896 . . . . 61.340000000000003 110.599 -169.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -68.35 152.21 75.7 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.206 1.938 . . . . 70.239999999999995 112.45 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.73 145.66 63.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.717 2.278 . . . . 74.219999999999999 110.963 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -48.94 109.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.657 0.598 . . . . 74.219999999999999 111.378 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.63 -87.85 0.07 OUTLIER Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.266 -0.492 . . . . 75.530000000000001 112.276 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.45 -28.68 62.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.536 2.157 . . . . 75.019999999999996 111.266 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 2.7 p-10 -66.98 -5.75 14.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.858 -1.065 . . . . 74.25 111.648 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mttt -89.79 -6.57 55.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.516 0.198 . . . . 75.400000000000006 111.01 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.12 95.48 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 121.147 0.498 . . . . 54.140000000000001 110.61 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 90' ' ' ARG . 27.7 p -78.0 -178.01 5.31 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.75 -0.659 . . . . 52.43 111.703 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -38.25 53.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.795 -0.639 . . . . 75.430000000000007 111.811 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.12 -41.74 79.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 73.120000000000005 111.175 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -46.13 94.82 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.039 -0.6 . . . . 65.120000000000005 112.0 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.515 ' O ' HD11 ' A' ' 115' ' ' LEU . 42.8 mtp180 -74.0 -36.83 64.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.949 0.404 . . . . 71.109999999999999 110.466 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.03 -39.49 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.369 -0.832 . . . . 63.310000000000002 112.1 -173.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -108.36 75.2 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.711 0.767 . . . . 73.340000000000003 111.0 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.549 HD21 ' H ' ' A' ' 113' ' ' ARG . 1.5 tt -141.65 145.75 35.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 73.420000000000002 108.347 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.549 ' H ' HD21 ' A' ' 112' ' ' LEU . 16.9 ptt180 -64.8 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.172 -0.467 . . . . 72.209999999999994 111.466 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.26 68.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 70.450000000000003 110.533 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 HD11 ' O ' ' A' ' 109' ' ' ARG . 68.9 mt -98.7 20.57 12.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.641 -0.708 . . . . 72.200000000000003 110.703 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.52 68.14 1.52 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.759 -0.536 . . . . 71.530000000000001 111.759 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.4 147.51 51.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.537 -0.542 . . . . 64.120000000000005 109.537 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.8 m -66.23 -16.03 63.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.416 0.524 . . . . 73.010000000000005 112.416 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.726 -0.654 . . . . 65.140000000000001 110.325 -178.386 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.031 -0.428 . . . . 52.329999999999998 112.031 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.76 169.86 15.21 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.624 2.216 . . . . 54.100000000000001 111.983 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.39 -167.97 20.77 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.201 -0.523 . . . . 72.450000000000003 112.055 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 p -161.03 -168.52 2.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.334 . . . . 75.430000000000007 110.097 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.0 mtm -90.72 18.65 6.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.994 0.426 . . . . 71.420000000000002 110.395 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 m -108.67 178.43 4.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 72.209999999999994 110.806 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.631 ' H ' HD21 ' A' ' 44' ' ' LEU . 7.8 mm-40 51.33 57.04 7.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.508 0.67 . . . . 70.219999999999999 111.612 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -95.62 9.68 39.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 74.129999999999995 110.992 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -76.31 156.91 32.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.94 -0.573 . . . . 71.439999999999998 110.624 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 70.52 152.57 0.14 Allowed Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.564 0.54 . . . . 55.520000000000003 111.692 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.52 159.41 36.45 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.572 2.181 . . . . 62.439999999999998 112.549 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.0 -51.57 65.82 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.781 1.03 . . . . 72.030000000000001 113.781 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.62 -52.45 64.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.674 0.273 . . . . 71.140000000000001 111.534 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.43 -41.29 63.44 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.95 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.68 -43.12 72.16 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 110.257 -0.275 . . . . 74.450000000000003 110.257 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.7 tp -57.42 -56.32 23.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.279 -0.419 . . . . 73.040000000000006 110.906 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.03 65.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.877 -0.601 . . . . 72.120000000000005 111.018 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -60.9 -42.72 98.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.986 -0.552 . . . . 63.240000000000002 111.465 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -69.87 -40.91 79.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.711 -0.396 . . . . 74.530000000000001 110.4 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.91 -46.01 92.37 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.527 -0.546 . . . . 75.319999999999993 109.527 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -50.6 71.79 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.888 -0.596 . . . . 71.140000000000001 110.831 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -44.92 76.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.088 0.471 . . . . 64.019999999999996 110.333 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.554 ' HA ' HG21 ' A' ' 26' ' ' VAL . 25.1 mmt -57.88 -28.36 64.11 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.452 -0.795 . . . . 73.310000000000002 110.507 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -24.99 59.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.537 -0.301 . . . . 74.420000000000002 110.88 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.76 -20.95 15.34 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.923 0.342 . . . . 74.420000000000002 111.923 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' A' ' 23' ' ' MET . 26.4 m -87.71 -17.47 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.975 0.417 . . . . 72.140000000000001 110.455 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 34' ' ' ASN . 5.7 p -89.15 168.83 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.969 -0.559 . . . . 73.340000000000003 109.65 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.9 92.39 6.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.115 -0.698 . . . . 53.329999999999998 109.115 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.1 -4.77 10.42 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.465 2.11 . . . . 60.509999999999998 111.93 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.85 -57.71 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 53.109999999999999 110.632 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.98 -18.59 16.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.977 0.418 . . . . 75.329999999999998 110.285 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.5 49.21 2.41 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.138 -0.553 . . . . 64.120000000000005 113.13 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -111.56 140.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.131 -0.692 . . . . 72.340000000000003 109.131 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.512 ' HA ' HG22 ' A' ' 27' ' ' VAL . 9.3 p30 -122.82 113.13 18.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.427 0.632 . . . . 54.399999999999999 110.59 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.81 -28.51 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.642 -0.708 . . . . 72.239999999999995 110.811 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG13 HG23 ' A' ' 41' ' ' VAL . 34.7 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.041 -0.527 . . . . 64.019999999999996 111.166 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 36.6 t70 -58.88 -26.01 63.86 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.894 0.378 . . . . 72.219999999999999 111.131 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.94 -15.04 63.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.238 -0.437 . . . . 44.43 110.301 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.0 61.83 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.661 -0.7 . . . . 61.149999999999999 113.542 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.72 -16.29 22.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.999 0.428 . . . . 64.120000000000005 110.192 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 36' ' ' VAL . 47.7 t -59.66 -15.88 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.881 -0.599 . . . . 75.329999999999998 110.618 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.56 -24.11 44.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.722 -0.672 . . . . 73.400000000000006 110.628 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.78 67.29 1.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.997 -0.547 . . . . 71.019999999999996 112.303 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.631 HD21 ' H ' ' A' ' 7' ' ' GLU . 35.3 tp -110.98 130.72 55.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.639 -0.504 . . . . 71.019999999999996 109.639 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -157.91 109.12 2.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.527 -0.546 . . . . 71.219999999999999 109.527 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 118.74 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.704 -0.225 . . . . 71.25 110.505 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.66 120.65 38.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.078 -0.712 . . . . 73.140000000000001 109.078 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.68 140.99 37.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 74.120000000000005 110.198 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.15 167.34 35.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.713 -0.755 . . . . 61.32 112.079 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.95 -18.84 65.6 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.981 0.419 . . . . 75.099999999999994 110.657 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.22 -11.69 61.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.592 -0.731 . . . . 72.420000000000002 110.44 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.48 116.56 2.0 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.417 -0.673 . . . . 72.530000000000001 111.417 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.8 m -70.94 102.48 2.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.702 -0.481 . . . . 43.299999999999997 109.702 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 5.5 p -113.52 125.02 70.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.796 . . . . 54.229999999999997 111.834 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.99 114.21 26.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.664 . . . . 63.020000000000003 110.095 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -85.67 119.13 25.67 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.103 -0.332 . . . . 75.340000000000003 110.103 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.483 HG23 ' HG3' ' A' ' 59' ' ' MET . 27.3 mm -116.73 127.98 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.742 -0.663 . . . . 74.239999999999995 109.45 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -107.47 116.48 32.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.477 -0.564 . . . . 54.229999999999997 109.477 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.483 ' HG3' HG23 ' A' ' 57' ' ' ILE . 42.5 mtm -140.87 170.56 15.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.748 0.785 . . . . 71.209999999999994 112.187 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -155.9 140.97 17.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.565 -1.198 . . . . 73.430000000000007 109.277 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 72' ' ' ILE . 3.7 mm? -85.4 167.43 15.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.589 -0.523 . . . . 73.120000000000005 109.589 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -50.1 -49.55 51.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.083 0.24 . . . . 75.329999999999998 111.431 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 m -102.27 -11.69 18.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.142 0.496 . . . . 71.349999999999994 110.34 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 62.58 8.21 2.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.347 -0.842 . . . . 75.010000000000005 112.467 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.04 -16.13 8.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.919 0.39 . . . . 51.530000000000001 110.958 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 p -66.15 144.99 98.97 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.967 -0.56 . . . . 65.310000000000002 111.327 -176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 8.3 Cg_exo -73.74 38.96 0.47 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.625 2.883 . . . . 74.540000000000006 113.852 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.8 mm? -92.98 -12.05 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.174 -0.306 . . . . 75.129999999999995 110.174 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -49.77 -57.71 6.79 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.682 -0.69 . . . . 74.430000000000007 111.733 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.15 -32.95 74.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.598 -0.274 . . . . 74.319999999999993 110.726 -174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 59.6 t -64.17 -53.43 43.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 54.439999999999998 110.68 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 68' ' ' LEU . 5.4 pt -71.93 -27.11 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 111.762 0.282 . . . . 64.239999999999995 111.762 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HA ' HD11 ' A' ' 91' ' ' ILE . 43.4 mt-10 -66.19 -45.64 80.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.946 0.403 . . . . 70.530000000000001 110.695 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.51 -49.53 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.734 . . . . 64.140000000000001 110.335 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 79.9 mm-40 -58.16 -45.61 87.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 72.209999999999994 110.491 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.402 ' O ' HD11 ' A' ' 80' ' ' LEU . 41.0 t -58.15 -63.69 1.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 62.350000000000001 110.541 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -54.85 -47.83 73.68 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.885 -0.326 . . . . 75.129999999999995 110.812 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -55.54 -45.23 77.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.127 -0.488 . . . . 74.099999999999994 111.277 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.49 -51.07 18.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 74.310000000000002 110.816 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HA ' HD11 ' A' ' 85' ' ' LEU . 10.8 mp -58.75 -32.65 69.45 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.335 -0.393 . . . . 71.319999999999993 111.065 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.2 -27.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 63.310000000000002 110.084 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.08 71.02 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.087 -0.578 . . . . 55.5 111.989 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.1 t -97.53 1.67 49.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.194 0.521 . . . . 55.340000000000003 110.064 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.39 23.06 78.49 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.895 -0.593 . . . . 23.239999999999998 112.913 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 80' ' ' LEU . 43.9 mt -66.81 -57.81 6.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.58 0.705 . . . . 74.409999999999997 109.186 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.02 -173.77 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.803 -1.09 . . . . 75.25 108.953 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -119.72 -39.01 2.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.161 -0.681 . . . . 71.510000000000005 109.161 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.8 m-20 -112.64 151.68 29.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 63.399999999999999 109.916 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 pt -140.17 170.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.532 -0.544 . . . . 62.039999999999999 109.532 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.471 ' HB2' ' OG1' ' A' ' 105' ' ' THR . 0.2 OUTLIER -148.57 106.7 3.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.101 -0.5 . . . . 74.209999999999994 109.665 172.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 73' ' ' GLU . 53.6 mt -93.55 121.35 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 74.409999999999997 109.81 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' CB ' ' HE2' ' A' ' 103' ' ' LYS . 7.9 t30 -100.23 133.09 45.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.89 -0.596 . . . . 73.310000000000002 109.804 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -97.9 106.7 19.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.47 . . . . 75.510000000000005 110.423 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.28 124.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.424 -0.584 . . . . 63.439999999999998 109.424 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.423 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 4.3 m-90 -102.35 -34.99 8.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.422 -0.584 . . . . 74.319999999999993 109.422 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 23.1 t-20 168.67 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.419 -1.264 . . . . 74.5 109.243 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 49.5 Cg_exo -60.14 161.1 20.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.545 2.164 . . . . 64.349999999999994 112.324 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.59 -177.54 2.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.123 2.548 . . . . 71.25 112.986 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -89.21 -163.1 0.94 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.389 -0.823 . . . . 74.319999999999993 110.515 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.73 -173.88 45.99 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.079 -0.581 . . . . 73.450000000000003 112.485 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.74 -5.7 7.8 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.217 2.611 . . . . 50.439999999999998 112.512 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 31.7 t70 -57.53 -19.9 28.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 74.540000000000006 110.631 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 90.8 mttt -76.27 5.87 6.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.228 -0.442 . . . . 63.299999999999997 111.512 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.96 98.47 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.269 -0.641 . . . . 74.409999999999997 109.269 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -50.88 166.37 0.09 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.31 0.856 . . . . 75.010000000000005 113.31 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -50.99 -50.42 58.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.12 -0.946 . . . . 63.43 111.446 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 4.8 m-20 -57.05 -43.17 81.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.324 -0.853 . . . . 63.350000000000001 111.234 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.96 -36.49 86.41 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.98 -0.628 . . . . 55.340000000000003 111.65 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -66.57 -36.28 82.25 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.17 0.188 . . . . 71.450000000000003 110.93 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.594 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.2 tt0 -57.22 -37.76 72.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.138 0.494 . . . . 73.209999999999994 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 107' ' ' ASP . 35.7 mt-30 -93.73 17.0 12.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 63.329999999999998 111.433 -168.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -114.44 144.41 43.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 75.200000000000003 110.117 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.02 -29.77 63.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.352 -0.386 . . . . 74.200000000000003 111.014 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.38 -18.66 51.89 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.016 -0.538 . . . . 72.209999999999994 111.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 110' ' ' GLU . 1.1 tm? -73.61 -34.24 64.95 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.378 -0.601 . . . . 73.329999999999998 109.378 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.51 -94.79 0.2 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.626 -0.715 . . . . 61.509999999999998 112.276 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 52.75 82.34 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.958 0.503 . . . . 73.540000000000006 110.538 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.7 t -116.24 5.16 13.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.200000000000003 110.234 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 C--O 1.25 1.116 0 CA-C-N 115.675 -0.693 . . . . 64.420000000000002 110.84 -177.063 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 112.008 -0.437 . . . . 73.030000000000001 112.008 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.2 113.61 2.41 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.148 2.565 . . . . 64.519999999999996 112.359 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.08 -178.72 53.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.373 -0.441 . . . . 52.420000000000002 113.023 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.6 m 68.12 11.05 8.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 74.230000000000004 111.657 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.5 ptp -69.2 91.53 0.52 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.42 0.629 . . . . 74.409999999999997 110.181 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 42' ' ' TYR . 15.3 m -94.61 -23.48 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 75.420000000000002 110.905 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -74.28 2.16 9.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.629 -0.714 . . . . 72.230000000000004 111.475 -178.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.422 HG23 HD11 ' A' ' 15' ' ' LEU . 23.0 p -74.19 31.56 0.08 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.393 0.516 . . . . 72.209999999999994 112.393 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 7' ' ' GLU . 15.5 m -86.35 35.26 0.65 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.018 0.437 . . . . 52.109999999999999 110.873 -178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 157.49 49.16 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 109.809 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.53 146.38 95.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.51 2.14 . . . . 62.229999999999997 111.906 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.88 -44.37 49.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.345 0.869 . . . . 71.129999999999995 113.345 -169.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -63.2 -52.41 62.39 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.899 0.381 . . . . 72.099999999999994 110.845 -172.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -72.11 -43.8 64.17 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.295 0.569 . . . . 74.25 110.449 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 tm? -58.74 -39.86 82.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.294 -0.866 . . . . 52.530000000000001 110.249 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.59 -53.21 57.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.905 0.383 . . . . 73.25 110.472 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.62 -51.93 66.48 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.785 -0.643 . . . . 61.130000000000003 110.996 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.2 -48.44 80.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.904 -0.589 . . . . 54.049999999999997 111.02 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 23' ' ' MET . 5.4 p -65.96 -34.48 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.945 -0.391 . . . . 63.310000000000002 109.945 -177.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.91 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.696 -0.483 . . . . 71.209999999999994 109.696 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 28.5 mm-40 -65.92 -46.39 78.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.64 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.05 86.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 50.130000000000003 110.827 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.38 -12.62 14.9 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.042 -0.527 . . . . 71.219999999999999 111.564 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 76.9 ttt180 -87.31 -20.86 26.2 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.158 0.583 . . . . 72.230000000000004 111.459 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.27 -27.22 5.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.243 0.544 . . . . 74.209999999999994 110.84 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -74.74 -16.69 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.197 -0.911 . . . . 61.509999999999998 110.163 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p -94.2 155.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 74.120000000000005 110.445 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.15 89.74 0.62 Allowed Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 107.072 -1.455 . . . . 71.049999999999997 107.072 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 55.6 Cg_endo -81.27 -6.95 12.96 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.084 1.856 . . . . 63.130000000000003 111.712 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.82 -57.57 5.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.434 -0.803 . . . . 74.439999999999998 109.894 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -92.29 -18.77 22.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.137 -0.483 . . . . 62.43 110.178 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.83 52.75 3.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.782 -0.644 . . . . 60.409999999999997 113.846 171.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.29 140.09 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 117.263 0.531 . . . . 74.230000000000004 109.939 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 24.2 m-80 -103.1 130.6 50.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.807 -0.442 . . . . 73.209999999999994 109.807 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.5 t -56.72 -33.11 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.545 0.688 . . . . 65.230000000000004 109.866 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.94 -30.61 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.245 -0.889 . . . . 70.140000000000001 111.005 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 2.0 m-20 -63.08 -23.58 67.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.57 -0.286 . . . . 73.340000000000003 111.581 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 -16.37 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.094 0.473 . . . . 74.129999999999995 110.276 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.03 22.82 60.87 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.618 -0.719 . . . . 71.200000000000003 112.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.5 tp -90.53 -24.76 20.53 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.476 -0.565 . . . . 74.450000000000003 109.476 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.59 -8.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.534 -0.757 . . . . 72.310000000000002 110.32 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 6' ' ' SER . 52.9 t80 -71.16 -16.13 62.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.881 -0.599 . . . . 74.230000000000004 109.692 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 52.12 3.51 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.834 -0.906 . . . . 63.32 110.834 172.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.553 HD11 HG12 ' A' ' 57' ' ' ILE . 61.6 tp -102.1 121.06 41.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.027 0.441 . . . . 73.420000000000002 109.974 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.42 108.58 10.95 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.144 -1.058 . . . . 51.100000000000001 108.144 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 55' ' ' ALA . 10.8 m -99.43 128.0 51.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.476 -0.565 . . . . 75.329999999999998 109.476 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -120.54 145.55 47.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 74.099999999999994 110.844 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.47 163.34 19.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.498 -0.773 . . . . 73.299999999999997 110.309 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.9 155.71 26.68 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.866 -0.894 . . . . 63.200000000000003 110.866 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.66 -20.27 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.484 . . . . 73.140000000000001 110.48 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -89.48 -27.92 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.746 -0.661 . . . . 64.109999999999999 110.575 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.89 176.42 32.99 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.395 -0.682 . . . . 54.030000000000001 111.395 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.1 m -99.29 129.91 45.54 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.792 0.33 . . . . 72.109999999999999 110.483 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 137.09 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.145 -0.48 . . . . 74.239999999999995 110.814 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB1' HG11 ' A' ' 86' ' ' VAL . . . -98.71 120.5 39.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.081 -0.509 . . . . 62.310000000000002 110.285 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.585 HD21 ' O ' ' A' ' 103' ' ' LYS . 20.7 mt -96.65 114.02 25.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.564 -0.532 . . . . 64.230000000000004 109.564 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.553 HG12 HD11 ' A' ' 44' ' ' LEU . 51.1 mt -111.42 118.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.544 0.211 . . . . 75.310000000000002 110.822 -176.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -82.86 120.86 26.19 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.282 -0.266 . . . . 64.010000000000005 110.282 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 87.5 mtp -139.23 163.5 32.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.363 0.602 . . . . 73.319999999999993 111.339 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.423 ' OG1' ' HB ' ' A' ' 94' ' ' VAL . 73.7 m -136.62 137.73 40.43 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.839 -0.618 . . . . 73.109999999999999 109.595 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.4 mt -89.23 146.92 24.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.656 -0.498 . . . . 74.329999999999998 109.656 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -36.1 -57.26 0.71 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.839 0.856 . . . . 71.319999999999993 113.027 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -121.29 12.6 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 72.409999999999997 110.622 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB3' ' HD1' ' A' ' 95' ' ' TRP . . . 59.38 8.56 1.19 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.718 -0.674 . . . . 62.420000000000002 112.567 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.83 13.07 12.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 73.310000000000002 110.547 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 44.5 t -95.9 139.82 22.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 71.5 110.507 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.37 17.45 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.922 2.415 . . . . 73.099999999999994 112.376 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.565 ' HB2' ' SG ' ' A' ' 66' ' ' CYS . 48.5 tp -69.09 -13.83 62.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.956 -0.565 . . . . 72.200000000000003 110.499 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.432 HG22 ' N ' ' A' ' 70' ' ' ASP . 12.7 t -49.72 -56.8 8.88 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.591 -0.731 . . . . 74.430000000000007 111.903 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' THR . 22.7 t70 -63.67 -37.24 86.61 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.889 0.376 . . . . 64.109999999999999 110.356 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 60.9 t -62.28 -52.76 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 63.329999999999998 110.753 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.8 pp -68.47 -34.94 68.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.791 -0.186 . . . . 74.319999999999993 111.258 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' N ' HD12 ' A' ' 72' ' ' ILE . 41.2 mt-10 -62.47 -46.58 87.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.697 0.284 . . . . 71.549999999999997 110.462 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 78' ' ' SER . 23.4 t70 -63.27 -47.53 81.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 110.917 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 26.4 mm-40 -57.46 -55.64 32.2 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 74.430000000000007 110.444 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.418 ' O ' HD22 ' A' ' 80' ' ' LEU . 36.6 t -59.44 -54.61 44.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.819 -0.628 . . . . 72.010000000000005 110.587 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -54.79 -42.79 72.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.448 -0.342 . . . . 72.5 110.555 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 7.1 t -56.28 -52.89 62.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 52.439999999999998 110.88 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.49 -51.89 13.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.87 -0.332 . . . . 72.439999999999998 111.446 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 76' ' ' SER . 4.3 mm? -60.68 -33.92 73.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.272 0.558 . . . . 72.140000000000001 111.186 -173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -85.85 -27.2 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.785 -0.643 . . . . 70.409999999999997 109.911 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.72 79.05 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.292 -0.48 . . . . 71.019999999999996 112.149 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -79.25 -23.04 43.94 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.649 -0.5 . . . . 64.409999999999997 109.649 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 48.58 3.56 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.578 -0.737 . . . . 53.509999999999998 113.25 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.0 mt -80.47 -35.3 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.989 -0.745 . . . . 71.150000000000006 108.989 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB1' ' A' ' 55' ' ' ALA . 16.7 m -143.84 160.35 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.109 -0.95 . . . . 73.140000000000001 109.336 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.69 -30.92 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 63.109999999999999 110.675 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -152.5 166.07 33.14 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.02 -0.536 . . . . 73.319999999999993 110.238 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.443 HG21 ' HB3' ' A' ' 55' ' ' ALA . 35.7 pt -136.95 154.46 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.132 0.492 . . . . 74.510000000000005 110.86 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.689 ' HB2' HG21 ' A' ' 105' ' ' THR . 8.6 tpt85 -133.24 110.42 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.74 -0.664 . . . . 72.040000000000006 109.215 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 58.6 mt -91.61 123.17 43.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.224 -0.443 . . . . 72.140000000000001 110.224 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.452 ' C ' HD22 ' A' ' 92' ' ' ASN . 0.2 OUTLIER -88.2 118.21 27.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.42 -0.956 . . . . 72.519999999999996 108.42 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.411 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.8 m-90 -89.69 114.0 25.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.242 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HB ' ' OG1' ' A' ' 60' ' ' THR . 7.4 t -86.07 124.02 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.863 -0.421 . . . . 73.030000000000001 109.863 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' HD1' ' HB3' ' A' ' 64' ' ' ALA . 3.5 m-90 -112.08 -32.16 6.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 75.530000000000001 109.408 174.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.427 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 1.6 m120 -179.57 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 114.354 -1.294 . . . . 71.140000000000001 109.379 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 23.6 Cg_exo -65.96 154.15 75.17 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.222 1.948 . . . . 63.039999999999999 111.664 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.18 -176.64 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 52.43 112.061 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.531 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m-90 -79.64 145.59 32.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 72.310000000000002 110.276 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.29 -110.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.923 -0.656 . . . . 71.099999999999994 112.226 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.57 -33.76 86.44 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.563 2.175 . . . . 71.109999999999999 112.163 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.63 -4.11 14.3 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.895 -0.593 . . . . 73.329999999999998 110.719 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.585 ' O ' HD21 ' A' ' 56' ' ' LEU . 30.2 mtpp -82.45 6.2 18.08 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.86 -0.525 . . . . 65.099999999999994 110.277 172.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.52 130.03 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.224 -0.297 . . . . 64.430000000000007 110.327 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 90' ' ' ARG . 11.7 p -53.82 150.43 7.52 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.019 0.437 . . . . 65.230000000000004 111.376 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.02 -41.0 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 61.32 109.924 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.62 ' HB3' HD12 ' A' ' 115' ' ' LEU . 6.6 m-20 -57.27 -45.29 84.19 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.458 -0.792 . . . . 74.329999999999998 110.588 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.47 -47.2 89.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.838 -0.696 . . . . 74.109999999999999 111.942 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -64.6 -37.22 86.8 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.941 0.401 . . . . 65.239999999999995 110.781 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.78 -42.16 18.27 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.168 0.433 . . . . 71.120000000000005 112.168 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.68 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 35.7 mt-30 -104.23 -28.16 11.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.772 0.656 . . . . 74.150000000000006 112.772 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 112' ' ' LEU . 3.1 mm? 53.49 -98.9 0.08 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.445 0.298 . . . . 71.439999999999998 110.733 -176.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -70.95 -37.28 72.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.926 0.393 . . . . 74.430000000000007 110.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.68 ' HB2' ' HB3' ' A' ' 111' ' ' GLN . . . -64.79 -7.58 11.63 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.943 -0.571 . . . . 73.310000000000002 111.907 -176.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.62 HD12 ' HB3' ' A' ' 107' ' ' ASP . 55.8 tp -72.16 -29.66 64.24 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.919 0.39 . . . . 63.420000000000002 110.178 176.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.03 122.47 5.84 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.779 -0.646 . . . . 74.420000000000002 112.192 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.74 124.89 23.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.272 -0.27 . . . . 72.209999999999994 110.272 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.0 m -65.54 87.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.985 0.422 . . . . 64.120000000000005 110.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.5 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.488 -0.768 . . . . 75.019999999999996 111.045 -178.576 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 N-CA-C 112.262 -0.335 . . . . 61.32 112.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.63 -1.47 10.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.193 2.595 . . . . 74.209999999999994 112.585 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.74 86.15 1.66 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 111.225 -0.75 . . . . 54.439999999999998 111.225 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.5 p -74.86 66.12 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.134 0.492 . . . . 71.0 111.669 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.613 ' HA ' ' HE3' ' A' ' 5' ' ' MET . 21.4 mmt -98.16 -6.53 31.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.527 0.68 . . . . 63.439999999999998 109.363 174.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 42' ' ' TYR . 32.1 t -161.42 -177.62 6.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.017 -0.992 . . . . 72.510000000000005 108.928 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 56.85 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.716 0.769 . . . . 74.010000000000005 111.271 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 p -148.98 32.89 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.037 -0.983 . . . . 71.219999999999999 109.03 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.565 ' HG ' ' HB3' ' A' ' 85' ' ' LEU . 35.7 t -68.23 125.39 26.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.49 -0.777 . . . . 75.209999999999994 110.958 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . 69.11 163.55 0.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.812 -0.631 . . . . 53.109999999999999 111.823 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 80.9 Cg_exo -47.86 153.59 2.44 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.978 2.452 . . . . 64.549999999999997 112.194 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.5 -29.87 51.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 61.310000000000002 112.072 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -63.63 -45.4 90.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.173 0.511 . . . . 74.0 109.932 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.73 -47.35 39.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.408 -0.815 . . . . 74.209999999999994 109.402 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.45 -45.49 73.1 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 114.819 -1.082 . . . . 74.200000000000003 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.99 -59.72 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.977 0.418 . . . . 62.43 111.163 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.86 66.41 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.118 -0.492 . . . . 62.5 111.129 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.16 -32.58 72.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.6 -0.727 . . . . 71.299999999999997 111.915 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -72.39 -38.17 60.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 109.396 -0.594 . . . . 62.130000000000003 109.396 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -58.88 -41.62 87.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.512 -0.313 . . . . 65.530000000000001 110.731 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -69.67 -51.66 32.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.036 0.446 . . . . 74.439999999999998 110.683 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.24 -34.64 75.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.839 -0.618 . . . . 65.430000000000007 111.391 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.4 mmt -61.25 -13.29 17.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.236 -0.438 . . . . 74.230000000000004 112.114 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -90.77 -17.46 26.63 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.748 0.249 . . . . 72.150000000000006 111.493 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.52 -25.81 5.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.503 0.668 . . . . 74.450000000000003 110.466 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.85 -23.13 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.092 -0.958 . . . . 60.210000000000001 109.878 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.449 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 9.9 p -89.0 159.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 72.430000000000007 109.071 174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 94.61 4.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.527 -0.916 . . . . 73.230000000000004 108.527 168.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 72.8 Cg_endo -81.54 -3.84 12.08 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.257 1.971 . . . . 63.350000000000001 111.989 -176.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.72 -57.55 5.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.14 0.495 . . . . 74.340000000000003 109.862 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.5 mt -92.79 -18.75 22.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.708 -0.678 . . . . 62.299999999999997 109.864 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.34 51.46 3.7 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.955 -0.566 . . . . 25.199999999999999 113.49 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.68 143.85 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.026 0.413 . . . . 65.319999999999993 110.432 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.41 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.2 p30 -108.79 134.82 50.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 75.010000000000005 110.637 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.42 -25.69 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.012 0.434 . . . . 74.420000000000002 111.121 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.81 -24.96 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.927 -0.579 . . . . 62.119999999999997 110.348 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.75 -33.61 68.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 73.299999999999997 110.642 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.91 -16.7 62.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 74.430000000000007 110.297 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.98 21.1 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.48 -0.782 . . . . 62.140000000000001 113.782 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 40' ' ' LEU . 2.5 mt -88.58 -19.2 26.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.892 0.346 . . . . 72.109999999999999 110.157 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.6 -9.59 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.853 -0.612 . . . . 75.150000000000006 110.512 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 88.3 t80 -55.89 -31.23 62.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.546 -0.752 . . . . 74.109999999999999 109.678 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 75.76 1.48 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.539 -0.755 . . . . 72.319999999999993 111.585 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.521 HD11 HG12 ' A' ' 57' ' ' ILE . 50.8 tp -119.94 126.33 50.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.768 0.427 . . . . 75.219999999999999 109.951 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -150.92 115.38 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.498 -0.556 . . . . 73.430000000000007 109.498 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -94.8 136.25 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.848 0.356 . . . . 60.149999999999999 110.176 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -130.63 150.21 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.626 -0.509 . . . . 72.200000000000003 109.626 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 33.2 t70 -92.01 117.39 29.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.446 -0.343 . . . . 72.25 110.891 -176.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.45 174.16 24.62 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.406 -0.426 . . . . 63.219999999999999 112.087 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.04 -32.16 69.49 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.917 0.389 . . . . 72.230000000000004 111.46 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.39 -14.29 22.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.148 -0.478 . . . . 61.030000000000001 111.513 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.18 172.23 22.63 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.094 -0.574 . . . . 24.449999999999999 111.992 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.0 m -78.88 115.46 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.712 0.256 . . . . 65.150000000000006 110.782 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 33.3 m -103.94 144.97 13.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.46 -0.337 . . . . 75.099999999999994 110.648 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -98.59 112.85 24.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 70.230000000000004 110.599 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.5 115.62 19.23 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.126 -0.694 . . . . 73.420000000000002 109.126 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 44' ' ' LEU . 49.5 mt -120.51 125.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.091 -0.337 . . . . 74.400000000000006 110.091 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.518 ' OD2' HG23 ' A' ' 94' ' ' VAL . 24.8 t0 -96.12 130.83 43.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 74.530000000000001 110.772 176.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.406 ' HE1' ' HZ3' ' A' ' 93' ' ' TRP . 84.4 mtp -141.64 170.96 14.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.292 0.568 . . . . 54.310000000000002 111.268 -175.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -154.43 153.46 31.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.735 . . . . 72.409999999999997 109.86 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 72' ' ' ILE . 6.5 mp -110.72 170.8 7.85 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.971 -0.381 . . . . 63.439999999999998 109.971 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 p -57.12 -60.22 3.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.21 -0.45 . . . . 64.319999999999993 111.824 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.409 ' OG ' ' SG ' ' A' ' 66' ' ' CYS . 86.2 p -91.88 -24.34 19.36 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.362 -0.381 . . . . 75.230000000000004 110.315 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.4 8.93 4.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.427 -0.806 . . . . 62.530000000000001 110.826 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.63 -25.93 8.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.589 . . . . 70.439999999999998 110.53 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.409 ' SG ' ' OG ' ' A' ' 63' ' ' SER . 64.3 m -59.43 135.57 88.82 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.007 -0.542 . . . . 70.200000000000003 110.628 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.29 25.7 0.31 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.892 2.395 . . . . 75.439999999999998 113.038 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' HG12 ' A' ' 72' ' ' ILE . 89.8 mt -78.19 -6.26 54.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.988 -0.375 . . . . 74.530000000000001 109.988 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.635 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.3 t -49.37 -44.31 44.8 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.548 -0.751 . . . . 74.310000000000002 109.946 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.48 -51.57 68.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.67 -0.695 . . . . 71.439999999999998 110.693 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 49.2 t -62.78 -53.04 51.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.533 -0.758 . . . . 61.329999999999998 111.46 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 68' ' ' LEU . 6.7 pt -71.01 -35.96 61.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.759 -0.376 . . . . 74.299999999999997 111.713 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.635 ' HB2' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.51 -54.27 46.06 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.892 0.853 . . . . 72.349999999999994 108.76 173.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.89 -51.29 70.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.864 -1.516 . . . . 71.049999999999997 111.231 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 21.2 mm-40 -59.36 -49.08 79.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.657 0.265 . . . . 72.140000000000001 110.564 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.497 ' O ' HD23 ' A' ' 80' ' ' LEU . 45.7 m -59.29 -60.56 3.66 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.432 . . . . 74.319999999999993 111.016 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.464 ' HB3' HG12 ' A' ' 89' ' ' ILE . 14.4 ptm180 -62.11 -36.68 82.47 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.047 -0.261 . . . . 71.25 111.208 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 t -60.07 -40.94 91.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.252 -0.431 . . . . 72.450000000000003 110.672 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -51.18 16.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.73 0.3 . . . . 65.019999999999996 110.749 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -55.26 -38.12 68.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.108 -0.496 . . . . 70.120000000000005 111.148 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.24 -27.77 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.594 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.71 -34.04 69.34 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.32 -0.467 . . . . 74.109999999999999 112.094 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.536 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 29.9 m -107.67 6.79 28.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.797 0.332 . . . . 64.25 111.15 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.71 69.51 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.125 -0.559 . . . . 72.239999999999995 112.07 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.565 ' HB3' ' HG ' ' A' ' 9' ' ' SER . 78.2 mt -60.68 -43.12 98.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.672 0.749 . . . . 70.310000000000002 108.99 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' A' ' 55' ' ' ALA . 19.2 m -143.9 159.15 16.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.361 -1.29 . . . . 71.239999999999995 108.114 170.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.42 -43.19 86.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.309 0.576 . . . . 73.099999999999994 110.081 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 27.2 t70 -161.55 168.63 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.248 -0.887 . . . . 72.129999999999995 108.753 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 77' ' ' ARG . 32.6 pt -122.68 148.05 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.815 0.341 . . . . 71.450000000000003 110.118 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 90' ' ' ARG . 2.8 tpp180 -119.44 106.38 12.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.473 -0.936 . . . . 74.319999999999993 108.473 176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.3 mt -93.78 145.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.78 0.324 . . . . 71.25 110.853 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -118.71 139.67 51.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.877 -0.786 . . . . 71.200000000000003 108.877 172.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.434 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 49.1 m95 -106.43 106.79 17.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.748 -0.464 . . . . 73.519999999999996 109.748 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.518 HG23 ' OD2' ' A' ' 58' ' ' ASP . 39.5 t -87.3 123.84 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.945 -0.702 . . . . 73.219999999999999 109.882 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -140.88 -0.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.071 -0.513 . . . . 70.0 111.105 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.574 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t-20 167.88 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 116.071 -0.513 . . . . 53.439999999999998 110.435 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 94.5 Cg_endo -80.72 156.69 21.2 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.947 1.765 . . . . 54.520000000000003 111.855 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.08 170.09 17.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.208 1.939 . . . . 50.130000000000003 111.653 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -61.11 101.69 0.17 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.057 -0.52 . . . . 73.109999999999999 110.412 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.85 -83.75 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.075 -0.512 . . . . 63.420000000000002 112.451 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.52 -51.96 3.65 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.725 2.284 . . . . 72.010000000000005 112.244 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 93' ' ' TRP . 6.1 m-20 -64.01 -4.01 3.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 64.439999999999998 112.466 -176.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -76.23 -7.82 55.7 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.598 0.237 . . . . 74.120000000000005 110.508 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.53 102.81 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.913 -0.403 . . . . 75.200000000000003 109.913 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 p -70.45 176.65 3.88 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.13 -0.486 . . . . 72.439999999999998 112.106 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 68.2 mm-40 -54.13 -21.06 7.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.683 -0.689 . . . . 75.25 112.222 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.63 -51.28 69.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.979 0.419 . . . . 73.420000000000002 110.381 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -27.63 66.6 Favored Glycine 0 C--N 1.33 0.201 0 CA-C-N 115.842 -0.617 . . . . 75.530000000000001 111.874 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 10.9 mmm180 -65.45 -51.1 62.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.65 0.38 . . . . 73.510000000000005 111.361 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -80.65 -44.55 18.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 73.530000000000001 111.887 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -95.7 115.44 27.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.157 0.503 . . . . 73.109999999999999 111.591 -168.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.559 ' H ' HD21 ' A' ' 112' ' ' LEU . 2.2 pt? -134.03 166.79 21.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.344 -0.843 . . . . 74.540000000000006 109.775 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.93 -31.07 71.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.558 0.218 . . . . 73.120000000000005 111.244 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.78 -16.42 61.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.679 0.276 . . . . 54.119999999999997 111.413 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 115' ' ' LEU . 8.6 tt -75.97 -26.37 56.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.97 -0.559 . . . . 65.219999999999999 109.8 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.28 92.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.892 -0.595 . . . . 51.200000000000003 112.653 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -125.47 154.93 41.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 75.120000000000005 109.88 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.0 m -90.58 149.49 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.19 -0.3 . . . . 75.010000000000005 110.19 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 119.224 -0.417 . . . . 74.310000000000002 111.558 -178.465 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.113 -0.395 . . . . 43.130000000000003 112.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.83 160.25 30.89 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.785 2.323 . . . . 74.430000000000007 112.611 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.0 -106.84 0.23 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.708 -0.557 . . . . 72.340000000000003 111.708 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.481 ' HB2' HG21 ' A' ' 36' ' ' VAL . 37.3 m -156.1 165.59 35.96 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.899 -0.408 . . . . 75.340000000000003 109.899 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 70.5 mtm -92.94 -69.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.621 -0.511 . . . . 75.420000000000002 109.621 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.409 ' HB3' HD23 ' A' ' 44' ' ' LEU . 50.7 m 70.7 -56.41 0.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.42 0.688 . . . . 75.349999999999994 112.414 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 143.33 53.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.345 0.258 . . . . 74.430000000000007 110.637 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 t -163.19 20.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.513 -0.312 . . . . 73.010000000000005 111.318 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -82.54 18.28 1.55 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 111.901 0.334 . . . . 72.219999999999999 111.901 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.49 157.89 55.05 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.679 -0.237 . . . . 63.109999999999999 110.664 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.33 176.77 3.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.847 2.364 . . . . 74.200000000000003 112.05 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.08 -64.45 0.81 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.039 0.755 . . . . 74.230000000000004 113.039 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -64.43 -46.77 81.73 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.026 0.441 . . . . 74.340000000000003 110.937 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.34 -46.67 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.344 -0.844 . . . . 75.530000000000001 110.761 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.9 -49.12 77.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 110.16 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.33 -59.89 3.99 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 52.130000000000003 111.449 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -45.06 80.51 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.098 -0.501 . . . . 75.420000000000002 111.25 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.26 -41.24 73.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 73.099999999999994 110.812 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.11 -32.82 55.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 109.54 -0.541 . . . . 73.310000000000002 109.54 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.19 -48.79 75.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.211 -0.663 . . . . 75.349999999999994 109.211 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -61.58 -50.57 72.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.798 -0.637 . . . . 62.539999999999999 111.267 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.04 75.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.153 0.501 . . . . 60.039999999999999 111.188 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.28 -13.52 62.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.812 -0.631 . . . . 61.43 110.651 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -96.85 -8.01 32.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.635 . . . . 70.140000000000001 110.405 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.61 -27.13 5.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.499 0.666 . . . . 55.43 110.127 -173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -90.98 -33.04 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.152 -0.931 . . . . 74.010000000000005 111.257 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 33' ' ' ILE . 1.2 p -74.7 174.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.221 -0.445 . . . . 73.129999999999995 110.12 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.55 96.22 8.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 109.722 -0.473 . . . . 53.030000000000001 109.722 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 67.8 Cg_endo -89.13 3.16 5.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.627 2.218 . . . . 74.120000000000005 111.775 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.81 -57.93 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 74.230000000000004 110.461 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.58 -11.29 14.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.897 -0.592 . . . . 73.530000000000001 110.444 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 51.48 2.58 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.952 -0.567 . . . . 30.300000000000001 112.905 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.546 ' O ' HG21 ' A' ' 27' ' ' VAL . 3.2 mp -106.69 140.09 26.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.531 -0.544 . . . . 63.420000000000002 109.531 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -116.62 109.03 16.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.509 -0.769 . . . . 51.140000000000001 109.59 -176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 ' HE3' ' A' ' 59' ' ' MET . 39.9 t -54.23 -39.09 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.051 0.453 . . . . 75.219999999999999 111.257 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' A' ' 4' ' ' SER . 15.0 p -58.1 -24.85 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.025 -0.534 . . . . 64.409999999999997 111.323 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.57 -24.75 67.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 71.129999999999995 110.988 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.16 -10.74 59.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.266 0.555 . . . . 72.239999999999995 110.509 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 22.52 66.09 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.358 -0.837 . . . . 75.409999999999997 114.321 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.4 tp -98.46 -30.08 12.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.06 0.457 . . . . 73.519999999999996 110.372 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.53 -14.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.587 -0.733 . . . . 74.099999999999994 111.826 -172.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -62.04 -23.4 66.44 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 73.239999999999995 109.888 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.89 70.18 2.56 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.684 -0.689 . . . . 74.310000000000002 112.085 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 44' ' ' LEU . 3.4 pp -126.06 144.51 50.69 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 74.120000000000005 109.896 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -163.7 138.06 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.679 -0.86 . . . . 72.439999999999998 108.679 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.66 132.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.84 0.352 . . . . 73.239999999999995 110.822 -175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -115.7 127.3 55.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.132 -0.486 . . . . 62.009999999999998 111.346 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -81.6 113.88 19.91 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.677 -0.692 . . . . 72.420000000000002 109.275 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.02 158.94 18.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.139 -0.553 . . . . 65.219999999999999 111.732 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.9 -24.74 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 73.019999999999996 110.258 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.31 -16.19 50.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.145 -0.479 . . . . 72.430000000000007 110.254 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.87 158.75 9.48 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.879 -0.6 . . . . 73.340000000000003 111.971 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 m -98.48 102.43 14.17 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.625 -0.88 . . . . 72.519999999999996 108.625 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 t -102.92 123.65 56.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 63.439999999999998 111.219 -168.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.91 115.29 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.846 -0.616 . . . . 73.040000000000006 109.585 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 90' ' ' ARG . 50.3 mt -93.89 127.89 39.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.553 0.341 . . . . 74.319999999999993 110.404 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.27 129.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.829 -0.434 . . . . 75.150000000000006 109.829 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.86 129.78 35.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.037 0.446 . . . . 73.150000000000006 111.1 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.528 ' HE3' HG12 ' A' ' 35' ' ' VAL . 79.9 mtp -141.18 171.07 14.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.972 -0.558 . . . . 73.030000000000001 110.183 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -148.63 157.48 43.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 74.099999999999994 110.144 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mm? -117.1 150.93 37.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.185 -0.672 . . . . 70.439999999999998 109.185 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -51.03 -53.86 29.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.651 0.611 . . . . 74.319999999999993 112.651 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -113.65 0.2 14.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.69 -0.232 . . . . 74.230000000000004 111.227 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 7.81 1.8 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.983 0.513 . . . . 62.340000000000003 112.228 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.33 3.78 10.8 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.498 0.666 . . . . 70.209999999999994 109.644 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.403 ' C ' ' H ' ' A' ' 68' ' ' LEU . 7.5 m -83.87 138.64 40.25 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.169 -0.923 . . . . 73.140000000000001 110.476 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.3 23.87 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.907 2.405 . . . . 75.140000000000001 112.622 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.466 ' HB2' HD12 ' A' ' 61' ' ' LEU . 83.5 mt -78.28 -18.01 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.427 . . . . 70.209999999999994 110.171 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -59.8 -46.44 89.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.915 -0.584 . . . . 63.219999999999999 110.824 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.13 -43.27 78.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.269 0.557 . . . . 64.310000000000002 110.209 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.4 t -65.15 -52.59 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 72.349999999999994 110.85 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.14 -37.29 78.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.751 0.31 . . . . 74.120000000000005 110.958 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.79 -47.23 84.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.177 -0.465 . . . . 64.420000000000002 110.213 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 78' ' ' SER . 32.4 t70 -60.23 -48.49 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 74.030000000000001 110.906 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 19.5 mm-40 -61.7 -51.2 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.874 0.369 . . . . 74.450000000000003 110.54 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -60.44 -56.21 24.19 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.954 -0.566 . . . . 72.120000000000005 110.437 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.19 -41.74 72.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.949 -0.568 . . . . 73.010000000000005 110.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 22.9 t -53.57 -53.02 57.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.589 -0.732 . . . . 62.210000000000001 110.783 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.74 -52.08 12.47 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.71 -0.396 . . . . 65.329999999999998 111.234 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.68 -44.33 73.25 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.213 0.53 . . . . 63.43 110.895 -171.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.97 -27.45 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.105 -0.952 . . . . 72.439999999999998 110.127 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -48.03 79.26 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.998 -0.62 . . . . 43.420000000000002 112.442 -170.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . 14.1 m -91.22 -12.65 34.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.117 0.484 . . . . 74.310000000000002 110.414 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.93 43.0 6.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.099999999999994 113.168 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 83' ' ' SER . 3.0 mm? -73.29 -45.25 56.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.57 -0.9 . . . . 71.129999999999995 108.57 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.41 162.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 53.409999999999997 108.897 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.54 -45.29 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.265 0.555 . . . . 71.010000000000005 109.992 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -101.13 133.74 45.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 64.310000000000002 109.809 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.6 pt -127.66 156.27 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 75.299999999999997 110.336 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.754 ' HD2' HG21 ' A' ' 105' ' ' THR . 3.4 tpm_? -150.49 106.77 3.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.176 -0.466 . . . . 74.099999999999994 109.753 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.3 mt -95.03 108.95 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.053 -0.721 . . . . 75.219999999999999 109.053 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 7.3 t30 -88.3 121.84 31.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.419 -0.585 . . . . 75.109999999999999 109.419 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.49 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.9 m-90 -97.9 108.78 21.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.169 -0.308 . . . . 72.420000000000002 110.169 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 98' ' ' PRO . 32.8 m -87.18 123.9 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.672 -0.492 . . . . 71.540000000000006 109.672 176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -111.91 -35.51 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.733 0.778 . . . . 72.450000000000003 109.669 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.657 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 8.7 t30 -175.19 -47.9 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.277 -1.329 . . . . 73.340000000000003 108.354 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 26.7 Cg_exo -64.75 134.15 39.43 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.811 1.674 . . . . 50.539999999999999 109.387 165.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.42 ' O ' HG13 ' A' ' 94' ' ' VAL . 22.0 Cg_exo -63.52 -88.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.376 2.051 . . . . 54.130000000000003 113.18 -173.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 10.7 m-90 -141.39 100.64 3.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.658 0.266 . . . . 74.310000000000002 110.333 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.69 -133.06 3.77 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-O 119.795 -0.447 . . . . 62.25 112.24 -173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.93 -24.31 75.82 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.748 2.299 . . . . 75.219999999999999 112.54 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.99 -4.53 13.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.994 0.426 . . . . 64.019999999999996 111.088 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HD3' ' HB3' ' A' ' 99' ' ' TRP . 33.7 mtmm -76.86 -3.1 36.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 72.319999999999993 110.184 175.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.6 mt -119.24 121.67 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.393 -0.367 . . . . 71.310000000000002 110.544 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.754 HG21 ' HD2' ' A' ' 90' ' ' ARG . 1.4 p -61.81 163.24 7.7 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.47 0.308 . . . . 72.430000000000007 111.189 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -61.63 -43.34 99.03 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.334 -0.617 . . . . 75.310000000000002 109.334 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -59.31 -36.6 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.654 -0.703 . . . . 63.149999999999999 110.713 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.9 -38.32 95.37 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.888 -0.596 . . . . 61.409999999999997 112.791 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -50.85 16.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.125 0.488 . . . . 74.299999999999997 110.287 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 60.7 mm-40 -67.18 -58.17 5.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.282 -0.872 . . . . 64.409999999999997 112.332 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.474 ' HG3' ' C ' ' A' ' 110' ' ' GLU . 14.9 mt-30 60.5 32.89 20.59 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 114.862 -1.063 . . . . 63.439999999999998 110.795 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 tp -100.57 -74.94 0.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.956 -0.566 . . . . 73.129999999999995 109.487 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.0 tpp85 -67.19 -32.81 74.14 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.462 -0.57 . . . . 71.450000000000003 109.462 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.53 -23.99 63.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.264 -0.88 . . . . 72.200000000000003 111.083 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.435 HD23 ' O ' ' A' ' 115' ' ' LEU . 7.3 tt -74.61 -34.66 62.88 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.487 -0.56 . . . . 71.439999999999998 109.487 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.03 -88.73 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.818 -0.628 . . . . 55.420000000000002 111.581 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -177.98 161.58 1.56 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 110.059 -0.349 . . . . 74.540000000000006 110.059 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.1 m -152.51 104.51 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 74.430000000000007 109.884 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.737 -0.649 . . . . 75.420000000000002 110.277 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 111.683 -0.567 . . . . 41.140000000000001 111.683 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -20.59 34.22 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.806 2.337 . . . . 72.540000000000006 111.711 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.88 -151.39 23.33 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.88 -0.888 . . . . 74.340000000000003 110.88 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.0 t -165.46 139.47 4.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 73.129999999999995 110.129 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.471 ' N ' ' SD ' ' A' ' 5' ' ' MET . 1.4 pmm? -104.6 2.32 30.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.135 -0.691 . . . . 73.109999999999999 109.135 172.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.4 t -91.63 -169.66 2.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.454 -0.794 . . . . 74.519999999999996 110.04 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' HG3' HG13 ' A' ' 19' ' ' VAL . 2.8 mp0 60.8 9.22 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.072 0.549 . . . . 63.5 111.102 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 37.7 p -99.83 16.78 22.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.11 0.481 . . . . 72.239999999999995 110.585 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -144.58 171.77 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 74.310000000000002 109.862 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . . . 68.75 161.52 0.14 Allowed Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 123.848 0.718 . . . . 70.510000000000005 111.476 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 11.1 Cg_endo -53.69 131.41 43.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.822 2.348 . . . . 75.439999999999998 111.921 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.16 -66.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.358 0.873 . . . . 53.340000000000003 113.358 -168.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.01 -50.49 73.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.949 0.404 . . . . 72.329999999999998 111.147 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -57.25 -46.41 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 74.010000000000005 110.916 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 7' ' ' GLU . 3.3 tm? -65.65 -39.77 91.76 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.828 -0.624 . . . . 72.099999999999994 110.082 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.6 tp -54.67 -59.63 4.44 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.837 0.351 . . . . 75.430000000000007 110.698 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.67 75.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.996 -0.547 . . . . 75.049999999999997 110.995 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.4 -45.12 92.4 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 111.14 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.484 HG13 ' HG3' ' A' ' 7' ' ' GLU . 3.4 p -73.45 -33.06 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.229 -0.285 . . . . 71.219999999999999 110.229 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -59.13 -41.52 88.45 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.345 0.593 . . . . 55.32 109.617 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.69 -45.8 57.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.486 -0.779 . . . . 75.439999999999998 111.008 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.58 72.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.336 -0.393 . . . . 75.030000000000001 111.567 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.15 -13.49 48.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 41.520000000000003 110.642 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.26 -15.63 35.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.448 -0.342 . . . . 73.530000000000001 110.731 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -109.38 -27.02 9.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 122.02 0.914 . . . . 62.329999999999998 108.891 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 26' ' ' VAL . 70.1 t -112.98 70.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 114.011 -1.449 . . . . 63.509999999999998 109.461 -175.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 34' ' ' ASN . 4.5 p -179.77 173.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.272 -0.876 . . . . 54.039999999999999 108.716 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.26 89.58 4.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.877 -0.786 . . . . 54.119999999999997 108.877 170.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.72 -23.77 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.176 1.917 . . . . 71.430000000000007 112.485 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -68.68 -57.75 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 111.013 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.48 -18.55 26.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.831 0.348 . . . . 72.230000000000004 110.117 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.04 47.03 3.46 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 60.43 113.704 169.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 33' ' ' ILE . 3.6 mp -112.95 140.2 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.514 -0.55 . . . . 71.239999999999995 109.514 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.433 ' HA ' HG21 ' A' ' 27' ' ' VAL . 4.4 p30 -108.46 129.73 55.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.153 -0.684 . . . . 73.439999999999998 109.153 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.13 -28.37 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.84 -0.618 . . . . 72.239999999999995 112.196 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.42 -24.7 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.706 -0.225 . . . . 73.109999999999999 111.064 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -52.86 -35.53 57.74 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.238 0.336 . . . . 74.140000000000001 110.667 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 38' ' ' LEU . 6.6 mp -78.05 -18.39 55.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.377 -0.374 . . . . 53.219999999999999 110.757 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.26 22.89 38.72 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.797 -0.638 . . . . 71.310000000000002 113.548 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -93.04 -22.02 19.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.877 0.37 . . . . 53.5 110.103 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.97 -11.88 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.918 -0.583 . . . . 51.439999999999998 110.905 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -71.75 -24.34 61.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 75.120000000000005 109.94 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.6 81.96 0.96 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.214 -0.754 . . . . 34.109999999999999 111.214 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 44' ' ' LEU . 4.1 pp -130.44 137.04 49.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.262 0.553 . . . . 64.019999999999996 111.006 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 16.3 m-20 -134.4 160.41 38.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.103 -1.443 . . . . 63.119999999999997 107.103 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.9 t -149.12 123.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.506 . . . . 52.240000000000002 109.635 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.688 -0.486 . . . . 71.019999999999996 109.688 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' HA ' HG22 ' A' ' 53' ' ' THR . 7.0 p-10 -88.78 136.66 32.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.92 0.39 . . . . 72.450000000000003 110.086 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.96 134.55 4.75 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.482 -1.047 . . . . 54.43 110.482 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -25.58 67.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.098 0.475 . . . . 75.430000000000007 110.654 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.35 -34.15 65.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.578 -0.737 . . . . 74.219999999999999 109.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.48 124.27 0.77 Allowed Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.683 -0.689 . . . . 72.109999999999999 111.608 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 48' ' ' ASP . 26.1 m -77.62 117.32 18.93 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.248 -0.279 . . . . 65.019999999999996 110.248 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 88' ' ' ASP . 43.7 t -108.2 123.68 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.905 0.383 . . . . 73.319999999999993 110.912 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB3' HG13 ' A' ' 86' ' ' VAL . . . -94.76 122.42 37.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.108 -0.496 . . . . 71.310000000000002 110.269 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 12.2 mt -97.29 102.01 13.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.655 -0.498 . . . . 74.329999999999998 109.655 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -108.65 125.15 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.092 0.157 . . . . 70.319999999999993 110.69 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.11 118.98 25.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.849 0.357 . . . . 75.150000000000006 110.099 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 72.0 mtp -140.87 170.87 14.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.383 0.611 . . . . 53.140000000000001 111.01 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -157.03 177.47 11.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.973 -1.012 . . . . 65.030000000000001 108.907 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -108.57 163.11 13.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.29 -0.633 . . . . 74.420000000000002 109.29 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -47.46 -57.48 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.484 0.49 . . . . 73.400000000000006 112.008 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -96.88 -13.59 22.38 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.385 -0.37 . . . . 74.530000000000001 111.024 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.39 8.84 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.89 0.7 . . . . 53.210000000000001 112.89 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.81 9.61 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.05 0.453 . . . . 53.229999999999997 110.486 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.3 t -119.92 124.47 27.87 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.865 -0.607 . . . . 75.230000000000004 109.786 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.17 83.16 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.682 2.254 . . . . 73.340000000000003 112.087 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 tp -107.05 8.2 30.17 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.678 0.752 . . . . 64.409999999999997 108.997 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.685 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.1 t -63.7 -39.72 95.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.303 -0.862 . . . . 63.420000000000002 111.341 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.8 -44.71 74.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 74.430000000000007 110.198 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.46 -51.93 52.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.436 -0.802 . . . . 70.409999999999997 110.795 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.685 HG12 ' HA ' ' A' ' 69' ' ' THR . 27.0 pt -62.55 -33.73 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.697 -0.401 . . . . 74.420000000000002 111.075 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.438 ' HG2' HD12 ' A' ' 91' ' ' ILE . 43.8 mt-10 -68.0 -44.17 77.19 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.457 -0.338 . . . . 70.25 110.225 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.88 -44.24 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 73.040000000000006 110.425 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -65.06 -46.2 82.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.331 -0.395 . . . . 75.540000000000006 110.72 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -58.91 -53.81 54.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.066 -0.516 . . . . 73.329999999999998 109.944 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 ttp85 -54.87 -44.11 73.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 75.230000000000004 110.395 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -53.32 -53.65 47.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.815 -0.63 . . . . 71.120000000000005 111.159 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.22 -52.49 10.78 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.55 -0.46 . . . . 74.430000000000007 111.462 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.433 ' HB3' HG21 ' A' ' 86' ' ' VAL . 92.1 mt -60.14 -41.09 91.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.05 0.452 . . . . 74.120000000000005 111.227 -169.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.04 -27.42 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 74.040000000000006 110.188 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.21 -45.71 18.57 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.688 -0.768 . . . . 63.229999999999997 111.776 -171.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 m -82.89 2.87 32.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.41 . . . . 73.120000000000005 110.659 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.76 35.91 90.41 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.013 -0.539 . . . . 74.340000000000003 112.811 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.0 mt -76.57 -43.65 38.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 51.32 109.555 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 55' ' ' ALA . 27.2 m -144.29 169.32 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.367 -0.833 . . . . 72.329999999999998 109.387 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -91.71 -48.0 7.06 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.961 0.41 . . . . 64.040000000000006 110.447 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' HB2' HG21 ' A' ' 54' ' ' VAL . 18.6 m-20 -131.38 151.12 51.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.059 -0.519 . . . . 51.350000000000001 110.687 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.1 pt -113.96 151.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 71.420000000000002 110.447 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.749 ' HG2' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.98 106.64 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.207 -1.034 . . . . 70.340000000000003 108.207 177.452 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 HD12 ' HG2' ' A' ' 73' ' ' GLU . 47.7 mt -95.94 114.33 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 73.329999999999998 110.373 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 3.4 t30 -88.68 102.85 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 72.310000000000002 109.093 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -82.34 106.87 14.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.501 -0.318 . . . . 73.450000000000003 110.585 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.9 123.56 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.387 -0.597 . . . . 64.439999999999998 109.387 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -122.08 -17.62 7.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.047 0.451 . . . . 75.230000000000004 110.18 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.521 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 28.0 t-20 173.86 -47.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.186 -0.915 . . . . 72.0 109.449 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.3 Cg_endo -68.08 140.12 48.72 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.629 1.553 . . . . 61.299999999999997 110.123 168.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.55 -92.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.203 1.935 . . . . 73.109999999999999 112.482 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -146.09 163.12 36.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.962 -0.384 . . . . 73.340000000000003 109.962 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.44 -127.17 1.58 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.72 -0.552 . . . . 71.420000000000002 111.72 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.64 -17.73 56.1 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.627 2.218 . . . . 65.409999999999997 111.685 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 4.0 m-20 -63.96 -11.1 25.47 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.577 -0.738 . . . . 62.240000000000002 110.978 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 71.9 mmtt -76.69 0.71 19.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.071 -0.513 . . . . 73.129999999999995 110.431 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.99 139.01 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.674 -0.491 . . . . 73.510000000000005 109.674 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 90' ' ' ARG . 19.7 p -70.29 151.19 45.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.983 0.42 . . . . 72.219999999999999 111.09 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.02 -36.23 78.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.741 -0.837 . . . . 73.209999999999994 108.741 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -57.01 -53.13 61.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.547 -1.206 . . . . 70.239999999999995 110.537 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.78 -34.12 88.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.818 -0.628 . . . . 63.130000000000003 112.513 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -73.58 -34.94 65.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.487 . . . . 74.409999999999997 110.711 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -48.36 66.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.556 -0.747 . . . . 71.109999999999999 110.138 -177.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -95.33 79.36 3.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 73.439999999999998 111.072 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -128.36 -166.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.286 -0.87 . . . . 75.310000000000002 109.779 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -55.53 -29.96 59.85 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.879 0.326 . . . . 71.25 111.879 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.93 67.84 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.92 0.391 . . . . 64.540000000000006 111.065 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.06 -24.39 60.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 64.450000000000003 110.007 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.64 -161.51 51.42 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.977 -0.556 . . . . 70.349999999999994 112.416 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.5 94.82 2.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 75.549999999999997 110.308 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -69.05 -19.23 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 75.239999999999995 110.324 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.237 -0.887 . . . . 74.310000000000002 109.054 176.572 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.139 -0.384 . . . . 64.530000000000001 112.139 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.45 158.8 40.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.625 2.217 . . . . 74.230000000000004 111.913 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.9 -44.29 0.83 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.753 -0.539 . . . . 61.130000000000003 111.753 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -101.14 133.84 45.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.071 -0.344 . . . . 72.209999999999994 110.071 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.706 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 21.7 ptp -89.03 -166.34 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 75.010000000000005 110.36 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 m -102.25 22.78 12.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.815 -0.439 . . . . 74.510000000000005 109.815 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.706 ' H ' ' HG3' ' A' ' 5' ' ' MET . 4.3 mm-40 54.07 92.77 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.332 -0.849 . . . . 72.439999999999998 110.757 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -66.35 95.54 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.516 -0.765 . . . . 74.519999999999996 112.11 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -164.61 154.78 14.15 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.949 -0.76 . . . . 74.319999999999993 108.949 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB2' ' HD2' ' A' ' 11' ' ' PRO . . . 65.03 164.14 0.12 Allowed Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 123.24 0.338 . . . . 42.439999999999998 111.336 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 30.1 Cg_endo -64.28 143.52 83.55 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.366 2.044 . . . . 71.219999999999999 111.707 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -38.75 58.57 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.644 0.609 . . . . 75.400000000000006 112.644 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -55.01 -50.24 69.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.411 0.624 . . . . 64.109999999999999 110.843 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 -40.42 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.539 -0.755 . . . . 53.109999999999999 110.187 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.97 -53.75 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.763 -0.653 . . . . 72.230000000000004 111.367 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 16' ' ' LEU . 1.7 pp -58.09 -48.87 78.83 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.952 0.406 . . . . 74.239999999999995 110.951 -172.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.69 -46.89 65.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.059 -0.519 . . . . 45.210000000000001 110.714 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -64.09 -45.0 90.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.495 -0.775 . . . . 74.099999999999994 110.419 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.3 -38.02 80.14 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 109.946 -0.39 . . . . 54.0 109.946 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.71 -43.19 72.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.008 0.433 . . . . 73.439999999999998 110.079 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 43.9 mt-10 -72.36 -43.36 64.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 71.329999999999998 111.067 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.82 73.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.416 0.627 . . . . 60.200000000000003 110.751 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 21.7 mmt -63.11 -13.63 38.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.425 -0.807 . . . . 75.010000000000005 111.213 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 40.3 ttt180 -74.8 -24.17 58.61 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.739 0.304 . . . . 74.349999999999994 111.15 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.14 -23.56 9.43 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.672 0.749 . . . . 74.109999999999999 109.911 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.532 ' O ' HG11 ' A' ' 26' ' ' VAL . 60.5 t -95.08 26.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.728 -1.123 . . . . 74.530000000000001 110.23 -178.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.8 p -150.08 169.23 2.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.592 -0.892 . . . . 71.209999999999994 108.592 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -103.2 100.22 17.02 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 110.012 -0.366 . . . . 72.219999999999999 110.012 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 97.1 Cg_endo -88.93 -3.75 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.758 2.306 . . . . 71.310000000000002 111.827 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.1 -57.75 5.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.05 0.452 . . . . 71.310000000000002 110.642 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.1 -17.49 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 73.010000000000005 109.994 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.19 52.62 1.71 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.746 -0.661 . . . . 22.32 112.999 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -109.67 142.66 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.116 0.484 . . . . 72.299999999999997 109.902 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' A' ' 37' ' ' ASP . 6.0 p30 -120.16 112.6 19.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 72.219999999999999 109.347 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD22 ' A' ' 38' ' ' LEU . 35.8 m -55.22 -30.05 24.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.544 -0.753 . . . . 63.140000000000001 112.086 -173.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.84 -31.5 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 74.450000000000003 111.377 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t70 -67.3 -19.56 65.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.462 -0.335 . . . . 65.349999999999994 111.351 -176.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -72.85 -17.5 61.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.084 0.469 . . . . 74.129999999999995 109.992 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.86 65.39 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.549 -0.751 . . . . 65.0 113.362 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.99 -20.14 17.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.14 0.495 . . . . 72.340000000000003 110.011 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG13 HD23 ' A' ' 44' ' ' LEU . 42.1 t -59.27 -9.62 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.695 -0.684 . . . . 71.430000000000007 111.422 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.18 -7.24 40.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.059 0.457 . . . . 73.5 110.0 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 58' ' ' ASP . . . -81.52 18.96 9.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.524 -0.762 . . . . 42.119999999999997 112.249 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.513 HD23 HG13 ' A' ' 41' ' ' VAL . 4.6 pp -89.16 129.8 35.7 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.939 -0.763 . . . . 73.409999999999997 108.939 171.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -161.59 113.29 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.75 -0.463 . . . . 72.319999999999993 109.75 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.1 p -93.02 116.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.178 0.513 . . . . 71.510000000000005 110.782 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.54 128.25 56.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.785 -0.643 . . . . 74.230000000000004 109.606 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 2.1 p-10 -101.66 161.06 13.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 110.651 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.54 -175.03 32.12 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.641 -0.984 . . . . 72.299999999999997 110.641 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.4 -35.48 71.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.271 0.558 . . . . 75.340000000000003 109.916 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.98 -18.17 63.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.157 -0.928 . . . . 73.239999999999995 110.584 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.64 172.37 18.41 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 112.527 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 29.1 m -105.85 111.03 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.461 -0.57 . . . . 74.319999999999993 109.461 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -112.26 133.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.671 0.272 . . . . 62.329999999999998 111.095 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -97.82 106.52 18.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.29 -0.414 . . . . 75.209999999999994 110.431 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 46.1 mt -75.61 141.0 42.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 73.219999999999999 109.707 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.5 HG23 ' HG3' ' A' ' 59' ' ' MET . 60.6 mt -144.64 113.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.148 -0.315 . . . . 74.450000000000003 110.148 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 30.7 m-20 -86.95 128.72 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.654 -0.248 . . . . 74.109999999999999 110.463 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.5 ' HG3' HG23 ' A' ' 57' ' ' ILE . 87.4 mtp -140.9 170.51 15.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 122.261 1.029 . . . . 63.030000000000001 113.051 -174.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 94' ' ' VAL . 19.9 p -149.51 172.74 14.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 113.294 -1.775 . . . . 72.519999999999996 109.089 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.26 145.3 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.685 -1.228 . . . . 63.329999999999998 107.685 164.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 p -59.69 -48.43 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 74.129999999999995 111.021 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -67.99 -38.64 82.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.394 -0.821 . . . . 75.319999999999993 111.335 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.71 8.16 2.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.102 -0.954 . . . . 70.209999999999994 111.361 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.08 -36.0 3.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.215 0.531 . . . . 71.150000000000006 109.887 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.9 116.18 53.11 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.643 -0.708 . . . . 75.25 110.039 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.94 77.38 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.812 2.341 . . . . 74.150000000000006 113.577 -173.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.85 7.27 31.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.26 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 4.2 t -50.35 -60.21 3.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.569 -0.741 . . . . 73.230000000000004 112.113 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -58.92 -35.83 73.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.139 0.495 . . . . 74.019999999999996 110.335 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.489 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.9 t -65.32 -53.29 41.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.547 -0.751 . . . . 62.229999999999997 110.857 -175.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.579 HG12 ' HH2' ' A' ' 93' ' ' TRP . 1.8 pp -69.12 -36.63 74.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.428 -0.351 . . . . 71.540000000000006 110.246 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.402 ' N ' HD13 ' A' ' 72' ' ' ILE . 40.2 mt-10 -63.37 -45.81 89.41 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 74.510000000000005 110.603 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.52 -42.91 86.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 65.040000000000006 110.921 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 56.5 mt-30 -59.57 -54.05 50.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.11 0.481 . . . . 61.43 110.671 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.52 -53.98 51.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.579 -0.737 . . . . 62.340000000000003 110.603 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -55.05 -51.2 67.07 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.114 -0.494 . . . . 75.409999999999997 111.326 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.7 t -53.29 -51.76 61.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.077 -0.51 . . . . 60.229999999999997 111.01 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.06 -52.0 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.517 -0.473 . . . . 64.409999999999997 111.334 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.79 -39.46 85.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.761 0.315 . . . . 74.340000000000003 111.116 -172.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.07 -27.83 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 110.361 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.14 -33.15 33.42 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.857 -0.687 . . . . 64.409999999999997 112.194 -172.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 85' ' ' LEU . 15.0 m -95.97 -0.17 51.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 53.32 110.962 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.56 29.86 67.31 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.353 -0.451 . . . . 61.509999999999998 113.488 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 83' ' ' SER . 9.4 mp -79.8 -8.14 59.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.11 0.481 . . . . 72.400000000000006 110.233 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 53' ' ' THR . 9.9 p -164.02 161.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.601 -0.727 . . . . 74.140000000000001 109.332 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.18 -19.68 58.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.847 -0.427 . . . . 75.230000000000004 109.847 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.8 t0 174.85 150.89 0.1 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.352 -170.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 18.6 pt -116.4 152.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 61.32 110.335 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 2.4 tpp180 -133.35 106.15 7.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.145 -0.687 . . . . 63.299999999999997 109.145 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.24 143.55 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.349 -0.387 . . . . 61.119999999999997 110.227 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -119.54 143.45 47.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 72.519999999999996 110.286 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.579 ' HH2' HG12 ' A' ' 72' ' ' ILE . 70.6 m95 -110.96 106.41 15.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 75.109999999999999 110.102 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 60' ' ' THR . 31.5 m -100.09 123.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.009 -0.676 . . . . 44.329999999999998 110.788 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -109.14 -35.37 6.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 72.409999999999997 110.023 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.582 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 3.1 t-20 -171.21 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.116 -0.947 . . . . 54.340000000000003 110.746 -173.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.582 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 53.1 Cg_endo -68.02 158.05 59.12 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.929 1.752 . . . . 55.409999999999997 112.213 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.87 175.0 6.9 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.963 2.442 . . . . 72.349999999999994 111.756 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 25.0 m0 -75.57 123.4 25.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.64 -0.254 . . . . 74.430000000000007 110.477 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.66 -123.02 1.11 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.384 -0.436 . . . . 72.239999999999995 112.428 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.24 -19.28 38.8 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.688 2.258 . . . . 43.539999999999999 111.452 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -17.03 16.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.035 -0.984 . . . . 63.030000000000001 111.713 177.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 29.1 mtpp -76.62 -8.13 56.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.687 0.279 . . . . 74.0 111.034 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -80.67 115.84 23.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.639 0.256 . . . . 75.519999999999996 110.53 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.7 p -75.53 172.17 13.01 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.451 -0.34 . . . . 73.25 111.196 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -59.11 -20.45 53.68 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 72.510000000000005 110.998 176.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -56.52 -52.98 62.71 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.861 0.362 . . . . 65.409999999999997 110.382 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.57 -37.37 17.31 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.099 -0.572 . . . . 71.219999999999999 112.35 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.52 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 51.7 ttt180 -62.5 -47.73 82.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.559 0.577 . . . . 75.530000000000001 112.559 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.43 -6.71 37.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.979 1.103 . . . . 73.430000000000007 113.979 -167.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -86.4 -14.42 43.42 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.868 0.366 . . . . 75.340000000000003 111.073 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -76.72 -80.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.606 . . . . 71.129999999999995 111.721 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -64.99 -29.56 70.49 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.821 -0.627 . . . . 73.109999999999999 110.44 -174.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 -12.01 59.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.669 -0.696 . . . . 72.439999999999998 111.388 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.67 -34.82 60.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 63.240000000000002 109.996 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.57 -44.57 4.87 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.327 -0.709 . . . . 71.040000000000006 111.327 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -83.17 90.13 7.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.108 -0.701 . . . . 74.230000000000004 109.108 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.2 p -74.76 134.04 41.9 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.86 -0.609 . . . . 65.140000000000001 111.84 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-N 115.539 -0.755 . . . . 71.120000000000005 109.613 177.895 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 111.968 0.359 . . . . 72.34 111.968 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.81 148.87 90.21 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.633 2.222 . . . . 73.44 111.474 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.62 -37.53 40.82 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.785 0.661 . . . . 73.14 112.785 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.53 -51.92 56.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.198 0.523 . . . . 72.41 110.243 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -46.41 65.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.251 -0.886 . . . . 71.21 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.51 -50.15 68.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.566 -0.743 . . . . 75.11 110.785 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.55 -59.6 4.26 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.943 0.402 . . . . 71.0 111.301 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.62 77.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.182 -0.463 . . . . 33.24 111.224 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.98 -44.38 92.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.521 . . . . 73.14 110.837 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -68.46 -34.72 67.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.944 -0.391 . . . . 54.21 109.944 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.93 -43.32 91.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.695 -0.484 . . . . 74.2 109.695 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 44.7 mt-10 -66.46 -50.84 61.99 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.015 -0.539 . . . . 73.1 110.614 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -56.47 -44.24 80.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.159 -0.473 . . . . 73.21 111.044 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.0 mmt -62.68 -13.59 33.96 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.65 -0.705 . . . . 71.21 111.584 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 23.9 ttp85 -80.14 -30.64 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.394 -0.224 . . . . 75.14 110.394 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -99.8 -27.15 13.77 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.881 0.326 . . . . 70.3 111.881 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.6 m -99.58 20.39 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.837 0.351 . . . . 63.31 111.658 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.2 p -128.0 171.5 16.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.628 -0.508 . . . . 71.25 109.628 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -107.31 90.86 6.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.356 -0.609 . . . . 61.02 109.356 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.99 -1.43 10.82 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.3 2.0 . . . . 64.42 111.444 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.45 -57.69 5.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.57 -0.741 . . . . 71.15 110.5 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.4 -10.02 14.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 75.51 110.235 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.11 52.84 2.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.205 -0.521 . . . . 74.24 113.124 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -112.45 141.78 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.749 -0.463 . . . . 34.22 109.749 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -122.37 112.55 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.987 -0.552 . . . . 74.3 109.685 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.0 m -54.81 -34.47 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.108 -0.497 . . . . 74.12 112.12 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 9.3 p -56.0 -30.66 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.447 -0.342 . . . . 70.3 111.322 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.11 -18.36 63.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.162 -0.472 . . . . 74.24 111.503 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.9 mm? -69.03 -12.54 61.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.443 0.64 . . . . 70.52 109.861 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.35 21.89 62.69 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 114.881 -1.054 . . . . 74.22 114.849 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.3 tt -98.19 -31.71 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.902 -1.147 . . . . 70.15 107.902 164.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 26.0 t -65.69 -8.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.862 -1.063 . . . . 75.24 110.831 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -59.39 -26.11 64.85 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.073 0.464 . . . . 63.13 109.762 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.06 91.23 1.72 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.595 -0.729 . . . . 71.42 112.015 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.04 136.8 38.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.534 -0.543 . . . . 73.22 109.534 174.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.55 109.37 7.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.568 -0.53 . . . . 44.12 109.568 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.2 m -94.24 108.75 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.693 0.758 . . . . 72.41 109.757 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -100.13 120.96 40.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.455 -0.793 . . . . 64.42 110.027 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -107.08 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.678 -0.49 . . . . 65.12 109.678 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.85 -163.75 12.54 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.216 -0.516 . . . . 72.52 112.003 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.9 -27.9 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.515 0.674 . . . . 70.1 109.692 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.43 -39.33 81.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.013 -0.994 . . . . 63.33 109.77 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.84 -171.82 43.49 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.682 -0.69 . . . . 54.3 111.852 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.2 m -124.48 104.42 8.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.379 -0.6 . . . . 64.1 109.379 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.4 p -114.99 124.26 71.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.346 0.593 . . . . 64.24 112.1 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.08 107.53 19.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.766 . . . . 71.14 109.993 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -87.64 130.32 34.82 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.541 HG22 ' HG3' ' A' ' 59' ' ' MET . 45.1 mt -130.86 113.82 25.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.75 0.31 . . . . 63.53 110.622 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.36 116.5 20.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 72.42 109.723 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 57' ' ' ILE . 81.9 mtp -134.61 170.85 15.17 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.326 0.584 . . . . 72.31 111.373 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -152.59 161.13 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.289 -0.869 . . . . 55.22 109.245 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.2 mt -132.57 174.1 10.63 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.362 -0.607 . . . . 74.53 109.362 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.7 m -44.18 -42.43 6.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.483 0.489 . . . . 74.42 112.04 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -141.37 4.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.428 -0.351 . . . . 55.15 110.325 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 57.64 8.88 0.72 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.744 0.646 . . . . 44.13 112.744 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.73 15.06 15.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.224 0.535 . . . . 63.32 110.285 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 35.1 m -91.46 144.2 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.756 . . . . 72.05 110.296 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 26.6 Cg_exo -64.66 10.38 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 123.346 2.697 . . . . 74.42 113.377 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 71' ' ' VAL . 1.2 tt -75.08 -15.12 60.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -57.52 -45.76 84.6 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.51 -41.64 85.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.251 0.548 . . . . 54.01 110.253 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.595 ' HB ' HD23 ' A' ' 68' ' ' LEU . 60.3 t -63.4 -52.25 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.251 -0.886 . . . . 52.11 111.078 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.97 -41.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 120.779 -0.368 . . . . 72.21 111.13 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.23 -51.26 68.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.6 0.238 . . . . 73.34 110.803 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.84 -51.83 66.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 74.43 110.9 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -64.2 -43.97 93.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.356 -0.384 . . . . 72.33 111.146 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 -59.19 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 65.35 110.23 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -55.17 -45.95 75.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.552 -0.295 . . . . 71.41 110.83 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -55.16 -47.49 75.09 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.631 0.582 . . . . 74.25 111.131 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.3 -51.05 16.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.503 -0.317 . . . . 74.12 111.083 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.03 -39.62 82.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.377 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.87 -28.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.106 0.479 . . . . 52.43 109.882 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.07 -27.97 47.35 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.139 -0.553 . . . . 65.12 111.739 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 85' ' ' LEU . 19.4 m -70.93 -23.21 62.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.966 0.412 . . . . 74.04 110.461 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.09 -10.02 59.18 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.992 -0.549 . . . . 73.41 113.125 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.5 mp -61.51 -39.43 90.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.648 0.261 . . . . 61.52 110.652 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 m -143.39 152.29 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.12 -0.491 . . . . 75.02 109.752 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.12 -40.67 6.36 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 75.55 110.059 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 20.0 m-20 -102.99 139.43 38.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.923 -0.58 . . . . 64.14 109.9 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 9.4 pt -133.98 169.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.151 -0.685 . . . . 75.41 109.151 170.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' ILE . 22.8 mtt85 -156.35 106.61 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.134 -0.485 . . . . 64.34 109.837 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.73 113.46 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.819 -0.808 . . . . 71.14 108.819 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 103' ' ' LYS . 4.4 p-10 -105.53 140.69 38.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.981 0.419 . . . . 65.21 110.687 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.82 106.64 17.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.715 -0.675 . . . . 74.5 109.597 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 99' ' ' TRP . 10.7 m -113.04 131.09 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 65.1 112.065 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -152.73 8.86 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.023 -0.989 . . . . 65.53 110.621 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.3 m-20 -167.12 -60.05 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.586 0.354 . . . . 72.5 111.275 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 88.6 Cg_endo -78.17 159.51 30.02 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.042 1.828 . . . . 75.12 113.097 -171.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.7 137.07 37.72 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.053 2.502 . . . . 52.32 111.633 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.9 m-90 -53.88 109.79 0.51 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.724 0.64 . . . . 74.43 111.313 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.3 -78.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.862 -0.608 . . . . 63.4 111.817 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.59 -37.05 90.82 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.782 2.322 . . . . 64.54 111.375 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.54 -20.62 47.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.221 -0.899 . . . . 61.25 111.6 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 99' ' ' TRP . 54.4 mttp . . . . . 0 C--N 1.33 -0.249 0 N-CA-C 111.753 0.279 . . . . 70.44 111.753 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.377 0.51 . . . . 71.51 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.65 153.72 54.38 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.55 2.167 . . . . 72.2 111.209 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.6 -40.69 28.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.579 0.585 . . . . 31.3 112.579 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.54 -50.14 68.61 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.165 0.507 . . . . 73.14 111.086 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -81.29 -47.48 13.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 75.22 110.452 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.04 -48.33 70.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.949 -1.023 . . . . 61.22 112.463 -172.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 tp -54.63 -59.28 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.68 0.276 . . . . 42.52 110.866 -174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -65.36 -40.19 93.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 74.52 110.829 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.21 -48.94 79.6 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.807 -0.633 . . . . 60.22 110.668 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 23' ' ' MET . 7.9 p -73.93 -32.79 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 70.23 109.675 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.1 -39.04 77.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.106 -0.497 . . . . 73.24 110.263 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 41.9 mt-10 -72.65 -51.7 18.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.429 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.99 -48.77 75.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 63.4 111.037 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.487 ' HG2' HG22 ' A' ' 19' ' ' VAL . 23.8 mmt -58.0 -13.55 4.85 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.51 -0.768 . . . . 62.52 111.832 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 24' ' ' ARG . 40.1 ttt-85 -87.97 -35.8 17.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.68 0.276 . . . . 74.14 110.584 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -90.15 -26.82 19.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.439 -0.346 . . . . 71.25 111.44 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ALA . 29.7 m -98.12 27.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.92 0.391 . . . . 71.21 111.35 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.96 162.68 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 62.04 110.172 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 m-20 -110.15 82.92 2.77 Favored Pre-proline 0 C--O 1.233 0.218 0 N-CA-C 109.071 -0.714 . . . . 54.53 109.071 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 14.38 2.07 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.736 2.291 . . . . 74.44 112.618 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.55 -58.34 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.145 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 33' ' ' ILE . 87.9 mt -115.78 3.64 13.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 73.23 110.438 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.44 39.72 4.96 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.037 -0.602 . . . . 72.03 112.633 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 31' ' ' LEU . 3.7 mp -88.68 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.843 -0.799 . . . . 71.13 108.843 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 52.1 t-20 -143.83 120.14 10.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.102 -0.333 . . . . 74.53 110.102 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -59.83 -32.03 48.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 54.43 110.739 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 HG11 ' A' ' 41' ' ' VAL . 91.7 t -59.27 -26.41 33.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.897 -0.592 . . . . 62.35 110.566 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 8.3 t0 -59.2 -27.46 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.971 -0.559 . . . . 75.2 111.022 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 38' ' ' LEU . 3.5 mm? -77.72 -8.41 57.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.755 0.312 . . . . 71.13 110.93 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.25 22.95 59.25 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.001 -0.545 . . . . 62.42 113.03 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.699 HD21 HG23 ' A' ' 94' ' ' VAL . 39.2 tp -93.3 -26.29 17.37 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.616 -0.343 . . . . 72.15 110.249 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.415 HG11 HG22 ' A' ' 36' ' ' VAL . 11.8 p -62.0 -12.19 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.924 -0.58 . . . . 72.23 110.824 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.94 -14.09 42.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.826 -0.624 . . . . 72.44 110.264 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.78 67.89 2.59 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.196 -0.761 . . . . 62.53 111.196 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.0 pp -120.96 141.77 50.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.103 -0.332 . . . . 64.1 110.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.03 110.77 1.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 71.34 110.185 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 38.7 t -93.66 126.06 46.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.441 -0.345 . . . . 71.25 110.304 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -121.35 133.06 55.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.428 -0.351 . . . . 75.43 110.662 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.2 p-10 -92.4 147.04 23.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.144 -0.687 . . . . 75.55 109.144 173.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.78 177.87 35.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.729 . . . . 62.54 112.171 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.08 -41.62 65.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.21 0.529 . . . . 74.4 111.059 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.54 17.73 9.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.54 -0.754 . . . . 72.2 111.701 -174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.41 174.91 17.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.151 -0.547 . . . . 73.22 112.981 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 13.9 m -102.79 109.15 20.64 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.126 -0.324 . . . . 63.11 110.126 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.73 135.97 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 75.21 111.168 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.531 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -93.78 105.02 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 61.31 109.917 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HB3' ' HE3' ' A' ' 103' ' ' LYS . 69.9 mt -70.97 113.39 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.538 -0.542 . . . . 73.03 109.538 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 63.9 mt -120.69 114.04 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 73.31 110.264 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -89.9 116.51 28.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.886 0.374 . . . . 75.41 110.188 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.1 mtp -125.57 170.66 11.25 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.538 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 40' ' ' LEU . 14.8 t -137.67 150.43 47.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.915 0.388 . . . . 73.41 110.7 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 3.2 mm? -118.17 147.5 43.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.312 -0.996 . . . . 53.44 108.312 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 m -42.42 -51.74 4.85 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.614 0.598 . . . . 63.01 112.614 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 t -116.83 6.54 13.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.567 0.222 . . . . 70.04 110.723 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.22 8.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.282 0.475 . . . . 71.34 112.282 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.93 16.67 12.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.591 0.71 . . . . 75.21 109.324 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 61' ' ' LEU . 10.3 m -72.25 133.24 83.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.797 -1.092 . . . . 44.43 110.753 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.38 -3.45 13.01 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.453 2.102 . . . . 75.32 111.694 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.21 -0.39 36.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 75.21 111.195 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 70' ' ' ASP . 13.1 t -62.54 -48.91 77.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.546 0.212 . . . . 55.14 110.551 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 69' ' ' THR . 15.9 t70 -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.255 0.55 . . . . 71.24 109.794 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.535 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 81.1 t -67.48 -52.61 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.78 -0.645 . . . . 73.55 110.912 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -68.31 -35.94 73.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 121.03 -0.268 . . . . 73.34 110.819 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 72' ' ' ILE . 45.3 mt-10 -58.37 -50.67 72.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.351 -0.611 . . . . 73.43 109.351 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.07 -51.37 69.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.729 . . . . 64.13 111.112 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 23.7 mm-40 -60.87 -56.76 17.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.999 0.428 . . . . 75.14 110.781 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.484 ' O ' HD23 ' A' ' 80' ' ' LEU . 32.4 t -61.27 -53.58 54.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.898 -0.592 . . . . 53.51 110.592 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.539 ' HG2' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -57.02 -46.96 81.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.079 -0.509 . . . . 74.11 110.434 -176.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 t -58.93 -43.36 91.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 73.35 110.95 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.97 -51.56 17.88 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.944 -0.302 . . . . 72.25 110.869 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -56.12 -41.07 74.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.312 -0.404 . . . . 64.42 110.771 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.76 -27.8 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 63.25 110.467 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.43 -47.58 56.6 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.842 -0.695 . . . . 74.45 111.766 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -77.36 -22.91 51.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.865 0.364 . . . . 61.43 110.029 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.25 26.32 28.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.155 -0.475 . . . . 44.05 113.262 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 80' ' ' LEU . 83.0 mt -62.55 -33.92 75.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.156 0.503 . . . . 73.42 110.168 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 55' ' ' ALA . 5.0 m -147.06 164.82 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.574 -0.739 . . . . 63.23 109.734 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.95 -40.96 75.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 62.0 110.188 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -158.15 172.89 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.672 -0.862 . . . . 63.31 108.672 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' HG2' ' A' ' 77' ' ' ARG . 16.6 pt -131.95 145.09 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.889 0.376 . . . . 71.31 110.074 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 4.5 tpt180 -120.66 106.77 12.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.625 -0.509 . . . . 75.33 109.625 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.7 mt -88.66 140.86 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 65.32 110.675 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.658 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -118.7 127.48 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.407 -0.59 . . . . 71.43 109.407 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.492 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.3 m-90 -87.23 106.62 18.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.891 -0.411 . . . . 73.45 109.891 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.699 HG23 HD21 ' A' ' 40' ' ' LEU . 14.6 m -118.5 158.95 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.746 0.308 . . . . 75.45 110.557 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -177.68 -31.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 73.01 110.262 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.693 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 44.2 t30 -155.27 -49.2 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.911 -0.586 . . . . 74.41 110.168 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.693 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 5.6 Cg_exo -76.68 147.76 28.24 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.07 1.846 . . . . 55.21 110.687 169.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 14.7 Cg_exo -69.58 -163.97 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.775 2.317 . . . . 75.14 112.439 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.4 m-90 -89.84 124.4 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 62.45 110.942 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -113.48 0.3 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.181 -0.533 . . . . 61.33 112.213 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.39 -17.84 54.25 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.724 2.282 . . . . 65.11 111.568 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' ND2' ' A' ' 92' ' ' ASN . 7.0 m-20 -67.09 -3.92 8.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 70.2 111.373 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 35.8 mmtm . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.7 0.286 . . . . 71.51 110.319 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 111.742 0.275 . . . . 62.43 111.742 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.49 -178.98 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.352 2.034 . . . . 65.53 111.836 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.6 -66.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.081 0.771 . . . . 60.32 113.081 -170.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -65.84 -41.07 92.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.504 -0.317 . . . . 75.25 111.543 -174.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -60.99 -39.4 89.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.412 . . . . 61.11 110.678 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.01 -43.38 91.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.286 -0.416 . . . . 70.14 110.349 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -57.71 -52.21 66.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 71.53 110.087 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.69 -51.96 67.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.725 -0.67 . . . . 73.31 110.94 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.6 -48.04 82.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.915 -0.584 . . . . 64.31 111.125 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.1 p -66.64 -32.97 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.131 -0.322 . . . . 72.23 110.131 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.28 -45.22 92.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.092 -0.336 . . . . 73.31 110.092 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.57 -51.56 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.205 0.526 . . . . 65.45 110.0 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.99 -47.38 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.407 -0.815 . . . . 71.21 110.889 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.4 mmt -62.54 -13.39 30.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.354 0.502 . . . . 60.53 112.354 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 24' ' ' ARG . 2.7 tpp180 -99.06 -13.8 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.142 -0.349 . . . . 74.44 111.059 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -119.52 -26.5 5.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.295 0.569 . . . . 63.54 110.411 -173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.08 -15.8 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.946 0.879 . . . . 73.31 109.805 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 7.8 p -92.95 163.77 2.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 114.917 -1.038 . . . . 74.44 109.67 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -104.0 91.86 4.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.453 -0.943 . . . . 52.21 108.453 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 93.8 Cg_endo -83.01 -4.31 11.21 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.483 2.122 . . . . 63.03 111.944 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -69.02 -57.64 5.17 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.036 -0.529 . . . . 74.13 110.288 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.45 -17.49 17.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 71.44 110.546 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.82 43.34 3.62 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.026 -0.533 . . . . 73.12 113.351 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.0 mp -108.28 140.82 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.559 -0.534 . . . . 74.25 109.559 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.45 121.2 37.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 70.15 109.411 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.19 -27.38 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.972 -0.558 . . . . 73.43 112.014 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 p -62.19 -24.5 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.993 0.425 . . . . 72.42 110.817 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.94 -15.45 62.98 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.122 -0.49 . . . . 61.24 111.333 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.76 -16.67 61.75 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.039 0.447 . . . . 73.35 110.051 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.69 22.72 64.4 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.628 -0.715 . . . . 71.42 114.12 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -98.71 -31.35 11.95 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.143 -0.688 . . . . 71.53 109.143 170.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.47 -19.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.153 -0.93 . . . . 65.0 112.342 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.26 -23.81 16.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.786 0.327 . . . . 71.14 110.742 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.25 76.08 2.18 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.504 -0.638 . . . . 44.2 111.504 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -128.3 132.69 48.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 74.44 110.792 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -149.75 173.0 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.509 -0.922 . . . . 71.23 108.509 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 55' ' ' ALA . 20.5 m -137.2 142.63 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.791 -0.448 . . . . 75.45 109.791 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -113.02 121.01 43.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.987 -0.375 . . . . 63.43 109.987 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 112.43 15.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.116 -0.493 . . . . 72.41 109.819 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.07 158.34 14.53 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.064 -0.589 . . . . 41.32 112.273 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.32 -34.99 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.863 0.465 . . . . 63.43 111.377 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.63 -0.7 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 73.04 111.186 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.47 155.1 6.42 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.316 -0.468 . . . . 62.54 112.318 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -74.7 121.68 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.251 -0.277 . . . . 65.12 110.251 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.75 135.26 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 74.43 110.125 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -98.8 124.48 43.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.398 0.142 . . . . 62.14 110.802 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.2 mt -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.168 -0.308 . . . . 53.01 110.168 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 59' ' ' MET . 30.9 mm -126.28 112.72 30.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 120.686 0.279 . . . . 64.3 110.384 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m-20 -80.24 121.69 25.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.497 -0.557 . . . . 73.2 109.497 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.523 ' HG3' HG22 ' A' ' 57' ' ' ILE . 85.7 mtp -136.62 171.2 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.709 0.29 . . . . 70.13 110.63 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 40' ' ' LEU . 15.2 t -152.92 163.14 40.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.07 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.8 mt -132.47 160.35 36.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.314 -0.624 . . . . 73.32 109.314 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -48.02 -54.6 12.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.585 0.553 . . . . 63.01 112.117 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 t -111.64 -9.68 14.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.771 0.32 . . . . 50.5 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 63.68 8.4 3.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.86 -0.609 . . . . 74.54 112.194 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.38 10.48 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.605 0.717 . . . . 73.12 109.072 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 68' ' ' LEU . 27.8 m -75.63 140.31 71.44 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 114.884 -1.053 . . . . 53.32 110.362 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.85 15.35 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.804 2.336 . . . . 70.13 112.81 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.0 mp -86.99 -5.78 58.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.38 -0.373 . . . . 74.21 110.459 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.6 t -61.58 -53.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.461 -0.336 . . . . 63.23 110.964 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.32 -27.65 67.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 74.41 110.266 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 70.0 t -65.01 -52.5 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.51 . . . . 55.04 110.369 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HE1' ' A' ' 93' ' ' TRP . 2.8 pp -68.74 -29.58 44.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.637 0.256 . . . . 64.33 110.753 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' N ' HD12 ' A' ' 72' ' ' ILE . 44.8 mt-10 -62.4 -48.16 80.95 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.409 -0.359 . . . . 75.31 110.131 173.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.87 -46.81 87.79 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.949 0.404 . . . . 74.44 110.419 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 96.6 mt-30 -55.53 -53.34 57.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.694 . . . . 53.42 111.143 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -68.04 -52.26 37.38 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.03 -0.532 . . . . 75.34 111.123 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -54.78 -46.38 74.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.652 -0.129 . . . . 63.44 110.652 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.2 p -60.27 -45.08 94.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.339 -0.392 . . . . 62.12 111.425 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.6 20.26 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.811 -0.355 . . . . 33.4 110.847 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.96 -29.49 70.85 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.884 0.373 . . . . 75.51 110.977 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -84.19 -27.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 44.2 109.925 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.5 -31.04 77.56 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.448 -0.661 . . . . 62.14 111.448 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.497 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 46.8 m -92.55 -10.02 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.379 . . . . 75.4 110.312 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.63 43.38 92.19 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.93 -0.577 . . . . 73.11 112.262 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 74.6 mt -86.43 -36.48 19.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.838 0.352 . . . . 74.53 110.9 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 55' ' ' ALA . 29.6 m -139.24 162.39 27.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.921 -0.581 . . . . 74.41 110.242 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.35 -37.28 28.53 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.855 0.36 . . . . 42.44 110.217 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.5 167.92 28.95 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.44 0.638 . . . . 53.43 110.715 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 55' ' ' ALA . 44.6 pt -124.44 135.55 63.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.42 -0.809 . . . . 73.41 110.689 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.81 106.32 16.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.276 -0.638 . . . . 54.43 109.276 171.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 57' ' ' ILE . 64.2 mt -99.32 120.02 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.782 -0.822 . . . . 74.43 108.782 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -111.5 129.93 55.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.87 -0.419 . . . . 73.13 109.87 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.604 ' HE1' HD11 ' A' ' 72' ' ' ILE . 4.8 m-90 -100.76 106.13 17.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 72.21 110.541 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.93 124.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 73.32 109.987 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -139.19 -6.93 1.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 74.14 111.845 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.5 t30 174.93 -52.82 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 122.409 0.283 . . . . 63.04 110.869 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 61.6 Cg_endo -70.55 145.75 53.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.739 1.626 . . . . 71.3 112.004 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.71 142.24 82.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.648 2.232 . . . . 72.0 111.647 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -46.63 109.24 0.18 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 123.691 0.619 . . . . 71.4 111.904 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -87.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.766 -0.652 . . . . 52.12 112.132 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.37 -30.49 80.76 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.928 2.419 . . . . 75.34 112.365 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 17.3 p-10 -65.16 -10.67 33.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 71.15 111.18 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 C--O 1.235 0.336 0 CA-C-N 116.277 -0.42 . . . . 71.12 111.623 179.586 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 111.965 0.357 . . . . 74.51 111.965 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 44.0 Cg_endo -68.83 169.02 18.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.258 1.972 . . . . 52.13 111.992 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.48 3.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.43 0.9 . . . . 61.44 113.43 -172.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -63.92 -48.56 76.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.921 0.391 . . . . 63.02 111.001 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -63.34 -40.63 97.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.763 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.79 -46.36 88.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 73.25 110.14 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 tp -54.93 -55.37 31.36 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.41 -0.359 . . . . 35.21 110.998 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.987 -0.551 . . . . 54.44 111.292 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.3 -48.39 81.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.894 -0.594 . . . . 74.13 111.12 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.43 -33.83 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.928 -0.397 . . . . 74.12 109.928 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -58.96 -48.74 80.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.088 -0.338 . . . . 64.11 110.088 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.15 -45.61 73.08 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 74.13 110.839 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.15 -38.85 74.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 72.11 110.679 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.5 mmt -62.69 -12.68 25.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.606 -0.725 . . . . 72.24 111.563 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -85.79 -23.36 27.26 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.623 0.249 . . . . 72.45 110.82 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.63 -27.43 9.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.363 0.505 . . . . 50.04 112.363 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.5 m -95.92 21.11 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.22 0.533 . . . . 73.12 111.099 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 5.2 p -134.27 161.32 40.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 71.32 110.589 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.25 93.68 1.94 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.957 -1.127 . . . . 51.05 107.957 165.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 95.6 Cg_endo -82.93 -9.8 10.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.226 1.951 . . . . 72.23 111.392 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.5 -41.81 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.146 -0.934 . . . . 72.11 110.439 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.94 -18.56 11.24 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.377 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.86 44.02 3.45 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.224 -0.512 . . . . 74.24 113.655 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -121.64 141.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.965 -0.754 . . . . 61.25 108.965 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 36' ' ' VAL . 8.7 p30 -107.73 141.85 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.771 -0.455 . . . . 74.24 109.771 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.77 -29.41 42.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.328 0.585 . . . . 72.45 110.747 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HB ' ' OD1' ' A' ' 34' ' ' ASN . 43.8 t -60.11 -24.62 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.688 -0.687 . . . . 75.04 110.548 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -56.04 -28.93 59.48 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.503 -0.317 . . . . 72.32 111.254 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.13 -14.55 60.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.154 0.502 . . . . 75.31 110.504 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.65 22.17 52.22 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.218 -0.901 . . . . 73.12 114.024 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.0 tp -98.22 -29.69 13.05 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.329 -0.619 . . . . 43.21 109.329 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.45 -13.15 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.204 -0.907 . . . . 62.23 111.145 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.14 -23.26 62.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.06 0.457 . . . . 65.34 109.882 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 50.37 3.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.741 -0.663 . . . . 53.34 112.163 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -109.09 136.88 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.715 -0.476 . . . . 75.41 109.715 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -157.25 113.82 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 74.14 109.76 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.7 p -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.781 -0.452 . . . . 74.54 109.781 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -125.13 153.24 43.31 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.053 0.454 . . . . 74.12 110.314 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -81.34 151.86 27.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.557 -0.747 . . . . 62.25 110.387 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.57 159.77 33.04 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.074 -0.81 . . . . 73.44 111.074 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.14 -21.06 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.079 0.439 . . . . 62.51 110.929 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.01 -20.27 62.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.979 -0.748 . . . . 61.44 108.979 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.15 162.24 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.909 -1.041 . . . . 72.24 111.103 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -70.92 107.03 3.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.505 -0.924 . . . . 73.44 108.505 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.24 130.01 60.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 54.14 111.46 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.45 104.38 16.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 62.2 110.558 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 90' ' ' ARG . 48.8 mt -78.18 128.67 34.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.003 -0.74 . . . . 65.4 109.003 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.0 mt -141.01 116.64 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.833 0.349 . . . . 64.44 110.686 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.41 122.76 30.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 75.21 109.726 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.517 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.2 mtp -135.63 170.56 15.78 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.4 0.619 . . . . 72.34 111.721 -174.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -161.97 150.16 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.104 -0.953 . . . . 65.44 109.39 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.59 148.46 22.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.738 -0.838 . . . . 73.32 108.738 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 -48.58 30.82 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.51 0.559 . . . . 43.41 112.51 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 26.5 t -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.869 0.366 . . . . 73.2 110.677 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.52 8.33 1.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.762 -0.653 . . . . 73.03 112.003 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.22 3.81 10.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.211 0.529 . . . . 75.22 110.177 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 63' ' ' SER . 27.5 m -81.04 126.72 76.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.486 -0.779 . . . . 74.52 110.657 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.63 32.02 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.014 2.476 . . . . 65.03 112.346 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.02 6.61 18.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.044 -0.526 . . . . 74.02 110.794 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -56.94 -42.8 80.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 73.02 110.866 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.47 -41.31 98.69 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.401 0.62 . . . . 75.03 110.163 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.39 -46.5 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.234 -0.894 . . . . 70.11 110.857 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.17 -37.87 77.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 121.198 -0.201 . . . . 51.43 111.068 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.84 -49.6 77.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.22 110.683 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.08 -51.39 68.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.118 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -63.1 -38.55 91.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.43 -0.35 . . . . 71.04 111.816 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' HD23 ' A' ' 80' ' ' LEU . 61.6 p -67.22 -54.97 16.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.904 -0.406 . . . . 61.44 109.904 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -54.76 -41.6 70.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.968 -0.56 . . . . 71.43 110.932 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.8 m -54.89 -53.16 59.0 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.275 -0.42 . . . . 51.41 111.763 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -51.56 13.85 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.65 -0.42 . . . . 74.03 111.221 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -58.6 -37.9 76.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.046 0.451 . . . . 74.31 111.51 -173.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.8 t -82.34 -27.37 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.193 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.28 -47.26 91.68 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.303 -0.475 . . . . 34.22 112.496 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.6 m -87.54 -5.1 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.409 . . . . 63.32 110.498 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.88 31.46 69.97 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.922 -0.581 . . . . 64.03 112.811 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 -38.21 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.029 0.442 . . . . 74.54 110.319 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 80' ' ' LEU . 20.6 m -128.39 159.48 39.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.94 -0.573 . . . . 53.12 110.049 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.7 -30.95 24.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.496 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -158.23 165.78 34.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.134 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -128.05 144.35 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.76 -0.459 . . . . 75.15 109.76 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.429 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.9 tpp180 -127.43 106.09 8.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.2 -0.667 . . . . 74.13 109.2 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.45 143.85 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.751 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -117.38 120.36 37.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.348 -0.982 . . . . 74.05 108.348 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -97.85 106.32 18.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.779 -0.452 . . . . 72.2 109.779 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.506 HG21 ' HE1' ' A' ' 99' ' ' TRP . 12.1 t -90.97 123.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.326 -0.397 . . . . 64.43 110.123 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -119.53 -24.13 6.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.809 -0.632 . . . . 73.4 109.592 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 49.7 t30 175.8 -49.7 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.095 -0.957 . . . . 61.52 110.418 -173.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 48.9 Cg_endo -67.59 145.17 69.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.818 1.679 . . . . 51.44 111.971 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 27.4 Cg_exo -63.91 168.55 11.86 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.003 2.469 . . . . 73.54 112.485 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.506 ' HE1' HG21 ' A' ' 94' ' ' VAL . 10.8 m0 -69.54 165.46 20.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.945 -0.57 . . . . 73.45 111.222 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.11 -129.53 2.75 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.977 -0.556 . . . . 41.03 111.827 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.7 -9.63 19.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.859 2.372 . . . . 72.44 112.489 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.59 -15.39 58.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.77 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.718 ' HG2' ' HB2' ' A' ' 92' ' ' ASN . 52.3 mttp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-N 116.329 -0.396 . . . . 72.4 110.939 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 110.685 -0.117 . . . . 74.41 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 26.2 Cg_endo -62.55 153.43 71.52 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.241 1.96 . . . . 73.41 111.761 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.46 -44.63 12.48 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.878 0.696 . . . . 71.43 112.878 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -63.2 -51.63 65.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.999 0.428 . . . . 63.02 110.896 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.44 -44.25 79.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 72.33 110.611 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.49 -42.34 78.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 54.12 110.537 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 tp -55.91 -58.32 8.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 73.55 110.875 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.24 89.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.02 -0.536 . . . . 61.34 111.331 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.64 -48.03 81.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.009 -0.541 . . . . 74.01 110.871 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.13 -33.65 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 54.32 110.356 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.61 -49.81 73.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.024 0.44 . . . . 71.05 109.849 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.72 -48.47 71.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 74.31 110.513 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -37.66 73.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.853 -0.612 . . . . 72.01 111.758 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 mmt -71.22 -13.54 61.95 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.078 0.466 . . . . 63.32 110.051 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -101.61 0.74 36.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.511 -0.768 . . . . 74.54 111.372 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -119.46 -27.85 5.47 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.289 0.566 . . . . 74.2 110.063 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -92.39 -16.91 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.895 -1.048 . . . . 53.14 110.757 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.3 p -84.83 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 54.41 110.33 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -104.45 87.82 1.88 Allowed Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 108.758 -0.83 . . . . 70.31 108.758 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 89.4 Cg_endo -84.98 -1.66 9.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.457 2.105 . . . . 75.04 111.071 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' HG2' HD12 ' A' ' 31' ' ' LEU . 41.7 tt0 -68.58 -57.65 5.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.442 -0.799 . . . . 74.25 110.206 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.405 HD12 ' HG2' ' A' ' 30' ' ' GLU . 7.3 mp -98.95 -17.14 18.48 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.841 -0.429 . . . . 73.05 109.841 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.76 40.97 4.24 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.984 -0.553 . . . . 61.15 113.415 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -108.9 140.18 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.343 -0.614 . . . . 71.14 109.343 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.635 ' HA ' HG23 ' A' ' 27' ' ' VAL . 2.0 m120 -108.67 138.17 45.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.229 -0.656 . . . . 63.33 109.229 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.11 -30.17 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.168 0.509 . . . . 63.41 110.678 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 34' ' ' ASN . 13.5 p -58.24 -24.39 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.798 -0.637 . . . . 74.33 110.655 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.62 -29.1 58.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.707 -0.678 . . . . 61.41 111.195 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.7 -17.06 61.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.913 0.387 . . . . 73.2 110.488 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.51 22.71 57.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.732 -0.667 . . . . 64.02 113.371 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 94' ' ' VAL . 33.1 tp -98.06 -16.73 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 64.3 110.079 175.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.55 -15.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.898 -0.592 . . . . 74.43 111.298 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -70.04 -23.16 63.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.598 0.713 . . . . 74.33 109.121 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' ASP . . . -85.44 95.67 2.01 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.956 -1.02 . . . . 61.15 111.031 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -146.47 132.74 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.157 -0.683 . . . . 63.3 109.157 173.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.99 109.02 9.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.306 -0.628 . . . . 74.4 109.306 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 55' ' ' ALA . 16.1 m -93.56 115.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.276 -0.638 . . . . 74.21 109.276 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.8 124.27 42.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.531 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.29 89.13 5.5 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.729 0.776 . . . . 62.1 109.729 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.38 164.55 45.71 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.511 -1.222 . . . . 72.35 111.481 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.2 -37.04 69.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.001 0.429 . . . . 61.41 110.575 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.24 -39.66 71.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 75.32 110.079 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.48 -178.44 39.73 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.702 -0.681 . . . . 64.21 111.549 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.1 m -81.75 112.2 18.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.811 0.339 . . . . 73.12 110.62 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.39 124.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 74.01 109.866 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -88.54 106.34 18.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 73.54 111.083 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.97 101.97 14.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 74.11 109.913 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 59' ' ' MET . 53.3 mt -96.93 132.31 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.567 -0.288 . . . . 73.24 110.617 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.2 m-20 -94.01 113.45 25.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.03 110.076 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 90.2 mtp -141.04 171.05 14.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 73.34 110.646 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -163.05 162.05 25.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 65.23 109.649 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -106.6 171.83 7.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.945 -0.761 . . . . 41.05 108.945 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -44.63 -56.76 4.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.118 0.485 . . . . 73.54 111.48 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.6 t -104.22 -2.28 25.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 64.43 110.672 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.85 8.82 2.63 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.917 -0.583 . . . . 54.53 112.033 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.88 -8.81 12.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.994 0.426 . . . . 63.13 110.47 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.0 m -57.49 139.82 80.47 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.459 -0.791 . . . . 74.23 111.004 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.85 17.56 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.011 2.474 . . . . 71.43 112.788 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.33 -4.16 58.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 65.24 110.462 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 70' ' ' ASP . 4.8 t -61.93 -54.01 47.72 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.329 -0.396 . . . . 63.42 111.339 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' THR . 6.8 p-10 -64.98 -28.54 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 73.44 109.597 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 60.1 t -65.88 -52.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.49 -0.777 . . . . 75.53 110.52 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -69.02 -32.39 54.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 121.108 -0.237 . . . . 73.01 111.585 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 72' ' ' ILE . 8.5 mt-10 -64.5 -45.04 89.01 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.589 -0.444 . . . . 64.31 109.874 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.01 -49.12 77.94 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 74.15 110.764 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 95.3 mt-30 -56.82 -55.91 28.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.981 -0.554 . . . . 72.03 110.868 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -61.15 -53.23 59.57 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.94 -0.573 . . . . 73.54 110.798 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -56.12 -48.88 75.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -53.68 -50.58 65.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 64.34 111.161 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.74 14.21 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.694 -0.402 . . . . 63.14 111.556 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 89' ' ' ILE . 78.8 mt -60.96 -37.35 82.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 53.43 110.921 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.2 t -78.21 -27.73 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 64.12 110.145 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.5 -48.05 46.55 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.018 -0.611 . . . . 64.45 111.746 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -82.09 -23.13 35.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.134 0.492 . . . . 74.25 109.854 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.77 42.03 6.98 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.977 -0.556 . . . . 63.01 113.533 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 85' ' ' LEU . 6.2 mp -71.0 -38.27 72.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.975 0.417 . . . . 74.43 109.887 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.5 m -137.1 170.02 18.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.61 -0.723 . . . . 74.22 110.011 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.19 -48.66 64.62 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.285 0.564 . . . . 70.23 109.556 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.4 -179.03 5.77 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.089 -0.959 . . . . 64.35 108.587 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 80' ' ' LEU . 35.1 pt -122.43 177.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.371 0.605 . . . . 64.32 111.167 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -155.56 106.01 2.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.496 -1.298 . . . . 74.22 107.496 170.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 73' ' ' GLU . 52.6 mt -95.56 101.25 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.609 -0.515 . . . . 74.45 109.609 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -88.78 139.93 29.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.712 -0.676 . . . . 52.13 109.364 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.592 ' HA ' ' O ' ' A' ' 59' ' ' MET . 3.3 m-90 -95.25 106.07 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.553 -0.536 . . . . 73.43 109.553 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 40' ' ' LEU . 3.4 p -120.03 124.25 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.31 0.576 . . . . 73.44 110.175 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 1.1 p-90 -147.96 11.89 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.27 -0.877 . . . . 64.1 110.111 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 35.5 t30 -174.94 -60.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.968 -0.56 . . . . 74.42 111.347 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 85.0 Cg_endo -78.26 140.02 17.18 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.755 1.637 . . . . 42.05 112.528 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.56 151.84 51.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.662 2.241 . . . . 62.1 111.38 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -59.74 123.9 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 61.14 111.224 -172.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.54 -120.04 1.52 Allowed Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.003 -0.544 . . . . 64.13 111.765 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 -14.91 45.07 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.628 2.219 . . . . 74.34 111.66 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.47 -26.62 61.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.533 -0.758 . . . . 71.13 110.325 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 73.8 mmtt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 115.925 -0.58 . . . . 74.51 111.457 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.944 0.402 . . . . 72.23 112.023 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 14' ' ' GLU . 29.8 Cg_endo -66.01 168.61 15.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.469 2.112 . . . . 63.43 111.951 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.96 -67.22 0.27 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.184 1.179 . . . . 72.24 114.184 -167.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.82 -35.1 67.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 74.4 111.187 -172.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 20.0 mp0 -57.7 -46.84 83.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.591 -0.522 . . . . 54.53 109.591 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.8 -46.72 89.4 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.475 -0.784 . . . . 75.1 110.739 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.6 tp -52.79 -60.31 3.43 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.295 0.569 . . . . 54.35 110.874 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.44 69.28 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.091 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.86 -41.19 97.84 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.74 -0.664 . . . . 74.42 111.322 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.83 -35.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.575 -0.528 . . . . 43.04 109.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.19 -45.94 79.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.948 0.404 . . . . 74.22 109.966 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.37 -43.55 63.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 63.02 111.014 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.06 78.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.803 -0.635 . . . . 73.4 110.885 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -62.66 -13.44 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.579 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -87.28 -23.04 24.81 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.503 0.192 . . . . 65.34 111.428 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -116.01 -27.02 7.08 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.318 0.58 . . . . 73.13 110.11 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -27.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.032 -0.985 . . . . 62.32 110.101 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.5 p -91.32 165.1 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 63.32 109.697 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.5 91.95 5.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.81 . . . . 74.04 108.812 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.9 -7.53 13.3 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.326 2.017 . . . . 75.02 111.178 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -68.67 -57.96 4.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 72.43 110.619 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.49 -18.61 17.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 75.12 110.241 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.21 52.12 1.94 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.247 -0.501 . . . . 64.31 113.173 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.8 mp -126.91 141.55 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.667 -0.494 . . . . 62.11 109.667 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.444 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.4 p30 -108.77 138.6 44.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.017 -0.734 . . . . 75.22 109.017 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.15 -36.25 50.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.161 0.505 . . . . 74.44 111.312 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.78 -24.93 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.931 -0.577 . . . . 74.41 110.875 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.2 -26.04 64.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.357 -0.383 . . . . 65.52 111.358 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.53 -15.34 63.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.53 110.588 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.64 22.38 46.15 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.71 -0.677 . . . . 63.05 113.949 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -22.66 16.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.825 -0.806 . . . . 74.44 108.825 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.77 -4.96 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.188 -0.914 . . . . 72.15 111.731 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -66.3 -19.08 65.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.066 0.46 . . . . 73.25 110.044 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.96 110.47 3.94 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.241 -0.744 . . . . 44.23 111.241 174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.9 pp -167.34 149.63 5.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.302 -0.258 . . . . 70.4 110.302 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -163.69 122.51 1.98 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.804 -0.443 . . . . 74.45 109.804 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -99.54 118.34 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 75.31 110.129 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -113.4 137.47 51.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.128 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 8.8 p-10 -91.83 154.36 18.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 74.0 110.158 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.16 162.47 30.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.16 -0.543 . . . . 72.42 112.031 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.21 -29.48 70.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.126 0.489 . . . . 64.41 110.507 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.98 -24.5 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.765 -0.652 . . . . 71.24 109.907 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.53 15.21 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.044 -0.525 . . . . 44.22 111.925 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 16.8 m -93.68 120.41 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.881 -0.414 . . . . 72.11 109.881 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.2 p -115.62 131.58 67.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.218 0.533 . . . . 73.45 111.442 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.51 116.04 29.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.56 -0.746 . . . . 53.12 110.544 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 55.8 mt -96.44 117.4 30.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.088 -0.338 . . . . 71.44 110.088 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 ' HG3' ' A' ' 59' ' ' MET . 39.9 mm -115.09 118.05 57.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.717 -0.475 . . . . 74.4 109.717 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.39 118.63 28.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.531 -0.544 . . . . 42.22 109.531 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.529 ' HG3' HG22 ' A' ' 57' ' ' ILE . 71.9 mtp -141.02 170.92 14.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 45.32 111.364 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 t -147.13 175.16 10.94 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.944 -0.761 . . . . 61.52 108.944 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mm? -109.73 150.78 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.585 -0.524 . . . . 63.21 109.585 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.2 p -46.61 -54.8 8.73 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.616 0.572 . . . . 73.12 112.489 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 t -104.02 -1.38 27.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 73.51 110.627 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.3 1.43 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.058 0.543 . . . . 41.44 112.184 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.95 -17.46 8.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.279 0.562 . . . . 41.32 109.966 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 4.1 p -87.3 114.43 58.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 71.13 110.42 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 7.5 Cg_exo -72.83 73.78 2.95 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.996 2.464 . . . . 62.25 112.89 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 4.2 mm? -94.29 9.53 37.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.3 0.572 . . . . 74.11 109.81 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.1 t -60.25 -37.81 81.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.703 -0.68 . . . . 52.55 110.572 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.74 -53.32 59.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.137 0.494 . . . . 71.42 110.199 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 11.8 p -66.11 -46.37 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 74.11 111.01 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -62.61 -38.92 82.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.42 -0.512 . . . . 72.13 111.018 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.49 -43.38 90.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.011 -0.54 . . . . 53.24 110.71 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.84 -39.76 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.858 -0.337 . . . . 71.25 110.28 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 98.8 mt-30 -56.15 -52.59 63.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.07 0.462 . . . . 65.33 110.218 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.3 m -60.03 -52.18 66.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.697 -0.683 . . . . 64.33 110.627 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.622 ' O ' HG12 ' A' ' 81' ' ' VAL . 6.0 tmm_? -54.43 -52.91 60.29 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.852 -0.613 . . . . 71.02 111.0 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -52.85 -53.24 51.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.605 0.566 . . . . 63.33 111.535 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -52.51 11.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.259 -0.576 . . . . 64.2 110.995 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.74 -40.2 75.32 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.816 0.341 . . . . 72.52 111.441 -169.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 77' ' ' ARG . 4.8 p -89.31 -27.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 74.4 110.193 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.01 -24.92 70.4 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.646 -0.787 . . . . 71.54 111.658 -167.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.753 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 9.2 t -87.17 -11.85 48.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.224 0.535 . . . . 61.01 109.962 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.84 61.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.581 -0.736 . . . . 34.02 112.023 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 82.1 mt -74.39 -53.51 9.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.028 0.442 . . . . 72.33 110.415 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 55' ' ' ALA . 33.4 m -124.91 165.91 21.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.986 -0.552 . . . . 64.14 110.611 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.66 -47.92 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 51.31 109.787 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 m-20 -135.11 169.7 17.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.634 -0.712 . . . . 53.21 110.65 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.2 pt -134.94 175.97 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.92 -0.582 . . . . 71.2 110.368 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.436 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 26.3 tpt180 -164.61 119.84 1.44 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.551 -0.75 . . . . 74.11 109.815 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 47.2 mt -97.12 123.28 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 73.32 110.009 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 26.6 t30 -93.89 115.0 27.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.851 -0.613 . . . . 63.24 109.539 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -84.39 106.22 15.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.582 -0.525 . . . . 64.01 109.582 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 99' ' ' TRP . 28.0 t -93.93 124.13 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.639 . . . . 75.52 110.473 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -113.33 -20.62 11.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.03 110.801 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.454 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 t-20 -177.01 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.036 -0.529 . . . . 65.4 111.092 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 41.0 Cg_endo -64.1 151.39 85.54 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.137 1.891 . . . . 61.44 112.701 -172.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.44 157.15 52.26 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.627 2.218 . . . . 75.14 111.582 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.834 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 5.9 m0 -64.78 130.78 44.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.034 -0.53 . . . . 74.04 110.7 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.08 -120.95 0.59 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.728 -0.749 . . . . 73.55 113.415 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.5 -36.34 66.09 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.287 2.658 . . . . 75.25 113.638 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.3 -14.46 11.45 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.028 0.442 . . . . 60.13 111.247 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 99' ' ' TRP . 36.3 mtpt . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 116.268 -0.423 . . . . 64.03 111.041 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 110.671 -0.122 . . . . 75.33 110.671 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 14' ' ' GLU . 18.9 Cg_endo -57.91 131.07 41.56 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.74 2.293 . . . . 62.43 111.731 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.29 -51.92 17.77 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.494 0.924 . . . . 64.3 113.494 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.68 -50.32 74.32 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.009 0.433 . . . . 71.14 111.043 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 35.6 tt0 -64.62 -46.7 81.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 72.2 110.353 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.89 -36.55 84.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.919 -1.037 . . . . 74.11 111.209 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 tp -53.07 -55.31 24.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.172 0.51 . . . . 75.04 109.772 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -64.83 -47.13 79.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 30.14 110.847 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 75.34 111.211 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.37 -34.35 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 71.22 110.211 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.04 -40.3 93.09 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.998 0.428 . . . . 71.25 110.025 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 24.8 mm-40 -72.26 -47.24 51.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.906 -0.588 . . . . 73.24 110.226 176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.94 65.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.934 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.05 -13.65 7.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.178 -0.465 . . . . 73.41 111.579 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 63.1 ttt-85 -93.8 -29.44 15.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.596 0.358 . . . . 74.43 111.31 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.97 -5.14 10.07 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.215 0.531 . . . . 64.12 110.346 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 99.9 t -107.01 19.95 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.505 1.145 . . . . 70.31 109.317 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 11.6 p -148.25 160.8 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.571 -1.195 . . . . 55.54 108.47 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.57 98.28 3.55 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.461 -0.57 . . . . 75.13 109.461 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 96.2 Cg_endo -87.68 -1.08 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.705 2.27 . . . . 74.41 111.655 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.6 -57.49 5.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 75.12 109.957 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.32 -14.56 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 75.5 110.654 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.97 47.76 2.59 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.182 -0.532 . . . . 71.41 112.981 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 33' ' ' ILE . 3.2 mp -110.52 143.27 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 109.822 -0.436 . . . . 75.04 109.822 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.8 t30 -115.02 111.67 21.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.098 -0.501 . . . . 65.53 110.015 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.8 -39.68 72.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.28 0.562 . . . . 61.05 110.105 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.94 -24.57 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.508 -0.769 . . . . 73.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 25.3 t70 -64.43 -22.97 67.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.902 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.74 -8.6 56.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.185 0.517 . . . . 74.34 110.227 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.32 53.03 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.142 -0.935 . . . . 63.42 114.229 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 tt -98.23 -32.13 11.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.453 -0.573 . . . . 73.21 109.453 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.26 -11.0 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 65.23 110.217 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -64.07 -21.19 66.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.512 -0.767 . . . . 72.24 109.406 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.42 64.25 3.55 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.522 -0.763 . . . . 71.43 112.024 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.5 pp -107.66 142.31 37.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.899 -0.408 . . . . 72.12 109.899 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.3 118.86 4.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 74.45 109.088 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.59 123.93 56.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.757 0.313 . . . . 74.23 110.677 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.74 120.9 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.255 -0.646 . . . . 53.45 109.255 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.07 129.75 56.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 64.33 110.348 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.89 167.7 28.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.221 -0.752 . . . . 71.0 111.221 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.6 -31.67 66.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.898 0.38 . . . . 72.42 110.687 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.44 -31.14 70.24 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.862 -0.608 . . . . 63.32 110.565 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.98 163.44 16.91 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 116.081 -0.509 . . . . 71.22 112.189 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.2 m -110.71 109.09 19.19 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.558 -0.534 . . . . 74.12 109.558 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.05 123.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.577 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -89.98 109.88 20.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.28 -0.418 . . . . 52.13 110.966 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.23 107.43 19.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.749 -0.463 . . . . 73.24 109.749 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.6 117.61 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.094 -0.335 . . . . 72.45 110.094 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.36 122.04 26.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 110.247 -0.279 . . . . 72.24 110.247 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 83.5 mtp -141.17 170.88 14.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.428 0.632 . . . . 74.41 111.246 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.2 t -160.49 158.8 29.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 72.33 109.486 174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -99.89 160.74 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.985 -0.376 . . . . 62.05 109.985 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 m -45.92 -56.03 5.97 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.604 0.565 . . . . 65.35 112.405 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 m -103.0 4.58 37.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.934 0.397 . . . . 63.44 110.633 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.448 0.699 . . . . 71.43 112.398 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.42 2.45 10.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 73.22 110.048 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.628 ' HB3' HD13 ' A' ' 68' ' ' LEU . 14.1 m -81.66 120.93 79.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.391 -0.822 . . . . 74.43 110.389 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.13 33.44 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.921 2.414 . . . . 74.42 113.186 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.0 mp -79.76 3.08 20.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.946 0.403 . . . . 73.33 110.616 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.8 t -57.37 -44.23 84.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.03 -0.532 . . . . 54.14 110.789 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.32 -41.44 69.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.222 0.534 . . . . 75.42 110.384 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.24 -52.71 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.36 -0.836 . . . . 71.53 110.668 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 69' ' ' THR . 33.3 pt -63.52 -39.69 86.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 120.824 0.345 . . . . 75.1 111.225 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.18 -49.96 72.22 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.936 -0.574 . . . . 74.05 110.323 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.77 -49.8 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.422 -0.353 . . . . 70.43 110.667 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -55.57 -58.94 5.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.743 -0.662 . . . . 51.4 111.773 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -52.66 52.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.071 0.463 . . . . 51.33 111.026 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -56.72 -49.52 74.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.761 -0.654 . . . . 64.41 110.731 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -54.0 -48.28 70.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.676 -0.693 . . . . 64.24 111.346 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.09 13.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.907 -0.317 . . . . 71.32 111.384 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 89' ' ' ILE . 82.9 mt -61.05 -36.17 78.89 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.985 0.422 . . . . 70.22 111.162 -172.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.56 -27.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 60.41 110.033 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.71 -47.29 34.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.171 -0.538 . . . . 63.32 112.221 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.8 m -75.97 -23.12 55.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.1 0.476 . . . . 65.01 110.14 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 33.36 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.123 -0.56 . . . . 74.4 113.35 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.71 -44.33 67.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.87 0.367 . . . . 74.31 110.017 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.1 m -135.91 166.82 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 71.51 110.36 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -41.69 74.66 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.583 -0.525 . . . . 64.33 109.583 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -167.11 175.91 7.2 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.224 -0.898 . . . . 73.53 109.146 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 80' ' ' LEU . 38.7 pt -120.19 178.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.6 0.714 . . . . 75.53 111.065 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -150.72 106.31 3.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.791 -1.095 . . . . 63.23 108.096 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.26 117.96 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.093 -0.706 . . . . 74.02 109.093 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -88.63 143.57 26.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.938 -0.574 . . . . 72.25 109.481 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -111.16 109.58 19.7 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.791 -0.818 . . . . 74.05 108.791 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 t -85.1 123.61 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 64.41 110.711 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -120.86 -21.07 6.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.318 -0.855 . . . . 74.45 109.769 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.9 t30 178.27 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.498 -0.773 . . . . 55.13 111.439 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 91.9 Cg_exo -44.44 131.91 9.48 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.795 2.33 . . . . 55.41 113.469 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 2.4 Cg_endo -82.25 41.97 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.446 2.764 . . . . 71.51 112.119 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.8 m0 63.42 -154.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.155 -0.475 . . . . 71.55 110.787 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 101' ' ' PRO . . . 97.07 -134.31 11.71 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.478 -0.649 . . . . 71.12 111.478 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' ' HA3' ' A' ' 100' ' ' GLY . 27.8 Cg_endo -61.41 -22.54 74.82 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.442 2.094 . . . . 34.4 110.803 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.19 -12.85 22.32 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.791 -1.095 . . . . 54.0 111.06 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt . . . . . 0 C--O 1.224 -0.256 0 CA-C-N 116.408 -0.36 . . . . 72.23 111.162 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.384 0.135 . . . . 43.51 110.803 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 31.1 Cg_endo -63.1 152.18 80.91 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.558 2.172 . . . . 54.24 111.921 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.54 -47.88 63.25 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.953 0.723 . . . . 72.54 112.953 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.74 -46.03 88.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.614 0.245 . . . . 63.33 111.438 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 52.4 110.298 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.4 tt -54.15 -44.98 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.41 -0.813 . . . . 72.05 109.636 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 53.2 tp -54.04 -59.65 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.873 -0.603 . . . . 73.24 110.714 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -51.98 67.12 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.052 0.453 . . . . 63.35 111.122 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.73 -44.26 85.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.387 -0.824 . . . . 42.43 110.98 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.9 -38.41 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.781 -0.368 . . . . 61.14 110.821 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 16' ' ' LEU . 42.9 mt-10 -61.03 -44.03 98.01 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.96 -0.296 . . . . 72.42 110.623 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.91 -43.79 67.56 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.277 -0.569 . . . . 73.23 110.327 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -35.56 72.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.889 0.376 . . . . 73.21 111.017 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.3 mmt -62.44 -12.53 22.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.829 -0.623 . . . . 74.24 111.93 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -72.01 -31.92 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.424 0.154 . . . . 71.21 111.344 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -115.31 -27.27 7.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.874 0.845 . . . . 54.55 109.54 -171.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 26' ' ' VAL . 62.4 t -90.21 55.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.595 -1.184 . . . . 73.12 109.496 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.2 p -173.02 170.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.19 -0.914 . . . . 74.32 109.575 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -110.61 91.94 13.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 54.41 109.102 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' HG13 ' A' ' 27' ' ' VAL . 59.5 Cg_endo -82.92 0.35 9.68 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.286 1.99 . . . . 61.31 111.906 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.66 -57.83 5.13 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.18 0.514 . . . . 75.42 109.822 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.66 -18.49 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 73.35 110.187 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 52.02 2.5 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.044 -0.525 . . . . 54.31 113.148 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -128.42 140.76 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.968 -0.382 . . . . 73.43 109.968 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.513 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.9 t-20 -100.43 141.13 33.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.13 -35.32 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 63.1 111.675 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.11 -24.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.351 -0.386 . . . . 73.15 110.848 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.7 -21.62 66.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.043 -0.526 . . . . 74.33 111.275 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.87 -15.12 63.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.546 0.689 . . . . 74.24 109.98 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.18 22.08 66.74 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 114.844 -1.071 . . . . 55.23 114.356 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.9 tp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.28 0.562 . . . . 71.34 109.553 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.54 -4.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.206 -0.906 . . . . 65.32 111.637 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -70.36 -15.01 62.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.194 0.521 . . . . 65.51 109.777 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.95 66.65 3.82 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.284 -0.726 . . . . 62.4 111.284 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -98.68 135.84 39.6 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.643 -0.502 . . . . 74.1 109.643 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.48 109.02 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.861 -0.792 . . . . 71.41 108.861 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -114.23 145.24 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 122.147 -0.346 . . . . 73.51 110.32 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -136.61 124.49 22.67 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 70.03 109.646 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.9 p-10 -91.59 88.54 6.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.566 0.698 . . . . 63.42 110.172 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.25 42.16 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.386 -0.825 . . . . 31.33 111.722 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -67.28 -18.17 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.793 0.33 . . . . 73.1 110.518 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -98.16 -21.03 16.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.222 -0.444 . . . . 73.51 111.375 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 131.69 1.83 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.807 -0.711 . . . . 42.12 112.648 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.9 m -85.33 109.07 18.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.791 -0.448 . . . . 73.42 109.791 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.6 p -115.23 133.6 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.079 0.466 . . . . 61.32 111.193 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -103.74 115.69 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.716 -0.674 . . . . 72.32 110.329 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' A' ' 103' ' ' LYS . 6.5 mt -96.91 129.61 44.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.218 -0.66 . . . . 51.45 109.218 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.9 118.59 49.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.234 -0.284 . . . . 72.43 110.234 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.55 116.2 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.01 110.494 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 72' ' ' ILE . 26.0 mtm -134.93 170.83 15.29 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.468 0.652 . . . . 72.42 111.216 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -160.06 146.16 15.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.489 -1.232 . . . . 54.43 108.012 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 87.8 mt -90.29 163.17 14.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.64 -0.504 . . . . 75.21 109.64 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -45.45 -47.61 13.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.18 0.437 . . . . 65.2 112.18 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -96.04 -17.96 20.57 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.156 0.503 . . . . 71.42 110.548 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.42 8.59 2.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.798 -0.637 . . . . 72.54 111.544 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.05 -3.7 13.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 73.1 109.973 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.468 ' HB3' HD13 ' A' ' 68' ' ' LEU . 23.3 m -69.75 123.91 89.55 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.608 -0.724 . . . . 74.4 110.042 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.18 35.08 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.04 2.493 . . . . 75.33 113.119 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.2 mp -98.04 13.65 30.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.578 -0.283 . . . . 73.23 110.685 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 70' ' ' ASP . 5.2 t -55.07 -54.17 46.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.822 0.344 . . . . 71.45 111.29 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 69' ' ' THR . 28.3 t70 -65.71 -27.44 68.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 75.25 110.224 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 62.0 t -70.17 -52.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.986 -0.552 . . . . 64.53 110.681 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.628 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.7 pp -64.07 -37.95 81.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.789 0.328 . . . . 54.12 110.259 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.628 ' N ' HD12 ' A' ' 72' ' ' ILE . 42.8 mt-10 -64.89 -42.23 94.96 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.163 -0.471 . . . . 70.3 110.521 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.42 -48.25 82.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.054 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 22.3 mm-40 -60.15 -46.76 88.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.853 -0.612 . . . . 73.43 110.198 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.59 -62.31 1.97 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.641 -0.709 . . . . 54.32 110.799 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -56.82 -43.73 81.31 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.354 -0.384 . . . . 75.22 111.687 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -60.02 -42.03 93.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 72.35 110.652 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 -50.97 16.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 62.05 110.671 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 89' ' ' ILE . 83.1 mt -56.65 -37.46 70.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.188 -0.46 . . . . 72.33 111.348 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.89 -28.3 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 63.32 110.328 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.34 -34.58 60.68 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.721 -0.951 . . . . 63.44 110.721 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 m -81.8 -23.09 36.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.186 -0.507 . . . . 64.21 110.379 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.46 11.75 81.5 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.983 -0.553 . . . . 73.22 113.326 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.51 -41.03 93.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.604 0.24 . . . . 53.45 111.563 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 23.8 m -136.29 170.21 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.482 -0.326 . . . . 70.44 110.77 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.64 -38.14 10.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 62.45 110.507 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 21.2 t70 -145.67 164.05 32.98 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.727 -0.67 . . . . 63.11 109.31 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 80' ' ' LEU . 19.6 pt -136.24 172.58 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.201 0.524 . . . . 71.42 110.532 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.9 tpm_? -160.83 106.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.531 -0.759 . . . . 70.12 109.541 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.456 HD12 ' HG2' ' A' ' 73' ' ' GLU . 62.7 mt -90.74 110.48 22.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.017 -0.364 . . . . 74.24 110.017 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 5.6 t30 -88.55 125.11 34.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 72.42 110.173 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.3 m95 -89.77 112.99 24.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 73.24 111.066 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.13 123.93 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.367 -0.605 . . . . 74.24 109.367 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -153.69 8.34 0.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.492 . . . . 55.12 110.904 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.635 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 24.5 t-20 171.51 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.916 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 69.0 Cg_endo -84.68 149.78 11.3 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.047 1.831 . . . . 60.11 112.448 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 22.7 Cg_exo -65.42 166.44 19.48 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.599 2.199 . . . . 74.11 111.86 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -64.19 109.93 2.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 73.1 110.333 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.02 -79.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.701 -0.761 . . . . 52.53 112.912 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.28 -58.59 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.792 2.328 . . . . 65.15 112.508 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 3.2 m-20 -66.29 -4.36 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 64.4 111.524 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 56' ' ' LEU . 21.5 mmtp . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 111.752 0.278 . . . . 75.52 111.752 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 110.316 -0.253 . . . . 74.01 110.316 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.6 Cg_endo -65.47 153.24 79.13 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.822 1.681 . . . . 75.05 111.455 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.33 -32.53 49.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.302 -0.408 . . . . 71.34 111.952 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 9.0 pt-20 -62.57 -52.51 63.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.23 111.363 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.72 -39.14 70.31 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.688 0.28 . . . . 73.12 110.256 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.37 -46.39 86.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 64.44 110.08 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.16 -56.77 17.79 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.82 0.343 . . . . 70.14 110.831 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.88 67.4 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.987 -0.551 . . . . 45.12 111.04 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.55 -48.33 82.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.903 -0.59 . . . . 63.25 111.064 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' MET . 2.4 p -66.95 -36.58 77.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.974 -0.291 . . . . 62.21 110.435 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.8 -47.24 86.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.96 -0.385 . . . . 61.31 109.96 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.75 -51.18 68.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 63.42 110.281 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.2 -49.78 71.05 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.667 -0.697 . . . . 72.13 110.766 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.9 mmt -61.16 -20.32 62.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.866 0.321 . . . . 73.41 111.866 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -101.38 -13.77 17.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 73.04 110.464 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' GLN . 8.6 t70 -119.43 -10.1 9.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.244 0.545 . . . . 74.15 109.845 -168.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -117.83 -19.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.525 -0.762 . . . . 53.22 110.501 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.6 p -77.83 163.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.513 -0.767 . . . . 75.34 110.577 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.07 87.65 1.11 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.279 -1.378 . . . . 44.4 107.279 166.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 51.6 Cg_endo -82.17 -9.35 11.66 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.158 1.905 . . . . 55.11 111.903 -172.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -56.94 6.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.817 -0.629 . . . . 74.15 110.463 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.87 -19.01 29.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.516 -0.311 . . . . 55.33 110.544 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.38 40.1 6.57 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 116.054 -0.521 . . . . 62.15 113.493 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 33' ' ' ILE . 4.0 mp -127.84 140.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 117.201 0.5 . . . . 75.21 110.22 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HA ' HG23 ' A' ' 27' ' ' VAL . 21.2 t-20 -101.48 147.72 26.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.464 -0.939 . . . . 63.43 108.464 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.66 -36.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 53.33 111.118 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.71 -24.58 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 70.41 110.942 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.75 -28.04 63.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.25 -0.432 . . . . 63.1 111.231 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.72 -15.37 63.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.308 0.575 . . . . 64.2 110.268 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 57.53 21.92 43.73 Favored Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.037 -0.983 . . . . 73.04 114.015 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 40' ' ' LEU . 2.6 tm? -98.78 -29.0 13.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.327 -0.99 . . . . 73.45 108.327 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 59' ' ' MET . 16.4 t -69.82 1.74 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.629 -1.169 . . . . 75.22 111.75 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.44 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 60.2 m-85 -64.76 -22.74 67.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.319 -0.622 . . . . 72.23 109.319 171.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.39 72.35 1.94 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.388 -0.824 . . . . 73.21 112.209 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.52 121.28 44.65 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.072 -0.714 . . . . 52.14 109.072 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.42 108.88 7.88 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.028 -0.36 . . . . 74.22 110.028 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.65 126.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.66 136.18 46.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.684 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.19 148.2 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 73.34 110.705 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.51 40.77 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.803 -0.919 . . . . 53.33 110.803 175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.9 -18.62 63.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.433 0.616 . . . . 42.3 109.995 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.59 -31.74 71.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.44 0.638 . . . . 72.54 109.582 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.89 -163.64 24.77 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.1 -0.954 . . . . 21.01 111.094 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 p -93.21 118.85 31.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.849 0.357 . . . . 73.12 110.54 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.44 123.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.774 -0.454 . . . . 74.2 109.774 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.46 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -101.38 121.62 42.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.413 -0.358 . . . . 24.44 111.228 -175.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -98.84 129.52 45.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' HG3' ' A' ' 59' ' ' MET . 58.1 mt -125.38 113.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 62.22 110.544 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.85 117.68 22.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.715 -0.476 . . . . 71.0 109.715 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 88.2 mtp -140.96 170.93 14.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 71.52 110.617 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -158.95 159.15 34.55 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.629 -0.714 . . . . 72.42 109.886 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.45 155.68 34.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.576 -0.898 . . . . 71.51 108.576 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -48.05 -59.79 3.11 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.406 0.441 . . . . 63.32 112.04 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 p -96.7 -13.61 22.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.416 -0.356 . . . . 74.42 110.977 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.87 8.66 3.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.755 -0.657 . . . . 64.42 111.51 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.18 -8.52 13.98 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.113 0.483 . . . . 72.05 110.697 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.605 ' HB3' HD13 ' A' ' 68' ' ' LEU . 62.9 m -67.73 136.13 92.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.636 -0.711 . . . . 53.43 110.626 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.76 36.0 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.104 2.536 . . . . 63.11 112.644 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.6 mp -97.25 1.19 49.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.336 -0.393 . . . . 73.13 110.249 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -58.53 8.07 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 75.22 111.432 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.27 -27.08 68.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 75.11 109.893 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.04 -52.43 38.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.674 -0.694 . . . . 74.33 110.663 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 pt -64.14 -38.61 82.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.917 -0.313 . . . . 63.34 110.72 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' ' 91' ' ' ILE . 3.4 mt-10 -63.33 -44.53 94.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.673 -0.239 . . . . 54.4 111.391 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.18 -51.11 70.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 60.53 110.427 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 25' ' ' ASP . 94.9 mt-30 -56.27 -52.35 64.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.873 -0.603 . . . . 51.41 110.806 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.5 t -62.11 -55.13 31.95 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.806 -0.634 . . . . 72.41 111.183 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -58.59 -41.49 85.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.779 -0.191 . . . . 74.34 110.94 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -56.12 -47.15 78.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.378 -0.374 . . . . 72.34 110.693 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.22 16.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 71.55 111.189 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.12 -38.87 80.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.865 0.364 . . . . 65.53 111.107 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.36 -27.92 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 64.12 109.97 175.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.74 -47.31 56.58 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.123 -0.561 . . . . 75.25 111.706 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.8 m -73.25 -11.36 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 62.4 110.563 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.07 38.66 95.63 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.001 -0.545 . . . . 63.25 112.538 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.5 -33.21 19.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 74.22 110.729 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.508 ' HA ' ' OG1' ' A' ' 53' ' ' THR . 31.2 m -136.26 169.36 20.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.174 -0.467 . . . . 75.33 110.907 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.86 -41.73 6.07 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.44 . . . . 54.24 110.748 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -137.71 143.69 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.345 -0.613 . . . . 63.24 109.345 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.77 146.62 28.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.729 -0.471 . . . . 74.31 109.729 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 112.85 13.6 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.885 -0.413 . . . . 64.25 109.885 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 73' ' ' GLU . 56.1 mt -90.72 98.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.164 -0.68 . . . . 72.24 109.164 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.45 121.36 30.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.2 0.524 . . . . 74.21 109.887 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' MET . 2.9 m-90 -90.45 106.44 18.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.557 -0.747 . . . . 73.34 109.47 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.62 123.62 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.415 0.626 . . . . 65.31 110.138 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -136.97 -7.97 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 75.53 111.215 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -179.7 -55.68 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 O-C-N 123.1 0.25 . . . . 74.4 110.952 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -87.09 169.07 7.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.299 1.999 . . . . 62.44 112.402 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.38 159.51 19.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.485 2.123 . . . . 72.42 111.545 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -69.72 -22.04 63.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.549 -0.296 . . . . 70.34 110.759 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -39.53 -63.81 1.12 Allowed Glycine 0 C--N 1.338 0.688 0 O-C-N 123.803 0.689 . . . . 62.21 114.521 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -46.72 5.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.147 1.898 . . . . 75.24 111.949 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 -4.19 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 71.41 111.512 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm . . . . . 0 N--CA 1.463 0.215 0 N-CA-C 109.835 -0.431 . . . . 71.41 109.835 173.917 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.519 0.199 . . . . 71.04 111.513 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.87 152.14 52.27 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.439 2.093 . . . . 42.53 111.161 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.76 -42.37 7.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 73.44 112.679 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.2 -52.1 51.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.167 0.508 . . . . 71.02 110.274 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 -32.4 73.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 64.42 110.299 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -50.31 66.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.694 -0.685 . . . . 73.31 109.448 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.04 -51.82 67.75 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.991 -0.55 . . . . 63.53 110.768 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -60.95 -49.18 78.48 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.947 -0.569 . . . . 61.44 110.906 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -57.76 -48.53 79.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.703 -0.681 . . . . 64.25 110.857 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.0 p -68.77 -42.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.656 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -67.32 -37.68 83.72 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.577 -0.449 . . . . 71.33 110.805 -175.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.7 pt-20 -72.7 -46.44 53.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.601 -0.439 . . . . 71.21 110.529 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.583 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.49 -31.36 69.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.867 0.365 . . . . 62.3 110.755 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 13.2 mmt -62.97 -13.14 31.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.067 -0.515 . . . . 63.1 110.719 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -33.37 16.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.326 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 4.5 m-20 -85.51 -27.5 25.58 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.392 -0.367 . . . . 74.41 111.713 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 22' ' ' ALA . 35.0 m -113.37 42.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.715 0.769 . . . . 61.51 110.972 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG23 ' HA ' ' A' ' 34' ' ' ASN . 8.9 p -144.13 159.93 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.317 -0.856 . . . . 71.21 110.135 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.05 89.88 2.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.535 -0.913 . . . . 45.42 108.535 167.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 74.5 Cg_endo -81.09 -5.72 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.551 2.167 . . . . 74.14 111.924 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -68.68 -53.74 20.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.903 -0.589 . . . . 53.13 110.03 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.98 -16.76 16.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.097 -0.502 . . . . 53.12 110.295 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.81 40.76 4.87 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.175 -0.536 . . . . 51.23 113.237 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -106.91 140.04 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.154 -0.684 . . . . 70.23 109.154 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.503 ' HA ' HG23 ' A' ' 27' ' ' VAL . 2.1 m120 -114.26 124.92 53.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.082 -0.71 . . . . 73.13 109.082 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.3 m -57.91 -28.65 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.44 . . . . 74.15 110.82 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 34' ' ' ASN . 10.3 p -57.77 -30.81 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.616 . . . . 74.53 111.186 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 34' ' ' ASN . 57.6 m-20 -66.25 -21.15 66.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.633 -0.258 . . . . 72.25 110.862 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -75.34 -16.53 60.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.101 0.477 . . . . 72.44 110.039 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.65 61.19 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.513 -0.767 . . . . 71.31 113.994 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 tp -96.06 -31.68 12.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.37 0.585 . . . . 73.14 109.688 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 36' ' ' VAL . 11.1 p -67.74 -11.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.493 0.663 . . . . 64.22 109.55 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -63.52 -27.14 69.06 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.273 -0.876 . . . . 73.02 108.805 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.57 68.59 2.95 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.672 -1.149 . . . . 63.22 111.098 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 pp -115.27 138.45 50.93 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.105 -0.702 . . . . 74.25 109.105 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.25 108.99 3.84 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.355 -0.609 . . . . 71.11 109.355 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 45.9 t -89.17 114.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.616 -0.513 . . . . 62.44 109.616 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -97.46 133.06 42.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 64.44 110.702 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.46 68.8 10.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.93 -0.767 . . . . 61.22 108.93 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 164.68 53.79 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.376 -0.829 . . . . 54.3 112.868 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.78 -26.94 68.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.672 0.389 . . . . 75.1 110.43 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -81.85 -7.46 59.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.162 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.82 177.11 14.73 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 112.0 -0.44 . . . . 54.34 112.0 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 m -72.55 110.18 6.75 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.172 -0.307 . . . . 71.23 110.172 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.3 p -115.14 124.49 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.828 0.347 . . . . 54.31 110.716 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -86.95 107.3 18.32 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.31 -0.405 . . . . 34.23 110.653 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 90' ' ' ARG . 28.3 mt -87.57 105.08 17.08 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.449 . . . . 64.34 109.789 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.53 124.19 68.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 110.257 -0.275 . . . . 50.11 110.257 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.61 128.49 36.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 55.35 111.367 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 80.6 mtp -141.24 171.12 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.652 -0.704 . . . . 64.41 110.636 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -145.49 171.51 14.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.326 -0.397 . . . . 74.45 109.935 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -121.18 166.64 13.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.468 -0.567 . . . . 73.23 109.468 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.4 p -62.13 -60.28 3.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.87 0.367 . . . . 74.45 111.967 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -114.28 -8.09 12.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.318 -0.401 . . . . 62.02 110.749 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.35 8.84 4.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.903 -0.589 . . . . 74.32 111.912 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.9 -25.6 13.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.113 0.483 . . . . 54.33 110.22 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.5 m -79.14 138.13 56.54 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 115.598 -0.728 . . . . 35.33 110.351 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.89 50.57 2.82 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.867 2.378 . . . . 74.3 112.335 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.14 -9.31 59.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.376 -0.375 . . . . 71.13 110.673 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.8 t -60.19 -43.4 95.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.006 -0.543 . . . . 42.2 110.838 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.95 -42.28 79.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.368 0.604 . . . . 75.11 109.941 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -65.41 -52.5 51.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 114.942 -1.026 . . . . 62.52 110.615 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.67 -41.35 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.617 -0.265 . . . . 73.14 111.224 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-10 -62.55 -47.77 82.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.527 0.203 . . . . 54.02 110.671 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 35.8 t70 -59.71 -48.15 82.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 75.13 110.942 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' ASP . 91.9 mt-30 -62.51 -43.72 98.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 63.34 111.182 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.3 m -62.57 -55.22 29.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.258 -0.428 . . . . 71.33 110.689 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 6.9 ppt_? -57.04 -38.03 72.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.943 -0.303 . . . . 65.11 110.32 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.8 t -55.66 -53.71 53.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.235 -0.439 . . . . 73.44 111.184 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.59 -52.41 11.86 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.546 -0.462 . . . . 70.43 111.395 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -39.74 89.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.924 0.392 . . . . 65.24 111.55 -171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.23 -27.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 74.22 109.847 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.81 -45.83 56.12 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.832 -0.699 . . . . 42.43 111.622 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 p -75.9 -22.98 55.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.967 0.413 . . . . 64.13 110.195 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.13 45.34 41.01 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.87 -0.604 . . . . 74.11 112.107 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.26 -32.8 33.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 65.3 110.576 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.2 m -141.18 165.51 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.137 -0.483 . . . . 71.23 110.646 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.35 -47.46 19.86 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.668 -0.493 . . . . 65.1 109.668 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 22.1 m-20 -133.54 158.14 43.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.475 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -111.46 164.92 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.102 -0.703 . . . . 72.13 109.102 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HB3' HD23 ' A' ' 56' ' ' LEU . 14.5 tpp85 -153.23 106.63 3.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.02 -0.272 . . . . 70.23 110.43 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 73' ' ' GLU . 57.0 mt -94.31 131.03 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 75.14 110.071 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.666 HD22 ' N ' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -107.9 131.73 54.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.951 . . . . 63.32 108.431 175.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.666 ' N ' HD22 ' A' ' 92' ' ' ASN . 2.7 m-90 -102.67 106.12 16.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.46 -0.57 . . . . 75.34 109.46 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.4 m -102.93 124.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.141 0.495 . . . . 74.21 109.711 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -111.27 -33.23 6.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 61.55 110.373 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.616 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 20.1 t-20 -171.71 -50.89 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.768 -0.651 . . . . 72.25 110.761 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 17.1 Cg_exo -68.33 157.78 60.37 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.296 1.997 . . . . 63.24 111.8 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.72 167.21 15.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.831 2.354 . . . . 51.4 112.402 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -62.56 142.85 57.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.68 -0.691 . . . . 72.42 111.371 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -120.21 0.53 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.966 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.0 -20.36 67.7 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.64 2.227 . . . . 44.41 111.266 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -5.54 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.905 -1.043 . . . . 74.51 111.753 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 57.2 mmtt . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.267 -0.272 . . . . 72.5 110.267 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.289 0.09 . . . . 73.42 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 12.0 Cg_endo -55.61 152.88 31.94 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.535 2.157 . . . . 72.44 112.147 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.86 -38.51 35.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.969 0.507 . . . . 61.35 112.365 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 18.5 mp0 -68.2 -51.95 39.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 74.35 110.362 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.88 -45.99 80.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.541 -0.754 . . . . 73.43 110.324 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 15' ' ' LEU . 2.7 tm? -55.19 -49.37 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.298 -0.864 . . . . 73.41 110.272 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.67 -53.72 47.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.771 -0.649 . . . . 73.24 110.903 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.2 74.37 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.546 . . . . 75.05 111.124 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 75.32 110.902 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 8.8 p -69.45 -32.67 53.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 110.085 -0.339 . . . . 54.12 110.085 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -62.17 -41.14 98.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.78 -0.452 . . . . 50.24 109.78 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 38.0 mt-10 -69.26 -43.91 72.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.066 -0.515 . . . . 72.13 110.342 174.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -45.17 77.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 63.41 110.434 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.72 -13.48 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.613 -0.721 . . . . 73.43 111.639 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 32.3 ttp180 -87.86 -32.66 18.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.832 0.453 . . . . 63.45 110.53 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -100.27 -26.93 13.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.144 -0.48 . . . . 74.41 112.17 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -84.96 3.01 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 43.25 111.063 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.5 p -125.59 158.45 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.236 -0.653 . . . . 63.31 109.236 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -101.21 95.37 4.78 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.72 -0.844 . . . . 71.23 108.72 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 78.2 Cg_endo -83.08 -6.15 11.23 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.647 2.231 . . . . 74.41 111.926 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -69.04 -57.62 5.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.787 -0.642 . . . . 63.34 110.265 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.1 mm? -94.55 -18.68 21.2 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.272 -0.422 . . . . 72.33 109.95 176.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 48.76 4.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.675 -0.693 . . . . 54.21 113.365 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.91 145.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 117.144 0.472 . . . . 72.42 110.499 177.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 36' ' ' VAL . 18.5 p-10 -112.86 107.21 15.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 74.32 111.789 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.43 -31.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.843 -0.617 . . . . 75.21 110.865 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 34' ' ' ASN . 12.2 p -55.75 -25.04 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.881 -0.6 . . . . 74.34 111.399 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.05 -22.46 65.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.569 -0.287 . . . . 54.32 111.498 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.59 -23.35 65.94 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.103 0.477 . . . . 75.22 110.384 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.61 61.07 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.396 -0.82 . . . . 65.54 114.081 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.4 -32.09 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.332 0.566 . . . . 55.34 109.744 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.78 -14.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.491 -0.777 . . . . 63.43 110.254 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -65.97 -17.76 64.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.155 -0.929 . . . . 71.4 110.291 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.81 62.43 4.17 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.024 -0.534 . . . . 64.22 112.0 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 pp -101.42 148.63 24.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 51.34 110.706 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -161.36 110.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.979 -0.378 . . . . 73.43 109.979 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.8 p -92.5 121.01 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 61.11 110.292 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -109.21 127.87 54.58 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.872 -0.603 . . . . 71.01 110.434 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -82.94 138.75 33.7 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.681 -0.691 . . . . 75.23 110.405 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.56 154.0 21.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.832 -0.907 . . . . 60.24 110.832 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -58.25 -36.9 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 72.22 110.719 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -78.5 -24.67 45.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.705 -0.679 . . . . 71.14 110.409 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.98 158.38 12.8 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.225 -0.512 . . . . 61.02 112.526 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.29 117.28 29.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.138 -0.319 . . . . 74.03 110.138 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 8.7 p -108.82 134.88 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.727 0.298 . . . . 72.45 111.081 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -100.76 110.39 22.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.511 -0.313 . . . . 72.33 110.638 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 90' ' ' ARG . 52.6 mt -84.85 137.92 32.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.119 -0.326 . . . . 74.31 110.119 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.505 ' HB ' HG12 ' A' ' 91' ' ' ILE . 62.4 mt -135.66 118.51 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.783 -0.451 . . . . 73.43 109.783 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' HE1' ' A' ' 99' ' ' TRP . 35.1 t0 -84.38 116.33 22.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 75.41 110.723 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.5 mtp -141.41 170.92 14.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.292 0.567 . . . . 62.31 111.46 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -150.23 176.69 10.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.366 -0.834 . . . . 62.22 108.801 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 68' ' ' LEU . 63.1 mt -121.52 145.67 47.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.624 -0.509 . . . . 55.44 109.624 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.7 p -52.53 -55.11 24.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 71.3 112.614 -172.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -99.84 -4.49 30.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.104 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.89 8.91 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.98 -0.554 . . . . 72.4 112.363 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.26 -35.91 3.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.951 0.405 . . . . 64.25 110.491 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -67.02 123.53 86.48 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.719 -0.673 . . . . 62.24 110.141 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.49 64.94 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.986 2.458 . . . . 73.41 113.055 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 mm? -85.89 -3.21 58.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.478 -0.328 . . . . 73.3 110.791 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 t -56.98 -44.97 83.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.321 -0.4 . . . . 73.04 111.168 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.95 -41.49 87.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.073 0.463 . . . . 72.23 110.152 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.93 -51.56 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.349 -0.841 . . . . 51.44 110.926 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.41 HD11 ' HE1' ' A' ' 93' ' ' TRP . 32.5 pt -64.01 -41.26 91.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 74.0 111.185 -176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 90' ' ' ARG . 1.8 mm-40 -68.78 -38.21 79.85 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.525 -0.307 . . . . 75.01 111.162 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.62 -46.69 71.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.988 -0.285 . . . . 73.22 110.561 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -65.12 -41.54 94.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.484 0.183 . . . . 70.44 110.53 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 t -61.15 -52.38 65.1 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.451 -0.574 . . . . 54.02 109.451 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -54.59 -40.28 68.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.534 -0.757 . . . . 74.24 111.424 176.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.432 ' N ' ' HD3' ' A' ' 77' ' ' ARG . 75.7 m -54.48 -53.04 59.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.415 0.15 . . . . 74.25 111.188 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.7 -51.47 14.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.995 -0.282 . . . . 41.4 111.499 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.31 -30.39 69.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.77 0.319 . . . . 72.12 111.408 -172.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.74 -27.61 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 71.54 110.053 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.57 90.69 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.31 -0.405 . . . . 32.22 112.371 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -102.65 -0.57 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 71.14 110.551 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.03 52.16 54.51 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.071 -0.513 . . . . 74.14 112.093 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.4 -30.49 69.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.708 0.289 . . . . 61.32 110.824 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.8 m -137.15 175.46 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.04 -0.527 . . . . 71.34 110.505 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.7 -37.68 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.111 0.481 . . . . 71.2 110.322 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 28.9 t70 -145.82 157.78 43.9 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.838 -0.619 . . . . 73.52 110.038 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.47 157.03 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.948 -0.389 . . . . 53.05 109.948 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.496 ' HA ' ' NH1' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -154.71 106.38 2.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.478 -0.328 . . . . 72.12 110.932 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 57' ' ' ILE . 57.9 mt -93.54 113.53 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.181 -0.674 . . . . 74.21 109.181 171.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.5 140.23 29.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.246 -0.65 . . . . 73.41 109.246 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' MET . 6.2 m-90 -107.35 106.76 17.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.49 -0.323 . . . . 64.25 110.314 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.15 124.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.141 0.496 . . . . 51.2 110.406 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -103.87 -43.57 5.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.216 -0.661 . . . . 75.44 109.216 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 75.4 m-20 -164.77 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 114.468 -1.242 . . . . 75.02 109.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 27.7 Cg_exo -64.45 164.78 22.18 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.284 1.989 . . . . 72.34 111.561 173.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.14 -179.32 5.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.562 2.175 . . . . 75.41 113.065 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.405 ' HE1' ' CG ' ' A' ' 58' ' ' ASP . 4.7 m-90 -73.12 112.08 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.983 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.55 -115.45 1.49 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.974 -0.631 . . . . 64.03 112.12 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 -24.68 74.84 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.826 2.351 . . . . 62.4 112.074 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.44 -13.07 11.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.749 -0.66 . . . . 72.03 111.025 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 75.21 111.219 -179.846 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.82 0.343 . . . . 54.12 111.698 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 32.5 Cg_exo -55.89 143.37 82.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.505 2.137 . . . . 71.24 110.944 171.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.01 17.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.853 0.316 . . . . 51.35 111.853 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -62.73 -42.56 99.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.994 0.426 . . . . 70.04 110.845 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.59 -49.67 74.3 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.784 -0.644 . . . . 64.34 110.144 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 tp -54.44 -41.75 69.78 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.069 -0.969 . . . . 73.23 110.737 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 tp -53.39 -56.57 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 54.35 110.868 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.2 -51.97 52.53 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 116.086 -0.506 . . . . 64.02 111.242 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.47 -44.92 95.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.637 -0.711 . . . . 74.42 111.202 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' LEU . 3.3 p -71.49 -33.54 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.015 -0.365 . . . . 71.23 110.015 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.85 -51.57 68.51 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.992 0.425 . . . . 62.53 109.956 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.32 -39.33 68.29 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.096 -0.502 . . . . 62.53 111.373 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.23 79.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.158 0.504 . . . . 25.14 110.567 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.56 -13.31 58.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 73.43 111.069 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -97.71 -7.31 31.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.768 0.318 . . . . 74.03 110.639 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.55 -27.56 5.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.333 0.587 . . . . 64.44 110.506 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -84.08 -26.29 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.903 -1.044 . . . . 55.04 110.821 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.3 p -86.84 154.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.555 . . . . 75.45 109.881 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 12.4 t70 -86.29 102.3 2.69 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.861 -1.162 . . . . 74.22 107.861 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 5.9 Cg_endo -84.24 -10.05 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.857 2.371 . . . . 73.13 112.498 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.55 -56.54 7.96 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.028 0.442 . . . . 42.52 110.208 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 65.8 mt -93.98 -18.49 21.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 74.03 109.855 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.15 56.13 3.11 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.782 -0.644 . . . . 65.4 113.078 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.7 140.52 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.049 0.424 . . . . 74.53 111.085 179.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -102.11 138.33 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 72.14 109.545 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.69 -25.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.019 0.437 . . . . 73.02 111.292 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.77 -25.51 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.9 -0.591 . . . . 72.31 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.11 -21.94 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.771 -0.649 . . . . 73.42 111.679 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.43 -6.88 43.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.931 0.396 . . . . 74.23 110.89 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.81 22.82 54.95 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.633 -0.712 . . . . 43.14 114.15 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.89 -31.72 12.05 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.888 -0.412 . . . . 65.23 109.888 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.94 -13.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.62 -0.718 . . . . 75.23 110.246 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -56.73 -29.96 63.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.185 -0.916 . . . . 60.04 110.168 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.73 92.0 1.77 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.643 -0.708 . . . . 60.11 111.695 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.5 pt? -141.93 160.18 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.61 -0.347 . . . . 65.0 110.124 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.76 123.14 6.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 54.31 109.466 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.1 p -103.69 122.69 56.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.016 0.436 . . . . 74.24 110.171 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.408 ' OE1' HD11 ' A' ' 56' ' ' LEU . 45.0 mt-30 -97.69 120.36 37.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 71.03 109.727 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.36 83.45 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.732 0.777 . . . . 72.14 109.672 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.97 163.82 19.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 114.998 -1.001 . . . . 60.25 112.184 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -55.27 -40.03 70.52 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.181 0.515 . . . . 62.34 110.941 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -68.38 -30.54 69.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.653 -0.703 . . . . 63.34 110.664 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.31 154.99 7.79 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.966 -0.635 . . . . 63.13 112.41 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 10.8 m -85.78 102.33 13.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.936 0.398 . . . . 74.2 110.12 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 60.0 t -107.07 126.72 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.093 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -93.34 107.28 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 53.44 110.849 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 47' ' ' GLN . 48.4 mt -82.12 131.89 35.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.469 -0.567 . . . . 73.01 109.469 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.1 mt -129.76 129.7 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.443 0.164 . . . . 71.13 110.623 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.09 114.56 26.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.693 -0.484 . . . . 61.31 109.693 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.54 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.9 mtp -141.03 170.76 15.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.622 0.725 . . . . 62.54 111.69 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 6.3 t -162.63 160.69 26.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.642 -1.163 . . . . 72.45 108.302 171.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -88.67 158.13 18.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.752 -0.462 . . . . 74.55 109.752 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -43.13 -52.92 5.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.968 0.507 . . . . 63.42 112.187 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -113.32 13.11 19.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 61.24 110.951 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.2 8.7 1.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.956 0.724 . . . . 64.24 112.956 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.36 11.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.45 . . . . 64.21 110.423 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.3 m -92.59 129.28 41.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 40.41 110.463 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.63 34.29 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.857 2.372 . . . . 40.34 112.061 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -83.15 -11.34 58.01 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 74.31 109.974 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.578 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 10.2 t -49.92 -56.03 12.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.895 -0.593 . . . . 65.22 111.348 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' THR . 5.6 m-20 -56.59 -34.94 67.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.484 . . . . 74.33 110.46 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 68' ' ' LEU . 47.2 t -70.93 -52.71 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 64.22 110.864 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.643 HD12 ' HH2' ' A' ' 93' ' ' TRP . 0.3 OUTLIER -60.31 -43.03 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.33 0.586 . . . . 65.34 109.47 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 69' ' ' THR . 23.5 mt-10 -61.72 -53.57 54.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.123 -0.944 . . . . 73.44 110.871 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.05 -51.42 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.653 0.263 . . . . 71.42 110.891 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -55.83 -58.73 6.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.084 -0.507 . . . . 72.24 111.141 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.4 t -65.06 -55.63 17.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 73.44 110.911 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 89' ' ' ILE . 47.8 ttt180 -55.63 -52.84 62.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.304 -0.407 . . . . 73.24 111.281 -174.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -64.51 -33.95 77.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.814 -0.63 . . . . 53.13 111.006 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.0 -51.31 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.83 -0.348 . . . . 73.41 110.364 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 76' ' ' SER . 4.4 mm? -56.21 -44.4 79.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.214 -0.448 . . . . 72.1 111.015 -177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.18 -28.25 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.422 -0.353 . . . . 74.24 110.538 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.74 -23.47 55.82 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.03 -0.605 . . . . 62.43 111.983 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -94.41 -11.69 29.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 75.3 110.178 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.38 75.89 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.873 -0.603 . . . . 75.31 113.347 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.01 -33.67 76.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.961 0.41 . . . . 70.12 109.949 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.11 175.75 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.581 -0.736 . . . . 61.32 109.556 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 53' ' ' THR . 22.7 t70 -78.23 -50.97 10.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 71.32 110.181 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 37.2 t70 -167.54 169.79 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.937 -0.764 . . . . 65.15 108.937 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 77' ' ' ARG . 18.0 pt -125.06 166.86 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.962 0.411 . . . . 60.24 110.914 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 56' ' ' LEU . 19.8 ttm180 -152.38 113.25 4.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.698 -0.683 . . . . 75.54 109.247 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG12 ' HB ' ' A' ' 57' ' ' ILE . 67.7 mt -100.68 124.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 74.24 110.496 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 6.9 p30 -95.37 122.14 37.77 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.259 -0.645 . . . . 64.42 109.259 173.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.643 ' HH2' HD12 ' A' ' 72' ' ' ILE . 88.5 m95 -90.37 106.67 18.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.019 -0.537 . . . . 72.42 109.94 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 m -91.11 124.34 43.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.412 0.625 . . . . 75.42 111.395 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -112.15 -32.24 6.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 74.31 109.832 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.62 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 31.2 t30 -166.49 -51.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.362 -0.836 . . . . 73.43 110.53 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 43.5 Cg_endo -66.61 132.17 28.16 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.11 1.873 . . . . 63.14 112.005 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.73 81.66 2.5 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.566 2.177 . . . . 71.3 112.912 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 56.07 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.571 -0.74 . . . . 74.42 112.267 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.89 -113.14 0.76 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.214 -0.754 . . . . 73.21 111.214 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.77 -15.44 50.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.173 1.915 . . . . 64.13 110.599 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.39 -17.64 31.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.838 -1.074 . . . . 70.11 110.709 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 97.9 mttt . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 115.783 -0.644 . . . . 74.34 111.33 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.602 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.849 -0.426 . . . . 70.01 109.849 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . 81.8 Cg_exo -44.17 115.29 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.742 2.294 . . . . 73.12 112.137 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.41 -20.62 7.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.693 0.627 . . . . 40.22 112.693 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -71.13 -53.31 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 74.13 110.552 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 12.0 pt-20 -82.01 -30.88 31.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.988 -0.551 . . . . 64.15 110.702 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.3 tm? -54.49 -37.04 64.81 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.668 -0.696 . . . . 55.25 110.577 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.22 -53.41 57.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.063 0.459 . . . . 73.21 110.168 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.55 -52.03 62.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 65.13 110.699 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.14 -44.01 92.03 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.571 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.443 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.7 p -67.27 -37.75 79.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.744 -0.465 . . . . 62.21 109.744 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.47 -35.58 79.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.802 0.334 . . . . 75.41 110.406 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 9.6 mm-40 -66.34 -51.07 60.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.319 -0.4 . . . . 70.24 110.349 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.7 83.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.487 . . . . 65.13 110.599 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 22.3 mmt -58.78 -12.64 4.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.737 -0.665 . . . . 72.51 111.709 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 29' ' ' PRO . 4.0 tpm_? -76.23 -25.48 55.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.597 0.221 . . . . 72.14 111.597 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.65 -27.54 5.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.141 0.496 . . . . 70.1 109.917 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 26' ' ' VAL . 58.9 t -81.51 51.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.153 -0.931 . . . . 51.43 109.4 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.52 HG13 ' HD3' ' A' ' 29' ' ' PRO . 9.6 p -171.56 162.89 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.706 -0.679 . . . . 72.24 110.628 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 27' ' ' VAL . 13.0 t70 -109.43 91.28 9.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.422 -1.325 . . . . 61.42 107.422 164.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.52 ' HD3' HG13 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -80.42 -3.77 12.7 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.128 1.885 . . . . 73.25 111.772 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.1 -57.63 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 74.22 110.055 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.2 mm? -90.1 -16.75 29.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.725 -0.67 . . . . 73.55 109.894 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 40.55 6.62 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.867 -0.606 . . . . 45.23 113.5 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.52 140.27 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.107 0.479 . . . . 73.32 110.416 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.5 p30 -116.63 115.04 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 74.35 110.274 -176.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -46.0 -32.45 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.465 0.542 . . . . 72.33 112.465 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.58 -24.81 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.223 0.453 . . . . 74.33 112.223 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.93 -15.33 62.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.468 0.175 . . . . 62.25 111.228 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.65 -17.16 62.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.205 0.526 . . . . 72.15 109.771 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.44 22.7 67.85 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.371 -0.831 . . . . 65.52 113.425 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 59' ' ' MET . 3.0 tm? -97.46 -31.46 12.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.918 -1.141 . . . . 74.43 107.918 171.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.07 -7.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.235 -0.893 . . . . 63.45 110.409 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.12 -24.83 56.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 61.41 109.65 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.13 67.74 1.42 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 111.14 -0.784 . . . . 35.43 111.14 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -125.64 121.45 33.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.246 -0.65 . . . . 61.5 109.246 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -141.74 113.15 7.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.333 -0.618 . . . . 71.45 109.333 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 11.2 m -102.86 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.26 -0.644 . . . . 73.21 109.26 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -121.07 120.17 34.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.771 0.32 . . . . 74.43 110.28 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' A' ' 53' ' ' THR . 9.1 p-10 -94.11 88.24 5.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 52.33 109.658 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.36 159.17 24.98 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.414 -0.812 . . . . 50.13 111.869 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.88 -23.39 66.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.74 0.305 . . . . 74.31 110.717 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.36 -38.48 21.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 61.53 110.252 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.1 157.76 23.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.066 -0.587 . . . . 55.54 112.26 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.543 HG22 HG12 ' A' ' 86' ' ' VAL . 12.4 m -101.0 119.1 38.26 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.97 -0.381 . . . . 64.24 109.97 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.93 143.23 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.468 -0.333 . . . . 71.42 110.652 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -108.38 119.08 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 43.05 110.209 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.97 121.27 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.509 -0.552 . . . . 72.33 109.509 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' A' ' 44' ' ' LEU . 57.5 mt -125.2 138.61 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.82 -0.437 . . . . 63.4 109.82 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 92' ' ' ASN . 42.7 m-20 -111.87 120.7 42.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.076 -0.342 . . . . 72.51 110.076 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.615 ' HA ' HD12 ' A' ' 40' ' ' LEU . 30.3 mtm -141.38 171.2 14.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.204 0.526 . . . . 75.41 111.538 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 12.1 t -154.45 147.26 24.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.249 -0.887 . . . . 74.54 109.957 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 85.0 mt -109.19 149.25 29.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.847 -0.797 . . . . 64.43 108.847 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -34.69 -49.84 0.43 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.755 1.02 . . . . 73.23 113.755 -170.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.7 t -119.57 0.2 10.96 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.293 -0.255 . . . . 73.34 111.207 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.32 8.4 1.59 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.29 0.478 . . . . 63.42 112.29 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.45 -5.33 18.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.304 0.573 . . . . 40.1 109.708 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.417 ' HB3' HD23 ' A' ' 68' ' ' LEU . 22.6 m -65.29 128.07 93.47 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.226 -0.897 . . . . 62.23 109.945 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.27 16.88 0.36 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.76 2.307 . . . . 71.41 113.129 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 66' ' ' CYS . 3.4 mm? -85.64 0.52 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 62.51 111.254 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 70' ' ' ASP . 11.6 t -58.24 -57.23 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.47 0.176 . . . . 71.33 110.614 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 69' ' ' THR . 11.3 t70 -68.18 -25.47 65.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.041 0.448 . . . . 70.03 110.171 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.22 -52.79 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.065 -0.516 . . . . 75.42 110.534 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.6 pp -69.37 -33.77 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 121.043 -0.263 . . . . 65.11 110.608 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.588 ' N ' HD12 ' A' ' 72' ' ' ILE . 43.9 mt-10 -64.56 -45.07 88.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.699 0.285 . . . . 75.14 110.259 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.21 -51.0 69.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.162 -0.472 . . . . 62.52 110.881 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -57.22 -52.8 63.87 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.014 -0.539 . . . . 72.1 110.391 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.8 t -56.49 -60.21 3.86 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.612 -0.722 . . . . 73.35 111.207 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -55.87 -42.42 75.87 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 121.257 -0.177 . . . . 74.13 111.007 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 t -62.16 -46.59 88.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.469 -0.332 . . . . 75.14 110.803 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.84 -51.43 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.878 -0.329 . . . . 74.2 110.237 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -56.51 -39.02 72.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 62.13 111.218 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.98 -27.47 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.471 -0.332 . . . . 63.04 110.302 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.78 -31.56 62.31 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.997 -0.841 . . . . 61.31 110.997 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 85' ' ' LEU . 66.7 m -76.94 -22.09 53.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.027 -0.587 . . . . 45.32 110.329 176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.58 74.0 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 116.088 -0.505 . . . . 73.45 113.064 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.7 mp -78.22 -50.76 11.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 72.11 110.503 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 55' ' ' ALA . 17.6 m -124.93 168.8 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 64.32 110.478 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -111.06 -39.69 4.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.328 0.585 . . . . 71.03 110.166 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.43 151.06 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.755 -0.657 . . . . 65.13 110.273 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 55' ' ' ALA . 20.8 pt -136.91 152.75 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.858 -0.423 . . . . 71.0 109.858 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -135.98 116.03 13.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 63.5 110.146 172.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 63.7 mt -98.13 110.99 26.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 61.54 109.504 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.642 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 3.2 t30 -88.34 120.09 29.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.558 -0.746 . . . . 71.12 109.447 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.563 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.6 m95 -86.83 106.75 17.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.764 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.89 124.54 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.002 0.429 . . . . 72.31 110.589 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -117.65 -34.33 4.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.414 0.626 . . . . 72.31 109.636 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.0 t30 -172.47 -47.17 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.041 . . . . 53.05 109.589 -176.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 29.8 Cg_endo -63.64 140.95 77.52 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.519 1.48 . . . . 62.1 109.548 167.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.99 -95.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.144 1.896 . . . . 74.01 112.712 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -146.34 124.74 12.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.783 -0.451 . . . . 61.41 109.783 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.45 -98.74 0.11 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.714 -0.755 . . . . 63.02 113.04 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.72 -37.98 64.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.973 2.448 . . . . 62.14 112.432 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 6.0 m-20 -67.11 -4.79 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 71.41 111.424 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 72.7 mmtt . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.577 -0.283 . . . . 62.1 110.387 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 111.938 0.347 . . . . 40.33 111.938 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.44 149.32 80.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.705 2.27 . . . . 63.12 111.703 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.42 -49.68 24.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.353 0.871 . . . . 74.1 113.353 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.84 -49.52 75.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.621 0.248 . . . . 65.31 111.572 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -74.99 -46.46 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.47 -0.332 . . . . 74.54 110.881 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.4 tm? -54.75 -44.86 73.97 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.714 -0.676 . . . . 53.42 110.803 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 61.6 tp -53.52 -59.81 4.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 64.35 111.189 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.63 80.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.065 -0.516 . . . . 73.01 110.899 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.69 -48.05 82.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 62.23 110.594 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.458 HG22 ' HG2' ' A' ' 23' ' ' MET . 5.3 p -69.36 -34.06 60.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 110.058 -0.349 . . . . 63.02 110.058 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 16' ' ' LEU . 2.2 tm-20 -54.06 -49.27 69.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.264 -0.643 . . . . 54.45 109.264 177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.15 -50.88 43.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.1 -0.5 . . . . 75.05 110.834 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.25 67.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.049 -0.523 . . . . 62.11 111.897 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' HG12 ' A' ' 27' ' ' VAL . 13.3 mmt -58.67 -24.89 62.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 60.24 111.578 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -66.13 -16.96 64.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.607 0.241 . . . . 74.05 111.034 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -119.37 -23.37 6.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.145 0.498 . . . . 71.01 109.926 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 23' ' ' MET . 43.2 t -66.78 -40.05 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.295 -0.866 . . . . 72.13 110.623 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.595 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.7 p -89.88 153.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.479 -0.563 . . . . 71.22 109.479 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -92.25 97.65 1.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 108.753 -0.832 . . . . 71.34 108.753 170.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 86.1 Cg_endo -85.38 -7.55 8.85 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.547 2.164 . . . . 72.41 111.852 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.66 -57.75 5.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 74.54 110.452 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.31 -18.54 16.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.716 0.293 . . . . 61.32 110.317 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.84 54.23 1.81 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.96 -0.638 . . . . 73.44 112.591 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.3 mp -117.81 143.23 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.193 -0.669 . . . . 62.22 109.193 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -125.45 109.85 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.557 -0.292 . . . . 65.14 110.603 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.9 m -54.63 -41.96 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.84 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' VAL . 68.9 t -56.96 -32.18 38.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.126 0.489 . . . . 52.23 110.748 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.8 -14.82 62.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.696 -0.684 . . . . 73.31 111.005 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 35' ' ' VAL . 4.4 mm? -63.61 -17.69 63.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.153 0.501 . . . . 75.3 110.093 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 72.1 22.86 78.67 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.423 -0.808 . . . . 74.22 114.363 172.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 40' ' ' LEU . 5.0 mt -98.25 -27.06 14.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.483 0.641 . . . . 63.12 110.421 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 59' ' ' MET . 35.8 t -63.57 -11.91 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.693 -0.685 . . . . 75.54 111.908 -169.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 98.7 m-85 -62.09 -17.68 58.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.187 0.518 . . . . 73.2 109.98 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.38 63.57 3.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.811 -0.915 . . . . 61.03 110.811 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.7 tt -125.62 128.94 48.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.212 -0.662 . . . . 74.54 109.212 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 44' ' ' LEU . 7.3 m-20 -149.16 173.47 13.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.483 -0.932 . . . . 43.44 108.483 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 55' ' ' ALA . 23.8 m -136.48 132.52 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 44.31 109.37 173.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.26 145.83 47.45 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.714 -0.476 . . . . 71.54 109.714 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.0 p-10 -100.62 129.31 46.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.313 0.578 . . . . 74.41 111.098 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.32 164.32 29.42 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.623 -1.791 . . . . 43.42 108.623 163.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.36 -19.62 66.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.164 0.982 . . . . 65.32 109.902 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 2.6 mp0 -77.64 -39.05 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.456 -0.793 . . . . 74.3 109.938 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.7 170.36 35.61 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.526 -0.761 . . . . 64.23 111.807 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 30.3 m -85.74 129.05 34.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.731 0.301 . . . . 70.3 111.299 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.54 140.68 39.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.993 -0.549 . . . . 72.51 110.23 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -85.22 154.56 21.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.15 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -128.72 122.74 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.281 0.632 . . . . 71.43 109.332 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 91' ' ' ILE . 54.3 mt -130.47 116.6 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.428 0.156 . . . . 72.15 111.124 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.37 118.8 24.46 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.261 -0.644 . . . . 70.1 109.261 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 41' ' ' VAL . 43.6 mmm -139.8 170.44 15.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.248 0.547 . . . . 71.02 111.941 -174.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -153.59 178.92 9.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.226 -0.897 . . . . 62.33 109.405 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 61.8 mt -120.48 156.35 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.012 -0.366 . . . . 40.4 110.012 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.9 p -47.46 -60.11 2.76 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.032 0.533 . . . . 75.01 112.343 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.9 t -104.23 2.17 31.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.843 0.354 . . . . 72.23 110.234 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.87 8.0 1.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.568 0.747 . . . . 72.44 112.154 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.36 -7.67 9.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 71.02 110.239 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.546 ' O ' HD13 ' A' ' 61' ' ' LEU . 11.8 m -76.84 145.09 73.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.506 -0.77 . . . . 52.11 110.41 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.69 27.89 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.579 2.186 . . . . 62.42 112.328 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 61' ' ' LEU . 91.8 mt -77.35 -6.52 53.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.747 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.9 t -58.2 -35.68 71.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.724 -0.473 . . . . 71.24 109.724 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.6 -50.01 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 64.41 111.217 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 14.2 p -68.66 -39.55 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.755 -0.202 . . . . 61.43 111.343 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 69' ' ' THR . 34.8 pt -66.81 -40.46 85.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 120.418 -0.513 . . . . 63.22 110.34 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.88 -46.93 88.67 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 116.41 -0.359 . . . . 65.44 110.186 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.76 -51.89 67.72 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.969 -0.56 . . . . 70.43 110.827 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 4.0 pt20 -64.86 -45.05 87.71 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.955 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.462 ' O ' HD23 ' A' ' 80' ' ' LEU . 77.4 p -66.74 -55.6 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.709 -0.223 . . . . 63.13 110.847 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.704 ' HD2' HG12 ' A' ' 89' ' ' ILE . 19.7 mmm180 -55.22 -53.07 60.61 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.731 0.3 . . . . 72.42 110.466 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 t -60.44 -43.49 96.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.575 -0.739 . . . . 73.44 111.49 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.91 -51.22 16.83 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 121.02 -0.272 . . . . 63.33 110.931 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -57.8 -37.98 74.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.156 -175.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 77' ' ' ARG . 20.6 m -78.0 -28.04 15.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.678 -0.409 . . . . 74.22 110.786 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.26 -42.63 97.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 61.33 112.087 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 p -94.27 1.4 55.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.93 0.395 . . . . 73.11 110.852 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.76 35.42 89.85 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.829 -0.623 . . . . 61.43 112.588 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.33 -36.94 80.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.353 0.597 . . . . 64.43 109.416 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.4 m -145.31 153.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.074 -0.966 . . . . 43.4 109.059 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.6 -44.46 70.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.267 0.556 . . . . 70.11 110.263 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.64 156.73 45.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 73.23 109.276 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.704 HG12 ' HD2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -125.97 144.04 37.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.716 -0.476 . . . . 72.32 109.716 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -123.7 106.75 10.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.373 0.606 . . . . 64.22 109.981 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 57' ' ' ILE . 59.6 mt -95.58 128.02 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 71.13 109.545 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 7.4 p30 -102.27 111.29 23.51 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.061 -0.718 . . . . 73.13 109.061 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -86.78 106.29 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 70.14 109.692 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.66 123.75 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.647 -0.501 . . . . 62.54 109.647 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -121.18 -27.16 4.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.224 -0.443 . . . . 74.13 109.89 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 24.4 m-20 -179.57 -48.82 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.229 -0.896 . . . . 61.34 110.599 -169.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 17.8 Cg_exo -68.35 152.21 75.7 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.206 1.938 . . . . 70.24 112.45 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 16.4 Cg_exo -68.73 145.66 63.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.717 2.278 . . . . 74.22 110.963 172.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -48.94 109.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.657 0.598 . . . . 71.35 111.378 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.63 -87.85 0.07 OUTLIER Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.266 -0.492 . . . . 75.53 112.276 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.45 -28.68 62.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.536 2.157 . . . . 43.31 111.266 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 2.7 p-10 -66.98 -5.75 14.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.858 -1.065 . . . . 74.25 111.648 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HG2' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mttt . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.516 0.198 . . . . 75.4 111.01 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.823 0.344 . . . . 55.52 111.692 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.52 159.41 36.45 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.572 2.181 . . . . 55.23 112.549 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.0 -51.57 65.82 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.781 1.03 . . . . 72.03 113.781 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.62 -52.45 64.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.674 0.273 . . . . 71.14 111.534 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.43 -41.29 63.44 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.243 -0.435 . . . . 64.43 110.95 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.68 -43.12 72.16 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 110.257 -0.275 . . . . 74.45 110.257 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.7 tp -57.42 -56.32 23.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.279 -0.419 . . . . 73.04 110.906 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.03 65.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.877 -0.601 . . . . 72.12 111.018 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -60.9 -42.72 98.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.986 -0.552 . . . . 63.24 111.465 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -69.87 -40.91 79.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.711 -0.396 . . . . 74.53 110.4 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.91 -46.01 92.37 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.527 -0.546 . . . . 75.32 109.527 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 53.8 mt-10 -61.72 -50.6 71.79 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.888 -0.596 . . . . 71.14 110.831 177.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -44.92 76.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.088 0.471 . . . . 64.02 110.333 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.1 mmt -57.88 -28.36 64.11 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.452 -0.795 . . . . 73.31 110.507 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.39 -24.99 59.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.537 -0.301 . . . . 74.42 110.88 -178.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.76 -20.95 15.34 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.923 0.342 . . . . 74.42 111.923 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 23' ' ' MET . 26.4 m -87.71 -17.47 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.975 0.417 . . . . 72.14 110.455 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.7 p -89.15 168.83 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.969 -0.559 . . . . 73.34 109.65 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.9 92.39 6.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.115 -0.698 . . . . 53.33 109.115 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.1 -4.77 10.42 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.465 2.11 . . . . 60.51 111.93 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.85 -57.71 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 53.11 110.632 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.98 -18.59 16.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.977 0.418 . . . . 71.12 110.285 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.5 49.21 2.41 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.138 -0.553 . . . . 64.12 113.13 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -111.56 140.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.131 -0.692 . . . . 72.34 109.131 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.3 p30 -122.82 113.13 18.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.427 0.632 . . . . 53.14 110.59 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.81 -28.51 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.642 -0.708 . . . . 72.24 110.811 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG12 HG21 ' A' ' 41' ' ' VAL . 34.7 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.041 -0.527 . . . . 64.02 111.166 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 36.6 t70 -58.88 -26.01 63.86 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.894 0.378 . . . . 72.22 111.131 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.94 -15.04 63.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.238 -0.437 . . . . 44.43 110.301 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.0 61.83 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.661 -0.7 . . . . 61.15 113.542 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.72 -16.29 22.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.999 0.428 . . . . 60.52 110.192 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 HG12 ' A' ' 36' ' ' VAL . 47.7 t -59.66 -15.88 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.881 -0.599 . . . . 75.33 110.618 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.56 -24.11 44.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.722 -0.672 . . . . 63.12 110.628 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.78 67.29 1.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.997 -0.547 . . . . 71.02 112.303 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.3 tp -110.98 130.72 55.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.639 -0.504 . . . . 71.02 109.639 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -157.91 109.12 2.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.527 -0.546 . . . . 71.22 109.527 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 118.74 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.704 -0.225 . . . . 62.13 110.505 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.66 120.65 38.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.078 -0.712 . . . . 70.2 109.078 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.68 140.99 37.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 74.12 110.198 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.15 167.34 35.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.713 -0.755 . . . . 61.32 112.079 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.95 -18.84 65.6 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.981 0.419 . . . . 75.1 110.657 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.22 -11.69 61.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.44 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.48 116.56 2.0 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.417 -0.673 . . . . 72.53 111.417 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.8 m -70.94 102.48 2.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.702 -0.481 . . . . 43.3 109.702 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 5.5 p -113.52 125.02 70.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.796 . . . . 54.23 111.834 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.99 114.21 26.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.664 . . . . 53.11 110.095 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -85.67 119.13 25.67 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.103 -0.332 . . . . 75.34 110.103 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 59' ' ' MET . 27.3 mm -116.73 127.98 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.742 -0.663 . . . . 65.4 109.45 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -107.47 116.48 32.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.477 -0.564 . . . . 54.23 109.477 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.519 ' HG3' HG22 ' A' ' 57' ' ' ILE . 42.5 mtm -140.87 170.56 15.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.748 0.785 . . . . 71.21 112.187 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -155.9 140.97 17.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.565 -1.198 . . . . 73.43 109.277 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 72' ' ' ILE . 3.7 mm? -85.4 167.43 15.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.589 -0.523 . . . . 73.12 109.589 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -50.1 -49.55 51.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.083 0.24 . . . . 73.31 111.431 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 m -102.27 -11.69 18.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.142 0.496 . . . . 71.35 110.34 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB1' ' HD1' ' A' ' 95' ' ' TRP . . . 62.58 8.21 2.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.347 -0.842 . . . . 75.01 112.467 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.04 -16.13 8.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.919 0.39 . . . . 51.53 110.958 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 p -66.15 144.99 98.97 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.967 -0.56 . . . . 65.31 111.327 -176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 8.3 Cg_exo -73.74 38.96 0.47 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.625 2.883 . . . . 74.54 113.852 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.8 mm? -92.98 -12.05 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.174 -0.306 . . . . 64.24 110.174 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.6 t -49.77 -57.71 6.79 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.682 -0.69 . . . . 62.11 111.733 -177.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 69' ' ' THR . 7.8 p-10 -66.15 -32.95 74.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.598 -0.274 . . . . 74.32 110.726 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.588 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 59.6 t -64.17 -53.43 43.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 53.4 110.68 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 68' ' ' LEU . 5.4 pt -71.93 -27.11 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 111.762 0.282 . . . . 64.24 111.762 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 91' ' ' ILE . 43.4 mt-10 -66.19 -45.64 80.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.946 0.403 . . . . 70.53 110.695 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.51 -49.53 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.734 . . . . 64.14 110.335 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 79.9 mm-40 -58.16 -45.61 87.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 72.21 110.491 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 80' ' ' LEU . 41.0 t -58.15 -63.69 1.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 62.35 110.541 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' O ' HG12 ' A' ' 81' ' ' VAL . 75.7 ttt180 -54.85 -47.83 73.68 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.885 -0.326 . . . . 53.5 110.812 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -55.54 -45.23 77.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.127 -0.488 . . . . 74.1 111.277 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.49 -51.07 18.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 74.31 110.816 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 85' ' ' LEU . 10.8 mp -58.75 -32.65 69.45 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.335 -0.393 . . . . 71.32 111.065 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 77' ' ' ARG . 8.6 p -84.2 -27.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 63.31 110.084 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.08 71.02 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.087 -0.578 . . . . 55.5 111.989 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.1 t -97.53 1.67 49.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.194 0.521 . . . . 53.41 110.064 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.39 23.06 78.49 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.895 -0.593 . . . . 23.24 112.913 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 80' ' ' LEU . 43.9 mt -66.81 -57.81 6.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.58 0.705 . . . . 74.41 109.186 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.02 -173.77 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.803 -1.09 . . . . 75.25 108.953 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -119.72 -39.01 2.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.161 -0.681 . . . . 71.51 109.161 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.8 m-20 -112.64 151.68 29.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 63.4 109.916 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 pt -140.17 170.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.532 -0.544 . . . . 62.04 109.532 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -148.57 106.7 3.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.101 -0.5 . . . . 74.14 109.665 172.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 73' ' ' GLU . 53.6 mt -93.55 121.35 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 74.41 109.81 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.441 ' CB ' ' HE2' ' A' ' 103' ' ' LYS . 26.3 t-20 -100.23 133.09 45.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.89 -0.596 . . . . 72.2 109.804 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -97.9 106.7 19.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.47 . . . . 75.51 110.423 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.28 124.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.424 -0.584 . . . . 63.44 109.424 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.444 ' HD1' ' HB1' ' A' ' 64' ' ' ALA . 4.3 m-90 -102.35 -34.99 8.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.422 -0.584 . . . . 74.32 109.422 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 23.1 t-20 168.67 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.419 -1.264 . . . . 74.5 109.243 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 49.5 Cg_exo -60.14 161.1 20.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.545 2.164 . . . . 64.35 112.324 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.59 -177.54 2.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.123 2.548 . . . . 71.25 112.986 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -89.21 -163.1 0.94 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.389 -0.823 . . . . 74.32 110.515 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.73 -173.88 45.99 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.079 -0.581 . . . . 73.45 112.485 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.74 -5.7 7.8 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.217 2.611 . . . . 50.44 112.512 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 31.7 t70 -57.53 -19.9 28.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 44.44 110.631 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 90.8 mttt . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.228 -0.442 . . . . 63.3 111.512 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.809 -0.441 . . . . 73.21 109.809 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.53 146.38 95.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.51 2.14 . . . . 62.23 111.906 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.88 -44.37 49.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.345 0.869 . . . . 71.13 113.345 -169.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 14.5 mp0 -63.2 -52.41 62.39 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.899 0.381 . . . . 72.1 110.845 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -72.11 -43.8 64.17 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.295 0.569 . . . . 74.25 110.449 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.74 -39.86 82.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.294 -0.866 . . . . 51.03 110.249 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.59 -53.21 57.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.905 0.383 . . . . 73.25 110.472 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.62 -51.93 66.48 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.785 -0.643 . . . . 61.13 110.996 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.2 -48.44 80.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.904 -0.589 . . . . 54.05 111.02 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 5.4 p -65.96 -34.48 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.945 -0.391 . . . . 63.31 109.945 -177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.91 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.696 -0.483 . . . . 71.21 109.696 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 28.5 mm-40 -65.92 -46.39 78.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.64 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.05 86.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 40.44 110.827 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.38 -12.62 14.9 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.042 -0.527 . . . . 71.22 111.564 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 76.9 ttt180 -87.31 -20.86 26.2 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.158 0.583 . . . . 72.23 111.459 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.27 -27.22 5.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.243 0.544 . . . . 74.21 110.84 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -74.74 -16.69 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.197 -0.911 . . . . 61.51 110.163 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.557 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p -94.2 155.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 74.12 110.445 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.15 89.74 0.62 Allowed Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 107.072 -1.455 . . . . 71.05 107.072 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 55.6 Cg_endo -81.27 -6.95 12.96 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.084 1.856 . . . . 63.13 111.712 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.82 -57.57 5.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.434 -0.803 . . . . 74.44 109.894 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 7.0 mp -92.29 -18.77 22.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.137 -0.483 . . . . 62.43 110.178 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.83 52.75 3.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.782 -0.644 . . . . 60.41 113.846 171.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.29 140.09 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 117.263 0.531 . . . . 74.23 109.939 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 24.2 m-80 -103.1 130.6 50.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.807 -0.442 . . . . 73.21 109.807 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.5 t -56.72 -33.11 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.545 0.688 . . . . 62.53 109.866 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.94 -30.61 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.245 -0.889 . . . . 70.14 111.005 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 2.0 m-20 -63.08 -23.58 67.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.57 -0.286 . . . . 73.34 111.581 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 -16.37 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.094 0.473 . . . . 74.13 110.276 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.03 22.82 60.87 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.618 -0.719 . . . . 71.2 112.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.5 tp -90.53 -24.76 20.53 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.476 -0.565 . . . . 74.45 109.476 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.59 -8.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.534 -0.757 . . . . 72.31 110.32 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.16 -16.13 62.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.881 -0.599 . . . . 74.23 109.692 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 52.12 3.51 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.834 -0.906 . . . . 63.32 110.834 172.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.569 HD13 HG12 ' A' ' 57' ' ' ILE . 61.6 tp -102.1 121.06 41.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.027 0.441 . . . . 73.42 109.974 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.42 108.58 10.95 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.144 -1.058 . . . . 51.1 108.144 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 10.8 m -99.43 128.0 51.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.476 -0.565 . . . . 75.33 109.476 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -120.54 145.55 47.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 74.1 110.844 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.47 163.34 19.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.498 -0.773 . . . . 73.3 110.309 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.9 155.71 26.68 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.866 -0.894 . . . . 63.2 110.866 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.66 -20.27 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.484 . . . . 72.35 110.48 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -89.48 -27.92 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.746 -0.661 . . . . 64.11 110.575 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.89 176.42 32.99 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.395 -0.682 . . . . 54.03 111.395 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.1 m -99.29 129.91 45.54 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.792 0.33 . . . . 62.04 110.483 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 137.09 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.145 -0.48 . . . . 74.24 110.814 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.71 120.5 39.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.081 -0.509 . . . . 62.31 110.285 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 103' ' ' LYS . 20.7 mt -96.65 114.02 25.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.564 -0.532 . . . . 64.12 109.564 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 44' ' ' LEU . 51.1 mt -111.42 118.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.544 0.211 . . . . 75.31 110.822 -176.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -82.86 120.86 26.19 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.282 -0.266 . . . . 64.01 110.282 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.5 mtp -139.23 163.5 32.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.363 0.602 . . . . 72.1 111.339 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 94' ' ' VAL . 73.7 m -136.62 137.73 40.43 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.839 -0.618 . . . . 73.11 109.595 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 69' ' ' THR . 87.4 mt -89.23 146.92 24.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.656 -0.498 . . . . 74.33 109.656 177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -36.1 -57.26 0.71 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.839 0.856 . . . . 71.32 113.027 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -121.29 12.6 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 72.41 110.622 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 8.56 1.19 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.718 -0.674 . . . . 62.42 112.567 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.83 13.07 12.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 73.31 110.547 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 44.5 t -95.9 139.82 22.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 71.5 110.507 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.37 17.45 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.922 2.415 . . . . 73.1 112.376 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HB2' ' SG ' ' A' ' 66' ' ' CYS . 48.5 tp -69.09 -13.83 62.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.956 -0.565 . . . . 72.2 110.499 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.499 HG23 ' N ' ' A' ' 70' ' ' ASP . 12.7 t -49.72 -56.8 8.88 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.591 -0.731 . . . . 74.43 111.903 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 69' ' ' THR . 22.7 t70 -63.67 -37.24 86.61 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.889 0.376 . . . . 64.11 110.356 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 60.9 t -62.28 -52.76 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 63.33 110.753 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.54 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.8 pp -68.47 -34.94 68.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.791 -0.186 . . . . 74.32 111.258 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 72' ' ' ILE . 41.2 mt-10 -62.47 -46.58 87.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.697 0.284 . . . . 71.55 110.462 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' SER . 23.4 t70 -63.27 -47.53 81.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 61.22 110.917 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 26.4 mm-40 -57.46 -55.64 32.2 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 74.43 110.444 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' HD23 ' A' ' 80' ' ' LEU . 36.6 t -59.44 -54.61 44.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.819 -0.628 . . . . 72.01 110.587 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 77' ' ' ARG . 1.4 tmt_? -54.79 -42.79 72.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.448 -0.342 . . . . 72.5 110.555 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 7.1 t -56.28 -52.89 62.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 51.23 110.88 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.49 -51.89 13.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.87 -0.332 . . . . 55.42 111.446 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 76' ' ' SER . 4.3 mm? -60.68 -33.92 73.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.272 0.558 . . . . 72.14 111.186 -173.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -85.85 -27.2 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.785 -0.643 . . . . 64.41 109.911 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.72 79.05 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.292 -0.48 . . . . 71.02 112.149 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -79.25 -23.04 43.94 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.649 -0.5 . . . . 64.41 109.649 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 48.58 3.56 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.578 -0.737 . . . . 53.51 113.25 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.0 mt -80.47 -35.3 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.989 -0.745 . . . . 60.1 108.989 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.7 m -143.84 160.35 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.109 -0.95 . . . . 73.14 109.336 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.69 -30.92 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 63.11 110.675 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -152.5 166.07 33.14 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.02 -0.536 . . . . 73.32 110.238 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 55' ' ' ALA . 35.7 pt -136.95 154.46 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.132 0.492 . . . . 72.11 110.86 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 8.6 tpt85 -133.24 110.42 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.74 -0.664 . . . . 72.04 109.215 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 58.6 mt -91.61 123.17 43.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.224 -0.443 . . . . 72.14 110.224 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.47 HD22 ' C ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -88.2 118.21 27.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.42 -0.956 . . . . 72.52 108.42 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.447 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.8 m-90 -89.69 114.0 25.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.242 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HB ' ' OG1' ' A' ' 60' ' ' THR . 7.4 t -86.07 124.02 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.863 -0.421 . . . . 73.03 109.863 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -112.08 -32.16 6.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 75.53 109.408 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.451 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 35.3 m-20 -179.57 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 114.354 -1.294 . . . . 71.14 109.379 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 23.6 Cg_exo -65.96 154.15 75.17 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.222 1.948 . . . . 52.32 111.664 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.18 -176.64 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 52.43 112.061 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m-90 -79.64 145.59 32.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 72.31 110.276 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.29 -110.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.923 -0.656 . . . . 71.1 112.226 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.57 -33.76 86.44 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.563 2.175 . . . . 64.12 112.163 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.63 -4.11 14.3 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.895 -0.593 . . . . 73.33 110.719 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 56' ' ' LEU . 30.2 mtpp . . . . . 0 CA--C 1.535 0.377 0 O-C-N 121.86 -0.525 . . . . 65.1 110.277 172.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.823 0.305 . . . . 53.11 111.823 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 80.9 Cg_exo -47.86 153.59 2.44 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.978 2.452 . . . . 64.55 112.194 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.5 -29.87 51.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 61.31 112.072 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 7.9 mp0 -63.63 -45.4 90.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.173 0.511 . . . . 52.23 109.932 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.73 -47.35 39.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.408 -0.815 . . . . 74.21 109.402 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.45 -45.49 73.1 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 114.819 -1.082 . . . . 74.2 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.99 -59.72 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.977 0.418 . . . . 62.43 111.163 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.86 66.41 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.118 -0.492 . . . . 62.5 111.129 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.16 -32.58 72.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.6 -0.727 . . . . 71.3 111.915 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -72.39 -38.17 60.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 109.396 -0.594 . . . . 61.0 109.396 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -58.88 -41.62 87.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.512 -0.313 . . . . 65.53 110.731 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -69.67 -51.66 32.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.036 0.446 . . . . 74.44 110.683 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.24 -34.64 75.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.839 -0.618 . . . . 61.42 111.391 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.4 mmt -61.25 -13.29 17.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.236 -0.438 . . . . 74.23 112.114 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -90.77 -17.46 26.63 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.748 0.249 . . . . 72.15 111.493 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.52 -25.81 5.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.503 0.668 . . . . 74.45 110.466 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.85 -23.13 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.092 -0.958 . . . . 60.21 109.878 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 9.9 p -89.0 159.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.071 174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 94.61 4.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.527 -0.916 . . . . 73.23 108.527 168.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 72.8 Cg_endo -81.54 -3.84 12.08 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.257 1.971 . . . . 63.35 111.989 -176.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.72 -57.55 5.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.14 0.495 . . . . 74.34 109.862 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.5 mt -92.79 -18.75 22.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.708 -0.678 . . . . 62.3 109.864 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.34 51.46 3.7 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.955 -0.566 . . . . 25.2 113.49 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.68 143.85 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.026 0.413 . . . . 65.32 110.432 177.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.411 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.2 p30 -108.79 134.82 50.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 75.01 110.637 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.42 -25.69 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.012 0.434 . . . . 74.42 111.121 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.81 -24.96 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.927 -0.579 . . . . 62.12 110.348 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.75 -33.61 68.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 73.3 110.642 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 38' ' ' LEU . 3.5 mm? -71.91 -16.7 62.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 74.43 110.297 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.98 21.1 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.48 -0.782 . . . . 62.14 113.782 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.5 mt -88.58 -19.2 26.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.892 0.346 . . . . 72.11 110.157 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.6 -9.59 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.853 -0.612 . . . . 55.32 110.512 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.89 -31.23 62.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.546 -0.752 . . . . 71.01 109.678 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 75.76 1.48 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.539 -0.755 . . . . 72.32 111.585 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.535 HD13 HG12 ' A' ' 57' ' ' ILE . 50.8 tp -119.94 126.33 50.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.768 0.427 . . . . 75.22 109.951 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -150.92 115.38 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.498 -0.556 . . . . 73.43 109.498 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -94.8 136.25 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.848 0.356 . . . . 54.52 110.176 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -130.63 150.21 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.626 -0.509 . . . . 72.2 109.626 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 33.2 t70 -92.01 117.39 29.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.446 -0.343 . . . . 72.25 110.891 -176.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.45 174.16 24.62 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.406 -0.426 . . . . 63.22 112.087 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.04 -32.16 69.49 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.917 0.389 . . . . 72.23 111.46 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.39 -14.29 22.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.148 -0.478 . . . . 61.03 111.513 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.18 172.23 22.63 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.094 -0.574 . . . . 24.45 111.992 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.0 m -78.88 115.46 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.712 0.256 . . . . 51.24 110.782 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 33.3 m -103.94 144.97 13.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.46 -0.337 . . . . 75.1 110.648 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.59 112.85 24.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 70.23 110.599 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 44.1 mt -79.5 115.62 19.23 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.126 -0.694 . . . . 73.42 109.126 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.535 HG12 HD13 ' A' ' 44' ' ' LEU . 49.5 mt -120.51 125.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.091 -0.337 . . . . 74.4 110.091 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD2' HG23 ' A' ' 94' ' ' VAL . 24.8 t0 -96.12 130.83 43.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 74.53 110.772 176.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.4 mtp -141.64 170.96 14.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.292 0.568 . . . . 54.31 111.268 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -154.43 153.46 31.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.735 . . . . 72.41 109.86 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 mp -110.72 170.8 7.85 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.971 -0.381 . . . . 63.44 109.971 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 p -57.12 -60.22 3.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.21 -0.45 . . . . 60.35 111.824 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.429 ' HG ' ' HG ' ' A' ' 66' ' ' CYS . 86.2 p -91.88 -24.34 19.36 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.362 -0.381 . . . . 75.23 110.315 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.4 8.93 4.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.427 -0.806 . . . . 53.4 110.826 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.63 -25.93 8.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.589 . . . . 70.44 110.53 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.429 ' HG ' ' HG ' ' A' ' 63' ' ' SER . 64.3 m -59.43 135.57 88.82 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.007 -0.542 . . . . 65.02 110.628 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.29 25.7 0.31 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.892 2.395 . . . . 75.44 113.038 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 72' ' ' ILE . 89.8 mt -78.19 -6.26 54.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.988 -0.375 . . . . 65.51 109.988 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.3 t -49.37 -44.31 44.8 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.548 -0.751 . . . . 74.31 109.946 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.48 -51.57 68.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.67 -0.695 . . . . 71.44 110.693 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 49.2 t -62.78 -53.04 51.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.533 -0.758 . . . . 61.33 111.46 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 68' ' ' LEU . 6.7 pt -71.01 -35.96 61.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.759 -0.376 . . . . 74.3 111.713 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.51 -54.27 46.06 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.892 0.853 . . . . 72.35 108.76 173.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.89 -51.29 70.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.864 -1.516 . . . . 62.44 111.231 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 21.2 mm-40 -59.36 -49.08 79.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.657 0.265 . . . . 72.14 110.564 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 45.7 m -59.29 -60.56 3.66 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.016 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.476 ' HB3' HG12 ' A' ' 89' ' ' ILE . 14.4 ptm180 -62.11 -36.68 82.47 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.047 -0.261 . . . . 71.25 111.208 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 t -60.07 -40.94 91.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.252 -0.431 . . . . 72.45 110.672 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -51.18 16.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.73 0.3 . . . . 65.02 110.749 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -55.26 -38.12 68.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.108 -0.496 . . . . 70.12 111.148 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.24 -27.77 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.594 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.71 -34.04 69.34 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.32 -0.467 . . . . 74.11 112.094 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 29.9 m -107.67 6.79 28.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.797 0.332 . . . . 64.25 111.15 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.71 69.51 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.125 -0.559 . . . . 72.24 112.07 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 78.2 mt -60.68 -43.12 98.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.672 0.749 . . . . 70.31 108.99 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 19.2 m -143.9 159.15 16.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.361 -1.29 . . . . 71.24 108.114 170.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.42 -43.19 86.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.309 0.576 . . . . 73.1 110.081 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 27.2 t70 -161.55 168.63 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.248 -0.887 . . . . 72.13 108.753 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 77' ' ' ARG . 32.6 pt -122.68 148.05 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.815 0.341 . . . . 71.45 110.118 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 90' ' ' ARG . 2.8 tpp180 -119.44 106.38 12.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.473 -0.936 . . . . 71.31 108.473 176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.3 mt -93.78 145.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.78 0.324 . . . . 71.25 110.853 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -118.71 139.67 51.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.877 -0.786 . . . . 71.2 108.877 172.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.531 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 49.1 m95 -106.43 106.79 17.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.748 -0.464 . . . . 71.31 109.748 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.521 HG23 ' OD2' ' A' ' 58' ' ' ASP . 39.5 t -87.3 123.84 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.945 -0.702 . . . . 73.22 109.882 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 7.3 p-90 -140.88 -0.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.071 -0.513 . . . . 70.0 111.105 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.586 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t-20 167.88 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 116.071 -0.513 . . . . 53.44 110.435 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 94.5 Cg_endo -80.72 156.69 21.2 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.947 1.765 . . . . 54.52 111.855 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.08 170.09 17.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.208 1.939 . . . . 34.44 111.653 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -61.11 101.69 0.17 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.057 -0.52 . . . . 73.11 110.412 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.85 -83.75 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.075 -0.512 . . . . 63.42 112.451 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.52 -51.96 3.65 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.725 2.284 . . . . 64.25 112.244 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 93' ' ' TRP . 6.1 m-20 -64.01 -4.01 3.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 64.44 112.466 -176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.598 0.237 . . . . 74.12 110.508 176.733 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.664 -0.124 . . . . 63.11 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.33 176.77 3.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.847 2.364 . . . . 74.2 112.05 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.08 -64.45 0.81 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.039 0.755 . . . . 74.23 113.039 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -64.43 -46.77 81.73 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.026 0.441 . . . . 74.34 110.937 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.34 -46.67 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.344 -0.844 . . . . 75.53 110.761 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.9 -49.12 77.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.774 -0.648 . . . . 75.13 110.16 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.33 -59.89 3.99 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 52.13 111.449 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -45.06 80.51 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.098 -0.501 . . . . 75.42 111.25 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.26 -41.24 73.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 73.1 110.812 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.11 -32.82 55.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 109.54 -0.541 . . . . 73.31 109.54 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.19 -48.79 75.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.211 -0.663 . . . . 75.35 109.211 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -61.58 -50.57 72.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.798 -0.637 . . . . 45.42 111.267 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.04 75.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.153 0.501 . . . . 60.04 111.188 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.28 -13.52 62.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.812 -0.631 . . . . 61.43 110.651 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -96.85 -8.01 32.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.635 . . . . 70.14 110.405 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.61 -27.13 5.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.499 0.666 . . . . 52.23 110.127 -173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -90.98 -33.04 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.152 -0.931 . . . . 74.01 111.257 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 33' ' ' ILE . 1.2 p -74.7 174.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.12 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.55 96.22 8.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 109.722 -0.473 . . . . 53.03 109.722 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 67.8 Cg_endo -89.13 3.16 5.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.627 2.218 . . . . 74.12 111.775 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.81 -57.93 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 74.23 110.461 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.58 -11.29 14.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.897 -0.592 . . . . 61.42 110.444 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 51.48 2.58 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.952 -0.567 . . . . 30.3 112.905 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 27' ' ' VAL . 3.2 mp -106.69 140.09 26.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.531 -0.544 . . . . 63.42 109.531 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 67.4 m-20 -116.62 109.03 16.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.509 -0.769 . . . . 51.14 109.59 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.23 -39.09 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.051 0.453 . . . . 75.22 111.257 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.1 -24.85 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.025 -0.534 . . . . 64.41 111.323 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.57 -24.75 67.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 71.13 110.988 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.16 -10.74 59.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.266 0.555 . . . . 72.24 110.509 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 22.52 66.09 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.358 -0.837 . . . . 75.41 114.321 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.4 tp -98.46 -30.08 12.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.06 0.457 . . . . 65.04 110.372 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.53 -14.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.587 -0.733 . . . . 74.1 111.826 -172.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -62.04 -23.4 66.44 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 71.12 109.888 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.89 70.18 2.56 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.684 -0.689 . . . . 74.31 112.085 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.4 pp -126.06 144.51 50.69 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 73.45 109.896 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -163.7 138.06 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.679 -0.86 . . . . 72.44 108.679 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.66 132.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.84 0.352 . . . . 73.01 110.822 -175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -115.7 127.3 55.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.132 -0.486 . . . . 62.01 111.346 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -81.6 113.88 19.91 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.677 -0.692 . . . . 72.42 109.275 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.02 158.94 18.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.139 -0.553 . . . . 65.22 111.732 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.9 -24.74 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 73.02 110.258 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.31 -16.19 50.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.254 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.87 158.75 9.48 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.971 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 m -98.48 102.43 14.17 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.625 -0.88 . . . . 72.52 108.625 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 t -102.92 123.65 56.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 63.44 111.219 -168.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.91 115.29 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.846 -0.616 . . . . 73.04 109.585 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 90' ' ' ARG . 50.3 mt -93.89 127.89 39.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.553 0.341 . . . . 74.32 110.404 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.27 129.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.829 -0.434 . . . . 75.15 109.829 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.86 129.78 35.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.037 0.446 . . . . 73.15 111.1 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 79.9 mtp -141.18 171.07 14.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.972 -0.558 . . . . 73.03 110.183 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -148.63 157.48 43.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.144 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mm? -117.1 150.93 37.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.185 -0.672 . . . . 63.24 109.185 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -51.03 -53.86 29.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.651 0.611 . . . . 74.32 112.651 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -113.65 0.2 14.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.69 -0.232 . . . . 74.23 111.227 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 7.81 1.8 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.983 0.513 . . . . 62.34 112.228 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.33 3.78 10.8 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.498 0.666 . . . . 70.21 109.644 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.5 m -83.87 138.64 40.25 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.169 -0.923 . . . . 73.14 110.476 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.3 23.87 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.907 2.405 . . . . 75.14 112.622 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 83.5 mt -78.28 -18.01 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.427 . . . . 61.52 110.171 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -59.8 -46.44 89.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.915 -0.584 . . . . 63.22 110.824 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.13 -43.27 78.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.269 0.557 . . . . 64.31 110.209 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.4 t -65.15 -52.59 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 70.31 110.85 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.14 -37.29 78.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.751 0.31 . . . . 74.12 110.958 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.79 -47.23 84.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.213 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 78' ' ' SER . 32.4 t70 -60.23 -48.49 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 74.03 110.906 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 9.3 mm100 -61.7 -51.2 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.874 0.369 . . . . 74.45 110.54 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -60.44 -56.21 24.19 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.954 -0.566 . . . . 72.12 110.437 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.19 -41.74 72.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.949 -0.568 . . . . 73.01 110.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 22.9 t -53.57 -53.02 57.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.589 -0.732 . . . . 62.21 110.783 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.74 -52.08 12.47 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.71 -0.396 . . . . 65.33 111.234 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.68 -44.33 73.25 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.213 0.53 . . . . 63.43 110.895 -171.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.97 -27.45 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.105 -0.952 . . . . 72.44 110.127 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -48.03 79.26 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.998 -0.62 . . . . 43.42 112.442 -170.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . 14.1 m -91.22 -12.65 34.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.117 0.484 . . . . 74.31 110.414 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.93 43.0 6.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.1 113.168 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.432 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.0 mm? -73.29 -45.25 56.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.57 -0.9 . . . . 71.13 108.57 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.41 162.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.897 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.54 -45.29 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.265 0.555 . . . . 71.01 109.992 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -101.13 133.74 45.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 64.31 109.809 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.6 pt -127.66 156.27 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 75.3 110.336 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.482 ' HB3' HD23 ' A' ' 56' ' ' LEU . 3.4 tpm_? -150.49 106.77 3.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.176 -0.466 . . . . 74.1 109.753 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.3 mt -95.03 108.95 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.053 -0.721 . . . . 75.22 109.053 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -88.3 121.84 31.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.419 -0.585 . . . . 75.11 109.419 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.9 m-90 -97.9 108.78 21.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.169 -0.308 . . . . 72.42 110.169 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 98' ' ' PRO . 32.8 m -87.18 123.9 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.672 -0.492 . . . . 71.54 109.672 176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -111.91 -35.51 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.733 0.778 . . . . 72.45 109.669 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.671 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 8.7 t30 -175.19 -47.9 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.277 -1.329 . . . . 73.34 108.354 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 26.7 Cg_exo -64.75 134.15 39.43 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.811 1.674 . . . . 50.54 109.387 165.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 99' ' ' TRP . 22.0 Cg_exo -63.52 -88.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.376 2.051 . . . . 54.13 113.18 -173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.691 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 10.7 m-90 -141.39 100.64 3.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.658 0.266 . . . . 73.25 110.333 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.69 -133.06 3.77 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-O 119.795 -0.447 . . . . 62.25 112.24 -173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.93 -24.31 75.82 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.748 2.299 . . . . 75.22 112.54 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.99 -4.53 13.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.994 0.426 . . . . 62.35 111.088 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.691 ' HD3' ' HB3' ' A' ' 99' ' ' TRP . 33.7 mtmm . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 72.32 110.184 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.476 0.176 . . . . 55.11 111.476 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 11.1 Cg_endo -53.69 131.41 43.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.822 2.348 . . . . 71.12 111.921 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.16 -66.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.358 0.873 . . . . 53.34 113.358 -168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.01 -50.49 73.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.949 0.404 . . . . 72.33 111.147 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -57.25 -46.41 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 74.01 110.916 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.65 -39.77 91.76 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.828 -0.624 . . . . 72.1 110.082 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.6 tp -54.67 -59.63 4.44 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.837 0.351 . . . . 74.01 110.698 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.67 75.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.996 -0.547 . . . . 75.05 110.995 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.4 -45.12 92.4 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.994 -0.548 . . . . 73.33 111.14 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.45 -33.06 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.229 -0.285 . . . . 71.22 110.229 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -59.13 -41.52 88.45 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.345 0.593 . . . . 55.32 109.617 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.69 -45.8 57.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.486 -0.779 . . . . 75.44 111.008 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.58 72.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.336 -0.393 . . . . 75.03 111.567 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.15 -13.49 48.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 35.52 110.642 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 12.8 ttm180 -88.26 -15.63 35.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.448 -0.342 . . . . 73.53 110.731 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -109.38 -27.02 9.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 122.02 0.914 . . . . 62.33 108.891 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -112.98 70.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 114.011 -1.449 . . . . 63.51 109.461 -175.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 34' ' ' ASN . 4.5 p -179.77 173.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.272 -0.876 . . . . 54.04 108.716 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 27' ' ' VAL . 9.7 t70 -106.26 89.58 4.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.877 -0.786 . . . . 54.12 108.877 170.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.72 -23.77 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.176 1.917 . . . . 71.43 112.485 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -68.68 -57.75 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.013 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.48 -18.55 26.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.831 0.348 . . . . 72.23 110.117 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.04 47.03 3.46 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 60.43 113.704 169.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.6 mp -112.95 140.2 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.514 -0.55 . . . . 71.24 109.514 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HA ' HG23 ' A' ' 27' ' ' VAL . 4.4 p30 -108.46 129.73 55.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.153 -0.684 . . . . 73.44 109.153 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.13 -28.37 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.84 -0.618 . . . . 72.24 112.196 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.42 -24.7 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.706 -0.225 . . . . 73.11 111.064 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -52.86 -35.53 57.74 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.238 0.336 . . . . 74.14 110.667 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.6 mp -78.05 -18.39 55.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.377 -0.374 . . . . 53.22 110.757 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.26 22.89 38.72 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.797 -0.638 . . . . 71.31 113.548 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -93.04 -22.02 19.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.877 0.37 . . . . 53.5 110.103 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.97 -11.88 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.918 -0.583 . . . . 51.44 110.905 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -71.75 -24.34 61.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 70.14 109.94 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.6 81.96 0.96 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.214 -0.754 . . . . 34.11 111.214 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -130.44 137.04 49.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.262 0.553 . . . . 64.02 111.006 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 16.3 m-20 -134.4 160.41 38.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.103 -1.443 . . . . 63.12 107.103 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.9 t -149.12 123.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.506 . . . . 52.24 109.635 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.688 -0.486 . . . . 71.02 109.688 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HG23 ' A' ' 53' ' ' THR . 7.0 p-10 -88.78 136.66 32.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.92 0.39 . . . . 72.45 110.086 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.96 134.55 4.75 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.482 -1.047 . . . . 54.43 110.482 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -25.58 67.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.098 0.475 . . . . 75.43 110.654 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.35 -34.15 65.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.578 -0.737 . . . . 74.22 109.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.48 124.27 0.77 Allowed Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.683 -0.689 . . . . 72.11 111.608 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' ASP . 26.1 m -77.62 117.32 18.93 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.248 -0.279 . . . . 65.02 110.248 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 88' ' ' ASP . 43.7 t -108.2 123.68 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.905 0.383 . . . . 71.34 110.912 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -94.76 122.42 37.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.108 -0.496 . . . . 71.31 110.269 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 12.2 mt -97.29 102.01 13.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.655 -0.498 . . . . 74.33 109.655 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 59' ' ' MET . 59.2 mt -108.65 125.15 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.092 0.157 . . . . 55.15 110.69 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.11 118.98 25.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.849 0.357 . . . . 75.13 110.099 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.419 ' HG3' HG22 ' A' ' 57' ' ' ILE . 72.0 mtp -140.87 170.87 14.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.383 0.611 . . . . 53.14 111.01 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -157.03 177.47 11.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.973 -1.012 . . . . 65.03 108.907 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -108.57 163.11 13.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.29 -0.633 . . . . 70.34 109.29 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -47.46 -57.48 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.484 0.49 . . . . 73.4 112.008 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -96.88 -13.59 22.38 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.385 -0.37 . . . . 63.01 111.024 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.39 8.84 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.89 0.7 . . . . 53.21 112.89 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.81 9.61 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.05 0.453 . . . . 53.23 110.486 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.3 t -119.92 124.47 27.87 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.865 -0.607 . . . . 32.03 109.786 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.17 83.16 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.682 2.254 . . . . 73.34 112.087 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 tp -107.05 8.2 30.17 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.678 0.752 . . . . 64.41 108.997 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.1 t -63.7 -39.72 95.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.303 -0.862 . . . . 63.42 111.341 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.8 -44.71 74.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 64.34 110.198 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.46 -51.93 52.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.436 -0.802 . . . . 64.32 110.795 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.675 HG12 ' HA ' ' A' ' 69' ' ' THR . 27.0 pt -62.55 -33.73 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.697 -0.401 . . . . 72.23 111.075 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' A' ' 91' ' ' ILE . 43.8 mt-10 -68.0 -44.17 77.19 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.457 -0.338 . . . . 70.25 110.225 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.88 -44.24 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 73.04 110.425 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.06 -46.2 82.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.331 -0.395 . . . . 75.54 110.72 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -58.91 -53.81 54.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.066 -0.516 . . . . 52.14 109.944 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 ttp85 -54.87 -44.11 73.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 73.04 110.395 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -53.32 -53.65 47.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.815 -0.63 . . . . 71.12 111.159 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.22 -52.49 10.78 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.55 -0.46 . . . . 74.43 111.462 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 86' ' ' VAL . 92.1 mt -60.14 -41.09 91.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.05 0.452 . . . . 74.12 111.227 -169.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.04 -27.42 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 74.04 110.188 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.21 -45.71 18.57 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.688 -0.768 . . . . 63.23 111.776 -171.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 m -82.89 2.87 32.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.41 . . . . 61.33 110.659 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.76 35.91 90.41 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.013 -0.539 . . . . 74.34 112.811 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 HD23 ' A' ' 80' ' ' LEU . 84.0 mt -76.57 -43.65 38.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 51.32 109.555 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 55' ' ' ALA . 27.2 m -144.29 169.32 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.367 -0.833 . . . . 72.33 109.387 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -91.71 -48.0 7.06 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.961 0.41 . . . . 64.04 110.447 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HB2' HG22 ' A' ' 54' ' ' VAL . 18.6 m-20 -131.38 151.12 51.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.059 -0.519 . . . . 51.35 110.687 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.1 pt -113.96 151.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 71.42 110.447 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -137.98 106.64 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.207 -1.034 . . . . 70.34 108.207 177.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.484 HD12 ' HG2' ' A' ' 73' ' ' GLU . 47.7 mt -95.94 114.33 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 73.33 110.373 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 3.4 t30 -88.68 102.85 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 72.31 109.093 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.3 m-90 -82.34 106.87 14.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.501 -0.318 . . . . 73.45 110.585 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.9 123.56 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.387 -0.597 . . . . 64.44 109.387 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -122.08 -17.62 7.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.047 0.451 . . . . 73.03 110.18 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.525 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 28.0 t-20 173.86 -47.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.186 -0.915 . . . . 72.0 109.449 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.3 Cg_endo -68.08 140.12 48.72 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.629 1.553 . . . . 61.3 110.123 168.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.55 -92.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.203 1.935 . . . . 73.11 112.482 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -146.09 163.12 36.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.962 -0.384 . . . . 71.52 109.962 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.44 -127.17 1.58 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.72 -0.552 . . . . 71.42 111.72 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.64 -17.73 56.1 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.627 2.218 . . . . 55.2 111.685 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 4.0 m-20 -63.96 -11.1 25.47 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.577 -0.738 . . . . 62.24 110.978 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 71.9 mmtt . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.431 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.56 0.219 . . . . 42.44 111.336 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 30.1 Cg_endo -64.28 143.52 83.55 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.366 2.044 . . . . 70.21 111.707 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -38.75 58.57 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.644 0.609 . . . . 75.4 112.644 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -55.01 -50.24 69.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.411 0.624 . . . . 64.11 110.843 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 -40.42 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.539 -0.755 . . . . 53.11 110.187 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.97 -53.75 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.763 -0.653 . . . . 72.23 111.367 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.09 -48.87 78.83 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.952 0.406 . . . . 70.35 110.951 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.69 -46.89 65.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.059 -0.519 . . . . 45.21 110.714 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -64.09 -45.0 90.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.495 -0.775 . . . . 74.1 110.419 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.3 -38.02 80.14 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 109.946 -0.39 . . . . 54.0 109.946 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.71 -43.19 72.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.008 0.433 . . . . 73.44 110.079 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 43.9 mt-10 -72.36 -43.36 64.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 71.33 111.067 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.82 73.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.416 0.627 . . . . 60.2 110.751 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 21.7 mmt -63.11 -13.63 38.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.425 -0.807 . . . . 75.01 111.213 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 40.3 ttt180 -74.8 -24.17 58.61 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.739 0.304 . . . . 74.35 111.15 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.14 -23.56 9.43 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.672 0.749 . . . . 74.11 109.911 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.5 t -95.08 26.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.728 -1.123 . . . . 74.53 110.23 -178.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 2.8 p -150.08 169.23 2.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -103.2 100.22 17.02 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 110.012 -0.366 . . . . 72.22 110.012 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 97.1 Cg_endo -88.93 -3.75 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.758 2.306 . . . . 54.45 111.827 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.1 -57.75 5.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.05 0.452 . . . . 71.31 110.642 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.1 -17.49 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 73.01 109.994 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.19 52.62 1.71 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.746 -0.661 . . . . 22.32 112.999 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -109.67 142.66 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.116 0.484 . . . . 72.3 109.902 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 37' ' ' ASP . 6.0 p30 -120.16 112.6 19.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 72.22 109.347 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.8 m -55.22 -30.05 24.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.544 -0.753 . . . . 54.24 112.086 -173.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.84 -31.5 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 74.23 111.377 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t70 -67.3 -19.56 65.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.462 -0.335 . . . . 65.35 111.351 -176.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -72.85 -17.5 61.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.084 0.469 . . . . 74.05 109.992 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.86 65.39 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.549 -0.751 . . . . 65.0 113.362 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.99 -20.14 17.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.14 0.495 . . . . 72.34 110.011 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 HD23 ' A' ' 44' ' ' LEU . 42.1 t -59.27 -9.62 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.695 -0.684 . . . . 71.43 111.422 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.18 -7.24 40.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.059 0.457 . . . . 71.24 110.0 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 58' ' ' ASP . . . -81.52 18.96 9.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.524 -0.762 . . . . 42.12 112.249 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 HG12 ' A' ' 41' ' ' VAL . 4.6 pp -89.16 129.8 35.7 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.939 -0.763 . . . . 70.42 108.939 171.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -161.59 113.29 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.75 -0.463 . . . . 72.32 109.75 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.1 p -93.02 116.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.178 0.513 . . . . 71.51 110.782 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.54 128.25 56.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.785 -0.643 . . . . 74.23 109.606 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 2.1 p-10 -101.66 161.06 13.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.124 0.488 . . . . 72.24 110.651 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.54 -175.03 32.12 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.641 -0.984 . . . . 72.3 110.641 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.4 -35.48 71.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.271 0.558 . . . . 75.34 109.916 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.98 -18.17 63.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.157 -0.928 . . . . 73.24 110.584 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.64 172.37 18.41 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.208 -0.451 . . . . 71.24 112.527 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 29.1 m -105.85 111.03 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.461 -0.57 . . . . 63.03 109.461 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -112.26 133.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.671 0.272 . . . . 53.25 111.095 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -97.82 106.52 18.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.29 -0.414 . . . . 75.21 110.431 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 46.1 mt -75.61 141.0 42.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 73.22 109.707 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HG3' ' A' ' 59' ' ' MET . 60.6 mt -144.64 113.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.148 -0.315 . . . . 74.45 110.148 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 30.7 m-20 -86.95 128.72 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.654 -0.248 . . . . 74.11 110.463 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.4 mtp -140.9 170.51 15.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 122.261 1.029 . . . . 63.03 113.051 -174.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 94' ' ' VAL . 19.9 p -149.51 172.74 14.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 113.294 -1.775 . . . . 72.52 109.089 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.26 145.3 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.685 -1.228 . . . . 63.33 107.685 164.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 p -59.69 -48.43 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 74.13 111.021 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -67.99 -38.64 82.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.394 -0.821 . . . . 75.32 111.335 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.71 8.16 2.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.102 -0.954 . . . . 70.21 111.361 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.08 -36.0 3.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.215 0.531 . . . . 54.51 109.887 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.9 116.18 53.11 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.643 -0.708 . . . . 75.25 110.039 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.94 77.38 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.812 2.341 . . . . 74.15 113.577 -173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.85 7.27 31.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.26 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.2 t -50.35 -60.21 3.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.569 -0.741 . . . . 73.23 112.113 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 69' ' ' THR . 10.9 t70 -58.92 -35.83 73.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.139 0.495 . . . . 74.02 110.335 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.9 t -65.32 -53.29 41.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.547 -0.751 . . . . 62.23 110.857 -175.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.581 HG12 ' HH2' ' A' ' 93' ' ' TRP . 1.8 pp -69.12 -36.63 74.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.428 -0.351 . . . . 71.54 110.246 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.37 -45.81 89.41 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 74.51 110.603 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.52 -42.91 86.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 65.04 110.921 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 56.5 mt-30 -59.57 -54.05 50.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.11 0.481 . . . . 61.43 110.671 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.52 -53.98 51.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.579 -0.737 . . . . 62.34 110.603 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -55.05 -51.2 67.07 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.114 -0.494 . . . . 75.41 111.326 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.7 t -53.29 -51.76 61.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.077 -0.51 . . . . 44.32 111.01 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.06 -52.0 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.517 -0.473 . . . . 51.52 111.334 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.79 -39.46 85.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.761 0.315 . . . . 74.34 111.116 -172.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.07 -27.83 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.361 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.14 -33.15 33.42 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.857 -0.687 . . . . 64.41 112.194 -172.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB2' HD13 ' A' ' 85' ' ' LEU . 15.0 m -95.97 -0.17 51.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 43.14 110.962 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.56 29.86 67.31 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.353 -0.451 . . . . 61.51 113.488 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 83' ' ' SER . 9.4 mp -79.8 -8.14 59.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.11 0.481 . . . . 72.4 110.233 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 88' ' ' ASP . 9.9 p -164.02 161.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.601 -0.727 . . . . 74.14 109.332 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.18 -19.68 58.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.847 -0.427 . . . . 75.23 109.847 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 86' ' ' VAL . 15.8 t0 174.85 150.89 0.1 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.352 -170.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 18.6 pt -116.4 152.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 61.32 110.335 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 2.4 tpp180 -133.35 106.15 7.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.145 -0.687 . . . . 63.3 109.145 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.24 143.55 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.349 -0.387 . . . . 61.12 110.227 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -119.54 143.45 47.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.286 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.581 ' HH2' HG12 ' A' ' 72' ' ' ILE . 70.6 m95 -110.96 106.41 15.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 75.11 110.102 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' THR . 31.5 m -100.09 123.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.009 -0.676 . . . . 44.33 110.788 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -109.14 -35.37 6.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 64.5 110.023 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.643 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 3.1 t-20 -171.21 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.116 -0.947 . . . . 53.1 110.746 -173.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 53.1 Cg_endo -68.02 158.05 59.12 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.929 1.752 . . . . 55.41 112.213 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.87 175.0 6.9 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.963 2.442 . . . . 72.35 111.756 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 25.0 m0 -75.57 123.4 25.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.64 -0.254 . . . . 72.13 110.477 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.66 -123.02 1.11 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.384 -0.436 . . . . 72.24 112.428 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.24 -19.28 38.8 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.688 2.258 . . . . 43.54 111.452 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -17.03 16.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.035 -0.984 . . . . 63.03 111.713 177.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 29.1 mtpp . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.687 0.279 . . . . 74.0 111.034 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.273 -0.331 . . . . 63.12 112.273 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.48 -159.34 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.82 2.347 . . . . 61.1 112.017 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.65 169.94 12.18 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.667 -0.573 . . . . 62.12 111.667 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 t -76.88 78.54 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.492 -0.559 . . . . 60.0 109.492 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.7 ttp -91.66 171.33 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.654 . . . . 75.33 109.714 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 p -130.96 95.75 3.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.792 0.329 . . . . 54.22 111.704 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.8 mp0 -91.39 -4.13 56.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.233 -0.439 . . . . 63.1 110.474 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 m 74.63 -35.98 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.604 0.762 . . . . 63.44 112.295 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -78.25 147.96 34.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.669 -0.242 . . . . 34.12 110.699 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.18 154.12 0.14 Allowed Pre-proline 0 N--CA 1.471 0.601 0 O-C-N 123.588 0.555 . . . . 72.34 111.968 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.81 148.87 90.21 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.633 2.222 . . . . 73.44 111.474 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.62 -37.53 40.82 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.785 0.661 . . . . 73.14 112.785 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.53 -51.92 56.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.198 0.523 . . . . 72.41 110.243 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -46.41 65.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.251 -0.886 . . . . 71.21 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 7' ' ' GLU . 3.2 tm? -54.51 -50.15 68.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.566 -0.743 . . . . 75.11 110.785 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.55 -59.6 4.26 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.943 0.402 . . . . 71.0 111.301 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.62 77.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.182 -0.463 . . . . 33.24 111.224 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.98 -44.38 92.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.521 . . . . 73.14 110.837 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -68.46 -34.72 67.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.944 -0.391 . . . . 54.21 109.944 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.93 -43.32 91.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.695 -0.484 . . . . 74.2 109.695 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 44.7 mt-10 -66.46 -50.84 61.99 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.015 -0.539 . . . . 73.1 110.614 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -56.47 -44.24 80.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.159 -0.473 . . . . 73.21 111.044 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.0 mmt -62.68 -13.59 33.96 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.65 -0.705 . . . . 71.21 111.584 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 23.9 ttp85 -80.14 -30.64 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.394 -0.224 . . . . 75.14 110.394 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -99.8 -27.15 13.77 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.881 0.326 . . . . 70.3 111.881 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.6 m -99.58 20.39 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.837 0.351 . . . . 63.31 111.658 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.2 p -128.0 171.5 16.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.628 -0.508 . . . . 71.25 109.628 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -107.31 90.86 6.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.356 -0.609 . . . . 61.02 109.356 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.99 -1.43 10.82 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.3 2.0 . . . . 64.42 111.444 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.45 -57.69 5.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.57 -0.741 . . . . 71.15 110.5 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.4 -10.02 14.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 75.51 110.235 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.11 52.84 2.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.205 -0.521 . . . . 74.24 113.124 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -112.45 141.78 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.749 -0.463 . . . . 34.22 109.749 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -122.37 112.55 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.987 -0.552 . . . . 74.3 109.685 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.0 m -54.81 -34.47 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.108 -0.497 . . . . 74.12 112.12 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 9.3 p -56.0 -30.66 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.447 -0.342 . . . . 70.3 111.322 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.11 -18.36 63.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.162 -0.472 . . . . 74.24 111.503 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.9 mm? -69.03 -12.54 61.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.443 0.64 . . . . 70.52 109.861 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.35 21.89 62.69 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 114.881 -1.054 . . . . 74.22 114.849 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.3 tt -98.19 -31.71 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.902 -1.147 . . . . 70.15 107.902 164.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 26.0 t -65.69 -8.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.862 -1.063 . . . . 75.24 110.831 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -59.39 -26.11 64.85 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.073 0.464 . . . . 63.13 109.762 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.06 91.23 1.72 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.595 -0.729 . . . . 71.42 112.015 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.04 136.8 38.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.534 -0.543 . . . . 73.22 109.534 174.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.55 109.37 7.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.568 -0.53 . . . . 44.12 109.568 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.2 m -94.24 108.75 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.693 0.758 . . . . 72.41 109.757 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -100.13 120.96 40.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.455 -0.793 . . . . 64.42 110.027 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -107.08 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.678 -0.49 . . . . 65.12 109.678 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.85 -163.75 12.54 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.216 -0.516 . . . . 72.52 112.003 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.9 -27.9 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.515 0.674 . . . . 70.1 109.692 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.43 -39.33 81.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.013 -0.994 . . . . 63.33 109.77 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.84 -171.82 43.49 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.682 -0.69 . . . . 54.3 111.852 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.2 m -124.48 104.42 8.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.379 -0.6 . . . . 64.1 109.379 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.4 p -114.99 124.26 71.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.346 0.593 . . . . 64.24 112.1 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.08 107.53 19.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.766 . . . . 71.14 109.993 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -87.64 130.32 34.82 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.541 HG22 ' HG3' ' A' ' 59' ' ' MET . 45.1 mt -130.86 113.82 25.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.75 0.31 . . . . 63.53 110.622 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.36 116.5 20.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 72.42 109.723 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 57' ' ' ILE . 81.9 mtp -134.61 170.85 15.17 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.326 0.584 . . . . 72.31 111.373 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -152.59 161.13 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.289 -0.869 . . . . 55.22 109.245 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.2 mt -132.57 174.1 10.63 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.362 -0.607 . . . . 74.53 109.362 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.7 m -44.18 -42.43 6.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.483 0.489 . . . . 74.42 112.04 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -141.37 4.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.428 -0.351 . . . . 55.15 110.325 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 57.64 8.88 0.72 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.744 0.646 . . . . 44.13 112.744 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.73 15.06 15.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.224 0.535 . . . . 63.32 110.285 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 35.1 m -91.46 144.2 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.756 . . . . 72.05 110.296 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 26.6 Cg_exo -64.66 10.38 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 123.346 2.697 . . . . 74.42 113.377 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 71' ' ' VAL . 1.2 tt -75.08 -15.12 60.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -57.52 -45.76 84.6 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.51 -41.64 85.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.251 0.548 . . . . 54.01 110.253 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.595 ' HB ' HD23 ' A' ' 68' ' ' LEU . 60.3 t -63.4 -52.25 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.251 -0.886 . . . . 52.11 111.078 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.97 -41.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 120.779 -0.368 . . . . 72.21 111.13 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.23 -51.26 68.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.6 0.238 . . . . 73.34 110.803 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.84 -51.83 66.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 74.43 110.9 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -64.2 -43.97 93.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.356 -0.384 . . . . 72.33 111.146 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 -59.19 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 65.35 110.23 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.475 HH12 ' HB2' ' A' ' 107' ' ' ASP . 61.7 ttt180 -55.17 -45.95 75.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.552 -0.295 . . . . 71.41 110.83 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -55.16 -47.49 75.09 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.631 0.582 . . . . 74.25 111.131 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.3 -51.05 16.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.503 -0.317 . . . . 74.12 111.083 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.03 -39.62 82.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.377 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.87 -28.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.106 0.479 . . . . 52.43 109.882 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.07 -27.97 47.35 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.139 -0.553 . . . . 65.12 111.739 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 85' ' ' LEU . 19.4 m -70.93 -23.21 62.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.966 0.412 . . . . 74.04 110.461 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.09 -10.02 59.18 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.992 -0.549 . . . . 73.41 113.125 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.5 mp -61.51 -39.43 90.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.648 0.261 . . . . 61.52 110.652 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 m -143.39 152.29 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.12 -0.491 . . . . 75.02 109.752 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.12 -40.67 6.36 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 75.55 110.059 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 20.0 m-20 -102.99 139.43 38.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.923 -0.58 . . . . 64.14 109.9 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 9.4 pt -133.98 169.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.151 -0.685 . . . . 75.41 109.151 170.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' ILE . 22.8 mtt85 -156.35 106.61 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.134 -0.485 . . . . 64.34 109.837 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.73 113.46 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.819 -0.808 . . . . 71.14 108.819 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 103' ' ' LYS . 4.4 p-10 -105.53 140.69 38.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.981 0.419 . . . . 65.21 110.687 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.82 106.64 17.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.715 -0.675 . . . . 74.5 109.597 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 99' ' ' TRP . 10.7 m -113.04 131.09 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 65.1 112.065 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -152.73 8.86 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.023 -0.989 . . . . 65.53 110.621 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.3 m-20 -167.12 -60.05 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.586 0.354 . . . . 72.5 111.275 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 88.6 Cg_endo -78.17 159.51 30.02 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.042 1.828 . . . . 75.12 113.097 -171.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.7 137.07 37.72 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.053 2.502 . . . . 52.32 111.633 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.9 m-90 -53.88 109.79 0.51 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.724 0.64 . . . . 74.43 111.313 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.3 -78.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.862 -0.608 . . . . 63.4 111.817 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.59 -37.05 90.82 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.782 2.322 . . . . 64.54 111.375 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.54 -20.62 47.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.221 -0.899 . . . . 61.25 111.6 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 99' ' ' TRP . 54.4 mttp -89.4 10.55 22.15 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.753 0.279 . . . . 70.44 111.753 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -96.44 92.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.849 -0.426 . . . . 73.0 109.849 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.6 p -85.14 -179.26 6.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.212 -0.449 . . . . 73.54 111.305 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -29.9 44.14 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.958 -0.564 . . . . 65.42 111.484 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' HB2' HH12 ' A' ' 77' ' ' ARG . 32.1 t70 -57.13 -48.99 77.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.868 -0.606 . . . . 41.25 110.579 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.85 22.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.811 -0.631 . . . . 53.22 112.653 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -74.19 -50.75 17.87 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.054 0.39 . . . . 74.44 112.054 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -79.4 -34.41 41.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.993 0.425 . . . . 73.23 111.274 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HG2' ' HD2' ' A' ' 117' ' ' PHE . 41.9 mt-30 -102.12 26.63 7.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.061 -0.518 . . . . 72.5 111.017 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 113' ' ' ARG . 1.6 tt -71.23 147.52 48.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.196 -0.668 . . . . 74.23 109.196 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.619 ' H ' HD23 ' A' ' 112' ' ' LEU . 1.7 tmm_? -57.45 -35.07 69.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 72.31 110.444 -175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -33.01 67.0 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.025 -0.534 . . . . 63.23 110.966 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.2 mm? -83.33 -34.13 25.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 53.11 109.823 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.15 15.09 81.31 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.784 -0.644 . . . . 74.44 112.239 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.487 ' HD2' ' HG2' ' A' ' 111' ' ' GLN . 74.2 t80 -74.21 143.08 45.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 73.34 110.79 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.6 m -147.39 129.57 15.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.676 -0.693 . . . . 72.42 109.278 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.205 -0.903 . . . . 44.15 110.8 -176.53 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 112.21 -0.356 . . . . 52.12 112.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.05 64.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.536 2.158 . . . . 64.21 112.305 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' HA3' ' SD ' ' A' ' 5' ' ' MET . . . 148.95 -52.79 0.53 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 111.74 -0.544 . . . . 74.14 111.74 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p 48.57 43.96 20.59 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.086 0.554 . . . . 73.22 111.425 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.501 ' SD ' ' HA3' ' A' ' 3' ' ' GLY . 3.5 mpp? -70.82 -168.86 0.3 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.709 -0.678 . . . . 75.11 110.943 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m -133.68 -63.07 0.76 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.704 0.288 . . . . 74.33 111.267 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.699 ' HB3' HD21 ' A' ' 15' ' ' LEU . 1.1 mp0 53.4 36.2 22.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.57 0.7 . . . . 73.34 110.426 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -77.39 -16.68 58.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.423 -0.808 . . . . 72.54 111.746 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' HD13 ' A' ' 15' ' ' LEU . 22.7 p -93.34 154.25 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 74.21 111.158 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 149.36 0.12 Allowed Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.359 0.664 . . . . 71.51 112.377 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.65 153.72 54.38 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.55 2.167 . . . . 72.2 111.209 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.6 -40.69 28.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.579 0.585 . . . . 31.3 112.579 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.54 -50.14 68.61 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.165 0.507 . . . . 73.14 111.086 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -81.29 -47.48 13.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 75.22 110.452 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 7' ' ' GLU . 46.5 tp -54.04 -48.33 70.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.949 -1.023 . . . . 61.22 112.463 -172.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 tp -54.63 -59.28 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.68 0.276 . . . . 42.52 110.866 -174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -65.36 -40.19 93.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 74.52 110.829 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.21 -48.94 79.6 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.807 -0.633 . . . . 60.22 110.668 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 23' ' ' MET . 7.9 p -73.93 -32.79 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 70.23 109.675 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.1 -39.04 77.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.106 -0.497 . . . . 73.24 110.263 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 41.9 mt-10 -72.65 -51.7 18.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.429 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.99 -48.77 75.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 63.4 111.037 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.487 ' HG2' HG22 ' A' ' 19' ' ' VAL . 23.8 mmt -58.0 -13.55 4.85 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.51 -0.768 . . . . 62.52 111.832 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 24' ' ' ARG . 40.1 ttt-85 -87.97 -35.8 17.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.68 0.276 . . . . 74.14 110.584 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -90.15 -26.82 19.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.439 -0.346 . . . . 71.25 111.44 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ALA . 29.7 m -98.12 27.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.92 0.391 . . . . 71.21 111.35 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.96 162.68 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 62.04 110.172 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 m-20 -110.15 82.92 2.77 Favored Pre-proline 0 C--O 1.233 0.218 0 N-CA-C 109.071 -0.714 . . . . 54.53 109.071 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 14.38 2.07 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.736 2.291 . . . . 74.44 112.618 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.55 -58.34 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.145 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 33' ' ' ILE . 87.9 mt -115.78 3.64 13.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 73.23 110.438 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.44 39.72 4.96 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.037 -0.602 . . . . 72.03 112.633 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 31' ' ' LEU . 3.7 mp -88.68 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.843 -0.799 . . . . 71.13 108.843 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 52.1 t-20 -143.83 120.14 10.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.102 -0.333 . . . . 74.53 110.102 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -59.83 -32.03 48.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 54.43 110.739 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 HG11 ' A' ' 41' ' ' VAL . 91.7 t -59.27 -26.41 33.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.897 -0.592 . . . . 62.35 110.566 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 8.3 t0 -59.2 -27.46 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.971 -0.559 . . . . 75.2 111.022 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 38' ' ' LEU . 3.5 mm? -77.72 -8.41 57.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.755 0.312 . . . . 71.13 110.93 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.25 22.95 59.25 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.001 -0.545 . . . . 62.42 113.03 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.699 HD21 HG23 ' A' ' 94' ' ' VAL . 39.2 tp -93.3 -26.29 17.37 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.616 -0.343 . . . . 72.15 110.249 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.415 HG11 HG22 ' A' ' 36' ' ' VAL . 11.8 p -62.0 -12.19 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.924 -0.58 . . . . 72.23 110.824 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.94 -14.09 42.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.826 -0.624 . . . . 72.44 110.264 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.78 67.89 2.59 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.196 -0.761 . . . . 62.53 111.196 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.0 pp -120.96 141.77 50.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.103 -0.332 . . . . 64.1 110.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.03 110.77 1.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 71.34 110.185 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 38.7 t -93.66 126.06 46.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.441 -0.345 . . . . 71.25 110.304 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -121.35 133.06 55.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.428 -0.351 . . . . 75.43 110.662 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.2 p-10 -92.4 147.04 23.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.144 -0.687 . . . . 75.55 109.144 173.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.78 177.87 35.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.729 . . . . 62.54 112.171 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.08 -41.62 65.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.21 0.529 . . . . 74.4 111.059 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.54 17.73 9.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.54 -0.754 . . . . 72.2 111.701 -174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.41 174.91 17.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.151 -0.547 . . . . 73.22 112.981 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 13.9 m -102.79 109.15 20.64 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.126 -0.324 . . . . 63.11 110.126 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.73 135.97 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 75.21 111.168 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.531 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -93.78 105.02 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 61.31 109.917 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HB3' ' HE3' ' A' ' 103' ' ' LYS . 69.9 mt -70.97 113.39 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.538 -0.542 . . . . 73.03 109.538 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 63.9 mt -120.69 114.04 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 73.31 110.264 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -89.9 116.51 28.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.886 0.374 . . . . 75.41 110.188 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.1 mtp -125.57 170.66 11.25 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.538 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 40' ' ' LEU . 14.8 t -137.67 150.43 47.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.915 0.388 . . . . 73.41 110.7 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 3.2 mm? -118.17 147.5 43.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.312 -0.996 . . . . 53.44 108.312 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 m -42.42 -51.74 4.85 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.614 0.598 . . . . 63.01 112.614 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 t -116.83 6.54 13.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.567 0.222 . . . . 70.04 110.723 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.22 8.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.282 0.475 . . . . 71.34 112.282 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.93 16.67 12.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.591 0.71 . . . . 75.21 109.324 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 61' ' ' LEU . 10.3 m -72.25 133.24 83.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.797 -1.092 . . . . 44.43 110.753 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.38 -3.45 13.01 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.453 2.102 . . . . 75.32 111.694 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.21 -0.39 36.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 75.21 111.195 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 70' ' ' ASP . 13.1 t -62.54 -48.91 77.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.546 0.212 . . . . 55.14 110.551 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 69' ' ' THR . 15.9 t70 -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.255 0.55 . . . . 71.24 109.794 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.535 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 81.1 t -67.48 -52.61 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.78 -0.645 . . . . 73.55 110.912 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -68.31 -35.94 73.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 121.03 -0.268 . . . . 73.34 110.819 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 72' ' ' ILE . 45.3 mt-10 -58.37 -50.67 72.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.351 -0.611 . . . . 73.43 109.351 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.07 -51.37 69.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.729 . . . . 64.13 111.112 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 23.7 mm-40 -60.87 -56.76 17.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.999 0.428 . . . . 75.14 110.781 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.484 ' O ' HD23 ' A' ' 80' ' ' LEU . 32.4 t -61.27 -53.58 54.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.898 -0.592 . . . . 53.51 110.592 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.539 ' HG2' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -57.02 -46.96 81.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.079 -0.509 . . . . 74.11 110.434 -176.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 t -58.93 -43.36 91.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 73.35 110.95 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.97 -51.56 17.88 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.944 -0.302 . . . . 72.25 110.869 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -56.12 -41.07 74.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.312 -0.404 . . . . 64.42 110.771 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.76 -27.8 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 63.25 110.467 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.43 -47.58 56.6 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.842 -0.695 . . . . 74.45 111.766 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -77.36 -22.91 51.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.865 0.364 . . . . 61.43 110.029 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.25 26.32 28.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.155 -0.475 . . . . 44.05 113.262 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 80' ' ' LEU . 83.0 mt -62.55 -33.92 75.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.156 0.503 . . . . 73.42 110.168 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 55' ' ' ALA . 5.0 m -147.06 164.82 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.574 -0.739 . . . . 63.23 109.734 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.95 -40.96 75.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 62.0 110.188 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -158.15 172.89 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.672 -0.862 . . . . 63.31 108.672 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' HG2' ' A' ' 77' ' ' ARG . 16.6 pt -131.95 145.09 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.889 0.376 . . . . 71.31 110.074 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 4.5 tpt180 -120.66 106.77 12.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.625 -0.509 . . . . 75.33 109.625 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.7 mt -88.66 140.86 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 65.32 110.675 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.658 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -118.7 127.48 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.407 -0.59 . . . . 71.43 109.407 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.492 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.3 m-90 -87.23 106.62 18.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.891 -0.411 . . . . 73.45 109.891 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.699 HG23 HD21 ' A' ' 40' ' ' LEU . 14.6 m -118.5 158.95 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.746 0.308 . . . . 75.45 110.557 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -177.68 -31.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 73.01 110.262 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.693 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 44.2 t30 -155.27 -49.2 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.911 -0.586 . . . . 74.41 110.168 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.693 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 5.6 Cg_exo -76.68 147.76 28.24 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.07 1.846 . . . . 55.21 110.687 169.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 14.7 Cg_exo -69.58 -163.97 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.775 2.317 . . . . 75.14 112.439 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.4 m-90 -89.84 124.4 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 62.45 110.942 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -113.48 0.3 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.181 -0.533 . . . . 61.33 112.213 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.39 -17.84 54.25 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.724 2.282 . . . . 65.11 111.568 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' ND2' ' A' ' 92' ' ' ASN . 7.0 m-20 -67.09 -3.92 8.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 70.2 111.373 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 35.8 mmtm -76.54 -18.52 58.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.7 0.286 . . . . 71.51 110.319 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -75.75 99.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.766 -0.457 . . . . 72.3 109.766 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.455 ' HB ' ' OE1' ' A' ' 73' ' ' GLU . 41.0 p -59.71 154.08 18.84 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.74 -0.663 . . . . 74.21 112.175 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.99 -26.78 63.29 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.004 -0.739 . . . . 75.33 109.004 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 10.9 t70 -57.01 -39.44 74.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.439 -0.801 . . . . 61.22 110.035 171.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -39.99 53.85 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.85 -0.614 . . . . 72.03 112.855 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -60.28 -33.85 72.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.968 0.414 . . . . 73.55 111.329 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -75.72 -14.06 60.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.31 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.506 ' HA ' HD22 ' A' ' 115' ' ' LEU . 43.3 mt-30 -112.11 77.26 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.268 0.556 . . . . 65.21 110.842 -172.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -111.22 -172.82 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.327 -0.851 . . . . 72.23 109.826 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -60.83 -35.94 77.84 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.917 0.389 . . . . 71.01 111.192 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.31 -16.68 62.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.14 111.587 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 111' ' ' GLN . 53.0 tp -73.72 -13.08 60.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.853 0.359 . . . . 64.54 110.59 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.04 -4.7 73.27 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.188 -0.53 . . . . 42.41 112.64 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.08 40.25 1.7 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.07 0.462 . . . . 75.11 110.796 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -75.42 138.42 41.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.071 -0.513 . . . . 73.31 110.764 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.822 -0.608 . . . . 61.34 110.049 -178.408 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.706 -0.558 . . . . 44.13 111.706 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.85 -70.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.707 2.272 . . . . 63.52 112.124 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.82 75.95 1.23 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.037 -0.601 . . . . 63.15 111.84 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 m -64.3 -37.53 87.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.033 0.444 . . . . 42.34 110.297 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 19.9 ptp -108.36 101.15 10.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.561 -0.533 . . . . 64.2 109.561 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -144.07 -65.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.041 -0.527 . . . . 72.43 110.543 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.59 103.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.567 . . . . 74.53 110.855 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.4 m -104.86 104.03 13.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.43 110.711 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HD13 ' A' ' 15' ' ' LEU . 32.3 t -158.55 149.3 20.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.759 -0.46 . . . . 63.21 109.759 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.96 162.78 0.14 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.303 0.377 . . . . 62.43 111.742 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.49 -178.98 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.352 2.034 . . . . 65.53 111.836 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.6 -66.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.081 0.771 . . . . 60.32 113.081 -170.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -65.84 -41.07 92.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.504 -0.317 . . . . 75.25 111.543 -174.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -60.99 -39.4 89.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.412 . . . . 61.11 110.678 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 9' ' ' SER . 38.4 tp -59.01 -43.38 91.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.286 -0.416 . . . . 70.14 110.349 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -57.71 -52.21 66.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 71.53 110.087 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.69 -51.96 67.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.725 -0.67 . . . . 73.31 110.94 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.6 -48.04 82.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.915 -0.584 . . . . 64.31 111.125 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.1 p -66.64 -32.97 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.131 -0.322 . . . . 72.23 110.131 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.28 -45.22 92.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.092 -0.336 . . . . 73.31 110.092 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.57 -51.56 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.205 0.526 . . . . 65.45 110.0 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.99 -47.38 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.407 -0.815 . . . . 71.21 110.889 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.4 mmt -62.54 -13.39 30.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.354 0.502 . . . . 60.53 112.354 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 24' ' ' ARG . 2.7 tpp180 -99.06 -13.8 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.142 -0.349 . . . . 74.44 111.059 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -119.52 -26.5 5.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.295 0.569 . . . . 63.54 110.411 -173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.08 -15.8 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.946 0.879 . . . . 73.31 109.805 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 7.8 p -92.95 163.77 2.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 114.917 -1.038 . . . . 74.44 109.67 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -104.0 91.86 4.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.453 -0.943 . . . . 52.21 108.453 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 93.8 Cg_endo -83.01 -4.31 11.21 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.483 2.122 . . . . 63.03 111.944 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -69.02 -57.64 5.17 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.036 -0.529 . . . . 74.13 110.288 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.45 -17.49 17.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 71.44 110.546 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.82 43.34 3.62 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.026 -0.533 . . . . 73.12 113.351 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.0 mp -108.28 140.82 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.559 -0.534 . . . . 74.25 109.559 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.45 121.2 37.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 70.15 109.411 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.19 -27.38 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.972 -0.558 . . . . 73.43 112.014 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 p -62.19 -24.5 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.993 0.425 . . . . 72.42 110.817 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.94 -15.45 62.98 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.122 -0.49 . . . . 61.24 111.333 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.76 -16.67 61.75 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.039 0.447 . . . . 73.35 110.051 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.69 22.72 64.4 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.628 -0.715 . . . . 71.42 114.12 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -98.71 -31.35 11.95 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.143 -0.688 . . . . 71.53 109.143 170.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.47 -19.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.153 -0.93 . . . . 65.0 112.342 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.26 -23.81 16.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.786 0.327 . . . . 71.14 110.742 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.25 76.08 2.18 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.504 -0.638 . . . . 44.2 111.504 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -128.3 132.69 48.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 74.44 110.792 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -149.75 173.0 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.509 -0.922 . . . . 71.23 108.509 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 55' ' ' ALA . 20.5 m -137.2 142.63 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.791 -0.448 . . . . 75.45 109.791 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -113.02 121.01 43.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.987 -0.375 . . . . 63.43 109.987 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 112.43 15.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.116 -0.493 . . . . 72.41 109.819 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.07 158.34 14.53 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.064 -0.589 . . . . 41.32 112.273 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.32 -34.99 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.863 0.465 . . . . 63.43 111.377 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.63 -0.7 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 73.04 111.186 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.47 155.1 6.42 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.316 -0.468 . . . . 62.54 112.318 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -74.7 121.68 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.251 -0.277 . . . . 65.12 110.251 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.75 135.26 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 74.43 110.125 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -98.8 124.48 43.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.398 0.142 . . . . 62.14 110.802 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.2 mt -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.168 -0.308 . . . . 53.01 110.168 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 59' ' ' MET . 30.9 mm -126.28 112.72 30.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 120.686 0.279 . . . . 64.3 110.384 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m-20 -80.24 121.69 25.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.497 -0.557 . . . . 73.2 109.497 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.523 ' HG3' HG22 ' A' ' 57' ' ' ILE . 85.7 mtp -136.62 171.2 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.709 0.29 . . . . 70.13 110.63 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 40' ' ' LEU . 15.2 t -152.92 163.14 40.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.07 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.8 mt -132.47 160.35 36.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.314 -0.624 . . . . 73.32 109.314 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -48.02 -54.6 12.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.585 0.553 . . . . 63.01 112.117 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 t -111.64 -9.68 14.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.771 0.32 . . . . 50.5 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 63.68 8.4 3.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.86 -0.609 . . . . 74.54 112.194 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.38 10.48 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.605 0.717 . . . . 73.12 109.072 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 68' ' ' LEU . 27.8 m -75.63 140.31 71.44 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 114.884 -1.053 . . . . 53.32 110.362 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.85 15.35 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.804 2.336 . . . . 70.13 112.81 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.0 mp -86.99 -5.78 58.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.38 -0.373 . . . . 74.21 110.459 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.6 t -61.58 -53.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.461 -0.336 . . . . 63.23 110.964 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.32 -27.65 67.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 74.41 110.266 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 70.0 t -65.01 -52.5 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.51 . . . . 55.04 110.369 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HE1' ' A' ' 93' ' ' TRP . 2.8 pp -68.74 -29.58 44.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.637 0.256 . . . . 64.33 110.753 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' N ' HD12 ' A' ' 72' ' ' ILE . 44.8 mt-10 -62.4 -48.16 80.95 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.409 -0.359 . . . . 75.31 110.131 173.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.87 -46.81 87.79 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.949 0.404 . . . . 74.44 110.419 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 96.6 mt-30 -55.53 -53.34 57.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.694 . . . . 53.42 111.143 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -68.04 -52.26 37.38 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.03 -0.532 . . . . 75.34 111.123 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -54.78 -46.38 74.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.652 -0.129 . . . . 63.44 110.652 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.2 p -60.27 -45.08 94.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.339 -0.392 . . . . 62.12 111.425 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.6 20.26 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.811 -0.355 . . . . 33.4 110.847 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.96 -29.49 70.85 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.884 0.373 . . . . 75.51 110.977 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -84.19 -27.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 44.2 109.925 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.5 -31.04 77.56 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.448 -0.661 . . . . 62.14 111.448 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.497 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 46.8 m -92.55 -10.02 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.379 . . . . 75.4 110.312 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.63 43.38 92.19 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.93 -0.577 . . . . 73.11 112.262 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 74.6 mt -86.43 -36.48 19.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.838 0.352 . . . . 74.53 110.9 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 55' ' ' ALA . 29.6 m -139.24 162.39 27.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.921 -0.581 . . . . 74.41 110.242 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.35 -37.28 28.53 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.855 0.36 . . . . 42.44 110.217 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.5 167.92 28.95 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.44 0.638 . . . . 53.43 110.715 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 55' ' ' ALA . 44.6 pt -124.44 135.55 63.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.42 -0.809 . . . . 73.41 110.689 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.81 106.32 16.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.276 -0.638 . . . . 54.43 109.276 171.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 57' ' ' ILE . 64.2 mt -99.32 120.02 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.782 -0.822 . . . . 74.43 108.782 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -111.5 129.93 55.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.87 -0.419 . . . . 73.13 109.87 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.604 ' HE1' HD11 ' A' ' 72' ' ' ILE . 4.8 m-90 -100.76 106.13 17.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 72.21 110.541 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.93 124.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 73.32 109.987 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -139.19 -6.93 1.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 74.14 111.845 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.5 t30 174.93 -52.82 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 122.409 0.283 . . . . 63.04 110.869 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 61.6 Cg_endo -70.55 145.75 53.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.739 1.626 . . . . 71.3 112.004 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.71 142.24 82.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.648 2.232 . . . . 72.0 111.647 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -46.63 109.24 0.18 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 123.691 0.619 . . . . 71.4 111.904 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -87.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.766 -0.652 . . . . 52.12 112.132 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.37 -30.49 80.76 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.928 2.419 . . . . 75.34 112.365 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 17.3 p-10 -65.16 -10.67 33.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 71.15 111.18 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.08 -3.51 57.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.277 -0.42 . . . . 71.12 111.623 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.34 98.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 61.04 110.875 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 90' ' ' ARG . 17.7 p -76.52 -178.11 4.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.571 -0.741 . . . . 73.33 112.305 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 14.3 pt-20 -51.25 -21.07 1.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.508 -0.769 . . . . 74.23 112.686 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -52.5 64.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.793 0.33 . . . . 72.05 110.34 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.35 -42.5 9.25 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 116.083 -0.508 . . . . 73.24 111.975 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 59.5 ttt180 -53.52 -42.31 67.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.155 0.582 . . . . 71.24 111.85 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.73 -24.64 63.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.906 -0.588 . . . . 62.21 111.26 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -124.54 90.41 3.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.3 110.846 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.4 tp -152.71 154.93 36.25 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.099 0.476 . . . . 53.32 110.513 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -67.79 -30.22 69.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 75.3 111.02 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.38 -13.69 32.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.506 . . . . 64.54 112.023 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 115' ' ' LEU . 5.9 tt -86.49 -26.08 24.79 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.723 -0.473 . . . . 63.05 109.723 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.83 21.78 2.0 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.958 -0.564 . . . . 72.42 114.135 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -93.54 -8.05 42.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.233 0.517 . . . . 72.43 109.942 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.4 m -80.51 108.28 14.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.544 -0.753 . . . . 54.33 111.558 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.757 -0.656 . . . . 54.24 109.755 175.094 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.596 -0.602 . . . . 20.22 111.596 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.13 -62.71 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.6 2.2 . . . . 74.14 111.781 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.3 16.45 8.61 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.834 -0.621 . . . . 72.15 111.626 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -66.78 84.0 0.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.709 0.29 . . . . 75.11 110.423 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.0 ttm -156.89 34.43 0.3 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.614 0.721 . . . . 71.52 109.538 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 p -85.57 1.42 49.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.23 -0.895 . . . . 51.25 110.742 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.32 103.61 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.166 -0.924 . . . . 72.25 110.495 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -91.36 95.13 9.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.989 -0.551 . . . . 72.14 110.822 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -162.0 140.45 9.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.721 -0.474 . . . . 75.34 109.721 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 64.74 160.93 0.12 Allowed Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 123.477 0.485 . . . . 74.51 111.965 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 44.0 Cg_endo -68.83 169.02 18.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.258 1.972 . . . . 52.13 111.992 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.48 3.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.43 0.9 . . . . 61.44 113.43 -172.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -63.92 -48.56 76.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.921 0.391 . . . . 63.02 111.001 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -63.34 -40.63 97.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.763 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.79 -46.36 88.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 73.25 110.14 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 tp -54.93 -55.37 31.36 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.41 -0.359 . . . . 35.21 110.998 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.987 -0.551 . . . . 54.44 111.292 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.3 -48.39 81.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.894 -0.594 . . . . 74.13 111.12 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.43 -33.83 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.928 -0.397 . . . . 74.12 109.928 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -58.96 -48.74 80.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.088 -0.338 . . . . 64.11 110.088 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.15 -45.61 73.08 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 74.13 110.839 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.15 -38.85 74.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 72.11 110.679 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.5 mmt -62.69 -12.68 25.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.606 -0.725 . . . . 72.24 111.563 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -85.79 -23.36 27.26 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.623 0.249 . . . . 72.45 110.82 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.63 -27.43 9.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.363 0.505 . . . . 50.04 112.363 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.5 m -95.92 21.11 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.22 0.533 . . . . 73.12 111.099 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 5.2 p -134.27 161.32 40.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 71.32 110.589 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.25 93.68 1.94 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.957 -1.127 . . . . 51.05 107.957 165.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 95.6 Cg_endo -82.93 -9.8 10.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.226 1.951 . . . . 72.23 111.392 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.5 -41.81 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.146 -0.934 . . . . 72.11 110.439 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.94 -18.56 11.24 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.377 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.86 44.02 3.45 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.224 -0.512 . . . . 74.24 113.655 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -121.64 141.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.965 -0.754 . . . . 61.25 108.965 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 36' ' ' VAL . 8.7 p30 -107.73 141.85 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.771 -0.455 . . . . 74.24 109.771 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.77 -29.41 42.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.328 0.585 . . . . 72.45 110.747 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HB ' ' OD1' ' A' ' 34' ' ' ASN . 43.8 t -60.11 -24.62 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.688 -0.687 . . . . 75.04 110.548 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -56.04 -28.93 59.48 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.503 -0.317 . . . . 72.32 111.254 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.13 -14.55 60.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.154 0.502 . . . . 75.31 110.504 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.65 22.17 52.22 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.218 -0.901 . . . . 73.12 114.024 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.0 tp -98.22 -29.69 13.05 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.329 -0.619 . . . . 43.21 109.329 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.45 -13.15 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.204 -0.907 . . . . 62.23 111.145 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.14 -23.26 62.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.06 0.457 . . . . 65.34 109.882 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 50.37 3.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.741 -0.663 . . . . 53.34 112.163 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -109.09 136.88 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.715 -0.476 . . . . 75.41 109.715 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -157.25 113.82 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 74.14 109.76 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.7 p -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.781 -0.452 . . . . 74.54 109.781 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -125.13 153.24 43.31 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.053 0.454 . . . . 74.12 110.314 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -81.34 151.86 27.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.557 -0.747 . . . . 62.25 110.387 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.57 159.77 33.04 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.074 -0.81 . . . . 73.44 111.074 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.14 -21.06 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.079 0.439 . . . . 62.51 110.929 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.01 -20.27 62.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.979 -0.748 . . . . 61.44 108.979 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.15 162.24 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.909 -1.041 . . . . 72.24 111.103 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -70.92 107.03 3.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.505 -0.924 . . . . 73.44 108.505 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.24 130.01 60.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 54.14 111.46 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.45 104.38 16.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 62.2 110.558 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 90' ' ' ARG . 48.8 mt -78.18 128.67 34.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.003 -0.74 . . . . 65.4 109.003 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.0 mt -141.01 116.64 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.833 0.349 . . . . 64.44 110.686 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.41 122.76 30.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 75.21 109.726 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.517 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.2 mtp -135.63 170.56 15.78 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.4 0.619 . . . . 72.34 111.721 -174.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -161.97 150.16 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.104 -0.953 . . . . 65.44 109.39 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.59 148.46 22.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.738 -0.838 . . . . 73.32 108.738 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 -48.58 30.82 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.51 0.559 . . . . 43.41 112.51 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 26.5 t -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.869 0.366 . . . . 73.2 110.677 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.52 8.33 1.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.762 -0.653 . . . . 73.03 112.003 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.22 3.81 10.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.211 0.529 . . . . 75.22 110.177 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 63' ' ' SER . 27.5 m -81.04 126.72 76.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.486 -0.779 . . . . 74.52 110.657 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.63 32.02 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.014 2.476 . . . . 65.03 112.346 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.02 6.61 18.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.044 -0.526 . . . . 74.02 110.794 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -56.94 -42.8 80.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 73.02 110.866 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.47 -41.31 98.69 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.401 0.62 . . . . 75.03 110.163 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.39 -46.5 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.234 -0.894 . . . . 70.11 110.857 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.17 -37.87 77.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 121.198 -0.201 . . . . 51.43 111.068 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.84 -49.6 77.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.22 110.683 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.08 -51.39 68.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.118 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -63.1 -38.55 91.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.43 -0.35 . . . . 71.04 111.816 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' HD23 ' A' ' 80' ' ' LEU . 61.6 p -67.22 -54.97 16.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.904 -0.406 . . . . 61.44 109.904 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -54.76 -41.6 70.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.968 -0.56 . . . . 71.43 110.932 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.8 m -54.89 -53.16 59.0 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.275 -0.42 . . . . 51.41 111.763 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -51.56 13.85 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.65 -0.42 . . . . 74.03 111.221 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -58.6 -37.9 76.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.046 0.451 . . . . 74.31 111.51 -173.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.8 t -82.34 -27.37 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.193 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.28 -47.26 91.68 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.303 -0.475 . . . . 34.22 112.496 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.6 m -87.54 -5.1 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.409 . . . . 63.32 110.498 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.88 31.46 69.97 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.922 -0.581 . . . . 64.03 112.811 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 -38.21 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.029 0.442 . . . . 74.54 110.319 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 80' ' ' LEU . 20.6 m -128.39 159.48 39.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.94 -0.573 . . . . 53.12 110.049 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.7 -30.95 24.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.496 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -158.23 165.78 34.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.134 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -128.05 144.35 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.76 -0.459 . . . . 75.15 109.76 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.429 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.9 tpp180 -127.43 106.09 8.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.2 -0.667 . . . . 74.13 109.2 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.45 143.85 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.751 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -117.38 120.36 37.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.348 -0.982 . . . . 74.05 108.348 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.554 ' HH2' ' HA ' ' A' ' 105' ' ' THR . 8.8 m-90 -97.85 106.32 18.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.779 -0.452 . . . . 72.2 109.779 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.506 HG21 ' HE1' ' A' ' 99' ' ' TRP . 12.1 t -90.97 123.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.326 -0.397 . . . . 64.43 110.123 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -119.53 -24.13 6.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.809 -0.632 . . . . 73.4 109.592 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 49.7 t30 175.8 -49.7 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.095 -0.957 . . . . 61.52 110.418 -173.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 48.9 Cg_endo -67.59 145.17 69.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.818 1.679 . . . . 51.44 111.971 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 27.4 Cg_exo -63.91 168.55 11.86 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.003 2.469 . . . . 73.54 112.485 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.506 ' HE1' HG21 ' A' ' 94' ' ' VAL . 10.8 m0 -69.54 165.46 20.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.945 -0.57 . . . . 73.45 111.222 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.11 -129.53 2.75 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.977 -0.556 . . . . 41.03 111.827 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.7 -9.63 19.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.859 2.372 . . . . 72.44 112.489 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.59 -15.39 58.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.77 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.718 ' HG2' ' HB2' ' A' ' 92' ' ' ASN . 52.3 mttp -76.17 -9.76 58.88 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.329 -0.396 . . . . 72.4 110.939 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 96.83 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.132 -0.692 . . . . 74.21 109.132 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.554 ' HA ' ' HH2' ' A' ' 93' ' ' TRP . 19.5 p -62.24 156.35 22.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.871 -0.604 . . . . 73.43 111.693 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -56.85 -33.18 66.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.762 -0.654 . . . . 64.21 110.217 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 21.8 t70 -56.78 -45.58 82.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.616 -0.72 . . . . 63.51 110.358 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.54 98.68 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.804 -0.634 . . . . 71.1 111.965 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -57.63 -41.65 81.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.009 0.433 . . . . 75.5 110.161 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.32 -23.59 65.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.7 . . . . 73.41 111.886 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.438 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 43.6 mt-30 -109.08 5.61 24.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 74.12 110.836 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.6 -69.57 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.496 -0.774 . . . . 71.1 109.826 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -53.42 -29.44 35.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 74.15 109.604 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 111' ' ' GLN . . . -69.56 -7.17 36.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.826 -1.079 . . . . 41.04 112.166 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 115' ' ' LEU . 4.2 pp -62.55 -18.75 62.71 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.921 0.341 . . . . 74.44 111.921 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.0 39.4 1.96 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.905 -0.664 . . . . 75.33 112.701 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 t80 64.82 4.31 2.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.006 0.431 . . . . 75.54 111.565 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 m -71.2 85.55 0.76 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.945 0.402 . . . . 62.43 110.792 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.17 -0.919 . . . . 64.32 110.315 178.884 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 111.838 -0.505 . . . . 31.43 111.838 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.76 110.3 2.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.585 2.19 . . . . 75.24 111.902 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.78 102.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.166 -0.54 . . . . 73.53 111.77 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.8 t -166.89 -178.62 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 43.23 109.986 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.99 14.83 6.32 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.177 -0.675 . . . . 70.32 109.177 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 p -150.16 -157.3 0.8 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.13 -0.941 . . . . 64.0 109.456 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.62 83.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 71.42 111.745 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.0 p -136.95 107.8 6.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.03 -0.532 . . . . 61.3 110.816 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.601 ' HB3' HD23 ' A' ' 85' ' ' LEU . 22.8 t -158.5 157.96 33.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.661 -0.866 . . . . 62.25 108.661 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 67.85 164.84 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 123.317 0.386 . . . . 74.41 110.685 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 26.2 Cg_endo -62.55 153.43 71.52 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.241 1.96 . . . . 73.41 111.761 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.46 -44.63 12.48 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.878 0.696 . . . . 71.43 112.878 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -63.2 -51.63 65.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.999 0.428 . . . . 63.02 110.896 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.44 -44.25 79.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 72.33 110.611 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.49 -42.34 78.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 54.12 110.537 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 tp -55.91 -58.32 8.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 73.55 110.875 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.24 89.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.02 -0.536 . . . . 61.34 111.331 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.64 -48.03 81.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.009 -0.541 . . . . 74.01 110.871 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.13 -33.65 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 54.32 110.356 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.61 -49.81 73.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.024 0.44 . . . . 71.05 109.849 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.72 -48.47 71.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 74.31 110.513 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -37.66 73.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.853 -0.612 . . . . 72.01 111.758 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 mmt -71.22 -13.54 61.95 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.078 0.466 . . . . 63.32 110.051 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -101.61 0.74 36.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.511 -0.768 . . . . 74.54 111.372 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -119.46 -27.85 5.47 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.289 0.566 . . . . 74.2 110.063 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -92.39 -16.91 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.895 -1.048 . . . . 53.14 110.757 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.3 p -84.83 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 54.41 110.33 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -104.45 87.82 1.88 Allowed Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 108.758 -0.83 . . . . 70.31 108.758 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 89.4 Cg_endo -84.98 -1.66 9.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.457 2.105 . . . . 75.04 111.071 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' HG2' HD12 ' A' ' 31' ' ' LEU . 41.7 tt0 -68.58 -57.65 5.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.442 -0.799 . . . . 74.25 110.206 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.405 HD12 ' HG2' ' A' ' 30' ' ' GLU . 7.3 mp -98.95 -17.14 18.48 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.841 -0.429 . . . . 73.05 109.841 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.76 40.97 4.24 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.984 -0.553 . . . . 61.15 113.415 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -108.9 140.18 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.343 -0.614 . . . . 71.14 109.343 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.635 ' HA ' HG23 ' A' ' 27' ' ' VAL . 2.0 m120 -108.67 138.17 45.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.229 -0.656 . . . . 63.33 109.229 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.11 -30.17 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.168 0.509 . . . . 63.41 110.678 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 34' ' ' ASN . 13.5 p -58.24 -24.39 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.798 -0.637 . . . . 74.33 110.655 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.62 -29.1 58.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.707 -0.678 . . . . 61.41 111.195 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.7 -17.06 61.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.913 0.387 . . . . 73.2 110.488 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.51 22.71 57.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.732 -0.667 . . . . 64.02 113.371 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 94' ' ' VAL . 33.1 tp -98.06 -16.73 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 64.3 110.079 175.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.55 -15.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.898 -0.592 . . . . 74.43 111.298 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -70.04 -23.16 63.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.598 0.713 . . . . 74.33 109.121 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' ASP . . . -85.44 95.67 2.01 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.956 -1.02 . . . . 61.15 111.031 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -146.47 132.74 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.157 -0.683 . . . . 63.3 109.157 173.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.99 109.02 9.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.306 -0.628 . . . . 74.4 109.306 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 55' ' ' ALA . 16.1 m -93.56 115.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.276 -0.638 . . . . 74.21 109.276 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.8 124.27 42.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.531 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.29 89.13 5.5 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.729 0.776 . . . . 62.1 109.729 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.38 164.55 45.71 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.511 -1.222 . . . . 72.35 111.481 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.2 -37.04 69.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.001 0.429 . . . . 61.41 110.575 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.24 -39.66 71.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 75.32 110.079 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.48 -178.44 39.73 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.702 -0.681 . . . . 64.21 111.549 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.1 m -81.75 112.2 18.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.811 0.339 . . . . 73.12 110.62 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.39 124.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 74.01 109.866 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -88.54 106.34 18.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 73.54 111.083 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.97 101.97 14.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 74.11 109.913 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 59' ' ' MET . 53.3 mt -96.93 132.31 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.567 -0.288 . . . . 73.24 110.617 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.2 m-20 -94.01 113.45 25.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.03 110.076 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 90.2 mtp -141.04 171.05 14.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 73.34 110.646 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -163.05 162.05 25.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 65.23 109.649 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -106.6 171.83 7.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.945 -0.761 . . . . 41.05 108.945 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -44.63 -56.76 4.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.118 0.485 . . . . 73.54 111.48 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.6 t -104.22 -2.28 25.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 64.43 110.672 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.85 8.82 2.63 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.917 -0.583 . . . . 54.53 112.033 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.88 -8.81 12.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.994 0.426 . . . . 63.13 110.47 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.0 m -57.49 139.82 80.47 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.459 -0.791 . . . . 74.23 111.004 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.85 17.56 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.011 2.474 . . . . 71.43 112.788 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.33 -4.16 58.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 65.24 110.462 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 70' ' ' ASP . 4.8 t -61.93 -54.01 47.72 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.329 -0.396 . . . . 63.42 111.339 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' THR . 6.8 p-10 -64.98 -28.54 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 73.44 109.597 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 60.1 t -65.88 -52.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.49 -0.777 . . . . 75.53 110.52 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -69.02 -32.39 54.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 121.108 -0.237 . . . . 73.01 111.585 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 72' ' ' ILE . 8.5 mt-10 -64.5 -45.04 89.01 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.589 -0.444 . . . . 64.31 109.874 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.01 -49.12 77.94 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 74.15 110.764 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 95.3 mt-30 -56.82 -55.91 28.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.981 -0.554 . . . . 72.03 110.868 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -61.15 -53.23 59.57 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.94 -0.573 . . . . 73.54 110.798 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -56.12 -48.88 75.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -53.68 -50.58 65.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 64.34 111.161 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.74 14.21 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.694 -0.402 . . . . 63.14 111.556 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 89' ' ' ILE . 78.8 mt -60.96 -37.35 82.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 53.43 110.921 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.2 t -78.21 -27.73 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 64.12 110.145 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.5 -48.05 46.55 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.018 -0.611 . . . . 64.45 111.746 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -82.09 -23.13 35.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.134 0.492 . . . . 74.25 109.854 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.77 42.03 6.98 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.977 -0.556 . . . . 63.01 113.533 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 9' ' ' SER . 6.2 mp -71.0 -38.27 72.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.975 0.417 . . . . 74.43 109.887 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.5 m -137.1 170.02 18.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.61 -0.723 . . . . 74.22 110.011 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.19 -48.66 64.62 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.285 0.564 . . . . 70.23 109.556 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.4 -179.03 5.77 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.089 -0.959 . . . . 64.35 108.587 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 80' ' ' LEU . 35.1 pt -122.43 177.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.371 0.605 . . . . 64.32 111.167 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.732 ' HG2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -155.56 106.01 2.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.496 -1.298 . . . . 74.22 107.496 170.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 73' ' ' GLU . 52.6 mt -95.56 101.25 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.609 -0.515 . . . . 74.45 109.609 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -88.78 139.93 29.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.712 -0.676 . . . . 52.13 109.364 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.592 ' HA ' ' O ' ' A' ' 59' ' ' MET . 3.3 m-90 -95.25 106.07 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.553 -0.536 . . . . 73.43 109.553 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 40' ' ' LEU . 3.4 p -120.03 124.25 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.31 0.576 . . . . 73.44 110.175 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 1.1 p-90 -147.96 11.89 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.27 -0.877 . . . . 64.1 110.111 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 35.5 t30 -174.94 -60.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.968 -0.56 . . . . 74.42 111.347 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 85.0 Cg_endo -78.26 140.02 17.18 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.755 1.637 . . . . 42.05 112.528 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.56 151.84 51.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.662 2.241 . . . . 62.1 111.38 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -59.74 123.9 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 61.14 111.224 -172.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.54 -120.04 1.52 Allowed Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.003 -0.544 . . . . 64.13 111.765 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 -14.91 45.07 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.628 2.219 . . . . 74.34 111.66 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.47 -26.62 61.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.533 -0.758 . . . . 71.13 110.325 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 73.8 mmtt -77.09 9.03 3.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.925 -0.58 . . . . 74.51 111.457 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.41 134.16 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 110.047 -0.353 . . . . 72.44 110.047 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.732 HG23 ' HG2' ' A' ' 90' ' ' ARG . 12.3 p -66.12 151.29 47.24 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.787 0.327 . . . . 42.42 111.587 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.28 -39.54 89.46 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.887 -0.783 . . . . 74.1 108.887 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.03 -48.63 78.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.945 -1.025 . . . . 75.22 109.747 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.06 -44.23 98.06 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.373 -0.83 . . . . 22.42 112.692 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -63.58 -40.49 97.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.674 0.237 . . . . 74.42 110.708 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -61.82 -35.82 79.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.146 0.498 . . . . 73.3 110.836 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -105.87 24.94 11.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.782 -0.645 . . . . 71.11 110.717 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.4 tp -80.07 158.24 26.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 72.54 109.697 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -66.89 -32.33 73.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 75.11 110.522 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.77 -7.45 53.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.723 -0.671 . . . . 62.34 111.51 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.95 24.71 8.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.219 0.533 . . . . 75.0 109.92 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.54 68.64 0.22 Allowed Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.866 -0.607 . . . . 73.21 112.673 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -121.2 167.11 13.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 74.31 110.589 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -81.83 150.68 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.854 -0.612 . . . . 74.21 110.637 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.676 -0.678 . . . . 64.21 110.066 178.001 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 111.807 -0.517 . . . . 50.12 111.807 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.84 121.24 8.69 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.41 2.073 . . . . 74.23 111.167 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.75 117.4 3.45 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 121.029 -0.605 . . . . 43.14 111.724 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 t -92.54 118.43 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.333 -0.617 . . . . 50.44 109.333 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.3 mtm -80.09 158.86 26.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.02 0.438 . . . . 75.32 110.932 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -144.5 -51.87 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.076 -0.713 . . . . 63.43 109.076 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 51.68 33.49 11.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.081 -0.963 . . . . 74.51 112.321 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 m -73.19 84.98 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.696 0.284 . . . . 43.23 110.578 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 t -171.78 152.66 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 74.1 109.78 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.63 154.82 0.14 Allowed Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 123.441 0.463 . . . . 72.23 112.023 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 14' ' ' GLU . 29.8 Cg_endo -66.01 168.61 15.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.469 2.112 . . . . 63.43 111.951 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.96 -67.22 0.27 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.184 1.179 . . . . 72.24 114.184 -167.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.82 -35.1 67.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 74.4 111.187 -172.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 20.0 mp0 -57.7 -46.84 83.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.591 -0.522 . . . . 54.53 109.591 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.8 -46.72 89.4 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.475 -0.784 . . . . 75.1 110.739 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.6 tp -52.79 -60.31 3.43 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.295 0.569 . . . . 54.35 110.874 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.44 69.28 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.091 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.86 -41.19 97.84 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.74 -0.664 . . . . 74.42 111.322 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.83 -35.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.575 -0.528 . . . . 43.04 109.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.19 -45.94 79.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.948 0.404 . . . . 74.22 109.966 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.37 -43.55 63.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 63.02 111.014 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.06 78.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.803 -0.635 . . . . 73.4 110.885 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -62.66 -13.44 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.579 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -87.28 -23.04 24.81 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.503 0.192 . . . . 65.34 111.428 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -116.01 -27.02 7.08 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.318 0.58 . . . . 73.13 110.11 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -27.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.032 -0.985 . . . . 62.32 110.101 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.5 p -91.32 165.1 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 63.32 109.697 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.5 91.95 5.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.81 . . . . 74.04 108.812 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.9 -7.53 13.3 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.326 2.017 . . . . 75.02 111.178 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -68.67 -57.96 4.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 72.43 110.619 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.49 -18.61 17.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 75.12 110.241 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.21 52.12 1.94 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.247 -0.501 . . . . 64.31 113.173 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.8 mp -126.91 141.55 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.667 -0.494 . . . . 62.11 109.667 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.444 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.4 p30 -108.77 138.6 44.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.017 -0.734 . . . . 75.22 109.017 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.15 -36.25 50.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.161 0.505 . . . . 74.44 111.312 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.78 -24.93 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.931 -0.577 . . . . 74.41 110.875 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.2 -26.04 64.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.357 -0.383 . . . . 65.52 111.358 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.53 -15.34 63.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.53 110.588 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.64 22.38 46.15 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.71 -0.677 . . . . 63.05 113.949 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -22.66 16.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.825 -0.806 . . . . 74.44 108.825 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.77 -4.96 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.188 -0.914 . . . . 72.15 111.731 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -66.3 -19.08 65.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.066 0.46 . . . . 73.25 110.044 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.96 110.47 3.94 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.241 -0.744 . . . . 44.23 111.241 174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.9 pp -167.34 149.63 5.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.302 -0.258 . . . . 70.4 110.302 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -163.69 122.51 1.98 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.804 -0.443 . . . . 74.45 109.804 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -99.54 118.34 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 75.31 110.129 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -113.4 137.47 51.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.128 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 8.8 p-10 -91.83 154.36 18.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 74.0 110.158 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.16 162.47 30.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.16 -0.543 . . . . 72.42 112.031 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.21 -29.48 70.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.126 0.489 . . . . 64.41 110.507 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.98 -24.5 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.765 -0.652 . . . . 71.24 109.907 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.53 15.21 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.044 -0.525 . . . . 44.22 111.925 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 16.8 m -93.68 120.41 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.881 -0.414 . . . . 72.11 109.881 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.2 p -115.62 131.58 67.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.218 0.533 . . . . 73.45 111.442 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.51 116.04 29.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.56 -0.746 . . . . 53.12 110.544 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 55.8 mt -96.44 117.4 30.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.088 -0.338 . . . . 71.44 110.088 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 ' HG3' ' A' ' 59' ' ' MET . 39.9 mm -115.09 118.05 57.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.717 -0.475 . . . . 74.4 109.717 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.39 118.63 28.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.531 -0.544 . . . . 42.22 109.531 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.529 ' HG3' HG22 ' A' ' 57' ' ' ILE . 71.9 mtp -141.02 170.92 14.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 45.32 111.364 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 t -147.13 175.16 10.94 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.944 -0.761 . . . . 61.52 108.944 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mm? -109.73 150.78 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.585 -0.524 . . . . 63.21 109.585 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.2 p -46.61 -54.8 8.73 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.616 0.572 . . . . 73.12 112.489 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 t -104.02 -1.38 27.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 73.51 110.627 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.3 1.43 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.058 0.543 . . . . 41.44 112.184 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.95 -17.46 8.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.279 0.562 . . . . 41.32 109.966 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 4.1 p -87.3 114.43 58.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 71.13 110.42 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 7.5 Cg_exo -72.83 73.78 2.95 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.996 2.464 . . . . 62.25 112.89 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 4.2 mm? -94.29 9.53 37.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.3 0.572 . . . . 74.11 109.81 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.1 t -60.25 -37.81 81.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.703 -0.68 . . . . 52.55 110.572 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.74 -53.32 59.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.137 0.494 . . . . 71.42 110.199 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 11.8 p -66.11 -46.37 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 74.11 111.01 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -62.61 -38.92 82.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.42 -0.512 . . . . 72.13 111.018 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.49 -43.38 90.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.011 -0.54 . . . . 53.24 110.71 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.84 -39.76 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.858 -0.337 . . . . 71.25 110.28 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 98.8 mt-30 -56.15 -52.59 63.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.07 0.462 . . . . 65.33 110.218 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.3 m -60.03 -52.18 66.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.697 -0.683 . . . . 64.33 110.627 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.622 ' O ' HG12 ' A' ' 81' ' ' VAL . 6.0 tmm_? -54.43 -52.91 60.29 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.852 -0.613 . . . . 71.02 111.0 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -52.85 -53.24 51.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.605 0.566 . . . . 63.33 111.535 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -52.51 11.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.259 -0.576 . . . . 64.2 110.995 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.74 -40.2 75.32 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.816 0.341 . . . . 72.52 111.441 -169.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 77' ' ' ARG . 4.8 p -89.31 -27.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 74.4 110.193 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.01 -24.92 70.4 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.646 -0.787 . . . . 71.54 111.658 -167.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.753 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 9.2 t -87.17 -11.85 48.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.224 0.535 . . . . 61.01 109.962 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.84 61.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.581 -0.736 . . . . 34.02 112.023 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 82.1 mt -74.39 -53.51 9.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.028 0.442 . . . . 72.33 110.415 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 55' ' ' ALA . 33.4 m -124.91 165.91 21.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.986 -0.552 . . . . 64.14 110.611 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.66 -47.92 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 51.31 109.787 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 m-20 -135.11 169.7 17.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.634 -0.712 . . . . 53.21 110.65 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.2 pt -134.94 175.97 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.92 -0.582 . . . . 71.2 110.368 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.704 ' HD3' ' HA ' ' A' ' 105' ' ' THR . 26.3 tpt180 -164.61 119.84 1.44 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.551 -0.75 . . . . 74.11 109.815 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 47.2 mt -97.12 123.28 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 73.32 110.009 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 26.6 t30 -93.89 115.0 27.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.851 -0.613 . . . . 63.24 109.539 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -84.39 106.22 15.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.582 -0.525 . . . . 64.01 109.582 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 99' ' ' TRP . 28.0 t -93.93 124.13 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.639 . . . . 75.52 110.473 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -113.33 -20.62 11.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.03 110.801 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.454 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 t-20 -177.01 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.036 -0.529 . . . . 65.4 111.092 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 41.0 Cg_endo -64.1 151.39 85.54 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.137 1.891 . . . . 61.44 112.701 -172.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.44 157.15 52.26 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.627 2.218 . . . . 75.14 111.582 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.834 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 5.9 m0 -64.78 130.78 44.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.034 -0.53 . . . . 74.04 110.7 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.08 -120.95 0.59 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.728 -0.749 . . . . 73.55 113.415 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.5 -36.34 66.09 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.287 2.658 . . . . 75.25 113.638 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.3 -14.46 11.45 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.028 0.442 . . . . 60.13 111.247 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 99' ' ' TRP . 36.3 mtpt -77.17 10.04 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.268 -0.423 . . . . 64.03 111.041 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.4 122.92 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 110.003 -0.369 . . . . 64.44 110.003 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.704 ' HA ' ' HD3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -50.79 161.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.919 0.711 . . . . 74.32 112.919 176.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.26 -39.58 57.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.945 -1.025 . . . . 75.33 112.53 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -56.78 -40.7 76.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.319 -0.401 . . . . 71.34 110.83 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.15 -27.68 72.58 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 116.16 -0.473 . . . . 65.25 112.636 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -73.49 -51.07 18.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 74.51 111.583 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.71 -35.34 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.348 . . . . 62.3 111.75 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -120.09 99.12 6.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.125 0.488 . . . . 75.12 111.365 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 112' ' ' LEU . 3.3 mm? -83.05 165.91 19.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 62.14 109.725 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -61.55 -29.89 70.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 73.01 110.298 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.26 -24.12 40.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.776 -0.647 . . . . 71.34 111.115 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.77 18.48 2.88 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.862 -0.608 . . . . 71.33 109.827 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.54 85.09 0.03 OUTLIER Glycine 0 C--N 1.338 0.669 0 N-CA-C 111.258 -0.737 . . . . 62.34 111.258 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -61.61 146.79 47.84 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.16 0.505 . . . . 63.32 111.898 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.4 m -85.08 129.33 34.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.503 -0.771 . . . . 75.14 109.937 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.922 -0.561 . . . . 72.03 109.708 178.329 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.968 -0.453 . . . . 74.21 111.968 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 135.19 40.42 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 62.11 111.834 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.33 53.58 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.177 -0.535 . . . . 71.34 112.495 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.52 ' HA ' HG21 ' A' ' 36' ' ' VAL . 16.8 p -66.06 130.85 44.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.558 0.218 . . . . 64.14 110.638 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.3 mmt -72.26 135.38 46.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 75.54 110.721 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.509 ' HB3' HG23 ' A' ' 19' ' ' VAL . 9.8 t -171.98 -42.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.179 -1.045 . . . . 73.23 108.179 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.639 ' HB3' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.42 56.49 0.86 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.647 -1.16 . . . . 74.41 110.483 176.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 m -116.39 91.75 3.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.026 -0.533 . . . . 74.44 110.845 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t 64.19 14.05 8.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.774 -0.648 . . . . 64.2 112.387 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.05 148.9 51.74 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 110.671 -0.122 . . . . 75.33 110.671 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 14' ' ' GLU . 18.9 Cg_endo -57.91 131.07 41.56 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.74 2.293 . . . . 62.43 111.731 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.29 -51.92 17.77 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.494 0.924 . . . . 64.3 113.494 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.68 -50.32 74.32 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.009 0.433 . . . . 71.14 111.043 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 35.6 tt0 -64.62 -46.7 81.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 72.2 110.353 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 7' ' ' GLU . 3.1 tm? -63.89 -36.55 84.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.919 -1.037 . . . . 74.11 111.209 -173.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 tp -53.07 -55.31 24.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.172 0.51 . . . . 75.04 109.772 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -64.83 -47.13 79.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 30.14 110.847 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 75.34 111.211 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 6' ' ' SER . 4.6 p -71.37 -34.35 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 71.22 110.211 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.04 -40.3 93.09 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.998 0.428 . . . . 71.25 110.025 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 24.8 mm-40 -72.26 -47.24 51.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.906 -0.588 . . . . 73.24 110.226 176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.94 65.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.934 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.05 -13.65 7.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.178 -0.465 . . . . 73.41 111.579 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 63.1 ttt-85 -93.8 -29.44 15.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.596 0.358 . . . . 74.43 111.31 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.97 -5.14 10.07 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.215 0.531 . . . . 64.12 110.346 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 99.9 t -107.01 19.95 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.505 1.145 . . . . 70.31 109.317 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 11.6 p -148.25 160.8 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.571 -1.195 . . . . 55.54 108.47 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.57 98.28 3.55 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.461 -0.57 . . . . 75.13 109.461 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 96.2 Cg_endo -87.68 -1.08 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.705 2.27 . . . . 74.41 111.655 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.6 -57.49 5.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 75.12 109.957 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.32 -14.56 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 75.5 110.654 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.97 47.76 2.59 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.182 -0.532 . . . . 71.41 112.981 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.2 mp -110.52 143.27 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 109.822 -0.436 . . . . 75.04 109.822 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.8 t30 -115.02 111.67 21.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.098 -0.501 . . . . 65.53 110.015 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.8 -39.68 72.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.28 0.562 . . . . 61.05 110.105 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 4' ' ' SER . 47.6 t -60.94 -24.57 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.508 -0.769 . . . . 73.31 110.598 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 25.3 t70 -64.43 -22.97 67.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.902 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.74 -8.6 56.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.185 0.517 . . . . 74.34 110.227 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.32 53.03 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.142 -0.935 . . . . 63.42 114.229 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 tt -98.23 -32.13 11.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.453 -0.573 . . . . 73.21 109.453 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.26 -11.0 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 65.23 110.217 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -64.07 -21.19 66.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.512 -0.767 . . . . 72.24 109.406 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.42 64.25 3.55 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.522 -0.763 . . . . 71.43 112.024 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.5 pp -107.66 142.31 37.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.899 -0.408 . . . . 72.12 109.899 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.3 118.86 4.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 74.45 109.088 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.59 123.93 56.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.757 0.313 . . . . 74.23 110.677 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -97.74 120.9 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.255 -0.646 . . . . 53.45 109.255 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.07 129.75 56.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 64.33 110.348 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.89 167.7 28.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.221 -0.752 . . . . 71.0 111.221 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.6 -31.67 66.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.898 0.38 . . . . 72.42 110.687 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.44 -31.14 70.24 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.862 -0.608 . . . . 63.32 110.565 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.98 163.44 16.91 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 116.081 -0.509 . . . . 71.22 112.189 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.2 m -110.71 109.09 19.19 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.558 -0.534 . . . . 74.12 109.558 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.05 123.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.577 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -89.98 109.88 20.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.28 -0.418 . . . . 52.13 110.966 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.23 107.43 19.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.749 -0.463 . . . . 73.24 109.749 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.6 117.61 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.094 -0.335 . . . . 72.45 110.094 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.36 122.04 26.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 110.247 -0.279 . . . . 72.24 110.247 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 83.5 mtp -141.17 170.88 14.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.428 0.632 . . . . 74.41 111.246 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.2 t -160.49 158.8 29.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 72.33 109.486 174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -99.89 160.74 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.985 -0.376 . . . . 62.05 109.985 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 m -45.92 -56.03 5.97 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.604 0.565 . . . . 65.35 112.405 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 m -103.0 4.58 37.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.934 0.397 . . . . 63.44 110.633 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.448 0.699 . . . . 71.43 112.398 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.42 2.45 10.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 73.22 110.048 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.628 ' HB3' HD13 ' A' ' 68' ' ' LEU . 14.1 m -81.66 120.93 79.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.391 -0.822 . . . . 74.43 110.389 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.13 33.44 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.921 2.414 . . . . 74.42 113.186 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.0 mp -79.76 3.08 20.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.946 0.403 . . . . 73.33 110.616 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.8 t -57.37 -44.23 84.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.03 -0.532 . . . . 54.14 110.789 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.32 -41.44 69.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.222 0.534 . . . . 75.42 110.384 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.24 -52.71 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.36 -0.836 . . . . 71.53 110.668 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 69' ' ' THR . 33.3 pt -63.52 -39.69 86.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 120.824 0.345 . . . . 75.1 111.225 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.18 -49.96 72.22 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.936 -0.574 . . . . 74.05 110.323 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.77 -49.8 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.422 -0.353 . . . . 70.43 110.667 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -55.57 -58.94 5.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.743 -0.662 . . . . 51.4 111.773 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -52.66 52.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.071 0.463 . . . . 51.33 111.026 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -56.72 -49.52 74.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.761 -0.654 . . . . 64.41 110.731 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -54.0 -48.28 70.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.676 -0.693 . . . . 64.24 111.346 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.09 13.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.907 -0.317 . . . . 71.32 111.384 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 89' ' ' ILE . 82.9 mt -61.05 -36.17 78.89 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.985 0.422 . . . . 70.22 111.162 -172.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.56 -27.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 60.41 110.033 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.71 -47.29 34.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.171 -0.538 . . . . 63.32 112.221 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.8 m -75.97 -23.12 55.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.1 0.476 . . . . 65.01 110.14 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 33.36 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.123 -0.56 . . . . 74.4 113.35 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.71 -44.33 67.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.87 0.367 . . . . 74.31 110.017 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.1 m -135.91 166.82 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 71.51 110.36 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -41.69 74.66 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.583 -0.525 . . . . 64.33 109.583 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 113' ' ' ARG . 7.0 t0 -167.11 175.91 7.2 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.224 -0.898 . . . . 73.53 109.146 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 80' ' ' LEU . 38.7 pt -120.19 178.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.6 0.714 . . . . 75.53 111.065 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.889 ' HD3' HG23 ' A' ' 105' ' ' THR . 12.5 tpt180 -150.72 106.31 3.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.791 -1.095 . . . . 63.23 108.096 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.26 117.96 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.093 -0.706 . . . . 74.02 109.093 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -88.63 143.57 26.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.938 -0.574 . . . . 72.25 109.481 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -111.16 109.58 19.7 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.791 -0.818 . . . . 74.05 108.791 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 t -85.1 123.61 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 64.41 110.711 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -120.86 -21.07 6.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.318 -0.855 . . . . 74.45 109.769 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.9 t30 178.27 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.498 -0.773 . . . . 55.13 111.439 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 91.9 Cg_exo -44.44 131.91 9.48 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.795 2.33 . . . . 55.41 113.469 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 2.4 Cg_endo -82.25 41.97 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.446 2.764 . . . . 71.51 112.119 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.8 m0 63.42 -154.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.155 -0.475 . . . . 71.55 110.787 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 101' ' ' PRO . . . 97.07 -134.31 11.71 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.478 -0.649 . . . . 71.12 111.478 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' ' HA3' ' A' ' 100' ' ' GLY . 27.8 Cg_endo -61.41 -22.54 74.82 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.442 2.094 . . . . 34.4 110.803 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.19 -12.85 22.32 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.791 -1.095 . . . . 54.0 111.06 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -76.43 -11.07 59.83 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.408 -0.36 . . . . 72.23 111.162 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 43.6 mt -120.12 140.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.466 0.174 . . . . 64.31 111.383 -174.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.889 HG23 ' HD3' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -72.11 151.07 43.3 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.775 0.322 . . . . 43.04 110.257 172.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.02 -33.13 71.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.434 -0.58 . . . . 53.3 109.434 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.62 -53.16 61.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.411 -0.813 . . . . 75.32 110.314 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.22 -28.08 73.1 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.575 -0.739 . . . . 65.11 112.437 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.87 -37.05 83.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.515 -0.55 . . . . 72.42 109.515 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.3 -57.3 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.78 -0.646 . . . . 73.44 111.42 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.442 ' HB2' HD22 ' A' ' 115' ' ' LEU . 68.5 mt-30 -140.44 167.63 21.69 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.63 0.253 . . . . 64.15 110.602 -176.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.0 pt? -79.03 173.11 12.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.182 0.515 . . . . 73.42 111.826 -173.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -55.45 -33.4 63.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.366 -0.834 . . . . 72.51 111.483 -176.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' H ' ' HG ' ' A' ' 112' ' ' LEU . . . -61.08 -6.71 2.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.932 0.716 . . . . 74.23 112.932 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' ' 111' ' ' GLN . 56.1 tp -62.11 -34.51 76.47 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.567 0.21 . . . . 74.3 111.567 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 133.77 -4.79 4.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.208 -0.996 . . . . 44.22 113.912 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 113' ' ' ARG . 45.3 p90 -79.56 12.6 2.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.484 0.642 . . . . 70.24 110.891 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 113' ' ' ARG . 2.7 m -134.03 32.91 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.696 0.76 . . . . 65.44 109.024 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.251 1.144 0 CA-C-N 115.07 -0.968 . . . . 73.42 111.393 -178.059 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.947 -0.461 . . . . 71.15 111.947 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.9 -29.27 67.28 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.606 2.204 . . . . 72.5 111.471 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.15 -114.04 0.6 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.596 -0.729 . . . . 45.25 111.666 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 p -166.89 172.83 9.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.68 -0.489 . . . . 55.03 109.68 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -70.5 142.52 51.86 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 110.063 -0.347 . . . . 74.44 110.063 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 t -146.01 88.13 1.8 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.22 -0.659 . . . . 61.1 109.22 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.62 101.26 0.18 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.168 -0.924 . . . . 74.12 110.062 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -57.68 91.69 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.404 -0.816 . . . . 63.22 112.826 -172.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 23.0 t -166.93 133.32 2.3 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.864 -0.791 . . . . 70.22 108.864 174.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 72.33 162.23 0.15 Allowed Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 123.336 0.397 . . . . 43.51 110.803 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 31.1 Cg_endo -63.1 152.18 80.91 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.558 2.172 . . . . 54.24 111.921 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.54 -47.88 63.25 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.953 0.723 . . . . 72.54 112.953 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.74 -46.03 88.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.614 0.245 . . . . 63.33 111.438 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 52.4 110.298 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.4 tt -54.15 -44.98 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.41 -0.813 . . . . 72.05 109.636 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 53.2 tp -54.04 -59.65 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.873 -0.603 . . . . 73.24 110.714 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -51.98 67.12 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.052 0.453 . . . . 63.35 111.122 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.73 -44.26 85.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.387 -0.824 . . . . 42.43 110.98 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.9 -38.41 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.781 -0.368 . . . . 61.14 110.821 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 16' ' ' LEU . 42.9 mt-10 -61.03 -44.03 98.01 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.96 -0.296 . . . . 72.42 110.623 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.91 -43.79 67.56 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.277 -0.569 . . . . 73.23 110.327 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -35.56 72.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.889 0.376 . . . . 73.21 111.017 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.3 mmt -62.44 -12.53 22.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.829 -0.623 . . . . 74.24 111.93 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -72.01 -31.92 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.424 0.154 . . . . 71.21 111.344 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -115.31 -27.27 7.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.874 0.845 . . . . 54.55 109.54 -171.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 26' ' ' VAL . 62.4 t -90.21 55.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.595 -1.184 . . . . 73.12 109.496 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.2 p -173.02 170.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.19 -0.914 . . . . 74.32 109.575 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -110.61 91.94 13.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 54.41 109.102 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' HG13 ' A' ' 27' ' ' VAL . 59.5 Cg_endo -82.92 0.35 9.68 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.286 1.99 . . . . 61.31 111.906 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.66 -57.83 5.13 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.18 0.514 . . . . 75.42 109.822 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.66 -18.49 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 73.35 110.187 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 52.02 2.5 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.044 -0.525 . . . . 54.31 113.148 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -128.42 140.76 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.968 -0.382 . . . . 73.43 109.968 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.513 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.9 t-20 -100.43 141.13 33.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.13 -35.32 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 63.1 111.675 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.11 -24.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.351 -0.386 . . . . 73.15 110.848 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.7 -21.62 66.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.043 -0.526 . . . . 74.33 111.275 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.87 -15.12 63.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.546 0.689 . . . . 74.24 109.98 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.18 22.08 66.74 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 114.844 -1.071 . . . . 55.23 114.356 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.9 tp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.28 0.562 . . . . 71.34 109.553 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.54 -4.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.206 -0.906 . . . . 65.32 111.637 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -70.36 -15.01 62.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.194 0.521 . . . . 65.51 109.777 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.95 66.65 3.82 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.284 -0.726 . . . . 62.4 111.284 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -98.68 135.84 39.6 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.643 -0.502 . . . . 74.1 109.643 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.48 109.02 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.861 -0.792 . . . . 71.41 108.861 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -114.23 145.24 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 122.147 -0.346 . . . . 73.51 110.32 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -136.61 124.49 22.67 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 70.03 109.646 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.9 p-10 -91.59 88.54 6.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.566 0.698 . . . . 63.42 110.172 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.25 42.16 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.386 -0.825 . . . . 31.33 111.722 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -67.28 -18.17 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.793 0.33 . . . . 73.1 110.518 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -98.16 -21.03 16.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.222 -0.444 . . . . 73.51 111.375 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 131.69 1.83 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.807 -0.711 . . . . 42.12 112.648 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.9 m -85.33 109.07 18.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.791 -0.448 . . . . 73.42 109.791 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.6 p -115.23 133.6 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.079 0.466 . . . . 61.32 111.193 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -103.74 115.69 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.716 -0.674 . . . . 72.32 110.329 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' A' ' 103' ' ' LYS . 6.5 mt -96.91 129.61 44.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.218 -0.66 . . . . 51.45 109.218 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.9 118.59 49.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.234 -0.284 . . . . 72.43 110.234 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.55 116.2 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.01 110.494 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 72' ' ' ILE . 26.0 mtm -134.93 170.83 15.29 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.468 0.652 . . . . 72.42 111.216 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -160.06 146.16 15.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.489 -1.232 . . . . 54.43 108.012 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 87.8 mt -90.29 163.17 14.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.64 -0.504 . . . . 75.21 109.64 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -45.45 -47.61 13.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.18 0.437 . . . . 65.2 112.18 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -96.04 -17.96 20.57 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.156 0.503 . . . . 71.42 110.548 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.42 8.59 2.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.798 -0.637 . . . . 72.54 111.544 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.05 -3.7 13.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 73.1 109.973 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.468 ' HB3' HD13 ' A' ' 68' ' ' LEU . 23.3 m -69.75 123.91 89.55 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.608 -0.724 . . . . 74.4 110.042 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.18 35.08 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.04 2.493 . . . . 75.33 113.119 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.2 mp -98.04 13.65 30.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.578 -0.283 . . . . 73.23 110.685 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 70' ' ' ASP . 5.2 t -55.07 -54.17 46.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.822 0.344 . . . . 71.45 111.29 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 69' ' ' THR . 28.3 t70 -65.71 -27.44 68.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 75.25 110.224 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 62.0 t -70.17 -52.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.986 -0.552 . . . . 64.53 110.681 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.628 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.7 pp -64.07 -37.95 81.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.789 0.328 . . . . 54.12 110.259 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.628 ' N ' HD12 ' A' ' 72' ' ' ILE . 42.8 mt-10 -64.89 -42.23 94.96 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.163 -0.471 . . . . 70.3 110.521 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.42 -48.25 82.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.054 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 22.3 mm-40 -60.15 -46.76 88.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.853 -0.612 . . . . 73.43 110.198 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.59 -62.31 1.97 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.641 -0.709 . . . . 54.32 110.799 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -56.82 -43.73 81.31 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.354 -0.384 . . . . 75.22 111.687 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -60.02 -42.03 93.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 72.35 110.652 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 -50.97 16.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 62.05 110.671 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 89' ' ' ILE . 83.1 mt -56.65 -37.46 70.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.188 -0.46 . . . . 72.33 111.348 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.89 -28.3 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 63.32 110.328 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.34 -34.58 60.68 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.721 -0.951 . . . . 63.44 110.721 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 m -81.8 -23.09 36.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.186 -0.507 . . . . 64.21 110.379 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.46 11.75 81.5 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.983 -0.553 . . . . 73.22 113.326 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.51 -41.03 93.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.604 0.24 . . . . 53.45 111.563 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 23.8 m -136.29 170.21 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.482 -0.326 . . . . 70.44 110.77 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.64 -38.14 10.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 62.45 110.507 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 21.2 t70 -145.67 164.05 32.98 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.727 -0.67 . . . . 63.11 109.31 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 80' ' ' LEU . 19.6 pt -136.24 172.58 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.201 0.524 . . . . 71.42 110.532 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.536 ' HD2' ' N ' ' A' ' 105' ' ' THR . 6.9 tpm_? -160.83 106.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.531 -0.759 . . . . 70.12 109.541 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.456 HD12 ' HG2' ' A' ' 73' ' ' GLU . 62.7 mt -90.74 110.48 22.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.017 -0.364 . . . . 74.24 110.017 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 5.6 t30 -88.55 125.11 34.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 72.42 110.173 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.3 m95 -89.77 112.99 24.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 73.24 111.066 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.13 123.93 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.367 -0.605 . . . . 74.24 109.367 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -153.69 8.34 0.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.492 . . . . 55.12 110.904 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.635 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 24.5 t-20 171.51 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.916 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 69.0 Cg_endo -84.68 149.78 11.3 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.047 1.831 . . . . 60.11 112.448 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 22.7 Cg_exo -65.42 166.44 19.48 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.599 2.199 . . . . 74.11 111.86 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -64.19 109.93 2.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 73.1 110.333 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.02 -79.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.701 -0.761 . . . . 52.53 112.912 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.28 -58.59 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.792 2.328 . . . . 65.15 112.508 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 3.2 m-20 -66.29 -4.36 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 64.4 111.524 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 56' ' ' LEU . 21.5 mmtp -86.38 2.79 46.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.752 0.278 . . . . 75.52 111.752 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.0 mt -118.45 111.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.598 0.237 . . . . 73.02 110.619 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.536 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -55.98 154.41 7.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.065 0.46 . . . . 64.22 111.97 177.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -53.13 -41.4 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.54 -0.754 . . . . 70.25 111.807 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.73 -53.08 61.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.332 -0.395 . . . . 41.33 111.115 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.76 -33.71 55.96 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-N 116.058 -0.519 . . . . 44.54 112.376 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 109' ' ' ARG . 4.8 tpp180 -73.62 -39.17 64.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 65.15 110.611 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.83 -55.52 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.993 -0.549 . . . . 64.51 111.298 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.92 92.39 3.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 73.34 110.513 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 152.94 44.14 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.611 -0.722 . . . . 64.45 110.322 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -58.43 -30.02 66.57 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.831 0.348 . . . . 74.23 110.426 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 73.23 110.402 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.1 tp -83.56 -12.79 55.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.9 -0.591 . . . . 74.44 110.717 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.98 66.87 2.44 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 116.134 -0.485 . . . . 73.22 112.632 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -85.59 -53.23 5.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.293 0.568 . . . . 74.14 110.111 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.7 p -105.25 146.18 29.65 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.59 -0.732 . . . . 72.01 110.882 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.999 -0.741 . . . . 75.25 108.999 173.678 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 CA-C-O 119.919 -0.379 . . . . 74.14 112.243 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.4 161.02 19.87 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.549 2.166 . . . . 74.35 111.999 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.94 125.54 37.52 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.145 -0.55 . . . . 64.21 111.959 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.0 m -133.97 103.69 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.103 -0.332 . . . . 70.54 110.103 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 62.26 11.99 4.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.043 0.537 . . . . 73.15 110.93 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 p -98.17 -10.75 23.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 51.51 110.345 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -124.14 -5.63 7.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.043 -0.98 . . . . 75.52 110.536 -174.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -64.33 94.51 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 75.33 111.416 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.2 p -159.74 168.89 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.392 -0.822 . . . . 54.45 108.993 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 66.34 166.07 0.12 Allowed Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 123.322 0.389 . . . . 74.01 110.316 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.6 Cg_endo -65.47 153.24 79.13 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.822 1.681 . . . . 75.05 111.455 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.33 -32.53 49.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.302 -0.408 . . . . 71.34 111.952 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 9.0 pt-20 -62.57 -52.51 63.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.23 111.363 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.72 -39.14 70.31 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.688 0.28 . . . . 73.12 110.256 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.37 -46.39 86.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 64.44 110.08 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.16 -56.77 17.79 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.82 0.343 . . . . 70.14 110.831 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.88 67.4 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.987 -0.551 . . . . 45.12 111.04 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.55 -48.33 82.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.903 -0.59 . . . . 63.25 111.064 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' MET . 2.4 p -66.95 -36.58 77.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.974 -0.291 . . . . 62.21 110.435 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.8 -47.24 86.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.96 -0.385 . . . . 61.31 109.96 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.75 -51.18 68.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 63.42 110.281 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.2 -49.78 71.05 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.667 -0.697 . . . . 72.13 110.766 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.9 mmt -61.16 -20.32 62.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.866 0.321 . . . . 73.41 111.866 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -101.38 -13.77 17.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 73.04 110.464 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' GLN . 8.6 t70 -119.43 -10.1 9.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.244 0.545 . . . . 74.15 109.845 -168.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -117.83 -19.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.525 -0.762 . . . . 53.22 110.501 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.6 p -77.83 163.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.513 -0.767 . . . . 75.34 110.577 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.07 87.65 1.11 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.279 -1.378 . . . . 44.4 107.279 166.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 51.6 Cg_endo -82.17 -9.35 11.66 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.158 1.905 . . . . 55.11 111.903 -172.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -56.94 6.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.817 -0.629 . . . . 74.15 110.463 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.87 -19.01 29.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.516 -0.311 . . . . 55.33 110.544 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.38 40.1 6.57 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 116.054 -0.521 . . . . 62.15 113.493 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -127.84 140.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 117.201 0.5 . . . . 75.21 110.22 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HA ' HG23 ' A' ' 27' ' ' VAL . 21.2 t-20 -101.48 147.72 26.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.464 -0.939 . . . . 63.43 108.464 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.66 -36.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 53.33 111.118 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.71 -24.58 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 70.41 110.942 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.75 -28.04 63.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.25 -0.432 . . . . 63.1 111.231 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.72 -15.37 63.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.308 0.575 . . . . 64.2 110.268 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 57.53 21.92 43.73 Favored Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.037 -0.983 . . . . 73.04 114.015 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -98.78 -29.0 13.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.327 -0.99 . . . . 73.45 108.327 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 59' ' ' MET . 16.4 t -69.82 1.74 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.629 -1.169 . . . . 75.22 111.75 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.44 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 60.2 m-85 -64.76 -22.74 67.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.319 -0.622 . . . . 72.23 109.319 171.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.39 72.35 1.94 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.388 -0.824 . . . . 73.21 112.209 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.52 121.28 44.65 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.072 -0.714 . . . . 52.14 109.072 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.42 108.88 7.88 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.028 -0.36 . . . . 74.22 110.028 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.65 126.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.66 136.18 46.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.684 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.19 148.2 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 73.34 110.705 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.51 40.77 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.803 -0.919 . . . . 53.33 110.803 175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.9 -18.62 63.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.433 0.616 . . . . 42.3 109.995 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.59 -31.74 71.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.44 0.638 . . . . 72.54 109.582 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.89 -163.64 24.77 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.1 -0.954 . . . . 21.01 111.094 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 p -93.21 118.85 31.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.849 0.357 . . . . 73.12 110.54 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.44 123.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.774 -0.454 . . . . 74.2 109.774 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.46 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -101.38 121.62 42.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.413 -0.358 . . . . 24.44 111.228 -175.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -98.84 129.52 45.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' HG3' ' A' ' 59' ' ' MET . 58.1 mt -125.38 113.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 62.22 110.544 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.85 117.68 22.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.715 -0.476 . . . . 71.0 109.715 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 88.2 mtp -140.96 170.93 14.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 71.52 110.617 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -158.95 159.15 34.55 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.629 -0.714 . . . . 72.42 109.886 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.45 155.68 34.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.576 -0.898 . . . . 71.51 108.576 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -48.05 -59.79 3.11 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.406 0.441 . . . . 63.32 112.04 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 p -96.7 -13.61 22.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.416 -0.356 . . . . 74.42 110.977 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.87 8.66 3.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.755 -0.657 . . . . 64.42 111.51 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.18 -8.52 13.98 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.113 0.483 . . . . 72.05 110.697 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.605 ' HB3' HD13 ' A' ' 68' ' ' LEU . 62.9 m -67.73 136.13 92.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.636 -0.711 . . . . 53.43 110.626 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.76 36.0 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.104 2.536 . . . . 63.11 112.644 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.6 mp -97.25 1.19 49.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.336 -0.393 . . . . 73.13 110.249 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -58.53 8.07 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 75.22 111.432 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.27 -27.08 68.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 75.11 109.893 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.04 -52.43 38.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.674 -0.694 . . . . 74.33 110.663 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 pt -64.14 -38.61 82.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.917 -0.313 . . . . 63.34 110.72 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' ' 91' ' ' ILE . 3.4 mt-10 -63.33 -44.53 94.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.673 -0.239 . . . . 54.4 111.391 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.18 -51.11 70.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 60.53 110.427 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 25' ' ' ASP . 94.9 mt-30 -56.27 -52.35 64.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.873 -0.603 . . . . 51.41 110.806 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.5 t -62.11 -55.13 31.95 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.806 -0.634 . . . . 72.41 111.183 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -58.59 -41.49 85.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.779 -0.191 . . . . 74.34 110.94 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -56.12 -47.15 78.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.378 -0.374 . . . . 72.34 110.693 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.22 16.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 71.55 111.189 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.12 -38.87 80.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.865 0.364 . . . . 65.53 111.107 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.36 -27.92 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 64.12 109.97 175.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.74 -47.31 56.58 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.123 -0.561 . . . . 75.25 111.706 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.8 m -73.25 -11.36 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 62.4 110.563 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.07 38.66 95.63 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.001 -0.545 . . . . 63.25 112.538 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.5 -33.21 19.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 74.22 110.729 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' HA ' ' OG1' ' A' ' 53' ' ' THR . 31.2 m -136.26 169.36 20.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.174 -0.467 . . . . 75.33 110.907 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.86 -41.73 6.07 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.44 . . . . 54.24 110.748 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -137.71 143.69 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.345 -0.613 . . . . 63.24 109.345 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.77 146.62 28.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.729 -0.471 . . . . 74.31 109.729 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 112.85 13.6 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.885 -0.413 . . . . 64.25 109.885 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 73' ' ' GLU . 56.1 mt -90.72 98.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.164 -0.68 . . . . 72.24 109.164 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.45 121.36 30.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.2 0.524 . . . . 74.21 109.887 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' MET . 2.9 m-90 -90.45 106.44 18.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.557 -0.747 . . . . 73.34 109.47 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.62 123.62 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.415 0.626 . . . . 65.31 110.138 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -136.97 -7.97 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 75.53 111.215 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -179.7 -55.68 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 O-C-N 123.1 0.25 . . . . 74.4 110.952 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -87.09 169.07 7.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.299 1.999 . . . . 62.44 112.402 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.38 159.51 19.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.485 2.123 . . . . 72.42 111.545 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -69.72 -22.04 63.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.549 -0.296 . . . . 70.34 110.759 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -39.53 -63.81 1.12 Allowed Glycine 0 C--N 1.338 0.688 0 O-C-N 123.803 0.689 . . . . 62.21 114.521 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -46.72 5.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.147 1.898 . . . . 75.24 111.949 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 -4.19 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 71.41 111.512 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -76.22 -18.49 59.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.835 -0.431 . . . . 71.41 109.835 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.26 89.19 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.028 -0.73 . . . . 75.44 109.028 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' OE2' ' A' ' 73' ' ' GLU . 17.6 p -71.3 178.49 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.244 -0.889 . . . . 63.33 112.16 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.57 -28.57 67.26 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.604 0.594 . . . . 53.13 112.604 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -58.78 -38.87 79.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.105 0.479 . . . . 73.42 110.157 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.2 -27.89 47.17 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.864 -0.607 . . . . 52.11 112.456 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -73.26 -49.04 29.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.716 0.293 . . . . 74.44 111.602 -175.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.21 -39.38 65.59 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.949 0.722 . . . . 72.4 112.949 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -91.76 82.85 5.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.424 0.631 . . . . 74.23 111.742 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 tp -93.35 157.81 16.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 71.43 109.677 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 113' ' ' ARG . 30.0 mtm-85 -65.33 -40.14 93.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 74.33 111.197 -173.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.66 -24.2 60.76 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 72.44 111.659 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.43 25.93 1.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.215 -0.448 . . . . 63.54 111.251 -175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.05 72.28 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.269 -0.423 . . . . 71.01 112.248 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -124.72 131.18 53.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.665 -0.494 . . . . 73.31 109.665 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -139.09 160.39 39.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.294 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.037 -0.982 . . . . 75.55 110.298 -179.907 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.864 -0.495 . . . . 54.42 111.864 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.14 -28.21 56.6 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.757 2.305 . . . . 74.42 112.15 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.51 100.85 0.14 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.891 -0.595 . . . . 72.41 113.002 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.1 t -153.9 106.82 2.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -168.8 16.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.573 -0.285 . . . . 71.15 111.134 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.485 ' HB3' HD21 ' A' ' 44' ' ' LEU . 16.0 m -125.71 -12.38 6.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.358 0.599 . . . . 71.55 110.642 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.603 ' HB3' HD21 ' A' ' 15' ' ' LEU . 10.1 mp0 -76.15 89.62 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 32.24 109.894 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -143.2 28.87 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.108 -0.497 . . . . 71.25 111.494 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -125.34 147.91 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 71.21 110.396 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 71.74 155.76 0.16 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.627 0.579 . . . . 71.04 111.513 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.87 152.14 52.27 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.439 2.093 . . . . 42.53 111.161 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.76 -42.37 7.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 73.44 112.679 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.2 -52.1 51.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.167 0.508 . . . . 71.02 110.274 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 -32.4 73.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 64.42 110.299 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 7' ' ' GLU . 6.1 tt -64.98 -50.31 66.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.694 -0.685 . . . . 73.31 109.448 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.04 -51.82 67.75 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.991 -0.55 . . . . 63.53 110.768 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -60.95 -49.18 78.48 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.947 -0.569 . . . . 61.44 110.906 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -57.76 -48.53 79.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.703 -0.681 . . . . 64.25 110.857 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.0 p -68.77 -42.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.656 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -67.32 -37.68 83.72 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.577 -0.449 . . . . 71.33 110.805 -175.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.7 pt-20 -72.7 -46.44 53.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.601 -0.439 . . . . 71.21 110.529 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.583 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.49 -31.36 69.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.867 0.365 . . . . 62.3 110.755 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 13.2 mmt -62.97 -13.14 31.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.067 -0.515 . . . . 63.1 110.719 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -33.37 16.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.326 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 4.5 m-20 -85.51 -27.5 25.58 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.392 -0.367 . . . . 74.41 111.713 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 22' ' ' ALA . 35.0 m -113.37 42.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.715 0.769 . . . . 61.51 110.972 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG23 ' HA ' ' A' ' 34' ' ' ASN . 8.9 p -144.13 159.93 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.317 -0.856 . . . . 71.21 110.135 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.05 89.88 2.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.535 -0.913 . . . . 45.42 108.535 167.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 74.5 Cg_endo -81.09 -5.72 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.551 2.167 . . . . 74.14 111.924 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -68.68 -53.74 20.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.903 -0.589 . . . . 53.13 110.03 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.98 -16.76 16.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.097 -0.502 . . . . 53.12 110.295 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.81 40.76 4.87 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.175 -0.536 . . . . 51.23 113.237 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -106.91 140.04 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.154 -0.684 . . . . 70.23 109.154 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.55 HD22 ' N ' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -114.26 124.92 53.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.082 -0.71 . . . . 73.13 109.082 178.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.3 m -57.91 -28.65 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.44 . . . . 74.15 110.82 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 34' ' ' ASN . 10.3 p -57.77 -30.81 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.616 . . . . 74.53 111.186 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 34' ' ' ASN . 57.6 m-20 -66.25 -21.15 66.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.633 -0.258 . . . . 72.25 110.862 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -75.34 -16.53 60.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.101 0.477 . . . . 72.44 110.039 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.65 61.19 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.513 -0.767 . . . . 71.31 113.994 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 tp -96.06 -31.68 12.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.37 0.585 . . . . 73.14 109.688 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 36' ' ' VAL . 11.1 p -67.74 -11.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.493 0.663 . . . . 64.22 109.55 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -63.52 -27.14 69.06 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.273 -0.876 . . . . 73.02 108.805 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.57 68.59 2.95 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.672 -1.149 . . . . 63.22 111.098 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 pp -115.27 138.45 50.93 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.105 -0.702 . . . . 74.25 109.105 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.25 108.99 3.84 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.355 -0.609 . . . . 71.11 109.355 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 45.9 t -89.17 114.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.616 -0.513 . . . . 62.44 109.616 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -97.46 133.06 42.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 64.44 110.702 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.46 68.8 10.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.93 -0.767 . . . . 61.22 108.93 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 164.68 53.79 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.376 -0.829 . . . . 54.3 112.868 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.78 -26.94 68.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.672 0.389 . . . . 75.1 110.43 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -81.85 -7.46 59.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.162 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.82 177.11 14.73 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 112.0 -0.44 . . . . 54.34 112.0 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 m -72.55 110.18 6.75 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.172 -0.307 . . . . 71.23 110.172 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.3 p -115.14 124.49 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.828 0.347 . . . . 54.31 110.716 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -86.95 107.3 18.32 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.31 -0.405 . . . . 34.23 110.653 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 90' ' ' ARG . 28.3 mt -87.57 105.08 17.08 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.449 . . . . 64.34 109.789 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.53 124.19 68.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 110.257 -0.275 . . . . 50.11 110.257 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.61 128.49 36.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 55.35 111.367 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 80.6 mtp -141.24 171.12 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.652 -0.704 . . . . 64.41 110.636 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -145.49 171.51 14.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.326 -0.397 . . . . 74.45 109.935 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -121.18 166.64 13.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.468 -0.567 . . . . 73.23 109.468 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.4 p -62.13 -60.28 3.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.87 0.367 . . . . 74.45 111.967 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -114.28 -8.09 12.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.318 -0.401 . . . . 62.02 110.749 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.35 8.84 4.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.903 -0.589 . . . . 74.32 111.912 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.9 -25.6 13.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.113 0.483 . . . . 54.33 110.22 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.5 m -79.14 138.13 56.54 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 115.598 -0.728 . . . . 35.33 110.351 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.89 50.57 2.82 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.867 2.378 . . . . 74.3 112.335 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.14 -9.31 59.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.376 -0.375 . . . . 71.13 110.673 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.8 t -60.19 -43.4 95.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.006 -0.543 . . . . 42.2 110.838 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.95 -42.28 79.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.368 0.604 . . . . 75.11 109.941 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -65.41 -52.5 51.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 114.942 -1.026 . . . . 62.52 110.615 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.67 -41.35 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.617 -0.265 . . . . 73.14 111.224 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-10 -62.55 -47.77 82.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.527 0.203 . . . . 54.02 110.671 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 35.8 t70 -59.71 -48.15 82.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 75.13 110.942 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' ASP . 91.9 mt-30 -62.51 -43.72 98.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 63.34 111.182 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.3 m -62.57 -55.22 29.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.258 -0.428 . . . . 71.33 110.689 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 6.9 ppt_? -57.04 -38.03 72.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.943 -0.303 . . . . 65.11 110.32 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.8 t -55.66 -53.71 53.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.235 -0.439 . . . . 73.44 111.184 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.59 -52.41 11.86 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.546 -0.462 . . . . 70.43 111.395 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -39.74 89.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.924 0.392 . . . . 65.24 111.55 -171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.23 -27.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 74.22 109.847 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.81 -45.83 56.12 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.832 -0.699 . . . . 42.43 111.622 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 p -75.9 -22.98 55.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.967 0.413 . . . . 64.13 110.195 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.13 45.34 41.01 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.87 -0.604 . . . . 74.11 112.107 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.26 -32.8 33.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 65.3 110.576 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.2 m -141.18 165.51 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.137 -0.483 . . . . 71.23 110.646 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.35 -47.46 19.86 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.668 -0.493 . . . . 65.1 109.668 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 22.1 m-20 -133.54 158.14 43.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.475 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -111.46 164.92 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.102 -0.703 . . . . 72.13 109.102 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HB3' HD23 ' A' ' 56' ' ' LEU . 14.5 tpp85 -153.23 106.63 3.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.02 -0.272 . . . . 70.23 110.43 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 73' ' ' GLU . 57.0 mt -94.31 131.03 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 75.14 110.071 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.666 HD22 ' N ' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -107.9 131.73 54.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.951 . . . . 63.32 108.431 175.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.666 ' N ' HD22 ' A' ' 92' ' ' ASN . 2.7 m-90 -102.67 106.12 16.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.46 -0.57 . . . . 75.34 109.46 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.4 m -102.93 124.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.141 0.495 . . . . 74.21 109.711 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -111.27 -33.23 6.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 61.55 110.373 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.616 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 20.1 t-20 -171.71 -50.89 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.768 -0.651 . . . . 72.25 110.761 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 17.1 Cg_exo -68.33 157.78 60.37 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.296 1.997 . . . . 63.24 111.8 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.72 167.21 15.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.831 2.354 . . . . 51.4 112.402 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -62.56 142.85 57.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.68 -0.691 . . . . 72.42 111.371 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -120.21 0.53 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.966 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.0 -20.36 67.7 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.64 2.227 . . . . 44.41 111.266 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -5.54 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.905 -1.043 . . . . 74.51 111.753 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 57.2 mmtt -81.13 9.78 6.27 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 110.267 -0.272 . . . . 72.5 110.267 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.87 134.61 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.846 -0.428 . . . . 73.12 109.846 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.8 p -79.15 153.49 30.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.607 -0.27 . . . . 52.24 111.241 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 3.7 tp10 -66.95 -25.52 66.38 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.794 -0.817 . . . . 71.41 108.794 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.85 -34.41 67.76 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.225 -0.898 . . . . 74.04 110.575 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.73 -36.49 92.37 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.049 -0.596 . . . . 70.13 112.054 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 74.6 ttt180 -58.52 -36.41 73.79 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.221 0.534 . . . . 52.32 110.423 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.46 -17.36 64.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 64.32 111.354 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -115.59 102.29 9.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.26 0.553 . . . . 64.44 111.969 -170.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.4 tp -156.65 155.81 32.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.817 -0.808 . . . . 72.1 108.817 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.33 -37.27 80.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.895 0.378 . . . . 62.23 110.89 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 -21.33 65.66 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.061 -0.518 . . . . 65.13 111.288 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.76 -17.56 37.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.094 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.51 82.71 1.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.947 -0.57 . . . . 30.44 111.692 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -64.69 111.57 2.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.711 0.291 . . . . 73.24 110.847 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.4 m -69.45 142.27 53.83 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.167 -0.469 . . . . 71.03 111.059 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.703 -0.665 . . . . 72.03 110.129 176.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.215 -0.354 . . . . 24.21 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.88 151.09 14.33 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.847 2.365 . . . . 74.03 112.064 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.19 -105.53 0.58 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.075 -0.584 . . . . 72.24 111.655 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -88.43 -37.29 15.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.086 0.47 . . . . 74.35 110.005 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mmt -68.84 101.89 1.44 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.826 -0.625 . . . . 72.31 110.076 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -148.6 -159.84 1.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.723 -0.671 . . . . 65.11 109.336 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.883 ' HB3' HD11 ' A' ' 15' ' ' LEU . 1.6 mp0 -61.03 87.75 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.981 0.419 . . . . 73.25 110.819 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.4 m -143.64 86.01 1.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.164 0.507 . . . . 73.12 110.026 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 24.9 p -173.46 126.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.484 -0.78 . . . . 53.0 109.498 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 71.67 162.24 0.15 Allowed Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.361 0.413 . . . . 73.42 110.889 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 12.0 Cg_endo -55.61 152.88 31.94 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.535 2.157 . . . . 72.44 112.147 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.86 -38.51 35.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.969 0.507 . . . . 61.35 112.365 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 18.5 mp0 -68.2 -51.95 39.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 74.35 110.362 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.88 -45.99 80.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.541 -0.754 . . . . 73.43 110.324 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.883 HD11 ' HB3' ' A' ' 7' ' ' GLU . 2.7 tm? -55.19 -49.37 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.298 -0.864 . . . . 73.41 110.272 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.67 -53.72 47.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.771 -0.649 . . . . 73.24 110.903 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.2 74.37 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.546 . . . . 75.05 111.124 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 75.32 110.902 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 8.8 p -69.45 -32.67 53.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 110.085 -0.339 . . . . 54.12 110.085 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -62.17 -41.14 98.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.78 -0.452 . . . . 50.24 109.78 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 38.0 mt-10 -69.26 -43.91 72.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.066 -0.515 . . . . 72.13 110.342 174.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -45.17 77.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 63.41 110.434 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.72 -13.48 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.613 -0.721 . . . . 73.43 111.639 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 32.3 ttp180 -87.86 -32.66 18.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.832 0.453 . . . . 63.45 110.53 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -100.27 -26.93 13.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.144 -0.48 . . . . 74.41 112.17 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -84.96 3.01 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 43.25 111.063 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.5 p -125.59 158.45 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.236 -0.653 . . . . 63.31 109.236 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -101.21 95.37 4.78 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.72 -0.844 . . . . 71.23 108.72 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 78.2 Cg_endo -83.08 -6.15 11.23 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.647 2.231 . . . . 74.41 111.926 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -69.04 -57.62 5.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.787 -0.642 . . . . 63.34 110.265 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.1 mm? -94.55 -18.68 21.2 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.272 -0.422 . . . . 72.33 109.95 176.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 48.76 4.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.675 -0.693 . . . . 54.21 113.365 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.91 145.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 117.144 0.472 . . . . 72.42 110.499 177.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 36' ' ' VAL . 18.5 p-10 -112.86 107.21 15.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 74.32 111.789 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.43 -31.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.843 -0.617 . . . . 75.21 110.865 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 34' ' ' ASN . 12.2 p -55.75 -25.04 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.881 -0.6 . . . . 74.34 111.399 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.05 -22.46 65.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.569 -0.287 . . . . 54.32 111.498 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.59 -23.35 65.94 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.103 0.477 . . . . 75.22 110.384 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.61 61.07 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.396 -0.82 . . . . 65.54 114.081 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.4 -32.09 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.332 0.566 . . . . 55.34 109.744 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.78 -14.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.491 -0.777 . . . . 63.43 110.254 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -65.97 -17.76 64.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.155 -0.929 . . . . 71.4 110.291 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.81 62.43 4.17 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.024 -0.534 . . . . 64.22 112.0 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 pp -101.42 148.63 24.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 51.34 110.706 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -161.36 110.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.979 -0.378 . . . . 73.43 109.979 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.8 p -92.5 121.01 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 61.11 110.292 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -109.21 127.87 54.58 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.872 -0.603 . . . . 71.01 110.434 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -82.94 138.75 33.7 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.681 -0.691 . . . . 75.23 110.405 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.56 154.0 21.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.832 -0.907 . . . . 60.24 110.832 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -58.25 -36.9 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 72.22 110.719 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -78.5 -24.67 45.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.705 -0.679 . . . . 71.14 110.409 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.98 158.38 12.8 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.225 -0.512 . . . . 61.02 112.526 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.29 117.28 29.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.138 -0.319 . . . . 74.03 110.138 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 8.7 p -108.82 134.88 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.727 0.298 . . . . 72.45 111.081 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -100.76 110.39 22.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.511 -0.313 . . . . 72.33 110.638 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 90' ' ' ARG . 52.6 mt -84.85 137.92 32.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.119 -0.326 . . . . 74.31 110.119 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.505 ' HB ' HG12 ' A' ' 91' ' ' ILE . 62.4 mt -135.66 118.51 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.783 -0.451 . . . . 73.43 109.783 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' HE1' ' A' ' 99' ' ' TRP . 35.1 t0 -84.38 116.33 22.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 75.41 110.723 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.5 mtp -141.41 170.92 14.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.292 0.567 . . . . 62.31 111.46 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -150.23 176.69 10.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.366 -0.834 . . . . 62.22 108.801 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 68' ' ' LEU . 63.1 mt -121.52 145.67 47.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.624 -0.509 . . . . 55.44 109.624 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.7 p -52.53 -55.11 24.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 71.3 112.614 -172.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -99.84 -4.49 30.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.104 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.89 8.91 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.98 -0.554 . . . . 72.4 112.363 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.26 -35.91 3.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.951 0.405 . . . . 64.25 110.491 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -67.02 123.53 86.48 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.719 -0.673 . . . . 62.24 110.141 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.49 64.94 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.986 2.458 . . . . 73.41 113.055 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 mm? -85.89 -3.21 58.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.478 -0.328 . . . . 73.3 110.791 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 t -56.98 -44.97 83.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.321 -0.4 . . . . 73.04 111.168 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.95 -41.49 87.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.073 0.463 . . . . 72.23 110.152 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.93 -51.56 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.349 -0.841 . . . . 51.44 110.926 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.41 HD11 ' HE1' ' A' ' 93' ' ' TRP . 32.5 pt -64.01 -41.26 91.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 74.0 111.185 -176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 90' ' ' ARG . 1.8 mm-40 -68.78 -38.21 79.85 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.525 -0.307 . . . . 75.01 111.162 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.62 -46.69 71.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.988 -0.285 . . . . 73.22 110.561 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -65.12 -41.54 94.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.484 0.183 . . . . 70.44 110.53 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 t -61.15 -52.38 65.1 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.451 -0.574 . . . . 54.02 109.451 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -54.59 -40.28 68.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.534 -0.757 . . . . 74.24 111.424 176.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.432 ' N ' ' HD3' ' A' ' 77' ' ' ARG . 75.7 m -54.48 -53.04 59.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.415 0.15 . . . . 74.25 111.188 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.7 -51.47 14.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.995 -0.282 . . . . 41.4 111.499 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.31 -30.39 69.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.77 0.319 . . . . 72.12 111.408 -172.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.74 -27.61 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 71.54 110.053 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.57 90.69 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.31 -0.405 . . . . 32.22 112.371 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -102.65 -0.57 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 71.14 110.551 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.03 52.16 54.51 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.071 -0.513 . . . . 74.14 112.093 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.4 -30.49 69.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.708 0.289 . . . . 61.32 110.824 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.8 m -137.15 175.46 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.04 -0.527 . . . . 71.34 110.505 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.7 -37.68 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.111 0.481 . . . . 71.2 110.322 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 28.9 t70 -145.82 157.78 43.9 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.838 -0.619 . . . . 73.52 110.038 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.47 157.03 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.948 -0.389 . . . . 53.05 109.948 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.623 ' NH1' HG23 ' A' ' 105' ' ' THR . 0.9 OUTLIER -154.71 106.38 2.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.478 -0.328 . . . . 72.12 110.932 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 57' ' ' ILE . 57.9 mt -93.54 113.53 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.181 -0.674 . . . . 74.21 109.181 171.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -90.5 140.23 29.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.246 -0.65 . . . . 73.41 109.246 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' MET . 6.2 m-90 -107.35 106.76 17.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.49 -0.323 . . . . 64.25 110.314 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.15 124.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.141 0.496 . . . . 51.2 110.406 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -103.87 -43.57 5.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.216 -0.661 . . . . 75.44 109.216 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 75.4 m-20 -164.77 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 114.468 -1.242 . . . . 75.02 109.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 27.7 Cg_exo -64.45 164.78 22.18 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.284 1.989 . . . . 72.34 111.561 173.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.14 -179.32 5.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.562 2.175 . . . . 75.41 113.065 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.405 ' HE1' ' CG ' ' A' ' 58' ' ' ASP . 4.7 m-90 -73.12 112.08 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.983 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.55 -115.45 1.49 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.974 -0.631 . . . . 64.03 112.12 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 -24.68 74.84 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.826 2.351 . . . . 62.4 112.074 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.44 -13.07 11.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.749 -0.66 . . . . 72.03 111.025 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -87.61 6.98 31.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 75.21 111.219 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.65 108.89 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.726 0.298 . . . . 74.13 110.849 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.623 HG23 ' NH1' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -58.49 155.53 11.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.297 0.639 . . . . 73.14 112.229 176.308 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -51.55 -47.99 63.22 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.867 -0.606 . . . . 62.02 111.065 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.99 -34.82 68.5 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.046 -0.525 . . . . 64.45 110.733 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.57 -34.31 57.13 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.832 -0.622 . . . . 52.35 112.223 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 109' ' ' ARG . 3.5 tmm_? -73.99 -32.0 63.21 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.265 0.555 . . . . 75.15 110.255 177.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' OE2' ' HA3' ' A' ' 116' ' ' GLY . 30.9 tt0 -69.78 -58.67 3.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.182 -0.917 . . . . 65.22 112.677 -170.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 61.67 5.53 1.31 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.004 -0.998 . . . . 74.42 113.501 171.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.777 ' HB3' HD23 ' A' ' 115' ' ' LEU . 32.5 tp -170.63 150.69 3.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.23 0.538 . . . . 75.15 110.473 175.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.71 ' HG3' HG21 ' A' ' 118' ' ' THR . 34.5 ttt180 -69.45 -30.13 67.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.992 -1.004 . . . . 61.45 111.522 -172.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.59 60.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 45.11 112.119 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' A' ' 112' ' ' LEU . 4.1 mm? -90.03 -34.92 15.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.649 0.261 . . . . 72.32 111.257 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.422 ' HA3' ' OE2' ' A' ' 110' ' ' GLU . . . -95.43 154.16 20.95 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.985 -0.626 . . . . 54.31 112.152 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -69.67 89.07 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 74.0 110.192 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.71 HG21 ' HG3' ' A' ' 113' ' ' ARG . 22.3 p -98.76 133.21 43.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.68 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.486 -0.769 . . . . 71.12 111.693 -175.146 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.991 -0.444 . . . . 52.23 111.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' HD2' HG21 ' A' ' 27' ' ' VAL . 11.2 Cg_exo -71.11 115.3 4.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.047 2.498 . . . . 72.41 111.544 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.92 -168.46 16.5 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.13 -0.486 . . . . 53.11 112.029 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -141.38 129.27 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.376 -0.602 . . . . 73.53 109.376 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.3 mtt -79.69 30.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.989 0.423 . . . . 71.51 111.448 -176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -75.35 -28.17 59.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.243 0.544 . . . . 74.41 109.852 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -71.52 111.59 6.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.516 -0.765 . . . . 73.14 111.822 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -140.28 24.26 2.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.031 -0.986 . . . . 75.24 108.792 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 t -107.28 173.5 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.647 -0.706 . . . . 54.21 110.589 -176.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 64.81 167.61 0.11 Allowed Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 123.72 0.638 . . . . 54.12 111.698 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 32.5 Cg_exo -55.89 143.37 82.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.505 2.137 . . . . 71.24 110.944 171.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.01 17.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.853 0.316 . . . . 51.35 111.853 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -62.73 -42.56 99.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.994 0.426 . . . . 70.04 110.845 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.59 -49.67 74.3 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.784 -0.644 . . . . 64.34 110.144 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 tp -54.44 -41.75 69.78 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.069 -0.969 . . . . 73.23 110.737 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 tp -53.39 -56.57 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 54.35 110.868 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.2 -51.97 52.53 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 116.086 -0.506 . . . . 64.02 111.242 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.47 -44.92 95.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.637 -0.711 . . . . 74.42 111.202 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' LEU . 3.3 p -71.49 -33.54 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.015 -0.365 . . . . 71.23 110.015 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.85 -51.57 68.51 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.992 0.425 . . . . 62.53 109.956 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.32 -39.33 68.29 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.096 -0.502 . . . . 62.53 111.373 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.23 79.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.158 0.504 . . . . 25.14 110.567 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.56 -13.31 58.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 73.43 111.069 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -97.71 -7.31 31.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.768 0.318 . . . . 74.03 110.639 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.55 -27.56 5.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.333 0.587 . . . . 64.44 110.506 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -84.08 -26.29 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.903 -1.044 . . . . 55.04 110.821 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.3 p -86.84 154.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.555 . . . . 75.45 109.881 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 12.4 t70 -86.29 102.3 2.69 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.861 -1.162 . . . . 74.22 107.861 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 5.9 Cg_endo -84.24 -10.05 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.857 2.371 . . . . 73.13 112.498 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.55 -56.54 7.96 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.028 0.442 . . . . 42.52 110.208 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 65.8 mt -93.98 -18.49 21.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 74.03 109.855 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.15 56.13 3.11 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.782 -0.644 . . . . 65.4 113.078 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.7 140.52 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.049 0.424 . . . . 74.53 111.085 179.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -102.11 138.33 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 72.14 109.545 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.69 -25.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.019 0.437 . . . . 73.02 111.292 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.77 -25.51 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.9 -0.591 . . . . 72.31 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.11 -21.94 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.771 -0.649 . . . . 73.42 111.679 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.43 -6.88 43.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.931 0.396 . . . . 74.23 110.89 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.81 22.82 54.95 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.633 -0.712 . . . . 43.14 114.15 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.89 -31.72 12.05 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.888 -0.412 . . . . 65.23 109.888 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.94 -13.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.62 -0.718 . . . . 75.23 110.246 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -56.73 -29.96 63.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.185 -0.916 . . . . 60.04 110.168 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.73 92.0 1.77 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.643 -0.708 . . . . 60.11 111.695 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.5 pt? -141.93 160.18 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.61 -0.347 . . . . 65.0 110.124 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.76 123.14 6.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 54.31 109.466 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.1 p -103.69 122.69 56.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.016 0.436 . . . . 74.24 110.171 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' OE1' HD11 ' A' ' 56' ' ' LEU . 45.0 mt-30 -97.69 120.36 37.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 71.03 109.727 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.36 83.45 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.732 0.777 . . . . 72.14 109.672 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.97 163.82 19.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 114.998 -1.001 . . . . 60.25 112.184 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -55.27 -40.03 70.52 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.181 0.515 . . . . 62.34 110.941 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -68.38 -30.54 69.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.653 -0.703 . . . . 63.34 110.664 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.31 154.99 7.79 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.966 -0.635 . . . . 63.13 112.41 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 10.8 m -85.78 102.33 13.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.936 0.398 . . . . 74.2 110.12 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 60.0 t -107.07 126.72 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.093 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -93.34 107.28 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 53.44 110.849 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.408 HD11 ' OE1' ' A' ' 47' ' ' GLN . 48.4 mt -82.12 131.89 35.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.469 -0.567 . . . . 73.01 109.469 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.1 mt -129.76 129.7 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.443 0.164 . . . . 71.13 110.623 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.09 114.56 26.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.693 -0.484 . . . . 61.31 109.693 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.54 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.9 mtp -141.03 170.76 15.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.622 0.725 . . . . 62.54 111.69 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 6.3 t -162.63 160.69 26.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.642 -1.163 . . . . 72.45 108.302 171.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -88.67 158.13 18.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.752 -0.462 . . . . 74.55 109.752 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -43.13 -52.92 5.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.968 0.507 . . . . 63.42 112.187 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -113.32 13.11 19.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 61.24 110.951 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.2 8.7 1.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.956 0.724 . . . . 64.24 112.956 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.36 11.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.45 . . . . 64.21 110.423 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.3 m -92.59 129.28 41.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 40.41 110.463 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.63 34.29 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.857 2.372 . . . . 40.34 112.061 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -83.15 -11.34 58.01 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 74.31 109.974 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.578 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 10.2 t -49.92 -56.03 12.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.895 -0.593 . . . . 65.22 111.348 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' THR . 5.6 m-20 -56.59 -34.94 67.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.484 . . . . 74.33 110.46 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 68' ' ' LEU . 47.2 t -70.93 -52.71 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 64.22 110.864 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.643 HD12 ' HH2' ' A' ' 93' ' ' TRP . 0.3 OUTLIER -60.31 -43.03 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.33 0.586 . . . . 65.34 109.47 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 69' ' ' THR . 23.5 mt-10 -61.72 -53.57 54.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.123 -0.944 . . . . 73.44 110.871 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.05 -51.42 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.653 0.263 . . . . 71.42 110.891 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -55.83 -58.73 6.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.084 -0.507 . . . . 72.24 111.141 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.4 t -65.06 -55.63 17.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 73.44 110.911 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 89' ' ' ILE . 47.8 ttt180 -55.63 -52.84 62.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.304 -0.407 . . . . 73.24 111.281 -174.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -64.51 -33.95 77.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.814 -0.63 . . . . 53.13 111.006 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.0 -51.31 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.83 -0.348 . . . . 73.41 110.364 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 76' ' ' SER . 4.4 mm? -56.21 -44.4 79.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.214 -0.448 . . . . 72.1 111.015 -177.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.18 -28.25 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.422 -0.353 . . . . 74.24 110.538 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.74 -23.47 55.82 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.03 -0.605 . . . . 62.43 111.983 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -94.41 -11.69 29.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 75.3 110.178 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.38 75.89 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.873 -0.603 . . . . 75.31 113.347 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.01 -33.67 76.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.961 0.41 . . . . 70.12 109.949 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.11 175.75 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.581 -0.736 . . . . 61.32 109.556 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 53' ' ' THR . 22.7 t70 -78.23 -50.97 10.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 71.32 110.181 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 37.2 t70 -167.54 169.79 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.937 -0.764 . . . . 65.15 108.937 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 77' ' ' ARG . 18.0 pt -125.06 166.86 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.962 0.411 . . . . 60.24 110.914 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 56' ' ' LEU . 19.8 ttm180 -152.38 113.25 4.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.698 -0.683 . . . . 75.54 109.247 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG12 ' HB ' ' A' ' 57' ' ' ILE . 67.7 mt -100.68 124.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 74.24 110.496 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 6.9 p30 -95.37 122.14 37.77 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.259 -0.645 . . . . 64.42 109.259 173.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.643 ' HH2' HD12 ' A' ' 72' ' ' ILE . 88.5 m95 -90.37 106.67 18.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.019 -0.537 . . . . 72.42 109.94 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 m -91.11 124.34 43.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.412 0.625 . . . . 75.42 111.395 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -112.15 -32.24 6.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 74.31 109.832 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.62 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 31.2 t30 -166.49 -51.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.362 -0.836 . . . . 73.43 110.53 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 43.5 Cg_endo -66.61 132.17 28.16 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.11 1.873 . . . . 63.14 112.005 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.73 81.66 2.5 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.566 2.177 . . . . 71.3 112.912 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 56.07 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.571 -0.74 . . . . 74.42 112.267 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.89 -113.14 0.76 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.214 -0.754 . . . . 73.21 111.214 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.77 -15.44 50.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.173 1.915 . . . . 64.13 110.599 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.39 -17.64 31.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.838 -1.074 . . . . 70.11 110.709 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 97.9 mttt -76.65 -19.31 57.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.783 -0.644 . . . . 74.34 111.33 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.34 92.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 50.43 111.078 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 p -61.67 154.85 24.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.65 -0.705 . . . . 52.11 110.82 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.99 -29.52 57.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.284 0.846 . . . . 74.14 113.284 -168.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -57.13 -30.21 64.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.778 0.263 . . . . 73.44 110.659 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.57 98.11 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.994 -0.622 . . . . 71.34 111.963 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -73.75 -46.88 43.13 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.07 0.462 . . . . 63.33 110.187 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.94 -38.54 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.304 -0.862 . . . . 71.33 111.55 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -103.93 23.82 12.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.018 -0.537 . . . . 70.4 111.285 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.76 ' HB3' HD23 ' A' ' 115' ' ' LEU . 22.8 tp -85.49 158.15 20.25 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.257 -0.645 . . . . 72.44 109.257 176.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -60.31 -50.02 75.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.847 0.355 . . . . 75.45 111.631 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.88 -20.92 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 64.52 112.015 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.76 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? -90.9 -0.97 57.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.788 0.328 . . . . 73.14 110.827 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.1 63.61 4.28 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 116.179 -0.464 . . . . 54.14 112.227 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.75 136.47 18.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.932 -0.396 . . . . 63.02 109.932 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -164.9 175.33 9.66 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.935 -0.575 . . . . 64.44 109.763 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.484 -0.77 . . . . 72.3 110.444 178.582 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.963 -0.455 . . . . 64.41 111.963 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.47 80.95 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.752 2.301 . . . . 72.22 111.648 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.66 99.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.946 -0.57 . . . . 74.43 112.288 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.6 t -171.05 103.54 0.22 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.965 0.412 . . . . 65.14 109.927 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 6' ' ' SER . 1.7 mpt? -132.28 -46.39 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 74.52 109.86 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 5' ' ' MET . 15.8 t 173.74 95.44 0.01 OUTLIER 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.732 -0.84 . . . . 72.13 108.732 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HA ' HD13 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -141.12 108.17 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.023 0.439 . . . . 72.32 111.806 -171.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 m 72.51 147.04 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.561 -0.745 . . . . 74.14 112.115 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -117.64 120.07 36.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.859 -0.609 . . . . 74.13 109.418 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.602 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . -169.77 163.24 6.78 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.849 -0.426 . . . . 70.01 109.849 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . 81.8 Cg_exo -44.17 115.29 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.742 2.294 . . . . 73.12 112.137 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.41 -20.62 7.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.693 0.627 . . . . 40.22 112.693 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -71.13 -53.31 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 74.13 110.552 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 12.0 pt-20 -82.01 -30.88 31.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.988 -0.551 . . . . 64.15 110.702 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.3 tm? -54.49 -37.04 64.81 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.668 -0.696 . . . . 55.25 110.577 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.22 -53.41 57.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.063 0.459 . . . . 73.21 110.168 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.55 -52.03 62.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 65.13 110.699 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.14 -44.01 92.03 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.571 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.443 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.7 p -67.27 -37.75 79.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.744 -0.465 . . . . 62.21 109.744 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.47 -35.58 79.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.802 0.334 . . . . 75.41 110.406 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 9.6 mm-40 -66.34 -51.07 60.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.319 -0.4 . . . . 70.24 110.349 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.7 83.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.487 . . . . 65.13 110.599 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 22.3 mmt -58.78 -12.64 4.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.737 -0.665 . . . . 72.51 111.709 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 29' ' ' PRO . 4.0 tpm_? -76.23 -25.48 55.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.597 0.221 . . . . 72.14 111.597 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.65 -27.54 5.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.141 0.496 . . . . 70.1 109.917 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 26' ' ' VAL . 58.9 t -81.51 51.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.153 -0.931 . . . . 51.43 109.4 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.52 HG13 ' HD3' ' A' ' 29' ' ' PRO . 9.6 p -171.56 162.89 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.706 -0.679 . . . . 72.24 110.628 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 27' ' ' VAL . 13.0 t70 -109.43 91.28 9.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.422 -1.325 . . . . 61.42 107.422 164.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.52 ' HD3' HG13 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -80.42 -3.77 12.7 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.128 1.885 . . . . 73.25 111.772 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.1 -57.63 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 74.22 110.055 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.2 mm? -90.1 -16.75 29.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.725 -0.67 . . . . 73.55 109.894 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 40.55 6.62 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.867 -0.606 . . . . 45.23 113.5 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.52 140.27 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.107 0.479 . . . . 73.32 110.416 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.3 p-10 -116.63 115.04 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 74.35 110.274 -176.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -46.0 -32.45 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.465 0.542 . . . . 72.33 112.465 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.58 -24.81 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.223 0.453 . . . . 74.33 112.223 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.93 -15.33 62.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.468 0.175 . . . . 62.25 111.228 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.65 -17.16 62.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.205 0.526 . . . . 72.15 109.771 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.44 22.7 67.85 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.371 -0.831 . . . . 65.52 113.425 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 59' ' ' MET . 3.0 tm? -97.46 -31.46 12.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.918 -1.141 . . . . 74.43 107.918 171.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.07 -7.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.235 -0.893 . . . . 63.45 110.409 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.12 -24.83 56.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 61.41 109.65 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.13 67.74 1.42 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 111.14 -0.784 . . . . 35.43 111.14 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -125.64 121.45 33.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.246 -0.65 . . . . 61.5 109.246 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -141.74 113.15 7.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.333 -0.618 . . . . 71.45 109.333 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 11.2 m -102.86 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.26 -0.644 . . . . 73.21 109.26 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -121.07 120.17 34.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.771 0.32 . . . . 74.43 110.28 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' A' ' 53' ' ' THR . 9.1 p-10 -94.11 88.24 5.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 52.33 109.658 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.36 159.17 24.98 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.414 -0.812 . . . . 50.13 111.869 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.88 -23.39 66.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.74 0.305 . . . . 74.31 110.717 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.36 -38.48 21.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 61.53 110.252 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.1 157.76 23.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.066 -0.587 . . . . 55.54 112.26 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.543 HG22 HG12 ' A' ' 86' ' ' VAL . 12.4 m -101.0 119.1 38.26 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.97 -0.381 . . . . 64.24 109.97 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.93 143.23 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.468 -0.333 . . . . 71.42 110.652 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -108.38 119.08 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 43.05 110.209 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.97 121.27 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.509 -0.552 . . . . 72.33 109.509 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' A' ' 44' ' ' LEU . 57.5 mt -125.2 138.61 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.82 -0.437 . . . . 63.4 109.82 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 92' ' ' ASN . 42.7 m-20 -111.87 120.7 42.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.076 -0.342 . . . . 72.51 110.076 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.615 ' HA ' HD12 ' A' ' 40' ' ' LEU . 30.3 mtm -141.38 171.2 14.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.204 0.526 . . . . 75.41 111.538 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 12.1 t -154.45 147.26 24.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.249 -0.887 . . . . 74.54 109.957 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 85.0 mt -109.19 149.25 29.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.847 -0.797 . . . . 64.43 108.847 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -34.69 -49.84 0.43 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.755 1.02 . . . . 73.23 113.755 -170.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.7 t -119.57 0.2 10.96 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.293 -0.255 . . . . 73.34 111.207 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.32 8.4 1.59 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.29 0.478 . . . . 63.42 112.29 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.45 -5.33 18.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.304 0.573 . . . . 40.1 109.708 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.417 ' HB3' HD23 ' A' ' 68' ' ' LEU . 22.6 m -65.29 128.07 93.47 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.226 -0.897 . . . . 62.23 109.945 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.27 16.88 0.36 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.76 2.307 . . . . 71.41 113.129 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 66' ' ' CYS . 3.4 mm? -85.64 0.52 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 62.51 111.254 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 70' ' ' ASP . 11.6 t -58.24 -57.23 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.47 0.176 . . . . 71.33 110.614 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 69' ' ' THR . 11.3 t70 -68.18 -25.47 65.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.041 0.448 . . . . 70.03 110.171 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.22 -52.79 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.065 -0.516 . . . . 75.42 110.534 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.6 pp -69.37 -33.77 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 121.043 -0.263 . . . . 65.11 110.608 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.588 ' N ' HD12 ' A' ' 72' ' ' ILE . 43.9 mt-10 -64.56 -45.07 88.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.699 0.285 . . . . 75.14 110.259 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.21 -51.0 69.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.162 -0.472 . . . . 62.52 110.881 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -57.22 -52.8 63.87 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.014 -0.539 . . . . 72.1 110.391 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.8 t -56.49 -60.21 3.86 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.612 -0.722 . . . . 73.35 111.207 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -55.87 -42.42 75.87 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 121.257 -0.177 . . . . 74.13 111.007 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 t -62.16 -46.59 88.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.469 -0.332 . . . . 75.14 110.803 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.84 -51.43 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.878 -0.329 . . . . 74.2 110.237 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -56.51 -39.02 72.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 62.13 111.218 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.98 -27.47 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.471 -0.332 . . . . 63.04 110.302 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.78 -31.56 62.31 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.997 -0.841 . . . . 61.31 110.997 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 85' ' ' LEU . 66.7 m -76.94 -22.09 53.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.027 -0.587 . . . . 45.32 110.329 176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.58 74.0 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 116.088 -0.505 . . . . 73.45 113.064 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.7 mp -78.22 -50.76 11.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 72.11 110.503 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 55' ' ' ALA . 17.6 m -124.93 168.8 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 64.32 110.478 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -111.06 -39.69 4.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.328 0.585 . . . . 71.03 110.166 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.43 151.06 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.755 -0.657 . . . . 65.13 110.273 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 55' ' ' ALA . 20.8 pt -136.91 152.75 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.858 -0.423 . . . . 71.0 109.858 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -135.98 116.03 13.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 63.5 110.146 172.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 63.7 mt -98.13 110.99 26.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 61.54 109.504 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.642 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 3.2 t30 -88.34 120.09 29.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.558 -0.746 . . . . 71.12 109.447 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.563 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.6 m95 -86.83 106.75 17.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.764 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.89 124.54 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.002 0.429 . . . . 72.31 110.589 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -117.65 -34.33 4.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.414 0.626 . . . . 72.31 109.636 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.0 t30 -172.47 -47.17 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.041 . . . . 53.05 109.589 -176.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 29.8 Cg_endo -63.64 140.95 77.52 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.519 1.48 . . . . 62.1 109.548 167.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.99 -95.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.144 1.896 . . . . 74.01 112.712 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -146.34 124.74 12.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.783 -0.451 . . . . 61.41 109.783 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.45 -98.74 0.11 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.714 -0.755 . . . . 63.02 113.04 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.72 -37.98 64.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.973 2.448 . . . . 62.14 112.432 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 6.0 m-20 -67.11 -4.79 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 71.41 111.424 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 72.7 mmtt -76.65 1.56 16.63 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.577 -0.283 . . . . 62.1 110.387 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.56 115.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.928 -0.397 . . . . 73.53 109.928 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 p -86.08 167.58 14.85 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.948 0.404 . . . . 75.24 111.416 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.73 -22.15 61.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.775 -0.648 . . . . 62.24 111.211 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.15 -53.17 61.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.879 0.371 . . . . 63.42 110.878 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.35 -27.85 46.63 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.001 -0.619 . . . . 61.22 112.125 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 109' ' ' ARG . 2.8 tmm_? -67.27 -39.64 86.07 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.648 -0.501 . . . . 75.21 109.648 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HG3' ' HG3' ' A' ' 111' ' ' GLN . 9.3 tp10 -77.03 -57.55 3.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.932 -0.576 . . . . 72.5 110.934 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.732 ' HB3' HD12 ' A' ' 115' ' ' LEU . 92.1 mt-30 -143.2 139.37 30.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.505 -0.316 . . . . 74.51 110.544 -176.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 114' ' ' ALA . 3.5 pp -69.57 142.84 53.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.262 0.553 . . . . 72.34 110.537 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -55.81 -29.8 60.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.221 -0.9 . . . . 74.3 111.877 -171.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.556 ' HB3' HD13 ' A' ' 112' ' ' LEU . . . -65.47 -7.48 14.47 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.529 0.566 . . . . 73.53 112.529 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 111' ' ' GLN . 27.4 mt -78.35 13.46 1.53 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.347 0.499 . . . . 75.44 112.347 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.29 92.2 0.05 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.364 -0.446 . . . . 51.42 112.143 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -68.94 105.86 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 73.24 111.343 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.8 m -128.0 129.85 47.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.189 -0.46 . . . . 55.34 110.299 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.87 -0.586 . . . . 63.22 109.568 178.957 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.823 -0.511 . . . . 72.51 111.823 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.88 -54.41 5.51 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.008 2.472 . . . . 74.1 112.553 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 74.05 1.44 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.088 -0.577 . . . . 74.43 111.814 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -78.21 -41.35 34.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.584 0.23 . . . . 72.32 110.893 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.8 mtm -146.1 148.49 32.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.888 -0.412 . . . . 62.03 109.888 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 t -147.82 15.55 1.08 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.074 0.464 . . . . 45.01 110.506 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 5.8 mp0 -77.26 131.49 38.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 63.11 110.655 -175.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -116.24 2.01 13.21 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.518 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -118.1 161.44 19.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.622 -0.263 . . . . 75.53 111.142 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . 74.77 142.86 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.42 0 O-C-N 124.145 0.903 . . . . 40.33 111.938 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.44 149.32 80.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.705 2.27 . . . . 63.12 111.703 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.42 -49.68 24.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.353 0.871 . . . . 74.1 113.353 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.84 -49.52 75.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.621 0.248 . . . . 65.31 111.572 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -74.99 -46.46 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.47 -0.332 . . . . 74.54 110.881 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.4 tm? -54.75 -44.86 73.97 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.714 -0.676 . . . . 53.42 110.803 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 61.6 tp -53.52 -59.81 4.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 64.35 111.189 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.63 80.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.065 -0.516 . . . . 73.01 110.899 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.69 -48.05 82.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 62.23 110.594 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.458 HG22 ' HG2' ' A' ' 23' ' ' MET . 5.3 p -69.36 -34.06 60.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 110.058 -0.349 . . . . 63.02 110.058 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 16' ' ' LEU . 2.2 tm-20 -54.06 -49.27 69.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.264 -0.643 . . . . 54.45 109.264 177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.15 -50.88 43.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.1 -0.5 . . . . 75.05 110.834 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.25 67.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.049 -0.523 . . . . 62.11 111.897 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' HG12 ' A' ' 27' ' ' VAL . 13.3 mmt -58.67 -24.89 62.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 60.24 111.578 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -66.13 -16.96 64.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.607 0.241 . . . . 74.05 111.034 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -119.37 -23.37 6.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.145 0.498 . . . . 71.01 109.926 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 23' ' ' MET . 43.2 t -66.78 -40.05 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.295 -0.866 . . . . 72.13 110.623 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.595 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.7 p -89.88 153.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.479 -0.563 . . . . 71.22 109.479 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -92.25 97.65 1.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 108.753 -0.832 . . . . 71.34 108.753 170.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 86.1 Cg_endo -85.38 -7.55 8.85 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.547 2.164 . . . . 72.41 111.852 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.66 -57.75 5.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 74.54 110.452 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.31 -18.54 16.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.716 0.293 . . . . 61.32 110.317 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.84 54.23 1.81 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.96 -0.638 . . . . 73.44 112.591 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.3 mp -117.81 143.23 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.193 -0.669 . . . . 62.22 109.193 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -125.45 109.85 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.557 -0.292 . . . . 65.14 110.603 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.9 m -54.63 -41.96 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.84 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' VAL . 68.9 t -56.96 -32.18 38.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.126 0.489 . . . . 52.23 110.748 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.8 -14.82 62.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.696 -0.684 . . . . 73.31 111.005 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 35' ' ' VAL . 4.4 mm? -63.61 -17.69 63.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.153 0.501 . . . . 75.3 110.093 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 72.1 22.86 78.67 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.423 -0.808 . . . . 74.22 114.363 172.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 40' ' ' LEU . 5.0 mt -98.25 -27.06 14.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.483 0.641 . . . . 63.12 110.421 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 59' ' ' MET . 35.8 t -63.57 -11.91 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.693 -0.685 . . . . 75.54 111.908 -169.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 98.7 m-85 -62.09 -17.68 58.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.187 0.518 . . . . 73.2 109.98 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.38 63.57 3.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.811 -0.915 . . . . 61.03 110.811 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.7 tt -125.62 128.94 48.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.212 -0.662 . . . . 74.54 109.212 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 44' ' ' LEU . 7.3 m-20 -149.16 173.47 13.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.483 -0.932 . . . . 43.44 108.483 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 55' ' ' ALA . 23.8 m -136.48 132.52 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 44.31 109.37 173.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -121.26 145.83 47.45 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.714 -0.476 . . . . 71.54 109.714 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.0 p-10 -100.62 129.31 46.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.313 0.578 . . . . 74.41 111.098 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.32 164.32 29.42 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.623 -1.791 . . . . 43.42 108.623 163.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.36 -19.62 66.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.164 0.982 . . . . 65.32 109.902 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 2.6 mp0 -77.64 -39.05 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.456 -0.793 . . . . 74.3 109.938 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.7 170.36 35.61 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.526 -0.761 . . . . 64.23 111.807 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 30.3 m -85.74 129.05 34.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.731 0.301 . . . . 70.3 111.299 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.54 140.68 39.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.993 -0.549 . . . . 72.51 110.23 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -85.22 154.56 21.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.15 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -128.72 122.74 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.281 0.632 . . . . 71.43 109.332 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 91' ' ' ILE . 54.3 mt -130.47 116.6 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.428 0.156 . . . . 72.15 111.124 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.37 118.8 24.46 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.261 -0.644 . . . . 70.1 109.261 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 41' ' ' VAL . 43.6 mmm -139.8 170.44 15.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.248 0.547 . . . . 71.02 111.941 -174.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -153.59 178.92 9.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.226 -0.897 . . . . 62.33 109.405 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 61.8 mt -120.48 156.35 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.012 -0.366 . . . . 40.4 110.012 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.9 p -47.46 -60.11 2.76 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.032 0.533 . . . . 75.01 112.343 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.9 t -104.23 2.17 31.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.843 0.354 . . . . 72.23 110.234 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.87 8.0 1.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.568 0.747 . . . . 72.44 112.154 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.36 -7.67 9.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 71.02 110.239 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.546 ' O ' HD13 ' A' ' 61' ' ' LEU . 11.8 m -76.84 145.09 73.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.506 -0.77 . . . . 52.11 110.41 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.69 27.89 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.579 2.186 . . . . 62.42 112.328 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 61' ' ' LEU . 91.8 mt -77.35 -6.52 53.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.747 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.9 t -58.2 -35.68 71.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.724 -0.473 . . . . 71.24 109.724 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.6 -50.01 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 64.41 111.217 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 14.2 p -68.66 -39.55 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.755 -0.202 . . . . 61.43 111.343 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 69' ' ' THR . 34.8 pt -66.81 -40.46 85.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 120.418 -0.513 . . . . 63.22 110.34 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.88 -46.93 88.67 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 116.41 -0.359 . . . . 65.44 110.186 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.76 -51.89 67.72 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.969 -0.56 . . . . 70.43 110.827 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 4.0 pt20 -64.86 -45.05 87.71 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.955 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.462 ' O ' HD23 ' A' ' 80' ' ' LEU . 77.4 p -66.74 -55.6 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.709 -0.223 . . . . 63.13 110.847 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.704 ' HD2' HG12 ' A' ' 89' ' ' ILE . 19.7 mmm180 -55.22 -53.07 60.61 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.731 0.3 . . . . 72.42 110.466 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 t -60.44 -43.49 96.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.575 -0.739 . . . . 73.44 111.49 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.91 -51.22 16.83 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 121.02 -0.272 . . . . 63.33 110.931 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -57.8 -37.98 74.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.156 -175.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 77' ' ' ARG . 20.6 m -78.0 -28.04 15.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.678 -0.409 . . . . 74.22 110.786 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.26 -42.63 97.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 61.33 112.087 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 p -94.27 1.4 55.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.93 0.395 . . . . 73.11 110.852 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.76 35.42 89.85 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.829 -0.623 . . . . 61.43 112.588 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.33 -36.94 80.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.353 0.597 . . . . 64.43 109.416 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.4 m -145.31 153.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.074 -0.966 . . . . 43.4 109.059 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.6 -44.46 70.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.267 0.556 . . . . 70.11 110.263 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.64 156.73 45.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 73.23 109.276 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.704 HG12 ' HD2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -125.97 144.04 37.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.716 -0.476 . . . . 72.32 109.716 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.56 ' HA ' HG21 ' A' ' 105' ' ' THR . 12.0 ttp180 -123.7 106.75 10.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.373 0.606 . . . . 64.22 109.981 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 57' ' ' ILE . 59.6 mt -95.58 128.02 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 71.13 109.545 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 7.4 p30 -102.27 111.29 23.51 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.061 -0.718 . . . . 73.13 109.061 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -86.78 106.29 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 70.14 109.692 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.66 123.75 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.647 -0.501 . . . . 62.54 109.647 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -121.18 -27.16 4.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.224 -0.443 . . . . 74.13 109.89 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 24.4 m-20 -179.57 -48.82 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.229 -0.896 . . . . 61.34 110.599 -169.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 17.8 Cg_exo -68.35 152.21 75.7 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.206 1.938 . . . . 70.24 112.45 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 16.4 Cg_exo -68.73 145.66 63.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.717 2.278 . . . . 74.22 110.963 172.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -48.94 109.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.657 0.598 . . . . 71.35 111.378 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.63 -87.85 0.07 OUTLIER Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.266 -0.492 . . . . 75.53 112.276 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.45 -28.68 62.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.536 2.157 . . . . 43.31 111.266 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 2.7 p-10 -66.98 -5.75 14.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.858 -1.065 . . . . 74.25 111.648 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HG2' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mttt -89.79 -6.57 55.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.516 0.198 . . . . 75.4 111.01 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.12 95.48 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 121.147 0.498 . . . . 54.14 110.61 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 90' ' ' ARG . 27.7 p -78.0 -178.01 5.31 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.75 -0.659 . . . . 52.13 111.703 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -38.25 53.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.795 -0.639 . . . . 75.43 111.811 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.12 -41.74 79.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 70.01 111.175 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -46.13 94.82 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.039 -0.6 . . . . 65.12 112.0 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.524 ' O ' HD12 ' A' ' 115' ' ' LEU . 42.8 mtp180 -74.0 -36.83 64.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.949 0.404 . . . . 71.11 110.466 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.03 -39.49 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.369 -0.832 . . . . 63.31 112.1 -173.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -108.36 75.2 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.711 0.767 . . . . 73.34 111.0 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 113' ' ' ARG . 1.5 tt -141.65 145.75 35.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 73.42 108.347 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.536 ' H ' HD23 ' A' ' 112' ' ' LEU . 16.9 ptt180 -64.8 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.466 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.26 68.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 70.45 110.533 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 109' ' ' ARG . 68.9 mt -98.7 20.57 12.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.641 -0.708 . . . . 72.2 110.703 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.52 68.14 1.52 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.759 -0.536 . . . . 71.53 111.759 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.4 147.51 51.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.537 -0.542 . . . . 62.42 109.537 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.8 m -66.23 -16.03 63.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.416 0.524 . . . . 65.34 112.416 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.726 -0.654 . . . . 62.23 110.325 -178.386 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.031 -0.428 . . . . 52.33 112.031 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.76 169.86 15.21 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.624 2.216 . . . . 54.1 111.983 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.39 -167.97 20.77 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.201 -0.523 . . . . 72.45 112.055 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 p -161.03 -168.52 2.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.334 . . . . 75.43 110.097 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.0 mtm -90.72 18.65 6.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.994 0.426 . . . . 71.42 110.395 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 m -108.67 178.43 4.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 63.11 110.806 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.632 ' H ' HD22 ' A' ' 44' ' ' LEU . 7.8 mm-40 51.33 57.04 7.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.508 0.67 . . . . 70.22 111.612 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -95.62 9.68 39.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 71.12 110.992 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -76.31 156.91 32.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.94 -0.573 . . . . 71.44 110.624 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 70.52 152.57 0.14 Allowed Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.564 0.54 . . . . 55.52 111.692 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.52 159.41 36.45 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.572 2.181 . . . . 55.23 112.549 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.0 -51.57 65.82 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.781 1.03 . . . . 72.03 113.781 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.62 -52.45 64.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.674 0.273 . . . . 71.14 111.534 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.43 -41.29 63.44 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.243 -0.435 . . . . 64.43 110.95 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.68 -43.12 72.16 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 110.257 -0.275 . . . . 74.45 110.257 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.7 tp -57.42 -56.32 23.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.279 -0.419 . . . . 73.04 110.906 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.03 65.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.877 -0.601 . . . . 72.12 111.018 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -60.9 -42.72 98.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.986 -0.552 . . . . 63.24 111.465 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -69.87 -40.91 79.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.711 -0.396 . . . . 74.53 110.4 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.91 -46.01 92.37 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.527 -0.546 . . . . 75.32 109.527 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 53.8 mt-10 -61.72 -50.6 71.79 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.888 -0.596 . . . . 71.14 110.831 177.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -44.92 76.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.088 0.471 . . . . 64.02 110.333 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.1 mmt -57.88 -28.36 64.11 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.452 -0.795 . . . . 73.31 110.507 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.39 -24.99 59.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.537 -0.301 . . . . 74.42 110.88 -178.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.76 -20.95 15.34 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.923 0.342 . . . . 74.42 111.923 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 23' ' ' MET . 26.4 m -87.71 -17.47 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.975 0.417 . . . . 72.14 110.455 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.7 p -89.15 168.83 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.969 -0.559 . . . . 73.34 109.65 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.9 92.39 6.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.115 -0.698 . . . . 53.33 109.115 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.1 -4.77 10.42 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.465 2.11 . . . . 60.51 111.93 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.85 -57.71 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 53.11 110.632 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.98 -18.59 16.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.977 0.418 . . . . 71.12 110.285 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.5 49.21 2.41 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.138 -0.553 . . . . 64.12 113.13 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -111.56 140.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.131 -0.692 . . . . 72.34 109.131 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.3 p30 -122.82 113.13 18.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.427 0.632 . . . . 53.14 110.59 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.81 -28.51 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.642 -0.708 . . . . 72.24 110.811 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG12 HG21 ' A' ' 41' ' ' VAL . 34.7 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.041 -0.527 . . . . 64.02 111.166 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 36.6 t70 -58.88 -26.01 63.86 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.894 0.378 . . . . 72.22 111.131 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.94 -15.04 63.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.238 -0.437 . . . . 44.43 110.301 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.0 61.83 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.661 -0.7 . . . . 61.15 113.542 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.72 -16.29 22.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.999 0.428 . . . . 60.52 110.192 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 HG12 ' A' ' 36' ' ' VAL . 47.7 t -59.66 -15.88 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.881 -0.599 . . . . 75.33 110.618 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.56 -24.11 44.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.722 -0.672 . . . . 63.12 110.628 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.78 67.29 1.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.997 -0.547 . . . . 71.02 112.303 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.632 HD22 ' H ' ' A' ' 7' ' ' GLU . 35.3 tp -110.98 130.72 55.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.639 -0.504 . . . . 71.02 109.639 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -157.91 109.12 2.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.527 -0.546 . . . . 71.22 109.527 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 118.74 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.704 -0.225 . . . . 62.13 110.505 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.66 120.65 38.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.078 -0.712 . . . . 70.2 109.078 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.68 140.99 37.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 74.12 110.198 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.15 167.34 35.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.713 -0.755 . . . . 61.32 112.079 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.95 -18.84 65.6 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.981 0.419 . . . . 75.1 110.657 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.22 -11.69 61.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.44 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.48 116.56 2.0 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.417 -0.673 . . . . 72.53 111.417 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.8 m -70.94 102.48 2.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.702 -0.481 . . . . 43.3 109.702 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 5.5 p -113.52 125.02 70.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.796 . . . . 54.23 111.834 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.99 114.21 26.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.664 . . . . 53.11 110.095 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -85.67 119.13 25.67 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.103 -0.332 . . . . 75.34 110.103 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 59' ' ' MET . 27.3 mm -116.73 127.98 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.742 -0.663 . . . . 65.4 109.45 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -107.47 116.48 32.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.477 -0.564 . . . . 54.23 109.477 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.519 ' HG3' HG22 ' A' ' 57' ' ' ILE . 42.5 mtm -140.87 170.56 15.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.748 0.785 . . . . 71.21 112.187 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -155.9 140.97 17.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.565 -1.198 . . . . 73.43 109.277 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 72' ' ' ILE . 3.7 mm? -85.4 167.43 15.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.589 -0.523 . . . . 73.12 109.589 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -50.1 -49.55 51.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.083 0.24 . . . . 73.31 111.431 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 m -102.27 -11.69 18.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.142 0.496 . . . . 71.35 110.34 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB1' ' HD1' ' A' ' 95' ' ' TRP . . . 62.58 8.21 2.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.347 -0.842 . . . . 75.01 112.467 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.04 -16.13 8.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.919 0.39 . . . . 51.53 110.958 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 p -66.15 144.99 98.97 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.967 -0.56 . . . . 65.31 111.327 -176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 8.3 Cg_exo -73.74 38.96 0.47 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.625 2.883 . . . . 74.54 113.852 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.8 mm? -92.98 -12.05 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.174 -0.306 . . . . 64.24 110.174 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.6 t -49.77 -57.71 6.79 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.682 -0.69 . . . . 62.11 111.733 -177.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 69' ' ' THR . 7.8 p-10 -66.15 -32.95 74.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.598 -0.274 . . . . 74.32 110.726 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.588 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 59.6 t -64.17 -53.43 43.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 53.4 110.68 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 68' ' ' LEU . 5.4 pt -71.93 -27.11 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 111.762 0.282 . . . . 64.24 111.762 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 91' ' ' ILE . 43.4 mt-10 -66.19 -45.64 80.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.946 0.403 . . . . 70.53 110.695 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.51 -49.53 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.734 . . . . 64.14 110.335 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 79.9 mm-40 -58.16 -45.61 87.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 72.21 110.491 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 80' ' ' LEU . 41.0 t -58.15 -63.69 1.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 62.35 110.541 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' O ' HG12 ' A' ' 81' ' ' VAL . 75.7 ttt180 -54.85 -47.83 73.68 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.885 -0.326 . . . . 53.5 110.812 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -55.54 -45.23 77.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.127 -0.488 . . . . 74.1 111.277 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.49 -51.07 18.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 74.31 110.816 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 85' ' ' LEU . 10.8 mp -58.75 -32.65 69.45 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.335 -0.393 . . . . 71.32 111.065 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 77' ' ' ARG . 8.6 p -84.2 -27.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 63.31 110.084 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.08 71.02 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.087 -0.578 . . . . 55.5 111.989 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.1 t -97.53 1.67 49.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.194 0.521 . . . . 53.41 110.064 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.39 23.06 78.49 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.895 -0.593 . . . . 23.24 112.913 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 80' ' ' LEU . 43.9 mt -66.81 -57.81 6.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.58 0.705 . . . . 74.41 109.186 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.02 -173.77 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.803 -1.09 . . . . 75.25 108.953 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -119.72 -39.01 2.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.161 -0.681 . . . . 71.51 109.161 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.8 m-20 -112.64 151.68 29.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 63.4 109.916 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 pt -140.17 170.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.532 -0.544 . . . . 62.04 109.532 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -148.57 106.7 3.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.101 -0.5 . . . . 74.14 109.665 172.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 73' ' ' GLU . 53.6 mt -93.55 121.35 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 74.41 109.81 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.441 ' CB ' ' HE2' ' A' ' 103' ' ' LYS . 26.3 t-20 -100.23 133.09 45.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.89 -0.596 . . . . 72.2 109.804 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -97.9 106.7 19.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.47 . . . . 75.51 110.423 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.28 124.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.424 -0.584 . . . . 63.44 109.424 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.444 ' HD1' ' HB1' ' A' ' 64' ' ' ALA . 4.3 m-90 -102.35 -34.99 8.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.422 -0.584 . . . . 74.32 109.422 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 23.1 t-20 168.67 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.419 -1.264 . . . . 74.5 109.243 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 49.5 Cg_exo -60.14 161.1 20.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.545 2.164 . . . . 64.35 112.324 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.59 -177.54 2.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.123 2.548 . . . . 71.25 112.986 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -89.21 -163.1 0.94 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.389 -0.823 . . . . 74.32 110.515 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.73 -173.88 45.99 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.079 -0.581 . . . . 73.45 112.485 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.74 -5.7 7.8 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.217 2.611 . . . . 50.44 112.512 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 31.7 t70 -57.53 -19.9 28.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 44.44 110.631 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 90.8 mttt -76.27 5.87 6.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.228 -0.442 . . . . 63.3 111.512 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.96 98.47 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.269 -0.641 . . . . 74.41 109.269 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -50.88 166.37 0.09 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.31 0.856 . . . . 65.44 113.31 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -50.99 -50.42 58.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.12 -0.946 . . . . 63.43 111.446 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 4.8 m-20 -57.05 -43.17 81.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.324 -0.853 . . . . 63.3 111.234 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.96 -36.49 86.41 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.98 -0.628 . . . . 55.34 111.65 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -66.57 -36.28 82.25 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.17 0.188 . . . . 71.45 110.93 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.617 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.2 tt0 -57.22 -37.76 72.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.138 0.494 . . . . 73.21 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 107' ' ' ASP . 35.7 mt-30 -93.73 17.0 12.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 63.33 111.433 -168.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -114.44 144.41 43.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 75.2 110.117 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.02 -29.77 63.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.352 -0.386 . . . . 74.2 111.014 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.38 -18.66 51.89 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.016 -0.538 . . . . 72.21 111.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.617 ' HG ' ' HA ' ' A' ' 110' ' ' GLU . 1.1 tm? -73.61 -34.24 64.95 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.378 -0.601 . . . . 73.33 109.378 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.51 -94.79 0.2 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.626 -0.715 . . . . 61.51 112.276 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 52.75 82.34 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.958 0.503 . . . . 71.51 110.538 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.7 t -116.24 5.16 13.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.2 110.234 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 C--O 1.25 1.116 0 CA-C-N 115.675 -0.693 . . . . 64.42 110.84 -177.063 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 112.008 -0.437 . . . . 73.03 112.008 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.2 113.61 2.41 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.148 2.565 . . . . 64.52 112.359 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.08 -178.72 53.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.373 -0.441 . . . . 52.42 113.023 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.6 m 68.12 11.05 8.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 74.23 111.657 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.5 ptp -69.2 91.53 0.52 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.42 0.629 . . . . 74.41 110.181 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' A' ' 42' ' ' TYR . 15.3 m -94.61 -23.48 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 75.42 110.905 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -74.28 2.16 9.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.629 -0.714 . . . . 53.0 111.475 -178.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.0 p -74.19 31.56 0.08 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.393 0.516 . . . . 72.21 112.393 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -86.35 35.26 0.65 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.018 0.437 . . . . 52.11 110.873 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 157.49 49.16 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.186 -0.461 . . . . 73.21 109.809 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.53 146.38 95.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.51 2.14 . . . . 62.23 111.906 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.88 -44.37 49.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.345 0.869 . . . . 71.13 113.345 -169.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 14.5 mp0 -63.2 -52.41 62.39 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.899 0.381 . . . . 72.1 110.845 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -72.11 -43.8 64.17 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.295 0.569 . . . . 74.25 110.449 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.74 -39.86 82.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.294 -0.866 . . . . 51.03 110.249 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.59 -53.21 57.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.905 0.383 . . . . 73.25 110.472 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.62 -51.93 66.48 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.785 -0.643 . . . . 61.13 110.996 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.2 -48.44 80.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.904 -0.589 . . . . 54.05 111.02 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 5.4 p -65.96 -34.48 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.945 -0.391 . . . . 63.31 109.945 -177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.91 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.696 -0.483 . . . . 71.21 109.696 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 28.5 mm-40 -65.92 -46.39 78.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.64 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.05 86.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 40.44 110.827 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.38 -12.62 14.9 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.042 -0.527 . . . . 71.22 111.564 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 76.9 ttt180 -87.31 -20.86 26.2 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.158 0.583 . . . . 72.23 111.459 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.27 -27.22 5.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.243 0.544 . . . . 74.21 110.84 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -74.74 -16.69 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.197 -0.911 . . . . 61.51 110.163 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.557 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p -94.2 155.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 74.12 110.445 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.15 89.74 0.62 Allowed Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 107.072 -1.455 . . . . 71.05 107.072 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 55.6 Cg_endo -81.27 -6.95 12.96 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.084 1.856 . . . . 63.13 111.712 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.82 -57.57 5.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.434 -0.803 . . . . 74.44 109.894 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 7.0 mp -92.29 -18.77 22.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.137 -0.483 . . . . 62.43 110.178 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.83 52.75 3.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.782 -0.644 . . . . 60.41 113.846 171.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.29 140.09 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 117.263 0.531 . . . . 74.23 109.939 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 24.2 m-80 -103.1 130.6 50.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.807 -0.442 . . . . 73.21 109.807 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.5 t -56.72 -33.11 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.545 0.688 . . . . 62.53 109.866 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.94 -30.61 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.245 -0.889 . . . . 70.14 111.005 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 2.0 m-20 -63.08 -23.58 67.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.57 -0.286 . . . . 73.34 111.581 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 -16.37 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.094 0.473 . . . . 74.13 110.276 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.03 22.82 60.87 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.618 -0.719 . . . . 71.2 112.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.5 tp -90.53 -24.76 20.53 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.476 -0.565 . . . . 74.45 109.476 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.59 -8.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.534 -0.757 . . . . 72.31 110.32 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.423 ' HA ' ' OG ' ' A' ' 6' ' ' SER . 52.9 t80 -71.16 -16.13 62.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.881 -0.599 . . . . 74.23 109.692 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 52.12 3.51 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.834 -0.906 . . . . 63.32 110.834 172.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.569 HD13 HG12 ' A' ' 57' ' ' ILE . 61.6 tp -102.1 121.06 41.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.027 0.441 . . . . 73.42 109.974 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.42 108.58 10.95 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.144 -1.058 . . . . 51.1 108.144 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 10.8 m -99.43 128.0 51.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.476 -0.565 . . . . 75.33 109.476 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -120.54 145.55 47.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 74.1 110.844 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.47 163.34 19.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.498 -0.773 . . . . 73.3 110.309 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.9 155.71 26.68 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.866 -0.894 . . . . 63.2 110.866 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.66 -20.27 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.484 . . . . 72.35 110.48 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -89.48 -27.92 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.746 -0.661 . . . . 64.11 110.575 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.89 176.42 32.99 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.395 -0.682 . . . . 54.03 111.395 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.1 m -99.29 129.91 45.54 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.792 0.33 . . . . 62.04 110.483 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 137.09 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.145 -0.48 . . . . 74.24 110.814 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.71 120.5 39.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.081 -0.509 . . . . 62.31 110.285 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 103' ' ' LYS . 20.7 mt -96.65 114.02 25.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.564 -0.532 . . . . 64.12 109.564 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 44' ' ' LEU . 51.1 mt -111.42 118.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.544 0.211 . . . . 75.31 110.822 -176.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -82.86 120.86 26.19 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.282 -0.266 . . . . 64.01 110.282 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.5 mtp -139.23 163.5 32.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.363 0.602 . . . . 72.1 111.339 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 94' ' ' VAL . 73.7 m -136.62 137.73 40.43 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.839 -0.618 . . . . 73.11 109.595 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 69' ' ' THR . 87.4 mt -89.23 146.92 24.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.656 -0.498 . . . . 74.33 109.656 177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -36.1 -57.26 0.71 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.839 0.856 . . . . 71.32 113.027 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -121.29 12.6 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 72.41 110.622 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 8.56 1.19 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.718 -0.674 . . . . 62.42 112.567 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.83 13.07 12.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 73.31 110.547 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 44.5 t -95.9 139.82 22.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 71.5 110.507 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.37 17.45 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.922 2.415 . . . . 73.1 112.376 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HB2' ' SG ' ' A' ' 66' ' ' CYS . 48.5 tp -69.09 -13.83 62.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.956 -0.565 . . . . 72.2 110.499 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.499 HG23 ' N ' ' A' ' 70' ' ' ASP . 12.7 t -49.72 -56.8 8.88 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.591 -0.731 . . . . 74.43 111.903 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 69' ' ' THR . 22.7 t70 -63.67 -37.24 86.61 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.889 0.376 . . . . 64.11 110.356 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 60.9 t -62.28 -52.76 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 63.33 110.753 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.54 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.8 pp -68.47 -34.94 68.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.791 -0.186 . . . . 74.32 111.258 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 72' ' ' ILE . 41.2 mt-10 -62.47 -46.58 87.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.697 0.284 . . . . 71.55 110.462 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' SER . 23.4 t70 -63.27 -47.53 81.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 61.22 110.917 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 26.4 mm-40 -57.46 -55.64 32.2 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 74.43 110.444 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' HD23 ' A' ' 80' ' ' LEU . 36.6 t -59.44 -54.61 44.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.819 -0.628 . . . . 72.01 110.587 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 77' ' ' ARG . 1.4 tmt_? -54.79 -42.79 72.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.448 -0.342 . . . . 72.5 110.555 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 7.1 t -56.28 -52.89 62.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 51.23 110.88 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.49 -51.89 13.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.87 -0.332 . . . . 55.42 111.446 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 76' ' ' SER . 4.3 mm? -60.68 -33.92 73.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.272 0.558 . . . . 72.14 111.186 -173.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -85.85 -27.2 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.785 -0.643 . . . . 64.41 109.911 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.72 79.05 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.292 -0.48 . . . . 71.02 112.149 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -79.25 -23.04 43.94 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.649 -0.5 . . . . 64.41 109.649 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 48.58 3.56 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.578 -0.737 . . . . 53.51 113.25 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.0 mt -80.47 -35.3 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.989 -0.745 . . . . 60.1 108.989 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.7 m -143.84 160.35 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.109 -0.95 . . . . 73.14 109.336 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.69 -30.92 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 63.11 110.675 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -152.5 166.07 33.14 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.02 -0.536 . . . . 73.32 110.238 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 55' ' ' ALA . 35.7 pt -136.95 154.46 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.132 0.492 . . . . 72.11 110.86 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.701 ' HB2' HG23 ' A' ' 105' ' ' THR . 8.6 tpt85 -133.24 110.42 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.74 -0.664 . . . . 72.04 109.215 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 58.6 mt -91.61 123.17 43.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.224 -0.443 . . . . 72.14 110.224 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.47 HD22 ' C ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -88.2 118.21 27.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.42 -0.956 . . . . 72.52 108.42 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.447 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.8 m-90 -89.69 114.0 25.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.242 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HB ' ' OG1' ' A' ' 60' ' ' THR . 7.4 t -86.07 124.02 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.863 -0.421 . . . . 73.03 109.863 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -112.08 -32.16 6.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 75.53 109.408 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.451 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 35.3 m-20 -179.57 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 114.354 -1.294 . . . . 71.14 109.379 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 23.6 Cg_exo -65.96 154.15 75.17 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.222 1.948 . . . . 52.32 111.664 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.18 -176.64 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 52.43 112.061 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m-90 -79.64 145.59 32.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 72.31 110.276 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.29 -110.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.923 -0.656 . . . . 71.1 112.226 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.57 -33.76 86.44 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.563 2.175 . . . . 64.12 112.163 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.63 -4.11 14.3 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.895 -0.593 . . . . 73.33 110.719 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 56' ' ' LEU . 30.2 mtpp -82.45 6.2 18.08 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.86 -0.525 . . . . 65.1 110.277 172.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.52 130.03 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.224 -0.297 . . . . 64.43 110.327 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 90' ' ' ARG . 11.7 p -53.82 150.43 7.52 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.019 0.437 . . . . 65.23 111.376 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.02 -41.0 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 61.32 109.924 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.645 ' HB3' HD13 ' A' ' 115' ' ' LEU . 6.6 m-20 -57.27 -45.29 84.19 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.458 -0.792 . . . . 74.33 110.588 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.47 -47.2 89.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.838 -0.696 . . . . 74.11 111.942 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -64.6 -37.22 86.8 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.941 0.401 . . . . 65.24 110.781 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.78 -42.16 18.27 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.168 0.433 . . . . 71.12 112.168 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.657 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 35.7 mt-30 -104.23 -28.16 11.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.772 0.656 . . . . 43.14 112.772 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 112' ' ' LEU . 3.1 mm? 53.49 -98.9 0.08 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.445 0.298 . . . . 71.44 110.733 -176.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -70.95 -37.28 72.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.926 0.393 . . . . 65.22 110.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -64.79 -7.58 11.63 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.943 -0.571 . . . . 73.31 111.907 -176.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 107' ' ' ASP . 55.8 tp -72.16 -29.66 64.24 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.919 0.39 . . . . 63.42 110.178 176.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.03 122.47 5.84 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.779 -0.646 . . . . 74.42 112.192 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.74 124.89 23.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.272 -0.27 . . . . 72.21 110.272 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.0 m -65.54 87.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.985 0.422 . . . . 64.12 110.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.5 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.488 -0.768 . . . . 75.02 111.045 -178.576 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 N-CA-C 112.262 -0.335 . . . . 61.32 112.262 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.63 -1.47 10.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.193 2.595 . . . . 74.21 112.585 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.74 86.15 1.66 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 111.225 -0.75 . . . . 54.44 111.225 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.5 p -74.86 66.12 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.134 0.492 . . . . 62.43 111.669 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.4 mmt -98.16 -6.53 31.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.527 0.68 . . . . 63.44 109.363 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 42' ' ' TYR . 32.1 t -161.42 -177.62 6.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.017 -0.992 . . . . 72.51 108.928 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 56.85 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.716 0.769 . . . . 74.01 111.271 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 p -148.98 32.89 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.037 -0.983 . . . . 71.22 109.03 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 85' ' ' LEU . 35.7 t -68.23 125.39 26.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.49 -0.777 . . . . 75.21 110.958 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 69.11 163.55 0.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.812 -0.631 . . . . 53.11 111.823 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 80.9 Cg_exo -47.86 153.59 2.44 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.978 2.452 . . . . 64.55 112.194 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.5 -29.87 51.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 61.31 112.072 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 7.9 mp0 -63.63 -45.4 90.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.173 0.511 . . . . 52.23 109.932 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.73 -47.35 39.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.408 -0.815 . . . . 74.21 109.402 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.45 -45.49 73.1 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 114.819 -1.082 . . . . 74.2 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.99 -59.72 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.977 0.418 . . . . 62.43 111.163 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.86 66.41 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.118 -0.492 . . . . 62.5 111.129 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.16 -32.58 72.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.6 -0.727 . . . . 71.3 111.915 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -72.39 -38.17 60.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 109.396 -0.594 . . . . 61.0 109.396 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -58.88 -41.62 87.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.512 -0.313 . . . . 65.53 110.731 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -69.67 -51.66 32.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.036 0.446 . . . . 74.44 110.683 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.24 -34.64 75.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.839 -0.618 . . . . 61.42 111.391 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.4 mmt -61.25 -13.29 17.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.236 -0.438 . . . . 74.23 112.114 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -90.77 -17.46 26.63 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.748 0.249 . . . . 72.15 111.493 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.52 -25.81 5.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.503 0.668 . . . . 74.45 110.466 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.85 -23.13 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.092 -0.958 . . . . 60.21 109.878 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 9.9 p -89.0 159.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.071 174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 94.61 4.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.527 -0.916 . . . . 73.23 108.527 168.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 72.8 Cg_endo -81.54 -3.84 12.08 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.257 1.971 . . . . 63.35 111.989 -176.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.72 -57.55 5.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.14 0.495 . . . . 74.34 109.862 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.5 mt -92.79 -18.75 22.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.708 -0.678 . . . . 62.3 109.864 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.34 51.46 3.7 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.955 -0.566 . . . . 25.2 113.49 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.68 143.85 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.026 0.413 . . . . 65.32 110.432 177.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.411 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.2 p30 -108.79 134.82 50.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 75.01 110.637 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.42 -25.69 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.012 0.434 . . . . 74.42 111.121 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.81 -24.96 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.927 -0.579 . . . . 62.12 110.348 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.75 -33.61 68.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 73.3 110.642 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 38' ' ' LEU . 3.5 mm? -71.91 -16.7 62.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 74.43 110.297 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.98 21.1 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.48 -0.782 . . . . 62.14 113.782 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.5 mt -88.58 -19.2 26.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.892 0.346 . . . . 72.11 110.157 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.6 -9.59 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.853 -0.612 . . . . 55.32 110.512 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 88.3 t80 -55.89 -31.23 62.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.546 -0.752 . . . . 71.01 109.678 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 75.76 1.48 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.539 -0.755 . . . . 72.32 111.585 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.535 HD13 HG12 ' A' ' 57' ' ' ILE . 50.8 tp -119.94 126.33 50.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.768 0.427 . . . . 75.22 109.951 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -150.92 115.38 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.498 -0.556 . . . . 73.43 109.498 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -94.8 136.25 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.848 0.356 . . . . 54.52 110.176 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -130.63 150.21 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.626 -0.509 . . . . 72.2 109.626 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 33.2 t70 -92.01 117.39 29.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.446 -0.343 . . . . 72.25 110.891 -176.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.45 174.16 24.62 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.406 -0.426 . . . . 63.22 112.087 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.04 -32.16 69.49 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.917 0.389 . . . . 72.23 111.46 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.39 -14.29 22.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.148 -0.478 . . . . 61.03 111.513 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.18 172.23 22.63 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.094 -0.574 . . . . 24.45 111.992 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.0 m -78.88 115.46 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.712 0.256 . . . . 51.24 110.782 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 33.3 m -103.94 144.97 13.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.46 -0.337 . . . . 75.1 110.648 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.59 112.85 24.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 70.23 110.599 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 44.1 mt -79.5 115.62 19.23 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.126 -0.694 . . . . 73.42 109.126 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.535 HG12 HD13 ' A' ' 44' ' ' LEU . 49.5 mt -120.51 125.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.091 -0.337 . . . . 74.4 110.091 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD2' HG23 ' A' ' 94' ' ' VAL . 24.8 t0 -96.12 130.83 43.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 74.53 110.772 176.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.4 mtp -141.64 170.96 14.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.292 0.568 . . . . 54.31 111.268 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -154.43 153.46 31.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.735 . . . . 72.41 109.86 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 mp -110.72 170.8 7.85 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.971 -0.381 . . . . 63.44 109.971 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 p -57.12 -60.22 3.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.21 -0.45 . . . . 60.35 111.824 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.429 ' HG ' ' HG ' ' A' ' 66' ' ' CYS . 86.2 p -91.88 -24.34 19.36 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.362 -0.381 . . . . 75.23 110.315 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.4 8.93 4.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.427 -0.806 . . . . 53.4 110.826 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.63 -25.93 8.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.589 . . . . 70.44 110.53 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.429 ' HG ' ' HG ' ' A' ' 63' ' ' SER . 64.3 m -59.43 135.57 88.82 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.007 -0.542 . . . . 65.02 110.628 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.29 25.7 0.31 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.892 2.395 . . . . 75.44 113.038 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 72' ' ' ILE . 89.8 mt -78.19 -6.26 54.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.988 -0.375 . . . . 65.51 109.988 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.3 t -49.37 -44.31 44.8 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.548 -0.751 . . . . 74.31 109.946 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.48 -51.57 68.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.67 -0.695 . . . . 71.44 110.693 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 49.2 t -62.78 -53.04 51.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.533 -0.758 . . . . 61.33 111.46 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 68' ' ' LEU . 6.7 pt -71.01 -35.96 61.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.759 -0.376 . . . . 74.3 111.713 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.51 -54.27 46.06 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.892 0.853 . . . . 72.35 108.76 173.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.89 -51.29 70.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.864 -1.516 . . . . 62.44 111.231 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 21.2 mm-40 -59.36 -49.08 79.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.657 0.265 . . . . 72.14 110.564 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 45.7 m -59.29 -60.56 3.66 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.016 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.476 ' HB3' HG12 ' A' ' 89' ' ' ILE . 14.4 ptm180 -62.11 -36.68 82.47 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.047 -0.261 . . . . 71.25 111.208 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 t -60.07 -40.94 91.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.252 -0.431 . . . . 72.45 110.672 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -51.18 16.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.73 0.3 . . . . 65.02 110.749 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -55.26 -38.12 68.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.108 -0.496 . . . . 70.12 111.148 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.24 -27.77 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.594 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.71 -34.04 69.34 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.32 -0.467 . . . . 74.11 112.094 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 29.9 m -107.67 6.79 28.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.797 0.332 . . . . 64.25 111.15 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.71 69.51 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.125 -0.559 . . . . 72.24 112.07 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 78.2 mt -60.68 -43.12 98.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.672 0.749 . . . . 70.31 108.99 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 19.2 m -143.9 159.15 16.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.361 -1.29 . . . . 71.24 108.114 170.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.42 -43.19 86.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.309 0.576 . . . . 73.1 110.081 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 27.2 t70 -161.55 168.63 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.248 -0.887 . . . . 72.13 108.753 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 77' ' ' ARG . 32.6 pt -122.68 148.05 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.815 0.341 . . . . 71.45 110.118 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 90' ' ' ARG . 2.8 tpp180 -119.44 106.38 12.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.473 -0.936 . . . . 71.31 108.473 176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.3 mt -93.78 145.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.78 0.324 . . . . 71.25 110.853 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -118.71 139.67 51.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.877 -0.786 . . . . 71.2 108.877 172.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.531 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 49.1 m95 -106.43 106.79 17.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.748 -0.464 . . . . 71.31 109.748 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.521 HG23 ' OD2' ' A' ' 58' ' ' ASP . 39.5 t -87.3 123.84 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.945 -0.702 . . . . 73.22 109.882 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 7.3 p-90 -140.88 -0.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.071 -0.513 . . . . 70.0 111.105 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.586 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t-20 167.88 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 116.071 -0.513 . . . . 53.44 110.435 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 94.5 Cg_endo -80.72 156.69 21.2 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.947 1.765 . . . . 54.52 111.855 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.08 170.09 17.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.208 1.939 . . . . 34.44 111.653 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -61.11 101.69 0.17 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.057 -0.52 . . . . 73.11 110.412 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.85 -83.75 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.075 -0.512 . . . . 63.42 112.451 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.52 -51.96 3.65 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.725 2.284 . . . . 64.25 112.244 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 93' ' ' TRP . 6.1 m-20 -64.01 -4.01 3.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 64.44 112.466 -176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -76.23 -7.82 55.7 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.598 0.237 . . . . 74.12 110.508 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.53 102.81 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.913 -0.403 . . . . 75.2 109.913 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 p -70.45 176.65 3.88 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.13 -0.486 . . . . 72.44 112.106 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 68.2 mm-40 -54.13 -21.06 7.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.683 -0.689 . . . . 75.25 112.222 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.63 -51.28 69.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.979 0.419 . . . . 73.42 110.381 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -27.63 66.6 Favored Glycine 0 C--N 1.33 0.201 0 CA-C-N 115.842 -0.617 . . . . 75.53 111.874 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 10.9 mmm180 -65.45 -51.1 62.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.65 0.38 . . . . 73.51 111.361 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -80.65 -44.55 18.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.887 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -95.7 115.44 27.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.157 0.503 . . . . 73.11 111.591 -168.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.2 pt? -134.03 166.79 21.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.344 -0.843 . . . . 74.54 109.775 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.93 -31.07 71.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.558 0.218 . . . . 73.12 111.244 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.78 -16.42 61.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.679 0.276 . . . . 54.12 111.413 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 ' O ' HD23 ' A' ' 115' ' ' LEU . 8.6 tt -75.97 -26.37 56.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.97 -0.559 . . . . 65.22 109.8 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.28 92.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.892 -0.595 . . . . 51.2 112.653 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -125.47 154.93 41.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 75.12 109.88 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.0 m -90.58 149.49 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.19 -0.3 . . . . 63.23 110.19 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 119.224 -0.417 . . . . 74.31 111.558 -178.465 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.113 -0.395 . . . . 43.13 112.113 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.83 160.25 30.89 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.785 2.323 . . . . 74.43 112.611 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.0 -106.84 0.23 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.708 -0.557 . . . . 72.34 111.708 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.515 ' HB2' HG21 ' A' ' 36' ' ' VAL . 37.3 m -156.1 165.59 35.96 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.899 -0.408 . . . . 75.34 109.899 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 70.5 mtm -92.94 -69.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.621 -0.511 . . . . 75.42 109.621 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.438 ' HB3' HD21 ' A' ' 44' ' ' LEU . 50.7 m 70.7 -56.41 0.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.42 0.688 . . . . 75.35 112.414 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 143.33 53.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.345 0.258 . . . . 74.43 110.637 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 t -163.19 20.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.513 -0.312 . . . . 73.01 111.318 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -82.54 18.28 1.55 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 111.901 0.334 . . . . 72.22 111.901 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.49 157.89 55.05 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.679 -0.237 . . . . 63.11 110.664 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.33 176.77 3.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.847 2.364 . . . . 74.2 112.05 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.08 -64.45 0.81 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.039 0.755 . . . . 74.23 113.039 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -64.43 -46.77 81.73 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.026 0.441 . . . . 74.34 110.937 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.34 -46.67 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.344 -0.844 . . . . 75.53 110.761 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.9 -49.12 77.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.774 -0.648 . . . . 75.13 110.16 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.33 -59.89 3.99 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 52.13 111.449 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -45.06 80.51 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.098 -0.501 . . . . 75.42 111.25 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.26 -41.24 73.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 73.1 110.812 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.11 -32.82 55.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 109.54 -0.541 . . . . 73.31 109.54 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.19 -48.79 75.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.211 -0.663 . . . . 75.35 109.211 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -61.58 -50.57 72.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.798 -0.637 . . . . 45.42 111.267 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.04 75.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.153 0.501 . . . . 60.04 111.188 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.28 -13.52 62.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.812 -0.631 . . . . 61.43 110.651 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -96.85 -8.01 32.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.635 . . . . 70.14 110.405 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.61 -27.13 5.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.499 0.666 . . . . 52.23 110.127 -173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -90.98 -33.04 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.152 -0.931 . . . . 74.01 111.257 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 33' ' ' ILE . 1.2 p -74.7 174.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.12 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.55 96.22 8.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 109.722 -0.473 . . . . 53.03 109.722 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 67.8 Cg_endo -89.13 3.16 5.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.627 2.218 . . . . 74.12 111.775 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.81 -57.93 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 74.23 110.461 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.58 -11.29 14.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.897 -0.592 . . . . 61.42 110.444 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 51.48 2.58 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.952 -0.567 . . . . 30.3 112.905 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 27' ' ' VAL . 3.2 mp -106.69 140.09 26.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.531 -0.544 . . . . 63.42 109.531 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 67.4 m-20 -116.62 109.03 16.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.509 -0.769 . . . . 51.14 109.59 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.23 -39.09 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.051 0.453 . . . . 75.22 111.257 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 4' ' ' SER . 15.0 p -58.1 -24.85 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.025 -0.534 . . . . 64.41 111.323 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.57 -24.75 67.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 71.13 110.988 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.16 -10.74 59.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.266 0.555 . . . . 72.24 110.509 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 22.52 66.09 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.358 -0.837 . . . . 75.41 114.321 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.4 tp -98.46 -30.08 12.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.06 0.457 . . . . 65.04 110.372 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.53 -14.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.587 -0.733 . . . . 74.1 111.826 -172.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -62.04 -23.4 66.44 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 71.12 109.888 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.89 70.18 2.56 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.684 -0.689 . . . . 74.31 112.085 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.4 pp -126.06 144.51 50.69 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 73.45 109.896 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -163.7 138.06 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.679 -0.86 . . . . 72.44 108.679 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.66 132.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.84 0.352 . . . . 73.01 110.822 -175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -115.7 127.3 55.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.132 -0.486 . . . . 62.01 111.346 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -81.6 113.88 19.91 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.677 -0.692 . . . . 72.42 109.275 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.02 158.94 18.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.139 -0.553 . . . . 65.22 111.732 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.9 -24.74 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 73.02 110.258 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.31 -16.19 50.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.254 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.87 158.75 9.48 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.971 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 m -98.48 102.43 14.17 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.625 -0.88 . . . . 72.52 108.625 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 t -102.92 123.65 56.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 63.44 111.219 -168.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.91 115.29 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.846 -0.616 . . . . 73.04 109.585 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 90' ' ' ARG . 50.3 mt -93.89 127.89 39.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.553 0.341 . . . . 74.32 110.404 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.27 129.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.829 -0.434 . . . . 75.15 109.829 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.86 129.78 35.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.037 0.446 . . . . 73.15 111.1 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 79.9 mtp -141.18 171.07 14.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.972 -0.558 . . . . 73.03 110.183 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -148.63 157.48 43.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.144 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mm? -117.1 150.93 37.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.185 -0.672 . . . . 63.24 109.185 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -51.03 -53.86 29.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.651 0.611 . . . . 74.32 112.651 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -113.65 0.2 14.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.69 -0.232 . . . . 74.23 111.227 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 7.81 1.8 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.983 0.513 . . . . 62.34 112.228 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.33 3.78 10.8 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.498 0.666 . . . . 70.21 109.644 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.5 m -83.87 138.64 40.25 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.169 -0.923 . . . . 73.14 110.476 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.3 23.87 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.907 2.405 . . . . 75.14 112.622 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 83.5 mt -78.28 -18.01 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.427 . . . . 61.52 110.171 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -59.8 -46.44 89.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.915 -0.584 . . . . 63.22 110.824 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.13 -43.27 78.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.269 0.557 . . . . 64.31 110.209 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.4 t -65.15 -52.59 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 70.31 110.85 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.14 -37.29 78.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.751 0.31 . . . . 74.12 110.958 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.79 -47.23 84.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.213 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 78' ' ' SER . 32.4 t70 -60.23 -48.49 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 74.03 110.906 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 9.3 mm100 -61.7 -51.2 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.874 0.369 . . . . 74.45 110.54 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -60.44 -56.21 24.19 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.954 -0.566 . . . . 72.12 110.437 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.19 -41.74 72.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.949 -0.568 . . . . 73.01 110.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 22.9 t -53.57 -53.02 57.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.589 -0.732 . . . . 62.21 110.783 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.74 -52.08 12.47 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.71 -0.396 . . . . 65.33 111.234 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.68 -44.33 73.25 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.213 0.53 . . . . 63.43 110.895 -171.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.97 -27.45 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.105 -0.952 . . . . 72.44 110.127 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -48.03 79.26 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.998 -0.62 . . . . 43.42 112.442 -170.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . 14.1 m -91.22 -12.65 34.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.117 0.484 . . . . 74.31 110.414 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.93 43.0 6.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.1 113.168 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 85' ' ' LEU . 3.0 mm? -73.29 -45.25 56.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.57 -0.9 . . . . 71.13 108.57 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.41 162.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.897 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.54 -45.29 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.265 0.555 . . . . 71.01 109.992 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -101.13 133.74 45.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 64.31 109.809 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.6 pt -127.66 156.27 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 75.3 110.336 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.79 ' HD2' HG23 ' A' ' 105' ' ' THR . 3.4 tpm_? -150.49 106.77 3.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.176 -0.466 . . . . 74.1 109.753 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.3 mt -95.03 108.95 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.053 -0.721 . . . . 75.22 109.053 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -88.3 121.84 31.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.419 -0.585 . . . . 75.11 109.419 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.9 m-90 -97.9 108.78 21.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.169 -0.308 . . . . 72.42 110.169 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 98' ' ' PRO . 32.8 m -87.18 123.9 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.672 -0.492 . . . . 71.54 109.672 176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -111.91 -35.51 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.733 0.778 . . . . 72.45 109.669 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.671 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 8.7 t30 -175.19 -47.9 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.277 -1.329 . . . . 73.34 108.354 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 26.7 Cg_exo -64.75 134.15 39.43 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.811 1.674 . . . . 50.54 109.387 165.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 99' ' ' TRP . 22.0 Cg_exo -63.52 -88.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.376 2.051 . . . . 54.13 113.18 -173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.691 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 10.7 m-90 -141.39 100.64 3.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.658 0.266 . . . . 73.25 110.333 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.69 -133.06 3.77 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-O 119.795 -0.447 . . . . 62.25 112.24 -173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.93 -24.31 75.82 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.748 2.299 . . . . 75.22 112.54 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.99 -4.53 13.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.994 0.426 . . . . 62.35 111.088 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.691 ' HD3' ' HB3' ' A' ' 99' ' ' TRP . 33.7 mtmm -76.86 -3.1 36.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 72.32 110.184 175.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.6 mt -119.24 121.67 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.393 -0.367 . . . . 71.31 110.544 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.79 HG23 ' HD2' ' A' ' 90' ' ' ARG . 1.4 p -61.81 163.24 7.7 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.47 0.308 . . . . 72.43 111.189 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -61.63 -43.34 99.03 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.334 -0.617 . . . . 75.31 109.334 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -59.31 -36.6 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.654 -0.703 . . . . 63.15 110.713 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.9 -38.32 95.37 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.888 -0.596 . . . . 61.41 112.791 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -50.85 16.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.125 0.488 . . . . 74.3 110.287 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 60.7 mm-40 -67.18 -58.17 5.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.282 -0.872 . . . . 64.41 112.332 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 110' ' ' GLU . 14.9 mt-30 60.5 32.89 20.59 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 114.862 -1.063 . . . . 63.44 110.795 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 tp -100.57 -74.94 0.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.956 -0.566 . . . . 73.13 109.487 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.0 tpp85 -67.19 -32.81 74.14 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.462 -0.57 . . . . 71.45 109.462 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.53 -23.99 63.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.264 -0.88 . . . . 72.2 111.083 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 115' ' ' LEU . 7.3 tt -74.61 -34.66 62.88 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.487 -0.56 . . . . 70.12 109.487 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.03 -88.73 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.818 -0.628 . . . . 55.42 111.581 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -177.98 161.58 1.56 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 110.059 -0.349 . . . . 74.54 110.059 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.1 m -152.51 104.51 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 74.43 109.884 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.737 -0.649 . . . . 62.35 110.277 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 111.683 -0.567 . . . . 41.14 111.683 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -20.59 34.22 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.806 2.337 . . . . 72.54 111.711 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.88 -151.39 23.33 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.88 -0.888 . . . . 74.34 110.88 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.0 t -165.46 139.47 4.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 73.13 110.129 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 5' ' ' MET . 1.4 pmm? -104.6 2.32 30.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.135 -0.691 . . . . 73.11 109.135 172.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.4 t -91.63 -169.66 2.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.454 -0.794 . . . . 74.52 110.04 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.8 mp0 60.8 9.22 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.072 0.549 . . . . 63.5 111.102 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 37.7 p -99.83 16.78 22.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.11 0.481 . . . . 72.24 110.585 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -144.58 171.77 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 62.12 109.862 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 68.75 161.52 0.14 Allowed Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 123.848 0.718 . . . . 55.11 111.476 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 11.1 Cg_endo -53.69 131.41 43.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.822 2.348 . . . . 71.12 111.921 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.16 -66.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.358 0.873 . . . . 53.34 113.358 -168.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.01 -50.49 73.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.949 0.404 . . . . 72.33 111.147 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -57.25 -46.41 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 74.01 110.916 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 7' ' ' GLU . 3.3 tm? -65.65 -39.77 91.76 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.828 -0.624 . . . . 72.1 110.082 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.6 tp -54.67 -59.63 4.44 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.837 0.351 . . . . 74.01 110.698 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.67 75.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.996 -0.547 . . . . 75.05 110.995 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.4 -45.12 92.4 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.994 -0.548 . . . . 73.33 111.14 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 7' ' ' GLU . 3.4 p -73.45 -33.06 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.229 -0.285 . . . . 71.22 110.229 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -59.13 -41.52 88.45 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.345 0.593 . . . . 55.32 109.617 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.69 -45.8 57.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.486 -0.779 . . . . 75.44 111.008 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.58 72.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.336 -0.393 . . . . 75.03 111.567 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.15 -13.49 48.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 35.52 110.642 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 12.8 ttm180 -88.26 -15.63 35.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.448 -0.342 . . . . 73.53 110.731 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -109.38 -27.02 9.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 122.02 0.914 . . . . 62.33 108.891 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -112.98 70.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 114.011 -1.449 . . . . 63.51 109.461 -175.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 34' ' ' ASN . 4.5 p -179.77 173.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.272 -0.876 . . . . 54.04 108.716 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 27' ' ' VAL . 9.7 t70 -106.26 89.58 4.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.877 -0.786 . . . . 54.12 108.877 170.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.72 -23.77 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.176 1.917 . . . . 71.43 112.485 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -68.68 -57.75 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.013 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.48 -18.55 26.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.831 0.348 . . . . 72.23 110.117 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.04 47.03 3.46 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 60.43 113.704 169.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.6 mp -112.95 140.2 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.514 -0.55 . . . . 71.24 109.514 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HA ' HG23 ' A' ' 27' ' ' VAL . 4.4 p30 -108.46 129.73 55.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.153 -0.684 . . . . 73.44 109.153 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.13 -28.37 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.84 -0.618 . . . . 72.24 112.196 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.42 -24.7 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.706 -0.225 . . . . 73.11 111.064 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -52.86 -35.53 57.74 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.238 0.336 . . . . 74.14 110.667 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.6 mp -78.05 -18.39 55.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.377 -0.374 . . . . 53.22 110.757 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.26 22.89 38.72 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.797 -0.638 . . . . 71.31 113.548 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -93.04 -22.02 19.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.877 0.37 . . . . 53.5 110.103 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.97 -11.88 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.918 -0.583 . . . . 51.44 110.905 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -71.75 -24.34 61.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 70.14 109.94 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.6 81.96 0.96 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.214 -0.754 . . . . 34.11 111.214 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -130.44 137.04 49.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.262 0.553 . . . . 64.02 111.006 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 16.3 m-20 -134.4 160.41 38.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.103 -1.443 . . . . 63.12 107.103 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.9 t -149.12 123.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.506 . . . . 52.24 109.635 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.688 -0.486 . . . . 71.02 109.688 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HG23 ' A' ' 53' ' ' THR . 7.0 p-10 -88.78 136.66 32.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.92 0.39 . . . . 72.45 110.086 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.96 134.55 4.75 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.482 -1.047 . . . . 54.43 110.482 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -25.58 67.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.098 0.475 . . . . 75.43 110.654 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.35 -34.15 65.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.578 -0.737 . . . . 74.22 109.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.48 124.27 0.77 Allowed Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.683 -0.689 . . . . 72.11 111.608 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' ASP . 26.1 m -77.62 117.32 18.93 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.248 -0.279 . . . . 65.02 110.248 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 88' ' ' ASP . 43.7 t -108.2 123.68 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.905 0.383 . . . . 71.34 110.912 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -94.76 122.42 37.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.108 -0.496 . . . . 71.31 110.269 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 12.2 mt -97.29 102.01 13.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.655 -0.498 . . . . 74.33 109.655 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 59' ' ' MET . 59.2 mt -108.65 125.15 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.092 0.157 . . . . 55.15 110.69 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.11 118.98 25.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.849 0.357 . . . . 75.13 110.099 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.419 ' HG3' HG22 ' A' ' 57' ' ' ILE . 72.0 mtp -140.87 170.87 14.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.383 0.611 . . . . 53.14 111.01 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -157.03 177.47 11.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.973 -1.012 . . . . 65.03 108.907 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -108.57 163.11 13.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.29 -0.633 . . . . 70.34 109.29 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -47.46 -57.48 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.484 0.49 . . . . 73.4 112.008 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -96.88 -13.59 22.38 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.385 -0.37 . . . . 63.01 111.024 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.39 8.84 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.89 0.7 . . . . 53.21 112.89 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.81 9.61 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.05 0.453 . . . . 53.23 110.486 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.3 t -119.92 124.47 27.87 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.865 -0.607 . . . . 32.03 109.786 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.17 83.16 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.682 2.254 . . . . 73.34 112.087 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 tp -107.05 8.2 30.17 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.678 0.752 . . . . 64.41 108.997 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.1 t -63.7 -39.72 95.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.303 -0.862 . . . . 63.42 111.341 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.8 -44.71 74.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 64.34 110.198 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.46 -51.93 52.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.436 -0.802 . . . . 64.32 110.795 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.675 HG12 ' HA ' ' A' ' 69' ' ' THR . 27.0 pt -62.55 -33.73 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.697 -0.401 . . . . 72.23 111.075 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' A' ' 91' ' ' ILE . 43.8 mt-10 -68.0 -44.17 77.19 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.457 -0.338 . . . . 70.25 110.225 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.88 -44.24 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 73.04 110.425 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.06 -46.2 82.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.331 -0.395 . . . . 75.54 110.72 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -58.91 -53.81 54.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.066 -0.516 . . . . 52.14 109.944 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 ttp85 -54.87 -44.11 73.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 73.04 110.395 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -53.32 -53.65 47.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.815 -0.63 . . . . 71.12 111.159 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.22 -52.49 10.78 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.55 -0.46 . . . . 74.43 111.462 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 86' ' ' VAL . 92.1 mt -60.14 -41.09 91.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.05 0.452 . . . . 74.12 111.227 -169.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.04 -27.42 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 74.04 110.188 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.21 -45.71 18.57 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.688 -0.768 . . . . 63.23 111.776 -171.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 m -82.89 2.87 32.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.41 . . . . 61.33 110.659 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.76 35.91 90.41 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.013 -0.539 . . . . 74.34 112.811 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 HD23 ' A' ' 80' ' ' LEU . 84.0 mt -76.57 -43.65 38.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 51.32 109.555 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 55' ' ' ALA . 27.2 m -144.29 169.32 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.367 -0.833 . . . . 72.33 109.387 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -91.71 -48.0 7.06 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.961 0.41 . . . . 64.04 110.447 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HB2' HG22 ' A' ' 54' ' ' VAL . 18.6 m-20 -131.38 151.12 51.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.059 -0.519 . . . . 51.35 110.687 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.1 pt -113.96 151.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 71.42 110.447 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.766 ' HG2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.98 106.64 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.207 -1.034 . . . . 70.34 108.207 177.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.484 HD12 ' HG2' ' A' ' 73' ' ' GLU . 47.7 mt -95.94 114.33 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 73.33 110.373 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 3.4 t30 -88.68 102.85 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 72.31 109.093 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.3 m-90 -82.34 106.87 14.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.501 -0.318 . . . . 73.45 110.585 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.9 123.56 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.387 -0.597 . . . . 64.44 109.387 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -122.08 -17.62 7.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.047 0.451 . . . . 73.03 110.18 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.525 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 28.0 t-20 173.86 -47.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.186 -0.915 . . . . 72.0 109.449 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.3 Cg_endo -68.08 140.12 48.72 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.629 1.553 . . . . 61.3 110.123 168.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.55 -92.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.203 1.935 . . . . 73.11 112.482 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -146.09 163.12 36.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.962 -0.384 . . . . 71.52 109.962 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.44 -127.17 1.58 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.72 -0.552 . . . . 71.42 111.72 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.64 -17.73 56.1 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.627 2.218 . . . . 55.2 111.685 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 4.0 m-20 -63.96 -11.1 25.47 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.577 -0.738 . . . . 62.24 110.978 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 71.9 mmtt -76.69 0.71 19.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.431 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.99 139.01 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.674 -0.491 . . . . 73.51 109.674 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.766 HG23 ' HG2' ' A' ' 90' ' ' ARG . 19.7 p -70.29 151.19 45.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.983 0.42 . . . . 72.22 111.09 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.02 -36.23 78.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.741 -0.837 . . . . 64.12 108.741 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -57.01 -53.13 61.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.547 -1.206 . . . . 70.24 110.537 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.78 -34.12 88.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.818 -0.628 . . . . 63.13 112.513 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -73.58 -34.94 65.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.487 . . . . 74.41 110.711 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -48.36 66.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.556 -0.747 . . . . 71.11 110.138 -177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -95.33 79.36 3.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 73.44 111.072 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -128.36 -166.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.286 -0.87 . . . . 75.31 109.779 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -55.53 -29.96 59.85 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.879 0.326 . . . . 71.25 111.879 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.93 67.84 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.92 0.391 . . . . 64.54 111.065 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.06 -24.39 60.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 64.45 110.007 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.64 -161.51 51.42 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.977 -0.556 . . . . 70.35 112.416 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.5 94.82 2.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 75.55 110.308 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -69.05 -19.23 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.324 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.237 -0.887 . . . . 74.31 109.054 176.572 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.139 -0.384 . . . . 64.53 112.139 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.45 158.8 40.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.625 2.217 . . . . 74.23 111.913 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.9 -44.29 0.83 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.753 -0.539 . . . . 61.13 111.753 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -101.14 133.84 45.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.071 -0.344 . . . . 72.21 110.071 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.794 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 21.7 ptp -89.03 -166.34 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 75.01 110.36 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 m -102.25 22.78 12.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.815 -0.439 . . . . 74.51 109.815 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.794 ' H ' ' HG3' ' A' ' 5' ' ' MET . 4.3 mm-40 54.07 92.77 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.332 -0.849 . . . . 64.31 110.757 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -66.35 95.54 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.516 -0.765 . . . . 74.52 112.11 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -164.61 154.78 14.15 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.949 -0.76 . . . . 74.31 108.949 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 65.03 164.14 0.12 Allowed Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 123.24 0.338 . . . . 42.44 111.336 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 30.1 Cg_endo -64.28 143.52 83.55 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.366 2.044 . . . . 70.21 111.707 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -38.75 58.57 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.644 0.609 . . . . 75.4 112.644 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -55.01 -50.24 69.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.411 0.624 . . . . 64.11 110.843 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 -40.42 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.539 -0.755 . . . . 53.11 110.187 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.97 -53.75 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.763 -0.653 . . . . 72.23 111.367 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.09 -48.87 78.83 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.952 0.406 . . . . 70.35 110.951 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.69 -46.89 65.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.059 -0.519 . . . . 45.21 110.714 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -64.09 -45.0 90.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.495 -0.775 . . . . 74.1 110.419 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.3 -38.02 80.14 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 109.946 -0.39 . . . . 54.0 109.946 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.71 -43.19 72.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.008 0.433 . . . . 73.44 110.079 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 43.9 mt-10 -72.36 -43.36 64.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 71.33 111.067 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.82 73.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.416 0.627 . . . . 60.2 110.751 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 21.7 mmt -63.11 -13.63 38.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.425 -0.807 . . . . 75.01 111.213 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 40.3 ttt180 -74.8 -24.17 58.61 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.739 0.304 . . . . 74.35 111.15 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.14 -23.56 9.43 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.672 0.749 . . . . 74.11 109.911 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.5 t -95.08 26.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.728 -1.123 . . . . 74.53 110.23 -178.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 2.8 p -150.08 169.23 2.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -103.2 100.22 17.02 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 110.012 -0.366 . . . . 72.22 110.012 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 97.1 Cg_endo -88.93 -3.75 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.758 2.306 . . . . 54.45 111.827 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.1 -57.75 5.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.05 0.452 . . . . 71.31 110.642 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.1 -17.49 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 73.01 109.994 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.19 52.62 1.71 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.746 -0.661 . . . . 22.32 112.999 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -109.67 142.66 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.116 0.484 . . . . 72.3 109.902 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 37' ' ' ASP . 6.0 p30 -120.16 112.6 19.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 72.22 109.347 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.8 m -55.22 -30.05 24.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.544 -0.753 . . . . 54.24 112.086 -173.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.84 -31.5 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 74.23 111.377 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t70 -67.3 -19.56 65.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.462 -0.335 . . . . 65.35 111.351 -176.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -72.85 -17.5 61.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.084 0.469 . . . . 74.05 109.992 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.86 65.39 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.549 -0.751 . . . . 65.0 113.362 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.99 -20.14 17.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.14 0.495 . . . . 72.34 110.011 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 HD23 ' A' ' 44' ' ' LEU . 42.1 t -59.27 -9.62 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.695 -0.684 . . . . 71.43 111.422 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.18 -7.24 40.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.059 0.457 . . . . 71.24 110.0 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 58' ' ' ASP . . . -81.52 18.96 9.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.524 -0.762 . . . . 42.12 112.249 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 HG12 ' A' ' 41' ' ' VAL . 4.6 pp -89.16 129.8 35.7 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.939 -0.763 . . . . 70.42 108.939 171.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -161.59 113.29 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.75 -0.463 . . . . 72.32 109.75 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.1 p -93.02 116.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.178 0.513 . . . . 71.51 110.782 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.54 128.25 56.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.785 -0.643 . . . . 74.23 109.606 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 2.1 p-10 -101.66 161.06 13.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.124 0.488 . . . . 72.24 110.651 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.54 -175.03 32.12 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.641 -0.984 . . . . 72.3 110.641 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.4 -35.48 71.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.271 0.558 . . . . 75.34 109.916 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.98 -18.17 63.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.157 -0.928 . . . . 73.24 110.584 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.64 172.37 18.41 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.208 -0.451 . . . . 71.24 112.527 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 29.1 m -105.85 111.03 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.461 -0.57 . . . . 63.03 109.461 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -112.26 133.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.671 0.272 . . . . 53.25 111.095 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -97.82 106.52 18.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.29 -0.414 . . . . 75.21 110.431 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 46.1 mt -75.61 141.0 42.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 73.22 109.707 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HG3' ' A' ' 59' ' ' MET . 60.6 mt -144.64 113.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.148 -0.315 . . . . 74.45 110.148 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 30.7 m-20 -86.95 128.72 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.654 -0.248 . . . . 74.11 110.463 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.4 mtp -140.9 170.51 15.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 122.261 1.029 . . . . 63.03 113.051 -174.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 94' ' ' VAL . 19.9 p -149.51 172.74 14.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 113.294 -1.775 . . . . 72.52 109.089 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.26 145.3 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.685 -1.228 . . . . 63.33 107.685 164.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 p -59.69 -48.43 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 74.13 111.021 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -67.99 -38.64 82.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.394 -0.821 . . . . 75.32 111.335 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.71 8.16 2.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.102 -0.954 . . . . 70.21 111.361 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.08 -36.0 3.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.215 0.531 . . . . 54.51 109.887 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.9 116.18 53.11 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.643 -0.708 . . . . 75.25 110.039 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.94 77.38 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.812 2.341 . . . . 74.15 113.577 -173.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.85 7.27 31.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.26 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.2 t -50.35 -60.21 3.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.569 -0.741 . . . . 73.23 112.113 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 69' ' ' THR . 10.9 t70 -58.92 -35.83 73.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.139 0.495 . . . . 74.02 110.335 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.9 t -65.32 -53.29 41.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.547 -0.751 . . . . 62.23 110.857 -175.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.581 HG12 ' HH2' ' A' ' 93' ' ' TRP . 1.8 pp -69.12 -36.63 74.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.428 -0.351 . . . . 71.54 110.246 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.37 -45.81 89.41 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 74.51 110.603 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.52 -42.91 86.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 65.04 110.921 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 56.5 mt-30 -59.57 -54.05 50.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.11 0.481 . . . . 61.43 110.671 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.52 -53.98 51.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.579 -0.737 . . . . 62.34 110.603 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -55.05 -51.2 67.07 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.114 -0.494 . . . . 75.41 111.326 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.7 t -53.29 -51.76 61.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.077 -0.51 . . . . 44.32 111.01 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.06 -52.0 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.517 -0.473 . . . . 51.52 111.334 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.79 -39.46 85.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.761 0.315 . . . . 74.34 111.116 -172.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.07 -27.83 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.361 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.14 -33.15 33.42 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.857 -0.687 . . . . 64.41 112.194 -172.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB2' HD13 ' A' ' 85' ' ' LEU . 15.0 m -95.97 -0.17 51.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 43.14 110.962 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.56 29.86 67.31 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.353 -0.451 . . . . 61.51 113.488 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 83' ' ' SER . 9.4 mp -79.8 -8.14 59.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.11 0.481 . . . . 72.4 110.233 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 88' ' ' ASP . 9.9 p -164.02 161.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.601 -0.727 . . . . 74.14 109.332 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.18 -19.68 58.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.847 -0.427 . . . . 75.23 109.847 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 86' ' ' VAL . 15.8 t0 174.85 150.89 0.1 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.352 -170.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 18.6 pt -116.4 152.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 61.32 110.335 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 2.4 tpp180 -133.35 106.15 7.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.145 -0.687 . . . . 63.3 109.145 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.24 143.55 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.349 -0.387 . . . . 61.12 110.227 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -119.54 143.45 47.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.286 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.581 ' HH2' HG12 ' A' ' 72' ' ' ILE . 70.6 m95 -110.96 106.41 15.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 75.11 110.102 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' THR . 31.5 m -100.09 123.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.009 -0.676 . . . . 44.33 110.788 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -109.14 -35.37 6.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 64.5 110.023 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.643 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 3.1 t-20 -171.21 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.116 -0.947 . . . . 53.1 110.746 -173.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 53.1 Cg_endo -68.02 158.05 59.12 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.929 1.752 . . . . 55.41 112.213 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.87 175.0 6.9 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.963 2.442 . . . . 72.35 111.756 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 25.0 m0 -75.57 123.4 25.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.64 -0.254 . . . . 72.13 110.477 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.66 -123.02 1.11 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.384 -0.436 . . . . 72.24 112.428 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.24 -19.28 38.8 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.688 2.258 . . . . 43.54 111.452 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -17.03 16.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.035 -0.984 . . . . 63.03 111.713 177.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 29.1 mtpp -76.62 -8.13 56.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.687 0.279 . . . . 74.0 111.034 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -80.67 115.84 23.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.639 0.256 . . . . 75.52 110.53 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.7 p -75.53 172.17 13.01 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.451 -0.34 . . . . 73.25 111.196 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -59.11 -20.45 53.68 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 72.51 110.998 176.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -56.52 -52.98 62.71 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.861 0.362 . . . . 65.41 110.382 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.57 -37.37 17.31 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.099 -0.572 . . . . 71.22 112.35 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.523 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 51.7 ttt180 -62.5 -47.73 82.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.559 0.577 . . . . 75.53 112.559 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.43 -6.71 37.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.979 1.103 . . . . 73.43 113.979 -167.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -86.4 -14.42 43.42 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.868 0.366 . . . . 75.34 111.073 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -76.72 -80.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.606 . . . . 71.13 111.721 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -64.99 -29.56 70.49 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.821 -0.627 . . . . 73.11 110.44 -174.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 -12.01 59.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.669 -0.696 . . . . 71.22 111.388 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.67 -34.82 60.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 63.24 109.996 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.57 -44.57 4.87 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.327 -0.709 . . . . 71.04 111.327 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -83.17 90.13 7.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.108 -0.701 . . . . 74.23 109.108 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.2 p -74.76 134.04 41.9 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.86 -0.609 . . . . 65.14 111.84 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-N 115.539 -0.755 . . . . 61.42 109.613 177.895 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 111.968 0.359 . . . . 72.34 111.968 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.81 148.87 90.21 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.633 2.222 . . . . 73.44 111.474 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.62 -37.53 40.82 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.785 0.661 . . . . 73.14 112.785 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.53 -51.92 56.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.198 0.523 . . . . 72.41 110.243 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -46.41 65.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.251 -0.886 . . . . 71.21 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.51 -50.15 68.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.566 -0.743 . . . . 75.11 110.785 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.55 -59.6 4.26 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.943 0.402 . . . . 71.0 111.301 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.62 77.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.182 -0.463 . . . . 33.24 111.224 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.98 -44.38 92.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.521 . . . . 73.14 110.837 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -68.46 -34.72 67.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.944 -0.391 . . . . 54.21 109.944 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.93 -43.32 91.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.695 -0.484 . . . . 74.2 109.695 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 44.7 mt-10 -66.46 -50.84 61.99 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.015 -0.539 . . . . 73.1 110.614 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -56.47 -44.24 80.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.159 -0.473 . . . . 73.21 111.044 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.0 mmt -62.68 -13.59 33.96 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.65 -0.705 . . . . 71.21 111.584 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 23.9 ttp85 -80.14 -30.64 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.394 -0.224 . . . . 75.14 110.394 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -99.8 -27.15 13.77 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.881 0.326 . . . . 70.3 111.881 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.6 m -99.58 20.39 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.837 0.351 . . . . 63.31 111.658 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.2 p -128.0 171.5 16.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.628 -0.508 . . . . 71.25 109.628 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -107.31 90.86 6.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.356 -0.609 . . . . 61.02 109.356 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.99 -1.43 10.82 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.3 2.0 . . . . 64.42 111.444 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.45 -57.69 5.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.57 -0.741 . . . . 71.15 110.5 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.4 -10.02 14.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 75.51 110.235 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.11 52.84 2.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.205 -0.521 . . . . 74.24 113.124 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -112.45 141.78 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.749 -0.463 . . . . 34.22 109.749 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -122.37 112.55 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.987 -0.552 . . . . 74.3 109.685 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.0 m -54.81 -34.47 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.108 -0.497 . . . . 74.12 112.12 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 9.3 p -56.0 -30.66 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.447 -0.342 . . . . 70.3 111.322 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.11 -18.36 63.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.162 -0.472 . . . . 74.24 111.503 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.9 mm? -69.03 -12.54 61.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.443 0.64 . . . . 70.52 109.861 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.35 21.89 62.69 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 114.881 -1.054 . . . . 74.22 114.849 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.3 tt -98.19 -31.71 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.902 -1.147 . . . . 70.15 107.902 164.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 26.0 t -65.69 -8.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.862 -1.063 . . . . 75.24 110.831 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -59.39 -26.11 64.85 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.073 0.464 . . . . 63.13 109.762 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.06 91.23 1.72 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.595 -0.729 . . . . 71.42 112.015 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.04 136.8 38.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.534 -0.543 . . . . 73.22 109.534 174.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.55 109.37 7.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.568 -0.53 . . . . 44.12 109.568 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.2 m -94.24 108.75 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.693 0.758 . . . . 72.41 109.757 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -100.13 120.96 40.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.455 -0.793 . . . . 64.42 110.027 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -107.08 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.678 -0.49 . . . . 65.12 109.678 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.85 -163.75 12.54 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.216 -0.516 . . . . 72.52 112.003 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.9 -27.9 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.515 0.674 . . . . 70.1 109.692 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.43 -39.33 81.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.013 -0.994 . . . . 63.33 109.77 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.84 -171.82 43.49 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.682 -0.69 . . . . 54.3 111.852 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.2 m -124.48 104.42 8.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.379 -0.6 . . . . 64.1 109.379 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.4 p -114.99 124.26 71.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.346 0.593 . . . . 64.24 112.1 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.08 107.53 19.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.766 . . . . 71.14 109.993 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -87.64 130.32 34.82 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.541 HG22 ' HG3' ' A' ' 59' ' ' MET . 45.1 mt -130.86 113.82 25.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.75 0.31 . . . . 63.53 110.622 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.36 116.5 20.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 72.42 109.723 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 57' ' ' ILE . 81.9 mtp -134.61 170.85 15.17 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.326 0.584 . . . . 72.31 111.373 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -152.59 161.13 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.289 -0.869 . . . . 55.22 109.245 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.2 mt -132.57 174.1 10.63 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.362 -0.607 . . . . 74.53 109.362 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.7 m -44.18 -42.43 6.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.483 0.489 . . . . 74.42 112.04 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -141.37 4.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.428 -0.351 . . . . 55.15 110.325 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 57.64 8.88 0.72 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.744 0.646 . . . . 44.13 112.744 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.73 15.06 15.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.224 0.535 . . . . 63.32 110.285 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 35.1 m -91.46 144.2 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.756 . . . . 72.05 110.296 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 26.6 Cg_exo -64.66 10.38 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 123.346 2.697 . . . . 74.42 113.377 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 71' ' ' VAL . 1.2 tt -75.08 -15.12 60.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -57.52 -45.76 84.6 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.51 -41.64 85.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.251 0.548 . . . . 54.01 110.253 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.595 ' HB ' HD23 ' A' ' 68' ' ' LEU . 60.3 t -63.4 -52.25 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.251 -0.886 . . . . 52.11 111.078 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.97 -41.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 120.779 -0.368 . . . . 72.21 111.13 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.23 -51.26 68.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.6 0.238 . . . . 73.34 110.803 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.84 -51.83 66.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 74.43 110.9 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -64.2 -43.97 93.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.356 -0.384 . . . . 72.33 111.146 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 -59.19 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 65.35 110.23 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -55.17 -45.95 75.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.552 -0.295 . . . . 71.41 110.83 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -55.16 -47.49 75.09 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.631 0.582 . . . . 74.25 111.131 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.3 -51.05 16.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.503 -0.317 . . . . 74.12 111.083 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.03 -39.62 82.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.377 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.87 -28.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.106 0.479 . . . . 52.43 109.882 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.07 -27.97 47.35 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.139 -0.553 . . . . 65.12 111.739 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 85' ' ' LEU . 19.4 m -70.93 -23.21 62.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.966 0.412 . . . . 74.04 110.461 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.09 -10.02 59.18 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.992 -0.549 . . . . 73.41 113.125 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.5 mp -61.51 -39.43 90.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.648 0.261 . . . . 61.52 110.652 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 m -143.39 152.29 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.12 -0.491 . . . . 75.02 109.752 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.12 -40.67 6.36 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 75.55 110.059 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 20.0 m-20 -102.99 139.43 38.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.923 -0.58 . . . . 64.14 109.9 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 9.4 pt -133.98 169.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.151 -0.685 . . . . 75.41 109.151 170.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' ILE . 22.8 mtt85 -156.35 106.61 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.134 -0.485 . . . . 64.34 109.837 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.73 113.46 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.819 -0.808 . . . . 71.14 108.819 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 103' ' ' LYS . 4.4 p-10 -105.53 140.69 38.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.981 0.419 . . . . 65.21 110.687 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.82 106.64 17.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.715 -0.675 . . . . 74.5 109.597 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 99' ' ' TRP . 10.7 m -113.04 131.09 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 65.1 112.065 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -152.73 8.86 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.023 -0.989 . . . . 65.53 110.621 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.3 m-20 -167.12 -60.05 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.586 0.354 . . . . 72.5 111.275 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 88.6 Cg_endo -78.17 159.51 30.02 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.042 1.828 . . . . 75.12 113.097 -171.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.7 137.07 37.72 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.053 2.502 . . . . 52.32 111.633 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.9 m-90 -53.88 109.79 0.51 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.724 0.64 . . . . 74.43 111.313 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.3 -78.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.862 -0.608 . . . . 63.4 111.817 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.59 -37.05 90.82 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.782 2.322 . . . . 64.54 111.375 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.54 -20.62 47.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.221 -0.899 . . . . 61.25 111.6 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 99' ' ' TRP . 54.4 mttp . . . . . 0 C--N 1.33 -0.249 0 N-CA-C 111.753 0.279 . . . . 70.44 111.753 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.377 0.51 . . . . 71.51 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.65 153.72 54.38 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.55 2.167 . . . . 72.2 111.209 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.6 -40.69 28.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.579 0.585 . . . . 31.3 112.579 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.54 -50.14 68.61 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.165 0.507 . . . . 73.14 111.086 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -81.29 -47.48 13.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 75.22 110.452 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.04 -48.33 70.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.949 -1.023 . . . . 61.22 112.463 -172.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 tp -54.63 -59.28 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.68 0.276 . . . . 42.52 110.866 -174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -65.36 -40.19 93.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 74.52 110.829 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.21 -48.94 79.6 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.807 -0.633 . . . . 60.22 110.668 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 23' ' ' MET . 7.9 p -73.93 -32.79 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 70.23 109.675 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.1 -39.04 77.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.106 -0.497 . . . . 73.24 110.263 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 41.9 mt-10 -72.65 -51.7 18.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.429 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.99 -48.77 75.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 63.4 111.037 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.487 ' HG2' HG22 ' A' ' 19' ' ' VAL . 23.8 mmt -58.0 -13.55 4.85 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.51 -0.768 . . . . 62.52 111.832 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 24' ' ' ARG . 40.1 ttt-85 -87.97 -35.8 17.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.68 0.276 . . . . 74.14 110.584 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -90.15 -26.82 19.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.439 -0.346 . . . . 71.25 111.44 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ALA . 29.7 m -98.12 27.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.92 0.391 . . . . 71.21 111.35 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.96 162.68 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 62.04 110.172 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 m-20 -110.15 82.92 2.77 Favored Pre-proline 0 C--O 1.233 0.218 0 N-CA-C 109.071 -0.714 . . . . 54.53 109.071 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 14.38 2.07 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.736 2.291 . . . . 74.44 112.618 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.55 -58.34 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.145 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 33' ' ' ILE . 87.9 mt -115.78 3.64 13.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 73.23 110.438 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.44 39.72 4.96 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.037 -0.602 . . . . 72.03 112.633 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 31' ' ' LEU . 3.7 mp -88.68 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.843 -0.799 . . . . 71.13 108.843 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 52.1 t-20 -143.83 120.14 10.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.102 -0.333 . . . . 74.53 110.102 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -59.83 -32.03 48.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 54.43 110.739 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 HG11 ' A' ' 41' ' ' VAL . 91.7 t -59.27 -26.41 33.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.897 -0.592 . . . . 62.35 110.566 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 8.3 t0 -59.2 -27.46 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.971 -0.559 . . . . 75.2 111.022 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 38' ' ' LEU . 3.5 mm? -77.72 -8.41 57.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.755 0.312 . . . . 71.13 110.93 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.25 22.95 59.25 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.001 -0.545 . . . . 62.42 113.03 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.699 HD21 HG23 ' A' ' 94' ' ' VAL . 39.2 tp -93.3 -26.29 17.37 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.616 -0.343 . . . . 72.15 110.249 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.415 HG11 HG22 ' A' ' 36' ' ' VAL . 11.8 p -62.0 -12.19 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.924 -0.58 . . . . 72.23 110.824 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.94 -14.09 42.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.826 -0.624 . . . . 72.44 110.264 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.78 67.89 2.59 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.196 -0.761 . . . . 62.53 111.196 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.0 pp -120.96 141.77 50.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.103 -0.332 . . . . 64.1 110.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.03 110.77 1.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 71.34 110.185 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 38.7 t -93.66 126.06 46.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.441 -0.345 . . . . 71.25 110.304 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -121.35 133.06 55.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.428 -0.351 . . . . 75.43 110.662 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.2 p-10 -92.4 147.04 23.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.144 -0.687 . . . . 75.55 109.144 173.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.78 177.87 35.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.729 . . . . 62.54 112.171 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.08 -41.62 65.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.21 0.529 . . . . 74.4 111.059 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.54 17.73 9.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.54 -0.754 . . . . 72.2 111.701 -174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.41 174.91 17.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.151 -0.547 . . . . 73.22 112.981 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 13.9 m -102.79 109.15 20.64 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.126 -0.324 . . . . 63.11 110.126 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.73 135.97 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 75.21 111.168 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.531 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -93.78 105.02 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 61.31 109.917 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HB3' ' HE3' ' A' ' 103' ' ' LYS . 69.9 mt -70.97 113.39 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.538 -0.542 . . . . 73.03 109.538 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 63.9 mt -120.69 114.04 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 73.31 110.264 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -89.9 116.51 28.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.886 0.374 . . . . 75.41 110.188 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.1 mtp -125.57 170.66 11.25 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.538 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 40' ' ' LEU . 14.8 t -137.67 150.43 47.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.915 0.388 . . . . 73.41 110.7 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 3.2 mm? -118.17 147.5 43.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.312 -0.996 . . . . 53.44 108.312 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 m -42.42 -51.74 4.85 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.614 0.598 . . . . 63.01 112.614 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 t -116.83 6.54 13.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.567 0.222 . . . . 70.04 110.723 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.22 8.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.282 0.475 . . . . 71.34 112.282 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.93 16.67 12.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.591 0.71 . . . . 75.21 109.324 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 61' ' ' LEU . 10.3 m -72.25 133.24 83.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.797 -1.092 . . . . 44.43 110.753 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.38 -3.45 13.01 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.453 2.102 . . . . 75.32 111.694 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.21 -0.39 36.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 75.21 111.195 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 70' ' ' ASP . 13.1 t -62.54 -48.91 77.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.546 0.212 . . . . 55.14 110.551 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 69' ' ' THR . 15.9 t70 -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.255 0.55 . . . . 71.24 109.794 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.535 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 81.1 t -67.48 -52.61 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.78 -0.645 . . . . 73.55 110.912 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -68.31 -35.94 73.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 121.03 -0.268 . . . . 73.34 110.819 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 72' ' ' ILE . 45.3 mt-10 -58.37 -50.67 72.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.351 -0.611 . . . . 73.43 109.351 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.07 -51.37 69.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.729 . . . . 64.13 111.112 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 23.7 mm-40 -60.87 -56.76 17.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.999 0.428 . . . . 75.14 110.781 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.484 ' O ' HD23 ' A' ' 80' ' ' LEU . 32.4 t -61.27 -53.58 54.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.898 -0.592 . . . . 53.51 110.592 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.539 ' HG2' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -57.02 -46.96 81.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.079 -0.509 . . . . 74.11 110.434 -176.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 t -58.93 -43.36 91.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 73.35 110.95 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.97 -51.56 17.88 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.944 -0.302 . . . . 72.25 110.869 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -56.12 -41.07 74.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.312 -0.404 . . . . 64.42 110.771 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.76 -27.8 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 63.25 110.467 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.43 -47.58 56.6 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.842 -0.695 . . . . 74.45 111.766 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -77.36 -22.91 51.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.865 0.364 . . . . 61.43 110.029 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.25 26.32 28.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.155 -0.475 . . . . 44.05 113.262 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 80' ' ' LEU . 83.0 mt -62.55 -33.92 75.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.156 0.503 . . . . 73.42 110.168 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 55' ' ' ALA . 5.0 m -147.06 164.82 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.574 -0.739 . . . . 63.23 109.734 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.95 -40.96 75.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 62.0 110.188 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -158.15 172.89 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.672 -0.862 . . . . 63.31 108.672 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' HG2' ' A' ' 77' ' ' ARG . 16.6 pt -131.95 145.09 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.889 0.376 . . . . 71.31 110.074 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 4.5 tpt180 -120.66 106.77 12.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.625 -0.509 . . . . 75.33 109.625 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.7 mt -88.66 140.86 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 65.32 110.675 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.658 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -118.7 127.48 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.407 -0.59 . . . . 71.43 109.407 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.492 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.3 m-90 -87.23 106.62 18.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.891 -0.411 . . . . 73.45 109.891 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.699 HG23 HD21 ' A' ' 40' ' ' LEU . 14.6 m -118.5 158.95 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.746 0.308 . . . . 75.45 110.557 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -177.68 -31.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 73.01 110.262 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.693 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 44.2 t30 -155.27 -49.2 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.911 -0.586 . . . . 74.41 110.168 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.693 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 5.6 Cg_exo -76.68 147.76 28.24 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.07 1.846 . . . . 55.21 110.687 169.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 14.7 Cg_exo -69.58 -163.97 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.775 2.317 . . . . 75.14 112.439 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.4 m-90 -89.84 124.4 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 62.45 110.942 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -113.48 0.3 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.181 -0.533 . . . . 61.33 112.213 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.39 -17.84 54.25 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.724 2.282 . . . . 65.11 111.568 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' ND2' ' A' ' 92' ' ' ASN . 7.0 m-20 -67.09 -3.92 8.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 70.2 111.373 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 35.8 mmtm . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 120.7 0.286 . . . . 71.51 110.319 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 111.742 0.275 . . . . 62.43 111.742 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.49 -178.98 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.352 2.034 . . . . 65.53 111.836 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.6 -66.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.081 0.771 . . . . 60.32 113.081 -170.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -65.84 -41.07 92.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.504 -0.317 . . . . 75.25 111.543 -174.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -60.99 -39.4 89.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.412 . . . . 61.11 110.678 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 tp -59.01 -43.38 91.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.286 -0.416 . . . . 70.14 110.349 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -57.71 -52.21 66.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 71.53 110.087 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.69 -51.96 67.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.725 -0.67 . . . . 73.31 110.94 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.6 -48.04 82.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.915 -0.584 . . . . 64.31 111.125 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.1 p -66.64 -32.97 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.131 -0.322 . . . . 72.23 110.131 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.28 -45.22 92.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.092 -0.336 . . . . 73.31 110.092 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.57 -51.56 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.205 0.526 . . . . 65.45 110.0 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.99 -47.38 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.407 -0.815 . . . . 71.21 110.889 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.4 mmt -62.54 -13.39 30.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.354 0.502 . . . . 60.53 112.354 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 24' ' ' ARG . 2.7 tpp180 -99.06 -13.8 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.142 -0.349 . . . . 74.44 111.059 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -119.52 -26.5 5.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.295 0.569 . . . . 63.54 110.411 -173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.08 -15.8 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.946 0.879 . . . . 73.31 109.805 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 7.8 p -92.95 163.77 2.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 114.917 -1.038 . . . . 74.44 109.67 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -104.0 91.86 4.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.453 -0.943 . . . . 52.21 108.453 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 93.8 Cg_endo -83.01 -4.31 11.21 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.483 2.122 . . . . 63.03 111.944 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -69.02 -57.64 5.17 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.036 -0.529 . . . . 74.13 110.288 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.45 -17.49 17.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 71.44 110.546 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.82 43.34 3.62 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.026 -0.533 . . . . 73.12 113.351 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.0 mp -108.28 140.82 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.559 -0.534 . . . . 74.25 109.559 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.45 121.2 37.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 70.15 109.411 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.19 -27.38 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.972 -0.558 . . . . 73.43 112.014 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 p -62.19 -24.5 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.993 0.425 . . . . 72.42 110.817 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.94 -15.45 62.98 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.122 -0.49 . . . . 61.24 111.333 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.76 -16.67 61.75 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.039 0.447 . . . . 73.35 110.051 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.69 22.72 64.4 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.628 -0.715 . . . . 71.42 114.12 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -98.71 -31.35 11.95 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.143 -0.688 . . . . 71.53 109.143 170.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.47 -19.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.153 -0.93 . . . . 65.0 112.342 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.26 -23.81 16.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.786 0.327 . . . . 71.14 110.742 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.25 76.08 2.18 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.504 -0.638 . . . . 44.2 111.504 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -128.3 132.69 48.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 74.44 110.792 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -149.75 173.0 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.509 -0.922 . . . . 71.23 108.509 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 55' ' ' ALA . 20.5 m -137.2 142.63 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.791 -0.448 . . . . 75.45 109.791 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.02 121.01 43.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.987 -0.375 . . . . 63.43 109.987 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 112.43 15.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.116 -0.493 . . . . 72.41 109.819 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.07 158.34 14.53 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.064 -0.589 . . . . 41.32 112.273 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.32 -34.99 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.863 0.465 . . . . 63.43 111.377 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.63 -0.7 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 73.04 111.186 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.47 155.1 6.42 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.316 -0.468 . . . . 62.54 112.318 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -74.7 121.68 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.251 -0.277 . . . . 65.12 110.251 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.75 135.26 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 74.43 110.125 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -98.8 124.48 43.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.398 0.142 . . . . 62.14 110.802 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.2 mt -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.168 -0.308 . . . . 53.01 110.168 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 59' ' ' MET . 30.9 mm -126.28 112.72 30.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 120.686 0.279 . . . . 64.3 110.384 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m-20 -80.24 121.69 25.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.497 -0.557 . . . . 73.2 109.497 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.523 ' HG3' HG22 ' A' ' 57' ' ' ILE . 85.7 mtp -136.62 171.2 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.709 0.29 . . . . 70.13 110.63 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 40' ' ' LEU . 15.2 t -152.92 163.14 40.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.07 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.8 mt -132.47 160.35 36.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.314 -0.624 . . . . 73.32 109.314 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -48.02 -54.6 12.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.585 0.553 . . . . 63.01 112.117 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 t -111.64 -9.68 14.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.771 0.32 . . . . 50.5 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 63.68 8.4 3.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.86 -0.609 . . . . 74.54 112.194 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.38 10.48 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.605 0.717 . . . . 73.12 109.072 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 68' ' ' LEU . 27.8 m -75.63 140.31 71.44 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 114.884 -1.053 . . . . 53.32 110.362 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.85 15.35 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.804 2.336 . . . . 70.13 112.81 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.0 mp -86.99 -5.78 58.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.38 -0.373 . . . . 74.21 110.459 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.6 t -61.58 -53.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.461 -0.336 . . . . 63.23 110.964 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.32 -27.65 67.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 74.41 110.266 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 70.0 t -65.01 -52.5 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.51 . . . . 55.04 110.369 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HE1' ' A' ' 93' ' ' TRP . 2.8 pp -68.74 -29.58 44.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.637 0.256 . . . . 64.33 110.753 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' N ' HD12 ' A' ' 72' ' ' ILE . 44.8 mt-10 -62.4 -48.16 80.95 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.409 -0.359 . . . . 75.31 110.131 173.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.87 -46.81 87.79 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.949 0.404 . . . . 74.44 110.419 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 96.6 mt-30 -55.53 -53.34 57.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.694 . . . . 53.42 111.143 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -68.04 -52.26 37.38 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.03 -0.532 . . . . 75.34 111.123 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -54.78 -46.38 74.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.652 -0.129 . . . . 63.44 110.652 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.2 p -60.27 -45.08 94.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.339 -0.392 . . . . 62.12 111.425 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.6 20.26 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.811 -0.355 . . . . 33.4 110.847 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.96 -29.49 70.85 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.884 0.373 . . . . 75.51 110.977 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -84.19 -27.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 44.2 109.925 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.5 -31.04 77.56 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.448 -0.661 . . . . 62.14 111.448 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.497 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 46.8 m -92.55 -10.02 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.379 . . . . 75.4 110.312 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.63 43.38 92.19 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.93 -0.577 . . . . 73.11 112.262 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 74.6 mt -86.43 -36.48 19.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.838 0.352 . . . . 74.53 110.9 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 55' ' ' ALA . 29.6 m -139.24 162.39 27.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.921 -0.581 . . . . 74.41 110.242 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.35 -37.28 28.53 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.855 0.36 . . . . 42.44 110.217 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.5 167.92 28.95 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.44 0.638 . . . . 53.43 110.715 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 55' ' ' ALA . 44.6 pt -124.44 135.55 63.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.42 -0.809 . . . . 73.41 110.689 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.81 106.32 16.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.276 -0.638 . . . . 54.43 109.276 171.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 57' ' ' ILE . 64.2 mt -99.32 120.02 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.782 -0.822 . . . . 74.43 108.782 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -111.5 129.93 55.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.87 -0.419 . . . . 73.13 109.87 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.604 ' HE1' HD11 ' A' ' 72' ' ' ILE . 4.8 m-90 -100.76 106.13 17.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 72.21 110.541 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.93 124.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 73.32 109.987 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -139.19 -6.93 1.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 74.14 111.845 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.5 t30 174.93 -52.82 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 122.409 0.283 . . . . 63.04 110.869 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 61.6 Cg_endo -70.55 145.75 53.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.739 1.626 . . . . 71.3 112.004 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.71 142.24 82.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.648 2.232 . . . . 72.0 111.647 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -46.63 109.24 0.18 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 123.691 0.619 . . . . 71.4 111.904 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -87.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.766 -0.652 . . . . 52.12 112.132 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.37 -30.49 80.76 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.928 2.419 . . . . 75.34 112.365 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 17.3 p-10 -65.16 -10.67 33.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 71.15 111.18 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 C--O 1.235 0.336 0 CA-C-N 116.277 -0.42 . . . . 71.12 111.623 179.586 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 111.965 0.357 . . . . 74.51 111.965 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 44.0 Cg_endo -68.83 169.02 18.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.258 1.972 . . . . 52.13 111.992 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.48 3.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.43 0.9 . . . . 61.44 113.43 -172.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -63.92 -48.56 76.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.921 0.391 . . . . 63.02 111.001 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -63.34 -40.63 97.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.763 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.79 -46.36 88.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 73.25 110.14 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 tp -54.93 -55.37 31.36 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.41 -0.359 . . . . 35.21 110.998 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.987 -0.551 . . . . 54.44 111.292 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.3 -48.39 81.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.894 -0.594 . . . . 74.13 111.12 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.43 -33.83 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.928 -0.397 . . . . 74.12 109.928 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -58.96 -48.74 80.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.088 -0.338 . . . . 64.11 110.088 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.15 -45.61 73.08 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 74.13 110.839 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.15 -38.85 74.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 72.11 110.679 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.5 mmt -62.69 -12.68 25.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.606 -0.725 . . . . 72.24 111.563 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -85.79 -23.36 27.26 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.623 0.249 . . . . 72.45 110.82 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.63 -27.43 9.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.363 0.505 . . . . 50.04 112.363 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.5 m -95.92 21.11 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.22 0.533 . . . . 73.12 111.099 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 5.2 p -134.27 161.32 40.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 71.32 110.589 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.25 93.68 1.94 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.957 -1.127 . . . . 51.05 107.957 165.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 95.6 Cg_endo -82.93 -9.8 10.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.226 1.951 . . . . 72.23 111.392 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.5 -41.81 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.146 -0.934 . . . . 72.11 110.439 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.94 -18.56 11.24 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.377 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.86 44.02 3.45 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.224 -0.512 . . . . 74.24 113.655 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -121.64 141.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.965 -0.754 . . . . 61.25 108.965 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 36' ' ' VAL . 8.7 p30 -107.73 141.85 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.771 -0.455 . . . . 74.24 109.771 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.77 -29.41 42.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.328 0.585 . . . . 72.45 110.747 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HB ' ' OD1' ' A' ' 34' ' ' ASN . 43.8 t -60.11 -24.62 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.688 -0.687 . . . . 75.04 110.548 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -56.04 -28.93 59.48 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.503 -0.317 . . . . 72.32 111.254 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.13 -14.55 60.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.154 0.502 . . . . 75.31 110.504 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.65 22.17 52.22 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.218 -0.901 . . . . 73.12 114.024 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.0 tp -98.22 -29.69 13.05 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.329 -0.619 . . . . 43.21 109.329 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.45 -13.15 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.204 -0.907 . . . . 62.23 111.145 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.14 -23.26 62.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.06 0.457 . . . . 65.34 109.882 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 50.37 3.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.741 -0.663 . . . . 53.34 112.163 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -109.09 136.88 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.715 -0.476 . . . . 75.41 109.715 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -157.25 113.82 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 74.14 109.76 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.7 p -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.781 -0.452 . . . . 74.54 109.781 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -125.13 153.24 43.31 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.053 0.454 . . . . 74.12 110.314 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -81.34 151.86 27.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.557 -0.747 . . . . 62.25 110.387 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.57 159.77 33.04 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.074 -0.81 . . . . 73.44 111.074 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.14 -21.06 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.079 0.439 . . . . 62.51 110.929 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.01 -20.27 62.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.979 -0.748 . . . . 61.44 108.979 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.15 162.24 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.909 -1.041 . . . . 72.24 111.103 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -70.92 107.03 3.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.505 -0.924 . . . . 73.44 108.505 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.24 130.01 60.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 54.14 111.46 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.45 104.38 16.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 62.2 110.558 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 90' ' ' ARG . 48.8 mt -78.18 128.67 34.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.003 -0.74 . . . . 65.4 109.003 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.0 mt -141.01 116.64 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.833 0.349 . . . . 64.44 110.686 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.41 122.76 30.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 75.21 109.726 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.517 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.2 mtp -135.63 170.56 15.78 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.4 0.619 . . . . 72.34 111.721 -174.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -161.97 150.16 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.104 -0.953 . . . . 65.44 109.39 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.59 148.46 22.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.738 -0.838 . . . . 73.32 108.738 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 -48.58 30.82 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.51 0.559 . . . . 43.41 112.51 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 26.5 t -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.869 0.366 . . . . 73.2 110.677 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.52 8.33 1.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.762 -0.653 . . . . 73.03 112.003 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.22 3.81 10.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.211 0.529 . . . . 75.22 110.177 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 63' ' ' SER . 27.5 m -81.04 126.72 76.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.486 -0.779 . . . . 74.52 110.657 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.63 32.02 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.014 2.476 . . . . 65.03 112.346 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.02 6.61 18.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.044 -0.526 . . . . 74.02 110.794 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -56.94 -42.8 80.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 73.02 110.866 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.47 -41.31 98.69 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.401 0.62 . . . . 75.03 110.163 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.39 -46.5 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.234 -0.894 . . . . 70.11 110.857 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.17 -37.87 77.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 121.198 -0.201 . . . . 51.43 111.068 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.84 -49.6 77.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.22 110.683 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.08 -51.39 68.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.118 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -63.1 -38.55 91.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.43 -0.35 . . . . 71.04 111.816 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' HD23 ' A' ' 80' ' ' LEU . 61.6 p -67.22 -54.97 16.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.904 -0.406 . . . . 61.44 109.904 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -54.76 -41.6 70.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.968 -0.56 . . . . 71.43 110.932 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.8 m -54.89 -53.16 59.0 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.275 -0.42 . . . . 51.41 111.763 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -51.56 13.85 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.65 -0.42 . . . . 74.03 111.221 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -58.6 -37.9 76.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.046 0.451 . . . . 74.31 111.51 -173.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.8 t -82.34 -27.37 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.193 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.28 -47.26 91.68 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.303 -0.475 . . . . 34.22 112.496 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.6 m -87.54 -5.1 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.409 . . . . 63.32 110.498 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.88 31.46 69.97 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.922 -0.581 . . . . 64.03 112.811 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 -38.21 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.029 0.442 . . . . 74.54 110.319 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 80' ' ' LEU . 20.6 m -128.39 159.48 39.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.94 -0.573 . . . . 53.12 110.049 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.7 -30.95 24.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.496 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -158.23 165.78 34.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.134 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -128.05 144.35 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.76 -0.459 . . . . 75.15 109.76 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.429 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.9 tpp180 -127.43 106.09 8.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.2 -0.667 . . . . 74.13 109.2 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.45 143.85 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.751 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -117.38 120.36 37.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.348 -0.982 . . . . 74.05 108.348 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -97.85 106.32 18.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.779 -0.452 . . . . 72.2 109.779 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.506 HG21 ' HE1' ' A' ' 99' ' ' TRP . 12.1 t -90.97 123.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.326 -0.397 . . . . 64.43 110.123 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -119.53 -24.13 6.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.809 -0.632 . . . . 73.4 109.592 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 49.7 t30 175.8 -49.7 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.095 -0.957 . . . . 61.52 110.418 -173.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 48.9 Cg_endo -67.59 145.17 69.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.818 1.679 . . . . 51.44 111.971 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 27.4 Cg_exo -63.91 168.55 11.86 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.003 2.469 . . . . 73.54 112.485 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.506 ' HE1' HG21 ' A' ' 94' ' ' VAL . 10.8 m0 -69.54 165.46 20.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.945 -0.57 . . . . 73.45 111.222 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.11 -129.53 2.75 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.977 -0.556 . . . . 41.03 111.827 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.7 -9.63 19.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.859 2.372 . . . . 72.44 112.489 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.59 -15.39 58.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.77 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.718 ' HG2' ' HB2' ' A' ' 92' ' ' ASN . 52.3 mttp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-N 116.329 -0.396 . . . . 72.4 110.939 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 110.685 -0.117 . . . . 74.41 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 26.2 Cg_endo -62.55 153.43 71.52 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.241 1.96 . . . . 73.41 111.761 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.46 -44.63 12.48 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.878 0.696 . . . . 71.43 112.878 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -63.2 -51.63 65.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.999 0.428 . . . . 63.02 110.896 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.44 -44.25 79.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 72.33 110.611 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.49 -42.34 78.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 54.12 110.537 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 tp -55.91 -58.32 8.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 73.55 110.875 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.24 89.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.02 -0.536 . . . . 61.34 111.331 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.64 -48.03 81.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.009 -0.541 . . . . 74.01 110.871 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.13 -33.65 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 54.32 110.356 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.61 -49.81 73.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.024 0.44 . . . . 71.05 109.849 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.72 -48.47 71.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 74.31 110.513 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -37.66 73.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.853 -0.612 . . . . 72.01 111.758 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 mmt -71.22 -13.54 61.95 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.078 0.466 . . . . 63.32 110.051 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -101.61 0.74 36.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.511 -0.768 . . . . 74.54 111.372 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -119.46 -27.85 5.47 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.289 0.566 . . . . 74.2 110.063 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -92.39 -16.91 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.895 -1.048 . . . . 53.14 110.757 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.3 p -84.83 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 54.41 110.33 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -104.45 87.82 1.88 Allowed Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 108.758 -0.83 . . . . 70.31 108.758 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 89.4 Cg_endo -84.98 -1.66 9.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.457 2.105 . . . . 75.04 111.071 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' HG2' HD12 ' A' ' 31' ' ' LEU . 41.7 tt0 -68.58 -57.65 5.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.442 -0.799 . . . . 74.25 110.206 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.405 HD12 ' HG2' ' A' ' 30' ' ' GLU . 7.3 mp -98.95 -17.14 18.48 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.841 -0.429 . . . . 73.05 109.841 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.76 40.97 4.24 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.984 -0.553 . . . . 61.15 113.415 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -108.9 140.18 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.343 -0.614 . . . . 71.14 109.343 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.635 ' HA ' HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -108.67 138.17 45.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.229 -0.656 . . . . 63.33 109.229 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.11 -30.17 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.168 0.509 . . . . 63.41 110.678 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 34' ' ' ASN . 13.5 p -58.24 -24.39 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.798 -0.637 . . . . 74.33 110.655 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.62 -29.1 58.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.707 -0.678 . . . . 61.41 111.195 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.7 -17.06 61.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.913 0.387 . . . . 73.2 110.488 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.51 22.71 57.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.732 -0.667 . . . . 64.02 113.371 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 94' ' ' VAL . 33.1 tp -98.06 -16.73 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 64.3 110.079 175.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.55 -15.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.898 -0.592 . . . . 74.43 111.298 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -70.04 -23.16 63.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.598 0.713 . . . . 74.33 109.121 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' ASP . . . -85.44 95.67 2.01 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.956 -1.02 . . . . 61.15 111.031 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -146.47 132.74 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.157 -0.683 . . . . 63.3 109.157 173.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.99 109.02 9.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.306 -0.628 . . . . 74.4 109.306 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 55' ' ' ALA . 16.1 m -93.56 115.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.276 -0.638 . . . . 74.21 109.276 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.8 124.27 42.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.531 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.29 89.13 5.5 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.729 0.776 . . . . 62.1 109.729 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.38 164.55 45.71 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.511 -1.222 . . . . 72.35 111.481 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.2 -37.04 69.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.001 0.429 . . . . 61.41 110.575 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.24 -39.66 71.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 75.32 110.079 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.48 -178.44 39.73 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.702 -0.681 . . . . 64.21 111.549 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.1 m -81.75 112.2 18.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.811 0.339 . . . . 73.12 110.62 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.39 124.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 74.01 109.866 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -88.54 106.34 18.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 73.54 111.083 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.97 101.97 14.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 74.11 109.913 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 59' ' ' MET . 53.3 mt -96.93 132.31 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.567 -0.288 . . . . 73.24 110.617 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.2 m-20 -94.01 113.45 25.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.03 110.076 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 90.2 mtp -141.04 171.05 14.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 73.34 110.646 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -163.05 162.05 25.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 65.23 109.649 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -106.6 171.83 7.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.945 -0.761 . . . . 41.05 108.945 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -44.63 -56.76 4.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.118 0.485 . . . . 73.54 111.48 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.6 t -104.22 -2.28 25.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 64.43 110.672 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.85 8.82 2.63 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.917 -0.583 . . . . 54.53 112.033 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.88 -8.81 12.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.994 0.426 . . . . 63.13 110.47 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.0 m -57.49 139.82 80.47 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.459 -0.791 . . . . 74.23 111.004 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.85 17.56 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.011 2.474 . . . . 71.43 112.788 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.33 -4.16 58.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 65.24 110.462 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 70' ' ' ASP . 4.8 t -61.93 -54.01 47.72 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.329 -0.396 . . . . 63.42 111.339 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' THR . 6.8 p-10 -64.98 -28.54 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 73.44 109.597 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 60.1 t -65.88 -52.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.49 -0.777 . . . . 75.53 110.52 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -69.02 -32.39 54.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 121.108 -0.237 . . . . 73.01 111.585 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 72' ' ' ILE . 8.5 mt-10 -64.5 -45.04 89.01 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.589 -0.444 . . . . 64.31 109.874 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.01 -49.12 77.94 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 74.15 110.764 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 95.3 mt-30 -56.82 -55.91 28.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.981 -0.554 . . . . 72.03 110.868 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -61.15 -53.23 59.57 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.94 -0.573 . . . . 73.54 110.798 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -56.12 -48.88 75.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -53.68 -50.58 65.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 64.34 111.161 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.74 14.21 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.694 -0.402 . . . . 63.14 111.556 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 89' ' ' ILE . 78.8 mt -60.96 -37.35 82.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 53.43 110.921 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.2 t -78.21 -27.73 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 64.12 110.145 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.5 -48.05 46.55 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.018 -0.611 . . . . 64.45 111.746 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -82.09 -23.13 35.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.134 0.492 . . . . 74.25 109.854 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.77 42.03 6.98 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.977 -0.556 . . . . 63.01 113.533 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 85' ' ' LEU . 6.2 mp -71.0 -38.27 72.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.975 0.417 . . . . 74.43 109.887 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.5 m -137.1 170.02 18.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.61 -0.723 . . . . 74.22 110.011 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.19 -48.66 64.62 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.285 0.564 . . . . 70.23 109.556 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.4 -179.03 5.77 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.089 -0.959 . . . . 64.35 108.587 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 80' ' ' LEU . 35.1 pt -122.43 177.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.371 0.605 . . . . 64.32 111.167 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -155.56 106.01 2.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.496 -1.298 . . . . 74.22 107.496 170.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 73' ' ' GLU . 52.6 mt -95.56 101.25 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.609 -0.515 . . . . 74.45 109.609 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -88.78 139.93 29.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.712 -0.676 . . . . 52.13 109.364 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.592 ' HA ' ' O ' ' A' ' 59' ' ' MET . 3.3 m-90 -95.25 106.07 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.553 -0.536 . . . . 73.43 109.553 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 40' ' ' LEU . 3.4 p -120.03 124.25 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.31 0.576 . . . . 73.44 110.175 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 1.1 p-90 -147.96 11.89 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.27 -0.877 . . . . 64.1 110.111 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 35.5 t30 -174.94 -60.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.968 -0.56 . . . . 74.42 111.347 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 85.0 Cg_endo -78.26 140.02 17.18 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.755 1.637 . . . . 42.05 112.528 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.56 151.84 51.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.662 2.241 . . . . 62.1 111.38 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -59.74 123.9 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 61.14 111.224 -172.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.54 -120.04 1.52 Allowed Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.003 -0.544 . . . . 64.13 111.765 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 -14.91 45.07 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.628 2.219 . . . . 74.34 111.66 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.47 -26.62 61.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.533 -0.758 . . . . 71.13 110.325 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 73.8 mmtt . . . . . 0 CA--C 1.535 0.4 0 CA-C-N 115.925 -0.58 . . . . 74.51 111.457 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.944 0.402 . . . . 72.23 112.023 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 14' ' ' GLU . 29.8 Cg_endo -66.01 168.61 15.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.469 2.112 . . . . 63.43 111.951 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.96 -67.22 0.27 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.184 1.179 . . . . 72.24 114.184 -167.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.82 -35.1 67.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 74.4 111.187 -172.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 20.0 mp0 -57.7 -46.84 83.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.591 -0.522 . . . . 54.53 109.591 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.8 -46.72 89.4 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.475 -0.784 . . . . 75.1 110.739 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.6 tp -52.79 -60.31 3.43 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.295 0.569 . . . . 54.35 110.874 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.44 69.28 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.091 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.86 -41.19 97.84 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.74 -0.664 . . . . 74.42 111.322 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.83 -35.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.575 -0.528 . . . . 43.04 109.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.19 -45.94 79.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.948 0.404 . . . . 74.22 109.966 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.37 -43.55 63.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 63.02 111.014 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.06 78.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.803 -0.635 . . . . 73.4 110.885 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -62.66 -13.44 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.579 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -87.28 -23.04 24.81 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.503 0.192 . . . . 65.34 111.428 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -116.01 -27.02 7.08 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.318 0.58 . . . . 73.13 110.11 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -27.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.032 -0.985 . . . . 62.32 110.101 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.5 p -91.32 165.1 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 63.32 109.697 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.5 91.95 5.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.81 . . . . 74.04 108.812 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.9 -7.53 13.3 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.326 2.017 . . . . 75.02 111.178 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -68.67 -57.96 4.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 72.43 110.619 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.49 -18.61 17.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 75.12 110.241 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.21 52.12 1.94 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.247 -0.501 . . . . 64.31 113.173 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.8 mp -126.91 141.55 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.667 -0.494 . . . . 62.11 109.667 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.444 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.4 p30 -108.77 138.6 44.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.017 -0.734 . . . . 75.22 109.017 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.15 -36.25 50.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.161 0.505 . . . . 74.44 111.312 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.78 -24.93 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.931 -0.577 . . . . 74.41 110.875 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.2 -26.04 64.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.357 -0.383 . . . . 65.52 111.358 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.53 -15.34 63.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.53 110.588 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.64 22.38 46.15 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.71 -0.677 . . . . 63.05 113.949 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -22.66 16.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.825 -0.806 . . . . 74.44 108.825 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.77 -4.96 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.188 -0.914 . . . . 72.15 111.731 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -66.3 -19.08 65.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.066 0.46 . . . . 73.25 110.044 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.96 110.47 3.94 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.241 -0.744 . . . . 44.23 111.241 174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.9 pp -167.34 149.63 5.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.302 -0.258 . . . . 70.4 110.302 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -163.69 122.51 1.98 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.804 -0.443 . . . . 74.45 109.804 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -99.54 118.34 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 75.31 110.129 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -113.4 137.47 51.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.128 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 8.8 p-10 -91.83 154.36 18.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 74.0 110.158 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.16 162.47 30.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.16 -0.543 . . . . 72.42 112.031 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.21 -29.48 70.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.126 0.489 . . . . 64.41 110.507 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.98 -24.5 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.765 -0.652 . . . . 71.24 109.907 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.53 15.21 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.044 -0.525 . . . . 44.22 111.925 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 16.8 m -93.68 120.41 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.881 -0.414 . . . . 72.11 109.881 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.2 p -115.62 131.58 67.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.218 0.533 . . . . 73.45 111.442 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.51 116.04 29.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.56 -0.746 . . . . 53.12 110.544 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 55.8 mt -96.44 117.4 30.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.088 -0.338 . . . . 71.44 110.088 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 ' HG3' ' A' ' 59' ' ' MET . 39.9 mm -115.09 118.05 57.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.717 -0.475 . . . . 74.4 109.717 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.39 118.63 28.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.531 -0.544 . . . . 42.22 109.531 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.529 ' HG3' HG22 ' A' ' 57' ' ' ILE . 71.9 mtp -141.02 170.92 14.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 45.32 111.364 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 t -147.13 175.16 10.94 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.944 -0.761 . . . . 61.52 108.944 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mm? -109.73 150.78 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.585 -0.524 . . . . 63.21 109.585 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.2 p -46.61 -54.8 8.73 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.616 0.572 . . . . 73.12 112.489 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 t -104.02 -1.38 27.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 73.51 110.627 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.3 1.43 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.058 0.543 . . . . 41.44 112.184 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.95 -17.46 8.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.279 0.562 . . . . 41.32 109.966 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 4.1 p -87.3 114.43 58.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 71.13 110.42 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 7.5 Cg_exo -72.83 73.78 2.95 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.996 2.464 . . . . 62.25 112.89 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 4.2 mm? -94.29 9.53 37.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.3 0.572 . . . . 74.11 109.81 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.1 t -60.25 -37.81 81.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.703 -0.68 . . . . 52.55 110.572 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.74 -53.32 59.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.137 0.494 . . . . 71.42 110.199 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 11.8 p -66.11 -46.37 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 74.11 111.01 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -62.61 -38.92 82.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.42 -0.512 . . . . 72.13 111.018 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.49 -43.38 90.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.011 -0.54 . . . . 53.24 110.71 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.84 -39.76 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.858 -0.337 . . . . 71.25 110.28 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 98.8 mt-30 -56.15 -52.59 63.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.07 0.462 . . . . 65.33 110.218 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.3 m -60.03 -52.18 66.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.697 -0.683 . . . . 64.33 110.627 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.622 ' O ' HG12 ' A' ' 81' ' ' VAL . 6.0 tmm_? -54.43 -52.91 60.29 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.852 -0.613 . . . . 71.02 111.0 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -52.85 -53.24 51.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.605 0.566 . . . . 63.33 111.535 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -52.51 11.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.259 -0.576 . . . . 64.2 110.995 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.74 -40.2 75.32 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.816 0.341 . . . . 72.52 111.441 -169.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 77' ' ' ARG . 4.8 p -89.31 -27.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 74.4 110.193 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.01 -24.92 70.4 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.646 -0.787 . . . . 71.54 111.658 -167.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.753 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 9.2 t -87.17 -11.85 48.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.224 0.535 . . . . 61.01 109.962 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.84 61.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.581 -0.736 . . . . 34.02 112.023 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 82.1 mt -74.39 -53.51 9.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.028 0.442 . . . . 72.33 110.415 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 55' ' ' ALA . 33.4 m -124.91 165.91 21.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.986 -0.552 . . . . 64.14 110.611 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.66 -47.92 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 51.31 109.787 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 m-20 -135.11 169.7 17.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.634 -0.712 . . . . 53.21 110.65 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.2 pt -134.94 175.97 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.92 -0.582 . . . . 71.2 110.368 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.436 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 26.3 tpt180 -164.61 119.84 1.44 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.551 -0.75 . . . . 74.11 109.815 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 47.2 mt -97.12 123.28 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 73.32 110.009 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 26.6 t30 -93.89 115.0 27.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.851 -0.613 . . . . 63.24 109.539 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -84.39 106.22 15.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.582 -0.525 . . . . 64.01 109.582 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 99' ' ' TRP . 28.0 t -93.93 124.13 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.639 . . . . 75.52 110.473 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -113.33 -20.62 11.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.03 110.801 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.454 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 t-20 -177.01 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.036 -0.529 . . . . 65.4 111.092 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 41.0 Cg_endo -64.1 151.39 85.54 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.137 1.891 . . . . 61.44 112.701 -172.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.44 157.15 52.26 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.627 2.218 . . . . 75.14 111.582 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.834 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 5.9 m0 -64.78 130.78 44.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.034 -0.53 . . . . 74.04 110.7 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.08 -120.95 0.59 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.728 -0.749 . . . . 73.55 113.415 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.5 -36.34 66.09 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.287 2.658 . . . . 75.25 113.638 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.3 -14.46 11.45 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.028 0.442 . . . . 60.13 111.247 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 99' ' ' TRP . 36.3 mtpt . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 116.268 -0.423 . . . . 64.03 111.041 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 110.671 -0.122 . . . . 75.33 110.671 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 14' ' ' GLU . 18.9 Cg_endo -57.91 131.07 41.56 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.74 2.293 . . . . 62.43 111.731 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.29 -51.92 17.77 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.494 0.924 . . . . 64.3 113.494 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.68 -50.32 74.32 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.009 0.433 . . . . 71.14 111.043 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 35.6 tt0 -64.62 -46.7 81.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 72.2 110.353 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.89 -36.55 84.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.919 -1.037 . . . . 74.11 111.209 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 tp -53.07 -55.31 24.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.172 0.51 . . . . 75.04 109.772 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -64.83 -47.13 79.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 30.14 110.847 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 75.34 111.211 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -71.37 -34.35 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 71.22 110.211 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.04 -40.3 93.09 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.998 0.428 . . . . 71.25 110.025 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 24.8 mm-40 -72.26 -47.24 51.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.906 -0.588 . . . . 73.24 110.226 176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.94 65.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.934 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.05 -13.65 7.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.178 -0.465 . . . . 73.41 111.579 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 63.1 ttt-85 -93.8 -29.44 15.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.596 0.358 . . . . 74.43 111.31 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.97 -5.14 10.07 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.215 0.531 . . . . 64.12 110.346 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 99.9 t -107.01 19.95 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.505 1.145 . . . . 70.31 109.317 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 11.6 p -148.25 160.8 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.571 -1.195 . . . . 55.54 108.47 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.57 98.28 3.55 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.461 -0.57 . . . . 75.13 109.461 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 96.2 Cg_endo -87.68 -1.08 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.705 2.27 . . . . 74.41 111.655 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.6 -57.49 5.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 75.12 109.957 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.32 -14.56 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 75.5 110.654 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.97 47.76 2.59 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.182 -0.532 . . . . 71.41 112.981 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.2 mp -110.52 143.27 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 109.822 -0.436 . . . . 75.04 109.822 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.8 t30 -115.02 111.67 21.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.098 -0.501 . . . . 65.53 110.015 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.8 -39.68 72.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.28 0.562 . . . . 61.05 110.105 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.94 -24.57 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.508 -0.769 . . . . 73.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 25.3 t70 -64.43 -22.97 67.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.902 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.74 -8.6 56.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.185 0.517 . . . . 74.34 110.227 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.32 53.03 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.142 -0.935 . . . . 63.42 114.229 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 tt -98.23 -32.13 11.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.453 -0.573 . . . . 73.21 109.453 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.26 -11.0 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 65.23 110.217 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -64.07 -21.19 66.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.512 -0.767 . . . . 72.24 109.406 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.42 64.25 3.55 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.522 -0.763 . . . . 71.43 112.024 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.5 pp -107.66 142.31 37.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.899 -0.408 . . . . 72.12 109.899 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.3 118.86 4.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 74.45 109.088 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.59 123.93 56.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.757 0.313 . . . . 74.23 110.677 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.599 HE21 HD21 ' A' ' 56' ' ' LEU . 24.8 pt20 -97.74 120.9 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.255 -0.646 . . . . 53.45 109.255 175.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.07 129.75 56.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 64.33 110.348 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.89 167.7 28.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.221 -0.752 . . . . 71.0 111.221 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.6 -31.67 66.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.898 0.38 . . . . 72.42 110.687 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.44 -31.14 70.24 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.862 -0.608 . . . . 63.32 110.565 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.98 163.44 16.91 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 116.081 -0.509 . . . . 71.22 112.189 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.2 m -110.71 109.09 19.19 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.558 -0.534 . . . . 74.12 109.558 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.05 123.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.577 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -89.98 109.88 20.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.28 -0.418 . . . . 52.13 110.966 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.599 HD21 HE21 ' A' ' 47' ' ' GLN . 12.3 mt -91.23 107.43 19.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.749 -0.463 . . . . 73.24 109.749 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.6 117.61 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.094 -0.335 . . . . 72.45 110.094 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.36 122.04 26.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 110.247 -0.279 . . . . 72.24 110.247 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 83.5 mtp -141.17 170.88 14.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.428 0.632 . . . . 74.41 111.246 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.2 t -160.49 158.8 29.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 72.33 109.486 174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -99.89 160.74 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.985 -0.376 . . . . 62.05 109.985 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 m -45.92 -56.03 5.97 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.604 0.565 . . . . 65.35 112.405 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 m -103.0 4.58 37.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.934 0.397 . . . . 63.44 110.633 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.448 0.699 . . . . 71.43 112.398 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.42 2.45 10.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 73.22 110.048 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.628 ' HB3' HD13 ' A' ' 68' ' ' LEU . 14.1 m -81.66 120.93 79.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.391 -0.822 . . . . 74.43 110.389 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.13 33.44 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.921 2.414 . . . . 74.42 113.186 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.0 mp -79.76 3.08 20.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.946 0.403 . . . . 73.33 110.616 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.8 t -57.37 -44.23 84.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.03 -0.532 . . . . 54.14 110.789 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.32 -41.44 69.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.222 0.534 . . . . 75.42 110.384 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.24 -52.71 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.36 -0.836 . . . . 71.53 110.668 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 69' ' ' THR . 33.3 pt -63.52 -39.69 86.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 120.824 0.345 . . . . 75.1 111.225 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.18 -49.96 72.22 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.936 -0.574 . . . . 74.05 110.323 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.77 -49.8 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.422 -0.353 . . . . 70.43 110.667 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -55.57 -58.94 5.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.743 -0.662 . . . . 51.4 111.773 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -52.66 52.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.071 0.463 . . . . 51.33 111.026 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -56.72 -49.52 74.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.761 -0.654 . . . . 64.41 110.731 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -54.0 -48.28 70.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.676 -0.693 . . . . 64.24 111.346 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.09 13.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.907 -0.317 . . . . 71.32 111.384 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 89' ' ' ILE . 82.9 mt -61.05 -36.17 78.89 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.985 0.422 . . . . 70.22 111.162 -172.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.56 -27.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 60.41 110.033 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.71 -47.29 34.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.171 -0.538 . . . . 63.32 112.221 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.8 m -75.97 -23.12 55.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.1 0.476 . . . . 65.01 110.14 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 33.36 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.123 -0.56 . . . . 74.4 113.35 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.71 -44.33 67.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.87 0.367 . . . . 74.31 110.017 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.1 m -135.91 166.82 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 71.51 110.36 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -41.69 74.66 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.583 -0.525 . . . . 64.33 109.583 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -167.11 175.91 7.2 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.224 -0.898 . . . . 73.53 109.146 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 80' ' ' LEU . 38.7 pt -120.19 178.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.6 0.714 . . . . 75.53 111.065 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -150.72 106.31 3.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.791 -1.095 . . . . 63.23 108.096 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.26 117.96 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.093 -0.706 . . . . 74.02 109.093 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -88.63 143.57 26.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.938 -0.574 . . . . 72.25 109.481 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -111.16 109.58 19.7 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.791 -0.818 . . . . 74.05 108.791 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 t -85.1 123.61 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 64.41 110.711 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -120.86 -21.07 6.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.318 -0.855 . . . . 74.45 109.769 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.9 t30 178.27 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.498 -0.773 . . . . 55.13 111.439 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 91.9 Cg_exo -44.44 131.91 9.48 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.795 2.33 . . . . 55.41 113.469 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 2.4 Cg_endo -82.25 41.97 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.446 2.764 . . . . 71.51 112.119 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.8 m0 63.42 -154.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.155 -0.475 . . . . 71.55 110.787 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 101' ' ' PRO . . . 97.07 -134.31 11.71 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.478 -0.649 . . . . 71.12 111.478 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' ' HA3' ' A' ' 100' ' ' GLY . 27.8 Cg_endo -61.41 -22.54 74.82 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.442 2.094 . . . . 34.4 110.803 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.19 -12.85 22.32 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.791 -1.095 . . . . 54.0 111.06 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt . . . . . 0 C--O 1.224 -0.256 0 CA-C-N 116.408 -0.36 . . . . 72.23 111.162 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.384 0.135 . . . . 43.51 110.803 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 31.1 Cg_endo -63.1 152.18 80.91 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.558 2.172 . . . . 54.24 111.921 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.54 -47.88 63.25 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.953 0.723 . . . . 72.54 112.953 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.74 -46.03 88.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.614 0.245 . . . . 63.33 111.438 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 52.4 110.298 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.4 tt -54.15 -44.98 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.41 -0.813 . . . . 72.05 109.636 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 53.2 tp -54.04 -59.65 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.873 -0.603 . . . . 73.24 110.714 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -51.98 67.12 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.052 0.453 . . . . 63.35 111.122 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.73 -44.26 85.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.387 -0.824 . . . . 42.43 110.98 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.9 -38.41 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.781 -0.368 . . . . 61.14 110.821 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 16' ' ' LEU . 42.9 mt-10 -61.03 -44.03 98.01 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.96 -0.296 . . . . 72.42 110.623 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.91 -43.79 67.56 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.277 -0.569 . . . . 73.23 110.327 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -35.56 72.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.889 0.376 . . . . 73.21 111.017 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.3 mmt -62.44 -12.53 22.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.829 -0.623 . . . . 74.24 111.93 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -72.01 -31.92 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.424 0.154 . . . . 71.21 111.344 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -115.31 -27.27 7.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.874 0.845 . . . . 54.55 109.54 -171.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 26' ' ' VAL . 62.4 t -90.21 55.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.595 -1.184 . . . . 73.12 109.496 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.2 p -173.02 170.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.19 -0.914 . . . . 74.32 109.575 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -110.61 91.94 13.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 54.41 109.102 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' HG13 ' A' ' 27' ' ' VAL . 59.5 Cg_endo -82.92 0.35 9.68 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.286 1.99 . . . . 61.31 111.906 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.66 -57.83 5.13 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.18 0.514 . . . . 75.42 109.822 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.66 -18.49 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 73.35 110.187 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 52.02 2.5 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.044 -0.525 . . . . 54.31 113.148 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -128.42 140.76 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.968 -0.382 . . . . 73.43 109.968 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.513 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.9 t-20 -100.43 141.13 33.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.13 -35.32 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 63.1 111.675 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.11 -24.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.351 -0.386 . . . . 73.15 110.848 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.7 -21.62 66.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.043 -0.526 . . . . 74.33 111.275 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.87 -15.12 63.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.546 0.689 . . . . 74.24 109.98 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.18 22.08 66.74 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 114.844 -1.071 . . . . 55.23 114.356 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.9 tp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.28 0.562 . . . . 71.34 109.553 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.54 -4.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.206 -0.906 . . . . 65.32 111.637 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -70.36 -15.01 62.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.194 0.521 . . . . 65.51 109.777 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.95 66.65 3.82 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.284 -0.726 . . . . 62.4 111.284 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -98.68 135.84 39.6 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.643 -0.502 . . . . 74.1 109.643 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.48 109.02 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.861 -0.792 . . . . 71.41 108.861 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -114.23 145.24 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 122.147 -0.346 . . . . 73.51 110.32 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -136.61 124.49 22.67 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 70.03 109.646 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.9 p-10 -91.59 88.54 6.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.566 0.698 . . . . 63.42 110.172 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.25 42.16 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.386 -0.825 . . . . 31.33 111.722 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -67.28 -18.17 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.793 0.33 . . . . 73.1 110.518 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -98.16 -21.03 16.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.222 -0.444 . . . . 73.51 111.375 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 131.69 1.83 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.807 -0.711 . . . . 42.12 112.648 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.9 m -85.33 109.07 18.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.791 -0.448 . . . . 73.42 109.791 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.6 p -115.23 133.6 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.079 0.466 . . . . 61.32 111.193 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -103.74 115.69 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.716 -0.674 . . . . 72.32 110.329 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' A' ' 103' ' ' LYS . 6.5 mt -96.91 129.61 44.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.218 -0.66 . . . . 51.45 109.218 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.9 118.59 49.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.234 -0.284 . . . . 72.43 110.234 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.55 116.2 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.01 110.494 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 72' ' ' ILE . 26.0 mtm -134.93 170.83 15.29 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.468 0.652 . . . . 72.42 111.216 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -160.06 146.16 15.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.489 -1.232 . . . . 54.43 108.012 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 87.8 mt -90.29 163.17 14.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.64 -0.504 . . . . 75.21 109.64 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -45.45 -47.61 13.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.18 0.437 . . . . 65.2 112.18 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -96.04 -17.96 20.57 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.156 0.503 . . . . 71.42 110.548 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.42 8.59 2.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.798 -0.637 . . . . 72.54 111.544 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.05 -3.7 13.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 73.1 109.973 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.468 ' HB3' HD13 ' A' ' 68' ' ' LEU . 23.3 m -69.75 123.91 89.55 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.608 -0.724 . . . . 74.4 110.042 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.18 35.08 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.04 2.493 . . . . 75.33 113.119 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.2 mp -98.04 13.65 30.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.578 -0.283 . . . . 73.23 110.685 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 70' ' ' ASP . 5.2 t -55.07 -54.17 46.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.822 0.344 . . . . 71.45 111.29 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 69' ' ' THR . 28.3 t70 -65.71 -27.44 68.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 75.25 110.224 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 62.0 t -70.17 -52.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.986 -0.552 . . . . 64.53 110.681 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.628 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.7 pp -64.07 -37.95 81.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.789 0.328 . . . . 54.12 110.259 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.628 ' N ' HD12 ' A' ' 72' ' ' ILE . 42.8 mt-10 -64.89 -42.23 94.96 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.163 -0.471 . . . . 70.3 110.521 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.42 -48.25 82.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.054 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 22.3 mm-40 -60.15 -46.76 88.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.853 -0.612 . . . . 73.43 110.198 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.59 -62.31 1.97 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.641 -0.709 . . . . 54.32 110.799 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -56.82 -43.73 81.31 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.354 -0.384 . . . . 75.22 111.687 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -60.02 -42.03 93.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 72.35 110.652 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 -50.97 16.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 62.05 110.671 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 89' ' ' ILE . 83.1 mt -56.65 -37.46 70.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.188 -0.46 . . . . 72.33 111.348 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.89 -28.3 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 63.32 110.328 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.34 -34.58 60.68 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.721 -0.951 . . . . 63.44 110.721 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 m -81.8 -23.09 36.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.186 -0.507 . . . . 64.21 110.379 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.46 11.75 81.5 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.983 -0.553 . . . . 73.22 113.326 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.51 -41.03 93.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.604 0.24 . . . . 53.45 111.563 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 23.8 m -136.29 170.21 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.482 -0.326 . . . . 70.44 110.77 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.64 -38.14 10.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 62.45 110.507 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 21.2 t70 -145.67 164.05 32.98 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.727 -0.67 . . . . 63.11 109.31 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 80' ' ' LEU . 19.6 pt -136.24 172.58 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.201 0.524 . . . . 71.42 110.532 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 6.9 tpm_? -160.83 106.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.531 -0.759 . . . . 70.12 109.541 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.456 HD12 ' HG2' ' A' ' 73' ' ' GLU . 62.7 mt -90.74 110.48 22.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.017 -0.364 . . . . 74.24 110.017 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 5.6 t30 -88.55 125.11 34.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 72.42 110.173 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.3 m95 -89.77 112.99 24.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 73.24 111.066 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.13 123.93 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.367 -0.605 . . . . 74.24 109.367 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -153.69 8.34 0.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.492 . . . . 55.12 110.904 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.635 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 24.5 t-20 171.51 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.916 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 69.0 Cg_endo -84.68 149.78 11.3 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.047 1.831 . . . . 60.11 112.448 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 22.7 Cg_exo -65.42 166.44 19.48 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.599 2.199 . . . . 74.11 111.86 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -64.19 109.93 2.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 73.1 110.333 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.02 -79.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.701 -0.761 . . . . 52.53 112.912 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.28 -58.59 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.792 2.328 . . . . 65.15 112.508 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 3.2 m-20 -66.29 -4.36 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 64.4 111.524 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 56' ' ' LEU . 21.5 mmtp . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 111.752 0.278 . . . . 75.52 111.752 175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 110.316 -0.253 . . . . 74.01 110.316 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.6 Cg_endo -65.47 153.24 79.13 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.822 1.681 . . . . 75.05 111.455 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.33 -32.53 49.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.302 -0.408 . . . . 71.34 111.952 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 9.0 pt-20 -62.57 -52.51 63.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.23 111.363 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.72 -39.14 70.31 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.688 0.28 . . . . 73.12 110.256 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.37 -46.39 86.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 64.44 110.08 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.16 -56.77 17.79 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.82 0.343 . . . . 70.14 110.831 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.88 67.4 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.987 -0.551 . . . . 45.12 111.04 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.55 -48.33 82.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.903 -0.59 . . . . 63.25 111.064 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' MET . 2.4 p -66.95 -36.58 77.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.974 -0.291 . . . . 62.21 110.435 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.8 -47.24 86.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.96 -0.385 . . . . 61.31 109.96 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.75 -51.18 68.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 63.42 110.281 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.2 -49.78 71.05 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.667 -0.697 . . . . 72.13 110.766 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.9 mmt -61.16 -20.32 62.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.866 0.321 . . . . 73.41 111.866 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -101.38 -13.77 17.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 73.04 110.464 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' GLN . 8.6 t70 -119.43 -10.1 9.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.244 0.545 . . . . 74.15 109.845 -168.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -117.83 -19.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.525 -0.762 . . . . 53.22 110.501 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.6 p -77.83 163.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.513 -0.767 . . . . 75.34 110.577 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.07 87.65 1.11 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.279 -1.378 . . . . 44.4 107.279 166.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 51.6 Cg_endo -82.17 -9.35 11.66 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.158 1.905 . . . . 55.11 111.903 -172.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -56.94 6.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.817 -0.629 . . . . 74.15 110.463 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.87 -19.01 29.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.516 -0.311 . . . . 55.33 110.544 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.38 40.1 6.57 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 116.054 -0.521 . . . . 62.15 113.493 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 33' ' ' ILE . 4.0 mp -127.84 140.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 117.201 0.5 . . . . 75.21 110.22 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HA ' HG23 ' A' ' 27' ' ' VAL . 21.2 t-20 -101.48 147.72 26.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.464 -0.939 . . . . 63.43 108.464 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.66 -36.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 53.33 111.118 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.71 -24.58 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 70.41 110.942 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.75 -28.04 63.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.25 -0.432 . . . . 63.1 111.231 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.72 -15.37 63.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.308 0.575 . . . . 64.2 110.268 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 57.53 21.92 43.73 Favored Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.037 -0.983 . . . . 73.04 114.015 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 40' ' ' LEU . 2.6 tm? -98.78 -29.0 13.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.327 -0.99 . . . . 73.45 108.327 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 59' ' ' MET . 16.4 t -69.82 1.74 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.629 -1.169 . . . . 75.22 111.75 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.44 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 60.2 m-85 -64.76 -22.74 67.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.319 -0.622 . . . . 72.23 109.319 171.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.39 72.35 1.94 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.388 -0.824 . . . . 73.21 112.209 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.52 121.28 44.65 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.072 -0.714 . . . . 52.14 109.072 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.42 108.88 7.88 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.028 -0.36 . . . . 74.22 110.028 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.65 126.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.66 136.18 46.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.684 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.19 148.2 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 73.34 110.705 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.51 40.77 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.803 -0.919 . . . . 53.33 110.803 175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.9 -18.62 63.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.433 0.616 . . . . 42.3 109.995 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.59 -31.74 71.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.44 0.638 . . . . 72.54 109.582 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.89 -163.64 24.77 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.1 -0.954 . . . . 21.01 111.094 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 p -93.21 118.85 31.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.849 0.357 . . . . 73.12 110.54 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.44 123.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.774 -0.454 . . . . 74.2 109.774 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.46 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -101.38 121.62 42.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.413 -0.358 . . . . 24.44 111.228 -175.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -98.84 129.52 45.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' HG3' ' A' ' 59' ' ' MET . 58.1 mt -125.38 113.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 62.22 110.544 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.85 117.68 22.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.715 -0.476 . . . . 71.0 109.715 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 88.2 mtp -140.96 170.93 14.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 71.52 110.617 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -158.95 159.15 34.55 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.629 -0.714 . . . . 72.42 109.886 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.45 155.68 34.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.576 -0.898 . . . . 71.51 108.576 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -48.05 -59.79 3.11 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.406 0.441 . . . . 63.32 112.04 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 p -96.7 -13.61 22.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.416 -0.356 . . . . 74.42 110.977 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.87 8.66 3.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.755 -0.657 . . . . 64.42 111.51 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.18 -8.52 13.98 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.113 0.483 . . . . 72.05 110.697 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.605 ' HB3' HD13 ' A' ' 68' ' ' LEU . 62.9 m -67.73 136.13 92.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.636 -0.711 . . . . 53.43 110.626 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.76 36.0 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.104 2.536 . . . . 63.11 112.644 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.6 mp -97.25 1.19 49.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.336 -0.393 . . . . 73.13 110.249 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -58.53 8.07 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 75.22 111.432 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.27 -27.08 68.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 75.11 109.893 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.04 -52.43 38.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.674 -0.694 . . . . 74.33 110.663 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 pt -64.14 -38.61 82.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.917 -0.313 . . . . 63.34 110.72 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' ' 91' ' ' ILE . 3.4 mt-10 -63.33 -44.53 94.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.673 -0.239 . . . . 54.4 111.391 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.18 -51.11 70.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 60.53 110.427 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 25' ' ' ASP . 25.9 mt-30 -56.27 -52.35 64.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.873 -0.603 . . . . 51.41 110.806 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.5 t -62.11 -55.13 31.95 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.806 -0.634 . . . . 72.41 111.183 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -58.59 -41.49 85.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.779 -0.191 . . . . 74.34 110.94 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -56.12 -47.15 78.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.378 -0.374 . . . . 72.34 110.693 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.22 16.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 71.55 111.189 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.12 -38.87 80.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.865 0.364 . . . . 65.53 111.107 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.36 -27.92 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 64.12 109.97 175.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.74 -47.31 56.58 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.123 -0.561 . . . . 75.25 111.706 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.8 m -73.25 -11.36 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 62.4 110.563 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.07 38.66 95.63 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.001 -0.545 . . . . 63.25 112.538 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.5 -33.21 19.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 74.22 110.729 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.508 ' HA ' ' OG1' ' A' ' 53' ' ' THR . 31.2 m -136.26 169.36 20.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.174 -0.467 . . . . 75.33 110.907 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.86 -41.73 6.07 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.44 . . . . 54.24 110.748 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -137.71 143.69 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.345 -0.613 . . . . 63.24 109.345 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.77 146.62 28.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.729 -0.471 . . . . 74.31 109.729 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 112.85 13.6 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.885 -0.413 . . . . 64.25 109.885 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 73' ' ' GLU . 56.1 mt -90.72 98.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.164 -0.68 . . . . 72.24 109.164 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.45 121.36 30.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.2 0.524 . . . . 74.21 109.887 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' MET . 2.9 m-90 -90.45 106.44 18.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.557 -0.747 . . . . 73.34 109.47 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.62 123.62 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.415 0.626 . . . . 65.31 110.138 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -136.97 -7.97 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 75.53 111.215 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -179.7 -55.68 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 O-C-N 123.1 0.25 . . . . 74.4 110.952 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -87.09 169.07 7.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.299 1.999 . . . . 62.44 112.402 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.38 159.51 19.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.485 2.123 . . . . 72.42 111.545 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -69.72 -22.04 63.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.549 -0.296 . . . . 70.34 110.759 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -39.53 -63.81 1.12 Allowed Glycine 0 C--N 1.338 0.688 0 O-C-N 123.803 0.689 . . . . 62.21 114.521 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -46.72 5.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.147 1.898 . . . . 75.24 111.949 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 -4.19 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 71.41 111.512 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm . . . . . 0 N--CA 1.463 0.215 0 N-CA-C 109.835 -0.431 . . . . 71.41 109.835 173.917 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 120.519 0.199 . . . . 71.04 111.513 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.87 152.14 52.27 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.439 2.093 . . . . 42.53 111.161 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.76 -42.37 7.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 73.44 112.679 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.2 -52.1 51.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.167 0.508 . . . . 71.02 110.274 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 -32.4 73.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 64.42 110.299 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -50.31 66.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.694 -0.685 . . . . 73.31 109.448 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.04 -51.82 67.75 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.991 -0.55 . . . . 63.53 110.768 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -60.95 -49.18 78.48 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.947 -0.569 . . . . 61.44 110.906 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -57.76 -48.53 79.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.703 -0.681 . . . . 64.25 110.857 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.0 p -68.77 -42.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.656 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -67.32 -37.68 83.72 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.577 -0.449 . . . . 71.33 110.805 -175.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.7 pt-20 -72.7 -46.44 53.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.601 -0.439 . . . . 71.21 110.529 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.583 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.49 -31.36 69.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.867 0.365 . . . . 62.3 110.755 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 13.2 mmt -62.97 -13.14 31.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.067 -0.515 . . . . 63.1 110.719 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -33.37 16.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.326 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 4.5 m-20 -85.51 -27.5 25.58 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.392 -0.367 . . . . 74.41 111.713 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 22' ' ' ALA . 35.0 m -113.37 42.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.715 0.769 . . . . 61.51 110.972 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG23 ' HA ' ' A' ' 34' ' ' ASN . 8.9 p -144.13 159.93 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.317 -0.856 . . . . 71.21 110.135 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.05 89.88 2.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.535 -0.913 . . . . 45.42 108.535 167.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 74.5 Cg_endo -81.09 -5.72 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.551 2.167 . . . . 74.14 111.924 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -68.68 -53.74 20.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.903 -0.589 . . . . 53.13 110.03 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.98 -16.76 16.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.097 -0.502 . . . . 53.12 110.295 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.81 40.76 4.87 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.175 -0.536 . . . . 51.23 113.237 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -106.91 140.04 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.154 -0.684 . . . . 70.23 109.154 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.55 HD22 ' N ' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -114.26 124.92 53.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.082 -0.71 . . . . 73.13 109.082 178.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.3 m -57.91 -28.65 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.44 . . . . 74.15 110.82 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 34' ' ' ASN . 10.3 p -57.77 -30.81 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.616 . . . . 74.53 111.186 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 34' ' ' ASN . 57.6 m-20 -66.25 -21.15 66.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.633 -0.258 . . . . 72.25 110.862 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -75.34 -16.53 60.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.101 0.477 . . . . 72.44 110.039 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.65 61.19 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.513 -0.767 . . . . 71.31 113.994 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 tp -96.06 -31.68 12.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.37 0.585 . . . . 73.14 109.688 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 36' ' ' VAL . 11.1 p -67.74 -11.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.493 0.663 . . . . 64.22 109.55 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -63.52 -27.14 69.06 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.273 -0.876 . . . . 73.02 108.805 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.57 68.59 2.95 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.672 -1.149 . . . . 63.22 111.098 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 pp -115.27 138.45 50.93 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.105 -0.702 . . . . 74.25 109.105 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.25 108.99 3.84 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.355 -0.609 . . . . 71.11 109.355 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 45.9 t -89.17 114.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.616 -0.513 . . . . 62.44 109.616 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -97.46 133.06 42.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 64.44 110.702 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.46 68.8 10.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.93 -0.767 . . . . 61.22 108.93 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 164.68 53.79 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.376 -0.829 . . . . 54.3 112.868 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.78 -26.94 68.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.672 0.389 . . . . 75.1 110.43 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -81.85 -7.46 59.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.162 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.82 177.11 14.73 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 112.0 -0.44 . . . . 54.34 112.0 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 m -72.55 110.18 6.75 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.172 -0.307 . . . . 71.23 110.172 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.3 p -115.14 124.49 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.828 0.347 . . . . 54.31 110.716 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -86.95 107.3 18.32 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.31 -0.405 . . . . 34.23 110.653 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 90' ' ' ARG . 28.3 mt -87.57 105.08 17.08 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.449 . . . . 64.34 109.789 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.53 124.19 68.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 110.257 -0.275 . . . . 50.11 110.257 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.61 128.49 36.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 55.35 111.367 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 80.6 mtp -141.24 171.12 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.652 -0.704 . . . . 64.41 110.636 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -145.49 171.51 14.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.326 -0.397 . . . . 74.45 109.935 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -121.18 166.64 13.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.468 -0.567 . . . . 73.23 109.468 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.4 p -62.13 -60.28 3.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.87 0.367 . . . . 74.45 111.967 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -114.28 -8.09 12.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.318 -0.401 . . . . 62.02 110.749 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.35 8.84 4.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.903 -0.589 . . . . 74.32 111.912 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.9 -25.6 13.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.113 0.483 . . . . 54.33 110.22 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.5 m -79.14 138.13 56.54 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 115.598 -0.728 . . . . 35.33 110.351 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.89 50.57 2.82 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.867 2.378 . . . . 74.3 112.335 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.14 -9.31 59.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.376 -0.375 . . . . 71.13 110.673 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.8 t -60.19 -43.4 95.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.006 -0.543 . . . . 42.2 110.838 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.95 -42.28 79.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.368 0.604 . . . . 75.11 109.941 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -65.41 -52.5 51.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 114.942 -1.026 . . . . 62.52 110.615 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.67 -41.35 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.617 -0.265 . . . . 73.14 111.224 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-10 -62.55 -47.77 82.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.527 0.203 . . . . 54.02 110.671 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 35.8 t70 -59.71 -48.15 82.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 75.13 110.942 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' ASP . 18.2 mt-30 -62.51 -43.72 98.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 63.34 111.182 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.3 m -62.57 -55.22 29.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.258 -0.428 . . . . 71.33 110.689 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 6.9 ppt_? -57.04 -38.03 72.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.943 -0.303 . . . . 65.11 110.32 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.8 t -55.66 -53.71 53.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.235 -0.439 . . . . 73.44 111.184 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.59 -52.41 11.86 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.546 -0.462 . . . . 70.43 111.395 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -39.74 89.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.924 0.392 . . . . 65.24 111.55 -171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.23 -27.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 74.22 109.847 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.81 -45.83 56.12 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.832 -0.699 . . . . 42.43 111.622 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 p -75.9 -22.98 55.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.967 0.413 . . . . 64.13 110.195 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.13 45.34 41.01 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.87 -0.604 . . . . 74.11 112.107 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.26 -32.8 33.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 65.3 110.576 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.2 m -141.18 165.51 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.137 -0.483 . . . . 71.23 110.646 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.35 -47.46 19.86 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.668 -0.493 . . . . 65.1 109.668 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 22.1 m-20 -133.54 158.14 43.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.475 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -111.46 164.92 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.102 -0.703 . . . . 72.13 109.102 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HB3' HD23 ' A' ' 56' ' ' LEU . 14.5 tpp85 -153.23 106.63 3.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.02 -0.272 . . . . 70.23 110.43 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 73' ' ' GLU . 57.0 mt -94.31 131.03 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 75.14 110.071 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.666 HD22 ' N ' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -107.9 131.73 54.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.951 . . . . 63.32 108.431 175.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.666 ' N ' HD22 ' A' ' 92' ' ' ASN . 2.7 m-90 -102.67 106.12 16.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.46 -0.57 . . . . 75.34 109.46 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.4 m -102.93 124.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.141 0.495 . . . . 74.21 109.711 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -111.27 -33.23 6.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 61.55 110.373 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.616 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 20.1 t-20 -171.71 -50.89 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.768 -0.651 . . . . 72.25 110.761 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 17.1 Cg_exo -68.33 157.78 60.37 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.296 1.997 . . . . 63.24 111.8 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.72 167.21 15.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.831 2.354 . . . . 51.4 112.402 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -62.56 142.85 57.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.68 -0.691 . . . . 72.42 111.371 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -120.21 0.53 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.966 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.0 -20.36 67.7 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.64 2.227 . . . . 44.41 111.266 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -5.54 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.905 -1.043 . . . . 74.51 111.753 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 57.2 mmtt . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.267 -0.272 . . . . 72.5 110.267 170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.289 0.09 . . . . 73.42 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 12.0 Cg_endo -55.61 152.88 31.94 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.535 2.157 . . . . 72.44 112.147 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.86 -38.51 35.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.969 0.507 . . . . 61.35 112.365 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 18.5 mp0 -68.2 -51.95 39.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 74.35 110.362 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.88 -45.99 80.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.541 -0.754 . . . . 73.43 110.324 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 15' ' ' LEU . 2.7 tm? -55.19 -49.37 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.298 -0.864 . . . . 73.41 110.272 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.67 -53.72 47.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.771 -0.649 . . . . 73.24 110.903 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.2 74.37 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.546 . . . . 75.05 111.124 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 75.32 110.902 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 8.8 p -69.45 -32.67 53.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 110.085 -0.339 . . . . 54.12 110.085 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -62.17 -41.14 98.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.78 -0.452 . . . . 50.24 109.78 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 38.0 mt-10 -69.26 -43.91 72.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.066 -0.515 . . . . 72.13 110.342 174.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -45.17 77.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 63.41 110.434 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.72 -13.48 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.613 -0.721 . . . . 73.43 111.639 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 32.3 ttp180 -87.86 -32.66 18.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.832 0.453 . . . . 63.45 110.53 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -100.27 -26.93 13.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.144 -0.48 . . . . 74.41 112.17 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -84.96 3.01 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 43.25 111.063 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.5 p -125.59 158.45 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.236 -0.653 . . . . 63.31 109.236 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -101.21 95.37 4.78 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.72 -0.844 . . . . 71.23 108.72 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 78.2 Cg_endo -83.08 -6.15 11.23 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.647 2.231 . . . . 74.41 111.926 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -69.04 -57.62 5.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.787 -0.642 . . . . 63.34 110.265 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.1 mm? -94.55 -18.68 21.2 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.272 -0.422 . . . . 72.33 109.95 176.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 48.76 4.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.675 -0.693 . . . . 54.21 113.365 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.91 145.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 117.144 0.472 . . . . 72.42 110.499 177.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 36' ' ' VAL . 18.5 p-10 -112.86 107.21 15.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 74.32 111.789 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.43 -31.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.843 -0.617 . . . . 75.21 110.865 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 34' ' ' ASN . 12.2 p -55.75 -25.04 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.881 -0.6 . . . . 74.34 111.399 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.05 -22.46 65.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.569 -0.287 . . . . 54.32 111.498 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.59 -23.35 65.94 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.103 0.477 . . . . 75.22 110.384 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.61 61.07 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.396 -0.82 . . . . 65.54 114.081 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.4 -32.09 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.332 0.566 . . . . 55.34 109.744 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.78 -14.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.491 -0.777 . . . . 63.43 110.254 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -65.97 -17.76 64.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.155 -0.929 . . . . 71.4 110.291 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.81 62.43 4.17 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.024 -0.534 . . . . 64.22 112.0 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 pp -101.42 148.63 24.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 51.34 110.706 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -161.36 110.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.979 -0.378 . . . . 73.43 109.979 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.8 p -92.5 121.01 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 61.11 110.292 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -109.21 127.87 54.58 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.872 -0.603 . . . . 71.01 110.434 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -82.94 138.75 33.7 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.681 -0.691 . . . . 75.23 110.405 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.56 154.0 21.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.832 -0.907 . . . . 60.24 110.832 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -58.25 -36.9 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 72.22 110.719 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -78.5 -24.67 45.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.705 -0.679 . . . . 71.14 110.409 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.98 158.38 12.8 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.225 -0.512 . . . . 61.02 112.526 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.29 117.28 29.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.138 -0.319 . . . . 74.03 110.138 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 8.7 p -108.82 134.88 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.727 0.298 . . . . 72.45 111.081 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -100.76 110.39 22.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.511 -0.313 . . . . 72.33 110.638 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 90' ' ' ARG . 52.6 mt -84.85 137.92 32.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.119 -0.326 . . . . 74.31 110.119 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.505 ' HB ' HG12 ' A' ' 91' ' ' ILE . 62.4 mt -135.66 118.51 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.783 -0.451 . . . . 73.43 109.783 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' HE1' ' A' ' 99' ' ' TRP . 35.1 t0 -84.38 116.33 22.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 75.41 110.723 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.5 mtp -141.41 170.92 14.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.292 0.567 . . . . 62.31 111.46 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -150.23 176.69 10.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.366 -0.834 . . . . 62.22 108.801 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 68' ' ' LEU . 63.1 mt -121.52 145.67 47.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.624 -0.509 . . . . 55.44 109.624 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.7 p -52.53 -55.11 24.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 71.3 112.614 -172.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -99.84 -4.49 30.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.104 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.89 8.91 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.98 -0.554 . . . . 72.4 112.363 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.26 -35.91 3.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.951 0.405 . . . . 64.25 110.491 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -67.02 123.53 86.48 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.719 -0.673 . . . . 62.24 110.141 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.49 64.94 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.986 2.458 . . . . 73.41 113.055 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 mm? -85.89 -3.21 58.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.478 -0.328 . . . . 73.3 110.791 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 t -56.98 -44.97 83.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.321 -0.4 . . . . 73.04 111.168 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.95 -41.49 87.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.073 0.463 . . . . 72.23 110.152 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.93 -51.56 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.349 -0.841 . . . . 51.44 110.926 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.41 HD11 ' HE1' ' A' ' 93' ' ' TRP . 32.5 pt -64.01 -41.26 91.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 74.0 111.185 -176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 90' ' ' ARG . 1.8 mm-40 -68.78 -38.21 79.85 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.525 -0.307 . . . . 75.01 111.162 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.62 -46.69 71.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.988 -0.285 . . . . 73.22 110.561 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.12 -41.54 94.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.484 0.183 . . . . 70.44 110.53 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 t -61.15 -52.38 65.1 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.451 -0.574 . . . . 54.02 109.451 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -54.59 -40.28 68.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.534 -0.757 . . . . 74.24 111.424 176.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.432 ' N ' ' HD3' ' A' ' 77' ' ' ARG . 75.7 m -54.48 -53.04 59.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.415 0.15 . . . . 74.25 111.188 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.7 -51.47 14.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.995 -0.282 . . . . 41.4 111.499 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.31 -30.39 69.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.77 0.319 . . . . 72.12 111.408 -172.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.74 -27.61 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 71.54 110.053 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.57 90.69 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.31 -0.405 . . . . 32.22 112.371 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -102.65 -0.57 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 71.14 110.551 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.03 52.16 54.51 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.071 -0.513 . . . . 74.14 112.093 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.4 -30.49 69.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.708 0.289 . . . . 61.32 110.824 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.8 m -137.15 175.46 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.04 -0.527 . . . . 71.34 110.505 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.7 -37.68 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.111 0.481 . . . . 71.2 110.322 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 28.9 t70 -145.82 157.78 43.9 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.838 -0.619 . . . . 73.52 110.038 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.47 157.03 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.948 -0.389 . . . . 53.05 109.948 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.496 ' HA ' ' NH1' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -154.71 106.38 2.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.478 -0.328 . . . . 72.12 110.932 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 57' ' ' ILE . 57.9 mt -93.54 113.53 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.181 -0.674 . . . . 74.21 109.181 171.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.523 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 2.5 p-10 -90.5 140.23 29.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.246 -0.65 . . . . 73.41 109.246 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' MET . 6.2 m-90 -107.35 106.76 17.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.49 -0.323 . . . . 64.25 110.314 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.15 124.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.141 0.496 . . . . 51.2 110.406 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -103.87 -43.57 5.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.216 -0.661 . . . . 75.44 109.216 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 m120 -164.77 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 114.468 -1.242 . . . . 75.02 109.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 27.7 Cg_exo -64.45 164.78 22.18 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.284 1.989 . . . . 72.34 111.561 173.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.14 -179.32 5.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.562 2.175 . . . . 75.41 113.065 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.523 ' HD1' ' ND2' ' A' ' 92' ' ' ASN . 4.7 m-90 -73.12 112.08 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.983 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.55 -115.45 1.49 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.974 -0.631 . . . . 64.03 112.12 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 -24.68 74.84 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.826 2.351 . . . . 62.4 112.074 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.44 -13.07 11.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.749 -0.66 . . . . 72.03 111.025 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 75.21 111.219 -179.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 120.82 0.343 . . . . 54.12 111.698 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 32.5 Cg_exo -55.89 143.37 82.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.505 2.137 . . . . 71.24 110.944 171.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.01 17.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.853 0.316 . . . . 51.35 111.853 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -62.73 -42.56 99.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.994 0.426 . . . . 70.04 110.845 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.59 -49.67 74.3 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.784 -0.644 . . . . 64.34 110.144 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 tp -54.44 -41.75 69.78 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.069 -0.969 . . . . 73.23 110.737 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 tp -53.39 -56.57 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 54.35 110.868 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.2 -51.97 52.53 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 116.086 -0.506 . . . . 64.02 111.242 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.47 -44.92 95.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.637 -0.711 . . . . 74.42 111.202 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' LEU . 3.3 p -71.49 -33.54 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.015 -0.365 . . . . 71.23 110.015 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.85 -51.57 68.51 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.992 0.425 . . . . 62.53 109.956 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.32 -39.33 68.29 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.096 -0.502 . . . . 62.53 111.373 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.23 79.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.158 0.504 . . . . 25.14 110.567 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.56 -13.31 58.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 73.43 111.069 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -97.71 -7.31 31.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.768 0.318 . . . . 74.03 110.639 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.55 -27.56 5.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.333 0.587 . . . . 64.44 110.506 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -84.08 -26.29 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.903 -1.044 . . . . 55.04 110.821 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.3 p -86.84 154.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.555 . . . . 75.45 109.881 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 12.4 t70 -86.29 102.3 2.69 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.861 -1.162 . . . . 74.22 107.861 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 5.9 Cg_endo -84.24 -10.05 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.857 2.371 . . . . 73.13 112.498 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.55 -56.54 7.96 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.028 0.442 . . . . 42.52 110.208 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 65.8 mt -93.98 -18.49 21.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 74.03 109.855 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.15 56.13 3.11 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.782 -0.644 . . . . 65.4 113.078 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.7 140.52 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.049 0.424 . . . . 74.53 111.085 179.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -102.11 138.33 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 72.14 109.545 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.69 -25.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.019 0.437 . . . . 73.02 111.292 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.77 -25.51 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.9 -0.591 . . . . 72.31 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.11 -21.94 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.771 -0.649 . . . . 73.42 111.679 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.43 -6.88 43.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.931 0.396 . . . . 74.23 110.89 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.81 22.82 54.95 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.633 -0.712 . . . . 43.14 114.15 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.89 -31.72 12.05 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.888 -0.412 . . . . 65.23 109.888 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.94 -13.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.62 -0.718 . . . . 75.23 110.246 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -56.73 -29.96 63.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.185 -0.916 . . . . 60.04 110.168 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.73 92.0 1.77 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.643 -0.708 . . . . 60.11 111.695 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.5 pt? -141.93 160.18 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.61 -0.347 . . . . 65.0 110.124 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.76 123.14 6.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 54.31 109.466 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.1 p -103.69 122.69 56.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.016 0.436 . . . . 74.24 110.171 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.554 ' NE2' HD11 ' A' ' 56' ' ' LEU . 40.7 mt-30 -97.69 120.36 37.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 71.03 109.727 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.36 83.45 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.732 0.777 . . . . 72.14 109.672 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.97 163.82 19.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 114.998 -1.001 . . . . 60.25 112.184 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -55.27 -40.03 70.52 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.181 0.515 . . . . 62.34 110.941 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -68.38 -30.54 69.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.653 -0.703 . . . . 63.34 110.664 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.31 154.99 7.79 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.966 -0.635 . . . . 63.13 112.41 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 10.8 m -85.78 102.33 13.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.936 0.398 . . . . 74.2 110.12 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 60.0 t -107.07 126.72 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.093 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -93.34 107.28 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 53.44 110.849 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.554 HD11 ' NE2' ' A' ' 47' ' ' GLN . 48.4 mt -82.12 131.89 35.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.469 -0.567 . . . . 73.01 109.469 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.1 mt -129.76 129.7 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.443 0.164 . . . . 71.13 110.623 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.09 114.56 26.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.693 -0.484 . . . . 61.31 109.693 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.54 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.9 mtp -141.03 170.76 15.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.622 0.725 . . . . 62.54 111.69 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 6.3 t -162.63 160.69 26.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.642 -1.163 . . . . 72.45 108.302 171.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -88.67 158.13 18.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.752 -0.462 . . . . 74.55 109.752 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -43.13 -52.92 5.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.968 0.507 . . . . 63.42 112.187 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -113.32 13.11 19.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 61.24 110.951 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.2 8.7 1.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.956 0.724 . . . . 64.24 112.956 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.36 11.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.45 . . . . 64.21 110.423 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.3 m -92.59 129.28 41.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 40.41 110.463 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.63 34.29 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.857 2.372 . . . . 40.34 112.061 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -83.15 -11.34 58.01 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 74.31 109.974 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.578 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 10.2 t -49.92 -56.03 12.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.895 -0.593 . . . . 65.22 111.348 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' THR . 5.6 m-20 -56.59 -34.94 67.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.484 . . . . 74.33 110.46 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 68' ' ' LEU . 47.2 t -70.93 -52.71 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 64.22 110.864 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.643 HD12 ' HH2' ' A' ' 93' ' ' TRP . 0.3 OUTLIER -60.31 -43.03 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.33 0.586 . . . . 65.34 109.47 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 69' ' ' THR . 23.5 mt-10 -61.72 -53.57 54.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.123 -0.944 . . . . 73.44 110.871 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.05 -51.42 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.653 0.263 . . . . 71.42 110.891 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -55.83 -58.73 6.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.084 -0.507 . . . . 72.24 111.141 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.4 t -65.06 -55.63 17.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 73.44 110.911 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 89' ' ' ILE . 47.8 ttt180 -55.63 -52.84 62.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.304 -0.407 . . . . 73.24 111.281 -174.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -64.51 -33.95 77.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.814 -0.63 . . . . 53.13 111.006 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.0 -51.31 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.83 -0.348 . . . . 73.41 110.364 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 76' ' ' SER . 4.4 mm? -56.21 -44.4 79.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.214 -0.448 . . . . 72.1 111.015 -177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.18 -28.25 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.422 -0.353 . . . . 74.24 110.538 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.74 -23.47 55.82 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.03 -0.605 . . . . 62.43 111.983 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -94.41 -11.69 29.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 75.3 110.178 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.38 75.89 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.873 -0.603 . . . . 75.31 113.347 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.01 -33.67 76.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.961 0.41 . . . . 70.12 109.949 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.11 175.75 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.581 -0.736 . . . . 61.32 109.556 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 53' ' ' THR . 22.7 t70 -78.23 -50.97 10.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 71.32 110.181 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 37.2 t70 -167.54 169.79 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.937 -0.764 . . . . 65.15 108.937 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 77' ' ' ARG . 18.0 pt -125.06 166.86 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.962 0.411 . . . . 60.24 110.914 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 56' ' ' LEU . 19.8 ttm180 -152.38 113.25 4.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.698 -0.683 . . . . 75.54 109.247 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG12 ' HB ' ' A' ' 57' ' ' ILE . 67.7 mt -100.68 124.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 74.24 110.496 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 2.2 p-10 -95.37 122.14 37.77 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.259 -0.645 . . . . 64.42 109.259 173.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.643 ' HH2' HD12 ' A' ' 72' ' ' ILE . 88.5 m95 -90.37 106.67 18.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.019 -0.537 . . . . 72.42 109.94 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 m -91.11 124.34 43.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.412 0.625 . . . . 75.42 111.395 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -112.15 -32.24 6.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 74.31 109.832 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.62 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 31.2 t30 -166.49 -51.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.362 -0.836 . . . . 73.43 110.53 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 43.5 Cg_endo -66.61 132.17 28.16 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.11 1.873 . . . . 63.14 112.005 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.73 81.66 2.5 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.566 2.177 . . . . 71.3 112.912 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.409 ' HD1' ' ND2' ' A' ' 92' ' ' ASN . 1.7 m-90 56.07 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.571 -0.74 . . . . 74.42 112.267 169.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.89 -113.14 0.76 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.214 -0.754 . . . . 73.21 111.214 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.77 -15.44 50.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.173 1.915 . . . . 64.13 110.599 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.39 -17.64 31.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.838 -1.074 . . . . 70.11 110.709 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 97.9 mttt . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 115.783 -0.644 . . . . 74.34 111.33 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.602 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.849 -0.426 . . . . 70.01 109.849 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . 81.8 Cg_exo -44.17 115.29 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.742 2.294 . . . . 73.12 112.137 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.41 -20.62 7.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.693 0.627 . . . . 40.22 112.693 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -71.13 -53.31 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 74.13 110.552 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 12.0 pt-20 -82.01 -30.88 31.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.988 -0.551 . . . . 64.15 110.702 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.3 tm? -54.49 -37.04 64.81 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.668 -0.696 . . . . 55.25 110.577 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.22 -53.41 57.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.063 0.459 . . . . 73.21 110.168 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.55 -52.03 62.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 65.13 110.699 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.14 -44.01 92.03 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.571 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.443 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.7 p -67.27 -37.75 79.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.744 -0.465 . . . . 62.21 109.744 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.47 -35.58 79.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.802 0.334 . . . . 75.41 110.406 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 9.6 mm-40 -66.34 -51.07 60.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.319 -0.4 . . . . 70.24 110.349 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.7 83.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.487 . . . . 65.13 110.599 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 22.3 mmt -58.78 -12.64 4.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.737 -0.665 . . . . 72.51 111.709 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 29' ' ' PRO . 4.0 tpm_? -76.23 -25.48 55.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.597 0.221 . . . . 72.14 111.597 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.65 -27.54 5.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.141 0.496 . . . . 70.1 109.917 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 26' ' ' VAL . 58.9 t -81.51 51.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.153 -0.931 . . . . 51.43 109.4 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.52 HG13 ' HD3' ' A' ' 29' ' ' PRO . 9.6 p -171.56 162.89 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.706 -0.679 . . . . 72.24 110.628 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 27' ' ' VAL . 13.0 t70 -109.43 91.28 9.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.422 -1.325 . . . . 61.42 107.422 164.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.52 ' HD3' HG13 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -80.42 -3.77 12.7 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.128 1.885 . . . . 73.25 111.772 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.1 -57.63 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 74.22 110.055 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.2 mm? -90.1 -16.75 29.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.725 -0.67 . . . . 73.55 109.894 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 40.55 6.62 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.867 -0.606 . . . . 45.23 113.5 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.52 140.27 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.107 0.479 . . . . 73.32 110.416 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.3 p-10 -116.63 115.04 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 74.35 110.274 -176.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -46.0 -32.45 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.465 0.542 . . . . 72.33 112.465 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.58 -24.81 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.223 0.453 . . . . 74.33 112.223 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.93 -15.33 62.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.468 0.175 . . . . 62.25 111.228 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.65 -17.16 62.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.205 0.526 . . . . 72.15 109.771 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.44 22.7 67.85 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.371 -0.831 . . . . 65.52 113.425 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 59' ' ' MET . 3.0 tm? -97.46 -31.46 12.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.918 -1.141 . . . . 74.43 107.918 171.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.07 -7.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.235 -0.893 . . . . 63.45 110.409 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.12 -24.83 56.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 61.41 109.65 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.13 67.74 1.42 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 111.14 -0.784 . . . . 35.43 111.14 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -125.64 121.45 33.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.246 -0.65 . . . . 61.5 109.246 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -141.74 113.15 7.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.333 -0.618 . . . . 71.45 109.333 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 11.2 m -102.86 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.26 -0.644 . . . . 73.21 109.26 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -121.07 120.17 34.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.771 0.32 . . . . 74.43 110.28 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' A' ' 53' ' ' THR . 9.1 p-10 -94.11 88.24 5.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 52.33 109.658 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.36 159.17 24.98 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.414 -0.812 . . . . 50.13 111.869 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.88 -23.39 66.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.74 0.305 . . . . 74.31 110.717 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.36 -38.48 21.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 61.53 110.252 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.1 157.76 23.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.066 -0.587 . . . . 55.54 112.26 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.543 HG22 HG12 ' A' ' 86' ' ' VAL . 12.4 m -101.0 119.1 38.26 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.97 -0.381 . . . . 64.24 109.97 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.93 143.23 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.468 -0.333 . . . . 71.42 110.652 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -108.38 119.08 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 43.05 110.209 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.97 121.27 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.509 -0.552 . . . . 72.33 109.509 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' A' ' 44' ' ' LEU . 57.5 mt -125.2 138.61 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.82 -0.437 . . . . 63.4 109.82 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 92' ' ' ASN . 42.7 m-20 -111.87 120.7 42.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.076 -0.342 . . . . 72.51 110.076 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.615 ' HA ' HD12 ' A' ' 40' ' ' LEU . 30.3 mtm -141.38 171.2 14.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.204 0.526 . . . . 75.41 111.538 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 12.1 t -154.45 147.26 24.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.249 -0.887 . . . . 74.54 109.957 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 85.0 mt -109.19 149.25 29.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.847 -0.797 . . . . 64.43 108.847 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -34.69 -49.84 0.43 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.755 1.02 . . . . 73.23 113.755 -170.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.7 t -119.57 0.2 10.96 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.293 -0.255 . . . . 73.34 111.207 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.32 8.4 1.59 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.29 0.478 . . . . 63.42 112.29 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.45 -5.33 18.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.304 0.573 . . . . 40.1 109.708 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.417 ' HB3' HD23 ' A' ' 68' ' ' LEU . 22.6 m -65.29 128.07 93.47 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.226 -0.897 . . . . 62.23 109.945 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.27 16.88 0.36 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.76 2.307 . . . . 71.41 113.129 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 66' ' ' CYS . 3.4 mm? -85.64 0.52 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 62.51 111.254 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 70' ' ' ASP . 11.6 t -58.24 -57.23 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.47 0.176 . . . . 71.33 110.614 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 69' ' ' THR . 11.3 t70 -68.18 -25.47 65.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.041 0.448 . . . . 70.03 110.171 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.22 -52.79 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.065 -0.516 . . . . 75.42 110.534 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.6 pp -69.37 -33.77 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 121.043 -0.263 . . . . 65.11 110.608 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.588 ' N ' HD12 ' A' ' 72' ' ' ILE . 43.9 mt-10 -64.56 -45.07 88.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.699 0.285 . . . . 75.14 110.259 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.21 -51.0 69.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.162 -0.472 . . . . 62.52 110.881 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -57.22 -52.8 63.87 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.014 -0.539 . . . . 72.1 110.391 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.8 t -56.49 -60.21 3.86 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.612 -0.722 . . . . 73.35 111.207 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -55.87 -42.42 75.87 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 121.257 -0.177 . . . . 74.13 111.007 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 t -62.16 -46.59 88.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.469 -0.332 . . . . 75.14 110.803 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.84 -51.43 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.878 -0.329 . . . . 74.2 110.237 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -56.51 -39.02 72.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 62.13 111.218 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.98 -27.47 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.471 -0.332 . . . . 63.04 110.302 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.78 -31.56 62.31 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.997 -0.841 . . . . 61.31 110.997 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 85' ' ' LEU . 66.7 m -76.94 -22.09 53.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.027 -0.587 . . . . 45.32 110.329 176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.58 74.0 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 116.088 -0.505 . . . . 73.45 113.064 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.7 mp -78.22 -50.76 11.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 72.11 110.503 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 55' ' ' ALA . 17.6 m -124.93 168.8 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 64.32 110.478 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -111.06 -39.69 4.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.328 0.585 . . . . 71.03 110.166 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.43 151.06 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.755 -0.657 . . . . 65.13 110.273 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 55' ' ' ALA . 20.8 pt -136.91 152.75 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.858 -0.423 . . . . 71.0 109.858 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -135.98 116.03 13.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 63.5 110.146 172.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 63.7 mt -98.13 110.99 26.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 61.54 109.504 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.642 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 3.2 t30 -88.34 120.09 29.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.558 -0.746 . . . . 71.12 109.447 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.563 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.6 m95 -86.83 106.75 17.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.764 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.89 124.54 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.002 0.429 . . . . 72.31 110.589 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -117.65 -34.33 4.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.414 0.626 . . . . 72.31 109.636 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.0 t30 -172.47 -47.17 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.041 . . . . 53.05 109.589 -176.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 29.8 Cg_endo -63.64 140.95 77.52 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.519 1.48 . . . . 62.1 109.548 167.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.99 -95.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.144 1.896 . . . . 74.01 112.712 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -146.34 124.74 12.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.783 -0.451 . . . . 61.41 109.783 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.45 -98.74 0.11 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.714 -0.755 . . . . 63.02 113.04 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.72 -37.98 64.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.973 2.448 . . . . 62.14 112.432 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 6.0 m-20 -67.11 -4.79 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 71.41 111.424 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 72.7 mmtt . . . . . 0 N--CA 1.465 0.304 0 CA-C-N 116.577 -0.283 . . . . 62.1 110.387 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 111.938 0.347 . . . . 40.33 111.938 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.44 149.32 80.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.705 2.27 . . . . 63.12 111.703 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.42 -49.68 24.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.353 0.871 . . . . 74.1 113.353 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.84 -49.52 75.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.621 0.248 . . . . 65.31 111.572 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -74.99 -46.46 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.47 -0.332 . . . . 74.54 110.881 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.4 tm? -54.75 -44.86 73.97 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.714 -0.676 . . . . 53.42 110.803 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 61.6 tp -53.52 -59.81 4.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 64.35 111.189 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.63 80.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.065 -0.516 . . . . 73.01 110.899 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.69 -48.05 82.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 62.23 110.594 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.458 HG22 ' HG2' ' A' ' 23' ' ' MET . 5.3 p -69.36 -34.06 60.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 110.058 -0.349 . . . . 63.02 110.058 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 16' ' ' LEU . 2.2 tm-20 -54.06 -49.27 69.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.264 -0.643 . . . . 54.45 109.264 177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.15 -50.88 43.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.1 -0.5 . . . . 75.05 110.834 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.25 67.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.049 -0.523 . . . . 62.11 111.897 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' HG12 ' A' ' 27' ' ' VAL . 13.3 mmt -58.67 -24.89 62.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 60.24 111.578 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -66.13 -16.96 64.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.607 0.241 . . . . 74.05 111.034 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -119.37 -23.37 6.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.145 0.498 . . . . 71.01 109.926 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 23' ' ' MET . 43.2 t -66.78 -40.05 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.295 -0.866 . . . . 72.13 110.623 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.595 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.7 p -89.88 153.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.479 -0.563 . . . . 71.22 109.479 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -92.25 97.65 1.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 108.753 -0.832 . . . . 71.34 108.753 170.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 86.1 Cg_endo -85.38 -7.55 8.85 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.547 2.164 . . . . 72.41 111.852 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.66 -57.75 5.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 74.54 110.452 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.31 -18.54 16.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.716 0.293 . . . . 61.32 110.317 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.84 54.23 1.81 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.96 -0.638 . . . . 73.44 112.591 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.3 mp -117.81 143.23 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.193 -0.669 . . . . 62.22 109.193 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -125.45 109.85 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.557 -0.292 . . . . 65.14 110.603 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.9 m -54.63 -41.96 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.84 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' VAL . 68.9 t -56.96 -32.18 38.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.126 0.489 . . . . 52.23 110.748 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.8 -14.82 62.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.696 -0.684 . . . . 73.31 111.005 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 35' ' ' VAL . 4.4 mm? -63.61 -17.69 63.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.153 0.501 . . . . 75.3 110.093 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 72.1 22.86 78.67 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.423 -0.808 . . . . 74.22 114.363 172.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 40' ' ' LEU . 5.0 mt -98.25 -27.06 14.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.483 0.641 . . . . 63.12 110.421 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 59' ' ' MET . 35.8 t -63.57 -11.91 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.693 -0.685 . . . . 75.54 111.908 -169.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 98.7 m-85 -62.09 -17.68 58.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.187 0.518 . . . . 73.2 109.98 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.38 63.57 3.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.811 -0.915 . . . . 61.03 110.811 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.7 tt -125.62 128.94 48.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.212 -0.662 . . . . 74.54 109.212 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 44' ' ' LEU . 7.3 m-20 -149.16 173.47 13.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.483 -0.932 . . . . 43.44 108.483 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 55' ' ' ALA . 23.8 m -136.48 132.52 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 44.31 109.37 173.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.26 145.83 47.45 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.714 -0.476 . . . . 71.54 109.714 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.0 p-10 -100.62 129.31 46.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.313 0.578 . . . . 74.41 111.098 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.32 164.32 29.42 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.623 -1.791 . . . . 43.42 108.623 163.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.36 -19.62 66.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.164 0.982 . . . . 65.32 109.902 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 2.6 mp0 -77.64 -39.05 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.456 -0.793 . . . . 74.3 109.938 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.7 170.36 35.61 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.526 -0.761 . . . . 64.23 111.807 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 30.3 m -85.74 129.05 34.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.731 0.301 . . . . 70.3 111.299 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.54 140.68 39.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.993 -0.549 . . . . 72.51 110.23 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -85.22 154.56 21.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.15 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -128.72 122.74 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.281 0.632 . . . . 71.43 109.332 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 91' ' ' ILE . 54.3 mt -130.47 116.6 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.428 0.156 . . . . 72.15 111.124 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.37 118.8 24.46 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.261 -0.644 . . . . 70.1 109.261 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 41' ' ' VAL . 43.6 mmm -139.8 170.44 15.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.248 0.547 . . . . 71.02 111.941 -174.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -153.59 178.92 9.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.226 -0.897 . . . . 62.33 109.405 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 61.8 mt -120.48 156.35 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.012 -0.366 . . . . 40.4 110.012 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.9 p -47.46 -60.11 2.76 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.032 0.533 . . . . 75.01 112.343 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.9 t -104.23 2.17 31.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.843 0.354 . . . . 72.23 110.234 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.87 8.0 1.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.568 0.747 . . . . 72.44 112.154 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.36 -7.67 9.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 71.02 110.239 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.546 ' O ' HD13 ' A' ' 61' ' ' LEU . 11.8 m -76.84 145.09 73.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.506 -0.77 . . . . 52.11 110.41 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.69 27.89 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.579 2.186 . . . . 62.42 112.328 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 61' ' ' LEU . 91.8 mt -77.35 -6.52 53.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.747 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.9 t -58.2 -35.68 71.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.724 -0.473 . . . . 71.24 109.724 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.6 -50.01 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 64.41 111.217 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 14.2 p -68.66 -39.55 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.755 -0.202 . . . . 61.43 111.343 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 69' ' ' THR . 34.8 pt -66.81 -40.46 85.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 120.418 -0.513 . . . . 63.22 110.34 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.88 -46.93 88.67 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 116.41 -0.359 . . . . 65.44 110.186 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.76 -51.89 67.72 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.969 -0.56 . . . . 70.43 110.827 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 4.0 pt20 -64.86 -45.05 87.71 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.955 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.462 ' O ' HD23 ' A' ' 80' ' ' LEU . 77.4 p -66.74 -55.6 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.709 -0.223 . . . . 63.13 110.847 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.704 ' HD2' HG12 ' A' ' 89' ' ' ILE . 19.7 mmm180 -55.22 -53.07 60.61 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.731 0.3 . . . . 72.42 110.466 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 t -60.44 -43.49 96.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.575 -0.739 . . . . 73.44 111.49 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.91 -51.22 16.83 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 121.02 -0.272 . . . . 63.33 110.931 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -57.8 -37.98 74.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.156 -175.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 77' ' ' ARG . 20.6 m -78.0 -28.04 15.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.678 -0.409 . . . . 74.22 110.786 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.26 -42.63 97.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 61.33 112.087 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 p -94.27 1.4 55.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.93 0.395 . . . . 73.11 110.852 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.76 35.42 89.85 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.829 -0.623 . . . . 61.43 112.588 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.33 -36.94 80.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.353 0.597 . . . . 64.43 109.416 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.4 m -145.31 153.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.074 -0.966 . . . . 43.4 109.059 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.6 -44.46 70.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.267 0.556 . . . . 70.11 110.263 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.64 156.73 45.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 73.23 109.276 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.704 HG12 ' HD2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -125.97 144.04 37.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.716 -0.476 . . . . 72.32 109.716 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -123.7 106.75 10.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.373 0.606 . . . . 64.22 109.981 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 57' ' ' ILE . 59.6 mt -95.58 128.02 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 71.13 109.545 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -102.27 111.29 23.51 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.061 -0.718 . . . . 73.13 109.061 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -86.78 106.29 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 70.14 109.692 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.66 123.75 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.647 -0.501 . . . . 62.54 109.647 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -121.18 -27.16 4.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.224 -0.443 . . . . 74.13 109.89 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 24.4 m-20 -179.57 -48.82 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.229 -0.896 . . . . 61.34 110.599 -169.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 17.8 Cg_exo -68.35 152.21 75.7 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.206 1.938 . . . . 70.24 112.45 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 16.4 Cg_exo -68.73 145.66 63.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.717 2.278 . . . . 74.22 110.963 172.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -48.94 109.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.657 0.598 . . . . 71.35 111.378 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.63 -87.85 0.07 OUTLIER Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.266 -0.492 . . . . 75.53 112.276 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.45 -28.68 62.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.536 2.157 . . . . 43.31 111.266 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 2.7 p-10 -66.98 -5.75 14.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.858 -1.065 . . . . 74.25 111.648 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HG2' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mttt . . . . . 0 C--O 1.234 0.262 0 CA-C-O 120.516 0.198 . . . . 75.4 111.01 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 120.823 0.344 . . . . 55.52 111.692 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.52 159.41 36.45 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.572 2.181 . . . . 55.23 112.549 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.0 -51.57 65.82 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.781 1.03 . . . . 72.03 113.781 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.62 -52.45 64.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.674 0.273 . . . . 71.14 111.534 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.43 -41.29 63.44 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.243 -0.435 . . . . 64.43 110.95 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.68 -43.12 72.16 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 110.257 -0.275 . . . . 74.45 110.257 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.7 tp -57.42 -56.32 23.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.279 -0.419 . . . . 73.04 110.906 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.03 65.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.877 -0.601 . . . . 72.12 111.018 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -60.9 -42.72 98.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.986 -0.552 . . . . 63.24 111.465 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -69.87 -40.91 79.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.711 -0.396 . . . . 74.53 110.4 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.91 -46.01 92.37 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.527 -0.546 . . . . 75.32 109.527 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 53.8 mt-10 -61.72 -50.6 71.79 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.888 -0.596 . . . . 71.14 110.831 177.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -44.92 76.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.088 0.471 . . . . 64.02 110.333 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.1 mmt -57.88 -28.36 64.11 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.452 -0.795 . . . . 73.31 110.507 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.39 -24.99 59.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.537 -0.301 . . . . 74.42 110.88 -178.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.76 -20.95 15.34 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.923 0.342 . . . . 74.42 111.923 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 23' ' ' MET . 26.4 m -87.71 -17.47 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.975 0.417 . . . . 72.14 110.455 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.7 p -89.15 168.83 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.969 -0.559 . . . . 73.34 109.65 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.9 92.39 6.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.115 -0.698 . . . . 53.33 109.115 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.1 -4.77 10.42 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.465 2.11 . . . . 60.51 111.93 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.85 -57.71 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 53.11 110.632 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.98 -18.59 16.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.977 0.418 . . . . 71.12 110.285 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.5 49.21 2.41 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.138 -0.553 . . . . 64.12 113.13 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -111.56 140.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.131 -0.692 . . . . 72.34 109.131 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.3 p30 -122.82 113.13 18.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.427 0.632 . . . . 53.14 110.59 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.81 -28.51 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.642 -0.708 . . . . 72.24 110.811 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG12 HG21 ' A' ' 41' ' ' VAL . 34.7 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.041 -0.527 . . . . 64.02 111.166 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 36.6 t70 -58.88 -26.01 63.86 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.894 0.378 . . . . 72.22 111.131 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.94 -15.04 63.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.238 -0.437 . . . . 44.43 110.301 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.0 61.83 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.661 -0.7 . . . . 61.15 113.542 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.72 -16.29 22.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.999 0.428 . . . . 60.52 110.192 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 HG12 ' A' ' 36' ' ' VAL . 47.7 t -59.66 -15.88 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.881 -0.599 . . . . 75.33 110.618 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.56 -24.11 44.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.722 -0.672 . . . . 63.12 110.628 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.78 67.29 1.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.997 -0.547 . . . . 71.02 112.303 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.3 tp -110.98 130.72 55.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.639 -0.504 . . . . 71.02 109.639 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -157.91 109.12 2.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.527 -0.546 . . . . 71.22 109.527 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 118.74 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.704 -0.225 . . . . 62.13 110.505 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.66 120.65 38.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.078 -0.712 . . . . 70.2 109.078 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.68 140.99 37.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 74.12 110.198 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.15 167.34 35.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.713 -0.755 . . . . 61.32 112.079 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.95 -18.84 65.6 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.981 0.419 . . . . 75.1 110.657 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.22 -11.69 61.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.44 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.48 116.56 2.0 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.417 -0.673 . . . . 72.53 111.417 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.8 m -70.94 102.48 2.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.702 -0.481 . . . . 43.3 109.702 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 5.5 p -113.52 125.02 70.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.796 . . . . 54.23 111.834 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.99 114.21 26.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.664 . . . . 53.11 110.095 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -85.67 119.13 25.67 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.103 -0.332 . . . . 75.34 110.103 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 59' ' ' MET . 27.3 mm -116.73 127.98 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.742 -0.663 . . . . 65.4 109.45 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -107.47 116.48 32.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.477 -0.564 . . . . 54.23 109.477 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.519 ' HG3' HG22 ' A' ' 57' ' ' ILE . 42.5 mtm -140.87 170.56 15.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.748 0.785 . . . . 71.21 112.187 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -155.9 140.97 17.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.565 -1.198 . . . . 73.43 109.277 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 72' ' ' ILE . 3.7 mm? -85.4 167.43 15.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.589 -0.523 . . . . 73.12 109.589 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -50.1 -49.55 51.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.083 0.24 . . . . 73.31 111.431 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 m -102.27 -11.69 18.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.142 0.496 . . . . 71.35 110.34 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB1' ' HD1' ' A' ' 95' ' ' TRP . . . 62.58 8.21 2.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.347 -0.842 . . . . 75.01 112.467 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.04 -16.13 8.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.919 0.39 . . . . 51.53 110.958 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 p -66.15 144.99 98.97 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.967 -0.56 . . . . 65.31 111.327 -176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 8.3 Cg_exo -73.74 38.96 0.47 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.625 2.883 . . . . 74.54 113.852 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.8 mm? -92.98 -12.05 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.174 -0.306 . . . . 64.24 110.174 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.6 t -49.77 -57.71 6.79 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.682 -0.69 . . . . 62.11 111.733 -177.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 69' ' ' THR . 7.8 p-10 -66.15 -32.95 74.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.598 -0.274 . . . . 74.32 110.726 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.588 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 59.6 t -64.17 -53.43 43.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 53.4 110.68 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 68' ' ' LEU . 5.4 pt -71.93 -27.11 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 111.762 0.282 . . . . 64.24 111.762 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 91' ' ' ILE . 43.4 mt-10 -66.19 -45.64 80.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.946 0.403 . . . . 70.53 110.695 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.51 -49.53 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.734 . . . . 64.14 110.335 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 79.9 mm-40 -58.16 -45.61 87.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 72.21 110.491 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 80' ' ' LEU . 41.0 t -58.15 -63.69 1.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 62.35 110.541 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' O ' HG12 ' A' ' 81' ' ' VAL . 75.7 ttt180 -54.85 -47.83 73.68 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.885 -0.326 . . . . 53.5 110.812 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -55.54 -45.23 77.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.127 -0.488 . . . . 74.1 111.277 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.49 -51.07 18.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 74.31 110.816 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 85' ' ' LEU . 10.8 mp -58.75 -32.65 69.45 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.335 -0.393 . . . . 71.32 111.065 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 77' ' ' ARG . 8.6 p -84.2 -27.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 63.31 110.084 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.08 71.02 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.087 -0.578 . . . . 55.5 111.989 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.1 t -97.53 1.67 49.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.194 0.521 . . . . 53.41 110.064 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.39 23.06 78.49 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.895 -0.593 . . . . 23.24 112.913 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 80' ' ' LEU . 43.9 mt -66.81 -57.81 6.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.58 0.705 . . . . 74.41 109.186 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.02 -173.77 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.803 -1.09 . . . . 75.25 108.953 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -119.72 -39.01 2.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.161 -0.681 . . . . 71.51 109.161 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.8 m-20 -112.64 151.68 29.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 63.4 109.916 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 pt -140.17 170.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.532 -0.544 . . . . 62.04 109.532 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -148.57 106.7 3.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.101 -0.5 . . . . 74.14 109.665 172.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 73' ' ' GLU . 53.6 mt -93.55 121.35 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 74.41 109.81 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.441 ' CB ' ' HE2' ' A' ' 103' ' ' LYS . 7.9 t30 -100.23 133.09 45.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.89 -0.596 . . . . 72.2 109.804 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -97.9 106.7 19.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.47 . . . . 75.51 110.423 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.28 124.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.424 -0.584 . . . . 63.44 109.424 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.444 ' HD1' ' HB1' ' A' ' 64' ' ' ALA . 4.3 m-90 -102.35 -34.99 8.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.422 -0.584 . . . . 74.32 109.422 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 23.1 t-20 168.67 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.419 -1.264 . . . . 74.5 109.243 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 49.5 Cg_exo -60.14 161.1 20.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.545 2.164 . . . . 64.35 112.324 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.59 -177.54 2.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.123 2.548 . . . . 71.25 112.986 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -89.21 -163.1 0.94 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.389 -0.823 . . . . 74.32 110.515 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.73 -173.88 45.99 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.079 -0.581 . . . . 73.45 112.485 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.74 -5.7 7.8 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.217 2.611 . . . . 50.44 112.512 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 31.7 t70 -57.53 -19.9 28.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 44.44 110.631 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 90.8 mttt . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.228 -0.442 . . . . 63.3 111.512 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.809 -0.441 . . . . 73.21 109.809 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.53 146.38 95.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.51 2.14 . . . . 62.23 111.906 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.88 -44.37 49.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.345 0.869 . . . . 71.13 113.345 -169.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 14.5 mp0 -63.2 -52.41 62.39 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.899 0.381 . . . . 72.1 110.845 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -72.11 -43.8 64.17 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.295 0.569 . . . . 74.25 110.449 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.74 -39.86 82.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.294 -0.866 . . . . 51.03 110.249 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.59 -53.21 57.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.905 0.383 . . . . 73.25 110.472 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.62 -51.93 66.48 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.785 -0.643 . . . . 61.13 110.996 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.2 -48.44 80.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.904 -0.589 . . . . 54.05 111.02 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 5.4 p -65.96 -34.48 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.945 -0.391 . . . . 63.31 109.945 -177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.91 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.696 -0.483 . . . . 71.21 109.696 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 28.5 mm-40 -65.92 -46.39 78.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.64 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.05 86.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 40.44 110.827 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.38 -12.62 14.9 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.042 -0.527 . . . . 71.22 111.564 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 76.9 ttt180 -87.31 -20.86 26.2 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.158 0.583 . . . . 72.23 111.459 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.27 -27.22 5.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.243 0.544 . . . . 74.21 110.84 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -74.74 -16.69 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.197 -0.911 . . . . 61.51 110.163 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.557 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p -94.2 155.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 74.12 110.445 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.15 89.74 0.62 Allowed Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 107.072 -1.455 . . . . 71.05 107.072 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 55.6 Cg_endo -81.27 -6.95 12.96 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.084 1.856 . . . . 63.13 111.712 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.82 -57.57 5.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.434 -0.803 . . . . 74.44 109.894 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 7.0 mp -92.29 -18.77 22.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.137 -0.483 . . . . 62.43 110.178 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.83 52.75 3.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.782 -0.644 . . . . 60.41 113.846 171.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.29 140.09 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 117.263 0.531 . . . . 74.23 109.939 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 24.2 m-80 -103.1 130.6 50.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.807 -0.442 . . . . 73.21 109.807 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.5 t -56.72 -33.11 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.545 0.688 . . . . 62.53 109.866 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.94 -30.61 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.245 -0.889 . . . . 70.14 111.005 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 2.0 m-20 -63.08 -23.58 67.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.57 -0.286 . . . . 73.34 111.581 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 -16.37 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.094 0.473 . . . . 74.13 110.276 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.03 22.82 60.87 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.618 -0.719 . . . . 71.2 112.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.5 tp -90.53 -24.76 20.53 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.476 -0.565 . . . . 74.45 109.476 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.59 -8.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.534 -0.757 . . . . 72.31 110.32 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -71.16 -16.13 62.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.881 -0.599 . . . . 74.23 109.692 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 52.12 3.51 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.834 -0.906 . . . . 63.32 110.834 172.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.569 HD13 HG12 ' A' ' 57' ' ' ILE . 61.6 tp -102.1 121.06 41.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.027 0.441 . . . . 73.42 109.974 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.42 108.58 10.95 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.144 -1.058 . . . . 51.1 108.144 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 10.8 m -99.43 128.0 51.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.476 -0.565 . . . . 75.33 109.476 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -120.54 145.55 47.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 74.1 110.844 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.47 163.34 19.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.498 -0.773 . . . . 73.3 110.309 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.9 155.71 26.68 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.866 -0.894 . . . . 63.2 110.866 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.66 -20.27 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.484 . . . . 72.35 110.48 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -89.48 -27.92 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.746 -0.661 . . . . 64.11 110.575 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.89 176.42 32.99 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.395 -0.682 . . . . 54.03 111.395 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.1 m -99.29 129.91 45.54 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.792 0.33 . . . . 62.04 110.483 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 137.09 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.145 -0.48 . . . . 74.24 110.814 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.71 120.5 39.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.081 -0.509 . . . . 62.31 110.285 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 103' ' ' LYS . 20.7 mt -96.65 114.02 25.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.564 -0.532 . . . . 64.12 109.564 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 44' ' ' LEU . 51.1 mt -111.42 118.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.544 0.211 . . . . 75.31 110.822 -176.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -82.86 120.86 26.19 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.282 -0.266 . . . . 64.01 110.282 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.5 mtp -139.23 163.5 32.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.363 0.602 . . . . 72.1 111.339 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 94' ' ' VAL . 73.7 m -136.62 137.73 40.43 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.839 -0.618 . . . . 73.11 109.595 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 69' ' ' THR . 87.4 mt -89.23 146.92 24.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.656 -0.498 . . . . 74.33 109.656 177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -36.1 -57.26 0.71 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.839 0.856 . . . . 71.32 113.027 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -121.29 12.6 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 72.41 110.622 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 8.56 1.19 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.718 -0.674 . . . . 62.42 112.567 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.83 13.07 12.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 73.31 110.547 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 44.5 t -95.9 139.82 22.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 71.5 110.507 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.37 17.45 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.922 2.415 . . . . 73.1 112.376 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HB2' ' SG ' ' A' ' 66' ' ' CYS . 48.5 tp -69.09 -13.83 62.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.956 -0.565 . . . . 72.2 110.499 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.499 HG23 ' N ' ' A' ' 70' ' ' ASP . 12.7 t -49.72 -56.8 8.88 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.591 -0.731 . . . . 74.43 111.903 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 69' ' ' THR . 22.7 t70 -63.67 -37.24 86.61 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.889 0.376 . . . . 64.11 110.356 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 60.9 t -62.28 -52.76 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 63.33 110.753 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.54 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.8 pp -68.47 -34.94 68.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.791 -0.186 . . . . 74.32 111.258 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 72' ' ' ILE . 41.2 mt-10 -62.47 -46.58 87.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.697 0.284 . . . . 71.55 110.462 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' SER . 23.4 t70 -63.27 -47.53 81.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 61.22 110.917 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 26.4 mm-40 -57.46 -55.64 32.2 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 74.43 110.444 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' HD23 ' A' ' 80' ' ' LEU . 36.6 t -59.44 -54.61 44.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.819 -0.628 . . . . 72.01 110.587 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 77' ' ' ARG . 1.4 tmt_? -54.79 -42.79 72.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.448 -0.342 . . . . 72.5 110.555 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 7.1 t -56.28 -52.89 62.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 51.23 110.88 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.49 -51.89 13.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.87 -0.332 . . . . 55.42 111.446 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 76' ' ' SER . 4.3 mm? -60.68 -33.92 73.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.272 0.558 . . . . 72.14 111.186 -173.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -85.85 -27.2 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.785 -0.643 . . . . 64.41 109.911 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.72 79.05 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.292 -0.48 . . . . 71.02 112.149 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -79.25 -23.04 43.94 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.649 -0.5 . . . . 64.41 109.649 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 48.58 3.56 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.578 -0.737 . . . . 53.51 113.25 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.0 mt -80.47 -35.3 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.989 -0.745 . . . . 60.1 108.989 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.7 m -143.84 160.35 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.109 -0.95 . . . . 73.14 109.336 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.69 -30.92 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 63.11 110.675 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -152.5 166.07 33.14 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.02 -0.536 . . . . 73.32 110.238 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 55' ' ' ALA . 35.7 pt -136.95 154.46 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.132 0.492 . . . . 72.11 110.86 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HB3' ' CD2' ' A' ' 56' ' ' LEU . 8.6 tpt85 -133.24 110.42 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.74 -0.664 . . . . 72.04 109.215 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 58.6 mt -91.61 123.17 43.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.224 -0.443 . . . . 72.14 110.224 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.47 HD22 ' C ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -88.2 118.21 27.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.42 -0.956 . . . . 72.52 108.42 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.447 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.8 m-90 -89.69 114.0 25.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.242 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HB ' ' OG1' ' A' ' 60' ' ' THR . 7.4 t -86.07 124.02 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.863 -0.421 . . . . 73.03 109.863 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -112.08 -32.16 6.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 75.53 109.408 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.451 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 1.6 m120 -179.57 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 114.354 -1.294 . . . . 71.14 109.379 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 23.6 Cg_exo -65.96 154.15 75.17 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.222 1.948 . . . . 52.32 111.664 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.18 -176.64 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 52.43 112.061 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m-90 -79.64 145.59 32.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 72.31 110.276 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.29 -110.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.923 -0.656 . . . . 71.1 112.226 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.57 -33.76 86.44 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.563 2.175 . . . . 64.12 112.163 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.63 -4.11 14.3 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.895 -0.593 . . . . 73.33 110.719 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 56' ' ' LEU . 30.2 mtpp . . . . . 0 CA--C 1.535 0.377 0 O-C-N 121.86 -0.525 . . . . 65.1 110.277 172.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.823 0.305 . . . . 53.11 111.823 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 80.9 Cg_exo -47.86 153.59 2.44 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.978 2.452 . . . . 64.55 112.194 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.5 -29.87 51.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 61.31 112.072 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 7.9 mp0 -63.63 -45.4 90.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.173 0.511 . . . . 52.23 109.932 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.73 -47.35 39.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.408 -0.815 . . . . 74.21 109.402 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.45 -45.49 73.1 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 114.819 -1.082 . . . . 74.2 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.99 -59.72 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.977 0.418 . . . . 62.43 111.163 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.86 66.41 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.118 -0.492 . . . . 62.5 111.129 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.16 -32.58 72.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.6 -0.727 . . . . 71.3 111.915 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -72.39 -38.17 60.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 109.396 -0.594 . . . . 61.0 109.396 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -58.88 -41.62 87.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.512 -0.313 . . . . 65.53 110.731 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -69.67 -51.66 32.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.036 0.446 . . . . 74.44 110.683 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.24 -34.64 75.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.839 -0.618 . . . . 61.42 111.391 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.4 mmt -61.25 -13.29 17.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.236 -0.438 . . . . 74.23 112.114 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -90.77 -17.46 26.63 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.748 0.249 . . . . 72.15 111.493 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.52 -25.81 5.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.503 0.668 . . . . 74.45 110.466 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.85 -23.13 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.092 -0.958 . . . . 60.21 109.878 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 9.9 p -89.0 159.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.071 174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 94.61 4.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.527 -0.916 . . . . 73.23 108.527 168.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 72.8 Cg_endo -81.54 -3.84 12.08 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.257 1.971 . . . . 63.35 111.989 -176.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.72 -57.55 5.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.14 0.495 . . . . 74.34 109.862 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.5 mt -92.79 -18.75 22.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.708 -0.678 . . . . 62.3 109.864 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.34 51.46 3.7 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.955 -0.566 . . . . 25.2 113.49 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.68 143.85 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.026 0.413 . . . . 65.32 110.432 177.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.411 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.2 p30 -108.79 134.82 50.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 75.01 110.637 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.42 -25.69 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.012 0.434 . . . . 74.42 111.121 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.81 -24.96 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.927 -0.579 . . . . 62.12 110.348 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.75 -33.61 68.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 73.3 110.642 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 38' ' ' LEU . 3.5 mm? -71.91 -16.7 62.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 74.43 110.297 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.98 21.1 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.48 -0.782 . . . . 62.14 113.782 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.5 mt -88.58 -19.2 26.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.892 0.346 . . . . 72.11 110.157 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.6 -9.59 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.853 -0.612 . . . . 55.32 110.512 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.89 -31.23 62.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.546 -0.752 . . . . 71.01 109.678 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 75.76 1.48 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.539 -0.755 . . . . 72.32 111.585 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.535 HD13 HG12 ' A' ' 57' ' ' ILE . 50.8 tp -119.94 126.33 50.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.768 0.427 . . . . 75.22 109.951 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -150.92 115.38 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.498 -0.556 . . . . 73.43 109.498 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -94.8 136.25 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.848 0.356 . . . . 54.52 110.176 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -130.63 150.21 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.626 -0.509 . . . . 72.2 109.626 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 33.2 t70 -92.01 117.39 29.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.446 -0.343 . . . . 72.25 110.891 -176.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.45 174.16 24.62 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.406 -0.426 . . . . 63.22 112.087 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.04 -32.16 69.49 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.917 0.389 . . . . 72.23 111.46 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.39 -14.29 22.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.148 -0.478 . . . . 61.03 111.513 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.18 172.23 22.63 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.094 -0.574 . . . . 24.45 111.992 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.0 m -78.88 115.46 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.712 0.256 . . . . 51.24 110.782 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 33.3 m -103.94 144.97 13.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.46 -0.337 . . . . 75.1 110.648 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.59 112.85 24.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 70.23 110.599 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 44.1 mt -79.5 115.62 19.23 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.126 -0.694 . . . . 73.42 109.126 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.535 HG12 HD13 ' A' ' 44' ' ' LEU . 49.5 mt -120.51 125.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.091 -0.337 . . . . 74.4 110.091 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD2' HG23 ' A' ' 94' ' ' VAL . 24.8 t0 -96.12 130.83 43.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 74.53 110.772 176.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.4 mtp -141.64 170.96 14.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.292 0.568 . . . . 54.31 111.268 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -154.43 153.46 31.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.735 . . . . 72.41 109.86 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 mp -110.72 170.8 7.85 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.971 -0.381 . . . . 63.44 109.971 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 p -57.12 -60.22 3.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.21 -0.45 . . . . 60.35 111.824 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.429 ' HG ' ' HG ' ' A' ' 66' ' ' CYS . 86.2 p -91.88 -24.34 19.36 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.362 -0.381 . . . . 75.23 110.315 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.4 8.93 4.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.427 -0.806 . . . . 53.4 110.826 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.63 -25.93 8.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.589 . . . . 70.44 110.53 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.429 ' HG ' ' HG ' ' A' ' 63' ' ' SER . 64.3 m -59.43 135.57 88.82 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.007 -0.542 . . . . 65.02 110.628 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.29 25.7 0.31 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.892 2.395 . . . . 75.44 113.038 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 72' ' ' ILE . 89.8 mt -78.19 -6.26 54.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.988 -0.375 . . . . 65.51 109.988 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.3 t -49.37 -44.31 44.8 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.548 -0.751 . . . . 74.31 109.946 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.48 -51.57 68.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.67 -0.695 . . . . 71.44 110.693 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 49.2 t -62.78 -53.04 51.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.533 -0.758 . . . . 61.33 111.46 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 68' ' ' LEU . 6.7 pt -71.01 -35.96 61.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.759 -0.376 . . . . 74.3 111.713 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.51 -54.27 46.06 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.892 0.853 . . . . 72.35 108.76 173.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.89 -51.29 70.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.864 -1.516 . . . . 62.44 111.231 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 21.2 mm-40 -59.36 -49.08 79.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.657 0.265 . . . . 72.14 110.564 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 45.7 m -59.29 -60.56 3.66 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.016 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.476 ' HB3' HG12 ' A' ' 89' ' ' ILE . 14.4 ptm180 -62.11 -36.68 82.47 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.047 -0.261 . . . . 71.25 111.208 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 t -60.07 -40.94 91.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.252 -0.431 . . . . 72.45 110.672 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -51.18 16.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.73 0.3 . . . . 65.02 110.749 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -55.26 -38.12 68.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.108 -0.496 . . . . 70.12 111.148 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.24 -27.77 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.594 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.71 -34.04 69.34 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.32 -0.467 . . . . 74.11 112.094 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 29.9 m -107.67 6.79 28.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.797 0.332 . . . . 64.25 111.15 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.71 69.51 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.125 -0.559 . . . . 72.24 112.07 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 78.2 mt -60.68 -43.12 98.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.672 0.749 . . . . 70.31 108.99 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 19.2 m -143.9 159.15 16.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.361 -1.29 . . . . 71.24 108.114 170.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.42 -43.19 86.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.309 0.576 . . . . 73.1 110.081 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 27.2 t70 -161.55 168.63 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.248 -0.887 . . . . 72.13 108.753 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 77' ' ' ARG . 32.6 pt -122.68 148.05 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.815 0.341 . . . . 71.45 110.118 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 90' ' ' ARG . 2.8 tpp180 -119.44 106.38 12.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.473 -0.936 . . . . 71.31 108.473 176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.3 mt -93.78 145.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.78 0.324 . . . . 71.25 110.853 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -118.71 139.67 51.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.877 -0.786 . . . . 71.2 108.877 172.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.531 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 49.1 m95 -106.43 106.79 17.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.748 -0.464 . . . . 71.31 109.748 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.521 HG23 ' OD2' ' A' ' 58' ' ' ASP . 39.5 t -87.3 123.84 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.945 -0.702 . . . . 73.22 109.882 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 7.3 p-90 -140.88 -0.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.071 -0.513 . . . . 70.0 111.105 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.586 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t-20 167.88 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 116.071 -0.513 . . . . 53.44 110.435 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 94.5 Cg_endo -80.72 156.69 21.2 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.947 1.765 . . . . 54.52 111.855 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.08 170.09 17.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.208 1.939 . . . . 34.44 111.653 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -61.11 101.69 0.17 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.057 -0.52 . . . . 73.11 110.412 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.85 -83.75 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.075 -0.512 . . . . 63.42 112.451 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.52 -51.96 3.65 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.725 2.284 . . . . 64.25 112.244 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 93' ' ' TRP . 6.1 m-20 -64.01 -4.01 3.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 64.44 112.466 -176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.598 0.237 . . . . 74.12 110.508 176.733 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.325 0 N-CA-C 110.664 -0.124 . . . . 63.11 110.664 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.33 176.77 3.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.847 2.364 . . . . 74.2 112.05 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.08 -64.45 0.81 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.039 0.755 . . . . 74.23 113.039 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -64.43 -46.77 81.73 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.026 0.441 . . . . 74.34 110.937 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.34 -46.67 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.344 -0.844 . . . . 75.53 110.761 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.9 -49.12 77.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.774 -0.648 . . . . 75.13 110.16 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.33 -59.89 3.99 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 52.13 111.449 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -45.06 80.51 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.098 -0.501 . . . . 75.42 111.25 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.26 -41.24 73.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 73.1 110.812 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.11 -32.82 55.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 109.54 -0.541 . . . . 73.31 109.54 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.19 -48.79 75.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.211 -0.663 . . . . 75.35 109.211 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -61.58 -50.57 72.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.798 -0.637 . . . . 45.42 111.267 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.04 75.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.153 0.501 . . . . 60.04 111.188 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.28 -13.52 62.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.812 -0.631 . . . . 61.43 110.651 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -96.85 -8.01 32.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.635 . . . . 70.14 110.405 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.61 -27.13 5.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.499 0.666 . . . . 52.23 110.127 -173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -90.98 -33.04 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.152 -0.931 . . . . 74.01 111.257 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 33' ' ' ILE . 1.2 p -74.7 174.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.12 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.55 96.22 8.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 109.722 -0.473 . . . . 53.03 109.722 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 67.8 Cg_endo -89.13 3.16 5.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.627 2.218 . . . . 74.12 111.775 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.81 -57.93 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 74.23 110.461 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.58 -11.29 14.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.897 -0.592 . . . . 61.42 110.444 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 51.48 2.58 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.952 -0.567 . . . . 30.3 112.905 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 27' ' ' VAL . 3.2 mp -106.69 140.09 26.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.531 -0.544 . . . . 63.42 109.531 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 67.4 m-20 -116.62 109.03 16.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.509 -0.769 . . . . 51.14 109.59 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.23 -39.09 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.051 0.453 . . . . 75.22 111.257 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.1 -24.85 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.025 -0.534 . . . . 64.41 111.323 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.57 -24.75 67.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 71.13 110.988 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.16 -10.74 59.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.266 0.555 . . . . 72.24 110.509 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 22.52 66.09 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.358 -0.837 . . . . 75.41 114.321 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.4 tp -98.46 -30.08 12.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.06 0.457 . . . . 65.04 110.372 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.53 -14.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.587 -0.733 . . . . 74.1 111.826 -172.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -62.04 -23.4 66.44 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 71.12 109.888 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.89 70.18 2.56 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.684 -0.689 . . . . 74.31 112.085 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.4 pp -126.06 144.51 50.69 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 73.45 109.896 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -163.7 138.06 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.679 -0.86 . . . . 72.44 108.679 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.66 132.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.84 0.352 . . . . 73.01 110.822 -175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -115.7 127.3 55.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.132 -0.486 . . . . 62.01 111.346 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -81.6 113.88 19.91 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.677 -0.692 . . . . 72.42 109.275 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.02 158.94 18.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.139 -0.553 . . . . 65.22 111.732 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.9 -24.74 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 73.02 110.258 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.31 -16.19 50.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.254 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.87 158.75 9.48 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.971 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 m -98.48 102.43 14.17 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.625 -0.88 . . . . 72.52 108.625 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 t -102.92 123.65 56.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 63.44 111.219 -168.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.91 115.29 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.846 -0.616 . . . . 73.04 109.585 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 90' ' ' ARG . 50.3 mt -93.89 127.89 39.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.553 0.341 . . . . 74.32 110.404 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.27 129.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.829 -0.434 . . . . 75.15 109.829 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.86 129.78 35.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.037 0.446 . . . . 73.15 111.1 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 79.9 mtp -141.18 171.07 14.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.972 -0.558 . . . . 73.03 110.183 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -148.63 157.48 43.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.144 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mm? -117.1 150.93 37.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.185 -0.672 . . . . 63.24 109.185 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -51.03 -53.86 29.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.651 0.611 . . . . 74.32 112.651 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -113.65 0.2 14.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.69 -0.232 . . . . 74.23 111.227 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 7.81 1.8 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.983 0.513 . . . . 62.34 112.228 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.33 3.78 10.8 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.498 0.666 . . . . 70.21 109.644 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.5 m -83.87 138.64 40.25 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.169 -0.923 . . . . 73.14 110.476 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.3 23.87 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.907 2.405 . . . . 75.14 112.622 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 83.5 mt -78.28 -18.01 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.427 . . . . 61.52 110.171 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -59.8 -46.44 89.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.915 -0.584 . . . . 63.22 110.824 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.13 -43.27 78.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.269 0.557 . . . . 64.31 110.209 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.4 t -65.15 -52.59 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 70.31 110.85 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.14 -37.29 78.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.751 0.31 . . . . 74.12 110.958 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.79 -47.23 84.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.213 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 78' ' ' SER . 32.4 t70 -60.23 -48.49 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 74.03 110.906 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 19.5 mm-40 -61.7 -51.2 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.874 0.369 . . . . 74.45 110.54 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -60.44 -56.21 24.19 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.954 -0.566 . . . . 72.12 110.437 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.19 -41.74 72.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.949 -0.568 . . . . 73.01 110.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 22.9 t -53.57 -53.02 57.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.589 -0.732 . . . . 62.21 110.783 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.74 -52.08 12.47 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.71 -0.396 . . . . 65.33 111.234 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.68 -44.33 73.25 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.213 0.53 . . . . 63.43 110.895 -171.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.97 -27.45 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.105 -0.952 . . . . 72.44 110.127 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -48.03 79.26 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.998 -0.62 . . . . 43.42 112.442 -170.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . 14.1 m -91.22 -12.65 34.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.117 0.484 . . . . 74.31 110.414 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.93 43.0 6.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.1 113.168 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.432 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.0 mm? -73.29 -45.25 56.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.57 -0.9 . . . . 71.13 108.57 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.41 162.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.897 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.54 -45.29 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.265 0.555 . . . . 71.01 109.992 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -101.13 133.74 45.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 64.31 109.809 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.6 pt -127.66 156.27 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 75.3 110.336 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.482 ' HB3' HD23 ' A' ' 56' ' ' LEU . 3.4 tpm_? -150.49 106.77 3.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.176 -0.466 . . . . 74.1 109.753 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.3 mt -95.03 108.95 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.053 -0.721 . . . . 75.22 109.053 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 7.3 t30 -88.3 121.84 31.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.419 -0.585 . . . . 75.11 109.419 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.9 m-90 -97.9 108.78 21.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.169 -0.308 . . . . 72.42 110.169 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 98' ' ' PRO . 32.8 m -87.18 123.9 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.672 -0.492 . . . . 71.54 109.672 176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -111.91 -35.51 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.733 0.778 . . . . 72.45 109.669 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.671 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 8.7 t30 -175.19 -47.9 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.277 -1.329 . . . . 73.34 108.354 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 26.7 Cg_exo -64.75 134.15 39.43 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.811 1.674 . . . . 50.54 109.387 165.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 99' ' ' TRP . 22.0 Cg_exo -63.52 -88.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.376 2.051 . . . . 54.13 113.18 -173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.691 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 10.7 m-90 -141.39 100.64 3.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.658 0.266 . . . . 73.25 110.333 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.69 -133.06 3.77 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-O 119.795 -0.447 . . . . 62.25 112.24 -173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.93 -24.31 75.82 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.748 2.299 . . . . 75.22 112.54 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.99 -4.53 13.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.994 0.426 . . . . 62.35 111.088 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.691 ' HD3' ' HB3' ' A' ' 99' ' ' TRP . 33.7 mtmm . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 72.32 110.184 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.476 0.176 . . . . 55.11 111.476 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 11.1 Cg_endo -53.69 131.41 43.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.822 2.348 . . . . 71.12 111.921 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.16 -66.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.358 0.873 . . . . 53.34 113.358 -168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.01 -50.49 73.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.949 0.404 . . . . 72.33 111.147 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -57.25 -46.41 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 74.01 110.916 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.65 -39.77 91.76 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.828 -0.624 . . . . 72.1 110.082 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.6 tp -54.67 -59.63 4.44 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.837 0.351 . . . . 74.01 110.698 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.67 75.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.996 -0.547 . . . . 75.05 110.995 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.4 -45.12 92.4 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.994 -0.548 . . . . 73.33 111.14 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.45 -33.06 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.229 -0.285 . . . . 71.22 110.229 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -59.13 -41.52 88.45 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.345 0.593 . . . . 55.32 109.617 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.69 -45.8 57.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.486 -0.779 . . . . 75.44 111.008 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.58 72.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.336 -0.393 . . . . 75.03 111.567 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.15 -13.49 48.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 35.52 110.642 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 12.8 ttm180 -88.26 -15.63 35.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.448 -0.342 . . . . 73.53 110.731 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -109.38 -27.02 9.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 122.02 0.914 . . . . 62.33 108.891 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -112.98 70.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 114.011 -1.449 . . . . 63.51 109.461 -175.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 34' ' ' ASN . 4.5 p -179.77 173.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.272 -0.876 . . . . 54.04 108.716 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 27' ' ' VAL . 9.7 t70 -106.26 89.58 4.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.877 -0.786 . . . . 54.12 108.877 170.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.72 -23.77 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.176 1.917 . . . . 71.43 112.485 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -68.68 -57.75 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.013 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.48 -18.55 26.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.831 0.348 . . . . 72.23 110.117 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.04 47.03 3.46 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 60.43 113.704 169.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.6 mp -112.95 140.2 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.514 -0.55 . . . . 71.24 109.514 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HA ' HG23 ' A' ' 27' ' ' VAL . 4.4 p30 -108.46 129.73 55.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.153 -0.684 . . . . 73.44 109.153 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.13 -28.37 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.84 -0.618 . . . . 72.24 112.196 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.42 -24.7 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.706 -0.225 . . . . 73.11 111.064 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -52.86 -35.53 57.74 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.238 0.336 . . . . 74.14 110.667 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.6 mp -78.05 -18.39 55.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.377 -0.374 . . . . 53.22 110.757 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.26 22.89 38.72 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.797 -0.638 . . . . 71.31 113.548 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -93.04 -22.02 19.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.877 0.37 . . . . 53.5 110.103 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.97 -11.88 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.918 -0.583 . . . . 51.44 110.905 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -71.75 -24.34 61.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 70.14 109.94 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.6 81.96 0.96 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.214 -0.754 . . . . 34.11 111.214 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -130.44 137.04 49.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.262 0.553 . . . . 64.02 111.006 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 16.3 m-20 -134.4 160.41 38.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.103 -1.443 . . . . 63.12 107.103 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.9 t -149.12 123.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.506 . . . . 52.24 109.635 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.688 -0.486 . . . . 71.02 109.688 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HG23 ' A' ' 53' ' ' THR . 7.0 p-10 -88.78 136.66 32.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.92 0.39 . . . . 72.45 110.086 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.96 134.55 4.75 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.482 -1.047 . . . . 54.43 110.482 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -25.58 67.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.098 0.475 . . . . 75.43 110.654 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.35 -34.15 65.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.578 -0.737 . . . . 74.22 109.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.48 124.27 0.77 Allowed Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.683 -0.689 . . . . 72.11 111.608 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' ASP . 26.1 m -77.62 117.32 18.93 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.248 -0.279 . . . . 65.02 110.248 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 88' ' ' ASP . 43.7 t -108.2 123.68 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.905 0.383 . . . . 71.34 110.912 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -94.76 122.42 37.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.108 -0.496 . . . . 71.31 110.269 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 12.2 mt -97.29 102.01 13.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.655 -0.498 . . . . 74.33 109.655 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 59' ' ' MET . 59.2 mt -108.65 125.15 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.092 0.157 . . . . 55.15 110.69 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.11 118.98 25.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.849 0.357 . . . . 75.13 110.099 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.419 ' HG3' HG22 ' A' ' 57' ' ' ILE . 72.0 mtp -140.87 170.87 14.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.383 0.611 . . . . 53.14 111.01 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -157.03 177.47 11.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.973 -1.012 . . . . 65.03 108.907 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -108.57 163.11 13.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.29 -0.633 . . . . 70.34 109.29 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -47.46 -57.48 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.484 0.49 . . . . 73.4 112.008 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -96.88 -13.59 22.38 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.385 -0.37 . . . . 63.01 111.024 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.39 8.84 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.89 0.7 . . . . 53.21 112.89 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.81 9.61 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.05 0.453 . . . . 53.23 110.486 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.3 t -119.92 124.47 27.87 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.865 -0.607 . . . . 32.03 109.786 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.17 83.16 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.682 2.254 . . . . 73.34 112.087 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 tp -107.05 8.2 30.17 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.678 0.752 . . . . 64.41 108.997 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.1 t -63.7 -39.72 95.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.303 -0.862 . . . . 63.42 111.341 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.8 -44.71 74.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 64.34 110.198 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.46 -51.93 52.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.436 -0.802 . . . . 64.32 110.795 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.675 HG12 ' HA ' ' A' ' 69' ' ' THR . 27.0 pt -62.55 -33.73 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.697 -0.401 . . . . 72.23 111.075 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' A' ' 91' ' ' ILE . 43.8 mt-10 -68.0 -44.17 77.19 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.457 -0.338 . . . . 70.25 110.225 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.88 -44.24 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 73.04 110.425 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -65.06 -46.2 82.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.331 -0.395 . . . . 75.54 110.72 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -58.91 -53.81 54.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.066 -0.516 . . . . 52.14 109.944 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 ttp85 -54.87 -44.11 73.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 73.04 110.395 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -53.32 -53.65 47.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.815 -0.63 . . . . 71.12 111.159 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.22 -52.49 10.78 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.55 -0.46 . . . . 74.43 111.462 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 86' ' ' VAL . 92.1 mt -60.14 -41.09 91.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.05 0.452 . . . . 74.12 111.227 -169.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.04 -27.42 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 74.04 110.188 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.21 -45.71 18.57 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.688 -0.768 . . . . 63.23 111.776 -171.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 m -82.89 2.87 32.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.41 . . . . 61.33 110.659 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.76 35.91 90.41 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.013 -0.539 . . . . 74.34 112.811 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 HD23 ' A' ' 80' ' ' LEU . 84.0 mt -76.57 -43.65 38.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 51.32 109.555 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 55' ' ' ALA . 27.2 m -144.29 169.32 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.367 -0.833 . . . . 72.33 109.387 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -91.71 -48.0 7.06 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.961 0.41 . . . . 64.04 110.447 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HB2' HG22 ' A' ' 54' ' ' VAL . 18.6 m-20 -131.38 151.12 51.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.059 -0.519 . . . . 51.35 110.687 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.1 pt -113.96 151.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 71.42 110.447 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -137.98 106.64 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.207 -1.034 . . . . 70.34 108.207 177.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.484 HD12 ' HG2' ' A' ' 73' ' ' GLU . 47.7 mt -95.94 114.33 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 73.33 110.373 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 3.4 t30 -88.68 102.85 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 72.31 109.093 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.3 m-90 -82.34 106.87 14.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.501 -0.318 . . . . 73.45 110.585 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.9 123.56 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.387 -0.597 . . . . 64.44 109.387 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -122.08 -17.62 7.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.047 0.451 . . . . 73.03 110.18 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.525 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 28.0 t-20 173.86 -47.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.186 -0.915 . . . . 72.0 109.449 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.3 Cg_endo -68.08 140.12 48.72 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.629 1.553 . . . . 61.3 110.123 168.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.55 -92.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.203 1.935 . . . . 73.11 112.482 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -146.09 163.12 36.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.962 -0.384 . . . . 71.52 109.962 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.44 -127.17 1.58 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.72 -0.552 . . . . 71.42 111.72 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.64 -17.73 56.1 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.627 2.218 . . . . 55.2 111.685 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 4.0 m-20 -63.96 -11.1 25.47 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.577 -0.738 . . . . 62.24 110.978 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 71.9 mmtt . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.431 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.56 0.219 . . . . 42.44 111.336 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 30.1 Cg_endo -64.28 143.52 83.55 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.366 2.044 . . . . 70.21 111.707 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -38.75 58.57 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.644 0.609 . . . . 75.4 112.644 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -55.01 -50.24 69.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.411 0.624 . . . . 64.11 110.843 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 -40.42 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.539 -0.755 . . . . 53.11 110.187 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.97 -53.75 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.763 -0.653 . . . . 72.23 111.367 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.09 -48.87 78.83 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.952 0.406 . . . . 70.35 110.951 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.69 -46.89 65.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.059 -0.519 . . . . 45.21 110.714 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -64.09 -45.0 90.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.495 -0.775 . . . . 74.1 110.419 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.3 -38.02 80.14 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 109.946 -0.39 . . . . 54.0 109.946 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.71 -43.19 72.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.008 0.433 . . . . 73.44 110.079 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 43.9 mt-10 -72.36 -43.36 64.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 71.33 111.067 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.82 73.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.416 0.627 . . . . 60.2 110.751 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 21.7 mmt -63.11 -13.63 38.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.425 -0.807 . . . . 75.01 111.213 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 40.3 ttt180 -74.8 -24.17 58.61 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.739 0.304 . . . . 74.35 111.15 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.14 -23.56 9.43 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.672 0.749 . . . . 74.11 109.911 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.5 t -95.08 26.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.728 -1.123 . . . . 74.53 110.23 -178.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 2.8 p -150.08 169.23 2.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -103.2 100.22 17.02 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 110.012 -0.366 . . . . 72.22 110.012 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 97.1 Cg_endo -88.93 -3.75 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.758 2.306 . . . . 54.45 111.827 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.1 -57.75 5.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.05 0.452 . . . . 71.31 110.642 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.1 -17.49 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 73.01 109.994 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.19 52.62 1.71 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.746 -0.661 . . . . 22.32 112.999 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -109.67 142.66 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.116 0.484 . . . . 72.3 109.902 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 37' ' ' ASP . 6.0 p30 -120.16 112.6 19.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 72.22 109.347 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.8 m -55.22 -30.05 24.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.544 -0.753 . . . . 54.24 112.086 -173.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.84 -31.5 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 74.23 111.377 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t70 -67.3 -19.56 65.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.462 -0.335 . . . . 65.35 111.351 -176.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -72.85 -17.5 61.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.084 0.469 . . . . 74.05 109.992 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.86 65.39 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.549 -0.751 . . . . 65.0 113.362 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.99 -20.14 17.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.14 0.495 . . . . 72.34 110.011 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 HD23 ' A' ' 44' ' ' LEU . 42.1 t -59.27 -9.62 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.695 -0.684 . . . . 71.43 111.422 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.18 -7.24 40.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.059 0.457 . . . . 71.24 110.0 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 58' ' ' ASP . . . -81.52 18.96 9.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.524 -0.762 . . . . 42.12 112.249 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 HG12 ' A' ' 41' ' ' VAL . 4.6 pp -89.16 129.8 35.7 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.939 -0.763 . . . . 70.42 108.939 171.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -161.59 113.29 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.75 -0.463 . . . . 72.32 109.75 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.1 p -93.02 116.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.178 0.513 . . . . 71.51 110.782 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.54 128.25 56.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.785 -0.643 . . . . 74.23 109.606 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 2.1 p-10 -101.66 161.06 13.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.124 0.488 . . . . 72.24 110.651 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.54 -175.03 32.12 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.641 -0.984 . . . . 72.3 110.641 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.4 -35.48 71.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.271 0.558 . . . . 75.34 109.916 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.98 -18.17 63.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.157 -0.928 . . . . 73.24 110.584 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.64 172.37 18.41 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.208 -0.451 . . . . 71.24 112.527 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 29.1 m -105.85 111.03 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.461 -0.57 . . . . 63.03 109.461 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -112.26 133.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.671 0.272 . . . . 53.25 111.095 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -97.82 106.52 18.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.29 -0.414 . . . . 75.21 110.431 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 46.1 mt -75.61 141.0 42.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 73.22 109.707 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HG3' ' A' ' 59' ' ' MET . 60.6 mt -144.64 113.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.148 -0.315 . . . . 74.45 110.148 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 30.7 m-20 -86.95 128.72 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.654 -0.248 . . . . 74.11 110.463 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.4 mtp -140.9 170.51 15.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 122.261 1.029 . . . . 63.03 113.051 -174.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 94' ' ' VAL . 19.9 p -149.51 172.74 14.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 113.294 -1.775 . . . . 72.52 109.089 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.26 145.3 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.685 -1.228 . . . . 63.33 107.685 164.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 p -59.69 -48.43 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 74.13 111.021 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -67.99 -38.64 82.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.394 -0.821 . . . . 75.32 111.335 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.71 8.16 2.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.102 -0.954 . . . . 70.21 111.361 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.08 -36.0 3.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.215 0.531 . . . . 54.51 109.887 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.9 116.18 53.11 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.643 -0.708 . . . . 75.25 110.039 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.94 77.38 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.812 2.341 . . . . 74.15 113.577 -173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.85 7.27 31.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.26 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.2 t -50.35 -60.21 3.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.569 -0.741 . . . . 73.23 112.113 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 69' ' ' THR . 10.9 t70 -58.92 -35.83 73.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.139 0.495 . . . . 74.02 110.335 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.9 t -65.32 -53.29 41.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.547 -0.751 . . . . 62.23 110.857 -175.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.581 HG12 ' HH2' ' A' ' 93' ' ' TRP . 1.8 pp -69.12 -36.63 74.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.428 -0.351 . . . . 71.54 110.246 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.37 -45.81 89.41 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 74.51 110.603 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.52 -42.91 86.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 65.04 110.921 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 56.5 mt-30 -59.57 -54.05 50.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.11 0.481 . . . . 61.43 110.671 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.52 -53.98 51.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.579 -0.737 . . . . 62.34 110.603 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -55.05 -51.2 67.07 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.114 -0.494 . . . . 75.41 111.326 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.7 t -53.29 -51.76 61.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.077 -0.51 . . . . 44.32 111.01 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.06 -52.0 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.517 -0.473 . . . . 51.52 111.334 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.79 -39.46 85.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.761 0.315 . . . . 74.34 111.116 -172.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.07 -27.83 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.361 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.14 -33.15 33.42 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.857 -0.687 . . . . 64.41 112.194 -172.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB2' HD13 ' A' ' 85' ' ' LEU . 15.0 m -95.97 -0.17 51.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 43.14 110.962 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.56 29.86 67.31 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.353 -0.451 . . . . 61.51 113.488 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 83' ' ' SER . 9.4 mp -79.8 -8.14 59.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.11 0.481 . . . . 72.4 110.233 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 88' ' ' ASP . 9.9 p -164.02 161.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.601 -0.727 . . . . 74.14 109.332 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.18 -19.68 58.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.847 -0.427 . . . . 75.23 109.847 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 86' ' ' VAL . 15.8 t0 174.85 150.89 0.1 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.352 -170.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 18.6 pt -116.4 152.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 61.32 110.335 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 2.4 tpp180 -133.35 106.15 7.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.145 -0.687 . . . . 63.3 109.145 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.24 143.55 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.349 -0.387 . . . . 61.12 110.227 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -119.54 143.45 47.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.286 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.581 ' HH2' HG12 ' A' ' 72' ' ' ILE . 70.6 m95 -110.96 106.41 15.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 75.11 110.102 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' THR . 31.5 m -100.09 123.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.009 -0.676 . . . . 44.33 110.788 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -109.14 -35.37 6.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 64.5 110.023 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.643 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 3.1 t-20 -171.21 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.116 -0.947 . . . . 53.1 110.746 -173.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 53.1 Cg_endo -68.02 158.05 59.12 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.929 1.752 . . . . 55.41 112.213 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.87 175.0 6.9 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.963 2.442 . . . . 72.35 111.756 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 25.0 m0 -75.57 123.4 25.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.64 -0.254 . . . . 72.13 110.477 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.66 -123.02 1.11 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.384 -0.436 . . . . 72.24 112.428 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.24 -19.28 38.8 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.688 2.258 . . . . 43.54 111.452 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -17.03 16.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.035 -0.984 . . . . 63.03 111.713 177.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 29.1 mtpp . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.687 0.279 . . . . 74.0 111.034 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.273 -0.331 . . . . 63.12 112.273 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.48 -159.34 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.82 2.347 . . . . 61.1 112.017 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 141.65 169.94 12.18 Favored Glycine 0 C--N 1.331 0.272 0 N-CA-C 111.667 -0.573 . . . . 62.12 111.667 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 t -76.88 78.54 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.492 -0.559 . . . . 60.0 109.492 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.7 ttp -91.66 171.33 9.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.76 -0.654 . . . . 75.33 109.714 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.5 p -130.96 95.75 3.89 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.792 0.329 . . . . 54.22 111.704 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' HB2' HD21 ' A' ' 15' ' ' LEU . 1.8 mp0 -91.39 -4.13 56.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.233 -0.439 . . . . 63.1 110.474 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.7 m 74.63 -35.98 0.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.604 0.762 . . . . 63.44 112.295 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -78.25 147.96 34.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.669 -0.242 . . . . 34.12 110.699 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.18 154.12 0.14 Allowed Pre-proline 0 N--CA 1.471 0.601 0 O-C-N 123.588 0.555 . . . . 72.34 111.968 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.81 148.87 90.21 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.633 2.222 . . . . 73.44 111.474 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.62 -37.53 40.82 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.785 0.661 . . . . 73.14 112.785 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -65.53 -51.92 56.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.198 0.523 . . . . 72.41 110.243 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.98 -46.41 65.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.251 -0.886 . . . . 71.21 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 7' ' ' GLU . 3.2 tm? -54.51 -50.15 68.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.566 -0.743 . . . . 75.11 110.785 -177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.55 -59.6 4.26 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.943 0.402 . . . . 71.0 111.301 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.62 77.23 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.182 -0.463 . . . . 33.24 111.224 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -63.98 -44.38 92.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.521 . . . . 73.14 110.837 -174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -68.46 -34.72 67.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.944 -0.391 . . . . 54.21 109.944 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.93 -43.32 91.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.695 -0.484 . . . . 74.2 109.695 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 44.7 mt-10 -66.46 -50.84 61.99 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.015 -0.539 . . . . 73.1 110.614 177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -56.47 -44.24 80.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.159 -0.473 . . . . 73.21 111.044 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.0 mmt -62.68 -13.59 33.96 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.65 -0.705 . . . . 71.21 111.584 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 23.9 ttp85 -80.14 -30.64 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.394 -0.224 . . . . 75.14 110.394 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -99.8 -27.15 13.77 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.881 0.326 . . . . 70.3 111.881 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.6 m -99.58 20.39 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 120.837 0.351 . . . . 63.31 111.658 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 33' ' ' ILE . 2.2 p -128.0 171.5 16.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.628 -0.508 . . . . 71.25 109.628 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -107.31 90.86 6.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.356 -0.609 . . . . 61.02 109.356 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.99 -1.43 10.82 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.3 2.0 . . . . 64.42 111.444 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.45 -57.69 5.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.57 -0.741 . . . . 71.15 110.5 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.1 mt -109.4 -10.02 14.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.355 -0.384 . . . . 75.51 110.235 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.11 52.84 2.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.205 -0.521 . . . . 74.24 113.124 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -112.45 141.78 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.749 -0.463 . . . . 34.22 109.749 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -122.37 112.55 18.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.987 -0.552 . . . . 74.3 109.685 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.49 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.0 m -54.81 -34.47 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.108 -0.497 . . . . 74.12 112.12 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 9.3 p -56.0 -30.66 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.447 -0.342 . . . . 70.3 111.322 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -69.11 -18.36 63.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.162 -0.472 . . . . 74.24 111.503 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.9 mm? -69.03 -12.54 61.78 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.443 0.64 . . . . 70.52 109.861 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.35 21.89 62.69 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 114.881 -1.054 . . . . 74.22 114.849 172.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 ' O ' HD23 ' A' ' 40' ' ' LEU . 3.3 tt -98.19 -31.71 11.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.902 -1.147 . . . . 70.15 107.902 164.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 26.0 t -65.69 -8.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 114.862 -1.063 . . . . 75.24 110.831 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.2 m-30 -59.39 -26.11 64.85 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.073 0.464 . . . . 63.13 109.762 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.06 91.23 1.72 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.595 -0.729 . . . . 71.42 112.015 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.04 136.8 38.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.534 -0.543 . . . . 73.22 109.534 174.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.55 109.37 7.58 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.568 -0.53 . . . . 44.12 109.568 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.2 m -94.24 108.75 21.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.693 0.758 . . . . 72.41 109.757 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -100.13 120.96 40.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.455 -0.793 . . . . 64.42 110.027 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -107.08 141.74 37.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.678 -0.49 . . . . 65.12 109.678 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.85 -163.75 12.54 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.216 -0.516 . . . . 72.52 112.003 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.9 -27.9 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.515 0.674 . . . . 70.1 109.692 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.43 -39.33 81.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.013 -0.994 . . . . 63.33 109.77 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.84 -171.82 43.49 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.682 -0.69 . . . . 54.3 111.852 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.2 m -124.48 104.42 8.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.379 -0.6 . . . . 64.1 109.379 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.4 p -114.99 124.26 71.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.346 0.593 . . . . 64.24 112.1 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.08 107.53 19.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.766 . . . . 71.14 109.993 175.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -87.64 130.32 34.82 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.636 -0.505 . . . . 62.14 109.636 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.541 HG22 ' HG3' ' A' ' 59' ' ' MET . 45.1 mt -130.86 113.82 25.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.75 0.31 . . . . 63.53 110.622 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.36 116.5 20.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 72.42 109.723 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 57' ' ' ILE . 81.9 mtp -134.61 170.85 15.17 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.326 0.584 . . . . 72.31 111.373 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -152.59 161.13 42.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.289 -0.869 . . . . 55.22 109.245 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.2 mt -132.57 174.1 10.63 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.362 -0.607 . . . . 74.53 109.362 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.7 m -44.18 -42.43 6.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.483 0.489 . . . . 74.42 112.04 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.1 t -141.37 4.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.428 -0.351 . . . . 55.15 110.325 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 57.64 8.88 0.72 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.744 0.646 . . . . 44.13 112.744 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.73 15.06 15.41 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.224 0.535 . . . . 63.32 110.285 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 35.1 m -91.46 144.2 29.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.538 -0.756 . . . . 72.05 110.296 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 26.6 Cg_exo -64.66 10.38 0.13 Allowed 'Trans proline' 0 N--CA 1.481 0.741 0 C-N-CA 123.346 2.697 . . . . 74.42 113.377 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD23 ' HB ' ' A' ' 71' ' ' VAL . 1.2 tt -75.08 -15.12 60.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -57.52 -45.76 84.6 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.945 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.51 -41.64 85.85 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.251 0.548 . . . . 54.01 110.253 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.595 ' HB ' HD23 ' A' ' 68' ' ' LEU . 60.3 t -63.4 -52.25 60.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.251 -0.886 . . . . 52.11 111.078 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.6 pt -62.97 -41.84 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 120.779 -0.368 . . . . 72.21 111.13 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.23 -51.26 68.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.6 0.238 . . . . 73.34 110.803 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.84 -51.83 66.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.399 -0.364 . . . . 74.43 110.9 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -64.2 -43.97 93.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.356 -0.384 . . . . 72.33 111.146 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 -59.19 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 65.35 110.23 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.475 HH12 ' HB2' ' A' ' 107' ' ' ASP . 61.7 ttt180 -55.17 -45.95 75.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.552 -0.295 . . . . 71.41 110.83 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.3 t -55.16 -47.49 75.09 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 123.631 0.582 . . . . 74.25 111.131 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.3 -51.05 16.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.503 -0.317 . . . . 74.12 111.083 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.03 -39.62 82.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.377 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.87 -28.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.106 0.479 . . . . 52.43 109.882 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.07 -27.97 47.35 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.139 -0.553 . . . . 65.12 111.739 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.48 ' HB3' HD13 ' A' ' 85' ' ' LEU . 19.4 m -70.93 -23.21 62.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.966 0.412 . . . . 74.04 110.461 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.09 -10.02 59.18 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.992 -0.549 . . . . 73.41 113.125 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.5 mp -61.51 -39.43 90.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.648 0.261 . . . . 61.52 110.652 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.5 m -143.39 152.29 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.12 -0.491 . . . . 75.02 109.752 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.12 -40.67 6.36 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 75.55 110.059 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 20.0 m-20 -102.99 139.43 38.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.923 -0.58 . . . . 64.14 109.9 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 9.4 pt -133.98 169.59 21.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.151 -0.685 . . . . 75.41 109.151 170.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' ILE . 22.8 mtt85 -156.35 106.61 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.134 -0.485 . . . . 64.34 109.837 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.73 113.46 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.819 -0.808 . . . . 71.14 108.819 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' HB3' ' HG2' ' A' ' 103' ' ' LYS . 4.4 p-10 -105.53 140.69 38.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.981 0.419 . . . . 65.21 110.687 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.82 106.64 17.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.715 -0.675 . . . . 74.5 109.597 -174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 99' ' ' TRP . 10.7 m -113.04 131.09 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.366 0.603 . . . . 65.1 112.065 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -152.73 8.86 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.023 -0.989 . . . . 65.53 110.621 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.3 m-20 -167.12 -60.05 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 122.586 0.354 . . . . 72.5 111.275 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 88.6 Cg_endo -78.17 159.51 30.02 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.042 1.828 . . . . 75.12 113.097 -171.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.7 137.07 37.72 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.053 2.502 . . . . 52.32 111.633 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.9 m-90 -53.88 109.79 0.51 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 123.724 0.64 . . . . 74.43 111.313 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.3 -78.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.862 -0.608 . . . . 63.4 111.817 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.59 -37.05 90.82 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.782 2.322 . . . . 64.54 111.375 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.54 -20.62 47.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.221 -0.899 . . . . 61.25 111.6 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 99' ' ' TRP . 54.4 mttp -89.4 10.55 22.15 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.753 0.279 . . . . 70.44 111.753 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.5 mt -96.44 92.11 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.849 -0.426 . . . . 73.0 109.849 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.6 p -85.14 -179.26 6.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.212 -0.449 . . . . 73.54 111.305 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -29.9 44.14 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.958 -0.564 . . . . 65.42 111.484 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.475 ' HB2' HH12 ' A' ' 77' ' ' ARG . 32.1 t70 -57.13 -48.99 77.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.868 -0.606 . . . . 41.25 110.579 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.14 -35.85 22.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.811 -0.631 . . . . 53.22 112.653 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -74.19 -50.75 17.87 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.054 0.39 . . . . 74.44 112.054 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -79.4 -34.41 41.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.993 0.425 . . . . 73.23 111.274 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HG2' ' HD2' ' A' ' 117' ' ' PHE . 41.9 mt-30 -102.12 26.63 7.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.061 -0.518 . . . . 72.5 111.017 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 113' ' ' ARG . 1.6 tt -71.23 147.52 48.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.196 -0.668 . . . . 74.23 109.196 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.619 ' H ' HD23 ' A' ' 112' ' ' LEU . 1.7 tmm_? -57.45 -35.07 69.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.948 -0.569 . . . . 72.31 110.444 -175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.16 -33.01 67.0 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.025 -0.534 . . . . 63.23 110.966 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.2 mm? -83.33 -34.13 25.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 53.11 109.823 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.15 15.09 81.31 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 115.784 -0.644 . . . . 74.44 112.239 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.487 ' HD2' ' HG2' ' A' ' 111' ' ' GLN . 74.2 t80 -74.21 143.08 45.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 73.34 110.79 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.6 m -147.39 129.57 15.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.676 -0.693 . . . . 72.42 109.278 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.205 -0.903 . . . . 44.15 110.8 -176.53 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 112.21 -0.356 . . . . 52.12 112.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -19.05 64.82 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.536 2.158 . . . . 64.21 112.305 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' HA3' ' SD ' ' A' ' 5' ' ' MET . . . 148.95 -52.79 0.53 Allowed Glycine 0 C--N 1.331 0.254 0 N-CA-C 111.74 -0.544 . . . . 74.14 111.74 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.8 p 48.57 43.96 20.59 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.086 0.554 . . . . 73.22 111.425 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.501 ' SD ' ' HA3' ' A' ' 3' ' ' GLY . 3.5 mpp? -70.82 -168.86 0.3 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.709 -0.678 . . . . 75.11 110.943 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m -133.68 -63.07 0.76 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.704 0.288 . . . . 74.33 111.267 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.699 ' HB3' HD21 ' A' ' 15' ' ' LEU . 1.1 mp0 53.4 36.2 22.43 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.57 0.7 . . . . 73.34 110.426 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -77.39 -16.68 58.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.423 -0.808 . . . . 72.54 111.746 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.419 ' O ' HD13 ' A' ' 15' ' ' LEU . 22.7 p -93.34 154.25 18.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 74.21 111.158 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 149.36 0.12 Allowed Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.359 0.664 . . . . 71.51 112.377 174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.65 153.72 54.38 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.55 2.167 . . . . 72.2 111.209 174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.6 -40.69 28.4 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.579 0.585 . . . . 31.3 112.579 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -54.54 -50.14 68.61 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.165 0.507 . . . . 73.14 111.086 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -81.29 -47.48 13.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.814 -0.63 . . . . 75.22 110.452 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' A' ' 7' ' ' GLU . 46.5 tp -54.04 -48.33 70.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.949 -1.023 . . . . 61.22 112.463 -172.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.5 tp -54.63 -59.28 4.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.68 0.276 . . . . 42.52 110.866 -174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 21' ' ' GLU . . . -65.36 -40.19 93.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.306 -0.406 . . . . 74.52 110.829 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -60.21 -48.94 79.6 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.807 -0.633 . . . . 60.22 110.668 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 23' ' ' MET . 7.9 p -73.93 -32.79 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 70.23 109.675 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.1 -39.04 77.59 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.106 -0.497 . . . . 73.24 110.263 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 41.9 mt-10 -72.65 -51.7 18.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.429 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -55.99 -48.77 75.25 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 63.4 111.037 -176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.487 ' HG2' HG22 ' A' ' 19' ' ' VAL . 23.8 mmt -58.0 -13.55 4.85 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.51 -0.768 . . . . 62.52 111.832 -177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 24' ' ' ARG . 40.1 ttt-85 -87.97 -35.8 17.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.68 0.276 . . . . 74.14 110.584 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -90.15 -26.82 19.98 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.439 -0.346 . . . . 71.25 111.44 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ALA . 29.7 m -98.12 27.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.92 0.391 . . . . 71.21 111.35 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.96 162.68 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 62.04 110.172 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 m-20 -110.15 82.92 2.77 Favored Pre-proline 0 C--O 1.233 0.218 0 N-CA-C 109.071 -0.714 . . . . 54.53 109.071 174.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 14.38 2.07 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.736 2.291 . . . . 74.44 112.618 -170.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -62.55 -58.34 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 72.13 110.145 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HB2' HD11 ' A' ' 33' ' ' ILE . 87.9 mt -115.78 3.64 13.85 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.845 -0.616 . . . . 73.23 110.438 173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.44 39.72 4.96 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.037 -0.602 . . . . 72.03 112.633 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 31' ' ' LEU . 3.7 mp -88.68 139.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.843 -0.799 . . . . 71.13 108.843 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 52.1 t-20 -143.83 120.14 10.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.102 -0.333 . . . . 74.53 110.102 -176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -59.83 -32.03 48.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 54.43 110.739 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.415 HG22 HG11 ' A' ' 41' ' ' VAL . 91.7 t -59.27 -26.41 33.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.897 -0.592 . . . . 62.35 110.566 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 8.3 t0 -59.2 -27.46 65.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.971 -0.559 . . . . 75.2 111.022 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 38' ' ' LEU . 3.5 mm? -77.72 -8.41 57.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.755 0.312 . . . . 71.13 110.93 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.25 22.95 59.25 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.001 -0.545 . . . . 62.42 113.03 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.699 HD21 HG23 ' A' ' 94' ' ' VAL . 39.2 tp -93.3 -26.29 17.37 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.616 -0.343 . . . . 72.15 110.249 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.415 HG11 HG22 ' A' ' 36' ' ' VAL . 11.8 p -62.0 -12.19 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.924 -0.58 . . . . 72.23 110.824 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -62.94 -14.09 42.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.826 -0.624 . . . . 72.44 110.264 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.78 67.89 2.59 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.196 -0.761 . . . . 62.53 111.196 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.0 pp -120.96 141.77 50.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.103 -0.332 . . . . 64.1 110.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.03 110.77 1.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 71.34 110.185 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 38.7 t -93.66 126.06 46.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.441 -0.345 . . . . 71.25 110.304 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -121.35 133.06 55.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.428 -0.351 . . . . 75.43 110.662 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.2 p-10 -92.4 147.04 23.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.144 -0.687 . . . . 75.55 109.144 173.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.78 177.87 35.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.768 -0.729 . . . . 62.54 112.171 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -53.08 -41.62 65.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.21 0.529 . . . . 74.4 111.059 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.54 17.73 9.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.54 -0.754 . . . . 72.2 111.701 -174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.41 174.91 17.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.151 -0.547 . . . . 73.22 112.981 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 13.9 m -102.79 109.15 20.64 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.126 -0.324 . . . . 63.11 110.126 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.73 135.97 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 75.21 111.168 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.531 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -93.78 105.02 17.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.038 -0.528 . . . . 61.31 109.917 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' HB3' ' HE3' ' A' ' 103' ' ' LYS . 69.9 mt -70.97 113.39 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.538 -0.542 . . . . 73.03 109.538 177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 91' ' ' ILE . 63.9 mt -120.69 114.04 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 73.31 110.264 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -89.9 116.51 28.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.886 0.374 . . . . 75.41 110.188 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 85.1 mtp -125.57 170.66 11.25 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.538 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.401 ' HB ' HD23 ' A' ' 40' ' ' LEU . 14.8 t -137.67 150.43 47.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.915 0.388 . . . . 73.41 110.7 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.764 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 3.2 mm? -118.17 147.5 43.28 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.312 -0.996 . . . . 53.44 108.312 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 m -42.42 -51.74 4.85 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.614 0.598 . . . . 63.01 112.614 -172.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.8 t -116.83 6.54 13.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.567 0.222 . . . . 70.04 110.723 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.22 8.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.282 0.475 . . . . 71.34 112.282 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.93 16.67 12.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.591 0.71 . . . . 75.21 109.324 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 61' ' ' LEU . 10.3 m -72.25 133.24 83.53 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 114.797 -1.092 . . . . 44.43 110.753 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.38 -3.45 13.01 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.453 2.102 . . . . 75.32 111.694 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -80.21 -0.39 36.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 75.21 111.195 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 70' ' ' ASP . 13.1 t -62.54 -48.91 77.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.546 0.212 . . . . 55.14 110.551 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 69' ' ' THR . 15.9 t70 -60.26 -32.54 71.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.255 0.55 . . . . 71.24 109.794 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.535 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 81.1 t -67.48 -52.61 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.78 -0.645 . . . . 73.55 110.912 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -68.31 -35.94 73.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 121.03 -0.268 . . . . 73.34 110.819 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 72' ' ' ILE . 45.3 mt-10 -58.37 -50.67 72.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.351 -0.611 . . . . 73.43 109.351 173.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.07 -51.37 69.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.729 . . . . 64.13 111.112 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 23.7 mm-40 -60.87 -56.76 17.32 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.999 0.428 . . . . 75.14 110.781 -177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.484 ' O ' HD23 ' A' ' 80' ' ' LEU . 32.4 t -61.27 -53.58 54.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.898 -0.592 . . . . 53.51 110.592 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.539 ' HG2' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -57.02 -46.96 81.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.079 -0.509 . . . . 74.11 110.434 -176.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.7 t -58.93 -43.36 91.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 73.35 110.95 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.97 -51.56 17.88 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.944 -0.302 . . . . 72.25 110.869 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -56.12 -41.07 74.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.312 -0.404 . . . . 64.42 110.771 -177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.76 -27.8 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.944 -0.571 . . . . 63.25 110.467 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.43 -47.58 56.6 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.842 -0.695 . . . . 74.45 111.766 -174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.4 m -77.36 -22.91 51.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.865 0.364 . . . . 61.43 110.029 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.25 26.32 28.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 116.155 -0.475 . . . . 44.05 113.262 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 80' ' ' LEU . 83.0 mt -62.55 -33.92 75.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.156 0.503 . . . . 73.42 110.168 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 55' ' ' ALA . 5.0 m -147.06 164.82 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.574 -0.739 . . . . 63.23 109.734 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.95 -40.96 75.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 62.0 110.188 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -158.15 172.89 17.59 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.672 -0.862 . . . . 63.31 108.672 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' HG2' ' A' ' 77' ' ' ARG . 16.6 pt -131.95 145.09 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.889 0.376 . . . . 71.31 110.074 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 4.5 tpt180 -120.66 106.77 12.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.625 -0.509 . . . . 75.33 109.625 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.7 mt -88.66 140.86 15.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.048 -0.524 . . . . 65.32 110.675 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.658 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -118.7 127.48 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.407 -0.59 . . . . 71.43 109.407 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.492 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.3 m-90 -87.23 106.62 18.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.891 -0.411 . . . . 73.45 109.891 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.699 HG23 HD21 ' A' ' 40' ' ' LEU . 14.6 m -118.5 158.95 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.746 0.308 . . . . 75.45 110.557 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -177.68 -31.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.755 -0.657 . . . . 73.01 110.262 -173.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.693 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 44.2 t30 -155.27 -49.2 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.911 -0.586 . . . . 74.41 110.168 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.693 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 5.6 Cg_exo -76.68 147.76 28.24 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.07 1.846 . . . . 55.21 110.687 169.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 14.7 Cg_exo -69.58 -163.97 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.775 2.317 . . . . 75.14 112.439 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CD1' HG11 ' A' ' 94' ' ' VAL . 12.4 m-90 -89.84 124.4 34.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 62.45 110.942 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -113.48 0.3 Allowed Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.181 -0.533 . . . . 61.33 112.213 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.39 -17.84 54.25 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.724 2.282 . . . . 65.11 111.568 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' ND2' ' A' ' 92' ' ' ASN . 7.0 m-20 -67.09 -3.92 8.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.334 -0.848 . . . . 70.2 111.373 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 35.8 mmtm -76.54 -18.52 58.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.7 0.286 . . . . 71.51 110.319 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.8 mt -75.75 99.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.766 -0.457 . . . . 72.3 109.766 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.455 ' HB ' ' OE1' ' A' ' 73' ' ' GLU . 41.0 p -59.71 154.08 18.84 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.74 -0.663 . . . . 74.21 112.175 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.99 -26.78 63.29 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.004 -0.739 . . . . 75.33 109.004 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 10.9 t70 -57.01 -39.44 74.74 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.439 -0.801 . . . . 61.22 110.035 171.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -39.99 53.85 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.85 -0.614 . . . . 72.03 112.855 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -60.28 -33.85 72.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.968 0.414 . . . . 73.55 111.329 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -75.72 -14.06 60.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.183 -0.462 . . . . 74.14 111.31 -175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.506 ' HA ' HD22 ' A' ' 115' ' ' LEU . 43.3 mt-30 -112.11 77.26 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.268 0.556 . . . . 65.21 110.842 -172.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -111.22 -172.82 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.327 -0.851 . . . . 72.23 109.826 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -60.83 -35.94 77.84 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.917 0.389 . . . . 71.01 111.192 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.31 -16.68 62.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 73.14 111.587 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 111' ' ' GLN . 53.0 tp -73.72 -13.08 60.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.853 0.359 . . . . 64.54 110.59 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.04 -4.7 73.27 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.188 -0.53 . . . . 42.41 112.64 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.08 40.25 1.7 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.07 0.462 . . . . 75.11 110.796 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 p -75.42 138.42 41.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.071 -0.513 . . . . 73.31 110.764 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.822 -0.608 . . . . 61.34 110.049 -178.408 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 111.706 -0.558 . . . . 44.13 111.706 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.85 -70.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.707 2.272 . . . . 63.52 112.124 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.82 75.95 1.23 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.037 -0.601 . . . . 63.15 111.84 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 m -64.3 -37.53 87.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.033 0.444 . . . . 42.34 110.297 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 19.9 ptp -108.36 101.15 10.36 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.561 -0.533 . . . . 64.2 109.561 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -144.07 -65.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.041 -0.527 . . . . 72.43 110.543 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.59 103.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.954 -0.567 . . . . 74.53 110.855 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.4 m -104.86 104.03 13.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.43 110.711 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' HD13 ' A' ' 15' ' ' LEU . 32.3 t -158.55 149.3 20.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.759 -0.46 . . . . 63.21 109.759 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.96 162.78 0.14 Allowed Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 123.303 0.377 . . . . 62.43 111.742 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.49 -178.98 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.352 2.034 . . . . 65.53 111.836 172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.6 -66.86 0.31 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.081 0.771 . . . . 60.32 113.081 -170.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -65.84 -41.07 92.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.504 -0.317 . . . . 75.25 111.543 -174.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -60.99 -39.4 89.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.412 . . . . 61.11 110.678 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 9' ' ' SER . 38.4 tp -59.01 -43.38 91.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.286 -0.416 . . . . 70.14 110.349 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -57.71 -52.21 66.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 71.53 110.087 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.69 -51.96 67.14 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.725 -0.67 . . . . 73.31 110.94 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.6 -48.04 82.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.915 -0.584 . . . . 64.31 111.125 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.464 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.1 p -66.64 -32.97 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.131 -0.322 . . . . 72.23 110.131 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.28 -45.22 92.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.092 -0.336 . . . . 73.31 110.092 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.57 -51.56 64.83 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.205 0.526 . . . . 65.45 110.0 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.99 -47.38 74.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.407 -0.815 . . . . 71.21 110.889 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 24.4 mmt -62.54 -13.39 30.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.354 0.502 . . . . 60.53 112.354 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HA ' HH11 ' A' ' 24' ' ' ARG . 2.7 tpp180 -99.06 -13.8 19.69 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.142 -0.349 . . . . 74.44 111.059 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -119.52 -26.5 5.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.295 0.569 . . . . 63.54 110.411 -173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.5 t -89.08 -15.8 8.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.946 0.879 . . . . 73.31 109.805 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 7.8 p -92.95 163.77 2.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 114.917 -1.038 . . . . 74.44 109.67 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -104.0 91.86 4.02 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.453 -0.943 . . . . 52.21 108.453 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 93.8 Cg_endo -83.01 -4.31 11.21 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.483 2.122 . . . . 63.03 111.944 -176.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -69.02 -57.64 5.17 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.036 -0.529 . . . . 74.13 110.288 177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.45 -17.49 17.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 71.44 110.546 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.82 43.34 3.62 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 116.026 -0.533 . . . . 73.12 113.351 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.0 mp -108.28 140.82 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.559 -0.534 . . . . 74.25 109.559 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -121.45 121.2 37.02 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 70.15 109.411 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.19 -27.38 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.972 -0.558 . . . . 73.43 112.014 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 p -62.19 -24.5 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 120.993 0.425 . . . . 72.42 110.817 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -65.94 -15.45 62.98 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.122 -0.49 . . . . 61.24 111.333 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.76 -16.67 61.75 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.039 0.447 . . . . 73.35 110.051 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.69 22.72 64.4 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.628 -0.715 . . . . 71.42 114.12 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HB2' HG22 ' A' ' 60' ' ' THR . 0.3 OUTLIER -98.71 -31.35 11.95 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.143 -0.688 . . . . 71.53 109.143 170.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.47 -19.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.153 -0.93 . . . . 65.0 112.342 -170.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -54.26 -23.81 16.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.786 0.327 . . . . 71.14 110.742 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.25 76.08 2.18 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.504 -0.638 . . . . 44.2 111.504 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -128.3 132.69 48.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 74.44 110.792 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -149.75 173.0 14.2 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.509 -0.922 . . . . 71.23 108.509 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 55' ' ' ALA . 20.5 m -137.2 142.63 36.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.791 -0.448 . . . . 75.45 109.791 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -113.02 121.01 43.33 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.987 -0.375 . . . . 63.43 109.987 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -78.82 112.43 15.97 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.116 -0.493 . . . . 72.41 109.819 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -110.07 158.34 14.53 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.064 -0.589 . . . . 41.32 112.273 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.32 -34.99 64.66 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 122.863 0.465 . . . . 63.43 111.377 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.63 -0.7 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.067 -0.515 . . . . 73.04 111.186 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.47 155.1 6.42 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 121.316 -0.468 . . . . 62.54 112.318 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -74.7 121.68 22.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.251 -0.277 . . . . 65.12 110.251 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.1 t -105.75 135.26 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 74.43 110.125 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -98.8 124.48 43.71 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.398 0.142 . . . . 62.14 110.802 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.2 mt -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.168 -0.308 . . . . 53.01 110.168 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 59' ' ' MET . 30.9 mm -126.28 112.72 30.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 120.686 0.279 . . . . 64.3 110.384 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m-20 -80.24 121.69 25.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.497 -0.557 . . . . 73.2 109.497 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.523 ' HG3' HG22 ' A' ' 57' ' ' ILE . 85.7 mtp -136.62 171.2 14.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.709 0.29 . . . . 70.13 110.63 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 40' ' ' LEU . 15.2 t -152.92 163.14 40.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.07 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 98.8 mt -132.47 160.35 36.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.314 -0.624 . . . . 73.32 109.314 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -48.02 -54.6 12.44 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.585 0.553 . . . . 63.01 112.117 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 t -111.64 -9.68 14.14 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.771 0.32 . . . . 50.5 110.753 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 63.68 8.4 3.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.86 -0.609 . . . . 74.54 112.194 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.38 10.48 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.605 0.717 . . . . 73.12 109.072 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 68' ' ' LEU . 27.8 m -75.63 140.31 71.44 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 114.884 -1.053 . . . . 53.32 110.362 -177.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.85 15.35 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.804 2.336 . . . . 70.13 112.81 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.0 mp -86.99 -5.78 58.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.38 -0.373 . . . . 74.21 110.459 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.6 t -61.58 -53.18 59.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.461 -0.336 . . . . 63.23 110.964 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -67.32 -27.65 67.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 74.41 110.266 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 70.0 t -65.01 -52.5 52.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.079 -0.51 . . . . 55.04 110.369 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HE1' ' A' ' 93' ' ' TRP . 2.8 pp -68.74 -29.58 44.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.637 0.256 . . . . 64.33 110.753 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' N ' HD12 ' A' ' 72' ' ' ILE . 44.8 mt-10 -62.4 -48.16 80.95 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.409 -0.359 . . . . 75.31 110.131 173.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.87 -46.81 87.79 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.949 0.404 . . . . 74.44 110.419 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 96.6 mt-30 -55.53 -53.34 57.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.694 . . . . 53.42 111.143 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.8 t -68.04 -52.26 37.38 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.03 -0.532 . . . . 75.34 111.123 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -54.78 -46.38 74.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.652 -0.129 . . . . 63.44 110.652 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.2 p -60.27 -45.08 94.55 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.339 -0.392 . . . . 62.12 111.425 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.23 -51.6 20.26 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.811 -0.355 . . . . 33.4 110.847 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.96 -29.49 70.85 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 120.884 0.373 . . . . 75.51 110.977 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 p -84.19 -27.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 44.2 109.925 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.5 -31.04 77.56 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.448 -0.661 . . . . 62.14 111.448 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.497 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 46.8 m -92.55 -10.02 39.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.897 0.379 . . . . 75.4 110.312 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.63 43.38 92.19 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.93 -0.577 . . . . 73.11 112.262 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 74.6 mt -86.43 -36.48 19.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.838 0.352 . . . . 74.53 110.9 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 55' ' ' ALA . 29.6 m -139.24 162.39 27.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.921 -0.581 . . . . 74.41 110.242 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.35 -37.28 28.53 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.855 0.36 . . . . 42.44 110.217 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -156.5 167.92 28.95 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.44 0.638 . . . . 53.43 110.715 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 55' ' ' ALA . 44.6 pt -124.44 135.55 63.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.42 -0.809 . . . . 73.41 110.689 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.559 ' HA ' ' HE ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -108.81 106.32 16.27 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.276 -0.638 . . . . 54.43 109.276 171.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.405 HG12 ' HB ' ' A' ' 57' ' ' ILE . 64.2 mt -99.32 120.02 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.782 -0.822 . . . . 74.43 108.782 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -111.5 129.93 55.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.87 -0.419 . . . . 73.13 109.87 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.604 ' HE1' HD11 ' A' ' 72' ' ' ILE . 4.8 m-90 -100.76 106.13 17.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.093 -0.503 . . . . 72.21 110.541 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.93 124.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 73.32 109.987 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -139.19 -6.93 1.38 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 74.14 111.845 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 43.5 t30 174.93 -52.82 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 122.409 0.283 . . . . 63.04 110.869 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 61.6 Cg_endo -70.55 145.75 53.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 121.739 1.626 . . . . 71.3 112.004 -178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.71 142.24 82.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.648 2.232 . . . . 72.0 111.647 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.0 m-90 -46.63 109.24 0.18 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 123.691 0.619 . . . . 71.4 111.904 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -87.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.766 -0.652 . . . . 52.12 112.132 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.37 -30.49 80.76 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.928 2.419 . . . . 75.34 112.365 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 17.3 p-10 -65.16 -10.67 33.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 71.15 111.18 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -83.08 -3.51 57.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.277 -0.42 . . . . 71.12 111.623 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.34 98.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.156 0.503 . . . . 61.04 110.875 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 90' ' ' ARG . 17.7 p -76.52 -178.11 4.51 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.571 -0.741 . . . . 73.33 112.305 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.589 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 14.3 pt-20 -51.25 -21.07 1.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.508 -0.769 . . . . 74.23 112.686 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -52.5 64.41 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.793 0.33 . . . . 72.05 110.34 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.35 -42.5 9.25 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 116.083 -0.508 . . . . 73.24 111.975 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.589 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 59.5 ttt180 -53.52 -42.31 67.25 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.155 0.582 . . . . 71.24 111.85 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.73 -24.64 63.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.906 -0.588 . . . . 62.21 111.26 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -124.54 90.41 3.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.132 -0.485 . . . . 73.3 110.846 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.4 tp -152.71 154.93 36.25 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.099 0.476 . . . . 53.32 110.513 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -67.79 -30.22 69.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 75.3 111.02 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.38 -13.69 32.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.506 . . . . 64.54 112.023 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 115' ' ' LEU . 5.9 tt -86.49 -26.08 24.79 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.723 -0.473 . . . . 63.05 109.723 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.83 21.78 2.0 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.958 -0.564 . . . . 72.42 114.135 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -93.54 -8.05 42.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.233 0.517 . . . . 72.43 109.942 177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.4 m -80.51 108.28 14.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.544 -0.753 . . . . 54.33 111.558 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.757 -0.656 . . . . 54.24 109.755 175.094 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.596 -0.602 . . . . 20.22 111.596 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.13 -62.71 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.6 2.2 . . . . 74.14 111.781 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.3 16.45 8.61 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.834 -0.621 . . . . 72.15 111.626 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 m -66.78 84.0 0.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.709 0.29 . . . . 75.11 110.423 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 36.0 ttm -156.89 34.43 0.3 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.614 0.721 . . . . 71.52 109.538 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 p -85.57 1.42 49.18 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.23 -0.895 . . . . 51.25 110.742 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -62.32 103.61 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.166 -0.924 . . . . 72.25 110.495 -172.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 m -91.36 95.13 9.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.989 -0.551 . . . . 72.14 110.822 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -162.0 140.45 9.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.721 -0.474 . . . . 75.34 109.721 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 64.74 160.93 0.12 Allowed Pre-proline 0 CA--C 1.54 0.59 0 O-C-N 123.477 0.485 . . . . 74.51 111.965 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 44.0 Cg_endo -68.83 169.02 18.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.258 1.972 . . . . 52.13 111.992 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.78 -57.48 3.7 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.43 0.9 . . . . 61.44 113.43 -172.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -63.92 -48.56 76.08 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.921 0.391 . . . . 63.02 111.001 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -63.34 -40.63 97.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.763 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.79 -46.36 88.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 73.25 110.14 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.8 tp -54.93 -55.37 31.36 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.41 -0.359 . . . . 35.21 110.998 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -50.58 70.0 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.987 -0.551 . . . . 54.44 111.292 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -59.3 -48.39 81.82 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.894 -0.594 . . . . 74.13 111.12 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.43 -33.83 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.928 -0.397 . . . . 74.12 109.928 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -58.96 -48.74 80.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 110.088 -0.338 . . . . 64.11 110.088 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -68.15 -45.61 73.08 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.289 -0.414 . . . . 74.13 110.839 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -57.15 -38.85 74.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.049 0.452 . . . . 72.11 110.679 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 19.5 mmt -62.69 -12.68 25.18 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.606 -0.725 . . . . 72.24 111.563 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.4 tpp180 -85.79 -23.36 27.26 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.623 0.249 . . . . 72.45 110.82 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.63 -27.43 9.38 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.363 0.505 . . . . 50.04 112.363 -174.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 22' ' ' ALA . 23.5 m -95.92 21.11 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.22 0.533 . . . . 73.12 111.099 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 5.2 p -134.27 161.32 40.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 71.32 110.589 -176.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.25 93.68 1.94 Allowed Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 107.957 -1.127 . . . . 51.05 107.957 165.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 95.6 Cg_endo -82.93 -9.8 10.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.226 1.951 . . . . 72.23 111.392 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -68.5 -41.81 79.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.146 -0.934 . . . . 72.11 110.439 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.94 -18.56 11.24 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.276 -0.42 . . . . 73.12 110.377 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.86 44.02 3.45 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.224 -0.512 . . . . 74.24 113.655 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -121.64 141.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.965 -0.754 . . . . 61.25 108.965 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' OD1' ' HB ' ' A' ' 36' ' ' VAL . 8.7 p30 -107.73 141.85 38.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.771 -0.455 . . . . 74.24 109.771 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.77 -29.41 42.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.328 0.585 . . . . 72.45 110.747 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HB ' ' OD1' ' A' ' 34' ' ' ASN . 43.8 t -60.11 -24.62 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.688 -0.687 . . . . 75.04 110.548 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -56.04 -28.93 59.48 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.503 -0.317 . . . . 72.32 111.254 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.13 -14.55 60.82 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.154 0.502 . . . . 75.31 110.504 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.65 22.17 52.22 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.218 -0.901 . . . . 73.12 114.024 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 41.0 tp -98.22 -29.69 13.05 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.329 -0.619 . . . . 43.21 109.329 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -59.45 -13.15 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 115.204 -0.907 . . . . 62.23 111.145 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.14 -23.26 62.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.06 0.457 . . . . 65.34 109.882 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.06 50.37 3.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.741 -0.663 . . . . 53.34 112.163 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -109.09 136.88 47.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.715 -0.476 . . . . 75.41 109.715 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -157.25 113.82 2.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 74.14 109.76 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 5.7 p -90.3 125.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.781 -0.452 . . . . 74.54 109.781 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -125.13 153.24 43.31 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.053 0.454 . . . . 74.12 110.314 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -81.34 151.86 27.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.557 -0.747 . . . . 62.25 110.387 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -168.57 159.77 33.04 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.074 -0.81 . . . . 73.44 111.074 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.14 -21.06 60.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.079 0.439 . . . . 62.51 110.929 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.01 -20.27 62.42 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.979 -0.748 . . . . 61.44 108.979 171.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.15 162.24 9.46 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.909 -1.041 . . . . 72.24 111.103 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.6 m -70.92 107.03 3.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.505 -0.924 . . . . 73.44 108.505 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -107.24 130.01 60.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.042 -0.526 . . . . 54.14 111.46 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -92.45 104.38 16.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 62.2 110.558 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 90' ' ' ARG . 48.8 mt -78.18 128.67 34.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.003 -0.74 . . . . 65.4 109.003 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.517 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.0 mt -141.01 116.64 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.833 0.349 . . . . 64.44 110.686 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.41 122.76 30.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 75.21 109.726 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.517 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.2 mtp -135.63 170.56 15.78 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.4 0.619 . . . . 72.34 111.721 -174.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -161.97 150.16 14.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.104 -0.953 . . . . 65.44 109.39 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.59 148.46 22.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.738 -0.838 . . . . 73.32 108.738 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 -48.58 30.82 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.51 0.559 . . . . 43.41 112.51 -172.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 26.5 t -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.869 0.366 . . . . 73.2 110.677 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.52 8.33 1.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.762 -0.653 . . . . 73.03 112.003 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.22 3.81 10.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.211 0.529 . . . . 75.22 110.177 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 63' ' ' SER . 27.5 m -81.04 126.72 76.59 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.486 -0.779 . . . . 74.52 110.657 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.63 32.02 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.014 2.476 . . . . 65.03 112.346 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.02 6.61 18.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.044 -0.526 . . . . 74.02 110.794 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -56.94 -42.8 80.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 73.02 110.866 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.47 -41.31 98.69 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.401 0.62 . . . . 75.03 110.163 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.39 -46.5 92.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.234 -0.894 . . . . 70.11 110.857 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.6 pt -69.17 -37.87 77.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 121.198 -0.201 . . . . 51.43 111.068 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -58.84 -49.6 77.12 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.829 0.347 . . . . 74.22 110.683 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.08 -51.39 68.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.53 111.118 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -63.1 -38.55 91.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.43 -0.35 . . . . 71.04 111.816 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.417 ' O ' HD23 ' A' ' 80' ' ' LEU . 61.6 p -67.22 -54.97 16.17 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.904 -0.406 . . . . 61.44 109.904 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -54.76 -41.6 70.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.968 -0.56 . . . . 71.43 110.932 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.8 m -54.89 -53.16 59.0 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.275 -0.42 . . . . 51.41 111.763 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -51.56 13.85 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.65 -0.42 . . . . 74.03 111.221 -177.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -58.6 -37.9 76.83 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.046 0.451 . . . . 74.31 111.51 -173.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.8 t -82.34 -27.37 8.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.936 -0.574 . . . . 63.32 110.193 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.28 -47.26 91.68 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.303 -0.475 . . . . 34.22 112.496 -172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.6 m -87.54 -5.1 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.409 . . . . 63.32 110.498 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.88 31.46 69.97 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.922 -0.581 . . . . 64.03 112.811 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.09 -38.21 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.029 0.442 . . . . 74.54 110.319 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 80' ' ' LEU . 20.6 m -128.39 159.48 39.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.94 -0.573 . . . . 53.12 110.049 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.7 -30.95 24.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.496 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -158.23 165.78 34.01 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.213 -0.449 . . . . 75.13 110.134 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -128.05 144.35 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.76 -0.459 . . . . 75.15 109.76 179.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.429 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.9 tpp180 -127.43 106.09 8.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.2 -0.667 . . . . 74.13 109.2 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 57.6 mt -100.45 143.85 13.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.751 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.718 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -117.38 120.36 37.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.348 -0.982 . . . . 74.05 108.348 175.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.554 ' HH2' ' HA ' ' A' ' 105' ' ' THR . 8.8 m-90 -97.85 106.32 18.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.779 -0.452 . . . . 72.2 109.779 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.506 HG21 ' HE1' ' A' ' 99' ' ' TRP . 12.1 t -90.97 123.72 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.326 -0.397 . . . . 64.43 110.123 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -119.53 -24.13 6.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.809 -0.632 . . . . 73.4 109.592 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 49.7 t30 175.8 -49.7 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.095 -0.957 . . . . 61.52 110.418 -173.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 48.9 Cg_endo -67.59 145.17 69.3 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.818 1.679 . . . . 51.44 111.971 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 27.4 Cg_exo -63.91 168.55 11.86 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.003 2.469 . . . . 73.54 112.485 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.506 ' HE1' HG21 ' A' ' 94' ' ' VAL . 10.8 m0 -69.54 165.46 20.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.945 -0.57 . . . . 73.45 111.222 -176.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 153.11 -129.53 2.75 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.977 -0.556 . . . . 41.03 111.827 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.7 -9.63 19.23 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.859 2.372 . . . . 72.44 112.489 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.59 -15.39 58.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.77 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.718 ' HG2' ' HB2' ' A' ' 92' ' ' ASN . 52.3 mttp -76.17 -9.76 58.88 Favored 'General case' 0 N--CA 1.458 -0.066 0 CA-C-N 116.329 -0.396 . . . . 72.4 110.939 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.52 96.83 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.132 -0.692 . . . . 74.21 109.132 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.554 ' HA ' ' HH2' ' A' ' 93' ' ' TRP . 19.5 p -62.24 156.35 22.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.871 -0.604 . . . . 73.43 111.693 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -56.85 -33.18 66.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.762 -0.654 . . . . 64.21 110.217 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 21.8 t70 -56.78 -45.58 82.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.616 -0.72 . . . . 63.51 110.358 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.54 98.68 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.804 -0.634 . . . . 71.1 111.965 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -57.63 -41.65 81.79 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.009 0.433 . . . . 75.5 110.161 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -67.32 -23.59 65.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.659 -0.7 . . . . 73.41 111.886 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.438 ' HA ' ' HB3' ' A' ' 114' ' ' ALA . 43.6 mt-30 -109.08 5.61 24.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.012 0.434 . . . . 74.12 110.836 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.6 -69.57 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.496 -0.774 . . . . 71.1 109.826 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -53.42 -29.44 35.2 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 74.15 109.604 175.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 111' ' ' GLN . . . -69.56 -7.17 36.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.826 -1.079 . . . . 41.04 112.166 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 115' ' ' LEU . 4.2 pp -62.55 -18.75 62.71 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.921 0.341 . . . . 74.44 111.921 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.0 39.4 1.96 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.905 -0.664 . . . . 75.33 112.701 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 73.6 t80 64.82 4.31 2.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.006 0.431 . . . . 75.54 111.565 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 m -71.2 85.55 0.76 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.945 0.402 . . . . 62.43 110.792 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.17 -0.919 . . . . 64.32 110.315 178.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 111.838 -0.505 . . . . 31.43 111.838 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.76 110.3 2.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.585 2.19 . . . . 75.24 111.902 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.78 102.6 0.23 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.166 -0.54 . . . . 73.53 111.77 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.8 t -166.89 -178.62 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.986 -0.375 . . . . 43.23 109.986 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.8 ptp -128.99 14.83 6.32 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.177 -0.675 . . . . 70.32 109.177 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 p -150.16 -157.3 0.8 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.13 -0.941 . . . . 64.0 109.456 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 61.62 83.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 71.42 111.745 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.0 p -136.95 107.8 6.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.03 -0.532 . . . . 61.3 110.816 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.601 ' HB3' HD23 ' A' ' 85' ' ' LEU . 22.8 t -158.5 157.96 33.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.661 -0.866 . . . . 62.25 108.661 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 67.85 164.84 0.13 Allowed Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 123.317 0.386 . . . . 74.41 110.685 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 26.2 Cg_endo -62.55 153.43 71.52 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.241 1.96 . . . . 73.41 111.761 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.46 -44.63 12.48 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.878 0.696 . . . . 71.43 112.878 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -63.2 -51.63 65.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.999 0.428 . . . . 63.02 110.896 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -67.44 -44.25 79.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 72.33 110.611 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -56.49 -42.34 78.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.032 -0.531 . . . . 54.12 110.537 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.9 tp -55.91 -58.32 8.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.878 -0.601 . . . . 73.55 110.875 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.24 89.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.02 -0.536 . . . . 61.34 111.331 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.64 -48.03 81.13 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.009 -0.541 . . . . 74.01 110.871 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -70.13 -33.65 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.471 -0.331 . . . . 54.32 110.356 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -56.61 -49.81 73.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.024 0.44 . . . . 71.05 109.849 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -65.72 -48.47 71.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 74.31 110.513 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -37.66 73.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.853 -0.612 . . . . 72.01 111.758 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.8 mmt -71.22 -13.54 61.95 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.078 0.466 . . . . 63.32 110.051 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -101.61 0.74 36.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.511 -0.768 . . . . 74.54 111.372 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -119.46 -27.85 5.47 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.289 0.566 . . . . 74.2 110.063 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.2 t -92.39 -16.91 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.895 -1.048 . . . . 53.14 110.757 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.3 p -84.83 165.42 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.574 . . . . 54.41 110.33 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -104.45 87.82 1.88 Allowed Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 108.758 -0.83 . . . . 70.31 108.758 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 89.4 Cg_endo -84.98 -1.66 9.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.457 2.105 . . . . 75.04 111.071 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' HG2' HD12 ' A' ' 31' ' ' LEU . 41.7 tt0 -68.58 -57.65 5.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.442 -0.799 . . . . 74.25 110.206 178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.405 HD12 ' HG2' ' A' ' 30' ' ' GLU . 7.3 mp -98.95 -17.14 18.48 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.841 -0.429 . . . . 73.05 109.841 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.76 40.97 4.24 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.984 -0.553 . . . . 61.15 113.415 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -108.9 140.18 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.343 -0.614 . . . . 71.14 109.343 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.635 ' HA ' HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -108.67 138.17 45.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.229 -0.656 . . . . 63.33 109.229 178.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.11 -30.17 47.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.168 0.509 . . . . 63.41 110.678 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 34' ' ' ASN . 13.5 p -58.24 -24.39 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.798 -0.637 . . . . 74.33 110.655 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.62 -29.1 58.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.707 -0.678 . . . . 61.41 111.195 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.7 -17.06 61.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.913 0.387 . . . . 73.2 110.488 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.51 22.71 57.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.732 -0.667 . . . . 64.02 113.371 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD21 HG13 ' A' ' 94' ' ' VAL . 33.1 tp -98.06 -16.73 19.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.881 0.372 . . . . 64.3 110.079 175.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.55 -15.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.898 -0.592 . . . . 74.43 111.298 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -70.04 -23.16 63.06 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.598 0.713 . . . . 74.33 109.121 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' ASP . . . -85.44 95.67 2.01 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.956 -1.02 . . . . 61.15 111.031 176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -146.47 132.74 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.157 -0.683 . . . . 63.3 109.157 173.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.99 109.02 9.74 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.306 -0.628 . . . . 74.4 109.306 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 55' ' ' ALA . 16.1 m -93.56 115.09 31.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.276 -0.638 . . . . 74.21 109.276 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.8 124.27 42.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.531 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.29 89.13 5.5 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.729 0.776 . . . . 62.1 109.729 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.38 164.55 45.71 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 114.511 -1.222 . . . . 72.35 111.481 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -56.2 -37.04 69.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.001 0.429 . . . . 61.41 110.575 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -71.24 -39.66 71.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 75.32 110.079 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 164.48 -178.44 39.73 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.702 -0.681 . . . . 64.21 111.549 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.1 m -81.75 112.2 18.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.811 0.339 . . . . 73.12 110.62 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.39 124.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 74.01 109.866 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -88.54 106.34 18.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 73.54 111.083 -175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.97 101.97 14.61 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.913 -0.403 . . . . 74.11 109.913 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.508 HG22 ' HG3' ' A' ' 59' ' ' MET . 53.3 mt -96.93 132.31 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.567 -0.288 . . . . 73.24 110.617 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.2 m-20 -94.01 113.45 25.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.03 110.076 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 90.2 mtp -141.04 171.05 14.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 73.34 110.646 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -163.05 162.05 25.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 65.23 109.649 173.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.6 mm? -106.6 171.83 7.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.945 -0.761 . . . . 41.05 108.945 176.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -44.63 -56.76 4.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.118 0.485 . . . . 73.54 111.48 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.6 t -104.22 -2.28 25.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 64.43 110.672 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.85 8.82 2.63 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.917 -0.583 . . . . 54.53 112.033 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.88 -8.81 12.53 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.994 0.426 . . . . 63.13 110.47 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 8.0 m -57.49 139.82 80.47 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.459 -0.791 . . . . 74.23 111.004 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.85 17.56 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.011 2.474 . . . . 71.43 112.788 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.33 -4.16 58.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 65.24 110.462 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 70' ' ' ASP . 4.8 t -61.93 -54.01 47.72 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.329 -0.396 . . . . 63.42 111.339 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 69' ' ' THR . 6.8 p-10 -64.98 -28.54 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.597 -0.52 . . . . 73.44 109.597 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 60.1 t -65.88 -52.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.49 -0.777 . . . . 75.53 110.52 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.9 pp -69.02 -32.39 54.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 121.108 -0.237 . . . . 73.01 111.585 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' N ' HD12 ' A' ' 72' ' ' ILE . 8.5 mt-10 -64.5 -45.04 89.01 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.589 -0.444 . . . . 64.31 109.874 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -58.01 -49.12 77.94 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.104 -0.498 . . . . 74.15 110.764 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 95.3 mt-30 -56.82 -55.91 28.33 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.981 -0.554 . . . . 72.03 110.868 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.2 t -61.15 -53.23 59.57 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.94 -0.573 . . . . 73.54 110.798 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -56.12 -48.88 75.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.141 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -53.68 -50.58 65.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.153 -0.476 . . . . 64.34 111.161 -175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.74 14.21 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.694 -0.402 . . . . 63.14 111.556 -176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD12 HG21 ' A' ' 89' ' ' ILE . 78.8 mt -60.96 -37.35 82.1 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.051 0.453 . . . . 53.43 110.921 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.2 t -78.21 -27.73 14.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 64.12 110.145 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.5 -48.05 46.55 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.018 -0.611 . . . . 64.45 111.746 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.8 t -82.09 -23.13 35.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.134 0.492 . . . . 74.25 109.854 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.77 42.03 6.98 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.977 -0.556 . . . . 63.01 113.533 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 9' ' ' SER . 6.2 mp -71.0 -38.27 72.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.975 0.417 . . . . 74.43 109.887 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.5 m -137.1 170.02 18.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.61 -0.723 . . . . 74.22 110.011 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -68.19 -48.66 64.62 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.285 0.564 . . . . 70.23 109.556 178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -164.4 -179.03 5.77 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.089 -0.959 . . . . 64.35 108.587 175.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 80' ' ' LEU . 35.1 pt -122.43 177.92 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.371 0.605 . . . . 64.32 111.167 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.732 ' HG2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -155.56 106.01 2.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.496 -1.298 . . . . 74.22 107.496 170.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 73' ' ' GLU . 52.6 mt -95.56 101.25 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.609 -0.515 . . . . 74.45 109.609 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -88.78 139.93 29.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.712 -0.676 . . . . 52.13 109.364 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.592 ' HA ' ' O ' ' A' ' 59' ' ' MET . 3.3 m-90 -95.25 106.07 18.07 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.553 -0.536 . . . . 73.43 109.553 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.474 HG13 HD21 ' A' ' 40' ' ' LEU . 3.4 p -120.03 124.25 72.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.31 0.576 . . . . 73.44 110.175 -177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 1.1 p-90 -147.96 11.89 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.27 -0.877 . . . . 64.1 110.111 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 35.5 t30 -174.94 -60.92 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.968 -0.56 . . . . 74.42 111.347 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 85.0 Cg_endo -78.26 140.02 17.18 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.755 1.637 . . . . 42.05 112.528 -172.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.56 151.84 51.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.662 2.241 . . . . 62.1 111.38 174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -59.74 123.9 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 61.14 111.224 -172.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.54 -120.04 1.52 Allowed Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.003 -0.544 . . . . 64.13 111.765 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.36 -14.91 45.07 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.628 2.219 . . . . 74.34 111.66 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.47 -26.62 61.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.533 -0.758 . . . . 71.13 110.325 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 73.8 mmtt -77.09 9.03 3.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.925 -0.58 . . . . 74.51 111.457 -178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.41 134.16 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 110.047 -0.353 . . . . 72.44 110.047 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.732 HG23 ' HG2' ' A' ' 90' ' ' ARG . 12.3 p -66.12 151.29 47.24 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.787 0.327 . . . . 42.42 111.587 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.28 -39.54 89.46 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.887 -0.783 . . . . 74.1 108.887 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -57.03 -48.63 78.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 114.945 -1.025 . . . . 75.22 109.747 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.06 -44.23 98.06 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.373 -0.83 . . . . 22.42 112.692 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -63.58 -40.49 97.08 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.674 0.237 . . . . 74.42 110.708 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -61.82 -35.82 79.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.146 0.498 . . . . 73.3 110.836 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -105.87 24.94 11.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.782 -0.645 . . . . 71.11 110.717 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.4 tp -80.07 158.24 26.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.519 . . . . 72.54 109.697 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -66.89 -32.33 73.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.055 0.455 . . . . 75.11 110.522 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.77 -7.45 53.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.723 -0.671 . . . . 62.34 111.51 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.95 24.71 8.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.219 0.533 . . . . 75.0 109.92 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.54 68.64 0.22 Allowed Glycine 0 CA--C 1.519 0.32 0 CA-C-N 115.866 -0.607 . . . . 73.21 112.673 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -121.2 167.11 13.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 74.31 110.589 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -81.83 150.68 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.854 -0.612 . . . . 74.21 110.637 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.676 -0.678 . . . . 64.21 110.066 178.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 N-CA-C 111.807 -0.517 . . . . 50.12 111.807 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.84 121.24 8.69 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.41 2.073 . . . . 74.23 111.167 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.75 117.4 3.45 Favored Glycine 0 C--O 1.236 0.275 0 C-N-CA 121.029 -0.605 . . . . 43.14 111.724 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 t -92.54 118.43 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.333 -0.617 . . . . 50.44 109.333 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.3 mtm -80.09 158.86 26.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.02 0.438 . . . . 75.32 110.932 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.2 t -144.5 -51.87 0.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.076 -0.713 . . . . 63.43 109.076 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 51.68 33.49 11.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.081 -0.963 . . . . 74.51 112.321 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 m -73.19 84.98 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.696 0.284 . . . . 43.23 110.578 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.1 t -171.78 152.66 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 74.1 109.78 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.63 154.82 0.14 Allowed Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 123.441 0.463 . . . . 72.23 112.023 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 14' ' ' GLU . 29.8 Cg_endo -66.01 168.61 15.15 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.469 2.112 . . . . 63.43 111.951 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.96 -67.22 0.27 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.184 1.179 . . . . 72.24 114.184 -167.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -72.82 -35.1 67.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.69 -0.404 . . . . 74.4 111.187 -172.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 11' ' ' PRO . 20.0 mp0 -57.7 -46.84 83.82 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.591 -0.522 . . . . 54.53 109.591 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.8 -46.72 89.4 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.475 -0.784 . . . . 75.1 110.739 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.6 tp -52.79 -60.31 3.43 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.295 0.569 . . . . 54.35 110.874 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.65 -50.44 69.28 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.702 -0.681 . . . . 73.03 111.091 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.86 -41.19 97.84 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.74 -0.664 . . . . 74.42 111.322 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.83 -35.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.575 -0.528 . . . . 43.04 109.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.19 -45.94 79.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.948 0.404 . . . . 74.22 109.966 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -72.37 -43.55 63.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 63.02 111.014 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.06 78.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.803 -0.635 . . . . 73.4 110.885 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 17.8 mmt -62.66 -13.44 32.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.579 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -87.28 -23.04 24.81 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.503 0.192 . . . . 65.34 111.428 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -116.01 -27.02 7.08 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.318 0.58 . . . . 73.13 110.11 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.85 -27.18 15.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.032 -0.985 . . . . 62.32 110.101 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.5 p -91.32 165.1 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 63.32 109.697 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -105.5 91.95 5.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.81 . . . . 74.04 108.812 169.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.9 -7.53 13.3 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.326 2.017 . . . . 75.02 111.178 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -68.67 -57.96 4.93 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.28 -0.873 . . . . 72.43 110.619 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.49 -18.61 17.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.041 -0.527 . . . . 75.12 110.241 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.21 52.12 1.94 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.247 -0.501 . . . . 64.31 113.173 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.8 mp -126.91 141.55 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.667 -0.494 . . . . 62.11 109.667 175.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.444 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.4 p30 -108.77 138.6 44.84 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.017 -0.734 . . . . 75.22 109.017 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.15 -36.25 50.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.161 0.505 . . . . 74.44 111.312 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.78 -24.93 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.931 -0.577 . . . . 74.41 110.875 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -59.2 -26.04 64.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.357 -0.383 . . . . 65.52 111.358 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.53 -15.34 63.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.53 110.588 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.64 22.38 46.15 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.71 -0.677 . . . . 63.05 113.949 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -22.66 16.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.825 -0.806 . . . . 74.44 108.825 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.77 -4.96 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.188 -0.914 . . . . 72.15 111.731 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -66.3 -19.08 65.71 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.066 0.46 . . . . 73.25 110.044 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.96 110.47 3.94 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.241 -0.744 . . . . 44.23 111.241 174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.9 pp -167.34 149.63 5.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.302 -0.258 . . . . 70.4 110.302 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -163.69 122.51 1.98 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.804 -0.443 . . . . 74.45 109.804 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 p -99.54 118.34 46.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 75.31 110.129 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -113.4 137.47 51.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.128 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 8.8 p-10 -91.83 154.36 18.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 74.0 110.158 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.16 162.47 30.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.16 -0.543 . . . . 72.42 112.031 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.21 -29.48 70.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.126 0.489 . . . . 64.41 110.507 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.98 -24.5 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.765 -0.652 . . . . 71.24 109.907 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.53 15.21 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.044 -0.525 . . . . 44.22 111.925 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 16.8 m -93.68 120.41 33.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.881 -0.414 . . . . 72.11 109.881 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.2 p -115.62 131.58 67.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.218 0.533 . . . . 73.45 111.442 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.504 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.51 116.04 29.86 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.56 -0.746 . . . . 53.12 110.544 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 55.8 mt -96.44 117.4 30.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.088 -0.338 . . . . 71.44 110.088 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.529 HG22 ' HG3' ' A' ' 59' ' ' MET . 39.9 mm -115.09 118.05 57.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.717 -0.475 . . . . 74.4 109.717 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.39 118.63 28.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.531 -0.544 . . . . 42.22 109.531 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.529 ' HG3' HG22 ' A' ' 57' ' ' ILE . 71.9 mtp -141.02 170.92 14.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 45.32 111.364 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.9 t -147.13 175.16 10.94 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.944 -0.761 . . . . 61.52 108.944 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.6 mm? -109.73 150.78 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.585 -0.524 . . . . 63.21 109.585 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.2 p -46.61 -54.8 8.73 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.616 0.572 . . . . 73.12 112.489 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.7 t -104.02 -1.38 27.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.33 -0.395 . . . . 73.51 110.627 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.05 8.3 1.43 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.058 0.543 . . . . 41.44 112.184 -177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.95 -17.46 8.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.279 0.562 . . . . 41.32 109.966 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 4.1 p -87.3 114.43 58.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 71.13 110.42 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 7.5 Cg_exo -72.83 73.78 2.95 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.996 2.464 . . . . 62.25 112.89 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 4.2 mm? -94.29 9.53 37.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.3 0.572 . . . . 74.11 109.81 172.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.471 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.1 t -60.25 -37.81 81.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.703 -0.68 . . . . 52.55 110.572 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.74 -53.32 59.49 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.137 0.494 . . . . 71.42 110.199 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 11.8 p -66.11 -46.37 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 115.955 -0.566 . . . . 74.11 111.01 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 69' ' ' THR . 32.6 pt -62.61 -38.92 82.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 120.42 -0.512 . . . . 72.13 111.018 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.49 -43.38 90.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.011 -0.54 . . . . 53.24 110.71 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.84 -39.76 79.79 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.858 -0.337 . . . . 71.25 110.28 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 98.8 mt-30 -56.15 -52.59 63.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.07 0.462 . . . . 65.33 110.218 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.3 m -60.03 -52.18 66.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.697 -0.683 . . . . 64.33 110.627 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.622 ' O ' HG12 ' A' ' 81' ' ' VAL . 6.0 tmm_? -54.43 -52.91 60.29 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.852 -0.613 . . . . 71.02 111.0 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -52.85 -53.24 51.65 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.605 0.566 . . . . 63.33 111.535 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.76 -52.51 11.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.259 -0.576 . . . . 64.2 110.995 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.74 -40.2 75.32 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.816 0.341 . . . . 72.52 111.441 -169.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 77' ' ' ARG . 4.8 p -89.31 -27.38 5.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 74.4 110.193 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.01 -24.92 70.4 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.646 -0.787 . . . . 71.54 111.658 -167.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.753 ' HB3' ' HG ' ' A' ' 85' ' ' LEU . 9.2 t -87.17 -11.85 48.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.224 0.535 . . . . 61.01 109.962 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.41 22.84 61.78 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.581 -0.736 . . . . 34.02 112.023 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.753 ' HG ' ' HB3' ' A' ' 83' ' ' SER . 82.1 mt -74.39 -53.51 9.47 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.028 0.442 . . . . 72.33 110.415 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 55' ' ' ALA . 33.4 m -124.91 165.91 21.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.986 -0.552 . . . . 64.14 110.611 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.66 -47.92 8.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.907 -0.588 . . . . 51.31 109.787 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.3 m-20 -135.11 169.7 17.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.634 -0.712 . . . . 53.21 110.65 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.2 pt -134.94 175.97 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.92 -0.582 . . . . 71.2 110.368 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.704 ' HD3' ' HA ' ' A' ' 105' ' ' THR . 26.3 tpt180 -164.61 119.84 1.44 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.551 -0.75 . . . . 74.11 109.815 171.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 47.2 mt -97.12 123.28 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 73.32 110.009 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.513 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 26.6 t30 -93.89 115.0 27.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.851 -0.613 . . . . 63.24 109.539 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -84.39 106.22 15.82 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.582 -0.525 . . . . 64.01 109.582 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG21 ' HE1' ' A' ' 99' ' ' TRP . 28.0 t -93.93 124.13 46.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.639 . . . . 75.52 110.473 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -113.33 -20.62 11.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.03 110.801 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.454 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 t-20 -177.01 -57.32 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 116.036 -0.529 . . . . 65.4 111.092 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 41.0 Cg_endo -64.1 151.39 85.54 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.137 1.891 . . . . 61.44 112.701 -172.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.44 157.15 52.26 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.627 2.218 . . . . 75.14 111.582 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.834 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 5.9 m0 -64.78 130.78 44.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.034 -0.53 . . . . 74.04 110.7 -175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -159.08 -120.95 0.59 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.728 -0.749 . . . . 73.55 113.415 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.5 -36.34 66.09 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.287 2.658 . . . . 75.25 113.638 -171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -59.3 -14.46 11.45 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.028 0.442 . . . . 60.13 111.247 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HD2' ' HB3' ' A' ' 99' ' ' TRP . 36.3 mtpt -77.17 10.04 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.268 -0.423 . . . . 64.03 111.041 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.5 mt -95.4 122.92 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 110.003 -0.369 . . . . 64.44 110.003 170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.704 ' HA ' ' HD3' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -50.79 161.45 0.35 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.919 0.711 . . . . 74.32 112.919 176.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -51.26 -39.58 57.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.945 -1.025 . . . . 75.33 112.53 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -56.78 -40.7 76.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.319 -0.401 . . . . 71.34 110.83 -176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.15 -27.68 72.58 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 116.16 -0.473 . . . . 65.25 112.636 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -73.49 -51.07 18.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 74.51 111.583 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.71 -35.34 26.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.433 -0.348 . . . . 62.3 111.75 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -120.09 99.12 6.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.125 0.488 . . . . 75.12 111.365 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 112' ' ' LEU . 3.3 mm? -83.05 165.91 19.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 62.14 109.725 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -61.55 -29.89 70.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.84 0.352 . . . . 73.01 110.298 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.26 -24.12 40.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.776 -0.647 . . . . 71.34 111.115 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.77 18.48 2.88 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.862 -0.608 . . . . 71.33 109.827 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.54 85.09 0.03 OUTLIER Glycine 0 C--N 1.338 0.669 0 N-CA-C 111.258 -0.737 . . . . 62.34 111.258 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -61.61 146.79 47.84 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.16 0.505 . . . . 63.32 111.898 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.4 m -85.08 129.33 34.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.503 -0.771 . . . . 75.14 109.937 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.922 -0.561 . . . . 72.03 109.708 178.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.968 -0.453 . . . . 74.21 111.968 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.81 135.19 40.42 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.82 2.347 . . . . 62.11 111.834 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.99 156.33 53.58 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 121.177 -0.535 . . . . 71.34 112.495 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.52 ' HA ' HG21 ' A' ' 36' ' ' VAL . 16.8 p -66.06 130.85 44.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.558 0.218 . . . . 64.14 110.638 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.3 mmt -72.26 135.38 46.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.271 -0.422 . . . . 75.54 110.721 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.509 ' HB3' HG23 ' A' ' 19' ' ' VAL . 9.8 t -171.98 -42.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.179 -1.045 . . . . 73.23 108.179 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.639 ' HB3' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.42 56.49 0.86 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.647 -1.16 . . . . 74.41 110.483 176.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 m -116.39 91.75 3.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.026 -0.533 . . . . 74.44 110.845 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t 64.19 14.05 8.33 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.774 -0.648 . . . . 64.2 112.387 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.05 148.9 51.74 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 110.671 -0.122 . . . . 75.33 110.671 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 14' ' ' GLU . 18.9 Cg_endo -57.91 131.07 41.56 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.74 2.293 . . . . 62.43 111.731 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.29 -51.92 17.77 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.494 0.924 . . . . 64.3 113.494 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.68 -50.32 74.32 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.009 0.433 . . . . 71.14 111.043 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 11' ' ' PRO . 35.6 tt0 -64.62 -46.7 81.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.562 -0.744 . . . . 72.2 110.353 178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 7' ' ' GLU . 3.1 tm? -63.89 -36.55 84.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.919 -1.037 . . . . 74.11 111.209 -173.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.2 tp -53.07 -55.31 24.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.172 0.51 . . . . 75.04 109.772 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -64.83 -47.13 79.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.313 -0.858 . . . . 30.14 110.847 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.18 -48.39 81.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 75.34 111.211 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 6' ' ' SER . 4.6 p -71.37 -34.35 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.419 -0.355 . . . . 71.22 110.211 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.04 -40.3 93.09 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.998 0.428 . . . . 71.25 110.025 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 24.8 mm-40 -72.26 -47.24 51.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.906 -0.588 . . . . 73.24 110.226 176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.94 65.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.934 -177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.1 mmt -59.05 -13.65 7.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.178 -0.465 . . . . 73.41 111.579 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 63.1 ttt-85 -93.8 -29.44 15.35 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.596 0.358 . . . . 74.43 111.31 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -119.97 -5.14 10.07 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.215 0.531 . . . . 64.12 110.346 -168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 99.9 t -107.01 19.95 5.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.505 1.145 . . . . 70.31 109.317 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.606 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 11.6 p -148.25 160.8 6.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.571 -1.195 . . . . 55.54 108.47 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.57 98.28 3.55 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.461 -0.57 . . . . 75.13 109.461 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 96.2 Cg_endo -87.68 -1.08 7.41 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.705 2.27 . . . . 74.41 111.655 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.6 -57.49 5.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 75.12 109.957 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.32 -14.56 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 75.5 110.654 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.97 47.76 2.59 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.182 -0.532 . . . . 71.41 112.981 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.2 mp -110.52 143.27 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 109.822 -0.436 . . . . 75.04 109.822 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.8 t30 -115.02 111.67 21.47 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.098 -0.501 . . . . 65.53 110.015 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.8 -39.68 72.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.28 0.562 . . . . 61.05 110.105 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 4' ' ' SER . 47.6 t -60.94 -24.57 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.508 -0.769 . . . . 73.31 110.598 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 25.3 t70 -64.43 -22.97 67.12 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.902 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.74 -8.6 56.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.185 0.517 . . . . 74.34 110.227 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.71 22.32 53.03 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 115.142 -0.935 . . . . 63.42 114.229 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 tt -98.23 -32.13 11.72 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.453 -0.573 . . . . 73.21 109.453 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.26 -11.0 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.557 -0.747 . . . . 65.23 110.217 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -64.07 -21.19 66.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.512 -0.767 . . . . 72.24 109.406 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.42 64.25 3.55 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.522 -0.763 . . . . 71.43 112.024 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.5 pp -107.66 142.31 37.82 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.899 -0.408 . . . . 72.12 109.899 175.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.3 118.86 4.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 74.45 109.088 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -102.59 123.93 56.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.757 0.313 . . . . 74.23 110.677 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.599 HE21 HD21 ' A' ' 56' ' ' LEU . 24.8 pt20 -97.74 120.9 38.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.255 -0.646 . . . . 53.45 109.255 175.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.07 129.75 56.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.066 -0.515 . . . . 64.33 110.348 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.89 167.7 28.23 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.221 -0.752 . . . . 71.0 111.221 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.6 -31.67 66.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.898 0.38 . . . . 72.42 110.687 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.44 -31.14 70.24 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.862 -0.608 . . . . 63.32 110.565 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 163.98 163.44 16.91 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 116.081 -0.509 . . . . 71.22 112.189 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.2 m -110.71 109.09 19.19 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.558 -0.534 . . . . 74.12 109.558 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.05 123.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.577 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -89.98 109.88 20.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.28 -0.418 . . . . 52.13 110.966 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.599 HD21 HE21 ' A' ' 47' ' ' GLN . 12.3 mt -91.23 107.43 19.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.749 -0.463 . . . . 73.24 109.749 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.3 mt -110.6 117.61 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 110.094 -0.335 . . . . 72.45 110.094 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.36 122.04 26.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 110.247 -0.279 . . . . 72.24 110.247 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 83.5 mtp -141.17 170.88 14.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.428 0.632 . . . . 74.41 111.246 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.2 t -160.49 158.8 29.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.659 -0.7 . . . . 72.33 109.486 174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -99.89 160.74 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.985 -0.376 . . . . 62.05 109.985 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.4 m -45.92 -56.03 5.97 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 123.604 0.565 . . . . 65.35 112.405 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.2 m -103.0 4.58 37.52 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.934 0.397 . . . . 63.44 110.633 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 8.11 1.06 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.448 0.699 . . . . 71.43 112.398 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.42 2.45 10.76 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.221 0.534 . . . . 73.22 110.048 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.628 ' HB3' HD13 ' A' ' 68' ' ' LEU . 14.1 m -81.66 120.93 79.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.391 -0.822 . . . . 74.43 110.389 -175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.13 33.44 0.41 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.921 2.414 . . . . 74.42 113.186 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 66' ' ' CYS . 9.0 mp -79.76 3.08 20.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.946 0.403 . . . . 73.33 110.616 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.8 t -57.37 -44.23 84.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.03 -0.532 . . . . 54.14 110.789 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.32 -41.44 69.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.222 0.534 . . . . 75.42 110.384 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.24 -52.71 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.36 -0.836 . . . . 71.53 110.668 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 69' ' ' THR . 33.3 pt -63.52 -39.69 86.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 120.824 0.345 . . . . 75.1 111.225 -177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.18 -49.96 72.22 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.936 -0.574 . . . . 74.05 110.323 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.77 -49.8 72.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.422 -0.353 . . . . 70.43 110.667 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -55.57 -58.94 5.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.743 -0.662 . . . . 51.4 111.773 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.3 t -65.27 -52.66 52.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.071 0.463 . . . . 51.33 111.026 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -56.72 -49.52 74.92 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.761 -0.654 . . . . 64.41 110.731 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.8 t -54.0 -48.28 70.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.676 -0.693 . . . . 64.24 111.346 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.32 -52.09 13.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.907 -0.317 . . . . 71.32 111.384 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 89' ' ' ILE . 82.9 mt -61.05 -36.17 78.89 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.985 0.422 . . . . 70.22 111.162 -172.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.56 -27.8 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 60.41 110.033 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.71 -47.29 34.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.171 -0.538 . . . . 63.32 112.221 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.8 m -75.97 -23.12 55.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.1 0.476 . . . . 65.01 110.14 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 33.36 7.21 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.123 -0.56 . . . . 74.4 113.35 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.71 -44.33 67.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.87 0.367 . . . . 74.31 110.017 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 55' ' ' ALA . 31.1 m -135.91 166.82 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 71.51 110.36 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -41.69 74.66 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.583 -0.525 . . . . 64.33 109.583 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 113' ' ' ARG . 7.0 t0 -167.11 175.91 7.2 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.224 -0.898 . . . . 73.53 109.146 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG21 HD12 ' A' ' 80' ' ' LEU . 38.7 pt -120.19 178.74 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.6 0.714 . . . . 75.53 111.065 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.889 ' HD3' HG23 ' A' ' 105' ' ' THR . 12.5 tpt180 -150.72 106.31 3.38 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.791 -1.095 . . . . 63.23 108.096 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 54.3 mt -92.26 117.96 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.093 -0.706 . . . . 74.02 109.093 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -88.63 143.57 26.86 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.938 -0.574 . . . . 72.25 109.481 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -111.16 109.58 19.7 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.791 -0.818 . . . . 74.05 108.791 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.1 t -85.1 123.61 39.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 64.41 110.711 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -120.86 -21.07 6.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.318 -0.855 . . . . 74.45 109.769 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 36.9 t30 178.27 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.498 -0.773 . . . . 55.13 111.439 -170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 91.9 Cg_exo -44.44 131.91 9.48 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.795 2.33 . . . . 55.41 113.469 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 2.4 Cg_endo -82.25 41.97 1.22 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.446 2.764 . . . . 71.51 112.119 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.8 m0 63.42 -154.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.155 -0.475 . . . . 71.55 110.787 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 101' ' ' PRO . . . 97.07 -134.31 11.71 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.478 -0.649 . . . . 71.12 111.478 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' ' HA3' ' A' ' 100' ' ' GLY . 27.8 Cg_endo -61.41 -22.54 74.82 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.442 2.094 . . . . 34.4 110.803 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -62.19 -12.85 22.32 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.791 -1.095 . . . . 54.0 111.06 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -76.43 -11.07 59.83 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 116.408 -0.36 . . . . 72.23 111.162 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 43.6 mt -120.12 140.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.466 0.174 . . . . 64.31 111.383 -174.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.889 HG23 ' HD3' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -72.11 151.07 43.3 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.775 0.322 . . . . 43.04 110.257 172.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.02 -33.13 71.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.434 -0.58 . . . . 53.3 109.434 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.62 -53.16 61.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.411 -0.813 . . . . 75.32 110.314 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.22 -28.08 73.1 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.575 -0.739 . . . . 65.11 112.437 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.87 -37.05 83.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.515 -0.55 . . . . 72.42 109.515 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -77.3 -57.3 3.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.78 -0.646 . . . . 73.44 111.42 -177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.581 ' NE2' HD13 ' A' ' 115' ' ' LEU . 18.9 mt-30 -140.44 167.63 21.69 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.63 0.253 . . . . 64.15 110.602 -176.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.0 pt? -79.03 173.11 12.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.182 0.515 . . . . 73.42 111.826 -173.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 117' ' ' PHE . 0.3 OUTLIER -55.45 -33.4 63.59 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.366 -0.834 . . . . 72.51 111.483 -176.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' H ' ' HG ' ' A' ' 112' ' ' LEU . . . -61.08 -6.71 2.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.932 0.716 . . . . 74.23 112.932 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.581 HD13 ' NE2' ' A' ' 111' ' ' GLN . 56.1 tp -62.11 -34.51 76.47 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.567 0.21 . . . . 74.3 111.567 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 133.77 -4.79 4.73 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.208 -0.996 . . . . 44.22 113.912 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 113' ' ' ARG . 45.3 p90 -79.56 12.6 2.43 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.484 0.642 . . . . 70.24 110.891 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 113' ' ' ARG . 2.7 m -134.03 32.91 3.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.696 0.76 . . . . 65.44 109.024 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.251 1.144 0 CA-C-N 115.07 -0.968 . . . . 73.42 111.393 -178.059 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.947 -0.461 . . . . 71.15 111.947 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.9 -29.27 67.28 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.606 2.204 . . . . 72.5 111.471 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.15 -114.04 0.6 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.596 -0.729 . . . . 45.25 111.666 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 p -166.89 172.83 9.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.68 -0.489 . . . . 55.03 109.68 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -70.5 142.52 51.86 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 110.063 -0.347 . . . . 74.44 110.063 177.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 t -146.01 88.13 1.8 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.22 -0.659 . . . . 61.1 109.22 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.62 101.26 0.18 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.168 -0.924 . . . . 74.12 110.062 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -57.68 91.69 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.404 -0.816 . . . . 63.22 112.826 -172.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 23.0 t -166.93 133.32 2.3 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.864 -0.791 . . . . 70.22 108.864 174.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 72.33 162.23 0.15 Allowed Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 123.336 0.397 . . . . 43.51 110.803 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 31.1 Cg_endo -63.1 152.18 80.91 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.558 2.172 . . . . 54.24 111.921 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.54 -47.88 63.25 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.953 0.723 . . . . 72.54 112.953 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.74 -46.03 88.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.614 0.245 . . . . 63.33 111.438 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.12 -41.8 66.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.399 . . . . 52.4 110.298 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 15' ' ' LEU . 4.4 tt -54.15 -44.98 71.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.41 -0.813 . . . . 72.05 109.636 -176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 53.2 tp -54.04 -59.65 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.873 -0.603 . . . . 73.24 110.714 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.62 -51.98 67.12 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-O 121.052 0.453 . . . . 63.35 111.122 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -57.73 -44.26 85.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.387 -0.824 . . . . 42.43 110.98 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.9 -38.41 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.781 -0.368 . . . . 61.14 110.821 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 16' ' ' LEU . 42.9 mt-10 -61.03 -44.03 98.01 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.96 -0.296 . . . . 72.42 110.623 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -70.91 -43.79 67.56 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 120.277 -0.569 . . . . 73.23 110.327 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -35.56 72.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.889 0.376 . . . . 73.21 111.017 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.3 mmt -62.44 -12.53 22.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.829 -0.623 . . . . 74.24 111.93 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -72.01 -31.92 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.424 0.154 . . . . 71.21 111.344 175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -115.31 -27.27 7.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.874 0.845 . . . . 54.55 109.54 -171.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 26' ' ' VAL . 62.4 t -90.21 55.46 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.595 -1.184 . . . . 73.12 109.496 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.2 p -173.02 170.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.19 -0.914 . . . . 74.32 109.575 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -110.61 91.94 13.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.102 -0.703 . . . . 54.41 109.102 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' HG13 ' A' ' 27' ' ' VAL . 59.5 Cg_endo -82.92 0.35 9.68 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.286 1.99 . . . . 61.31 111.906 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -68.66 -57.83 5.13 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.18 0.514 . . . . 75.42 109.822 175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.9 mt -100.66 -18.49 16.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.7 -0.682 . . . . 73.35 110.187 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.95 52.02 2.5 Favored Glycine 0 C--N 1.332 0.359 0 CA-C-N 116.044 -0.525 . . . . 54.31 113.148 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -128.42 140.76 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.968 -0.382 . . . . 73.43 109.968 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.513 ' HA ' HG23 ' A' ' 27' ' ' VAL . 24.9 t-20 -100.43 141.13 33.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 174.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.13 -35.32 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 63.1 111.675 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.11 -24.89 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.351 -0.386 . . . . 73.15 110.848 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.7 -21.62 66.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.043 -0.526 . . . . 74.33 111.275 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.87 -15.12 63.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.546 0.689 . . . . 74.24 109.98 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.18 22.08 66.74 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 114.844 -1.071 . . . . 55.23 114.356 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.9 tp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.28 0.562 . . . . 71.34 109.553 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.54 -4.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.206 -0.906 . . . . 65.32 111.637 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -70.36 -15.01 62.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.194 0.521 . . . . 65.51 109.777 175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.95 66.65 3.82 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.284 -0.726 . . . . 62.4 111.284 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -98.68 135.84 39.6 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.643 -0.502 . . . . 74.1 109.643 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -144.48 109.02 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.861 -0.792 . . . . 71.41 108.861 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 m -114.23 145.24 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 122.147 -0.346 . . . . 73.51 110.32 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -136.61 124.49 22.67 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.198 0.523 . . . . 70.03 109.646 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 9.9 p-10 -91.59 88.54 6.79 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.566 0.698 . . . . 63.42 110.172 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.09 150.25 42.16 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.386 -0.825 . . . . 31.33 111.722 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -67.28 -18.17 65.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.793 0.33 . . . . 73.1 110.518 -178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -98.16 -21.03 16.95 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.222 -0.444 . . . . 73.51 111.375 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.7 131.69 1.83 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.807 -0.711 . . . . 42.12 112.648 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.9 m -85.33 109.07 18.12 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.791 -0.448 . . . . 73.42 109.791 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.6 p -115.23 133.6 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.079 0.466 . . . . 61.32 111.193 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -103.74 115.69 30.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.716 -0.674 . . . . 72.32 110.329 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD13 ' HD2' ' A' ' 103' ' ' LYS . 6.5 mt -96.91 129.61 44.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.218 -0.66 . . . . 51.45 109.218 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.9 118.59 49.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.234 -0.284 . . . . 72.43 110.234 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -84.55 116.2 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 74.01 110.494 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 72' ' ' ILE . 26.0 mtm -134.93 170.83 15.29 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.468 0.652 . . . . 72.42 111.216 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.1 t -160.06 146.16 15.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.489 -1.232 . . . . 54.43 108.012 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.507 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 87.8 mt -90.29 163.17 14.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.64 -0.504 . . . . 75.21 109.64 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -45.45 -47.61 13.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.18 0.437 . . . . 65.2 112.18 -175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -96.04 -17.96 20.57 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.156 0.503 . . . . 71.42 110.548 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.42 8.59 2.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.798 -0.637 . . . . 72.54 111.544 -176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.05 -3.7 13.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.08 0.467 . . . . 73.1 109.973 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.468 ' HB3' HD13 ' A' ' 68' ' ' LEU . 23.3 m -69.75 123.91 89.55 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.608 -0.724 . . . . 74.4 110.042 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.18 35.08 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.04 2.493 . . . . 75.33 113.119 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 66' ' ' CYS . 7.2 mp -98.04 13.65 30.2 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.578 -0.283 . . . . 73.23 110.685 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 70' ' ' ASP . 5.2 t -55.07 -54.17 46.46 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.822 0.344 . . . . 71.45 111.29 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 69' ' ' THR . 28.3 t70 -65.71 -27.44 68.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.98 0.419 . . . . 75.25 110.224 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 62.0 t -70.17 -52.79 27.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.986 -0.552 . . . . 64.53 110.681 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.628 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.7 pp -64.07 -37.95 81.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.789 0.328 . . . . 54.12 110.259 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.628 ' N ' HD12 ' A' ' 72' ' ' ILE . 42.8 mt-10 -64.89 -42.23 94.96 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.163 -0.471 . . . . 70.3 110.521 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.42 -48.25 82.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.054 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 22.3 mm-40 -60.15 -46.76 88.57 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.853 -0.612 . . . . 73.43 110.198 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.59 -62.31 1.97 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.641 -0.709 . . . . 54.32 110.799 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -56.82 -43.73 81.31 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.354 -0.384 . . . . 75.22 111.687 -176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -60.02 -42.03 93.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 72.35 110.652 -174.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.24 -50.97 16.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 62.05 110.671 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 89' ' ' ILE . 83.1 mt -56.65 -37.46 70.82 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.188 -0.46 . . . . 72.33 111.348 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.89 -28.3 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.904 0.383 . . . . 63.32 110.328 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.34 -34.58 60.68 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.721 -0.951 . . . . 63.44 110.721 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.1 m -81.8 -23.09 36.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.186 -0.507 . . . . 64.21 110.379 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.46 11.75 81.5 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.983 -0.553 . . . . 73.22 113.326 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.51 -41.03 93.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.604 0.24 . . . . 53.45 111.563 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 23.8 m -136.29 170.21 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.482 -0.326 . . . . 70.44 110.77 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -96.64 -38.14 10.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 62.45 110.507 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 21.2 t70 -145.67 164.05 32.98 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.727 -0.67 . . . . 63.11 109.31 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 80' ' ' LEU . 19.6 pt -136.24 172.58 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.201 0.524 . . . . 71.42 110.532 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.536 ' HD2' ' N ' ' A' ' 105' ' ' THR . 6.9 tpm_? -160.83 106.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.531 -0.759 . . . . 70.12 109.541 177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.456 HD12 ' HG2' ' A' ' 73' ' ' GLU . 62.7 mt -90.74 110.48 22.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 110.017 -0.364 . . . . 74.24 110.017 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 5.6 t30 -88.55 125.11 34.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.747 -0.66 . . . . 72.42 110.173 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.507 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.3 m95 -89.77 112.99 24.46 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 73.24 111.066 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.13 123.93 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.367 -0.605 . . . . 74.24 109.367 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -153.69 8.34 0.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.119 -0.492 . . . . 55.12 110.904 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.635 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 24.5 t-20 171.51 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.916 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 69.0 Cg_endo -84.68 149.78 11.3 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.047 1.831 . . . . 60.11 112.448 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 22.7 Cg_exo -65.42 166.44 19.48 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.599 2.199 . . . . 74.11 111.86 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -64.19 109.93 2.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.26 -0.427 . . . . 73.1 110.333 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.02 -79.55 0.03 OUTLIER Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.701 -0.761 . . . . 52.53 112.912 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.28 -58.59 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.792 2.328 . . . . 65.15 112.508 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.5 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 3.2 m-20 -66.29 -4.36 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.833 -0.621 . . . . 64.4 111.524 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HD2' HD13 ' A' ' 56' ' ' LEU . 21.5 mmtp -86.38 2.79 46.26 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.752 0.278 . . . . 75.52 111.752 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.0 mt -118.45 111.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.598 0.237 . . . . 73.02 110.619 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.536 ' N ' ' HD2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -55.98 154.41 7.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.065 0.46 . . . . 64.22 111.97 177.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -53.13 -41.4 65.03 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.54 -0.754 . . . . 70.25 111.807 -176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.73 -53.08 61.75 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.332 -0.395 . . . . 41.33 111.115 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -54.76 -33.71 55.96 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-N 116.058 -0.519 . . . . 44.54 112.376 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 109' ' ' ARG . 4.8 tpp180 -73.62 -39.17 64.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 65.15 110.611 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -72.83 -55.52 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.993 -0.549 . . . . 64.51 111.298 -171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.92 92.39 3.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.086 0.47 . . . . 73.34 110.513 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 152.94 44.14 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.611 -0.722 . . . . 64.45 110.322 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -58.43 -30.02 66.57 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.831 0.348 . . . . 74.23 110.426 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.07 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.049 -0.523 . . . . 73.23 110.402 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.1 tp -83.56 -12.79 55.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.9 -0.591 . . . . 74.44 110.717 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.98 66.87 2.44 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 116.134 -0.485 . . . . 73.22 112.632 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -85.59 -53.23 5.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.293 0.568 . . . . 74.14 110.111 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.7 p -105.25 146.18 29.65 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.59 -0.732 . . . . 72.01 110.882 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.999 -0.741 . . . . 75.25 108.999 173.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.736 0 CA-C-O 119.919 -0.379 . . . . 74.14 112.243 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.4 161.02 19.87 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.549 2.166 . . . . 74.35 111.999 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -55.94 125.54 37.52 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.145 -0.55 . . . . 64.21 111.959 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.0 m -133.97 103.69 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.103 -0.332 . . . . 70.54 110.103 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 62.26 11.99 4.86 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.043 0.537 . . . . 73.15 110.93 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 p -98.17 -10.75 23.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.447 0.641 . . . . 51.51 110.345 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -124.14 -5.63 7.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.043 -0.98 . . . . 75.52 110.536 -174.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.1 m -64.33 94.51 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.975 -0.557 . . . . 75.33 111.416 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.2 p -159.74 168.89 24.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.392 -0.822 . . . . 54.45 108.993 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 66.34 166.07 0.12 Allowed Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 123.322 0.389 . . . . 74.01 110.316 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 36.6 Cg_endo -65.47 153.24 79.13 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.822 1.681 . . . . 75.05 111.455 175.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.33 -32.53 49.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.302 -0.408 . . . . 71.34 111.952 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 9.0 pt-20 -62.57 -52.51 63.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.23 111.363 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.72 -39.14 70.31 Favored 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 120.688 0.28 . . . . 73.12 110.256 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.37 -46.39 86.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.812 -0.631 . . . . 64.44 110.08 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.7 tp -58.16 -56.77 17.79 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.82 0.343 . . . . 70.14 110.831 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.88 67.4 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.987 -0.551 . . . . 45.12 111.04 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.55 -48.33 82.24 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.903 -0.59 . . . . 63.25 111.064 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.427 ' O ' ' HG2' ' A' ' 23' ' ' MET . 2.4 p -66.95 -36.58 77.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.974 -0.291 . . . . 62.21 110.435 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.8 -47.24 86.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.96 -0.385 . . . . 61.31 109.96 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -62.75 -51.18 68.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.019 -0.537 . . . . 63.42 110.281 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.2 -49.78 71.05 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.667 -0.697 . . . . 72.13 110.766 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.9 mmt -61.16 -20.32 62.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 111.866 0.321 . . . . 73.41 111.866 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -101.38 -13.77 17.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.935 0.397 . . . . 73.04 110.464 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' GLN . 8.6 t70 -119.43 -10.1 9.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.244 0.545 . . . . 74.15 109.845 -168.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.8 t -117.83 -19.81 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.525 -0.762 . . . . 53.22 110.501 -175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.6 p -77.83 163.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.513 -0.767 . . . . 75.34 110.577 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.07 87.65 1.11 Allowed Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 107.279 -1.378 . . . . 44.4 107.279 166.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 51.6 Cg_endo -82.17 -9.35 11.66 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.158 1.905 . . . . 55.11 111.903 -172.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -56.94 6.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.817 -0.629 . . . . 74.15 110.463 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.87 -19.01 29.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.516 -0.311 . . . . 55.33 110.544 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.38 40.1 6.57 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 116.054 -0.521 . . . . 62.15 113.493 173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.0 mp -127.84 140.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 117.201 0.5 . . . . 75.21 110.22 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HA ' HG23 ' A' ' 27' ' ' VAL . 21.2 t-20 -101.48 147.72 26.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.464 -0.939 . . . . 63.43 108.464 173.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.66 -36.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.974 0.416 . . . . 53.33 111.118 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.9 t -57.71 -24.58 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 70.41 110.942 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.75 -28.04 63.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.25 -0.432 . . . . 63.1 111.231 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.72 -15.37 63.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.308 0.575 . . . . 64.2 110.268 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 57.53 21.92 43.73 Favored Glycine 0 C--O 1.23 -0.131 0 CA-C-N 115.037 -0.983 . . . . 73.04 114.015 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 40' ' ' LEU . 2.6 tm? -98.78 -29.0 13.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.327 -0.99 . . . . 73.45 108.327 168.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.472 HG22 ' HG2' ' A' ' 59' ' ' MET . 16.4 t -69.82 1.74 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.629 -1.169 . . . . 75.22 111.75 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.44 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 60.2 m-85 -64.76 -22.74 67.05 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.319 -0.622 . . . . 72.23 109.319 171.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.39 72.35 1.94 Allowed Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.388 -0.824 . . . . 73.21 112.209 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.52 121.28 44.65 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.072 -0.714 . . . . 52.14 109.072 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -135.42 108.88 7.88 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.028 -0.36 . . . . 74.22 110.028 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.65 126.36 66.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.621 -0.511 . . . . 73.31 109.621 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -106.66 136.18 46.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.158 -0.474 . . . . 74.25 110.684 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.19 148.2 22.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.028 -0.533 . . . . 73.34 110.705 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.89 173.51 40.77 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.803 -0.919 . . . . 53.33 110.803 175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -69.9 -18.62 63.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.433 0.616 . . . . 42.3 109.995 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -68.59 -31.74 71.14 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.44 0.638 . . . . 72.54 109.582 172.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.89 -163.64 24.77 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.1 -0.954 . . . . 21.01 111.094 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 86' ' ' VAL . 1.3 p -93.21 118.85 31.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.849 0.357 . . . . 73.12 110.54 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.44 123.46 62.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.774 -0.454 . . . . 74.2 109.774 175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.46 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -101.38 121.62 42.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.413 -0.358 . . . . 24.44 111.228 -175.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -98.84 129.52 45.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.918 -0.771 . . . . 73.24 108.918 175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' HG3' ' A' ' 59' ' ' MET . 58.1 mt -125.38 113.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.722 0.296 . . . . 62.22 110.544 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -81.85 117.68 22.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.715 -0.476 . . . . 71.0 109.715 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 88.2 mtp -140.96 170.93 14.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.937 0.399 . . . . 71.52 110.617 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -158.95 159.15 34.55 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.629 -0.714 . . . . 72.42 109.886 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -121.45 155.68 34.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.576 -0.898 . . . . 71.51 108.576 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -48.05 -59.79 3.11 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.406 0.441 . . . . 63.32 112.04 -174.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.2 p -96.7 -13.61 22.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.416 -0.356 . . . . 74.42 110.977 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.87 8.66 3.99 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.755 -0.657 . . . . 64.42 111.51 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.18 -8.52 13.98 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.113 0.483 . . . . 72.05 110.697 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.605 ' HB3' HD13 ' A' ' 68' ' ' LEU . 62.9 m -67.73 136.13 92.54 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.636 -0.711 . . . . 53.43 110.626 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.76 36.0 0.5 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.104 2.536 . . . . 63.11 112.644 -176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB3' ' A' ' 66' ' ' CYS . 8.6 mp -97.25 1.19 49.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.336 -0.393 . . . . 73.13 110.249 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -58.53 8.07 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 75.22 111.432 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.27 -27.08 68.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 75.11 109.893 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.04 -52.43 38.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.674 -0.694 . . . . 74.33 110.663 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.5 pt -64.14 -38.61 82.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.917 -0.313 . . . . 63.34 110.72 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.519 ' HA ' HD12 ' A' ' 91' ' ' ILE . 3.4 mt-10 -63.33 -44.53 94.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.673 -0.239 . . . . 54.4 111.391 176.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.18 -51.11 70.99 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.721 0.296 . . . . 60.53 110.427 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 25' ' ' ASP . 25.9 mt-30 -56.27 -52.35 64.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.873 -0.603 . . . . 51.41 110.806 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.5 t -62.11 -55.13 31.95 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.806 -0.634 . . . . 72.41 111.183 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 mtt85 -58.59 -41.49 85.91 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.779 -0.191 . . . . 74.34 110.94 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -56.12 -47.15 78.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.378 -0.374 . . . . 72.34 110.693 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.86 -51.22 16.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.359 -0.382 . . . . 71.55 111.189 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.12 -38.87 80.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.865 0.364 . . . . 65.53 111.107 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.7 t -75.36 -27.92 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.026 -0.533 . . . . 64.12 109.97 175.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.74 -47.31 56.58 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.123 -0.561 . . . . 75.25 111.706 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.8 m -73.25 -11.36 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 62.4 110.563 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.07 38.66 95.63 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.001 -0.545 . . . . 63.25 112.538 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -87.5 -33.21 19.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 74.22 110.729 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' HA ' ' OG1' ' A' ' 53' ' ' THR . 31.2 m -136.26 169.36 20.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 116.174 -0.467 . . . . 75.33 110.907 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -102.86 -41.73 6.07 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.233 -0.44 . . . . 54.24 110.748 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -137.71 143.69 41.36 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.345 -0.613 . . . . 63.24 109.345 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.77 146.62 28.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.729 -0.471 . . . . 74.31 109.729 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 112.85 13.6 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.885 -0.413 . . . . 64.25 109.885 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 73' ' ' GLU . 56.1 mt -90.72 98.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.164 -0.68 . . . . 72.24 109.164 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -88.45 121.36 30.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.2 0.524 . . . . 74.21 109.887 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.574 ' HA ' ' O ' ' A' ' 59' ' ' MET . 2.9 m-90 -90.45 106.44 18.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.557 -0.747 . . . . 73.34 109.47 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.62 123.62 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.415 0.626 . . . . 65.31 110.138 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -136.97 -7.97 1.82 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 75.53 111.215 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -179.7 -55.68 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 O-C-N 123.1 0.25 . . . . 74.4 110.952 -173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -87.09 169.07 7.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.299 1.999 . . . . 62.44 112.402 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.38 159.51 19.32 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.485 2.123 . . . . 72.42 111.545 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -69.72 -22.04 63.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.549 -0.296 . . . . 70.34 110.759 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -39.53 -63.81 1.12 Allowed Glycine 0 C--N 1.338 0.688 0 O-C-N 123.803 0.689 . . . . 62.21 114.521 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -46.72 5.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.147 1.898 . . . . 75.24 111.949 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -71.31 -4.19 24.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 71.41 111.512 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -76.22 -18.49 59.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.835 -0.431 . . . . 71.41 109.835 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.26 89.19 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.028 -0.73 . . . . 75.44 109.028 173.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.408 ' HB ' ' OE2' ' A' ' 73' ' ' GLU . 17.6 p -71.3 178.49 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.244 -0.889 . . . . 63.33 112.16 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.57 -28.57 67.26 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.604 0.594 . . . . 53.13 112.604 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -58.78 -38.87 79.49 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.105 0.479 . . . . 73.42 110.157 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.2 -27.89 47.17 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.864 -0.607 . . . . 52.11 112.456 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HA ' ' HE ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -73.26 -49.04 29.92 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.716 0.293 . . . . 74.44 111.602 -175.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.21 -39.38 65.59 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.949 0.722 . . . . 72.4 112.949 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -91.76 82.85 5.22 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.424 0.631 . . . . 74.23 111.742 -167.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.9 tp -93.35 157.81 16.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.345 -0.843 . . . . 71.43 109.677 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 113' ' ' ARG . 30.0 mtm-85 -65.33 -40.14 93.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 74.33 111.197 -173.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.66 -24.2 60.76 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.249 -0.432 . . . . 72.44 111.659 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 90.0 mt -87.43 25.93 1.34 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.215 -0.448 . . . . 63.54 111.251 -175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.2 -34.05 72.28 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.269 -0.423 . . . . 71.01 112.248 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -124.72 131.18 53.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.665 -0.494 . . . . 73.31 109.665 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -139.09 160.39 39.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.294 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.037 -0.982 . . . . 75.55 110.298 -179.907 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.864 -0.495 . . . . 54.42 111.864 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.14 -28.21 56.6 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.757 2.305 . . . . 74.42 112.15 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.51 100.85 0.14 Allowed Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.891 -0.595 . . . . 72.41 113.002 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.1 t -153.9 106.82 2.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 71.32 109.218 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -168.8 16.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.573 -0.285 . . . . 71.15 111.134 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.485 ' HB3' HD21 ' A' ' 44' ' ' LEU . 16.0 m -125.71 -12.38 6.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.358 0.599 . . . . 71.55 110.642 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.603 ' HB3' HD21 ' A' ' 15' ' ' LEU . 10.1 mp0 -76.15 89.62 3.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.577 -0.738 . . . . 32.24 109.894 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -143.2 28.87 1.49 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.108 -0.497 . . . . 71.25 111.494 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 m -125.34 147.91 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 71.21 110.396 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 71.74 155.76 0.16 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.627 0.579 . . . . 71.04 111.513 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.87 152.14 52.27 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.439 2.093 . . . . 42.53 111.161 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -44.76 -42.37 7.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 73.44 112.679 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.2 -52.1 51.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.167 0.508 . . . . 71.02 110.274 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 -32.4 73.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 64.42 110.299 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 7' ' ' GLU . 6.1 tt -64.98 -50.31 66.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.694 -0.685 . . . . 73.31 109.448 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.04 -51.82 67.75 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.991 -0.55 . . . . 63.53 110.768 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLU . . . -60.95 -49.18 78.48 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.947 -0.569 . . . . 61.44 110.906 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -57.76 -48.53 79.39 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.703 -0.681 . . . . 64.25 110.857 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.0 p -68.77 -42.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 116.161 -0.472 . . . . 65.23 110.656 -176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -67.32 -37.68 83.72 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.577 -0.449 . . . . 71.33 110.805 -175.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 12.7 pt-20 -72.7 -46.44 53.73 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.601 -0.439 . . . . 71.21 110.529 175.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.583 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -59.49 -31.36 69.29 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.867 0.365 . . . . 62.3 110.755 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 13.2 mmt -62.97 -13.14 31.17 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.067 -0.515 . . . . 63.1 110.719 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -33.37 16.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.831 -0.622 . . . . 74.12 110.326 175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 4.5 m-20 -85.51 -27.5 25.58 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.392 -0.367 . . . . 74.41 111.713 -174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 22' ' ' ALA . 35.0 m -113.37 42.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.715 0.769 . . . . 61.51 110.972 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG23 ' HA ' ' A' ' 34' ' ' ASN . 8.9 p -144.13 159.93 15.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.317 -0.856 . . . . 71.21 110.135 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -104.05 89.88 2.71 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.535 -0.913 . . . . 45.42 108.535 167.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 74.5 Cg_endo -81.09 -5.72 12.94 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.551 2.167 . . . . 74.14 111.924 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -68.68 -53.74 20.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.903 -0.589 . . . . 53.13 110.03 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.98 -16.76 16.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.097 -0.502 . . . . 53.12 110.295 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.81 40.76 4.87 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.175 -0.536 . . . . 51.23 113.237 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.4 mp -106.91 140.04 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.154 -0.684 . . . . 70.23 109.154 175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.55 HD22 ' N ' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -114.26 124.92 53.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.082 -0.71 . . . . 73.13 109.082 178.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 ' HA ' HD23 ' A' ' 38' ' ' LEU . 28.3 m -57.91 -28.65 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.023 0.44 . . . . 74.15 110.82 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 34' ' ' ASN . 10.3 p -57.77 -30.81 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.846 -0.616 . . . . 74.53 111.186 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 34' ' ' ASN . 57.6 m-20 -66.25 -21.15 66.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.633 -0.258 . . . . 72.25 110.862 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -75.34 -16.53 60.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.101 0.477 . . . . 72.44 110.039 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.27 22.65 61.19 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.513 -0.767 . . . . 71.31 113.994 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.3 tp -96.06 -31.68 12.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.37 0.585 . . . . 73.14 109.688 173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 36' ' ' VAL . 11.1 p -67.74 -11.87 14.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.493 0.663 . . . . 64.22 109.55 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -63.52 -27.14 69.06 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.273 -0.876 . . . . 73.02 108.805 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.57 68.59 2.95 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.672 -1.149 . . . . 63.22 111.098 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 pp -115.27 138.45 50.93 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.105 -0.702 . . . . 74.25 109.105 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -150.25 108.99 3.84 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.355 -0.609 . . . . 71.11 109.355 -177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 45.9 t -89.17 114.48 27.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.616 -0.513 . . . . 62.44 109.616 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -97.46 133.06 42.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.099 0.476 . . . . 64.44 110.702 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.46 68.8 10.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.93 -0.767 . . . . 61.22 108.93 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.33 164.68 53.79 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.376 -0.829 . . . . 54.3 112.868 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.78 -26.94 68.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.672 0.389 . . . . 75.1 110.43 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -81.85 -7.46 59.6 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.203 -0.453 . . . . 72.02 111.162 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.82 177.11 14.73 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 112.0 -0.44 . . . . 54.34 112.0 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.0 m -72.55 110.18 6.75 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.172 -0.307 . . . . 71.23 110.172 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 7.3 p -115.14 124.49 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.828 0.347 . . . . 54.31 110.716 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -86.95 107.3 18.32 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.31 -0.405 . . . . 34.23 110.653 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD23 ' HB3' ' A' ' 90' ' ' ARG . 28.3 mt -87.57 105.08 17.08 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.449 . . . . 64.34 109.789 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.53 124.19 68.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 110.257 -0.275 . . . . 50.11 110.257 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.61 128.49 36.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.16 0.505 . . . . 55.35 111.367 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 80.6 mtp -141.24 171.12 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.652 -0.704 . . . . 64.41 110.636 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -145.49 171.51 14.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.326 -0.397 . . . . 74.45 109.935 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -121.18 166.64 13.67 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.468 -0.567 . . . . 73.23 109.468 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.4 p -62.13 -60.28 3.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.87 0.367 . . . . 74.45 111.967 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.3 t -114.28 -8.09 12.92 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.318 -0.401 . . . . 62.02 110.749 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.35 8.84 4.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.903 -0.589 . . . . 74.32 111.912 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.9 -25.6 13.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.113 0.483 . . . . 54.33 110.22 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 28.5 m -79.14 138.13 56.54 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 115.598 -0.728 . . . . 35.33 110.351 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.89 50.57 2.82 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.867 2.378 . . . . 74.3 112.335 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.8 mt -78.14 -9.31 59.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.376 -0.375 . . . . 71.13 110.673 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.8 t -60.19 -43.4 95.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.006 -0.543 . . . . 42.2 110.838 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.95 -42.28 79.82 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.368 0.604 . . . . 75.11 109.941 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -65.41 -52.5 51.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 114.942 -1.026 . . . . 62.52 110.615 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.4 pt -64.67 -41.35 92.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.617 -0.265 . . . . 73.14 111.224 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' HD12 ' A' ' 91' ' ' ILE . 44.4 mt-10 -62.55 -47.77 82.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.527 0.203 . . . . 54.02 110.671 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 35.8 t70 -59.71 -48.15 82.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 75.13 110.942 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' ASP . 18.2 mt-30 -62.51 -43.72 98.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.963 -0.562 . . . . 63.34 111.182 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.3 m -62.57 -55.22 29.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.258 -0.428 . . . . 71.33 110.689 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 74' ' ' ASP . 6.9 ppt_? -57.04 -38.03 72.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.943 -0.303 . . . . 65.11 110.32 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.8 t -55.66 -53.71 53.14 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.235 -0.439 . . . . 73.44 111.184 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.59 -52.41 11.86 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 120.546 -0.462 . . . . 70.43 111.395 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.7 -39.74 89.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.924 0.392 . . . . 65.24 111.55 -171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.23 -27.6 16.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 74.22 109.847 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.81 -45.83 56.12 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.832 -0.699 . . . . 42.43 111.622 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 p -75.9 -22.98 55.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.967 0.413 . . . . 64.13 110.195 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.13 45.34 41.01 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.87 -0.604 . . . . 74.11 112.107 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.26 -32.8 33.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.926 0.393 . . . . 65.3 110.576 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.2 m -141.18 165.51 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.137 -0.483 . . . . 71.23 110.646 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.35 -47.46 19.86 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.668 -0.493 . . . . 65.1 109.668 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 22.1 m-20 -133.54 158.14 43.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.475 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 pt -111.46 164.92 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.102 -0.703 . . . . 72.13 109.102 174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HB3' HD23 ' A' ' 56' ' ' LEU . 14.5 tpp85 -153.23 106.63 3.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.02 -0.272 . . . . 70.23 110.43 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 73' ' ' GLU . 57.0 mt -94.31 131.03 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 75.14 110.071 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.666 HD22 ' N ' ' A' ' 93' ' ' TRP . 0.2 OUTLIER -107.9 131.73 54.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.431 -0.951 . . . . 63.32 108.431 175.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.666 ' N ' HD22 ' A' ' 92' ' ' ASN . 2.7 m-90 -102.67 106.12 16.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.46 -0.57 . . . . 75.34 109.46 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.4 m -102.93 124.26 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.141 0.495 . . . . 74.21 109.711 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -111.27 -33.23 6.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.934 -0.575 . . . . 61.55 110.373 -175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.616 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 20.1 t-20 -171.71 -50.89 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.768 -0.651 . . . . 72.25 110.761 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 17.1 Cg_exo -68.33 157.78 60.37 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.296 1.997 . . . . 63.24 111.8 178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.72 167.21 15.93 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.831 2.354 . . . . 51.4 112.402 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -62.56 142.85 57.79 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.68 -0.691 . . . . 72.42 111.371 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -162.3 -120.21 0.53 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.143 -0.48 . . . . 72.14 111.966 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.0 -20.36 67.7 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.64 2.227 . . . . 44.41 111.266 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -5.54 5.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.905 -1.043 . . . . 74.51 111.753 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 57.2 mmtt -81.13 9.78 6.27 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 110.267 -0.272 . . . . 72.5 110.267 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.87 134.61 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.846 -0.428 . . . . 73.12 109.846 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 17.8 p -79.15 153.49 30.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.607 -0.27 . . . . 52.24 111.241 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 3.7 tp10 -66.95 -25.52 66.38 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.794 -0.817 . . . . 71.41 108.794 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -56.85 -34.41 67.76 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.225 -0.898 . . . . 74.04 110.575 172.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.73 -36.49 92.37 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.049 -0.596 . . . . 70.13 112.054 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 74.6 ttt180 -58.52 -36.41 73.79 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.221 0.534 . . . . 52.32 110.423 175.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.46 -17.36 64.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.265 -0.88 . . . . 64.32 111.354 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -115.59 102.29 9.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.26 0.553 . . . . 64.44 111.969 -170.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.4 tp -156.65 155.81 32.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.817 -0.808 . . . . 72.1 108.817 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -60.33 -37.27 80.09 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.895 0.378 . . . . 62.23 110.89 -176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.33 -21.33 65.66 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.061 -0.518 . . . . 65.13 111.288 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.0 tt -84.76 -17.56 37.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.094 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.51 82.71 1.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.947 -0.57 . . . . 30.44 111.692 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -64.69 111.57 2.82 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.711 0.291 . . . . 73.24 110.847 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.4 m -69.45 142.27 53.83 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.167 -0.469 . . . . 71.03 111.059 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.703 -0.665 . . . . 72.03 110.129 176.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.215 -0.354 . . . . 24.21 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.88 151.09 14.33 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.847 2.365 . . . . 74.03 112.064 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.19 -105.53 0.58 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.075 -0.584 . . . . 72.24 111.655 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -88.43 -37.29 15.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.086 0.47 . . . . 74.35 110.005 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mmt -68.84 101.89 1.44 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.826 -0.625 . . . . 72.31 110.076 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.3 p -148.6 -159.84 1.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.723 -0.671 . . . . 65.11 109.336 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.883 ' HB3' HD11 ' A' ' 15' ' ' LEU . 1.6 mp0 -61.03 87.75 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.981 0.419 . . . . 73.25 110.819 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.4 m -143.64 86.01 1.86 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.164 0.507 . . . . 73.12 110.026 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 24.9 p -173.46 126.17 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.484 -0.78 . . . . 53.0 109.498 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 71.67 162.24 0.15 Allowed Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.361 0.413 . . . . 73.42 110.889 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 12.0 Cg_endo -55.61 152.88 31.94 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.535 2.157 . . . . 72.44 112.147 177.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.86 -38.51 35.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.969 0.507 . . . . 61.35 112.365 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 18.5 mp0 -68.2 -51.95 39.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.147 0.499 . . . . 74.35 110.362 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -65.88 -45.99 80.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.541 -0.754 . . . . 73.43 110.324 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.883 HD11 ' HB3' ' A' ' 7' ' ' GLU . 2.7 tm? -55.19 -49.37 72.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.298 -0.864 . . . . 73.41 110.272 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.7 tp -53.67 -53.72 47.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.771 -0.649 . . . . 73.24 110.903 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.2 74.37 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.0 -0.546 . . . . 75.05 111.124 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -61.51 -48.4 81.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.751 -0.659 . . . . 75.32 110.902 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 8.8 p -69.45 -32.67 53.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 110.085 -0.339 . . . . 54.12 110.085 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -62.17 -41.14 98.02 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.78 -0.452 . . . . 50.24 109.78 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 38.0 mt-10 -69.26 -43.91 72.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.066 -0.515 . . . . 72.13 110.342 174.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -45.17 77.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 63.41 110.434 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.72 -13.48 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.613 -0.721 . . . . 73.43 111.639 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 32.3 ttp180 -87.86 -32.66 18.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.832 0.453 . . . . 63.45 110.53 177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -100.27 -26.93 13.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.144 -0.48 . . . . 74.41 112.17 -171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 m -84.96 3.01 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.244 0.545 . . . . 43.25 111.063 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 HG23 ' HA ' ' A' ' 34' ' ' ASN . 9.5 p -125.59 158.45 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.236 -0.653 . . . . 63.31 109.236 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -101.21 95.37 4.78 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.72 -0.844 . . . . 71.23 108.72 172.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 78.2 Cg_endo -83.08 -6.15 11.23 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.647 2.231 . . . . 74.41 111.926 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -69.04 -57.62 5.19 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.787 -0.642 . . . . 63.34 110.265 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.1 mm? -94.55 -18.68 21.2 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.272 -0.422 . . . . 72.33 109.95 176.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 48.76 4.03 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.675 -0.693 . . . . 54.21 113.365 174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.91 145.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 117.144 0.472 . . . . 72.42 110.499 177.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 36' ' ' VAL . 18.5 p-10 -112.86 107.21 15.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 74.32 111.789 -174.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 50.1 t -56.43 -31.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 115.843 -0.617 . . . . 75.21 110.865 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 34' ' ' ASN . 12.2 p -55.75 -25.04 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.881 -0.6 . . . . 74.34 111.399 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.05 -22.46 65.76 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.569 -0.287 . . . . 54.32 111.498 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.59 -23.35 65.94 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.103 0.477 . . . . 75.22 110.384 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.24 22.61 61.07 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.396 -0.82 . . . . 65.54 114.081 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 tp -97.4 -32.09 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.332 0.566 . . . . 55.34 109.744 172.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 p -63.78 -14.93 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.491 -0.777 . . . . 63.43 110.254 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -65.97 -17.76 64.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.155 -0.929 . . . . 71.4 110.291 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.81 62.43 4.17 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.024 -0.534 . . . . 64.22 112.0 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 pp -101.42 148.63 24.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.606 0.241 . . . . 51.34 110.706 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -161.36 110.83 1.61 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.979 -0.378 . . . . 73.43 109.979 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.8 p -92.5 121.01 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.034 0.445 . . . . 61.11 110.292 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -109.21 127.87 54.58 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.872 -0.603 . . . . 71.01 110.434 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -82.94 138.75 33.7 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.681 -0.691 . . . . 75.23 110.405 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.56 154.0 21.89 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.832 -0.907 . . . . 60.24 110.832 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -58.25 -36.9 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.034 0.445 . . . . 72.22 110.719 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -78.5 -24.67 45.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.705 -0.679 . . . . 71.14 110.409 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.98 158.38 12.8 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.225 -0.512 . . . . 61.02 112.526 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.29 117.28 29.89 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.138 -0.319 . . . . 74.03 110.138 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 8.7 p -108.82 134.88 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.727 0.298 . . . . 72.45 111.081 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -100.76 110.39 22.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.511 -0.313 . . . . 72.33 110.638 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 90' ' ' ARG . 52.6 mt -84.85 137.92 32.87 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.119 -0.326 . . . . 74.31 110.119 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.505 ' HB ' HG12 ' A' ' 91' ' ' ILE . 62.4 mt -135.66 118.51 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.783 -0.451 . . . . 73.43 109.783 177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' HE1' ' A' ' 99' ' ' TRP . 35.1 t0 -84.38 116.33 22.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 75.41 110.723 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.5 mtp -141.41 170.92 14.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.292 0.567 . . . . 62.31 111.46 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -150.23 176.69 10.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.366 -0.834 . . . . 62.22 108.801 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 68' ' ' LEU . 63.1 mt -121.52 145.67 47.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.624 -0.509 . . . . 55.44 109.624 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.7 p -52.53 -55.11 24.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 71.3 112.614 -172.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -99.84 -4.49 30.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.104 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.89 8.91 0.79 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.98 -0.554 . . . . 72.4 112.363 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.26 -35.91 3.34 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.951 0.405 . . . . 64.25 110.491 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 14.3 m -67.02 123.53 86.48 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.719 -0.673 . . . . 62.24 110.141 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.49 64.94 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.986 2.458 . . . . 73.41 113.055 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 61' ' ' LEU . 4.4 mm? -85.89 -3.21 58.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.478 -0.328 . . . . 73.3 110.791 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 t -56.98 -44.97 83.22 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.321 -0.4 . . . . 73.04 111.168 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.95 -41.49 87.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.073 0.463 . . . . 72.23 110.152 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.93 -51.56 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.349 -0.841 . . . . 51.44 110.926 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.41 HD11 ' HE1' ' A' ' 93' ' ' TRP . 32.5 pt -64.01 -41.26 91.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.32 -0.4 . . . . 74.0 111.185 -176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 90' ' ' ARG . 1.8 mm-40 -68.78 -38.21 79.85 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.525 -0.307 . . . . 75.01 111.162 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -67.62 -46.69 71.78 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.988 -0.285 . . . . 73.22 110.561 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -65.12 -41.54 94.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.484 0.183 . . . . 70.44 110.53 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.9 t -61.15 -52.38 65.1 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.451 -0.574 . . . . 54.02 109.451 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -54.59 -40.28 68.68 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.534 -0.757 . . . . 74.24 111.424 176.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.432 ' N ' ' HD3' ' A' ' 77' ' ' ARG . 75.7 m -54.48 -53.04 59.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.415 0.15 . . . . 74.25 111.188 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.7 -51.47 14.21 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.995 -0.282 . . . . 41.4 111.499 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.31 -30.39 69.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.77 0.319 . . . . 72.12 111.408 -172.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.74 -27.61 5.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 71.54 110.053 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.57 90.69 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.31 -0.405 . . . . 32.22 112.371 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -102.65 -0.57 31.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.788 0.328 . . . . 71.14 110.551 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.03 52.16 54.51 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 116.071 -0.513 . . . . 74.14 112.093 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.4 -30.49 69.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.708 0.289 . . . . 61.32 110.824 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 55' ' ' ALA . 28.8 m -137.15 175.46 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.04 -0.527 . . . . 71.34 110.505 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -90.7 -37.68 13.56 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.111 0.481 . . . . 71.2 110.322 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 28.9 t70 -145.82 157.78 43.9 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.838 -0.619 . . . . 73.52 110.038 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.2 pt -122.47 157.03 27.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.948 -0.389 . . . . 53.05 109.948 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.623 ' NH1' HG23 ' A' ' 105' ' ' THR . 0.9 OUTLIER -154.71 106.38 2.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.478 -0.328 . . . . 72.12 110.932 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 57' ' ' ILE . 57.9 mt -93.54 113.53 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.181 -0.674 . . . . 74.21 109.181 171.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.523 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 2.5 p-10 -90.5 140.23 29.94 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.246 -0.65 . . . . 73.41 109.246 177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.457 ' HA ' ' O ' ' A' ' 59' ' ' MET . 6.2 m-90 -107.35 106.76 17.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.49 -0.323 . . . . 64.25 110.314 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.8 m -91.15 124.06 43.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.141 0.496 . . . . 51.2 110.406 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -103.87 -43.57 5.28 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.216 -0.661 . . . . 75.44 109.216 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.604 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 m120 -164.77 -49.08 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 114.468 -1.242 . . . . 75.02 109.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 27.7 Cg_exo -64.45 164.78 22.18 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.284 1.989 . . . . 72.34 111.561 173.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.14 -179.32 5.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.562 2.175 . . . . 75.41 113.065 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.523 ' HD1' ' ND2' ' A' ' 92' ' ' ASN . 4.7 m-90 -73.12 112.08 8.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.983 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -135.55 -115.45 1.49 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.974 -0.631 . . . . 64.03 112.12 -173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.12 -24.68 74.84 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.826 2.351 . . . . 62.4 112.074 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.44 -13.07 11.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.749 -0.66 . . . . 72.03 111.025 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -87.61 6.98 31.88 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 75.21 111.219 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.8 mt -119.65 108.89 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.726 0.298 . . . . 74.13 110.849 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.623 HG23 ' NH1' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -58.49 155.53 11.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.297 0.639 . . . . 73.14 112.229 176.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -51.55 -47.99 63.22 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.867 -0.606 . . . . 62.02 111.065 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.99 -34.82 68.5 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.046 -0.525 . . . . 64.45 110.733 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.57 -34.31 57.13 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.832 -0.622 . . . . 52.35 112.223 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 109' ' ' ARG . 3.5 tmm_? -73.99 -32.0 63.21 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.265 0.555 . . . . 75.15 110.255 177.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' OE2' ' HA3' ' A' ' 116' ' ' GLY . 30.9 tt0 -69.78 -58.67 3.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.182 -0.917 . . . . 65.22 112.677 -170.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 61.67 5.53 1.31 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.004 -0.998 . . . . 74.42 113.501 171.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.777 ' HB3' HD23 ' A' ' 115' ' ' LEU . 32.5 tp -170.63 150.69 3.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.23 0.538 . . . . 75.15 110.473 175.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.71 ' HG3' HG21 ' A' ' 118' ' ' THR . 34.5 ttt180 -69.45 -30.13 67.98 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.992 -1.004 . . . . 61.45 111.522 -172.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.78 -19.59 60.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 45.11 112.119 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' A' ' 112' ' ' LEU . 4.1 mm? -90.03 -34.92 15.78 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.649 0.261 . . . . 72.32 111.257 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.422 ' HA3' ' OE2' ' A' ' 110' ' ' GLU . . . -95.43 154.16 20.95 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.985 -0.626 . . . . 54.31 112.152 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -69.67 89.07 0.53 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.034 0.445 . . . . 74.0 110.192 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.71 HG21 ' HG3' ' A' ' 113' ' ' ARG . 22.3 p -98.76 133.21 43.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.673 -0.694 . . . . 72.15 109.68 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.486 -0.769 . . . . 71.12 111.693 -175.146 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 111.991 -0.444 . . . . 52.23 111.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' HD2' HG21 ' A' ' 27' ' ' VAL . 11.2 Cg_exo -71.11 115.3 4.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.047 2.498 . . . . 72.41 111.544 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.92 -168.46 16.5 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 116.13 -0.486 . . . . 53.11 112.029 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -141.38 129.27 21.81 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.376 -0.602 . . . . 73.53 109.376 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 66.3 mtt -79.69 30.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.989 0.423 . . . . 71.51 111.448 -176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.1 m -75.35 -28.17 59.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.243 0.544 . . . . 74.41 109.852 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -71.52 111.59 6.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.516 -0.765 . . . . 73.14 111.822 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -140.28 24.26 2.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.031 -0.986 . . . . 75.24 108.792 174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 t -107.28 173.5 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.647 -0.706 . . . . 54.21 110.589 -176.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 64.81 167.61 0.11 Allowed Pre-proline 0 CA--C 1.535 0.379 0 O-C-N 123.72 0.638 . . . . 54.12 111.698 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 32.5 Cg_exo -55.89 143.37 82.1 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.505 2.137 . . . . 71.24 110.944 171.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.01 17.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 111.853 0.316 . . . . 51.35 111.853 -175.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -62.73 -42.56 99.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.994 0.426 . . . . 70.04 110.845 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -62.59 -49.67 74.3 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.784 -0.644 . . . . 64.34 110.144 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 tp -54.44 -41.75 69.78 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.069 -0.969 . . . . 73.23 110.737 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.7 tp -53.39 -56.57 15.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 54.35 110.868 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.2 -51.97 52.53 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 116.086 -0.506 . . . . 64.02 111.242 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.47 -44.92 95.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.637 -0.711 . . . . 74.42 111.202 -176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' LEU . 3.3 p -71.49 -33.54 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.015 -0.365 . . . . 71.23 110.015 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -56.85 -51.57 68.51 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.992 0.425 . . . . 62.53 109.956 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.32 -39.33 68.29 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.096 -0.502 . . . . 62.53 111.373 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.23 79.88 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.158 0.504 . . . . 25.14 110.567 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.1 mmt -65.56 -13.31 58.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.614 -0.721 . . . . 73.43 111.069 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -97.71 -7.31 31.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.768 0.318 . . . . 74.03 110.639 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -119.55 -27.56 5.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.333 0.587 . . . . 64.44 110.506 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.8 t -84.08 -26.29 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.903 -1.044 . . . . 55.04 110.821 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.3 p -86.84 154.94 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.98 -0.555 . . . . 75.45 109.881 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 12.4 t70 -86.29 102.3 2.69 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 107.861 -1.162 . . . . 74.22 107.861 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 5.9 Cg_endo -84.24 -10.05 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.857 2.371 . . . . 73.13 112.498 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -68.55 -56.54 7.96 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.028 0.442 . . . . 42.52 110.208 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 33' ' ' ILE . 65.8 mt -93.98 -18.49 21.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.916 -0.583 . . . . 74.03 109.855 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.15 56.13 3.11 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.782 -0.644 . . . . 65.4 113.078 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -139.7 140.52 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.049 0.424 . . . . 74.53 111.085 179.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -102.11 138.33 39.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.903 -0.59 . . . . 72.14 109.545 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.7 m -59.69 -25.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.019 0.437 . . . . 73.02 111.292 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.77 -25.51 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.9 -0.591 . . . . 72.31 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.11 -21.94 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.771 -0.649 . . . . 73.42 111.679 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.43 -6.88 43.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.931 0.396 . . . . 74.23 110.89 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.81 22.82 54.95 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.633 -0.712 . . . . 43.14 114.15 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.89 -31.72 12.05 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.888 -0.412 . . . . 65.23 109.888 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.94 -13.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.62 -0.718 . . . . 75.23 110.246 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -56.73 -29.96 63.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.185 -0.916 . . . . 60.04 110.168 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.73 92.0 1.77 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.643 -0.708 . . . . 60.11 111.695 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.5 pt? -141.93 160.18 40.73 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.61 -0.347 . . . . 65.0 110.124 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.76 123.14 6.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.762 -0.654 . . . . 54.31 109.466 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 6.1 p -103.69 122.69 56.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.016 0.436 . . . . 74.24 110.171 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.554 ' NE2' HD11 ' A' ' 56' ' ' LEU . 40.7 mt-30 -97.69 120.36 37.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 71.03 109.727 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -95.36 83.45 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.732 0.777 . . . . 72.14 109.672 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -99.97 163.82 19.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 114.998 -1.001 . . . . 60.25 112.184 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -55.27 -40.03 70.52 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.181 0.515 . . . . 62.34 110.941 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -68.38 -30.54 69.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.653 -0.703 . . . . 63.34 110.664 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 162.31 154.99 7.79 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.966 -0.635 . . . . 63.13 112.41 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 10.8 m -85.78 102.33 13.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.936 0.398 . . . . 74.2 110.12 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 60.0 t -107.07 126.72 63.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.093 -174.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -93.34 107.28 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 53.44 110.849 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.554 HD11 ' NE2' ' A' ' 47' ' ' GLN . 48.4 mt -82.12 131.89 35.24 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.469 -0.567 . . . . 73.01 109.469 176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HG3' ' A' ' 59' ' ' MET . 43.1 mt -129.76 129.7 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 120.443 0.164 . . . . 71.13 110.623 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -90.09 114.56 26.5 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.693 -0.484 . . . . 61.31 109.693 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.54 ' HG3' HG22 ' A' ' 57' ' ' ILE . 82.9 mtp -141.03 170.76 15.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.622 0.725 . . . . 62.54 111.69 -177.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.443 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 6.3 t -162.63 160.69 26.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.642 -1.163 . . . . 72.45 108.302 171.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -88.67 158.13 18.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.752 -0.462 . . . . 74.55 109.752 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -43.13 -52.92 5.25 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.968 0.507 . . . . 63.42 112.187 -173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m -113.32 13.11 19.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 61.24 110.951 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.2 8.7 1.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.956 0.724 . . . . 64.24 112.956 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.89 11.36 11.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.45 . . . . 64.21 110.423 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.3 m -92.59 129.28 41.06 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.917 -0.583 . . . . 40.41 110.463 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.63 34.29 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.857 2.372 . . . . 40.34 112.061 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.746 HD23 ' HB ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -83.15 -11.34 58.01 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.971 -0.559 . . . . 74.31 109.974 -176.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.578 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 10.2 t -49.92 -56.03 12.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.895 -0.593 . . . . 65.22 111.348 -176.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' THR . 5.6 m-20 -56.59 -34.94 67.67 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.115 0.484 . . . . 74.33 110.46 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.746 ' HB ' HD23 ' A' ' 68' ' ' LEU . 47.2 t -70.93 -52.71 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.567 -0.742 . . . . 64.22 110.864 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.643 HD12 ' HH2' ' A' ' 93' ' ' TRP . 0.3 OUTLIER -60.31 -43.03 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.33 0.586 . . . . 65.34 109.47 -178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 69' ' ' THR . 23.5 mt-10 -61.72 -53.57 54.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.123 -0.944 . . . . 73.44 110.871 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.05 -51.42 69.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.653 0.263 . . . . 71.42 110.891 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -55.83 -58.73 6.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.084 -0.507 . . . . 72.24 111.141 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' HD23 ' A' ' 80' ' ' LEU . 43.4 t -65.06 -55.63 17.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 73.44 110.911 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 89' ' ' ILE . 47.8 ttt180 -55.63 -52.84 62.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.304 -0.407 . . . . 73.24 111.281 -174.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -64.51 -33.95 77.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.814 -0.63 . . . . 53.13 111.006 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.0 -51.31 16.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.83 -0.348 . . . . 73.41 110.364 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 76' ' ' SER . 4.4 mm? -56.21 -44.4 79.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.214 -0.448 . . . . 72.1 111.015 -177.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.18 -28.25 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.422 -0.353 . . . . 74.24 110.538 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.74 -23.47 55.82 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.03 -0.605 . . . . 62.43 111.983 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -94.41 -11.69 29.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 75.3 110.178 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.25 17.38 75.89 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.873 -0.603 . . . . 75.31 113.347 176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.3 mp -67.01 -33.67 76.07 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.961 0.41 . . . . 70.12 109.949 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.11 175.75 3.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.581 -0.736 . . . . 61.32 109.556 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 53' ' ' THR . 22.7 t70 -78.23 -50.97 10.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.961 0.41 . . . . 71.32 110.181 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 37.2 t70 -167.54 169.79 11.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.937 -0.764 . . . . 65.15 108.937 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 77' ' ' ARG . 18.0 pt -125.06 166.86 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.962 0.411 . . . . 60.24 110.914 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HB3' HD23 ' A' ' 56' ' ' LEU . 19.8 ttm180 -152.38 113.25 4.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.698 -0.683 . . . . 75.54 109.247 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG12 ' HB ' ' A' ' 57' ' ' ILE . 67.7 mt -100.68 124.82 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 74.24 110.496 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 103' ' ' LYS . 2.2 p-10 -95.37 122.14 37.77 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.259 -0.645 . . . . 64.42 109.259 173.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.643 ' HH2' HD12 ' A' ' 72' ' ' ILE . 88.5 m95 -90.37 106.67 18.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.019 -0.537 . . . . 72.42 109.94 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 m -91.11 124.34 43.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.412 0.625 . . . . 75.42 111.395 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -112.15 -32.24 6.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 74.31 109.832 176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.62 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 31.2 t30 -166.49 -51.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.362 -0.836 . . . . 73.43 110.53 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 43.5 Cg_endo -66.61 132.17 28.16 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.11 1.873 . . . . 63.14 112.005 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.73 81.66 2.5 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.566 2.177 . . . . 71.3 112.912 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.409 ' HD1' ' ND2' ' A' ' 92' ' ' ASN . 1.7 m-90 56.07 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.571 -0.74 . . . . 74.42 112.267 169.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.89 -113.14 0.76 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.214 -0.754 . . . . 73.21 111.214 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.77 -15.44 50.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.173 1.915 . . . . 64.13 110.599 174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.39 -17.64 31.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.838 -1.074 . . . . 70.11 110.709 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 92' ' ' ASN . 97.9 mttt -76.65 -19.31 57.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.783 -0.644 . . . . 74.34 111.33 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.7 mt -84.34 92.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 50.43 111.078 -174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.9 p -61.67 154.85 24.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.65 -0.705 . . . . 52.11 110.82 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -54.99 -29.52 57.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.284 0.846 . . . . 74.14 113.284 -168.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -57.13 -30.21 64.23 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 117.778 0.263 . . . . 73.44 110.659 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.57 98.11 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.994 -0.622 . . . . 71.34 111.963 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -73.75 -46.88 43.13 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.07 0.462 . . . . 63.33 110.187 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -51.94 -38.54 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.304 -0.862 . . . . 71.33 111.55 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -103.93 23.82 12.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.018 -0.537 . . . . 70.4 111.285 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.76 ' HB3' HD23 ' A' ' 115' ' ' LEU . 22.8 tp -85.49 158.15 20.25 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.257 -0.645 . . . . 72.44 109.257 176.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -60.31 -50.02 75.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.847 0.355 . . . . 75.45 111.631 -174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.88 -20.92 66.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 64.52 112.015 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.76 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? -90.9 -0.97 57.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.788 0.328 . . . . 73.14 110.827 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.1 63.61 4.28 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 116.179 -0.464 . . . . 54.14 112.227 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -150.75 136.47 18.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.932 -0.396 . . . . 63.02 109.932 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -164.9 175.33 9.66 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.935 -0.575 . . . . 64.44 109.763 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.484 -0.77 . . . . 72.3 110.444 178.582 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.933 0 N-CA-C 111.963 -0.455 . . . . 64.41 111.963 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.47 80.95 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.752 2.301 . . . . 72.22 111.648 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.66 99.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.946 -0.57 . . . . 74.43 112.288 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.6 t -171.05 103.54 0.22 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.965 0.412 . . . . 65.14 109.927 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 6' ' ' SER . 1.7 mpt? -132.28 -46.39 0.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.629 . . . . 74.52 109.86 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 5' ' ' MET . 15.8 t 173.74 95.44 0.01 OUTLIER 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.732 -0.84 . . . . 72.13 108.732 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HA ' HD13 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -141.12 108.17 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.023 0.439 . . . . 72.32 111.806 -171.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.8 m 72.51 147.04 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.561 -0.745 . . . . 74.14 112.115 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.6 t -117.64 120.07 36.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.859 -0.609 . . . . 74.13 109.418 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.602 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . -169.77 163.24 6.78 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.849 -0.426 . . . . 70.01 109.849 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HB2' ' HG2' ' A' ' 14' ' ' GLU . 81.8 Cg_exo -44.17 115.29 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.742 2.294 . . . . 73.12 112.137 176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.41 -20.62 7.8 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.693 0.627 . . . . 40.22 112.693 -173.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mp0 -71.13 -53.31 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 74.13 110.552 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 11' ' ' PRO . 12.0 pt-20 -82.01 -30.88 31.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.988 -0.551 . . . . 64.15 110.702 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.3 tm? -54.49 -37.04 64.81 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.668 -0.696 . . . . 55.25 110.577 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.22 -53.41 57.52 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.063 0.459 . . . . 73.21 110.168 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.55 -52.03 62.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 65.13 110.699 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -59.14 -44.01 92.03 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.184 -0.462 . . . . 63.14 111.571 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.443 ' O ' ' HG2' ' A' ' 23' ' ' MET . 9.7 p -67.27 -37.75 79.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 109.744 -0.465 . . . . 62.21 109.744 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.47 -35.58 79.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.802 0.334 . . . . 75.41 110.406 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' ALA . 9.6 mm-40 -66.34 -51.07 60.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.319 -0.4 . . . . 70.24 110.349 176.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.7 83.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.13 -0.487 . . . . 65.13 110.599 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 22.3 mmt -58.78 -12.64 4.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.737 -0.665 . . . . 72.51 111.709 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 29' ' ' PRO . 4.0 tpm_? -76.23 -25.48 55.1 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.597 0.221 . . . . 72.14 111.597 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.65 -27.54 5.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.141 0.496 . . . . 70.1 109.917 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 26' ' ' VAL . 58.9 t -81.51 51.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.153 -0.931 . . . . 51.43 109.4 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.52 HG13 ' HD3' ' A' ' 29' ' ' PRO . 9.6 p -171.56 162.89 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.706 -0.679 . . . . 72.24 110.628 -174.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 27' ' ' VAL . 13.0 t70 -109.43 91.28 9.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 107.422 -1.325 . . . . 61.42 107.422 164.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.52 ' HD3' HG13 ' A' ' 27' ' ' VAL . 54.0 Cg_endo -80.42 -3.77 12.7 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.128 1.885 . . . . 73.25 111.772 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.1 -57.63 5.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.716 -0.674 . . . . 74.22 110.055 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.2 mm? -90.1 -16.75 29.02 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.725 -0.67 . . . . 73.55 109.894 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.9 40.55 6.62 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.867 -0.606 . . . . 45.23 113.5 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.52 140.27 46.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.107 0.479 . . . . 73.32 110.416 178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HG23 ' A' ' 27' ' ' VAL . 1.3 p-10 -116.63 115.04 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.572 -0.74 . . . . 74.35 110.274 -176.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -46.0 -32.45 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 112.465 0.542 . . . . 72.33 112.465 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.58 -24.81 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.223 0.453 . . . . 74.33 112.223 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -70.93 -15.33 62.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.468 0.175 . . . . 62.25 111.228 -176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.2 mp -63.65 -17.16 62.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.205 0.526 . . . . 72.15 109.771 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.44 22.7 67.85 Favored Glycine 0 C--N 1.334 0.423 0 CA-C-N 115.371 -0.831 . . . . 65.52 113.425 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 59' ' ' MET . 3.0 tm? -97.46 -31.46 12.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.918 -1.141 . . . . 74.43 107.918 171.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.07 -7.54 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.235 -0.893 . . . . 63.45 110.409 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -57.12 -24.83 56.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 61.41 109.65 174.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.13 67.74 1.42 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 111.14 -0.784 . . . . 35.43 111.14 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.8 tt -125.64 121.45 33.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.246 -0.65 . . . . 61.5 109.246 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -141.74 113.15 7.62 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.333 -0.618 . . . . 71.45 109.333 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 11.2 m -102.86 140.22 21.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.26 -0.644 . . . . 73.21 109.26 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -121.07 120.17 34.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.771 0.32 . . . . 74.43 110.28 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' HA ' HG23 ' A' ' 53' ' ' THR . 9.1 p-10 -94.11 88.24 5.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.492 0.663 . . . . 52.33 109.658 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.36 159.17 24.98 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.414 -0.812 . . . . 50.13 111.869 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -66.88 -23.39 66.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.74 0.305 . . . . 74.31 110.717 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.36 -38.48 21.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 61.53 110.252 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.1 157.76 23.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.066 -0.587 . . . . 55.54 112.26 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.543 HG22 HG12 ' A' ' 86' ' ' VAL . 12.4 m -101.0 119.1 38.26 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.97 -0.381 . . . . 64.24 109.97 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.2 t -122.93 143.23 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.468 -0.333 . . . . 71.42 110.652 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.552 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -108.38 119.08 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.33 -0.395 . . . . 43.05 110.209 177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.97 121.27 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.509 -0.552 . . . . 72.33 109.509 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' A' ' 44' ' ' LEU . 57.5 mt -125.2 138.61 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.82 -0.437 . . . . 63.4 109.82 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' ' HB3' ' A' ' 92' ' ' ASN . 42.7 m-20 -111.87 120.7 42.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.076 -0.342 . . . . 72.51 110.076 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.615 ' HA ' HD12 ' A' ' 40' ' ' LEU . 30.3 mtm -141.38 171.2 14.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.204 0.526 . . . . 75.41 111.538 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.421 ' HA ' ' HE3' ' A' ' 93' ' ' TRP . 12.1 t -154.45 147.26 24.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.249 -0.887 . . . . 74.54 109.957 175.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.563 ' HG ' ' CZ3' ' A' ' 93' ' ' TRP . 85.0 mt -109.19 149.25 29.66 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.847 -0.797 . . . . 64.43 108.847 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.8 m -34.69 -49.84 0.43 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.755 1.02 . . . . 73.23 113.755 -170.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.7 t -119.57 0.2 10.96 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.293 -0.255 . . . . 73.34 111.207 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.32 8.4 1.59 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.29 0.478 . . . . 63.42 112.29 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.45 -5.33 18.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.304 0.573 . . . . 40.1 109.708 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.417 ' HB3' HD23 ' A' ' 68' ' ' LEU . 22.6 m -65.29 128.07 93.47 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.226 -0.897 . . . . 62.23 109.945 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -72.27 16.88 0.36 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.76 2.307 . . . . 71.41 113.129 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 66' ' ' CYS . 3.4 mm? -85.64 0.52 52.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.575 -0.284 . . . . 62.51 111.254 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 70' ' ' ASP . 11.6 t -58.24 -57.23 13.78 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.47 0.176 . . . . 71.33 110.614 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' HG23 ' A' ' 69' ' ' THR . 11.3 t70 -68.18 -25.47 65.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.041 0.448 . . . . 70.03 110.171 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.22 -52.79 34.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.065 -0.516 . . . . 75.42 110.534 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.588 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.6 pp -69.37 -33.77 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 121.043 -0.263 . . . . 65.11 110.608 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.588 ' N ' HD12 ' A' ' 72' ' ' ILE . 43.9 mt-10 -64.56 -45.07 88.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.699 0.285 . . . . 75.14 110.259 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.21 -51.0 69.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.162 -0.472 . . . . 62.52 110.881 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -57.22 -52.8 63.87 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.014 -0.539 . . . . 72.1 110.391 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.419 ' O ' HD23 ' A' ' 80' ' ' LEU . 34.8 t -56.49 -60.21 3.86 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.612 -0.722 . . . . 73.35 111.207 -178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -55.87 -42.42 75.87 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 121.257 -0.177 . . . . 74.13 111.007 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 t -62.16 -46.59 88.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.469 -0.332 . . . . 75.14 110.803 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.84 -51.43 48.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.878 -0.329 . . . . 74.2 110.237 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB3' HG22 ' A' ' 86' ' ' VAL . 4.6 mm? -56.51 -39.02 72.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 62.13 111.218 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.98 -27.47 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.471 -0.332 . . . . 63.04 110.302 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.78 -31.56 62.31 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.997 -0.841 . . . . 61.31 110.997 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HB3' HD13 ' A' ' 85' ' ' LEU . 66.7 m -76.94 -22.09 53.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.027 -0.587 . . . . 45.32 110.329 176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.58 74.0 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 116.088 -0.505 . . . . 73.45 113.064 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 83' ' ' SER . 9.7 mp -78.22 -50.76 11.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 72.11 110.503 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG11 ' HB2' ' A' ' 55' ' ' ALA . 17.6 m -124.93 168.8 17.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.375 -0.375 . . . . 64.32 110.478 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -111.06 -39.69 4.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.328 0.585 . . . . 71.03 110.166 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.43 151.06 48.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.755 -0.657 . . . . 65.13 110.273 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 55' ' ' ALA . 20.8 pt -136.91 152.75 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.858 -0.423 . . . . 71.0 109.858 177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -135.98 116.03 13.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.982 0.42 . . . . 63.5 110.146 172.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 63.7 mt -98.13 110.99 26.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.425 -0.807 . . . . 61.54 109.504 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.642 ' HB2' ' HD3' ' A' ' 103' ' ' LYS . 3.2 t30 -88.34 120.09 29.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.558 -0.746 . . . . 71.12 109.447 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.563 ' CZ3' ' HG ' ' A' ' 61' ' ' LEU . 98.6 m95 -86.83 106.75 17.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.859 -0.61 . . . . 73.23 110.764 -177.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.2 m -90.89 124.54 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.002 0.429 . . . . 72.31 110.589 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -117.65 -34.33 4.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.414 0.626 . . . . 72.31 109.636 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.508 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.0 t30 -172.47 -47.17 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.911 -1.041 . . . . 53.05 109.589 -176.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 29.8 Cg_endo -63.64 140.95 77.52 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.519 1.48 . . . . 62.1 109.548 167.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.99 -95.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.144 1.896 . . . . 74.01 112.712 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -146.34 124.74 12.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.783 -0.451 . . . . 61.41 109.783 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.45 -98.74 0.11 Allowed Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.714 -0.755 . . . . 63.02 113.04 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.72 -37.98 64.11 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.973 2.448 . . . . 62.14 112.432 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 6.0 m-20 -67.11 -4.79 10.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 71.41 111.424 -176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 92' ' ' ASN . 72.7 mmtt -76.65 1.56 16.63 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.577 -0.283 . . . . 62.1 110.387 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.6 mt -111.56 115.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.928 -0.397 . . . . 73.53 109.928 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.7 p -86.08 167.58 14.85 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.948 0.404 . . . . 75.24 111.416 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -59.73 -22.15 61.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.775 -0.648 . . . . 62.24 111.211 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -57.15 -53.17 61.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.879 0.371 . . . . 63.42 110.878 -176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.35 -27.85 46.63 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.001 -0.619 . . . . 61.22 112.125 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 109' ' ' ARG . 2.8 tmm_? -67.27 -39.64 86.07 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.648 -0.501 . . . . 75.21 109.648 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HG3' ' HG3' ' A' ' 111' ' ' GLN . 9.3 tp10 -77.03 -57.55 3.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.932 -0.576 . . . . 72.5 110.934 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.732 ' HB3' HD12 ' A' ' 115' ' ' LEU . 92.1 mt-30 -143.2 139.37 30.26 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.505 -0.316 . . . . 74.51 110.544 -176.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 114' ' ' ALA . 3.5 pp -69.57 142.84 53.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.262 0.553 . . . . 72.34 110.537 177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -55.81 -29.8 60.33 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.221 -0.9 . . . . 74.3 111.877 -171.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.556 ' HB3' HD13 ' A' ' 112' ' ' LEU . . . -65.47 -7.48 14.47 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.529 0.566 . . . . 73.53 112.529 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 111' ' ' GLN . 27.4 mt -78.35 13.46 1.53 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.347 0.499 . . . . 75.44 112.347 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.29 92.2 0.05 OUTLIER Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.364 -0.446 . . . . 51.42 112.143 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -68.94 105.86 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 73.24 111.343 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.8 m -128.0 129.85 47.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.189 -0.46 . . . . 55.34 110.299 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.87 -0.586 . . . . 63.22 109.568 178.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.823 -0.511 . . . . 72.51 111.823 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.88 -54.41 5.51 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.008 2.472 . . . . 74.1 112.553 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.01 74.05 1.44 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.088 -0.577 . . . . 74.43 111.814 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 t -78.21 -41.35 34.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.584 0.23 . . . . 72.32 110.893 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.8 mtm -146.1 148.49 32.68 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.888 -0.412 . . . . 62.03 109.888 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 t -147.82 15.55 1.08 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.074 0.464 . . . . 45.01 110.506 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 5.8 mp0 -77.26 131.49 38.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 63.11 110.655 -175.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.3 p -116.24 2.01 13.21 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.518 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 m -118.1 161.44 19.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.622 -0.263 . . . . 75.53 111.142 -174.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HB3' HD23 ' A' ' 15' ' ' LEU . . . 74.77 142.86 0.09 OUTLIER Pre-proline 0 N--CA 1.467 0.42 0 O-C-N 124.145 0.903 . . . . 40.33 111.938 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.44 149.32 80.33 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.705 2.27 . . . . 63.12 111.703 177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.42 -49.68 24.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.353 0.871 . . . . 74.1 113.353 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.84 -49.52 75.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.621 0.248 . . . . 65.31 111.572 -172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -74.99 -46.46 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.47 -0.332 . . . . 74.54 110.881 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 10' ' ' ALA . 3.4 tm? -54.75 -44.86 73.97 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.714 -0.676 . . . . 53.42 110.803 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 61.6 tp -53.52 -59.81 4.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.952 0.406 . . . . 64.35 111.189 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.63 80.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.065 -0.516 . . . . 73.01 110.899 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -61.69 -48.05 82.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.704 -0.68 . . . . 62.23 110.594 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.458 HG22 ' HG2' ' A' ' 23' ' ' MET . 5.3 p -69.36 -34.06 60.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 110.058 -0.349 . . . . 63.02 110.058 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 16' ' ' LEU . 2.2 tm-20 -54.06 -49.27 69.4 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.264 -0.643 . . . . 54.45 109.264 177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.15 -50.88 43.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.1 -0.5 . . . . 75.05 110.834 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.5 -35.25 67.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.049 -0.523 . . . . 62.11 111.897 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.582 ' O ' HG12 ' A' ' 27' ' ' VAL . 13.3 mmt -58.67 -24.89 62.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 60.24 111.578 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -66.13 -16.96 64.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.607 0.241 . . . . 74.05 111.034 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -119.37 -23.37 6.71 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.145 0.498 . . . . 71.01 109.926 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 23' ' ' MET . 43.2 t -66.78 -40.05 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.295 -0.866 . . . . 72.13 110.623 173.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.595 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.7 p -89.88 153.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.479 -0.563 . . . . 71.22 109.479 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -92.25 97.65 1.69 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 108.753 -0.832 . . . . 71.34 108.753 170.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 86.1 Cg_endo -85.38 -7.55 8.85 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.547 2.164 . . . . 72.41 111.852 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.66 -57.75 5.25 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 74.54 110.452 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.31 -18.54 16.04 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.716 0.293 . . . . 61.32 110.317 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.84 54.23 1.81 Allowed Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.96 -0.638 . . . . 73.44 112.591 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.3 mp -117.81 143.23 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.193 -0.669 . . . . 62.22 109.193 175.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -125.45 109.85 13.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.557 -0.292 . . . . 65.14 110.603 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' A' ' 38' ' ' LEU . 29.9 m -54.63 -41.96 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.075 -0.511 . . . . 75.5 110.84 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' VAL . 68.9 t -56.96 -32.18 38.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 121.126 0.489 . . . . 52.23 110.748 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.8 -14.82 62.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.696 -0.684 . . . . 73.31 111.005 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 35' ' ' VAL . 4.4 mm? -63.61 -17.69 63.14 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.153 0.501 . . . . 75.3 110.093 174.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HE2' ' A' ' 42' ' ' TYR . . . 72.1 22.86 78.67 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.423 -0.808 . . . . 74.22 114.363 172.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 40' ' ' LEU . 5.0 mt -98.25 -27.06 14.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.483 0.641 . . . . 63.12 110.421 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 59' ' ' MET . 35.8 t -63.57 -11.91 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.693 -0.685 . . . . 75.54 111.908 -169.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.468 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 98.7 m-85 -62.09 -17.68 58.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.187 0.518 . . . . 73.2 109.98 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.38 63.57 3.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.811 -0.915 . . . . 61.03 110.811 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HG ' HG12 ' A' ' 57' ' ' ILE . 5.7 tt -125.62 128.94 48.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.212 -0.662 . . . . 74.54 109.212 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' N ' HD23 ' A' ' 44' ' ' LEU . 7.3 m-20 -149.16 173.47 13.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.483 -0.932 . . . . 43.44 108.483 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 55' ' ' ALA . 23.8 m -136.48 132.52 48.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.37 -0.604 . . . . 44.31 109.37 173.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.26 145.83 47.45 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.714 -0.476 . . . . 71.54 109.714 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.0 p-10 -100.62 129.31 46.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.313 0.578 . . . . 74.41 111.098 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.32 164.32 29.42 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 108.623 -1.791 . . . . 43.42 108.623 163.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.36 -19.62 66.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.164 0.982 . . . . 65.32 109.902 -178.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 2.6 mp0 -77.64 -39.05 46.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.456 -0.793 . . . . 74.3 109.938 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.7 170.36 35.61 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.526 -0.761 . . . . 64.23 111.807 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 30.3 m -85.74 129.05 34.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.731 0.301 . . . . 70.3 111.299 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.54 140.68 39.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.993 -0.549 . . . . 72.51 110.23 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -85.22 154.56 21.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.15 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -128.72 122.74 31.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.281 0.632 . . . . 71.43 109.332 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HB ' HG12 ' A' ' 91' ' ' ILE . 54.3 mt -130.47 116.6 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.428 0.156 . . . . 72.15 111.124 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.37 118.8 24.46 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.261 -0.644 . . . . 70.1 109.261 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 41' ' ' VAL . 43.6 mmm -139.8 170.44 15.87 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.248 0.547 . . . . 71.02 111.941 -174.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -153.59 178.92 9.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.226 -0.897 . . . . 62.33 109.405 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 61.8 mt -120.48 156.35 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.012 -0.366 . . . . 40.4 110.012 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.9 p -47.46 -60.11 2.76 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.032 0.533 . . . . 75.01 112.343 -175.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.9 t -104.23 2.17 31.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.843 0.354 . . . . 72.23 110.234 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . . . 60.87 8.0 1.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.568 0.747 . . . . 72.44 112.154 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.36 -7.67 9.72 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 71.02 110.239 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.546 ' O ' HD13 ' A' ' 61' ' ' LEU . 11.8 m -76.84 145.09 73.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.506 -0.77 . . . . 52.11 110.41 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.69 27.89 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.579 2.186 . . . . 62.42 112.328 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 61' ' ' LEU . 91.8 mt -77.35 -6.52 53.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.747 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 72' ' ' ILE . 14.9 t -58.2 -35.68 71.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.724 -0.473 . . . . 71.24 109.724 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.6 -50.01 74.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 64.41 111.217 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 14.2 p -68.66 -39.55 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.755 -0.202 . . . . 61.43 111.343 -177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 69' ' ' THR . 34.8 pt -66.81 -40.46 85.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 120.418 -0.513 . . . . 63.22 110.34 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -60.88 -46.93 88.67 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 116.41 -0.359 . . . . 65.44 110.186 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.76 -51.89 67.72 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.969 -0.56 . . . . 70.43 110.827 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 4.0 pt20 -64.86 -45.05 87.71 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.136 -0.484 . . . . 72.12 110.955 -176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.462 ' O ' HD23 ' A' ' 80' ' ' LEU . 77.4 p -66.74 -55.6 14.29 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.709 -0.223 . . . . 63.13 110.847 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.704 ' HD2' HG12 ' A' ' 89' ' ' ILE . 19.7 mmm180 -55.22 -53.07 60.61 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.731 0.3 . . . . 72.42 110.466 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.9 t -60.44 -43.49 96.77 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.575 -0.739 . . . . 73.44 111.49 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.91 -51.22 16.83 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 121.02 -0.272 . . . . 63.33 110.931 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -57.8 -37.98 74.73 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.305 -0.407 . . . . 71.44 111.156 -175.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 77' ' ' ARG . 20.6 m -78.0 -28.04 15.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 120.678 -0.409 . . . . 74.22 110.786 175.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.26 -42.63 97.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 61.33 112.087 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.1 p -94.27 1.4 55.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.93 0.395 . . . . 73.11 110.852 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.76 35.42 89.85 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.829 -0.623 . . . . 61.43 112.588 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.33 -36.94 80.01 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.353 0.597 . . . . 64.43 109.416 176.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.4 m -145.31 153.83 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.074 -0.966 . . . . 43.4 109.059 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.6 -44.46 70.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.267 0.556 . . . . 70.11 110.263 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -142.64 156.73 45.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.587 -0.733 . . . . 73.23 109.276 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.704 HG12 ' HD2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -125.97 144.04 37.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.716 -0.476 . . . . 72.32 109.716 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.56 ' HA ' HG21 ' A' ' 105' ' ' THR . 12.0 ttp180 -123.7 106.75 10.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.373 0.606 . . . . 64.22 109.981 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 57' ' ' ILE . 59.6 mt -95.58 128.02 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.213 -0.903 . . . . 71.13 109.545 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 102' ' ' ASP . 3.8 p-10 -102.27 111.29 23.51 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.061 -0.718 . . . . 73.13 109.061 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 11.3 m-90 -86.78 106.29 17.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 70.14 109.692 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.66 123.75 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.647 -0.501 . . . . 62.54 109.647 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -121.18 -27.16 4.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.224 -0.443 . . . . 74.13 109.89 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 24.4 m-20 -179.57 -48.82 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.229 -0.896 . . . . 61.34 110.599 -169.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 17.8 Cg_exo -68.35 152.21 75.7 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.206 1.938 . . . . 70.24 112.45 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 97' ' ' PRO . 16.4 Cg_exo -68.73 145.66 63.97 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.717 2.278 . . . . 74.22 110.963 172.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -48.94 109.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.657 0.598 . . . . 71.35 111.378 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.63 -87.85 0.07 OUTLIER Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.266 -0.492 . . . . 75.53 112.276 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.45 -28.68 62.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.536 2.157 . . . . 43.31 111.266 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 92' ' ' ASN . 2.7 p-10 -66.98 -5.75 14.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.858 -1.065 . . . . 74.25 111.648 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' HG2' ' HB3' ' A' ' 92' ' ' ASN . 98.0 mttt -89.79 -6.57 55.81 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.516 0.198 . . . . 75.4 111.01 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 mm -77.12 95.48 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 121.147 0.498 . . . . 54.14 110.61 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 90' ' ' ARG . 27.7 p -78.0 -178.01 5.31 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.75 -0.659 . . . . 52.13 111.703 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -38.25 53.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.795 -0.639 . . . . 75.43 111.811 -174.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.12 -41.74 79.57 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.991 0.424 . . . . 70.01 111.175 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.25 -46.13 94.82 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.039 -0.6 . . . . 65.12 112.0 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.524 ' O ' HD12 ' A' ' 115' ' ' LEU . 42.8 mtp180 -74.0 -36.83 64.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.949 0.404 . . . . 71.11 110.466 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -54.03 -39.49 66.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.369 -0.832 . . . . 63.31 112.1 -173.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -108.36 75.2 0.97 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.711 0.767 . . . . 73.34 111.0 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 113' ' ' ARG . 1.5 tt -141.65 145.75 35.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.737 -1.12 . . . . 73.42 108.347 176.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.536 ' H ' HD23 ' A' ' 112' ' ' LEU . 16.9 ptt180 -64.8 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.466 -173.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.1 -31.26 68.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 70.45 110.533 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 109' ' ' ARG . 68.9 mt -98.7 20.57 12.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.641 -0.708 . . . . 72.2 110.703 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.52 68.14 1.52 Allowed Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.759 -0.536 . . . . 71.53 111.759 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.4 147.51 51.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.537 -0.542 . . . . 62.42 109.537 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.8 m -66.23 -16.03 63.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.416 0.524 . . . . 65.34 112.416 -173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.726 -0.654 . . . . 62.23 110.325 -178.386 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.031 -0.428 . . . . 52.33 112.031 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.76 169.86 15.21 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.624 2.216 . . . . 54.1 111.983 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.39 -167.97 20.77 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.201 -0.523 . . . . 72.45 112.055 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.1 p -161.03 -168.52 2.09 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.334 . . . . 75.43 110.097 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 68.0 mtm -90.72 18.65 6.2 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.994 0.426 . . . . 71.42 110.395 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 m -108.67 178.43 4.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 63.11 110.806 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.632 ' H ' HD22 ' A' ' 44' ' ' LEU . 7.8 mm-40 51.33 57.04 7.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.508 0.67 . . . . 70.22 111.612 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -95.62 9.68 39.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 71.12 110.992 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.7 m -76.31 156.91 32.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.94 -0.573 . . . . 71.44 110.624 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 70.52 152.57 0.14 Allowed Pre-proline 0 N--CA 1.47 0.533 0 O-C-N 123.564 0.54 . . . . 55.52 111.692 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.52 159.41 36.45 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.572 2.181 . . . . 55.23 112.549 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.0 -51.57 65.82 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.781 1.03 . . . . 72.03 113.781 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -56.62 -52.45 64.84 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.674 0.273 . . . . 71.14 111.534 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.43 -41.29 63.44 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.243 -0.435 . . . . 64.43 110.95 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.68 -43.12 72.16 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 110.257 -0.275 . . . . 74.45 110.257 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.7 tp -57.42 -56.32 23.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 116.279 -0.419 . . . . 73.04 110.906 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 -52.03 65.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.877 -0.601 . . . . 72.12 111.018 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -60.9 -42.72 98.56 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.986 -0.552 . . . . 63.24 111.465 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 23' ' ' MET . 4.9 p -69.87 -40.91 79.43 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 120.711 -0.396 . . . . 74.53 110.4 -177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.91 -46.01 92.37 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.527 -0.546 . . . . 75.32 109.527 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 53.8 mt-10 -61.72 -50.6 71.79 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.888 -0.596 . . . . 71.14 110.831 177.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -44.92 76.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.088 0.471 . . . . 64.02 110.333 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 26' ' ' VAL . 25.1 mmt -57.88 -28.36 64.11 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.452 -0.795 . . . . 73.31 110.507 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -74.39 -24.99 59.21 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.537 -0.301 . . . . 74.42 110.88 -178.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.76 -20.95 15.34 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.923 0.342 . . . . 74.42 111.923 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 23' ' ' MET . 26.4 m -87.71 -17.47 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.975 0.417 . . . . 72.14 110.455 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 34' ' ' ASN . 5.7 p -89.15 168.83 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.969 -0.559 . . . . 73.34 109.65 177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.9 92.39 6.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.115 -0.698 . . . . 53.33 109.115 170.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.1 -4.77 10.42 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.465 2.11 . . . . 60.51 111.93 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.85 -57.71 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 53.11 110.632 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.98 -18.59 16.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.977 0.418 . . . . 71.12 110.285 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.5 49.21 2.41 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.138 -0.553 . . . . 64.12 113.13 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.5 mp -111.56 140.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.131 -0.692 . . . . 72.34 109.131 175.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.3 p30 -122.82 113.13 18.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.427 0.632 . . . . 53.14 110.59 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.2 t -58.81 -28.51 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.642 -0.708 . . . . 72.24 110.811 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG12 HG21 ' A' ' 41' ' ' VAL . 34.7 m -58.69 -24.53 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.041 -0.527 . . . . 64.02 111.166 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 36.6 t70 -58.88 -26.01 63.86 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.894 0.378 . . . . 72.22 111.131 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.94 -15.04 63.39 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.238 -0.437 . . . . 44.43 110.301 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.37 23.0 61.83 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.661 -0.7 . . . . 61.15 113.542 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.72 -16.29 22.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.999 0.428 . . . . 60.52 110.192 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 HG12 ' A' ' 36' ' ' VAL . 47.7 t -59.66 -15.88 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.881 -0.599 . . . . 75.33 110.618 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.56 -24.11 44.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.722 -0.672 . . . . 63.12 110.628 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.78 67.29 1.35 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.997 -0.547 . . . . 71.02 112.303 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.632 HD22 ' H ' ' A' ' 7' ' ' GLU . 35.3 tp -110.98 130.72 55.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.639 -0.504 . . . . 71.02 109.639 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -157.91 109.12 2.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.527 -0.546 . . . . 71.22 109.527 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 118.74 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.704 -0.225 . . . . 62.13 110.505 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -97.66 120.65 38.42 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.078 -0.712 . . . . 70.2 109.078 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -105.68 140.99 37.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.451 -0.34 . . . . 74.12 110.198 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.15 167.34 35.95 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.713 -0.755 . . . . 61.32 112.079 176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.95 -18.84 65.6 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.981 0.419 . . . . 75.1 110.657 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.22 -11.69 61.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.44 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.48 116.56 2.0 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 111.417 -0.673 . . . . 72.53 111.417 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.8 m -70.94 102.48 2.41 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.702 -0.481 . . . . 43.3 109.702 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 5.5 p -113.52 125.02 70.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.45 -0.796 . . . . 54.23 111.834 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.99 114.21 26.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.664 . . . . 53.11 110.095 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -85.67 119.13 25.67 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 110.103 -0.332 . . . . 75.34 110.103 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.519 HG22 ' HG3' ' A' ' 59' ' ' MET . 27.3 mm -116.73 127.98 74.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.742 -0.663 . . . . 65.4 109.45 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -107.47 116.48 32.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.477 -0.564 . . . . 54.23 109.477 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.519 ' HG3' HG22 ' A' ' 57' ' ' ILE . 42.5 mtm -140.87 170.56 15.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.748 0.785 . . . . 71.21 112.187 -175.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.3 t -155.9 140.97 17.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 114.565 -1.198 . . . . 73.43 109.277 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 72' ' ' ILE . 3.7 mm? -85.4 167.43 15.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.589 -0.523 . . . . 73.12 109.589 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -50.1 -49.55 51.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.083 0.24 . . . . 73.31 111.431 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.4 m -102.27 -11.69 18.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.142 0.496 . . . . 71.35 110.34 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB1' ' HD1' ' A' ' 95' ' ' TRP . . . 62.58 8.21 2.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.347 -0.842 . . . . 75.01 112.467 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.04 -16.13 8.65 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.919 0.39 . . . . 51.53 110.958 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 7.6 p -66.15 144.99 98.97 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.967 -0.56 . . . . 65.31 111.327 -176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 66' ' ' CYS . 8.3 Cg_exo -73.74 38.96 0.47 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.625 2.883 . . . . 74.54 113.852 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 72' ' ' ILE . 3.8 mm? -92.98 -12.05 31.67 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.174 -0.306 . . . . 64.24 110.174 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 70' ' ' ASP . 3.6 t -49.77 -57.71 6.79 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.682 -0.69 . . . . 62.11 111.733 -177.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 69' ' ' THR . 7.8 p-10 -66.15 -32.95 74.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.598 -0.274 . . . . 74.32 110.726 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.588 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 59.6 t -64.17 -53.43 43.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 53.4 110.68 -179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 68' ' ' LEU . 5.4 pt -71.93 -27.11 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 111.762 0.282 . . . . 64.24 111.762 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 91' ' ' ILE . 43.4 mt-10 -66.19 -45.64 80.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.946 0.403 . . . . 70.53 110.695 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.51 -49.53 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.584 -0.734 . . . . 64.14 110.335 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 79.9 mm-40 -58.16 -45.61 87.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 72.21 110.491 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 80' ' ' LEU . 41.0 t -58.15 -63.69 1.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.734 -0.667 . . . . 62.35 110.541 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' O ' HG12 ' A' ' 81' ' ' VAL . 75.7 ttt180 -54.85 -47.83 73.68 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.885 -0.326 . . . . 53.5 110.812 -177.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -55.54 -45.23 77.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.127 -0.488 . . . . 74.1 111.277 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.49 -51.07 18.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 74.31 110.816 -176.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 85' ' ' LEU . 10.8 mp -58.75 -32.65 69.45 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.335 -0.393 . . . . 71.32 111.065 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 77' ' ' ARG . 8.6 p -84.2 -27.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 63.31 110.084 175.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.08 71.02 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.087 -0.578 . . . . 55.5 111.989 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.1 t -97.53 1.67 49.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.194 0.521 . . . . 53.41 110.064 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.39 23.06 78.49 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.895 -0.593 . . . . 23.24 112.913 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 80' ' ' LEU . 43.9 mt -66.81 -57.81 6.3 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.58 0.705 . . . . 74.41 109.186 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.02 -173.77 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.803 -1.09 . . . . 75.25 108.953 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -119.72 -39.01 2.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.161 -0.681 . . . . 71.51 109.161 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 10.8 m-20 -112.64 151.68 29.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.311 -0.859 . . . . 63.4 109.916 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.1 pt -140.17 170.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.532 -0.544 . . . . 62.04 109.532 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.494 ' HG2' ' HA ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -148.57 106.7 3.73 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.101 -0.5 . . . . 74.14 109.665 172.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 73' ' ' GLU . 53.6 mt -93.55 121.35 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.81 -0.441 . . . . 74.41 109.81 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.441 ' CB ' ' HE2' ' A' ' 103' ' ' LYS . 7.9 t30 -100.23 133.09 45.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.89 -0.596 . . . . 72.2 109.804 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -97.9 106.7 19.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.47 . . . . 75.51 110.423 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 t -88.28 124.03 41.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.424 -0.584 . . . . 63.44 109.424 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.444 ' HD1' ' HB1' ' A' ' 64' ' ' ALA . 4.3 m-90 -102.35 -34.99 8.98 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.422 -0.584 . . . . 74.32 109.422 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 23.1 t-20 168.67 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.419 -1.264 . . . . 74.5 109.243 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 49.5 Cg_exo -60.14 161.1 20.4 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 122.545 2.164 . . . . 64.35 112.324 172.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -72.59 -177.54 2.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.123 2.548 . . . . 71.25 112.986 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -89.21 -163.1 0.94 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.389 -0.823 . . . . 74.32 110.515 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.73 -173.88 45.99 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.079 -0.581 . . . . 73.45 112.485 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.74 -5.7 7.8 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.217 2.611 . . . . 50.44 112.512 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.455 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 31.7 t70 -57.53 -19.9 28.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.024 -0.535 . . . . 44.44 110.631 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 90' ' ' ARG . 90.8 mttt -76.27 5.87 6.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.228 -0.442 . . . . 63.3 111.512 -178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 mm -95.96 98.47 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.269 -0.641 . . . . 74.41 109.269 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 90' ' ' ARG . 0.2 OUTLIER -50.88 166.37 0.09 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.31 0.856 . . . . 65.44 113.31 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -50.99 -50.42 58.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.12 -0.946 . . . . 63.43 111.446 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 4.8 m-20 -57.05 -43.17 81.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.324 -0.853 . . . . 63.3 111.234 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.96 -36.49 86.41 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.98 -0.628 . . . . 55.34 111.65 176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -66.57 -36.28 82.25 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 122.17 0.188 . . . . 71.45 110.93 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.617 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.2 tt0 -57.22 -37.76 72.73 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.138 0.494 . . . . 73.21 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 107' ' ' ASP . 35.7 mt-30 -93.73 17.0 12.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 63.33 111.433 -168.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -114.44 144.41 43.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 75.2 110.117 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -57.02 -29.77 63.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.352 -0.386 . . . . 74.2 111.014 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.38 -18.66 51.89 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.016 -0.538 . . . . 72.21 111.875 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.617 ' HG ' ' HA ' ' A' ' 110' ' ' GLU . 1.1 tm? -73.61 -34.24 64.95 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.378 -0.601 . . . . 73.33 109.378 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.51 -94.79 0.2 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.626 -0.715 . . . . 61.51 112.276 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 53.0 t80 52.75 82.34 0.07 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.958 0.503 . . . . 71.51 110.538 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.7 t -116.24 5.16 13.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.2 110.234 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 C--O 1.25 1.116 0 CA-C-N 115.675 -0.693 . . . . 64.42 110.84 -177.063 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 112.008 -0.437 . . . . 73.03 112.008 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.2 113.61 2.41 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.148 2.565 . . . . 64.52 112.359 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.08 -178.72 53.01 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.373 -0.441 . . . . 52.42 113.023 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.6 m 68.12 11.05 8.2 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 74.23 111.657 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.5 ptp -69.2 91.53 0.52 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.42 0.629 . . . . 74.41 110.181 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' A' ' 42' ' ' TYR . 15.3 m -94.61 -23.48 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 75.42 110.905 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -74.28 2.16 9.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.629 -0.714 . . . . 53.0 111.475 -178.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.0 p -74.19 31.56 0.08 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.393 0.516 . . . . 72.21 112.393 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -86.35 35.26 0.65 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.018 0.437 . . . . 52.11 110.873 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.28 157.49 49.16 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.186 -0.461 . . . . 73.21 109.809 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.53 146.38 95.29 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.51 2.14 . . . . 62.23 111.906 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.88 -44.37 49.82 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.345 0.869 . . . . 71.13 113.345 -169.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 14.5 mp0 -63.2 -52.41 62.39 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.899 0.381 . . . . 72.1 110.845 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -72.11 -43.8 64.17 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.295 0.569 . . . . 74.25 110.449 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.74 -39.86 82.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.294 -0.866 . . . . 51.03 110.249 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.59 -53.21 57.67 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.905 0.383 . . . . 73.25 110.472 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.62 -51.93 66.48 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-N 115.785 -0.643 . . . . 61.13 110.996 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -62.2 -48.44 80.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.904 -0.589 . . . . 54.05 111.02 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 23' ' ' MET . 5.4 p -65.96 -34.48 70.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.945 -0.391 . . . . 63.31 109.945 -177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.91 -46.35 91.02 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.696 -0.483 . . . . 71.21 109.696 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 28.5 mm-40 -65.92 -46.39 78.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.136 -0.484 . . . . 63.43 110.64 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.7 -45.05 86.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.205 0.526 . . . . 40.44 110.827 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 25.1 mmt -61.38 -12.62 14.9 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.042 -0.527 . . . . 71.22 111.564 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 76.9 ttt180 -87.31 -20.86 26.2 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.158 0.583 . . . . 72.23 111.459 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -120.27 -27.22 5.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.243 0.544 . . . . 74.21 110.84 -176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.2 t -74.74 -16.69 16.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.197 -0.911 . . . . 61.51 110.163 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.557 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 p -94.2 155.34 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.587 -0.733 . . . . 74.12 110.445 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.15 89.74 0.62 Allowed Pre-proline 0 C--N 1.318 -0.788 0 N-CA-C 107.072 -1.455 . . . . 71.05 107.072 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 55.6 Cg_endo -81.27 -6.95 12.96 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.084 1.856 . . . . 63.13 111.712 -172.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.82 -57.57 5.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.434 -0.803 . . . . 74.44 109.894 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 7.0 mp -92.29 -18.77 22.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.137 -0.483 . . . . 62.43 110.178 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.83 52.75 3.05 Favored Glycine 0 C--N 1.332 0.361 0 CA-C-N 115.782 -0.644 . . . . 60.41 113.846 171.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -130.29 140.09 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 117.263 0.531 . . . . 74.23 109.939 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 24.2 m-80 -103.1 130.6 50.31 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.807 -0.442 . . . . 73.21 109.807 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 66.5 t -56.72 -33.11 39.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.545 0.688 . . . . 62.53 109.866 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.94 -30.61 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.245 -0.889 . . . . 70.14 111.005 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 2.0 m-20 -63.08 -23.58 67.51 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.57 -0.286 . . . . 73.34 111.581 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 -16.37 63.11 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.094 0.473 . . . . 74.13 110.276 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.03 22.82 60.87 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.618 -0.719 . . . . 71.2 112.578 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 40.5 tp -90.53 -24.76 20.53 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.476 -0.565 . . . . 74.45 109.476 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.59 -8.6 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.534 -0.757 . . . . 72.31 110.32 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.423 ' HA ' ' OG ' ' A' ' 6' ' ' SER . 52.9 t80 -71.16 -16.13 62.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.881 -0.599 . . . . 74.23 109.692 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 52.12 3.51 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.834 -0.906 . . . . 63.32 110.834 172.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.569 HD13 HG12 ' A' ' 57' ' ' ILE . 61.6 tp -102.1 121.06 41.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.027 0.441 . . . . 73.42 109.974 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -127.42 108.58 10.95 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.144 -1.058 . . . . 51.1 108.144 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 55' ' ' ALA . 10.8 m -99.43 128.0 51.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.476 -0.565 . . . . 75.33 109.476 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -120.54 145.55 47.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 74.1 110.844 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.47 163.34 19.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.498 -0.773 . . . . 73.3 110.309 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.9 155.71 26.68 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.866 -0.894 . . . . 63.2 110.866 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.66 -20.27 66.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.115 0.484 . . . . 72.35 110.48 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -89.48 -27.92 20.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.746 -0.661 . . . . 64.11 110.575 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.89 176.42 32.99 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.395 -0.682 . . . . 54.03 111.395 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.1 m -99.29 129.91 45.54 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.792 0.33 . . . . 62.04 110.483 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 137.09 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.145 -0.48 . . . . 74.24 110.814 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.537 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.71 120.5 39.24 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.081 -0.509 . . . . 62.31 110.285 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 103' ' ' LYS . 20.7 mt -96.65 114.02 25.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.564 -0.532 . . . . 64.12 109.564 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 44' ' ' LEU . 51.1 mt -111.42 118.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 120.544 0.211 . . . . 75.31 110.822 -176.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -82.86 120.86 26.19 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.282 -0.266 . . . . 64.01 110.282 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.425 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.5 mtp -139.23 163.5 32.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.363 0.602 . . . . 72.1 111.339 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 94' ' ' VAL . 73.7 m -136.62 137.73 40.43 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.839 -0.618 . . . . 73.11 109.595 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 69' ' ' THR . 87.4 mt -89.23 146.92 24.44 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.656 -0.498 . . . . 74.33 109.656 177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -36.1 -57.26 0.71 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.839 0.856 . . . . 71.32 113.027 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.6 m -121.29 12.6 10.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 72.41 110.622 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 8.56 1.19 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.718 -0.674 . . . . 62.42 112.567 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.83 13.07 12.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 73.31 110.547 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 68' ' ' LEU . 44.5 t -95.9 139.82 22.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.968 -0.56 . . . . 71.5 110.507 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.37 17.45 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.922 2.415 . . . . 73.1 112.376 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HB2' ' SG ' ' A' ' 66' ' ' CYS . 48.5 tp -69.09 -13.83 62.66 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.956 -0.565 . . . . 72.2 110.499 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.499 HG23 ' N ' ' A' ' 70' ' ' ASP . 12.7 t -49.72 -56.8 8.88 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.591 -0.731 . . . . 74.43 111.903 -175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' N ' HG23 ' A' ' 69' ' ' THR . 22.7 t70 -63.67 -37.24 86.61 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.889 0.376 . . . . 64.11 110.356 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 60.9 t -62.28 -52.76 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 63.33 110.753 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.54 HD12 ' N ' ' A' ' 73' ' ' GLU . 2.8 pp -68.47 -34.94 68.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.791 -0.186 . . . . 74.32 111.258 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' N ' HD12 ' A' ' 72' ' ' ILE . 41.2 mt-10 -62.47 -46.58 87.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.697 0.284 . . . . 71.55 110.462 175.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 78' ' ' SER . 23.4 t70 -63.27 -47.53 81.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 61.22 110.917 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 26.4 mm-40 -57.46 -55.64 32.2 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 74.43 110.444 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' HD23 ' A' ' 80' ' ' LEU . 36.6 t -59.44 -54.61 44.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.819 -0.628 . . . . 72.01 110.587 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 77' ' ' ARG . 1.4 tmt_? -54.79 -42.79 72.22 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.448 -0.342 . . . . 72.5 110.555 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 7.1 t -56.28 -52.89 62.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 51.23 110.88 -174.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.49 -51.89 13.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.87 -0.332 . . . . 55.42 111.446 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 76' ' ' SER . 4.3 mm? -60.68 -33.92 73.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.272 0.558 . . . . 72.14 111.186 -173.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -85.85 -27.2 6.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.785 -0.643 . . . . 64.41 109.911 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.03 -47.72 79.05 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.292 -0.48 . . . . 71.02 112.149 -174.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.0 m -79.25 -23.04 43.94 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.649 -0.5 . . . . 64.41 109.649 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.0 48.58 3.56 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.578 -0.737 . . . . 53.51 113.25 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.0 mt -80.47 -35.3 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.989 -0.745 . . . . 60.1 108.989 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.537 HG11 ' HB2' ' A' ' 55' ' ' ALA . 16.7 m -143.84 160.35 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.109 -0.95 . . . . 73.14 109.336 174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.69 -30.92 26.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 63.11 110.675 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -152.5 166.07 33.14 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.02 -0.536 . . . . 73.32 110.238 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 55' ' ' ALA . 35.7 pt -136.95 154.46 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.132 0.492 . . . . 72.11 110.86 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.701 ' HB2' HG23 ' A' ' 105' ' ' THR . 8.6 tpt85 -133.24 110.42 10.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.74 -0.664 . . . . 72.04 109.215 175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 58.6 mt -91.61 123.17 43.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.224 -0.443 . . . . 72.14 110.224 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.47 HD22 ' C ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -88.2 118.21 27.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.42 -0.956 . . . . 72.52 108.42 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.447 ' N ' HD22 ' A' ' 92' ' ' ASN . 4.8 m-90 -89.69 114.0 25.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.242 -176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HB ' ' OG1' ' A' ' 60' ' ' THR . 7.4 t -86.07 124.02 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.863 -0.421 . . . . 73.03 109.863 177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -112.08 -32.16 6.66 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.408 -0.59 . . . . 75.53 109.408 174.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.451 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 1.6 m120 -179.57 -47.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 114.354 -1.294 . . . . 71.14 109.379 -174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 96' ' ' ASN . 23.6 Cg_exo -65.96 154.15 75.17 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.222 1.948 . . . . 52.32 111.664 175.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.18 -176.64 3.31 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 52.43 112.061 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m-90 -79.64 145.59 32.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.092 -0.504 . . . . 72.31 110.276 -178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.29 -110.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.923 -0.656 . . . . 71.1 112.226 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.57 -33.76 86.44 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.563 2.175 . . . . 64.12 112.163 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.63 -4.11 14.3 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.895 -0.593 . . . . 73.33 110.719 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.589 ' O ' HD22 ' A' ' 56' ' ' LEU . 30.2 mtpp -82.45 6.2 18.08 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.86 -0.525 . . . . 65.1 110.277 172.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.5 mt -120.52 130.03 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.224 -0.297 . . . . 64.43 110.327 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 90' ' ' ARG . 11.7 p -53.82 150.43 7.52 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.019 0.437 . . . . 65.23 111.376 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.02 -41.0 68.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.921 -0.582 . . . . 61.32 109.924 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.645 ' HB3' HD13 ' A' ' 115' ' ' LEU . 6.6 m-20 -57.27 -45.29 84.19 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.458 -0.792 . . . . 74.33 110.588 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.47 -47.2 89.44 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.838 -0.696 . . . . 74.11 111.942 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -64.6 -37.22 86.8 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.941 0.401 . . . . 65.24 110.781 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -82.78 -42.16 18.27 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.168 0.433 . . . . 71.12 112.168 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.657 ' HB3' ' HB3' ' A' ' 114' ' ' ALA . 35.7 mt-30 -104.23 -28.16 11.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.772 0.656 . . . . 43.14 112.772 -168.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 112' ' ' LEU . 3.1 mm? 53.49 -98.9 0.08 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.445 0.298 . . . . 71.44 110.733 -176.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -70.95 -37.28 72.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.926 0.393 . . . . 65.22 110.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -64.79 -7.58 11.63 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.943 -0.571 . . . . 73.31 111.907 -176.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 107' ' ' ASP . 55.8 tp -72.16 -29.66 64.24 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.919 0.39 . . . . 63.42 110.178 176.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.03 122.47 5.84 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.779 -0.646 . . . . 74.42 112.192 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -64.74 124.89 23.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.272 -0.27 . . . . 72.21 110.272 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 15.0 m -65.54 87.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.985 0.422 . . . . 64.12 110.198 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.5 m . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.488 -0.768 . . . . 75.02 111.045 -178.576 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 N-CA-C 112.262 -0.335 . . . . 61.32 112.262 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.63 -1.47 10.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.193 2.595 . . . . 74.21 112.585 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.74 86.15 1.66 Allowed Glycine 0 C--N 1.331 0.257 0 N-CA-C 111.225 -0.75 . . . . 54.44 111.225 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.5 p -74.86 66.12 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.134 0.492 . . . . 62.43 111.669 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.4 mmt -98.16 -6.53 31.25 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.527 0.68 . . . . 63.44 109.363 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 42' ' ' TYR . 32.1 t -161.42 -177.62 6.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.017 -0.992 . . . . 72.51 108.928 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 56.85 97.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.716 0.769 . . . . 74.01 111.271 -175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.1 p -148.98 32.89 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.037 -0.983 . . . . 71.22 109.03 178.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 85' ' ' LEU . 35.7 t -68.23 125.39 26.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.49 -0.777 . . . . 75.21 110.958 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 69.11 163.55 0.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.812 -0.631 . . . . 53.11 111.823 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 80.9 Cg_exo -47.86 153.59 2.44 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.978 2.452 . . . . 64.55 112.194 173.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.5 -29.87 51.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 61.31 112.072 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 7.9 mp0 -63.63 -45.4 90.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.173 0.511 . . . . 52.23 109.932 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -73.73 -47.35 39.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.408 -0.815 . . . . 74.21 109.402 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.45 -45.49 73.1 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 114.819 -1.082 . . . . 74.2 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.99 -59.72 4.27 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.977 0.418 . . . . 62.43 111.163 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.86 66.41 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 116.118 -0.492 . . . . 62.5 111.129 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -69.16 -32.58 72.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.6 -0.727 . . . . 71.3 111.915 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -72.39 -38.17 60.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 109.396 -0.594 . . . . 61.0 109.396 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -58.88 -41.62 87.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.512 -0.313 . . . . 65.53 110.731 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -69.67 -51.66 32.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.036 0.446 . . . . 74.44 110.683 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.24 -34.64 75.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.839 -0.618 . . . . 61.42 111.391 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 16.4 mmt -61.25 -13.29 17.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.236 -0.438 . . . . 74.23 112.114 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -90.77 -17.46 26.63 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.748 0.249 . . . . 72.15 111.493 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -119.52 -25.81 5.92 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.503 0.668 . . . . 74.45 110.466 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.1 t -77.85 -23.13 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.092 -0.958 . . . . 60.21 109.878 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 9.9 p -89.0 159.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.071 174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 94.61 4.35 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.527 -0.916 . . . . 73.23 108.527 168.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 72.8 Cg_endo -81.54 -3.84 12.08 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.257 1.971 . . . . 63.35 111.989 -176.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.72 -57.55 5.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.14 0.495 . . . . 74.34 109.862 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.5 mt -92.79 -18.75 22.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.708 -0.678 . . . . 62.3 109.864 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.34 51.46 3.7 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.955 -0.566 . . . . 25.2 113.49 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.414 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.68 143.85 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 117.026 0.413 . . . . 65.32 110.432 177.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.411 ' HA ' HG23 ' A' ' 27' ' ' VAL . 9.2 p30 -108.79 134.82 50.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 75.01 110.637 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.42 -25.69 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.012 0.434 . . . . 74.42 111.121 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.0 t -59.81 -24.96 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 115.927 -0.579 . . . . 62.12 110.348 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.75 -33.61 68.66 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.998 -0.546 . . . . 73.3 110.642 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 38' ' ' LEU . 3.5 mm? -71.91 -16.7 62.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.961 0.41 . . . . 74.43 110.297 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.98 21.1 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.48 -0.782 . . . . 62.14 113.782 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 40' ' ' LEU . 2.5 mt -88.58 -19.2 26.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.892 0.346 . . . . 72.11 110.157 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.6 -9.59 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.853 -0.612 . . . . 55.32 110.512 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 88.3 t80 -55.89 -31.23 62.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.546 -0.752 . . . . 71.01 109.678 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 75.76 1.48 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.539 -0.755 . . . . 72.32 111.585 176.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.535 HD13 HG12 ' A' ' 57' ' ' ILE . 50.8 tp -119.94 126.33 50.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.768 0.427 . . . . 75.22 109.951 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -150.92 115.38 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.498 -0.556 . . . . 73.43 109.498 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -94.8 136.25 26.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.848 0.356 . . . . 54.52 110.176 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -130.63 150.21 51.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.626 -0.509 . . . . 72.2 109.626 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 33.2 t70 -92.01 117.39 29.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.446 -0.343 . . . . 72.25 110.891 -176.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.45 174.16 24.62 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.406 -0.426 . . . . 63.22 112.087 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.04 -32.16 69.49 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.917 0.389 . . . . 72.23 111.46 -176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -96.39 -14.29 22.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.148 -0.478 . . . . 61.03 111.513 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.18 172.23 22.63 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.094 -0.574 . . . . 24.45 111.992 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 24.0 m -78.88 115.46 18.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.712 0.256 . . . . 51.24 110.782 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 88' ' ' ASP . 33.3 m -103.94 144.97 13.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.46 -0.337 . . . . 75.1 110.648 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.521 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -98.59 112.85 24.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.381 -0.372 . . . . 70.23 110.599 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 90' ' ' ARG . 44.1 mt -79.5 115.62 19.23 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.126 -0.694 . . . . 73.42 109.126 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.535 HG12 HD13 ' A' ' 44' ' ' LEU . 49.5 mt -120.51 125.45 74.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 110.091 -0.337 . . . . 74.4 110.091 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD2' HG23 ' A' ' 94' ' ' VAL . 24.8 t0 -96.12 130.83 43.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.985 0.421 . . . . 74.53 110.772 176.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 84.4 mtp -141.64 170.96 14.74 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.292 0.568 . . . . 54.31 111.268 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.4 t -154.43 153.46 31.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.584 -0.735 . . . . 72.41 109.86 175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 mp -110.72 170.8 7.85 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.971 -0.381 . . . . 63.44 109.971 176.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.1 p -57.12 -60.22 3.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.21 -0.45 . . . . 60.35 111.824 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.429 ' HG ' ' HG ' ' A' ' 66' ' ' CYS . 86.2 p -91.88 -24.34 19.36 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.362 -0.381 . . . . 75.23 110.315 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 64.4 8.93 4.56 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.427 -0.806 . . . . 53.4 110.826 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.63 -25.93 8.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.903 -0.589 . . . . 70.44 110.53 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.429 ' HG ' ' HG ' ' A' ' 63' ' ' SER . 64.3 m -59.43 135.57 88.82 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.007 -0.542 . . . . 65.02 110.628 178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.29 25.7 0.31 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.892 2.395 . . . . 75.44 113.038 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 72' ' ' ILE . 89.8 mt -78.19 -6.26 54.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.988 -0.375 . . . . 65.51 109.988 -177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 73' ' ' GLU . 9.3 t -49.37 -44.31 44.8 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.548 -0.751 . . . . 74.31 109.946 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -57.48 -51.57 68.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.67 -0.695 . . . . 71.44 110.693 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 49.2 t -62.78 -53.04 51.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.533 -0.758 . . . . 61.33 111.46 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 68' ' ' LEU . 6.7 pt -71.01 -35.96 61.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 120.759 -0.376 . . . . 74.3 111.713 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -55.51 -54.27 46.06 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.892 0.853 . . . . 72.35 108.76 173.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.89 -51.29 70.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 113.864 -1.516 . . . . 62.44 111.231 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 21.2 mm-40 -59.36 -49.08 79.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.657 0.265 . . . . 72.14 110.564 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . 45.7 m -59.29 -60.56 3.66 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.432 . . . . 74.32 111.016 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.476 ' HB3' HG12 ' A' ' 89' ' ' ILE . 14.4 ptm180 -62.11 -36.68 82.47 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 121.047 -0.261 . . . . 71.25 111.208 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.9 t -60.07 -40.94 91.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.252 -0.431 . . . . 72.45 110.672 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.25 -51.18 16.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.73 0.3 . . . . 65.02 110.749 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' SER . 4.5 mm? -55.26 -38.12 68.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.108 -0.496 . . . . 70.12 111.148 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.24 -27.77 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.397 -0.365 . . . . 72.25 110.594 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.71 -34.04 69.34 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.32 -0.467 . . . . 74.11 112.094 -174.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HB2' ' HG ' ' A' ' 85' ' ' LEU . 29.9 m -107.67 6.79 28.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.797 0.332 . . . . 64.25 111.15 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.13 26.71 69.51 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.125 -0.559 . . . . 72.24 112.07 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 78.2 mt -60.68 -43.12 98.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.672 0.749 . . . . 70.31 108.99 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 55' ' ' ALA . 19.2 m -143.9 159.15 16.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.361 -1.29 . . . . 71.24 108.114 170.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.42 -43.19 86.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.309 0.576 . . . . 73.1 110.081 -178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 27.2 t70 -161.55 168.63 23.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.248 -0.887 . . . . 72.13 108.753 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.476 HG12 ' HB3' ' A' ' 77' ' ' ARG . 32.6 pt -122.68 148.05 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.815 0.341 . . . . 71.45 110.118 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 90' ' ' ARG . 2.8 tpp180 -119.44 106.38 12.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.473 -0.936 . . . . 71.31 108.473 176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.3 mt -93.78 145.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.78 0.324 . . . . 71.25 110.853 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -118.71 139.67 51.18 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.877 -0.786 . . . . 71.2 108.877 172.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.531 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 49.1 m95 -106.43 106.79 17.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.748 -0.464 . . . . 71.31 109.748 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.521 HG23 ' OD2' ' A' ' 58' ' ' ASP . 39.5 t -87.3 123.84 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.945 -0.702 . . . . 73.22 109.882 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 96' ' ' ASN . 7.3 p-90 -140.88 -0.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.071 -0.513 . . . . 70.0 111.105 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.586 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.1 t-20 167.88 -55.97 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 116.071 -0.513 . . . . 53.44 110.435 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 94.5 Cg_endo -80.72 156.69 21.2 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.947 1.765 . . . . 54.52 111.855 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.08 170.09 17.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.208 1.939 . . . . 34.44 111.653 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -61.11 101.69 0.17 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.057 -0.52 . . . . 73.11 110.412 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.85 -83.75 0.05 OUTLIER Glycine 0 CA--C 1.52 0.387 0 CA-C-N 116.075 -0.512 . . . . 63.42 112.451 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.52 -51.96 3.65 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 122.725 2.284 . . . . 64.25 112.244 -177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 93' ' ' TRP . 6.1 m-20 -64.01 -4.01 3.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.594 -0.73 . . . . 64.44 112.466 -176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -76.23 -7.82 55.7 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.598 0.237 . . . . 74.12 110.508 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.8 mt -80.53 102.81 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 109.913 -0.403 . . . . 75.2 109.913 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 p -70.45 176.65 3.88 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.13 -0.486 . . . . 72.44 112.106 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.431 ' HA ' ' HB2' ' A' ' 109' ' ' ARG . 68.2 mm-40 -54.13 -21.06 7.73 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.683 -0.689 . . . . 75.25 112.222 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.63 -51.28 69.29 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.979 0.419 . . . . 73.42 110.381 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -27.63 66.6 Favored Glycine 0 C--N 1.33 0.201 0 CA-C-N 115.842 -0.617 . . . . 75.53 111.874 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 106' ' ' GLU . 10.9 mmm180 -65.45 -51.1 62.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.65 0.38 . . . . 73.51 111.361 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -80.65 -44.55 18.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.15 -0.477 . . . . 73.53 111.887 -174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -95.7 115.44 27.43 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.157 0.503 . . . . 73.11 111.591 -168.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.2 pt? -134.03 166.79 21.91 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.344 -0.843 . . . . 74.54 109.775 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.93 -31.07 71.4 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.558 0.218 . . . . 73.12 111.244 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.78 -16.42 61.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.679 0.276 . . . . 54.12 111.413 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 ' O ' HD23 ' A' ' 115' ' ' LEU . 8.6 tt -75.97 -26.37 56.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.97 -0.559 . . . . 65.22 109.8 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.28 92.17 0.85 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.892 -0.595 . . . . 51.2 112.653 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -125.47 154.93 41.29 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 75.12 109.88 174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 29.0 m -90.58 149.49 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.19 -0.3 . . . . 63.23 110.19 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 119.224 -0.417 . . . . 74.31 111.558 -178.465 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.113 -0.395 . . . . 43.13 112.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.83 160.25 30.89 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.785 2.323 . . . . 74.43 112.611 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.0 -106.84 0.23 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.708 -0.557 . . . . 72.34 111.708 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.515 ' HB2' HG21 ' A' ' 36' ' ' VAL . 37.3 m -156.1 165.59 35.96 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.899 -0.408 . . . . 75.34 109.899 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 70.5 mtm -92.94 -69.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.621 -0.511 . . . . 75.42 109.621 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.438 ' HB3' HD21 ' A' ' 44' ' ' LEU . 50.7 m 70.7 -56.41 0.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.42 0.688 . . . . 75.35 112.414 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 143.33 53.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.345 0.258 . . . . 74.43 110.637 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 t -163.19 20.93 0.08 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.513 -0.312 . . . . 73.01 111.318 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -82.54 18.28 1.55 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 111.901 0.334 . . . . 72.22 111.901 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.49 157.89 55.05 Favored Pre-proline 0 C--O 1.235 0.325 0 CA-C-N 116.679 -0.237 . . . . 63.11 110.664 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.33 176.77 3.03 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.847 2.364 . . . . 74.2 112.05 177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.08 -64.45 0.81 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.039 0.755 . . . . 74.23 113.039 -171.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -64.43 -46.77 81.73 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.026 0.441 . . . . 74.34 110.937 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.34 -46.67 87.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.344 -0.844 . . . . 75.53 110.761 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.9 -49.12 77.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.774 -0.648 . . . . 75.13 110.16 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.33 -59.89 3.99 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 52.13 111.449 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -45.06 80.51 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 116.098 -0.501 . . . . 75.42 111.25 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -70.26 -41.24 73.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 73.1 110.812 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.11 -32.82 55.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 109.54 -0.541 . . . . 73.31 109.54 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.19 -48.79 75.69 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.211 -0.663 . . . . 75.35 109.211 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -61.58 -50.57 72.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.798 -0.637 . . . . 45.42 111.267 175.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.42 -49.04 75.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.153 0.501 . . . . 60.04 111.188 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 26.4 mmt -67.28 -13.52 62.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.812 -0.631 . . . . 61.43 110.651 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -96.85 -8.01 32.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.635 . . . . 70.14 110.405 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -119.61 -27.13 5.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.499 0.666 . . . . 52.23 110.127 -173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -90.98 -33.04 5.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.152 -0.931 . . . . 74.01 111.257 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 33' ' ' ILE . 1.2 p -74.7 174.03 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.221 -0.445 . . . . 73.13 110.12 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -103.55 96.22 8.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 N-CA-C 109.722 -0.473 . . . . 53.03 109.722 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 67.8 Cg_endo -89.13 3.16 5.66 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.627 2.218 . . . . 74.12 111.775 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.81 -57.93 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 74.23 110.461 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.9 mt -110.58 -11.29 14.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.897 -0.592 . . . . 61.42 110.444 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 51.48 2.58 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.952 -0.567 . . . . 30.3 112.905 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 27' ' ' VAL . 3.2 mp -106.69 140.09 26.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.531 -0.544 . . . . 63.42 109.531 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' CG2' ' A' ' 27' ' ' VAL . 67.4 m-20 -116.62 109.03 16.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.509 -0.769 . . . . 51.14 109.59 -176.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.23 -39.09 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.051 0.453 . . . . 75.22 111.257 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' A' ' 4' ' ' SER . 15.0 p -58.1 -24.85 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.025 -0.534 . . . . 64.41 111.323 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.57 -24.75 67.16 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 71.13 110.988 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.16 -10.74 59.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.266 0.555 . . . . 72.24 110.509 177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 22.52 66.09 Favored Glycine 0 CA--C 1.519 0.315 0 CA-C-N 115.358 -0.837 . . . . 75.41 114.321 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.4 tp -98.46 -30.08 12.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.06 0.457 . . . . 65.04 110.372 171.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.53 -14.17 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.587 -0.733 . . . . 74.1 111.826 -172.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -62.04 -23.4 66.44 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.104 0.478 . . . . 71.12 109.888 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.89 70.18 2.56 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.684 -0.689 . . . . 74.31 112.085 177.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.4 pp -126.06 144.51 50.69 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 73.45 109.896 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -163.7 138.06 5.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.679 -0.86 . . . . 72.44 108.679 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.66 132.73 70.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.84 0.352 . . . . 73.01 110.822 -175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -115.7 127.3 55.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.132 -0.486 . . . . 62.01 111.346 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -81.6 113.88 19.91 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.677 -0.692 . . . . 72.42 109.275 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -124.02 158.94 18.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.139 -0.553 . . . . 65.22 111.732 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -74.9 -24.74 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 73.02 110.258 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.31 -16.19 50.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.254 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.87 158.75 9.48 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 115.879 -0.6 . . . . 73.34 111.971 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 m -98.48 102.43 14.17 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.625 -0.88 . . . . 72.52 108.625 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 t -102.92 123.65 56.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 63.44 111.219 -168.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.91 115.29 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.846 -0.616 . . . . 73.04 109.585 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 ' HB3' ' A' ' 90' ' ' ARG . 50.3 mt -93.89 127.89 39.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.553 0.341 . . . . 74.32 110.404 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -134.27 129.08 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 109.829 -0.434 . . . . 75.15 109.829 176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -88.86 129.78 35.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.037 0.446 . . . . 73.15 111.1 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 93' ' ' TRP . 79.9 mtp -141.18 171.07 14.58 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.972 -0.558 . . . . 73.03 110.183 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -148.63 157.48 43.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.144 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 68' ' ' LEU . 2.7 mm? -117.1 150.93 37.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.185 -0.672 . . . . 63.24 109.185 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.5 p -51.03 -53.86 29.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.651 0.611 . . . . 74.32 112.651 -173.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.9 t -113.65 0.2 14.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.69 -0.232 . . . . 74.23 111.227 -177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 7.81 1.8 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.983 0.513 . . . . 62.34 112.228 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.33 3.78 10.8 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.498 0.666 . . . . 70.21 109.644 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.5 m -83.87 138.64 40.25 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 115.169 -0.923 . . . . 73.14 110.476 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -75.3 23.87 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.907 2.405 . . . . 75.14 112.622 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB2' HD12 ' A' ' 61' ' ' LEU . 83.5 mt -78.28 -18.01 55.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.427 . . . . 61.52 110.171 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -59.8 -46.44 89.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.915 -0.584 . . . . 63.22 110.824 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.13 -43.27 78.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.269 0.557 . . . . 64.31 110.209 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 51.4 t -65.15 -52.59 51.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 70.31 110.85 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.14 -37.29 78.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.751 0.31 . . . . 74.12 110.958 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.79 -47.23 84.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.177 -0.465 . . . . 64.42 110.213 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 78' ' ' SER . 32.4 t70 -60.23 -48.49 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.591 . . . . 74.03 110.906 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 19.5 mm-40 -61.7 -51.2 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.874 0.369 . . . . 74.45 110.54 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.6 t -60.44 -56.21 24.19 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.954 -0.566 . . . . 72.12 110.437 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -55.19 -41.74 72.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.949 -0.568 . . . . 73.01 110.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 22.9 t -53.57 -53.02 57.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.589 -0.732 . . . . 62.21 110.783 -175.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.74 -52.08 12.47 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.71 -0.396 . . . . 65.33 111.234 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.68 -44.33 73.25 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.213 0.53 . . . . 63.43 110.895 -171.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.0 t -83.97 -27.45 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.105 -0.952 . . . . 72.44 110.127 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.15 -48.03 79.26 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.998 -0.62 . . . . 43.42 112.442 -170.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.426 ' HB2' ' CD2' ' A' ' 85' ' ' LEU . 14.1 m -91.22 -12.65 34.65 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.117 0.484 . . . . 74.31 110.414 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.93 43.0 6.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.878 -0.601 . . . . 73.1 113.168 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 85' ' ' LEU . 3.0 mm? -73.29 -45.25 56.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.57 -0.9 . . . . 71.13 108.57 173.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.1 m -144.41 162.32 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 53.41 108.897 175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -101.54 -45.29 5.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.265 0.555 . . . . 71.01 109.992 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -101.13 133.74 45.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 64.31 109.809 -175.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 41.6 pt -127.66 156.27 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.865 0.364 . . . . 75.3 110.336 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.79 ' HD2' HG23 ' A' ' 105' ' ' THR . 3.4 tpm_? -150.49 106.77 3.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.176 -0.466 . . . . 74.1 109.753 173.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.3 mt -95.03 108.95 21.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.053 -0.721 . . . . 75.22 109.053 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' ND2' ' HD1' ' A' ' 99' ' ' TRP . 7.3 t30 -88.3 121.84 31.15 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.419 -0.585 . . . . 75.11 109.419 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.9 m-90 -97.9 108.78 21.57 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.169 -0.308 . . . . 72.42 110.169 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 98' ' ' PRO . 32.8 m -87.18 123.9 40.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.672 -0.492 . . . . 71.54 109.672 176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -111.91 -35.51 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.733 0.778 . . . . 72.45 109.669 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.671 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 8.7 t30 -175.19 -47.9 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.277 -1.329 . . . . 73.34 108.354 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.671 ' HD3' ' HB3' ' A' ' 96' ' ' ASN . 26.7 Cg_exo -64.75 134.15 39.43 Favored 'Trans proline' 0 C--N 1.362 1.265 0 C-N-CA 121.811 1.674 . . . . 50.54 109.387 165.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 99' ' ' TRP . 22.0 Cg_exo -63.52 -88.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.376 2.051 . . . . 54.13 113.18 -173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.691 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 10.7 m-90 -141.39 100.64 3.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.658 0.266 . . . . 73.25 110.333 -174.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.69 -133.06 3.77 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-O 119.795 -0.447 . . . . 62.25 112.24 -173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.93 -24.31 75.82 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.748 2.299 . . . . 75.22 112.54 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.99 -4.53 13.51 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 120.994 0.426 . . . . 62.35 111.088 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.691 ' HD3' ' HB3' ' A' ' 99' ' ' TRP . 33.7 mtmm -76.86 -3.1 36.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 72.32 110.184 175.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.6 mt -119.24 121.67 67.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.393 -0.367 . . . . 71.31 110.544 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.79 HG23 ' HD2' ' A' ' 90' ' ' ARG . 1.4 p -61.81 163.24 7.7 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 122.47 0.308 . . . . 72.43 111.189 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -61.63 -43.34 99.03 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.334 -0.617 . . . . 75.31 109.334 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -59.31 -36.6 75.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.654 -0.703 . . . . 63.15 110.713 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.9 -38.32 95.37 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.888 -0.596 . . . . 61.41 112.791 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -50.85 16.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.125 0.488 . . . . 74.3 110.287 177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 60.7 mm-40 -67.18 -58.17 5.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.282 -0.872 . . . . 64.41 112.332 -172.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.457 ' HG3' ' C ' ' A' ' 110' ' ' GLU . 14.9 mt-30 60.5 32.89 20.59 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-N 114.862 -1.063 . . . . 63.44 110.795 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.2 tp -100.57 -74.94 0.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.956 -0.566 . . . . 73.13 109.487 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.0 tpp85 -67.19 -32.81 74.14 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.462 -0.57 . . . . 71.45 109.462 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.53 -23.99 63.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.264 -0.88 . . . . 72.2 111.083 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 115' ' ' LEU . 7.3 tt -74.61 -34.66 62.88 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.487 -0.56 . . . . 70.12 109.487 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.03 -88.73 0.39 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.818 -0.628 . . . . 55.42 111.581 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -177.98 161.58 1.56 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 110.059 -0.349 . . . . 74.54 110.059 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.1 m -152.51 104.51 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 74.43 109.884 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.737 -0.649 . . . . 62.35 110.277 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.86 0 N-CA-C 111.683 -0.567 . . . . 41.14 111.683 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.85 -20.59 34.22 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.806 2.337 . . . . 72.54 111.711 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.88 -151.39 23.33 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.88 -0.888 . . . . 74.34 110.88 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.0 t -165.46 139.47 4.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 73.13 110.129 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' A' ' 5' ' ' MET . 1.4 pmm? -104.6 2.32 30.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.135 -0.691 . . . . 73.11 109.135 172.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.4 t -91.63 -169.66 2.36 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.454 -0.794 . . . . 74.52 110.04 -178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' HG3' HG11 ' A' ' 19' ' ' VAL . 2.8 mp0 60.8 9.22 2.12 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.072 0.549 . . . . 63.5 111.102 -176.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 37.7 p -99.83 16.78 22.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.11 0.481 . . . . 72.24 110.585 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -144.58 171.77 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.989 -0.55 . . . . 62.12 109.862 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 68.75 161.52 0.14 Allowed Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 123.848 0.718 . . . . 55.11 111.476 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 11.1 Cg_endo -53.69 131.41 43.85 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.822 2.348 . . . . 71.12 111.921 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.16 -66.73 0.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.358 0.873 . . . . 53.34 113.358 -168.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -61.01 -50.49 73.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.949 0.404 . . . . 72.33 111.147 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -57.25 -46.41 83.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 74.01 110.916 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 7' ' ' GLU . 3.3 tm? -65.65 -39.77 91.76 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.828 -0.624 . . . . 72.1 110.082 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.6 tp -54.67 -59.63 4.44 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.837 0.351 . . . . 74.01 110.698 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.82 -48.67 75.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.996 -0.547 . . . . 75.05 110.995 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.4 -45.12 92.4 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.994 -0.548 . . . . 73.33 111.14 -176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 7' ' ' GLU . 3.4 p -73.45 -33.06 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 110.229 -0.285 . . . . 71.22 110.229 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -59.13 -41.52 88.45 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.345 0.593 . . . . 55.32 109.617 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -72.69 -45.8 57.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.486 -0.779 . . . . 75.44 111.008 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -31.58 72.79 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.336 -0.393 . . . . 75.03 111.567 -176.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.15 -13.49 48.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.258 -0.428 . . . . 35.52 110.642 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 24' ' ' ARG . 12.8 ttm180 -88.26 -15.63 35.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.448 -0.342 . . . . 73.53 110.731 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -109.38 -27.02 9.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 122.02 0.914 . . . . 62.33 108.891 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 26' ' ' VAL . 70.1 t -112.98 70.48 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 114.011 -1.449 . . . . 63.51 109.461 -175.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 34' ' ' ASN . 4.5 p -179.77 173.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.272 -0.876 . . . . 54.04 108.716 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 27' ' ' VAL . 9.7 t70 -106.26 89.58 4.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.877 -0.786 . . . . 54.12 108.877 170.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.72 -23.77 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.176 1.917 . . . . 71.43 112.485 -177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -68.68 -57.75 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.013 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.48 -18.55 26.49 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.831 0.348 . . . . 72.23 110.117 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.04 47.03 3.46 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 60.43 113.704 169.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 33' ' ' ILE . 3.6 mp -112.95 140.2 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 109.514 -0.55 . . . . 71.24 109.514 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HA ' HG23 ' A' ' 27' ' ' VAL . 4.4 p30 -108.46 129.73 55.27 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.153 -0.684 . . . . 73.44 109.153 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.13 -28.37 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.84 -0.618 . . . . 72.24 112.196 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.8 m -61.42 -24.7 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.706 -0.225 . . . . 73.11 111.064 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -52.86 -35.53 57.74 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.238 0.336 . . . . 74.14 110.667 174.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 38' ' ' LEU . 6.6 mp -78.05 -18.39 55.88 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.377 -0.374 . . . . 53.22 110.757 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.26 22.89 38.72 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.797 -0.638 . . . . 71.31 113.548 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -93.04 -22.02 19.39 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.877 0.37 . . . . 53.5 110.103 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.97 -11.88 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.918 -0.583 . . . . 51.44 110.905 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -71.75 -24.34 61.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.182 0.515 . . . . 70.14 109.94 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.6 81.96 0.96 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.214 -0.754 . . . . 34.11 111.214 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -130.44 137.04 49.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.262 0.553 . . . . 64.02 111.006 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 56' ' ' LEU . 16.3 m-20 -134.4 160.41 38.06 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.103 -1.443 . . . . 63.12 107.103 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.9 t -149.12 123.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.506 . . . . 52.24 109.635 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.688 -0.486 . . . . 71.02 109.688 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' HA ' HG23 ' A' ' 53' ' ' THR . 7.0 p-10 -88.78 136.66 32.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.92 0.39 . . . . 72.45 110.086 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.96 134.55 4.75 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.482 -1.047 . . . . 54.43 110.482 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -25.58 67.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.098 0.475 . . . . 75.43 110.654 -177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.35 -34.15 65.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.578 -0.737 . . . . 74.22 109.77 176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.48 124.27 0.77 Allowed Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.683 -0.689 . . . . 72.11 111.608 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 48' ' ' ASP . 26.1 m -77.62 117.32 18.93 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.248 -0.279 . . . . 65.02 110.248 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG22 ' HB2' ' A' ' 88' ' ' ASP . 43.7 t -108.2 123.68 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 120.905 0.383 . . . . 71.34 110.912 -176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HB2' HG11 ' A' ' 86' ' ' VAL . . . -94.76 122.42 37.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.108 -0.496 . . . . 71.31 110.269 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 12.2 mt -97.29 102.01 13.69 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.655 -0.498 . . . . 74.33 109.655 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' A' ' 59' ' ' MET . 59.2 mt -108.65 125.15 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 122.092 0.157 . . . . 55.15 110.69 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.11 118.98 25.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.849 0.357 . . . . 75.13 110.099 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.419 ' HG3' HG22 ' A' ' 57' ' ' ILE . 72.0 mtp -140.87 170.87 14.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.383 0.611 . . . . 53.14 111.01 -177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -157.03 177.47 11.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.973 -1.012 . . . . 65.03 108.907 173.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -108.57 163.11 13.53 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.29 -0.633 . . . . 70.34 109.29 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -47.46 -57.48 5.3 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.484 0.49 . . . . 73.4 112.008 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -96.88 -13.59 22.38 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.385 -0.37 . . . . 63.01 111.024 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.39 8.84 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.89 0.7 . . . . 53.21 112.89 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.81 9.61 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.05 0.453 . . . . 53.23 110.486 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.3 t -119.92 124.47 27.87 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.865 -0.607 . . . . 32.03 109.786 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.17 83.16 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.682 2.254 . . . . 73.34 112.087 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 tp -107.05 8.2 30.17 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.678 0.752 . . . . 64.41 108.997 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.675 ' HA ' HG12 ' A' ' 72' ' ' ILE . 10.1 t -63.7 -39.72 95.01 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.303 -0.862 . . . . 63.42 111.341 -174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.8 -44.71 74.02 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 64.34 110.198 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.46 -51.93 52.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.436 -0.802 . . . . 64.32 110.795 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.675 HG12 ' HA ' ' A' ' 69' ' ' THR . 27.0 pt -62.55 -33.73 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 120.697 -0.401 . . . . 72.23 111.075 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' A' ' 91' ' ' ILE . 43.8 mt-10 -68.0 -44.17 77.19 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 116.457 -0.338 . . . . 70.25 110.225 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.88 -44.24 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.362 -0.381 . . . . 73.04 110.425 -177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -65.06 -46.2 82.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.331 -0.395 . . . . 75.54 110.72 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -58.91 -53.81 54.18 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.066 -0.516 . . . . 52.14 109.944 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 ttp85 -54.87 -44.11 73.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.625 -0.716 . . . . 73.04 110.395 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.5 t -53.32 -53.65 47.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.815 -0.63 . . . . 71.12 111.159 -174.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.22 -52.49 10.78 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.55 -0.46 . . . . 74.43 111.462 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 86' ' ' VAL . 92.1 mt -60.14 -41.09 91.96 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.05 0.452 . . . . 74.12 111.227 -169.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.04 -27.42 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 74.04 110.188 178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.21 -45.71 18.57 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.688 -0.768 . . . . 63.23 111.776 -171.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.4 m -82.89 2.87 32.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.41 . . . . 61.33 110.659 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.76 35.91 90.41 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.013 -0.539 . . . . 74.34 112.811 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD12 HD23 ' A' ' 80' ' ' LEU . 84.0 mt -76.57 -43.65 38.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.555 -0.535 . . . . 51.32 109.555 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 55' ' ' ALA . 27.2 m -144.29 169.32 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.367 -0.833 . . . . 72.33 109.387 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -91.71 -48.0 7.06 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.961 0.41 . . . . 64.04 110.447 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' HB2' HG22 ' A' ' 54' ' ' VAL . 18.6 m-20 -131.38 151.12 51.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.059 -0.519 . . . . 51.35 110.687 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.1 pt -113.96 151.64 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.633 -0.712 . . . . 71.42 110.447 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.766 ' HG2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -137.98 106.64 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.207 -1.034 . . . . 70.34 108.207 177.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.484 HD12 ' HG2' ' A' ' 73' ' ' GLU . 47.7 mt -95.94 114.33 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 73.33 110.373 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 102' ' ' ASP . 3.4 t30 -88.68 102.85 15.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.576 -0.738 . . . . 72.31 109.093 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' MET . 4.3 m-90 -82.34 106.87 14.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.501 -0.318 . . . . 73.45 110.585 -176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.1 t -86.9 123.56 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.387 -0.597 . . . . 64.44 109.387 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -122.08 -17.62 7.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.047 0.451 . . . . 73.03 110.18 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.525 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 28.0 t-20 173.86 -47.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.186 -0.915 . . . . 72.0 109.449 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 96' ' ' ASN . 41.3 Cg_endo -68.08 140.12 48.72 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.629 1.553 . . . . 61.3 110.123 168.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.55 -92.49 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.203 1.935 . . . . 73.11 112.482 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m-90 -146.09 163.12 36.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.962 -0.384 . . . . 71.52 109.962 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.44 -127.17 1.58 Allowed Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.72 -0.552 . . . . 71.42 111.72 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.64 -17.73 56.1 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.627 2.218 . . . . 55.2 111.685 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB2' ' OD1' ' A' ' 92' ' ' ASN . 4.0 m-20 -63.96 -11.1 25.47 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.577 -0.738 . . . . 62.24 110.978 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 71.9 mmtt -76.69 0.71 19.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.431 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.99 139.01 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.674 -0.491 . . . . 73.51 109.674 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.766 HG23 ' HG2' ' A' ' 90' ' ' ARG . 19.7 p -70.29 151.19 45.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.983 0.42 . . . . 72.22 111.09 178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.02 -36.23 78.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.741 -0.837 . . . . 64.12 108.741 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -57.01 -53.13 61.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.547 -1.206 . . . . 70.24 110.537 175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -62.78 -34.12 88.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.818 -0.628 . . . . 63.13 112.513 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -73.58 -34.94 65.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.124 0.487 . . . . 74.41 110.711 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.95 -48.36 66.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.556 -0.747 . . . . 71.11 110.138 -177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -95.33 79.36 3.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 73.44 111.072 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.7 mt -128.36 -166.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.286 -0.87 . . . . 75.31 109.779 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -55.53 -29.96 59.85 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 111.879 0.326 . . . . 71.25 111.879 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.93 67.84 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.92 0.391 . . . . 64.54 111.065 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.06 -24.39 60.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 64.45 110.007 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.64 -161.51 51.42 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.977 -0.556 . . . . 70.35 112.416 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.5 94.82 2.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.766 0.317 . . . . 75.55 110.308 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -69.05 -19.23 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.324 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.237 -0.887 . . . . 74.31 109.054 176.572 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.139 -0.384 . . . . 64.53 112.139 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.45 158.8 40.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.625 2.217 . . . . 74.23 111.913 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.9 -44.29 0.83 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.753 -0.539 . . . . 61.13 111.753 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 m -101.14 133.84 45.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.071 -0.344 . . . . 72.21 110.071 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.794 ' HG3' ' H ' ' A' ' 7' ' ' GLU . 21.7 ptp -89.03 -166.34 1.57 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 75.01 110.36 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 m -102.25 22.78 12.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.815 -0.439 . . . . 74.51 109.815 176.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.794 ' H ' ' HG3' ' A' ' 5' ' ' MET . 4.3 mm-40 54.07 92.77 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.332 -0.849 . . . . 64.31 110.757 -173.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.0 p -66.35 95.54 0.31 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.516 -0.765 . . . . 74.52 112.11 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.8 t -164.61 154.78 14.15 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.949 -0.76 . . . . 74.31 108.949 174.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . 65.03 164.14 0.12 Allowed Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 123.24 0.338 . . . . 42.44 111.336 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 30.1 Cg_endo -64.28 143.52 83.55 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.366 2.044 . . . . 70.21 111.707 175.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -38.75 58.57 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.644 0.609 . . . . 75.4 112.644 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -55.01 -50.24 69.53 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.411 0.624 . . . . 64.11 110.843 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.34 -40.42 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.539 -0.755 . . . . 53.11 110.187 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -54.97 -53.75 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.763 -0.653 . . . . 72.23 111.367 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.09 -48.87 78.83 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.952 0.406 . . . . 70.35 110.951 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.69 -46.89 65.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.059 -0.519 . . . . 45.21 110.714 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -64.09 -45.0 90.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.495 -0.775 . . . . 74.1 110.419 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' O ' ' HG2' ' A' ' 23' ' ' MET . 6.1 p -67.3 -38.02 80.14 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 N-CA-C 109.946 -0.39 . . . . 54.0 109.946 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -54.71 -43.19 72.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.008 0.433 . . . . 73.44 110.079 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 43.9 mt-10 -72.36 -43.36 64.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 71.33 111.067 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.11 -33.82 73.98 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.416 0.627 . . . . 60.2 110.751 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 19' ' ' VAL . 21.7 mmt -63.11 -13.63 38.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.425 -0.807 . . . . 75.01 111.213 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 40.3 ttt180 -74.8 -24.17 58.61 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.739 0.304 . . . . 74.35 111.15 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.14 -23.56 9.43 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.672 0.749 . . . . 74.11 109.911 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 26' ' ' VAL . 60.5 t -95.08 26.82 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.728 -1.123 . . . . 74.53 110.23 -178.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 2.8 p -150.08 169.23 2.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -103.2 100.22 17.02 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 110.012 -0.366 . . . . 72.22 110.012 174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' VAL . 97.1 Cg_endo -88.93 -3.75 6.22 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.758 2.306 . . . . 54.45 111.827 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.1 -57.75 5.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.05 0.452 . . . . 71.31 110.642 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -105.1 -17.49 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 73.01 109.994 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.19 52.62 1.71 Allowed Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.746 -0.661 . . . . 22.32 112.999 175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -109.67 142.66 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.116 0.484 . . . . 72.3 109.902 177.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 37' ' ' ASP . 6.0 p30 -120.16 112.6 19.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.46 -0.791 . . . . 72.22 109.347 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 38' ' ' LEU . 35.8 m -55.22 -30.05 24.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.544 -0.753 . . . . 54.24 112.086 -173.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.84 -31.5 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 74.23 111.377 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.504 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t70 -67.3 -19.56 65.5 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.462 -0.335 . . . . 65.35 111.351 -176.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 35' ' ' VAL . 3.8 mm? -72.85 -17.5 61.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.084 0.469 . . . . 74.05 109.992 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 22.86 65.39 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.549 -0.751 . . . . 65.0 113.362 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.3 tp -97.99 -20.14 17.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.14 0.495 . . . . 72.34 110.011 173.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG12 HD23 ' A' ' 44' ' ' LEU . 42.1 t -59.27 -9.62 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.695 -0.684 . . . . 71.43 111.422 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -70.18 -7.24 40.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.059 0.457 . . . . 71.24 110.0 178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 58' ' ' ASP . . . -81.52 18.96 9.62 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.524 -0.762 . . . . 42.12 112.249 175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 HG12 ' A' ' 41' ' ' VAL . 4.6 pp -89.16 129.8 35.7 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.939 -0.763 . . . . 70.42 108.939 171.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -161.59 113.29 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.75 -0.463 . . . . 72.32 109.75 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 4.1 p -93.02 116.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.178 0.513 . . . . 71.51 110.782 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.54 128.25 56.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.785 -0.643 . . . . 74.23 109.606 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.637 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 2.1 p-10 -101.66 161.06 13.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.124 0.488 . . . . 72.24 110.651 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.54 -175.03 32.12 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.641 -0.984 . . . . 72.3 110.641 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.4 -35.48 71.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.271 0.558 . . . . 75.34 109.916 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.98 -18.17 63.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.157 -0.928 . . . . 73.24 110.584 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.64 172.37 18.41 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 116.208 -0.451 . . . . 71.24 112.527 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 29.1 m -105.85 111.03 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.461 -0.57 . . . . 63.03 109.461 176.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.3 t -112.26 133.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.671 0.272 . . . . 53.25 111.095 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . . . -97.82 106.52 18.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.29 -0.414 . . . . 75.21 110.431 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 46.1 mt -75.61 141.0 42.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 73.22 109.707 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG22 ' HG3' ' A' ' 59' ' ' MET . 60.6 mt -144.64 113.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 110.148 -0.315 . . . . 74.45 110.148 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.434 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 30.7 m-20 -86.95 128.72 35.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.654 -0.248 . . . . 74.11 110.463 177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' HG22 ' A' ' 57' ' ' ILE . 87.4 mtp -140.9 170.51 15.61 Favored 'General case' 0 C--O 1.251 1.157 0 CA-C-O 122.261 1.029 . . . . 63.03 113.051 -174.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 94' ' ' VAL . 19.9 p -149.51 172.74 14.49 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 113.294 -1.775 . . . . 72.52 109.089 177.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -115.26 145.3 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.685 -1.228 . . . . 63.33 107.685 164.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.8 p -59.69 -48.43 81.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 74.13 111.021 -177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.6 t -67.99 -38.64 82.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.394 -0.821 . . . . 75.32 111.335 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.71 8.16 2.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.102 -0.954 . . . . 70.21 111.361 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.08 -36.0 3.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.215 0.531 . . . . 54.51 109.887 174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.9 116.18 53.11 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 115.643 -0.708 . . . . 75.25 110.039 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.94 77.38 3.32 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.812 2.341 . . . . 74.15 113.577 -173.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.85 7.27 31.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.26 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 70' ' ' ASP . 4.2 t -50.35 -60.21 3.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.569 -0.741 . . . . 73.23 112.113 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' H ' HG23 ' A' ' 69' ' ' THR . 10.9 t70 -58.92 -35.83 73.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.139 0.495 . . . . 74.02 110.335 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.9 t -65.32 -53.29 41.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.547 -0.751 . . . . 62.23 110.857 -175.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.581 HG12 ' HH2' ' A' ' 93' ' ' TRP . 1.8 pp -69.12 -36.63 74.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.428 -0.351 . . . . 71.54 110.246 -175.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -63.37 -45.81 89.41 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 74.51 110.603 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.52 -42.91 86.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 65.04 110.921 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 56.5 mt-30 -59.57 -54.05 50.99 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.11 0.481 . . . . 61.43 110.671 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -59.52 -53.98 51.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.579 -0.737 . . . . 62.34 110.603 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -55.05 -51.2 67.07 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.114 -0.494 . . . . 75.41 111.326 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.7 t -53.29 -51.76 61.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.077 -0.51 . . . . 44.32 111.01 -175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.06 -52.0 14.05 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.517 -0.473 . . . . 51.52 111.334 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.79 -39.46 85.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.761 0.315 . . . . 74.34 111.116 -172.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.07 -27.83 14.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.155 -0.475 . . . . 74.12 110.361 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.14 -33.15 33.42 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.857 -0.687 . . . . 64.41 112.194 -172.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB2' HD13 ' A' ' 85' ' ' LEU . 15.0 m -95.97 -0.17 51.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 43.14 110.962 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.56 29.86 67.31 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.353 -0.451 . . . . 61.51 113.488 175.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 83' ' ' SER . 9.4 mp -79.8 -8.14 59.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.11 0.481 . . . . 72.4 110.233 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 88' ' ' ASP . 9.9 p -164.02 161.07 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.601 -0.727 . . . . 74.14 109.332 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.18 -19.68 58.22 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.847 -0.427 . . . . 75.23 109.847 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 86' ' ' VAL . 15.8 t0 174.85 150.89 0.1 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.181 -0.463 . . . . 74.22 110.352 -170.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.404 ' O ' ' NH1' ' A' ' 90' ' ' ARG . 18.6 pt -116.4 152.28 18.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 61.32 110.335 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 103' ' ' LYS . 2.4 tpp180 -133.35 106.15 7.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.145 -0.687 . . . . 63.3 109.145 175.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.24 143.55 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.349 -0.387 . . . . 61.12 110.227 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -119.54 143.45 47.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.286 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.581 ' HH2' HG12 ' A' ' 72' ' ' ILE . 70.6 m95 -110.96 106.41 15.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.196 -0.456 . . . . 75.11 110.102 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 60' ' ' THR . 31.5 m -100.09 123.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.009 -0.676 . . . . 44.33 110.788 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -109.14 -35.37 6.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 64.5 110.023 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.643 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 3.1 t-20 -171.21 -47.72 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.116 -0.947 . . . . 53.1 110.746 -173.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' A' ' 96' ' ' ASN . 53.1 Cg_endo -68.02 158.05 59.12 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 121.929 1.752 . . . . 55.41 112.213 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.87 175.0 6.9 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.963 2.442 . . . . 72.35 111.756 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 103' ' ' LYS . 25.0 m0 -75.57 123.4 25.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.64 -0.254 . . . . 72.13 110.477 -176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.66 -123.02 1.11 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.384 -0.436 . . . . 72.24 112.428 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.24 -19.28 38.8 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.688 2.258 . . . . 43.54 111.452 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -17.03 16.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.035 -0.984 . . . . 63.03 111.713 177.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 90' ' ' ARG . 29.1 mtpp -76.62 -8.13 56.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.687 0.279 . . . . 74.0 111.034 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.9 mt -80.67 115.84 23.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.639 0.256 . . . . 75.52 110.53 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.7 p -75.53 172.17 13.01 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.451 -0.34 . . . . 73.25 111.196 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -59.11 -20.45 53.68 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 72.51 110.998 176.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -56.52 -52.98 62.71 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.861 0.362 . . . . 65.41 110.382 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.57 -37.37 17.31 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.099 -0.572 . . . . 71.22 112.35 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.523 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 51.7 ttt180 -62.5 -47.73 82.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.559 0.577 . . . . 75.53 112.559 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -70.43 -6.71 37.77 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.979 1.103 . . . . 73.43 113.979 -167.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -86.4 -14.42 43.42 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.868 0.366 . . . . 75.34 111.073 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -76.72 -80.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.866 -0.606 . . . . 71.13 111.721 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -64.99 -29.56 70.49 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.821 -0.627 . . . . 73.11 110.44 -174.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.36 -12.01 59.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.669 -0.696 . . . . 71.22 111.388 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.6 tp -75.67 -34.82 60.49 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.077 0.465 . . . . 63.24 109.996 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.57 -44.57 4.87 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.327 -0.709 . . . . 71.04 111.327 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -83.17 90.13 7.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.108 -0.701 . . . . 74.23 109.108 175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.2 p -74.76 134.04 41.9 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.86 -0.609 . . . . 65.14 111.84 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-N 115.539 -0.755 . . . . 61.42 109.613 177.895 . . . . . . . . 0 0 . 1 stop_ save_